|
Clicking on the hetero component identifier generates an image. The structural information is taken from the first listed PDB/NDB entry. In addition, all hetero components can be visualized interactively (RasMol/Chime/VRML) on the JenaLib atlas pages. |
|---|
6190 entries selected from PDBlist WHERE class LIKE 'nuc'
Code Class Resolution Description
Code Class Resolution Description 2lg0 nuc NMR (6S,7S,8S,10R)-4-AMINO-8-HYDROXY-7,8,9,10-TETRAHYDRO- 6H-7,10-EPOXYAZEPINO[1,2-E]PURIN-6-YL DIHYDROGEN PHOSPHATE C10 H12 N5 O6 P STRUCTURE OF THE DUPLEX CONTAINING (5'S)-8,5'-CYCLO-2'-DEOXY DNA (5'-D(*GP*TP*GP*CP*(02I)P*TP*GP*TP*TP*TP*GP*T CHAIN: A, DNA (5'-D(*AP*CP*AP*AP*AP*CP*AP*TP*GP*CP*AP*C)-3' CHAIN: B DNA (5'S)-8,5'-CYCLO-2'-DEOXYADENOSINE, CYCLOPURINE, CYCLO-DA, D 2lsf nuc NMR (6S,7S,8S,10R)-4-AMINO-8-HYDROXY-7,8,9,10-TETRAHYDRO- 6H-7,10-EPOXYAZEPINO[1,2-E]PURIN-6-YL DIHYDROGEN PHOSPHATE C10 H12 N5 O6 P STRUCTURE AND STABILITY OF DUPLEX DNA CONTAINING (5'S) 5',8- DEOXYADENOSINE: AN OXIDATIVE LESION REPAIR BY NER DNA (5'-D(*CP*GP*TP*AP*CP*(02I)P*CP*AP*TP*GP*C)-3 CHAIN: B, DNA (5'-D(*GP*CP*AP*TP*GP*TP*GP*TP*AP*CP*G)-3') DNA NER, DNA
Code Class Resolution Description 1fv7 nuc NMR 2'-DEOXY-L-RIBO-FURANOSYL CYTOSINE-5'-MONOPHOSPHATE 2(C9 H14 N3 O7 P) A TWO B-Z JUNCTION CONTAINING DNA RESOLVES INTO AN ALL RIGHT DOUBLE HELIX 5'-D(*(5CM)P*GP*(5CM)P*GP*(0DC)P*(0DG)P*(5CM)P*GP P*G)-3' DNA DNA POLYMORPHISM, L ENANTIOMERY, ANTISENSE, DNA 1r4d nuc NMR 2'-DEOXY-L-RIBO-FURANOSYL CYTOSINE-5'-MONOPHOSPHATE 2(C9 H14 N3 O7 P) SOLUTION STRUCTURE OF THE CHIMERIC L/D DNA OLIGONUCLEOTIDE D(C8METGCGC(L)G(L)CGCG)2 5'-D(*CP*(8MG)P*CP*GP*(0DC)P*(0DG)P*CP*GP*CP*G)-3 CHAIN: A, B DNA DNA POLYMORPHISM, L ENANTIOMERY, ANTISENSE, HYBRID ZBZ DNA,
Code Class Resolution Description 1fv7 nuc NMR 2'-DEOXY-L-RIBO-FURANOSYL GUANINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O7 P) A TWO B-Z JUNCTION CONTAINING DNA RESOLVES INTO AN ALL RIGHT DOUBLE HELIX 5'-D(*(5CM)P*GP*(5CM)P*GP*(0DC)P*(0DG)P*(5CM)P*GP P*G)-3' DNA DNA POLYMORPHISM, L ENANTIOMERY, ANTISENSE, DNA 1r4d nuc NMR 2'-DEOXY-L-RIBO-FURANOSYL GUANINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O7 P) SOLUTION STRUCTURE OF THE CHIMERIC L/D DNA OLIGONUCLEOTIDE D(C8METGCGC(L)G(L)CGCG)2 5'-D(*CP*(8MG)P*CP*GP*(0DC)P*(0DG)P*CP*GP*CP*G)-3 CHAIN: A, B DNA DNA POLYMORPHISM, L ENANTIOMERY, ANTISENSE, HYBRID ZBZ DNA,
Code Class Resolution Description 1fv8 nuc NMR 2'-DEOXY-L-RIBO-FURANOSYL THYMIDINE-5'-MONOPHOSPHATE C10 H15 N2 O8 P NMR STUDY OF AN HETEROCHIRAL HAIRPIN 5'-D(*TP*AP*TP*CP*AP*(0DT)P*CP*GP*AP*TP*A)-3': AT(L)C HAIRPIN DNA HAIRPIN, HETEROCHIRAL LOOP, FLEXIBILTY, ANTISENSE DNA, DNA
Code Class Resolution Description
3uyh nuc 1.95 4,9-BIS{[3-(4-METHYLPIPERAZIN-1-YL)PROPYL]AMINO}-2,7- BIS[3-(MORPHOLIN-4-YL)PROPYL]BENZO[LMN][3, 8]PHENANTHROLINE-1,3,6,8(2H,7H)-TETRONE C44 H66 N10 O6 CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX BOUND BY THE NAPHTHALENE DIIMIDE COMPOUND, MM41 HUMAN TELOMERIC DNA SEQUENCE DNA INTRAMOLECULAR, LIGAND-COMPLEX, G-QUADRUPLEX, TELOMERE, DNA
4da3 nuc 2.40 4,9-BIS{[3-(4-METHYLPIPERAZIN-1-YL)PROPYL]AMINO}-2,7- BIS[3-(MORPHOLIN-4-YL)PROPYL]BENZO[LMN][3, 8]PHENANTHROLINE-1,3,6,8(2H,7H)-TETRONE C44 H66 N10 O6 CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX 21-MER BOUND BY THE NAPHTHALENE DIIMIDE COMPOUND DNA (5'- D(*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP 3') DNA INTRAMOLECULAR, LIGAND-COMPLEX, G-QUADRUPLEX, TELOMERE, DNA
Code Class Resolution Description 2lwk nuc NMR 6,7-DIMETHOXY-2-(PIPERAZIN-1-YL)QUINAZOLIN-4-AMINE C14 H19 N5 O2 SOLUTION STRUCTURE OF SMALL MOLECULE-INFLUENZA RNA COMPLEX RNA (32-MER) RNA DOUBLE HELIX, RNA, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL G CENTER FOR INFECTIOUS DISEASE, SSGCID
Code Class Resolution Description 4dkz nuc 1.80 [(1R,2S,4S,5S)-2-HYDROXY-4-(5-METHYL-2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)BICYCLO[3.1.0]HEX-1- YL]METHYL DIHYDROGEN PHOSPHATE 4(C12 H17 N2 O7 P) HAIRPIN STRUCTURE OF A DNA DODECAMER CONTAINING NORTH-METHAN DEOXYTHYMIDINE SYNTHETIC DNA DODECAMER CONTAING NORTH-METHANOCAR DEOXYTHYMIDINE (N-MCDT) DNA NORTH-METHANOCARBA-2'-DEOXYTHYMIDINE, N-MCDT, X-RAY CRYSTAL STRUCTURE, TETRA-LOOP HAIRPIN, C4'-EXO PUCKER, HAIRPIN DNA,
Code Class Resolution Description 4jd8 nuc 1.16 DELTA-RU(PHEN)2(DPPZ) COMPLEX C42 H26 N8 RU RACEMIC-[RU(PHEN)2(DPPZ)]2+] BOUND TO SYNTHETIC DNA AT HIGH DNA (5'-D(*AP*TP*GP*CP*AP*T)-3') DNA INTERCALATION, RACEMIC LIGAND-DNA, DNA 5jeu nuc 0.97 DELTA-RU(PHEN)2(DPPZ) COMPLEX 2(C42 H26 N8 RU) DEL-[RU(PHEN)2(DPPZ)]2+ BOUND TO D(TCGGCGCCGA) WITH BA2+ DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA, RUTHENIUM, LIGHT-SWITCH, SEMI-INTERCALATION 5jev nuc 0.99 DELTA-RU(PHEN)2(DPPZ) COMPLEX 2(C42 H26 N8 RU) DEL-[RU(PHEN)2(DPPZ]2+ BOUND TO D(TCGGCGCCGA) WITH COBALT HE DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA, RUTHENIUM, CROSS-LINKING, DNA PROBE
Code Class Resolution Description 1dj6 nuc 1.00 N,N'-BIS(2-AMINOETHYL)-1,2-ETHANEDIAMINE 2(C6 H18 N4) COMPLEX OF A Z-DNA HEXAMER, D(CG)3, WITH SYNTHETIC POLYAMINE AT ROOM TEMPERATURE 5'-D(*CP*GP*CP*GP*CP*G)-3' DNA Z-DNA:POLYAMINE COMPLEX, X-RAY CRYSTAL STRUCTURE, POLYAMINE BINDING IN MINOR GROOVE OF Z-DNA
Code Class Resolution Description
2oom nuc NMR 4-AMINO-1-{2,5-ANHYDRO-4-[(PHOSPHONOOXY)METHYL]-ALPHA- L-LYXOFURANOSYL}PYRIMIDIN-2(1H)-ONE C10 H14 N3 O8 P NMR STRUCTURE OF A KISSING COMPLEX FORMED BETWEEN THE TAR RNA ELEMENT OF HIV-1 AND A LNA/RNA APTAMER TAR RNA ELEMENT OF HIV-1, RNA 16-MER RNA LNA; LOCKED NUCLEIC ACID; NMR; APTAMER; TAR; HIV-1, RNA
2pn9 nuc NMR 4-AMINO-1-{2,5-ANHYDRO-4-[(PHOSPHONOOXY)METHYL]-ALPHA- L-LYXOFURANOSYL}PYRIMIDIN-2(1H)-ONE C10 H14 N3 O8 P NMR STRUCTURE OF A KISSING COMPLEX FORMED BETWEEN THE TAR RNA ELEMENT OF HIV-1 AND A LNA MODIFIED APTAMER 5'- R(*GP*GP*AP*GP*CP*CP*UP*GP*GP*GP*AP*GP*CP*UP*CP*C)-3', RNA 16-MER WITH LOCKED RESIDUES 9-10 RNA RNA; LNA; LOCKED NUCLEIC ACID; NMR; APTAMER; TAR; HIV-1; KISSING
Code Class Resolution Description 1i0g nuc 1.45 2'-O-FLUOROETHYL-5-METHYL-URIDINE-5'-MONOPHOSPHATE 2(C12 H18 F N2 O9 P) 1.45 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-FLUOROETHYL THYMINE IN PLACE OF T6, MEDIUM NA-SALT 5'-D(*GP*CP*GP*TP*AP*(125)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0m nuc 1.05 2'-O-FLUOROETHYL-5-METHYL-URIDINE-5'-MONOPHOSPHATE 2(C12 H18 F N2 O9 P) 1.05 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-FLUOROETHYL THYMINE IN PLACE OF T6, HIGH RB-SALT 5'-D(*GP*CP*GP*TP*AP*(125)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1y86 nuc 1.70 2'-O-FLUOROETHYL-5-METHYL-URIDINE-5'-MONOPHOSPHATE 2(C12 H18 F N2 O9 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (FLUORO)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(125)P*AP*CP*GP*C)-3' DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER
Code Class Resolution Description 1i0k nuc 1.05 2'-O-METHYL-[TRI(OXYETHYL)]-5-METHYL-URIDINE-5'- MONOPHOSPHATE 2(C17 H29 N2 O12 P) 1.05 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM CS-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0n nuc 1.30 2'-O-METHYL-[TRI(OXYETHYL)]-5-METHYL-URIDINE-5'- MONOPHOSPHATE 2(C17 H29 N2 O12 P) 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM RB-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0p nuc 1.30 2'-O-METHYL-[TRI(OXYETHYL)]-5-METHYL-URIDINE-5'- MONOPHOSPHATE 2(C17 H29 N2 O12 P) 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)], MEDIUM K-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0q nuc 1.30 2'-O-METHYL-[TRI(OXYETHYL)]-5-METHYL-URIDINE-5'- MONOPHOSPHATE 2(C17 H29 N2 O12 P) 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM NA-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 412d nuc 1.65 2'-O-METHYL-[TRI(OXYETHYL)]-5-METHYL-URIDINE-5'- MONOPHOSPHATE 2(C17 H29 N2 O12 P) DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O-METHYL- [TRI(OXYETHYL)] RIBONUCLEOSIDE DNA (5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3') DNA DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O-METHYL- [TRI(OXYETHYL)] RIBONUCLEOSIDE, DNA
Code Class Resolution Description 1i0f nuc 1.60 2'-O-AMINOOXY-ETHYL-5-METHYL-URIDINE-5'-MONOPHOSPHATE 2(C12 H20 N3 O10 P) 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-AMINOOXYETHYL THYMINE IN PLACE OF T6, BA-FORM 5'-D(*GP*CP*GP*TP*AP*(127)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA
Code Class Resolution Description 1fir nuc 3.30 2-METHYLTHIO-N6-(AMINOCARBONYL-L-THREONYL)-ADENOSINE- 5'-MONOPHOSPHATE C16 H23 N6 O11 P S CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 2l9e nuc NMR 2-METHYLTHIO-N6-(AMINOCARBONYL-L-THREONYL)-ADENOSINE- 5'-MONOPHOSPHATE C16 H23 N6 O11 P S SOLUTION STRUCTURE OF THE HUMAN ANTI-CODON STEM AND LOOP(HAS TRANSFER RNA LYSINE 3 (TRNALYS3) RNA (5'-R(*GP*CP*AP*GP*AP*CP*UP*(70U)P*UP*UP*(12A P*AP*UP*CP*UP*GP*C)-3') RNA RNA
Code Class Resolution Description 2f8w nuc 1.20 1,3-DIAMINOPROPANE C3 H10 N2 CRYSTAL STRUCTURE OF D(CACGTG)2 5'-D(*CP*AP*CP*GP*TP*G)-3' DNA D(CACGTG), POLYAMINE, Z-DNA, 1,3-PROPANEDIAMINE
Code Class Resolution Description 2lzk nuc NMR (11S,12S,13S)-11,12,13,14-TETRAHYDRONAPHTHO[1,2,3,4- PQR]TETRAPHENE-11,12,13-TRIOL C24 H18 O3 NMR SOLUTION STRUCTURE OF AN N2-GUANINE DNA ADDUCT DERIVED F POTENT TUMORIGEN DIBENZO[A,L]PYRENE: INTERCALATION FROM THE GROOVE WITH RUPTURED WATSON-CRICK BASE PAIRING DNA (5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3'), DNA (5'-D(*CP*CP*AP*TP*CP*GP*CP*TP*AP*CP*C)-3') DNA 14R (+)-TRANS-ANTI-DB[A,L]P-N2-DG, DNA ADDUCT, DNA
Code Class Resolution Description
2gxc nuc model 2,4-BIS{[4-(N-CYCLOPENTYLDIAMINOMETHYL)PHENYL]}FURAN C28 H36 N4 O MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 2,4-BIS{[4-(N-CYCLOPENTYLDIAMINOMETHYL)PHENYL]}FURAN. DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, FURAN DERIVATIVE
Code Class Resolution Description 1d76 nuc 1.30 2,6-DIAMINOPURINE NUCLEOTIDE 2(C10 H15 N6 O6 P) CRYSTAL AND MOLECULAR STRUCTURE OF A DNA FRAGMENT CONTAINING A 2-AMINO ADENINE MODIFICATION: THE RELATIONSHIP BETWEEN CONFORMATION, PACKING, AND HYDRATION IN Z-DNA HEXAMERS DNA (5'-D(*CP*GP*UP*(1AP)P*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1s1k nuc 1.90 2,6-DIAMINOPURINE NUCLEOTIDE C10 H15 N6 O6 P INFLUENCE OF GROOVE INTERACTIONS ON DNA HOLLIDAY JUNCTION FORMATION 5'-D(*CP*CP*(1AP)P*GP*TP*AP*CP*TP*GP*G)-3' DNA B-DNA, DOUBLE HELIX, 2, 6-DIAMINOPURINE, MINOR GROOVE INTERACTIONS 1vty nuc 1.30 2,6-DIAMINOPURINE NUCLEOTIDE 2(C10 H15 N6 O6 P) CRYSTAL STRUCTURE OF A Z-DNA FRAGMENT CONTAINING THYMINE/2- AMINOADENINE BASE PAIRS DNA (5'-D(*CP*(NH2)AP*CP*GP*TP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, DNA 210d nuc 1.35 2,6-DIAMINOPURINE NUCLEOTIDE C10 H15 N6 O6 P CRYSTAL AND MOLECULAR STRUCTURE OF A NEW Z-DNA CRYSTAL FORM: D[CGT(2-NH2-A)CG] AND ITS PLATINATED DERIVATIVE DNA (5'-D(*CP*GP*TP*(1AP)P*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 211d nuc 1.60 2,6-DIAMINOPURINE NUCLEOTIDE C10 H15 N6 O6 P THE CRYSTAL AND MOLECULAR STRUCTURE OF A NEW Z-DNA CRYSTAL FORM: D[CGT(2-NH2-A) CG] AND ITS PLATINATED DERIVATIVE DNA (5'-D(*CP*GP*TP*(1AP)P*CP*(PT(NH3)3)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED
Code Class Resolution Description 4pwm nuc 1.95 5-CARBOXY-2'-DEOXYCYTIDINE MONOPHOSPHATE 2(C10 H14 N3 O9 P) CRYSTAL STRUCTURE OF DICKERSON DREW DODECAMER WITH 5-CARBOXY 5'-[CGCGAATT(5CC)GCG]-3' DNA DNA CRYSTAL STRUCTURE, DICKERSON DREW DODECAMER, 5-CARBOXYCY 5-CARBOXYCYTOSINE, DNA
Code Class Resolution Description 2lyg nuc NMR 2-HYDROXYETHYL 6-DEOXY-BETA-L-GALACTOPYRANOSIDE C8 H16 O6 FUC_TBA DNA (5'-D(P*GP*GP*TP*TP*GP*GP*TP*GP*TP*GP*GP*TP*T 3') DNA CARBOHYDRATE-DNA INTERACTION, G-QUADRUPLEX STRUCTURE, DNA
Code Class Resolution Description 3i2q nuc 2.90 N1-DEAZA-ADENOSINE-5'-MONOPHOSPHATE C11 H15 N4 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH 2'OME SUBSTRA AND N1-DEAZAADENOSINE AT POSITION A9 DNA/RNA (30-MER), 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2r nuc 2.80 N1-DEAZA-ADENOSINE-5'-MONOPHOSPHATE C11 H15 N4 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE WITH N1-DEAZAADENOSINE AT POSITION A9 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2s nuc 2.75 N1-DEAZA-ADENOSINE-5'-MONOPHOSPHATE C11 H15 N4 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2'OME SUBST N1-DEAZAADENOSINE AT POSITION A10 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', DNA/RNA (30-MER) RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2u nuc 2.80 N1-DEAZA-ADENOSINE-5'-MONOPHOSPHATE C11 H15 N4 O7 P CRYSTAL STRUCTURE OF THE HAIPRIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE AND N1-DEAZAADENOSINE AT POSITION A10 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA
Code Class Resolution Description 1d83 nuc NMR 4-O-METHYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 2(C7 H14 O4) STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION DNA (5'-D(*AP*AP*GP*GP*CP*CP*TP*T)-3') DNA DNA, NMR, DOUBLE HELIX, CHROMOMYCIN 1ekh nuc NMR 4-O-METHYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 2(C7 H14 O4) NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND CO DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1eki nuc NMR 4-O-METHYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 2(C7 H14 O4) AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMY COBALT DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1vaq nuc 2.00 4-O-METHYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 4(C7 H14 O4) CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA) 2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION 5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3' DNA CHROMOMYCIN A3, X-RAY DIFFRACTION, MAD, DNA DUPLEX, GGCC SITE, DNA KINK, CD SPECTRA 5erz nuc 1.75 4-O-METHYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 2(C7 H14 O4) CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX 5es0 nuc 2.10 4-O-METHYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 2(C7 H14 O4) CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX
Code Class Resolution Description 1c2w nuc 7.50 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) 23S RRNA STRUCTURE FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP ANGSTROMS RESOLUTION 23S RIBOSOMAL RNA RIBOSOME 23S RRNA, RIBOSOME, LARGE RIBOSOMAL SUBUNIT, ATOMIC PROTEIN BIOSYNTHESIS, RIBONUCLEIC ACID, EM-RECONSTRUCTION, 3D ARRAN FITTING 1ehz nuc 1.93 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 5(C11 H16 N5 O7 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1fir nuc 3.30 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 1ipl nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1ipx nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H18 N5 O7 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID TRNA-TRNA INTERACTION 1ipz nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H18 N5 O7 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE TRNA-TRNA INTERACTION 1k7n nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H18 N5 O7 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1nrt nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 3(C11 H18 N5 O7 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1q49 nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O7 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1yfg nuc 3.00 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2z9q nuc 11.70 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 486d nuc 7.50 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4wcp nuc 2.40 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 3(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408ME1A-MUTANT RIBOSOMA SITE RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*(1MA) P*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA RIBOSOME, RNA, AMINOGLYCOSIDE, ANTIBIOTIC-RESISTANCE 4wcq nuc 2.10 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408ME1A-MUTANT RIBOSOMA SITE IN COMPLEX WITH GENETICIN RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*(1MA) P*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA RIBOSOME, RNA, AMINOGLYCOSIDE, ANTIBIOTIC-RESISTANCE 4wcr nuc 3.50 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408ME1A-MUTANT RIBOSOMA SITE IN COMPLEX WITH PAROMOMYCIN RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*(1MA) P*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA RIBOSOME, RNA, AMINOGLYCOSIDE, ANTIBIOTIC-RESISTANCE 4wcs nuc 3.10 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408ME1A-MUTANT RIBOSOMA SITE IN THE PRESENCE OF GENTAMICIN RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*(1MA) P*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA RIBOSOME, RNA, AMINOGLYCOSIDE, ANTIBIOTIC-RESISTANCE 6tna nuc 2.70 6-HYDRO-1-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1luu nuc NMR 1N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 4 MODIFICATIONS (OMC32 OMG34 1MG37 5MC40) 5'-R(*CP*CP*AP*GP*AP*(OMC)P*UP*(OMG) P*AP*AP*(1MG)P*AP*UP*(5MC)P*UP*GP*G)-3' RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, 1MG, 2'-O-METHYL, 5MC 1vtq nuc 3.00 1N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P THREE-DIMENSIONAL STRUCTURE OF YEAST T-RNA-ASP. I. STRUCTURE DETERMINATION TRNAASP RNA T-RNA, SINGLE STRAND, LOOPS, RNA 1yfg nuc 3.00 1N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2tra nuc 3.00 1N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 3tra nuc 3.00 1N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPARTIC ACID AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 486d nuc 7.50 1N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME
Code Class Resolution Description 3i5l nuc 1.18 (22R,51R)-22,51-DIAMINO-5,11,17,28,34,40,46,57- OCTAMETHYL-2,5,8,11,14,17,20,25,28,31,34,37,40,43,46, 49,54,57,60,61,64,65-DOCOSAAZANONACYCLO[54.2.1.1~4, 7~.1~10,13~.1~16,19~.1~27,30~.1~33,36~.1~39,42~.1~45, 48~]HEXAHEXACONTA-1(58),4(66),6,10(65),12,16(64 C52 H60 N24 O10 ALLOSTERIC MODULATION OF DNA BY SMALL MOLECULES 5'-D(*CP*CP*AP*GP*GP*(C38)P*CP*TP*GP*G)-3' DNA CYCLIC POLYAMIDE, DNA BINDER, MINOR GROOVE BINDER, PYIM POLYAMIDE
Code Class Resolution Description 3omj nuc 0.95 (23R,52R)-23,52-DIAMINO-5,11,17,28,34,40,46,57- OCTAMETHYL-2,5,8,11,14,17,20,25,28,31,34,37,40,43,46, 49,54,57,60,64-ICOSAAZANONACYCLO[54.2.1.1~4,7~.1~10, 13~.1~16,19~.1~27,30~.1~33,36~.1~39,42~.1~45, 48~]HEXAHEXACONTA-1(58),4(66),6,10(65),12,16(64),18, 2 C54 H62 N22 O10 STRUCTURAL BASIS FOR CYCLIC PY-IM POLYAMIDE ALLOSTERIC INHIB NUCLEAR RECEPTOR BINDING 5'-D(*CP*(C38)P*AP*GP*TP*AP*CP*TP*GP*G)-3' DNA CYCLIC PY-IM POLYAMIDE, DNA
Code Class Resolution Description 3dil nuc 1.90 PENTAETHYLENE GLYCOL 3(C10 H22 O6) CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dim nuc 2.90 PENTAETHYLENE GLYCOL C10 H22 O6 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, CS+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dio nuc 2.40 PENTAETHYLENE GLYCOL C10 H22 O6 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO LYSINE, IRIDIUM HEXAMINE SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diq nuc 2.70 PENTAETHYLENE GLYCOL C10 H22 O6 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO HOMOARGININE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA
Code Class Resolution Description 1pg9 nuc NMR CYCLOHEXANE-1(R),2(R)-DIAMINE-PLATINUM(II) C6 H14 N2 PT 2+ NMR SOLUTION STRUCTURE OF AN OXALIPLATIN 1,2-D(GG) INTRASTRAND CROSS-LINK IN A DNA DODECAMER DUPLEX 5'-D(*GP*GP*AP*GP*GP*CP*CP*TP*GP*AP*GP*G)-3', 5'-D(*CP*CP*TP*CP*AP*GP*GP*CP*CP*TP*CP*C)-3' DNA DEOXYRIBONUCLEIC ACID; OXALIPLATIN; DNA; DUPLEX; DODECAMER; NMR 1pgc nuc NMR CYCLOHEXANE-1(R),2(R)-DIAMINE-PLATINUM(II) C6 H14 N2 PT 2+ NMR SOLUTION STRUCTURE OF AN OXALIPLATIN 1,2-D(GG) INTRASTRAND CROSS-LINK IN A DNA DODECAMER DUPLEX 5'-D(*CP*CP*TP*CP*AP*GP*GP*CP*CP*TP*CP*C)-3', 5'-D(*GP*GP*AP*GP*GP*CP*CP*TP*GP*AP*GP*G)-3' DNA DEOXYRIBONUCLEIC ACID; OXALIPLATIN; DNA; DUPLEX; DODECAMER; NMR 2k0t nuc NMR CYCLOHEXANE-1(R),2(R)-DIAMINE-PLATINUM(II) C6 H14 N2 PT 2+ HIGH RESOLUTION SOLUTION NMR STRUCTURES OF OXALIPLATIN-DNA A DNA (5'-D(*DCP*DCP*DTP*DCP*DTP*DGP*DGP*DTP*DCP*DT 3'), DNA (5'-D(*DGP*DGP*DAP*DGP*DAP*DCP*DCP*DAP*DGP*DA 3') DNA OXALIPLATIN-DNA ADDUCT, DNA 2k0u nuc NMR CYCLOHEXANE-1(R),2(R)-DIAMINE-PLATINUM(II) C6 H14 N2 PT 2+ HIGH RESOLUTION SOLUTION NMR STRUCTURES OF OXALIPLATIN-DNA A DNA (5'-D(*DGP*DGP*DAP*DGP*DAP*DCP*DCP*DAP*DGP*DA 3'), DNA (5'-D(*DCP*DCP*DTP*DCP*DTP*DGP*DGP*DTP*DCP*DT 3') DNA OXALIPLATIN-DNA ADDUCT, DNA
Code Class Resolution Description 2gxv nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,2-BIS[5-(2-AMIDINO)-2-BENZIMIDAZOLYL]ETHENE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 364d nuc 3.00 5'-O-THIOPHOSPHONOCYTIDINE C9 H14 N3 O7 P S 3.0 A STRUCTURE OF FRAGMENT I FROM E. COLI 5S RRNA RNA (5'-R(*UP*GP*)-D(*(1SC)P*)- R(*CP*UP*GP*GP*CP*GP*GP*C)-3'), RNA (5'- R(*CP*CP*CP*CP*AP*UP*GP*CP*GP*AP*GP*AP*GP*UP*AP*GP*G P*GP*AP*AP*CP*UP*GP*CP*CP*AP*GP*GP*CP*AP*U)-3'), RNA (5'- R(*CP*CP*GP*AP*UP*GP*GP*UP*AP*GP*UP*GP*UP*GP*GP*GP*G *UP*C)-3') RNA U-RNA, DOUBLE HELIX, KINKED, INTERNAL LOOP, OVERHANGING BASE, MODIFIED, MISMATCHED
Code Class Resolution Description 2gxj nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-AMIDINO)-2-(4-HYDROXYPHENYL)BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description
3ukc nuc 1.54 1-{2,5-ANHYDRO-6-DEOXY-4-[(PHOSPHONOOXY)METHYL]-ALPHA- L-MANNOFURANOSYL}PYRIMIDINE-2,4(1H,3H)-DIONE 2(C11 H15 N2 O9 P) (S)-CET-BNA DECAMER STRUCTURE DNA (5'-D(*GP*CP*GP*TP*AP*(1TL)P*AP*CP*GP*C)-3') DNA A-FORM DNA, BICYCLIC NUCLEIC ACID, BNA, DNA, CET-BNA, ANTISE OLIGONUCLEOTIDES
Code Class Resolution Description 4kw0 nuc 1.49 2-AMINO-9-(2-SE-METHYL-5-O-PHOSPHONO-2-SELENO-BETA-D- ARABINOFURANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE 2(C11 H16 N5 O7 P SE) STRUCTURE OF DICKERSON-DREW DODECAMER WITH 2'-MESE-ARA-G MOD DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*(1TW)P*CP*G CHAIN: A, B DNA B-DNA, 2'-MESE-ARABINOSYL-DEOXYGUANOSINE, DNA
Code Class Resolution Description 4rhd nuc 1.70 (1R)-1-(6-AMINO-2-HYDROXY-5-NITROPYRIDIN-3-YL)-1,4- ANHYDRO-2-DEOXY-5-O-PHOSPHONO-D-ERYTHRO-PENTITOL 4(C10 H14 N3 O9 P) DNA DUPLEX WITH NOVEL ZP BASE PAIR DNA 9MER NOVEL Z NUCLEOBASE, DNA 9MER NOVEL P NUCLEOBASE DNA MODIFIED NUCLEOBASE Z AND P, DNA 4xno nuc 1.99 (1R)-1-(6-AMINO-2-HYDROXY-5-NITROPYRIDIN-3-YL)-1,4- ANHYDRO-2-DEOXY-5-O-PHOSPHONO-D-ERYTHRO-PENTITOL 6(C10 H14 N3 O9 P) CRYSTAL STRUCTURE OF 5'-CTTATPPPZZZATAAG DNA (5'-D(*CP*TP*(BRU)P*AP*TP*(1WA)P*(1WA)P*(1WA) P*(1W5)P*(1W5)P*AP*TP*AP*AP*G)-3') DNA A-FORM DNA, NON-NATURAL NUCLEOBASE PAIR, SYNTHETIC BIOLOGY, 5i4s nuc 2.46 (1R)-1-(6-AMINO-2-HYDROXY-5-NITROPYRIDIN-3-YL)-1,4- ANHYDRO-2-DEOXY-5-O-PHOSPHONO-D-ERYTHRO-PENTITOL 2(C10 H14 N3 O9 P) NON-NATURAL DNA PAIR Z (6-AMINO-5-NITRO-2[1H] PYRIDONE HETER GUANOSINE DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(D8Z)P*GP*CP*G)- CHAIN: A, B DNA NON-NATURAL NUCLEOTIDE BASE, SYNTHETIC BIOLOGY, 6-AMINO-5-NI PYRIDONE HETEROCYCLE), DNA 5ktv nuc 2.35 (1R)-1-(6-AMINO-2-HYDROXY-5-NITROPYRIDIN-3-YL)-1,4- ANHYDRO-2-DEOXY-5-O-PHOSPHONO-D-ERYTHRO-PENTITOL 2(C10 H14 N3 O9 P) MIS-PAIRING OF UNNATURAL BASE Z-G DNA DUPLEX AT PH 8.5 DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(1W5)P*GP*CP*G)- CHAIN: A, B DNA UNNATURAL DNA BASES, SYNTHETIC BIOLOGY, DNA 5lj4 nuc 2.17 (1R)-1-(6-AMINO-2-HYDROXY-5-NITROPYRIDIN-3-YL)-1,4- ANHYDRO-2-DEOXY-5-O-PHOSPHONO-D-ERYTHRO-PENTITOL 2(C10 H14 N3 O9 P) CRYSTAL STRUCTURE OF DNA DUPLEX CONTAINING ZP BASE PAIR ODN2 DNA SYNTHETIC NUCLEOTIDE, DNA
Code Class Resolution Description 4rhd nuc 1.70 2-AMINO-8-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-4-HYDROXY-1H-IMIDAZO[1,2-A][1,3, 5]TRIAZINE-5,8-DIIUM 4(C10 H16 N5 O7 P 2+) DNA DUPLEX WITH NOVEL ZP BASE PAIR DNA 9MER NOVEL Z NUCLEOBASE, DNA 9MER NOVEL P NUCLEOBASE DNA MODIFIED NUCLEOBASE Z AND P, DNA 4xno nuc 1.99 2-AMINO-8-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-4-HYDROXY-1H-IMIDAZO[1,2-A][1,3, 5]TRIAZINE-5,8-DIIUM 6(C10 H16 N5 O7 P 2+) CRYSTAL STRUCTURE OF 5'-CTTATPPPZZZATAAG DNA (5'-D(*CP*TP*(BRU)P*AP*TP*(1WA)P*(1WA)P*(1WA) P*(1W5)P*(1W5)P*AP*TP*AP*AP*G)-3') DNA A-FORM DNA, NON-NATURAL NUCLEOBASE PAIR, SYNTHETIC BIOLOGY, 5lj4 nuc 2.17 2-AMINO-8-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-4-HYDROXY-1H-IMIDAZO[1,2-A][1,3, 5]TRIAZINE-5,8-DIIUM 2(C10 H16 N5 O7 P 2+) CRYSTAL STRUCTURE OF DNA DUPLEX CONTAINING ZP BASE PAIR ODN2 DNA SYNTHETIC NUCLEOTIDE, DNA
Code Class Resolution Description 2hop nuc 3.30 1-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-3-(2- HYDROXYETHYL)-2-METHYLPYRIDINIUM C14 H19 N4 O 1+ CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO PYRITHIAMINE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH
Code Class Resolution Description 1c9z nuc 2.40 1,3-DI[[[10-METHOXY-7H-PYRIDO[4,3-C]CARBAZOL-2-IUMYL]- ETHYL]-PIPERIDIN-4-YL]-PROPANE C49 H56 N6 O2 2+ D232-CGTACG 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA, INTERCALATOR, INTERCALATION, DRUG, MAJOR GROOVE
Code Class Resolution Description 4qk8 nuc 3.05 GUANOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O10 P2 THERMOANAEROBACTER PSEUDETHANOLICUS C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qk9 nuc 3.05 GUANOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O10 P2 THERMOVIRGA LIENII C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qka nuc 3.20 GUANOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O10 P2 C-DI-AMP RIBOSWITCH FROM THERMOANAEROBACTER PSEUDETHANOLICUS HEXAMINE SOAK C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA
Code Class Resolution Description 4lx5 nuc 2.13 PYRIMIDO[4,5-D]PYRIMIDINE-2,4-DIAMINE C6 H6 N6 X-RAY CRYSTAL STRUCTURE OF THE M6" RIBOSWITCH APTAMER BOUND PYRIMIDO[4,5-D]PYRIMIDINE-2,4-DIAMINE (PPDA) MUTATED ADENINE RIBOSWITCH APTAMER RNA RIBOSWITCH, GENE EXPRESSION PLATFORM, RNA
Code Class Resolution Description 4lx6 nuc 2.15 2-AMINOPYRIMIDO[4,5-D]PYRIMIDIN-4(3H)-ONE C6 H5 N5 O X-RAY CRYSTAL STRUCTURE OF THE M6C" RIBOSWITCH APTAMER BOUND AMINOPYRIMIDO[4,5-D]PYRIMIDIN-4(3H)-ONE (PPAO) MUTATED ADENINE RIBOSWITCH APTAMER RNA RIBOSWITCH GENE EXPRESSION PLATFORM, RNA
Code Class Resolution Description 2gcs nuc 2.10 2'-AMINO-2'-DEOXYADENOSINE C10 H14 N6 O3 PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME AMINO RNA INHIBITOR, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 2h0x nuc 2.30 2'-AMINO-2'-DEOXYADENOSINE C10 H14 N6 O3 PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME RNA, GLMS RIBOZYME AMINO RNA INHIBITOR RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX
Code Class Resolution Description 1exl nuc NMR 2'-DEOXYARISTEROMYCIN-5'-PHOSPHATE C11 H16 N5 O5 P STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING THE CARBOCYCLIC NUCLEOTIDE ANALOG: 2'-DEOXYARISTEROMYCIN DNA (5'-D(*CP*AP*GP*TP*GP*(2AR)P*GP*TP*CP*AP*C)-3 CHAIN: A, DNA (5'-D(*GP*TP*GP*AP*CP*TP*CP*AP*CP*TP*G)-3') DNA DNA, MODIFIED NUCLEOTIDES, 2'-DEOXYARISTEROMYCIN 1fyi nuc NMR 2'-DEOXYARISTEROMYCIN-5'-PHOSPHATE C11 H16 N5 O5 P 11-MER DNA DUPLEX CONTAINING A 2'-DEOXYARISTEROMYCIN 8-OXO- GUANINE BASE PAIR; 5'-D(*GP*TP*GP*AP*CP*(8OG)P*CP*AP*CP*TP*G)-3', 5'-D(*CP*AP*GP*TP*GP*(2AR)P*GP*TP*CP*AP*C)-3' DNA 2'-DEOXYARISTEROMYCIN, 8-OXO-GUANINE, DNA
Code Class Resolution Description 1y9f nuc 1.60 2'-O-ALLYL THYMIDINE-5'-MONOPHOSPHATE 2(C13 H19 N2 O9 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-ALLYL THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(2AT)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER
Code Class Resolution Description 2bq2 nuc NMR 2'-AMINOURIDINE 2(C9 H14 N3 O8 P) SOLUTION STRUCTURE OF THE DNA DUPLEX ACGCGU-NA WITH A 2' AMIDO-LINKED NALIDIXIC ACID RESIDUE AT THE 3' TERMINAL NUCLEOTIDE 5'-D(*AP*CP*GP*CP*GP*2AU)-3' DNA NUCLEIC ACID, DEOXYRIBONUCLEIC ACID, DISRUPTED TERMINAL BASEPAIRS, DNA, QUINOLONE, SYNTHETIC HYBRID, DNA COMPLEX 2kk5 nuc NMR 2'-AMINOURIDINE 2(C9 H14 N3 O8 P) HIGH FIDELITY BASE PAIRING AT THE 3'-TERMINUS 5'-D(*AP*CP*GP*CP*GP*(2AU))-3' DNA ANTHRAQUINONE-LINKED DNA 2npy nuc 2.65 2'-AMINOURIDINE C9 H14 N3 O8 P CRYSTAL STRUCTURE OF A JUNCTIONED HAIRPIN RIBOZYME INCORPORA LINKER AND 2'-DEOXY 2'-AMINO U AT A-1 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(U2N)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3': S-TURN STRAND, 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA HAIRPIN RIBOZYME, MUTATION, S-TURN, E-LOOP, RIBOSE ZIPPER, C RNA, 2'-DEOXY 2'-AMINO, 9S LINKER, RNA
Code Class Resolution Description 4qk8 nuc 3.05 (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', 2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-3,5, 10,12-TETROL 5,12-DIOXIDE 2(C20 H24 N10 O12 P2) THERMOANAEROBACTER PSEUDETHANOLICUS C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qk9 nuc 3.05 (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', 2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-3,5, 10,12-TETROL 5,12-DIOXIDE 2(C20 H24 N10 O12 P2) THERMOVIRGA LIENII C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qka nuc 3.20 (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', 2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-3,5, 10,12-TETROL 5,12-DIOXIDE 2(C20 H24 N10 O12 P2) C-DI-AMP RIBOSWITCH FROM THERMOANAEROBACTER PSEUDETHANOLICUS HEXAMINE SOAK C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qlm nuc 2.72 (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', 2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-3,5, 10,12-TETROL 5,12-DIOXIDE 2(C20 H24 N10 O12 P2) YDAO RIBOSWITCH BINDING TO C-DI-AMP RNA (108-MER) RNA SECOND MESSAGE MOLECULE, C-DI-AMP BINDING, RNA 4qln nuc 2.65 (2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-2,9-BIS(6- AMINO-9H-PURIN-9-YL)OCTAHYDRO-2H,7H-DIFURO[3,2-D:3', 2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-3,5, 10,12-TETROL 5,12-DIOXIDE 2(C20 H24 N10 O12 P2) STRUCTURE OF YDAO RIBOSWITCH BINDING WITH C-DI-DAMP RNA (117-MER) RNA YDAO RIBOSWITCH, C-DI-AMP, RNA
Code Class Resolution Description 1u6n nuc NMR N1-(1-HYDROXY-3-BUTEN-2(S)-YL)-2'-DEOXYINOSINE MONO PHOSPHORIC ACID C14 H19 N4 O8 P SOLUTION STRUCTURE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING A BUTADIENE DERIVED N1 B-HYDROXYALKYL ADDUCT ON DEOXYINOSINE IN THE HUMAN N-RAS CODON 61 SEQUENCE 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3', 5'-D(*CP*GP*GP*AP*CP*(2BD)P*AP*GP*AP*AP*G)-3' DNA NMR, BUTADIENE, DEOXYINOSINE, RAS61,, DNA 1z7v nuc model N1-(1-HYDROXY-3-BUTEN-2(S)-YL)-2'-DEOXYINOSINE MONO PHOSPHORIC ACID C14 H19 N4 O8 P DUAL ROLES OF GLYCOSYL TORSION ANGLE CONFORMATION AND STEREOCHEMICAL CONFIGURATION IN BUTADIENE OXIDE-DERIVED N1 B-HYDROXYALKYL DEOXYINOSINE ADDUCTS: A STRUCTURAL PERSPECTIVE 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3', 5'-D(*CP*GP*GP*AP*CP*(2BD)P*AP*GP*AP*AP*G)-3' DEOXYRIBONUCLEIC ACID DNA
Code Class Resolution Description 3g4m nuc 2.40 9H-PURIN-2-AMINE C5 H5 N5 CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH BOUND TO 2- AMINOPURINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, 2-AMINOPURINE, GUANINE, THREE-WAY JUNCTION, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE-TRIPLE.
Code Class Resolution Description 1wv5 nuc 2.30 2'-O-BUTYL-THYMIDINE 2(C14 H23 N2 O9 P) X-RAY STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2' THYMINE IN PLACE OF T6, MG-FORM 5'-D(*GP*CP*GP*TP*AP*(2BT)P*AP*CP*GP*C)-3' DNA DNA 1wv6 nuc 2.55 2'-O-BUTYL-THYMIDINE 2(C14 H23 N2 O9 P) X-RAY STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2' THYMINE IN PLACE OF T6, SR-FORM 5'-D(*GP*CP*GP*TP*AP*(2BT)P*AP*CP*GP*C)-3' DNA DNA
Code Class Resolution Description 1u6c nuc NMR (2S,3S)-N6-(2,3,4-TRIHYDROXYBUTYL)-2'-DEOXYADENOSINE MONO PHOSPHORIC ACID C14 H22 N5 O9 P THE NMR-DERIVED SOLUTION STRUCTURE OF THE (2S,3S)-N6-(2,3,4- TRIHYDROXYBUTYL)-2'-DEOXYADENOSYL DNA ADDUCT OF BUTADIENE DIOL EPOXIDE (2S,3S)-N6-(2,3,4-TRIHYDROXYBUTYL)-2'- DEOXYADENOSYL DNA ADDUCT OF BUTADIENE DIOL EPOXIDE, (2S,3S)-N6-(2,3,4-TRIHYDROXYBUTYL)-2'- DEOXYADENOSYL DNA ADDUCT OF BUTADIENE DIOL EPOXIDE DNA DNA 1u6o nuc NMR (2S,3S)-N6-(2,3,4-TRIHYDROXYBUTYL)-2'-DEOXYADENOSINE MONO PHOSPHORIC ACID C14 H22 N5 O9 P MISPAIRING OF A SITE-SPECIFIC MAJOR GROOVE (2S,3S)-N6-(2,3, 4-TRIHYDROXYBUTYL)-2-DEOXYADENOSYL DNA ADDUCT OF BUTADIENE DIOL EPOXIDE WITH DEOXYGUANOSINE: FORMATION OF A DA(ANTI) DG(ANTI) PAIRING INTERACTION 5'-D(*CP*GP*GP*AP*CP*(2BU)P*AP*GP*AP*AP*G)-3', 5'-D(*CP*TP*TP*CP*TP*GP*GP*TP*CP*CP*G)-3' DNA BUTADIENE, MISMATCH, RAS61, DEOXYADENOSYL, DIOL EPOXIDE, DNA
Code Class Resolution Description 1osr nuc NMR N-(2-DEOXY-BETA-D-ERYTHO-PENTOFURANOSYL-5-PHOSPHATE) FORMAMIDE C6 H12 N O7 P STRUCTURAL STUDY OF DNA DUPLEX CONTAINAING A N-(2-DEOXY- BETA-ERYTHO-PENTOFURANOSYL) FORMAMIDE FRAMESHIFT BY NMR AND RESTRAINED MOLECULAR DYNAMICS 5'-D(*AP*GP*GP*AP*CP*CP*AP*CP*G)-3', 5'-D(*CP*GP*TP*GP*GP*(2DF)P*TP*CP*CP*T)-3' DNA MODIFIED BASE, MUTAGENESIS, DEOXYRIBONUCLEIC ACID, DNA
Code Class Resolution Description 1s88 nuc NMR 2-HYDROXY-3-(PYREN-1-YLMETHOXY)PROPYL DIHYDROGEN PHOSPHATE 2(C20 H19 O6 P) NMR STRUCTURE OF A DNA DUPLEX WITH TWO INA NUCLEOTIDES INSERTED OPPOSITE EACH OTHER, DCTCAACXCAAGCT:DAGCTTGXGTTGAG 5'-D(*AP*GP*CP*TP*TP*GP*(2DM)P*GP*TP*TP*GP*AP*G)- 3', 5'-D(*CP*TP*CP*AP*AP*CP*(2DM)P*CP*AP*AP*GP*CP*T)- 3' DNA DNA
Code Class Resolution Description 2hmd nuc NMR 2'-DEOXY-N-ETHYLGUANOSINE 5'-PHOSPHATE 2(C12 H18 N5 O7 P) STEREOCHEMISTRY MODULATES STABILITY OF REDUCED INTER-STRAND CROSS-LINKS ARISING FROM R- AND S-ALPHA-METHYL-GAMMA-OH-1, N2-PROPANO-2'-DEOXYGUANINE IN THE 5'-CPG-3' DNA SEQUENCE DNA DODECAMER WITH INTERSTRAND CROSS-LINK, DNA DODECAMER WITH INTERSTRAND CROSS-LINK DNA CROTONALDEHYDE INTERSTRAND DNA CROSS-LINK 2hmr nuc NMR 2'-DEOXY-N-ETHYLGUANOSINE 5'-PHOSPHATE 2(C12 H18 N5 O7 P) SOLUTION STRUCTURE OF REDUCED INTERSTRAND CROSS-LINK ARISING FROM S-ALPHA-METHYL-GAMMA-OH-1,N2-PROPANO-2'- DEOXYGUANOSINE IN THE 5'-CPG-3' DNA SEQUENCE DNA DODECAMER WITH INTERSTRAND CROSS-LINK, DNA DODECAMER WITH INTERSTRAND CROSS-LINK DNA CROTONALDEHYDE INTERSTRAND DNA CROSS-LINK
Code Class Resolution Description 2mco nuc NMR TETRAKIS(2,2'-BIPYRIDINE-KAPPA~2~N~1~,N~1'~)(MU- TETRAPYRIDO[3,2-A:2',3'-C:3'',2''-H:2''',3'''- J]PHENAZINE-1KAPPA~2~N~4~,N~5~:2KAPPA~2~N~13~,N~14~) DIRUTHENIUM(4+) L ENANTIOMER C64 H44 N14 RU2 4+ STRUCTURAL STUDIES ON DINUCLEAR RUTHENIUM(II) COMPLEXES THAT DIASTEREOSELECTIVELY TO AN ANTI-PARALLEL FOLDED HUMAN TELOM SEQUENCE HUMAN TELOMERE QUADRUPLEX DNA DNA, QUADRUPLEX, COMPLEX, RUTHENIUM
Code Class Resolution Description 4mgw nuc 1.93 [(2R,5R)-5-(4-AMINO-5-CHLORO-2-OXOPYRIMIDIN-1(2H)-YL)- 3-OXOTETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN PHOSPHATE 2(C9 H11 CL N3 O7 P) COMPARISON OF THE STRUCTURAL AND DYNAMIC EFFECTS OF 5-METHYL AND 5-CHLOROCYTOSINE IN A CPG DINUCLEOTIDE SEQUENCE CLC CONTAINING DICKERSON-DREW DODECAMER DNA DNA DODECAMER, STRUCTURAL STUDY OF DNA, DNA
Code Class Resolution Description 1ekh nuc NMR 4-O-ACETYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 2(C8 H14 O5) NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND CO DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1eki nuc NMR 4-O-ACETYL-2,6-DIDEOXY-ALPHA-D-GALACTO-HEXOPYRANOSE 2(C8 H14 O5) AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMY COBALT DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA
Code Class Resolution Description 1y9s nuc 1.55 2'-O-PROPARGYL THYMIDINE-5'-MONOPHOSPHATE 2(C13 H17 N2 O9 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O- PROPARGYL THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(2GT)P*AP*CP*GP*C)-3') DNA A-DNA DECAMER, O2'-MODIFICATION
Code Class Resolution Description 2h0n nuc 1.53 DIHYDROGENPHOSPHATE ION 2(H2 O4 P 1-) STRUCTURE OF THE FULLY MODIFIED LEFT-HANDED CYCLOHEXENE NUCLEIC ACID SEQUENCE GTGTACAC 5'-(*(XGL)P*(XTL)P*(XGL)P*(XTL)P*(XAL)P*(XCL) P*(XAL)P*(XCL)-PHOSPHATE)-3' DNA CYCLOHEXENE NUCLEIC ACID, DNA ANALOGUE, LEFT-HANDED, DOUBLE HELIX
Code Class Resolution Description 4mj9 nuc 0.97 (10-METHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM(2+) C39 H24 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ-10-ME)]2+ BOUND TO A SYNTHETIC DNA OLI DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA METHYL-SUBSTITUTED, INTERCALATION, RUTHENIUM, ASYMMETRIC SUBSTITUTION, DNA
Code Class Resolution Description
2l8i nuc NMR [(2R,3S,5R)-3-[(1-{[(2R,3S,5R)-3-HYDROXY-5-(5-METHYL-2, 4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN- 2-YL]METHYL}-1H-1,2,3-TRIAZOL-4-YL)METHOXY]-5-(5- METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL) TETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN PHOSPHA C23 H30 N7 O12 P A BIOCOMPATIBLE BACKBONE MODIFICATION? - STRUCTURE AND DYNAM TRIAZOLE-LINKED DNA DUPLEX DNA (5'-D(*CP*GP*AP*CP*G*(2L8)P*TP*GP*CP*AP*GP*C) CHAIN: B, DNA (5'-D(*GP*CP*TP*GP*CP*AP*AP*AP*CP*GP*TP*CP*G) CHAIN: A DNA DNA
Code Class Resolution Description 2lia nuc NMR 2-AMINO-5-(AMINOMETHYL)-7-(2-DEOXY-5-O-PHOSPHONO-BETA- D-ERYTHRO-PENTOFURANOSYL)-3,7-DIHYDRO-4H-PYRROLO[2,3- D]PYRIMIDIN-4-ONE 2(C12 H18 N5 O7 P) SOLUTION NMR STRUCTURE OF A DNA DODECAMER CONTAINING THE 7- AMINOMETHYL-7-DEAZA-2'-DEOXYGUANOSINE ADDUCT DNA (5'-D(*GP*AP*GP*AP*(2LA)P*CP*GP*CP*TP*CP*TP*C CHAIN: A, B DNA DNA
Code Class Resolution Description 2lg2 nuc NMR (2R,5S)-5-PENTYLTETRAHYDROFURAN-2-OL C9 H18 O2 STRUCTURE OF THE DUPLEX CONTAINING HNE DERIVED (6S,8R,11S) N CYCLIC HEMIACETAL WHEN PLACED OPPOSITE DT DNA (5'-D(*GP*CP*TP*AP*GP*CP*GP*AP*GP*TP*CP*C)-3' CHAIN: A, DNA (5'-D(*GP*GP*AP*CP*TP*TP*GP*CP*TP*AP*GP*C)-3' CHAIN: B DNA TRANS-4-HYDROXYNONENAL, N2-DG CYCLIC HEMIACETAL, DNA
Code Class Resolution Description 2lfa nuc NMR (6S,7S,8S,10R)-2-AMINO-8-HYDROXY-4-OXO-3,6,7,8,9,10- HEXAHYDRO-4H-7,10-EPOXYAZEPINO[1,2-E]PURIN-6-YL DIHYDROGEN PHOSPHATE C10 H12 N5 O7 P OLIGONUCLEOTIDE DUPLEX CONTANING (5'S)-8,5'-CYCLO-2'-DEOXYGU DNA (5'-D(*AP*CP*AP*AP*AP*CP*AP*CP*GP*CP*AP*C)-3' CHAIN: B, DNA (5'-D(*GP*TP*GP*CP*(2LF)P*TP*GP*TP*TP*TP*GP*T CHAIN: A DNA (5'S)-8,5'-CYCLO-2'-DEOXYGUANOSINE, CYCLOPURINE, CYCLO-DG, D 2lfx nuc NMR (6S,7S,8S,10R)-2-AMINO-8-HYDROXY-4-OXO-3,6,7,8,9,10- HEXAHYDRO-4H-7,10-EPOXYAZEPINO[1,2-E]PURIN-6-YL DIHYDROGEN PHOSPHATE C10 H12 N5 O7 P STRUCTURE OF THE DUPLEX WHEN (5'S)-8,5'-CYCLO-2'-DEOXYGUANOS PLACED OPPOSITE DT DNA (5'-D(*GP*TP*GP*CP*(2LF)P*TP*GP*TP*TP*TP*GP*T CHAIN: A, DNA (5'-D(*AP*CP*AP*AP*AP*CP*AP*TP*GP*CP*AP*C)-3' CHAIN: B DNA (5'S)-8,5'-CYCLO-2'-DEOXYGUANOSINE, CYCLOPURINE, CYCLO-DG, D 2lfy nuc NMR (6S,7S,8S,10R)-2-AMINO-8-HYDROXY-4-OXO-3,6,7,8,9,10- HEXAHYDRO-4H-7,10-EPOXYAZEPINO[1,2-E]PURIN-6-YL DIHYDROGEN PHOSPHATE C10 H12 N5 O7 P STRUCTURE OF THE DUPLEX WHEN (5'S)-8,5'-CYCLO-2'-DEOXYGUANOS PLACED OPPOSITE DA DNA (5'-D(*GP*TP*GP*CP*(2LF)P*TP*GP*TP*TP*TP*GP*T CHAIN: A, DNA (5'-D(*AP*CP*AP*AP*AP*CP*AP*AP*GP*CP*AP*C)-3' CHAIN: B DNA (5'S)-8,5'-CYCLO-2'-DEOXYGUANOSINE, CYCLOPURINE, CYCLO-DG, D
Code Class Resolution Description 1ehz nuc 1.93 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 5(C11 H16 N5 O8 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1fir nuc 3.30 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 1ipl nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1k7n nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1nrt nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 3(C11 H16 N5 O8 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1q49 nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1wts nuc NMR 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P HELIX 45 (16S RRNA) FROM B. STEAROTHERMOPHILUS, NMR, MINIMIZED AVERAGE STRUCTURE RNA (5'- R(*GP*GP*AP*CP*CP*2MGP*GP*MA6P*MA6P*GP*GP*UP*CP*C)-3'): HELIX 45 STEM-LOOP RNA RIBONUCLEIC ACID, RIBOSOME, RNA, 16S, MODIFIED NUCLEOTIDES, TETRALOOP 1wtt nuc NMR 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P HELIX 45 (16S RRNA) FROM B. STEAROTHERMOPHILUS, NMR, 11 STRUCTURES RNA (5'- R(*GP*GP*AP*CP*CP*2MGP*GP*MA6P*MA6P*GP*GP*UP*CP*C)-3'): HELIX 45 STEM-LOOP RNA RIBONUCLEIC ACID, RIBOSOME, RNA, 16S, MODIFIED NUCLEOTIDES, TETRALOOP 1yfg nuc 3.00 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2z9q nuc 11.70 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 486d nuc 7.50 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 6tna nuc 2.70 2N-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1fir nuc 3.30 2',5-DIMETHYLURIDINE-5'-MONOPHOSPHATE C11 H17 N2 O9 P CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 1pwf nuc 1.16 2',5-DIMETHYLURIDINE-5'-MONOPHOSPHATE 2(C11 H17 N2 O9 P) ONE SUGAR PUCKER FITS ALL: PAIRING VERSATILITY DESPITE CONFORMATIONAL UNIFORMITY IN TNA 5'-D(*GP*CP*GP*TP*AP*(2MU)P*(FA2)P*CP*GP*C)-3' DNA A-DNA, HYDROGEN BONDING, NUCLEIC ACID ETIOLOGY, TETROSE, FOUR CARBON SUGAR, X-RAY CRYSTALLOGRAPHY, NUCLEIC ACID ANALOGUE
Code Class Resolution Description 1y7f nuc 1.60 2'-O-[2-[HYDROXY(METHYLENEAMINO)OXY]ETHYL THYMIDINE- 5'-MONOPHOSPHATE 2(C13 H22 N3 O11 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- [HYDROXY(METHYLENEAMINO)OXY]ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(2NT)P*AP*CP*GP*C)-3') DNA A-DNA, MODIFIED
Code Class Resolution Description 5ihd nuc 1.57 (2S)-2-HYDROXYPROPANOIC ACID 2(C3 H6 O3) CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY L-LACTATE AND SUCCINATE DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA
Code Class Resolution Description 1yb9 nuc 1.65 2'-O-[2-(N,N-DIMETHYLAMINOOXY)ETHYL] THYMIDINE-5'- MONOPHOSPHATE 2(C14 H24 N3 O10 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2-(N, N-DIMETHYLAMINOOXY)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(2OT)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER
Code Class Resolution Description 2kv0 nuc NMR 2-AMINO-9-[2-DEOXYRIBOFURANOSYL]-9H-PURINE-5'- MONOPHOSPHATE C10 H14 N5 O6 P 2-AMINOPURINE INCORPORATION PERTURBS THE DYNAMICS AND STRUCT DNA (5'-D(*CP*GP*AP*CP*GP*TP*TP*TP*GP*CP*AP*GP*C) CHAIN: B, DNA (5'-D(*GP*CP*TP*GP*CP*AP*(2PR)P*AP*CP*GP*TP*C CHAIN: A DNA DNA, 2-AMINOPURINE, FLUOROPHORE, STRUCTURE PERTURBATION
Code Class Resolution Description 1xrw nuc NMR 1-[2-(ACRIDIN-9-YLAMINO)ETHYL]-1,3-DIMETHYLTHIOUREA- PLATINUM(II)-ETHANE-1,2-DIAMINE C20 H29 N6 PT S 3+ SOLUTION STRUCTURE OF A PLATINUM-ACRIDINE MODIFIED OCTAMER 5'-D(*CP*CP*TP*CP*GP*TP*CP*C)-3', 5'-D(*GP*GP*AP*CP*GP*AP*GP*G)-3' DNA PLATINUM, ACRIDINE, DUAL BINDING MODE, MAJOR GROOVE, UNWINDI
Code Class Resolution Description 4nya nuc 2.65 5-(AZIDOMETHYL)-2-METHYLPYRIMIDIN-4-AMINE 2(C6 H8 N6) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (AZIDOMETHYL)-2-METHYLPYRIMIDIN-4-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
Code Class Resolution Description 4nyb nuc 3.10 1-[4-(1,2,3-THIADIAZOL-4-YL)PHENYL]METHANAMINE C9 H9 N3 S CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (1,2,3-THIADIAZOL-4-YL)PHENYL)METHANAMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
Code Class Resolution Description 2miv nuc NMR (11R,12R,13R)-11,12,13,14-TETRAHYDRONAPHTHO[1,2,3,4- PQR]TETRAPHENE-11,12,13-TRIOL C24 H18 O3 NMR STUDIES OF N2-GUANINE ADDUCTS DERIVED FROM THE TUMORIGEN DIBENZO[A,L]PYRENE IN DNA: IMPACT OF ADDUCT STEREOCHEMISTRY AND LOCAL DNA STRUCTURE ON SOLUTION CONFORMATIONS DNA_(5'-D(*GP*GP*TP*AP*GP*GP*AP*TP*GP*G)-3'), DNA_(5'-D(*CP*CP*AP*TP*CP*GP*CP*TP*AP*CP*C)-3') DNA DNA, 14S(-)-TRANS-ANTI-DB[A,L]P-N2-DG, DNA ADDUCT 2miw nuc NMR (11R,12R,13R)-11,12,13,14-TETRAHYDRONAPHTHO[1,2,3,4- PQR]TETRAPHENE-11,12,13-TRIOL C24 H18 O3 NUCLEAR MAGNETIC RESONANCE STUDIES OF N2-GUANINE ADDUCTS DER THE TUMORIGEN DIBENZO[A,L]PYRENE IN DNA: IMPACT OF ADDUCT STEREOCHEMISTRY, SIZE, AND LOCAL DNA STRUCTURE ON SOLUTION CONFORMATIONS DNA_(5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3'), DNA_(5'-D(*CP*CP*AP*TP*CP*GP*CP*TP*AP*CP*C)-3') DNA DNA, 14S (-)-TRANS-ANTI-DB[A,L]P-N2-DG, DNA ADDUCT
Code Class Resolution Description 2irk nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO BIS[5-(2-AMIDINO)-2-BENZIMIDAZOLYL]METHANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 4rby nuc 1.19 GUANOSINE PHOSPHORODITHIOATE C10 H16 N5 O6 P S2 FIRST X-RAY STRUCTURE OF RNA CONTAINING GUANOSINE PHOSPHOROD 5'-R(*CP*GP*CP*(2SG)P*AP*AP*UP*UP*AP*GP*CP*G)-3' RNA PHOSPHORODITHIOATE RNA, GUANOSINE PHOSPHORODITHIOATE, PHOSPHOROTHIOATE, GUANOSINE ANALOGUE, HYDROPHOBIC, BACKBONE 4rc0 nuc 1.13 GUANOSINE PHOSPHORODITHIOATE C10 H16 N5 O6 P S2 X-RAY STRUCTURE OF RNA CONTAINING GUANOSINE PHOSPHORODITHIOA 5'-R(*CP*GP*CP*GP*AP*AP*UP*UP*(A2M)P*(2SG)P*CP*G) CHAIN: A RNA PHOSPHORODITHIOATE RNA, GUANOSINE PHOSPHORODITHIOATE, PHOSPHOROTHIOATE, GUANOSINE ANALOGUE, HYDROPHOBIC, BACKBONE 5do5 nuc 1.20 GUANOSINE PHOSPHORODITHIOATE C10 H16 N5 O6 P S2 CRYSTAL STRUCTURE OF 2'-FLUORO-RNA BEARING A PHOSPHORODITHIO RNA (5'-R(*CP*GP*CP*GP*AP*AP*UP*UP*(AF2)P*(2SG)P* CHAIN: A RNA RNA, 2'-FLUORO-RNA, PHOSPHORODITHIOATE RNA, PS2-RNA
Code Class Resolution Description 2hc7 nuc 1.40 5-METHYL-2'-SE-METHYL-2'-SELENOURIDINE 5'-(DIHYDROGEN PHOSPHATE) C11 H17 N2 O8 P SE 2'-SELENIUM-T A-DNA [G(TSE)GTACAC] 5'-D(*GP*(2ST)P*GP*TP*AP*CP*AP*C)-3' DNA SE-DNA, 2'-SE-T-DNA 4fp6 nuc 1.28 5-METHYL-2'-SE-METHYL-2'-SELENOURIDINE 5'-(DIHYDROGEN PHOSPHATE) C11 H17 N2 O8 P SE DNA OCTAMER D(GTGGCCAC) WITH 2'-SE MODIFICATION DNA (5'-D(*GP*(2ST)P*GP*GP*CP*CP*AP*C)-3') DNA 2'-SE-THYMIDINE DNA, DNA 4h5a nuc 1.42 5-METHYL-2'-SE-METHYL-2'-SELENOURIDINE 5'-(DIHYDROGEN PHOSPHATE) C11 H17 N2 O8 P SE DNA OCTAMER D (GTSEGTACAC) PARTIALLY CROSSLINKED WITH PLATIN DNA (5'-D(*GP*(2ST)P*GP*GP*CP*CP*AP*C)-3') DNA SELENIUM MODIFICATION TO FACILITATE CRYSTALLIZATION, DNA 4i1g nuc 1.25 5-METHYL-2'-SE-METHYL-2'-SELENOURIDINE 5'-(DIHYDROGEN PHOSPHATE) C11 H17 N2 O8 P SE DNA OCTAMER D(GTSEGTACAC) PARTIALLY CROSSLINKED WITH TWO PLA DNA (5'-D(*GP*(2ST)P*GP*GP*CP*CP*AP*C)-3') DNA PLATINUM CROSSLINK, SELENIUM, DNA
Code Class Resolution Description 2tob nuc NMR 1,3-DIAMINO-4,5,6-TRIHYDROXY-CYCLOHEXANE C6 H16 N2 O3 2+ SOLUTION STRUCTURE OF THE TOBRAMYCIN-RNA APTAMER COMPLEX, NMR, 13 STRUCTURES RNA (5'- R(*AP*CP*UP*UP*GP*GP*UP*UP*UP*AP*GP*GP*UP*AP*AP*UP*GP*AP*GP *U)-3') RNA AMINOGLYCOSIDE-RNA RECOGNITION, TOBRAMYCIN
Code Class Resolution Description 4ts0 nuc 2.80 (5Z)-5-(3,5-DIFLUORO-4-HYDROXYBENZYLIDENE)-2,3- DIMETHYL-3,5-DIHYDRO-4H-IMIDAZOL-4-ONE C12 H10 F2 N2 O2 CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH BARIUM IONS SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT, SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA 4ts2 nuc 2.88 (5Z)-5-(3,5-DIFLUORO-4-HYDROXYBENZYLIDENE)-2,3- DIMETHYL-3,5-DIHYDRO-4H-IMIDAZOL-4-ONE C12 H10 F2 N2 O2 CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH MAGNESIUM IONS SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT, SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA
Code Class Resolution Description 3b4b nuc 2.70 3'-DEOXYADENOSINE C10 H13 N5 O3 T. TENGCONGENSIS GLMS RIBOZYME WITH G40A MUTATION, BOUND TO GLUCOSAMINE-6-PHOSPHATE AND A SUBSTRATE RNA WITH A 2'5'- PHOSPHODIESTER LINKAGE GLMS RIBOZYME SUBSTRATE WITH 2'5'-PHOSPHODIESTER LINKAGE, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA 3b4c nuc 3.00 3'-DEOXYADENOSINE C10 H13 N5 O3 T. TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSAMINE-6- PHOSPHATE AND A SUBSTRATE RNA WITH A 2'5'-PHOSPHODIESTER LINKAGE GLMS RIBOZYME SUBSTRATE WITH A 2'5'- PHOSPHODIESTER LINKAGE, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA
Code Class Resolution Description
2gxe nuc model 2,5-BIS{[4-(2-PENTYL)DIAMINOMETHYL]PHENYL}FURAN C28 H40 N4 O MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 2,5-BIS{[4-(2-PENTYL)DIAMINOMETHYL]PHENYL}FURAN. DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, FURAN DERIVATIVE
Code Class Resolution Description 2xnz nuc 1.59 6-METHYL-1,3,5-TRIAZINE-2,4-DIAMINE C4 H7 N5 XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO ACETOGUAN IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA, APTAMER, RNA-LIGAND COMPLEX, MRNA
Code Class Resolution Description 2g9c nuc 1.70 PYRIMIDINE-2,4,6-TRIAMINE C4 H7 N5 MODIFIED PYRIMIDINES SPECIFICALLY BIND THE PURINE RIBOSWITCH GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, TRIAMINOPYRIMIDINE, RNA-LIGAND COMPLEX
Code Class Resolution Description 2mne nuc NMR AIK-18/51 2(C30 H38 N9 O4 S 1+) RECOGNITION COMPLEX OF DNA D(CGACTAGTCG)2 WITH THIAZOTROPSIN AIK-18/51 5'-D(*CP*GP*AP*CP*TP*AP*GP*TP*CP*G)-3' DNA THIAZOTROPSINS, DNA RECOGNITION, ISOTHERMAL TITRATION CALORI NMR, SELF-ASSEMBLY, MINOR GROOVE BINDER, DNA
Code Class Resolution Description 2mnd nuc NMR THIAZOTROPSIN B 2(C25 H36 N9 O4 S 1+) RECOGNITION COMPLEX OF DNA D(CGACGCGTCG)2 WITH THIAZOTROPSIN 5'-D(*CP*GP*AP*CP*GP*CP*GP*TP*CP*G)-3' DNA THIAZOTROPSINS, DNA RECOGNITION, ISOTHERMAL TITRATION CALORI NMR, SELF-ASSEMBLY, MINOR GROOVE BINDER, DNA
Code Class Resolution Description 1eg6 nuc 2.00 COBALT (III) ION 2(CO 3+) CRYSTAL STRUCTURE ANALYSIS OF D(CG(5-BRU)ACG) COMPLEXES TO A PHENAZINE 5'-D(*CP*GP*(BRO)UP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, INTERCALATION, MAJOR GROOVE BINDING, DOUBLE HELIX 1g5l nuc NMR COBALT (III) ION CO 3+ CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1gj2 nuc NMR COBALT (III) ION CO 3+ CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1mtg nuc NMR COBALT (III) ION CO 3+ NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GAGCTC 5'-D(*GP*AP*GP*CP*TP*C)-3' DNA DRUG-DNA COMPLEX, COBALT(III), DNA 1mxk nuc NMR COBALT (III) ION CO 3+ NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GGAAGCTTCC)(2) 5'-D(*GP*GP*AP*AP*GP*CP*TP*TP*CP*C)-3' DNA DRUG-DNA COMPLEX, COBALT(III) 1y6t nuc 2.60 COBALT (III) ION 5(CO 3+) HIV-1 DIS(MAL) DUPLEX CO HEXAMINE-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, METAL IONS 2gun nuc 2.80 COBALT (III) ION 2(CO 3+) RNA-BINDING AFFINITIES AND CRYSTAL STRUCTURE OF OLIGONUCLEOTIDES CONTAINING FIVE-ATOM AMIDE-BASED BACKBONE STRUCTURES 5'-D(*TP*TP*CP*(T2T)P*(CBR)P*TP*TP*C)-3', 5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*A)-3' DNA/RNA DNA:RNA HYBRID, AMIDE BEARING DNA, THYMIDINE DIMERS, INTERNUCLEOSIDIC AMIDE LINKAGE, DNA, RNA, DNA/RNA COMPLEX 4f2x nuc 1.57 COBALT (III) ION 6(CO 3+) STRUCTURE OF 3'-FLUORO CYCLOHEXENYL NUCLEIC ACID HEPTAMER 5'-D(*CP*GP*CP*AP*CP*GP*C)-3', 5'-D(*GP*CP*GP*(XTF)P*GP*CP*G)-3' DNA FLUORO CYCLOHEXENYL NUCLEIC ACID, F-CENA, MODIFIED DNA, B-FO DNA 5mvt nuc 1.90 COBALT (III) ION CO 3+ CRYSTAL STRUCTURE OF AN A-DNA DODECAMER FEATURING AN ALTERNA PYRIMIDINE-PURINE SEQUENCE DNA DNA A-DNA, UNMODIFIED, SELF-COMPLEMENTARY, DNA
Code Class Resolution Description 2p7f nuc 2.35 3'-DEOXYADENOSINE-5'-MONOPHOSPHATE C10 H14 N5 O6 P THE NOVEL USE OF A 2',5'-PHOSPHODIESTER LINKAGE AS A REACTION INTERMEDIATE AT THE ACTIVE SITE OF A SMALL RIBOZYME SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP B RIBOZYME STRAND, LOOP A RIBOZYME STRAND RNA HAIRPIN RIBOZYME; 2',5' PHOSPHODIESTER; VANADATE; REACTION INTERMEDIATE; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 4g6r nuc 2.83 3'-DEOXYADENOSINE-5'-MONOPHOSPHATE C10 H14 N5 O6 P MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH G8I VA LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND, LOOP A RIBOZYME STRAND, LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4g6s nuc 2.84 3'-DEOXYADENOSINE-5'-MONOPHOSPHATE C10 H14 N5 O6 P MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH A38P V LOOP A SUBSTRATE STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP B OF THE RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT
Code Class Resolution Description 1fzl nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE C5 H11 O6 P DNA WITH PYRENE PAIRED AT ABASIC SITES 5'-D(*GP*TP*GP*CP*(3DR)P*TP*GP*TP*TP*TP*GP*TP*G)- 3', 5'-D(*CP*AP*CP*AP*AP*AP*CP*AP*(PYP)P*GP*CP*AP*C)- 3' DNA PYRENE, TETRAHYDROFURAN, NON-HYDROGEN BONDED DNA BASE PAIR 1fzs nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE C5 H11 O6 P DNA WITH PYRENE PAIRED AT ABASIC SITE 5'-D(*GP*TP*GP*CP*(3DR)P*TP*GP*TP*TP*TP*GP*TP*G)- 3', 5'-D(*CP*AP*CP*AP*AP*AP*CP*AP*(PYP))-3' DNA PYRENE, FURAN, NON-POLAR DNA PAIR 1ht4 nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) SOLUTION STRUCTURE OF A BISTRAND ABASIC SITE LESION STAGGERED IN A 3'-ORIENTATION. 5'-D(*CP*GP*CP*AP*TP*GP*(3DR)P*GP*TP*AP*CP*GP*C)- 3', 5'-D(*GP*CP*GP*TP*AP*CP*AP*(3DR)P*AP*TP*GP*CP*G)- 3' DNA DOUBLE HELIX, ABASIC SITES, CLUSTERED LESIONS, DNA 1ht7 nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) STRUCTURE OF A DNA DUPLEX CONTAINING A BISTRAND ABASIC SITE LESION STAGGERED IN A 5'-ORIENTATION. 5'-D(*CP*GP*CP*AP*TP*GP*(3DR)P*GP*TP*AP*CP*GP*C)- 3', 5'-D(*GP*CP*GP*TP*AP*(3DR)P*AP*CP*AP*TP*GP*CP*G)- 3' DNA DOUBLE HELIX, ABASIC SITES, CLUSTERED DAMAGE, EXTRUDED RESIDUES., DNA 1yct nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) CLUSTERED ABASIC LESIONS IN DNA: NMR SOLUTION STRUCTURE OF C BISTRANDED +1 ABASIC LESION 5'-D(*CP*GP*CP*AP*TP*GP*(3DR)P*GP*TP*AP*CP*GP*C)- CHAIN: A, 5'-D(*GP*CP*GP*TP*AP*(3DR)P*CP*CP*AP*TP*GP*CP*G)- CHAIN: B DNA DOUBLE HELIX, ABASIC SITES, CLUSTERED DAMAGE, EXTRUDED RESID REDUCED AP SITE, FURAN, BISTRANDED ABASIC LESION., DNA 1ycw nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) CLUSTERED ABASIC LESIONS IN DNA: NMR SOLUTION STRUCTURES OF BISTRANDED-1 ABASIC LESION 5'-D(*GP*CP*GP*TP*AP*CP*CP*(3DR)P*AP*TP*GP*CP*G)- CHAIN: B, 5'-D(*CP*GP*CP*AP*TP*GP*(3DR)P*GP*TP*AP*CP*GP*C)- CHAIN: A DNA DOUBLE HELIX, ABASIC SITES, CLUSTERED DAMAGE, EXTRUDED RESID REDUCED AP SITE, FURAN, BISTRANDED ABASIC LESION, DNA 2kh0 nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) 2-HYDROXY-7-NITROFLUORENE COVALENTLY LINKED INTO A 13MER DNA DUPLEX - SOLUTION STRUCTURE OF THE FACE-DOWN ORIENTATION 5'-D(*GP*CP*TP*GP*CP*AP*(3DR)P*AP*CP*GP*TP*CP*G)- 3', 5'-D(*CP*GP*AP*CP*GP*TP*(3DR)P*TP*GP*CP*AP*GP*C)- 3' DNA DNA, SOLUTION STRUCTURE, BASE PAIR MIMIC, CONFORMATIONAL FLEXIBILITY 2kh1 nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) 2-HYDROXY-7-NITROFLUORENE COVALENTLY LINKED INTO A 13MER DNA DUPLEX - SOLUTION STRUCTURE OF THE FACE-UP ORIENTATION 5'-D(*GP*CP*TP*GP*CP*AP*(3DR)P*AP*CP*GP*TP*CP*G)- 3', 5'-D(*CP*GP*AP*CP*GP*TP*(3DR)P*TP*GP*CP*AP*GP*C)- 3' DNA DNA, SOLUTION STRUCTURE, BASE PAIR MIMIC, CONFORMATIONAL FLEXIBILITY 2l2u nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) NMR SOLUTION STRUCTURES OF +3 (5' STAGGERED) BISTRANDED ABAS LESIONS IN DNA DNA (5'-D(*CP*AP*GP*CP*GP*(3DR)P*GP*TP*AP*TP*AP*A 3'), DNA (5'-D(*GP*CP*TP*TP*AP*(3DR)P*AP*CP*AP*CP*GP*C 3') DNA ABASIC LESION, BISTRANDED DNA LESIONS, CLUSTERED DNA DAMAGE, DNA DAMAGE, IONIZING RADIATION, DNA 2l2v nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE 2(C5 H11 O6 P) NMR SOLUTION STRUCTURES OF -3 (3' STAGGERED) BISTRANDED ABAS LESIONS IN DNA DNA_(5'-D(*CP*AP*GP*CP*TP*AP*TP*GP*(3DR)P*GP*AP*A 3')_, DNA_(5'-D(*GP*CP*TP*TP*CP*AP*CP*AP*(3DR)P*AP*GP*C 3')_ DNA ABASIC LESION, BISTRANDED DNA LESIONS, CLUSTERED DNA DAMAGE, DNA DAMAGE, IONIZING RADIATION, DNA 2m40 nuc NMR 1',2'-DIDEOXYRIBOFURANOSE-5'-PHOSPHATE C5 H11 O6 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND THF LESION DNA (5'-D(*CP*GP*CP*TP*CP*(3DR)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER, 8-OXO-GUANINE, THF, DNA
Code Class Resolution Description 4u8a nuc 1.48 N,N'-BIS[3-(1,4,5,6-TETRAHYDROPYRIMIDIN-2-YL) PHENYL]BIPHENYL-4,4'-DICARBOXAMIDE C34 H32 N6 O2 CRYSTAL STRUCTURE OF D(CGCGAATTCGCG)2 COMPLEXED WITH BPH-150 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA/ANTIBIOTIC ANTIBACTERIAL AGENTS, BISAMIDINES, MINOR GROOVE BINDERS, MOD MOLECULAR, NUCLEIC ACID CONFORMATION, OLIGODEOXYRIBONUCLEOT
Code Class Resolution Description 4u8b nuc 1.31 N,N'-BIS[3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL) PHENYL]BIPHENYL-4,4'-DICARBOXAMIDE C32 H28 N6 O2 CRYSTAL STRUCTURE OF D(CGCGAATTCGCG)2 COMPLEXED WITH BPH-135 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA/ANTIBIOTIC ANTIBACTERIAL AGENTS, BISAMIDINES, MINOR GROOVE BINDERS, MOD MOLECULAR, NUCLEIC ACID CONFORMATION, OLIGODEOXYRIBONUCLEOT DNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 4u8c nuc 1.24 2,2'-BENZENE-1,4-DIYLBIS[6-(1,4,5,6- TETRAHYDROPYRIMIDIN-2-YL)-1H-INDOLE] C30 H28 N6 CRYSTAL STRUCTURE OF D(CGCGAATTCGCG)2 COMPLEXED WITH BPH-140 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA/ANTIBIOTIC ANTIBACTERIAL AGENTS, BISAMIDINES, MINOR GROOVE BINDERS, MOD MOLECULAR, NUCLEIC ACID CONFORMATION, OLIGODEOXYRIBONUCLEOT
Code Class Resolution Description
1nzg nuc 1.60 2'-O-{2-[2-(DIMETHYLAMINO)ETHOXY]ETHYL}-5-METHYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C16 H28 N3 O10 P) CRYSTAL STRUCTURE OF A-DNA DECAMER GCGTA(3ME)ACGC, WITH A MO METHYLURIDINE 5'-D(*GP*CP*GP*TP*AP*(3ME)P*AP*CP*GP*C)-3' DNA A-DNA, 2'-MODIFIED OLIGONUCLEOTIDES, DNA
Code Class Resolution Description 2gxx nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO BIS[5-(2- IMIDAZOLINYL)-2-BENZIMIDAZOLYL]METHANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 4x1a nuc 0.89 (10,12-DIMETHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM C40 H26 N12 RU LAMBDA-[RU(TAP)2(DPPZ-10,12-ME)]2+ BOUND TO D(TCGGCGCCGA) DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA RUTHENIUM, DNA, POLYPYRIDYL
Code Class Resolution Description 2mwz nuc NMR 2'-DEOXY-XANTHOSINE-5'-MONOPHOSPHATE C10 H13 N4 O8 P XANTHINE AND 8-OXOGUANINE IN G-QUADRUPLEXES: FORMATION OF A TETRAD DNA (5'-D(*TP*TP*GP*GP*GP*TP*TP*AP*(8OG) P*GP*GP*TP*TP*AP*GP*GP*(3ZO)P*TP*TP*AP*GP*GP*GP*A)-3') DNA XANTHOSINE, DNA
Code Class Resolution Description 1o9m nuc 2.40 4-AMINO-2-HYDROXYBUTANOIC ACID C4 H9 N O3 THE COMPLEX OF A NOVEL ANTIBIOTIC WITH THE AMINOACYL SITE OF THE BACTERIAL RIBOSOME REVEALED BY X-RAY CRYSTALLOGRAPHY. EUBACTERIAL A-SITE ANTIBIOTIC/RNA ANTIBIOTIC/RNA, RNA-ANTIBIOTIC INTERACTIONS, A-SITE
Code Class Resolution Description 1nab nuc 2.15 7-[5-(4-AMINO-5-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2- YLOXY)-4-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY]-6, 9,11-TRIHYDROXY-9-(2-HYDROXY-ACETYL)-7,8,9,10- TETRAHYDRO-NAPHTHACENE-5,12-DIONE 2(C32 H37 N O13) THE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN A DISACCHARIDE ANTHRACYCLINE AND THE DNA HEXAMER D(CGATCG) REVEALS TWO DIF BINDING SITES INVOLVING TWO DNA DUPLEXES 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
Code Class Resolution Description 4y27 nuc 1.00 5'-O-[(S)-HYDROXY(METHYL)PHOSPHORYL]ADENOSINE C11 H16 N5 O6 P E.COLI 23S SARCIN-RICIL LOOP, MODIFIED WITH A 2-ME ON G2661 METHYLPHOSPHONATE ON A2662 27-MER SRL RNA RNA RNA, MODIFICATION, RIBOSOME
Code Class Resolution Description 5tra nuc model N(4)-ACETYLCYTIDINE-5'-MONOPHOSPHATE C11 H16 N3 O9 P SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA
Code Class Resolution Description 4yaz nuc 2.00 2-AMINO-9-[(2R,3R,3AS,5R,7AR,9R,10R,10AS,12R,14AR)-9- (6-AMINO-9H-PURIN-9-YL)-3,5,10,12-TETRAHYDROXY-5,12- DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9, 2,8]TETRAOXADIPHOSPHACYCLODODECIN-2-YL]-1,9-DIHYDRO- 6H-PURIN-6-ONE 2(C20 H24 N10 O13 P2) 3',3'-CGAMP RIBOSWITCH BOUND WITH 3',3'-CGAMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP,
Code Class Resolution Description 2n4m nuc NMR 2'-DEOXY-8-[(7-OXO-7H-BENZO[DE]ANTHRACEN-3-YL) AMINO]GUANOSINE 5'-(DIHYDROGEN PHOSPHATE) C27 H23 N6 O8 P BASE-DISPLACED INTERCALATED STRUCTURE OF THE N-(2'DEOXYGUANO 3-AMINOBENZANTHRONE DNA ADDUCT DNA (5'-D(*AP*CP*AP*AP*AP*CP*AP*CP*GP*CP*AP*C)-3' CHAIN: B, DNA (5'-D(*GP*TP*GP*CP*(4E9)P*TP*GP*TP*TP*TP*GP*T CHAIN: A DNA DNA
Code Class Resolution Description 2n5o nuc NMR [(2R,3S,5R)-5-(4-AZANYLPYRAZOLO[3,4-D]PYRIMIDIN-2-YL)- 3-OXIDANYL-OXOLAN-2-YL]METHYL DIHYDROGEN PHOSPHATE C10 H14 N5 O6 P UNIVERSAL BASE OLIGONUCLEOTIDE STRUCTURE DNA_(5'-D(*AP*TP*GP*GP*(4EN)P*GP*CP*TP*C)-3'), DNA_(5'-D(*GP*AP*GP*CP*TP*CP*CP*AP*T)-3') DNA NUCLEIC ACID, DNA, UNIVERSAL BASE, SYNTHETIC BASE
Code Class Resolution Description 2n9f nuc NMR (2S)-3-[(6-DEOXY-BETA-D-GLUCOPYRANOSYL)OXY]-2- HYDROXYPROPYL DIHYDROGEN PHOSPHATE C9 H19 O10 P GLUCOSE AS NON NATURAL NUCLEOBASE DNA (5'-D(*CP*TP*AP*GP*CP*GP*GP*TP*CP*AP*TP*C)-3' CHAIN: A, DNA (5'-D(*GP*AP*TP*GP*AP*CP*(4JA)P*GP*CP*TP*AP*G CHAIN: B DNA CARBOHYDRATE-DNA INTERACTION, CARBOHYDRATE NUCLEOBASE, DNA 2n9h nuc NMR (2S)-3-[(6-DEOXY-BETA-D-GLUCOPYRANOSYL)OXY]-2- HYDROXYPROPYL DIHYDROGEN PHOSPHATE C9 H19 O10 P GLUCOSE AS A NUCLEASE MIMIC IN DNA DNA (5'-D(*GP*AP*TP*GP*AP*CP*TP*GP*CP*TP*AP*G)-3' CHAIN: A, DNA (5'-D(*CP*TP*AP*GP*CP*(GL6)P*GP*TP*CP*AP*TP*C CHAIN: B DNA CARBOHYDRATE-DNA INTERACTION, GLUCOSE-NUCLEOBASE, DNA
Code Class Resolution Description
2n96 nuc NMR (1R,1'R,2S,2'S,3R,3'R,5AR,10AR,11A'S)-2'-[(2,6-DIDEOXY- 3-O-METHYL-ALPHA-L-ARABINO-HEXOPYRANOSYL)OXY]-2,2'- DIETHYL-11,11'-DIHYDRAZINYL-6,6',9,9'-TETRAHYDROXY-4, 4',5,5',10,10'-HEXAOXO-1,1'-BIS{[2,4,6-TRIDEOXY-4- (DIMETHYLAMINO)-BETA-L-ARABINO-HEXOPYRANOS C68 H90 N6 O24 AN UNEXPECTED MODE OF SMALL MOLECULE DNA BINDING PROVIDES TH STRUCTURAL BASIS FOR DNA CLEAVAGE BY THE POTENT ANTIPROLIFE AGENT (-)-LOMAIVITICIN A DNA (5'-D(*GP*CP*TP*AP*TP*AP*GP*C)-3') DNA DIAZOFLUORENE, INTERCALATOR, DNA
Code Class Resolution Description 4z4b nuc 1.97 5-(4-METHYLPIPERAZIN-1-YL)-2'-(PYRIDIN-2-YL)-1H,1'H-2, 5'-BIBENZIMIDAZOLE C24 H23 N7 2-PYRIDYL HOECHST - A NEW GENERATION DNA-BINDING RADIOPROTEC DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)-3' CHAIN: A, B DNA DNA, HOECHST
Code Class Resolution Description 2gi5 nuc model 3-(2'-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-METHYL-3,7-DIHYDRO-2H-PYRROLO[2,3- D]PYRIMIDIN-2-ONE C12 H16 N3 O7 P 7-MER DNA DUPLEX CONTAINING PYRROLO-DC SUBSTITUTION 5'-D(*CP*CP*TP*(4PC)P*TP*GP*C)-3', 5'-D(*GP*CP*AP*GP*AP*GP*G)-3' DEOXYRIBONUCLEIC ACID PYRROLO-DC DUPLEX DNA
Code Class Resolution Description 2gi6 nuc model 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-METHYL-1,3-DIHYDRO-2H-PYRROLO[2,3- D]PYRIMIDIN-2-ONE C12 H16 N3 O7 P 7-MER DNA DUPLEX CONTAINING PYRROLO-DC SUBSTITUTION (TAUTOMER 2) 5'-D(*CP*CP*TP*(4PD)P*TP*GP*C)-3', 5'-D(*GP*CP*AP*GP*AP*GP*G)-3' DEOXYRIBONUCLEIC ACID PYRROLO-DC DNA DUPLEX
Code Class Resolution Description 2gi8 nuc model 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-METHYL-3H-PYRROLO[2,3-D]PYRIMIDIN-2- OL C12 H16 N3 O7 P 7-MER DNA DUPLEX CONTAINING PYRROLO-DC MODIFICATION (TAUTOMER 3) 5'-D(*GP*CP*AP*GP*AP*GP*G)-3', 5'-D(*CP*CP*TP*(4PE)P*TP*GP*C)-3' DEOXYRIBONUCLEIC ACID PYRROLO-DC DNA DUPLEX
Code Class Resolution Description 5kpy nuc 2.00 5-HYDROXY-L-TRYPTOPHAN C11 H12 N2 O3 STRUCTURE OF A 5-HYDROXYTRYPTOPHAN APTAMER 5-HYDROXYTRYPTOPHAN RNA APTAMER RNA RNA, APTAMER, RIBOSWITCH, 5-HYDROXYTRYPTOPHAN
Code Class Resolution Description 2gxy nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,2-BIS[5-(2-AMIDINO)-2-BENZIMIDAZOLYL]ETHANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 3bbv nuc 10.00 4-THIOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O8 P S THE TRNA(PHE) FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF 50S.NC-TRNA.HSP15 COMPLEX TRNA(PHE) RIBOSOME PHE, TRNA, RESCUE STALLED RIBOSOME, RIBOSOME 3cw5 nuc 3.10 4-THIOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O8 P S E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 3cw6 nuc 3.30 4-THIOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O8 P S E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 5l4o nuc 2.80 4-THIOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O8 P S STRUCTURE OF AN E.COLI INITIATOR TRNAFMET A1-U72 VARIANT TRNA (76-MER) TRANSLATION TRNA-TRANSLATION INITIATION, TRANSLATION
Code Class Resolution Description 5cdb nuc 1.70 13-DIPHENYLALKYL BERBERINE C36 H34 N O4 1+ STRUCTURE OF THE COMPLEX OF A BIMOLECULAR HUMAN TELOMERIC DN 13-DIPHENYLALKYL BERBERINE DERIVATIVE HUMAN TELOMERIC DNA DNA DRUG-DNA COMPLEX, G-QUADRUPLEX, DNA
Code Class Resolution Description
5c7w nuc 3.22 [(2R,3S,4R,5R)-5-(4-AZANYL-2-OXIDANYLIDENE-1$L^{4},3,5, 7-TETRAZABICYCLO[4.3.0]NONA-1(6),3,8-TRIEN-7-YL)-3,4- BIS(OXIDANYL)OXOLAN-2-YL]METHYL DIHYDROGEN PHOSPHATE C10 H15 N5 O8 P 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH BOUND TO HYPOXANTHIN 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH RNA EXPANDED RNA; RIBOSWITCH; UNNATURAL BASE PAIR, RNA
Code Class Resolution Description 5c7w nuc 3.22 (1S)-1-(6-AMINO-2-HYDROXY-5-NITROPYRIDIN-3-YL)-1,4- ANHYDRO-5-O-PHOSPHONO-D-RIBITOL C10 H14 N3 O10 P 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH BOUND TO HYPOXANTHIN 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH RNA EXPANDED RNA; RIBOSWITCH; UNNATURAL BASE PAIR, RNA
Code Class Resolution Description
5c45 nuc 2.93 2-[(3S)-1-{[2-(METHYLAMINO)PYRIMIDIN-5- YL]METHYL}PIPERIDIN-3-YL]-6-(THIOPHEN-2-YL)PYRIMIDIN- 4(1H)-ONE C19 H22 N6 O S SELECTIVE SMALL MOLECULE INHIBITION OF THE FMN RIBOSWITCH FMN RIBOSWITCH, FMN RIBOSWITCH RNA/INHIBITOR RNA, TRANSLATION, RNA-INHIBITOR COMPLEX
Code Class Resolution Description 5ccw nuc 1.89 AU(CAFFEIN-2-YLIDENE)2 3(C18 H24 AU N8 O4 3+) STRUCTURE OF THE COMPLEX OF A HUMAN TELOMERIC DNA WITH AU(CA YLIDENE)2 HUMAN TELOMERIC DNA DRUG/DNA DRUG-DNA COMPLEX, G-QUADRUPLEX
Code Class Resolution Description 5dam nuc 1.95 P-IODO HOECHST C25 H23 I N6 CRYSTAL STRUCTURE OF P-IODOHOECHST BOUND TO D(CGCAAATTTGCG) DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)-3' CHAIN: A, B DNA MINOR GROOVE BINDER DNA, DNA
Code Class Resolution Description 2gy6 nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-AMIDINO)-2-[2-(4-HYDROXYPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gy8 nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-AMIDINO)-2-[2-(4-METHOXYPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gye nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-AMIDINO)-2-[2-(4-ETHOXYPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gyf nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-IMIDAZOLINYL)-2-[2-(4-ETHOXYPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gyg nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-IMIDAZOLINYL)-2-[2-(4-ETHOXYPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gyh nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-PYRIMIDINYL)-2-[2-(4-HYDROXYPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gyj nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-IMIDAZOLINYL)-2-[2-(2-IMIDAZOLINYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gyl nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2- PYRIMIDINYL)-2-[2-(2- PYRIMIDINYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description
2gxi nuc model 2,5-BIS{[4-(3-PENTYL)DIAMINOMETHYL]PHENYL}FURAN C28 H40 N4 O MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 2,5-BIS{[4-(3-PENTYL)DIAMINOMETHYL]PHENYL}FURAN DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, FURAN DERIVATIVE
Code Class Resolution Description 1c95 nuc NMR 5'-AMINO-5'-DEOXYTHYMIDINE 2(C10 H15 N3 O4) SOLUTION STRUCTURE OF THE AMINOACYL-CAPPED OLIGODEOXYRIBONUCLEOTIDE DUPLEX TRP-D(TGCGCAC)2 5'-D((5AT)TP*GP*CP*GP*CP*AP*C)-3' DNA DOUBLE HELIX, AMINOACYL-CAPPED DNA 1kse nuc NMR 5'-AMINO-5'-DEOXYTHYMIDINE 2(C10 H15 N3 O4) SOLUTION STRUCTURE OF A QUINOLONE-CAPPED DNA DUPLEX 5'-D(*(5AT)P*GP*CP*GP*CP*A)-3' DNA DNA, QUINOLONE, SYNTHETIC HYBRID, DISRUPTED TERMINAL BASEPAIRS 1on5 nuc NMR 5'-AMINO-5'-DEOXYTHYMIDINE 2(C10 H15 N3 O4) SOLUTION STRUCTURE OF A CHOLIC ACID-CAPPED DNA DUPLEX STEROID-DNA HYBRID DNA DNA, STEROID, SYNTHETIC HYBRID
Code Class Resolution Description 3la5 nuc 1.70 6-AMINO-1,3,5-TRIAZIN-2(1H)-ONE C3 H4 N4 O X-RAY CRYSTAL STRUCTURE OF MC6 RNA RIBOSWITCH BOUND TO AZACYTOSINE ADENOSINE RIBOSWITCH RNA RNA, RIBOSWITCH, GENE REGULATION, SYNTHETIC BIOLOGY
Code Class Resolution Description 3gdd nuc 2.80 N,N'-(9,10-DIOXO-9,10-DIHYDROANTHRACENE-2,7-DIYL)BIS[2- (DIMETHYLAMINO)ACETAMIDE] 4(C22 H24 N4 O4) AN INVERTED ANTHRAQUINONE-DNA CRYSTAL STRUCTURE 5'-D(*(BRU)P*AP*GP*G)-3' DNA ANTHRAQUINONE, TELOMERE DNA SEQUENCE, DRUG-DNA COMPLEX, DNA
Code Class Resolution Description 5lfs nuc 1.85 5-BROMO-2'-DEOXYCYTIDINE C9 H12 BR N3 O4 LAMBDA-[RU(BPY)2(DPPZ)]2+ BOUND TO BROMINATED DNA DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, INTERCALATION, LIGHT-SWITCH 5lfw nuc 1.28 5-BROMO-2'-DEOXYCYTIDINE C9 H12 BR N3 O4 LAMBDA-[RU(PHEN)2(DPPZ)]2+ BOUND TO A SHORT SUBSTITUTED DNA DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, INTERCALATION, LIGHT-SWITCH 5lfx nuc 1.56 5-BROMO-2'-DEOXYCYTIDINE C9 H12 BR N3 O4 LAMBDA-[RU(PHEN)2(DPPZ-11,12-ME)]2+ BOUND TO A SHORT SUBSTIT SEQUENCE DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, LIGHT-SWITCH, INTERCALATION
Code Class Resolution Description 1f1t nuc 2.80 5-BROMO-URIDINE-5'-MONOPHOSPHATE 5(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE MALACHITE GREEN APTAMER COMPLEXED WITH TETRAMETHYL-ROSAMINE MALACHITE GREEN APTAMER RNA RNA U-TURN, BASE QUADRUPLE, BASE TRIPLE, GNRA TETRALOOP, 5- BROMO-URIDINE, RNA 1jzv nuc 1.70 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF A BULGED RNA FROM THE SL2 STEM-LOOP OF THE HIV-1 PSI-RNA 5'-R(*GP*GP*CP*GP*AP*CP*(5BU)P*G)-3', 5'-R(*CP*AP*GP*UP*AP*CP*GP*(5IC)P*C)-3' RNA A-BULGE, A-RNA, HIV-1 SL2, X-RAY 1kfo nuc 1.60 5-BROMO-URIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O9 P CRYSTAL STRUCTURE OF AN RNA HELIX RECOGNIZED BY A ZINC- FINGER PROTEIN: AN 18 BASE PAIR DUPLEX AT 1.6 RESOLUTION 5'- R(*GP*AP*AP*UP*GP*CP*CP*UP*GP*CP*GP*AP*GP*CP*AP*(5BU) P*CP*CP*C)-3' RNA RNA 1kh6 nuc 2.90 5-BROMO-URIDINE-5'-MONOPHOSPHATE 6(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF AN RNA TERTIARY DOMAIN ESSENTIAL TO HCV MEDIATED TRANSLATION INITIATION. JIIIABC RNA TRANSLATION, RNA STRUCTURE, IRES, HCV, BROMINE, FOUR-WAY JUN RNA 1y3o nuc 2.70 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) HIV-1 DIS RNA SUBTYPE F- MN SOAKED 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1y3s nuc 2.25 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) HIV-1 DIS RNA SUBTYPE F- MPD FORM 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1y90 nuc 3.08 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) HIV-1 DIS(MAL) DUPLEX MN-SOAKED 5'-R(*CP*(5BU) P*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP* AP*G)-3' RNA HIV-1, RNA, METAL IONS, BULGE 1yxp nuc 2.40 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) HIV-1 DIS RNA SUBTYPE F- ZN SOAKED 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA HIV-1, RNA, KISSING-LOOP, METAL IONS 1zci nuc 1.65 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) HIV-1 DIS RNA SUBTYPE F- MONOCLINIC FORM 5'-R(*CP*(5BU) P*UP*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP* AP*G)-3' RNA HIV-1, RNA, LOOP-LOOP COMPLEX, METAL IONS 2ao5 nuc 2.10 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF AN RNA DUPLEX R(GGCGBRUGCGCU)2 WITH TERMINAL AND INTERNAL TANDEM G-U BASE PAIRS 5'-R(*GP*GP*CP*GP*(5BU)P*GP*CP*GP*CP*U)-3' RNA G-U BASE PAIR, RNA DUPLEX 2fcx nuc 2.00 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEAMINE HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2fcy nuc 2.20 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2fcz nuc 2.01 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH RIBOSTAMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2fd0 nuc 1.80 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH LIVIDOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2jlt nuc 2.90 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF AN RNA KISSING COMPLEX R06, TAR RNA RNA, KISSING COMPLEX 2oeu nuc 2.00 5-BROMO-URIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O9 P FULL-LENGTH HAMMERHEAD RIBOZYME WITH MN(II) BOUND HAMMERHEAD RIBOZYME, 5'-R(*GP*GP*CP*GP*UP*(OMC)P*CP*UP*GP*GP*(5BU) P*AP*UP*CP*CP*AP*AP*UP*CP*(DC))-3' RNA RIBOZYME, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, MANGANESE, MN 2pn3 nuc 2.90 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF HEPATITIS C VIRUS IRES SUBDOMAIN IIA 5'-R(*GP*CP*GP*(5BU) P*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*(5BU)P*CP*CP*GP*G)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 98-117), 5'- R(*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*UP*CP*UP*UP*CP *AP*CP*GP*CP*C)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 47-70) RNA HCV, IRES, LOOP IIA, RNA, MAGNESIUM, CRYSTALLIZATION, CRYSTAL STRUCTURE 2pn4 nuc 2.32 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF HEPATITIS C VIRUS IRES SUBDOMAIN IIA 5'-R(*GP*CP*GP*(5BU) P*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*(5BU)P*CP*CP*GP*G)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 98-117), 5'-R(*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*U *CP*AP*CP*GP*CP*C)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 47-70) RNA HCV, IRES, SUBDOAMIN IIA, RNA, STRONTIUM, HEPATITIS 2r1s nuc 1.40 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.4 A (BR1) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA ASYMMETRY, ELECTROSTATIC, MONOVALENT CATIONS, STRUCTURAL PLASTICITY, RNA 2r20 nuc 1.30 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.3 A (BR2) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA ASYMMETRY, METAL ION BINDING, UNSTACKING, ELECTROSTATIC, RNA 2r21 nuc 1.59 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.6 A (BRMN) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA MANGANESE, ASYMMETRY, ELECROSTATIC, MNOVALENT, RNA 3bno nuc 2.35 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE (BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME RNA RIBOSOME, DECODING SITE, RNA 3bnq nuc 2.00 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF SRCL2 (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, B CHAIN, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, A CHAIN RNA RIBOSOME, DECODING SITE, RNA 3bnr nuc 2.10 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF NONSPECIFICALLY BOUND PAROMOMYCIN (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN THREE, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN TWO, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN ONE RNA RIBOSOME, DECODING SITE, RNA 3bns nuc 1.90 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMA SITE (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN TWO CHAIN: B, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN THR CHAIN: D, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN THR CHAIN: A, C RNA RIBOSOME, DECODING SITE, RNA 3bnt nuc 2.30 5-BROMO-URIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O9 P CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF [CO(NH3)6]CL3 (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME RNA RIBOSOME, DECODING SITE, RNA 3ibk nuc 2.20 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF A TELOMERIC RNA QUADRUPLEX RNA (5'-R(*(5BU)P*AP*GP*GP*GP*UP*UP*AP*GP*GP*GP*U CHAIN: A, B RNA RNA QUADRUPLEX, BIMOLECULAR QUADRUPLEX, PARALLEL STRANDED, R 3loa nuc 2.30 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE ANALYSIS OF THE RNA CONSTRUCT WITH TWO ADJ LIGAND BINDING SITES OF HELIX H44 IN 16S RIBOSOMAL RNA 5'-R(*CP*CP*GP*CP*GP*CP*CP*CP*GP*(5BU) P*CP*AP*CP*AP*CP*CP*AP*CP*CP*CP*G)-3', 5'-R(*GP*GP*GP*(5BU) P*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*UP*AP*AP*CP*GP*CP*GP*GP*C)- CHAIN: B RNA RNA, A-SITE, HYGROMYCIN B BINDING SITE, AMINOGLYCOSIDE 3mei nuc 1.97 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) REGULATORY MOTIF FROM THE THYMIDYLATE SYNTHASE MRNA RNA (5'-R(*CP*CP*GP*CP*CP*GP*CP*GP*CP*CP*AP*(5BU) P*GP*CP*CP*UP*GP*UP*GP*GP*CP*GP*G)-3') RNA S-TURN, C-C BASE PAIR, RNA 3p59 nuc 2.18 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) FIRST CRYSTAL STRUCTURE OF A RNA NANOSQUARE RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*CP*CP*U)-3'), RNA (5'-R(*CP*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP P*G)-3') RNA RNA SQUARE, RNA 3td0 nuc 1.60 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408G-MUTANT AND THE PRO CYTOPLASMIC RIBOSOMAL DECODING SITE RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA DECODING, RIBOSOME, RNA 3td1 nuc 2.10 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408G-MUTANT AND THE PRO CYTOPLASMIC RIBOSOMAL DECODING SITE IN COMPLEX WITH GENETIC RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA/ANTIBIOTIC DECODING, RIBOSOME, RNA-ANTIBIOTIC COMPLEX 3zd5 nuc 2.20 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) THE 2.2 A STRUCTURE OF A FULL-LENGTH CATALYTICALLY ACTIVE HAMMERHEAD RIBOZYME HAMMERHEAD RIBOZYME, ENZYME STRAND, HAMMERHEAD RIBOZYME, SUBSTRATE STRAND RNA CATALYTIC RNA, IN-LINE ATTACK, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, RNA 406d nuc 1.80 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) 5'-R(*CP*AP*CP*CP*GP*GP*AP*UP*GP*GP*UP*(BRO) UP*CP*GP*GP*UP* RNA (5'-R(*CP*AP*CP*CP*GP*GP*AP*UP*GP*GP*UP*(5BU) P*CP*GP*GP*UP*G)-3') RNA DISORDERED, RNA, DOUBLE HELIX 4p3s nuc 2.30 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408C-MUTANT RIBOSOMAL D SITE IN COMPLEX WITH GENETICIN 5'-R(*UP*UP*GP*CP*GP*UP*CP*CP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3' RNA/ANTIBIOTIC RIBOSOME, ANTIBIOTIC-RESISTANCE, AMINOGLYCOSIDE, DECODING, R ANTIBIOTIC COMPLEX 4p3t nuc 1.60 5-BROMO-URIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408C-MUTANT RIBOSOMAL D SITE 5'-D(*UP*UP*GP*CP*GP*UP*CP*CP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3' RNA RIBOSOME, ANTIBIOTIC-RESISTANCE, AMINOGLYCOSIDE, DECODING, R 4p3u nuc 3.00 5-BROMO-URIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O9 P) CRYSTAL STRUCTURE OF THE BACTERIAL A1408U-MUTANT RIBOSOMAL D SITE (C2 FORM 1) 5'-R(*UP*UP*GP*CP*GP*UP*CP*UP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3' RNA RIBOSOME, ANTIBIOTIC-RESISTANCE, AMINOGLYCOSIDE, DECODING, R
Code Class Resolution Description 3jxq nuc 1.45 5-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 4(C9 H13 F N3 O8 P) X-RAY STRUCTURE OF R[CGCG(5-FLUORO)CG]2 R[CGCG(5-FLUORO)CG]2 RNA RNA, DOUBLE HELIX 3jxr nuc 1.25 5-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 3(C9 H13 F N3 O8 P) X-RAY STRUCTURE OF R[CGCG(5-FLUORO)CG]2 R[CGCG(5-FLUORO)CG]2 RNA RNA, DOUBLE HELIX
Code Class Resolution Description 122d nuc 1.70 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) DNA HELIX STRUCTURE AND REFINEMENT ALGORITHM: COMPARISON OF MODELS FOR D(CCAGGCM==5==CTGG) DERIVED FROM NUCLSQ, TNT, AND X-PLOR DNA (5'-D(*CP*CP*AP*GP*GP*CP*(5CM)P*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 123d nuc 1.70 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) DNA HELIX STRUCTURE AND REFINEMENT ALGORITHM: COMPARISON OF MODELS FOR D(CCAGGCM==5==CTGG) DERIVED FROM NUCLSQ, TNT, AND X-PLOR DNA (5'-D(*CP*CP*AP*GP*GP*CP*(5CM)P*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 145d nuc 1.25 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 5(C10 H16 N3 O7 P) STRUCTURE AND THERMODYNAMICS OF NONALTERNATING C/G BASE PAIRS IN Z-DNA: THE 1.3 ANGSTROMS CRYSTAL STRUCTURE OF THE ASYMMETRIC HEXANUCLEOTIDE D(M(5)CGGGM(5) CG)/D(M(5) CGCCM(5)CG) DNA (5'-D(*(MCY)P*GP*GP*GP*(5CM)P*G)-3'), DNA (5'-D(*(5CM)P*DGP*DGP*DGP*(5CM)P*DG)-3'), DNA (5'-D(*(MCY)P*GP*CP*CP*(5CM)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1d17 nuc 2.00 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) DNA-NOGALAMYCIN INTERACTIONS DNA (5'-D(*(5CM)P*GP*TP*AP*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE 1d21 nuc 1.70 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) BINDING OF THE ANTITUMOR DRUG NOGALAMYCIN AND ITS DERIVATIVE STRUCTURAL COMPARISON DNA (5'-D(*(5CM)P*GP*TP*(AS)P*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE 1d22 nuc 1.80 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) BINDING OF THE ANTITUMOR DRUG NOGALAMYCIN AND ITS DERIVATIVES TO DNA: STRUCTURAL COMPARISON DNA (5'-D(*(5CM)P*GP*TP*(AS)P*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1d40 nuc 1.30 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) BASE SPECIFIC BINDING OF COPPER(II) TO Z-DNA: THE 1.3- ANGSTROMS SINGLE CRYSTAL STRUCTURE OF D(M5CGUAM5CG) IN THE PRESENCE OF CUCL2 DNA (5'-D(*(5CM)P*(CU)GP*UP*AP*(5CM)P*(CU)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1d41 nuc 1.30 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) STABILIZATION OF Z-DNA BY DEMETHYLATION OF THYMINE BASES: 1.3 ANGSTROMS SINGLE-CRYSTAL STRUCTURE OF D(M5CGUAM5CG) DNA (5'-D(*(5CM)P*GP*UP*AP*(5CM)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1el2 nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O7 P SOLUTION STRUCTURE OF A MODIFIED HUMAN TELOMERE FRAGMENT (STRUCTURE "A") 5'-D(*CP*CP*CP*TP*AP*AP*(5CM) P*CP*CP*TP*AP*AP*CP*CP*CP*UP*AP*AP*CP*CP*CP*T)-3' DNA DNA SOLUTION STRUCTURE, I-MOTIF, INTERACTING LOOPS, LOOP MOTIONS, NMR, TELOMERE 1eln nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O7 P SOLUTION STRUCTURE OF A MODIFIED HUMAN TELOMERE FRAGMENT (STRUCTURE "S") 5'-D(*CP*CP*CP*TP*AP*AP*(5CM) P*CP*CP*TP*AP*AP*CP*CP*CP*UP*AP*AP*CP*CP*CP*T)-3' DNA DNA SOLUTION STRUCTURE, I-MOTIF, INTERACTING LOOPS, LOOP MOTIONS, NMR, TELOMERE 1f6e nuc 2.00 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF THE A-DNA HEXAMER GGCGM5CC DNA (5'-D(*GP*GP*CP*GP*(5CM)P*C)-3') DNA A-DNA, E-DNA, DOUBLE HELIX 1f6i nuc 2.20 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF THE E-DNA HEXAMER GGCGM5CC DNA (5'-D(*GP*GP*CP*GP*(5CM)P*C)-3') DNA E-DNA, DOUBLE HELIX, METHYLATION 1fv7 nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 8(C10 H16 N3 O7 P) A TWO B-Z JUNCTION CONTAINING DNA RESOLVES INTO AN ALL RIGHT DOUBLE HELIX 5'-D(*(5CM)P*GP*(5CM)P*GP*(0DC)P*(0DG)P*(5CM)P*GP P*G)-3' DNA DNA POLYMORPHISM, L ENANTIOMERY, ANTISENSE, DNA 1ih3 nuc 2.40 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 16(C10 H16 N3 O7 P) MULTI-CONFORMATION CRYSTAL STRUCTURE OF GGM5CGM5CC 5'-D(*GP*GP*(5CM)P*GP*(5CM)P*C)-3' DNA B TO A DNA TRANSITION, DNA TRANSITION, STRUCTURAL TRANSITION 1ih4 nuc 1.90 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 8(C10 H16 N3 O7 P) MULTI-CONFORMATION CRYSTAL STRUCTURE OF GGM5CGCC 5'-D(*GP*GP*(5CM)P*GP*CP*C)-3' DNA B TO A DNA TRANSITION, DNA TRANSITION, STRUCTURAL TRANSITION 1l6b nuc 1.50 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE ALL DNA HOLLIDAY JUNCTION STRUCTURE OF CCGGTACM5CGG 5'-D(*CP*CP*GP*GP*TP*AP*CP*(5CM)P*GP*G)-3' DNA HOLLIDAY JUNCTION, DNA FOUR-WAY JUNCTION, CYTOSINE METHYLATION 1r3z nuc 1.70 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(GM5CGM5CGCGC) AND D(GCGCGM5CGM5C): EFFECTS OF METHYLATION ON ALTERNATING DNA OCTAMERS 5'-D(*GP*(5CM)P*GP*(5CM)P*GP*CP*GP*C)-3' DNA DNA 1r41 nuc 1.90 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(GM5CGM5CGCGC) AND D(GCGCGM5CGM5C): EFFECTS OF METHYLATION ON ALTERNATING DNA OCTAMERS 5'-D(*GP*CP*GP*CP*GP*(5CM)P*GP*(5CM))-3' DNA DNA 1s1l nuc 2.20 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) INFLUENCE OF GROOVE INTERACTIONS ON THE FORMATION OF DNA HOLLIDAY JUNCTIONS 5'-D(*CP*CP*(OIP)*GP*TP*AP*CP*(5CM)P*GP*G)-3' DNA HOLLIDAY JUNCTION, DNA FOUR-WAY JUNCTION, X-RAY DIFFRACTION, MAJOR GROOVE, INOSINE, MINOR GROOVE 1vtv nuc 1.30 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O7 P) MOLECULAR STRUCTURE OF (M5DC-DG)3: THE ROLE OF THE METHYL GR METHYL CYTOSINE IN STABILIZING Z-DNA DNA (5'-D(*(CH3)CP*GP*(CH3)CP*GP*(CH3)CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, DNA 1vtw nuc 1.20 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) AT BASE PAIRS ARE LESS STABLE THAN GC BASE PAIRS IN Z-DNA: T STRUCTURE OF D(M(5)CGTAM(5)CG) DNA (5'-D(*(CH3)CP*GP*TP*AP*(CH3)CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, DNA 1y9h nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O7 P METHYLATION OF CYTOSINE AT C5 IN A CPG SEQUENCE CONTEXT CAUSES A CONFORMATIONAL SWITCH OF A BENZO[A]PYRENE DIOL EPOXIDE-N2-GUANINE ADDUCT IN DNA FROM A MINOR GROOVE ALIGNMENT TO INTERCALATION WITH BASE DISPLACEMENT 5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3', 5'-D(*CP*CP*AP*TP*(5CM)P*(BPG)P*CP*TP*AP*CP*C)- 3' DNA CONFORMATIONAL SWITCH, CYTOSINE METHYLATION, P53 MUTATION HOT SPOT, DNA ADDUCT, BENZO[A]PYRENE, BPDE 213d nuc 1.60 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF THE A-DNA DECAMER D(CCIGGCCM5CGG) AT 1.6 ANGSTROMS SHOWING THE UNEXPECTED WOBBLE I.M5C BASE PAIR DNA (5'-D(*CP*CP*IP*GP*GP*CP*CP*(5CM)P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 229d nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O7 P DNA ANALOG OF YEAST TRANSFER RNA PHE ANTICODON DOMAIN WITH MODIFIED BASES 5-METHYL CYTOSINE AND 1-METHYL GUANINE DNA (5'-D(*CP*CP*AP*GP*AP*CP*(UMP) P*GP*AP*AP*(MG1)P*AP*(UMP)P*(5CM)P*(UMP)P*GP*G)-3') DNA DNA, TRANSFER RNA, ANTICODON, HAIRPIN LOOP 254d nuc 1.90 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) ALTERNATING AND NON-ALTERNATING DG-DC HEXANUCLEOTIDES CRYSTALLIZE AS CANONICAL A-DNA DNA (5'-D(*GP*(5CM)P*GP*(5CM)P*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 256d nuc 2.20 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) ALTERNATING AND NON-ALTERNATING DG-DC HEXANUCLEOTIDES CRYSTALLIZE AS CANONICAL A-DNA DNA (5'-D(*GP*(5CM)P*GP*CP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 265d nuc 2.01 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*(5CM)P*GP*AP*AP*TP*TP*(5CM)P*GP* CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA 266d nuc 2.03 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA 267d nuc 2.00 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA 268d nuc 2.02 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA 269d nuc 2.15 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA 270d nuc 2.01 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA 275d nuc 2.00 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) ALTERNATING AND NON-ALTERNATING DG-DC HEXANUCLEOTIDES CRYSTALLIZE AS CANONICAL A-DNA DNA (5'-D(*GP*(5CM)P*CP*GP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 285d nuc 2.50 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) X-RAY AND SOLUTION STUDIES OF DNA OLIGOMERS AND IMPLICATIONS FOR THE STRUCTURAL BASIS OF A-TRACT-DEPENDENT CURVATURE DNA (5'-D(*CP*GP*CP*AP*IP*AP*TP*(5CM) P*TP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 297d nuc 2.50 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) X-RAY AND SOLUTION STUDIES OF DNA OLIGOMERS AND IMPLICATIONS FOR THE STRUCTURAL BASIS OF A-TRACT-DEPENDENT CURVATURE DNA (5'-D(*CP*GP*CP*AP*IP*AP*TP*(5CM) P*TP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 2d25 nuc 1.75 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) C-C-A-G-G-C-M5C-T-G-G; HELICAL FINE STRUCTURE, HYDRATION, AND COMPARISON WITH C-C-A-G-G-C-C-T-G-G DNA (5'-D(*CP*CP*AP*GP*GP*CP*(5CM)P*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 313d nuc 1.68 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) Z-DNA HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE HOOGSTEEN BASE PAIR DNA (5'-D(*GP*(5CM)P*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, OVERHANGING BASE, FLIPPED- OUT BASE 322d nuc 2.50 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG)-HEXAGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*(5CM)P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 323d nuc 2.15 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*(5CM)P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 324d nuc 2.15 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*(5CM)P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 325d nuc 2.50 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(CM5CGGGCCM5CGG)-HEXAGONAL FORM DNA (5'-D(*CP*(5CM)P*GP*GP*GP*CP*CP*(5CM)P*GP*G)- 3') DNA A-DNA, DOUBLE HELIX, MODIFIED 326d nuc 2.15 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(CM5CGGGCCM5CGG)-ORTHOGONAL FORM DNA (5'-D(*CP*(5CM)P*GP*GP*GP*CP*CP*(5CM)P*GP*G)- 3') DNA A-DNA, DOUBLE HELIX, MODIFIED 327d nuc 1.94 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURES OF D(GM5CGM5CGCGCGC) DNA (5'-D(*GP*(5CM)P*GP*(5CM)P*GP*CP*GP*CP*GP*C)- 3') DNA A-DNA, DOUBLE HELIX, MODIFIED 329d nuc 2.70 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) EFFECT OF CYTOSINE METHYLATION ON DNA-DNA RECOGNITION AT CPG STEPS DNA (5'-D(*AP*CP*CP*GP*CP*(5CM) P*GP*GP*CP*GP*CP*C)-3'), DNA (5'-D(*GP*GP*CP*GP*CP*(5CM) P*GP*GP*CP*GP*GP*T)-3') DNA B-DNA, DOUBLE HELIX 337d nuc 1.85 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*CP*GP*(5CM)P*GP*(5CM)P*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 338d nuc 1.85 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O7 P STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*GP*CP*GP*CP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 339d nuc 2.20 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*GP*CP*GP*(5CM)P*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 340d nuc 1.60 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*GP*(5CM)P*GP*CP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 341d nuc 1.75 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*GP*(5CM)P*GP*CP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 342d nuc 2.10 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 3(C10 H16 N3 O7 P) STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*GP*(5CM)P*GP*(5CM)P*GP*C)- 3') DNA A-DNA, DOUBLE HELIX, MODIFIED 343d nuc 2.10 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 8(C10 H16 N3 O7 P) STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*TP*AP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 345d nuc 1.85 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O7 P STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*GP*CP*GP*CP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 346d nuc 2.10 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 3(C10 H16 N3 O7 P) STRUCTURAL PARAMETERS FROM SINGLE-CRYSTAL STRUCTURES FOR ACCURATE MODELS OF A-DNA DNA (5'-D(*GP*(5CM)P*GP*(5CM)P*GP*(5CM)P*GP*C)- 3') DNA A-DNA, DOUBLE HELIX, MODIFIED 383d nuc 1.70 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O7 P) HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DNA DNA (5'-D(*CP*(5CM)P*GP*CP*(5CM)P*GP*GP*(5CM) P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED DEOXYRIBONUCLEIC ACID 384d nuc 2.15 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O7 P) HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DNA 5'-D(*CP*(5CM)P*GP*CP*(5CM)P*GP*GP*(5CM)P*GP*G)- 3' DNA A-DNA, DOUBLE HELIX, MODIFIED 400d nuc 1.65 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) THE INTRINSIC STRUCTURE AND STABILITY OF OUT-OF-ALTERNATION IN Z-DNA DNA (5'-D(*(5CM)P*GP*GP*CP*(5CM)P*G)-3') DNA Z-DNA DOUBLE HELIX, DNA 4c63 nuc 1.32 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) ULTRA HIGH RESOLUTION DICKERSON-DREW DODECAMER B-DNA WITH 5- METHYLCYSTOSINE MODIFICATION 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*5CMP*GP*CP*GP)-3' DNA DNA, CYTOSINE MODIFICATION 4gju nuc 1.41 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) 5-METHYLCYTOSINE MODIFIED DNA OLIGOMER 5-METHYLCYTOSINE MODIFIED DNA OLIGOMER DNA DOUBLE-STRANDED B-DNA, 5-METHYLCYTOSINE, EPIGENETICS, DNA 4glg nuc 1.72 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) DNA DODECAMER CONTAINING 5-METHYL CYTOSINE DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA DODECAMER, EPIGENETICS, 5-METHYL CYTOSINE, DNA 4mkw nuc 1.22 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) COMPARISON OF THE STRUCTURAL AND DYNAMIC EFFECTS OF 5-METHYL AND 5-CHLOROCYTOSINE IN A CPG DINUCLEOTIDE SEQUENCE 5METHYLC DNA DODECAMER DNA MODIFIED DNA DODECAMER, DNA 4u6l nuc 1.90 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF DNA/RNA DUPLEX OBTAINED IN THE PRESENCE [CO(NH3)6]CL3 AND SRCL2 DNA (5'-D(*(5CM)P*TP*CP*TP*TP*CP*TP*TP*(5CM))-3') CHAIN: B, RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3') DNA/RNA DNA/RNA HYBRID DUPLEX, ANTISENSE, DNA-RNA COMPLEX 4u6m nuc 1.90 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF DNA/RNA DUPLEX OBTAINED IN THE PRESENCE SPERMINE DNA (5'-D(*(5CM)P*TP*CP*TP*TP*CP*TP*TP*(5CM))-3') CHAIN: B, RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3') DNA/RNA DNA/RNA HYBRID DUPLEX, ANTISENSE, DNA-RNA COMPLEX 5dsa nuc 1.69 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF HOLLIDAY JUNCTIONS STABILIZED BY 5-METH IN GCC JUNCTION CORE 5'-D(*CP*CP*GP*GP*CP*GP*5CMP*CP*GP*G)-3' DNA HOLLIDAY JUNCTION, 5-METHYLCYTOSINE, DNA 5l06 nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE POSITION DNA (5'-D(*CP*GP*(5CM)P*GP*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, CPG SITE 5l2g nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE POSITION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, CPG SITE 5tmi nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE POSITION AND 9TH POSITION DNA (5'-D(*CP*GP*(5CM)P*GP*AP*AP*TP*TP*(5CM)P*GP* CHAIN: A, B DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, CPG SITE 5uz1 nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE POSITION AND 8-OXOGUANINE AT THE 10TH POSITION DNA (5'-D(*CP*GP*(DMC)P*GP*AP*AP*TP*TP*CP*(8OG)P* CHAIN: A, B DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, 8-OXOGUANINE, OXIDIZED DNA, CPG SITE 5uz2 nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE AND 9TH POSITION AND 8-OXOGUANINE AT THE 10TH POSITION DNA (5'-D(*CP*GP*(DMC)P*GP*AP*AP*TP*TP*(DMC)P*(8O 3') DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, 8-OXOGUANINE, OXIDIZED DNA, CPG SITE 5uz3 nuc NMR 5-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE POSITION AND 8-OXOGUANINE AT THE 10TH POSITION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(DMC)P*(8OG)P* CHAIN: A, B DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, CPG SITE, 8-OXOGUANINE, 5-METHYLCYTOSINE
Code Class Resolution Description 1ve8 nuc 1.65 5-FORMYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H14 N3 O8 P) X-RAY ANALYSES OF OLIGONUCLEOTIDES CONTAINING 5- FORMYLCYTOSINE, SUGGESTING A STRUCTURAL REASON FOR CODON- ANTICODON RECOGNITION OF MITOCHONDRIAL TRNA-MET; PART 1, D(CGCGAATT(F5C)GCG) 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5FC)P*GP*CP*G)-3' DNA 5-FORMYLCYTOSINE, ANTICODON OF TRNA-MET, DNA DODECAMER 4qc7 nuc 1.90 5-FORMYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H14 N3 O8 P) DODECAMER STRUCTURE OF 5-FORMYLCYTOSINE CONTAINING DNA SHORT DNA STRANDS DNA DOUBLE HELIX, B-FORM DNA, 5-FORMYLCYTOSINE, DNA 4qkk nuc 1.40 5-FORMYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 3(C10 H14 N3 O8 P) CRYSTAL STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING 5-FORMYLC DNA (5'-D(*CP*TP*AP*(5FC)P*GP*(5FC)P*GP*(5FC)P*GP 3') DNA OLIGONUCLEOTIDE, EPIGENETIC TEN-ELEVEN, TRANSLOCATION PROTEI THYMINE DNA GLYCOSYLASE, FORMYLCYTOSINE, DNA 5mvu nuc 2.30 5-FORMYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 6(C10 H14 N3 O8 P) CRYSTAL STRUCTURE OF AN A-DNA DODECAMER CONTAINING 5-FORMYLC 3 CONSECUTIVE CPG STEPS DNA DNA A-DNA, DNA, 5-FORMYLCYTOSINE, CPG
Code Class Resolution Description 1me0 nuc NMR GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P CHIMERIC HAIRPIN WITH 2',5'-LINKED RNA LOOP AND DNA STEM DNA/RNA (5'-D(*GP*GP*AP*C)-R(P*(U25)P*(U25)P*(C25 D(P*GP*TP*CP*C)-3') DNA, RNA HAIRPIN, (2',5')-RNA, DNA, RNA 1me1 nuc NMR GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P CHIMERIC HAIRPIN WITH 2',5'-LINKED RNA LOOP AND RNA STEM 5'-R(*GP*GP*AP*CP*(U25)P*(U25)P*(C25)P*(5GP)P*GP* 3' RNA HAIRPIN, (2',5')-RNA, RNA 3slq nuc 2.50 GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 5dhb nuc 1.80 GUANOSINE-5'-MONOPHOSPHATE 4(C10 H14 N5 O8 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA, COOPERATIVITY, MONOMER 5dhc nuc 1.55 GUANOSINE-5'-MONOPHOSPHATE 8(C10 H14 N5 O8 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA, MONOMER, COOPERATIVITY
Code Class Resolution Description 4c5x nuc 1.30 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'- (DIHYDROGEN PHOSPHATE) 2(C10 H16 N3 O8 P) ULTRA HIGH RESOLUTION DICKERSON-DREW DODECAMER B-DNA WITH 5-HYDROXYMETHYL-CYTOSINE MODIFICATION 5'-D(CP*GP*CP*GP*AP*AP*TP*TP*5HCP*GP*CP*GP)-3': DICKERSON-DREW SEQUENCE DODECAMER DNA DNA, CYTOSINE MODIFICATION 4glc nuc 1.83 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H16 N3 O8 P) DNA DODECAMER CONTAINING 5-HYDROXYMETHYL-CYTOSINE DNA (5'-D(*CP*GP*(5HC)P*GP*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA DODECAMER, EPIGENETICS, 5-HYDROXYMETHYL CYTOSINE, DNA 4glh nuc 1.66 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H16 N3 O8 P) DNA DODECAMER CONTAINING 5-HYDROXYMETHYL CYTOSINE DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5HC)P*GP*CP*G CHAIN: A, B DNA B-DNA DODECAMER, EPIGENETICS, 5-HYDROXYMETHYL CYTOSINE, DNA 4hli nuc 1.99 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H16 N3 O8 P) DNA DODECAMER CONTAINING 5-HYDROXYMETHYL-CYTOSINE DNA (5'-D(*CP*GP*(5HC)P*GP*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA DODECAMER, EPIGENETICS, 5-HYDROXYMETHYL CYTOSINE, DNA 4i9v nuc 1.02 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H16 N3 O8 P) THE ATOMIC STRUCTURE OF 5-HYDROXYMETHYL 2'-DEOXYCITIDINE BAS WITH 2'-DEOXYGUANOSINE IN DICKERSON DREW DODECAMER DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5HC)P*GP*CP*G CHAIN: A, B DNA 5-HYDROXYMETHYL 2' DEOXYCITIDINE, 5-HYDROXYMETHYL-DC ADDUCT, DDD, DODECAMER OF B-DNA, DNA 5ch0 nuc 1.40 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H16 N3 O8 P CRYSTAL STRUCTURE OF AN A-FORM DNA DUPLEX CONTAINING 5- HYDROXYLMETHYLCYTIDINE DNA (5'-R(*G)-D(P*(UMS))-R(P*G)-D(P*T)-R(P*A)-D(P R(P*AP*C)-3') DNA A-FORM DNA DUPLEX, 5HMC, DNA 5cjy nuc 1.55 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF A B-FORM DNA DUPLEX CONTAINING 5- HYDROXYLMETHYLCYTIDINE DNA (5'-D(*CP*GP*(5HC)P*GP*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DNA DUPLEX, B-FORM, 5-HYDROXYLMETHYLCYTIDINE, DNA 5dsb nuc 1.50 2'-DEOXY-5-(HYDROXYMETHYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF HOLLIDAY JUNCTIONS STABILIZED BY 5- HYDROXYMETHYLCYTOSINE IN GCC JUNCTION CORE 5'-D(*CP*CP*GP*GP*CP*GP*5HCP*CP*GP*G)-3' DNA HOLLIDAY JUNCTION, 5-HYDROXYMETHYLCYTOSINE, DNA
Code Class Resolution Description 1jzv nuc 1.70 5-IODO-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 I N3 O8 P) CRYSTAL STRUCTURE OF A BULGED RNA FROM THE SL2 STEM-LOOP OF THE HIV-1 PSI-RNA 5'-R(*GP*GP*CP*GP*AP*CP*(5BU)P*G)-3', 5'-R(*CP*AP*GP*UP*AP*CP*GP*(5IC)P*C)-3' RNA A-BULGE, A-RNA, HIV-1 SL2, X-RAY
Code Class Resolution Description 1omk nuc 1.30 5-IODO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 I N2 O8 P) THE CRYSTAL STRUCTURE OF D(CACG(5IU)G) 5'-D(*CP*AP*CP*GP*(5IU)P*G)-3' DNA Z-DNA, 5-IODO-2'-DEOXYURIDINE 454d nuc 1.20 5-IODO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 10(C9 H12 I N2 O8 P) INTERCALATION AND MAJOR GROOVE RECOGNITION IN THE 1.2 A RESOLUTION CRYSTAL STRUCTURE OF RH[ME2TRIEN]PHI BOUND TO 5'-G(5IU)TGCAAC-3' 5'-D(*GP*(5IU)P*TP*GP*CP*AP*AP*C)-3' DNA METALLOINTERCALATOR, INTERCALATION, MAJOR GROOVE RECOGNITION, PHOTOEXCITABLE, DNA 4gre nuc 1.70 5-IODO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 I N2 O8 P DNA HOLLIDAY JUNCTION STABILIZED BY IODINE HALOGEN BOND. I2J OF RELATED REFERENCE DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*TP*AP*(IOU)P*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND, DNA 4gs2 nuc 1.90 5-IODO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 I N2 O8 P DNA HOLLIDAY JUNCTION STABILIZED BY IODINE HALOGEN BOND. I1J IN RELATED REFERENCE. DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*TP*AP*(5IU)P*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND, DNA
Code Class Resolution Description 5e36 nuc 1.60 2'-O-PROP-2-YN-1-YLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 3(C13 H16 N5 O7 P) CRYSTAL STRUCTURE OF 2'-PROPARGYL-MODIFIED DNA 8MER-DUPLEX DNA (5'-D(*GP*(OMU)P*GP*TP*(5JO)P*CP*AP*C)-3') DNA MODIFIED DNA, 2'-PROPARGYL, DNA
Code Class Resolution Description 1c2w nuc 7.50 5-METHYLCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P 23S RRNA STRUCTURE FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP ANGSTROMS RESOLUTION 23S RIBOSOMAL RNA RIBOSOME 23S RRNA, RIBOSOME, LARGE RIBOSOMAL SUBUNIT, ATOMIC PROTEIN BIOSYNTHESIS, RIBONUCLEIC ACID, EM-RECONSTRUCTION, 3D ARRAN FITTING 1ehz nuc 1.93 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 10(C10 H16 N3 O8 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1fir nuc 3.30 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 1ipl nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1k7n nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1luu nuc NMR 5-METHYLCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 4 MODIFICATIONS (OMC32 OMG34 1MG37 5MC40) 5'-R(*CP*CP*AP*GP*AP*(OMC)P*UP*(OMG) P*AP*AP*(1MG)P*AP*UP*(5MC)P*UP*GP*G)-3' RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, 1MG, 2'-O-METHYL, 5MC 1lux nuc NMR 5-METHYLCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 3 MODIFICATIONS (OMC32 OMG34 M5C40) 5'-R(*CP*CP*AP*GP*AP*(OMC)P*UP*(OMG) P*AP*AP*GP*AP*UP*(5MC)P*UP*GP*G)-3' RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, 2'-O- METHYL, M5C 1nrt nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O8 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1q49 nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1vtq nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P THREE-DIMENSIONAL STRUCTURE OF YEAST T-RNA-ASP. I. STRUCTURE DETERMINATION TRNAASP RNA T-RNA, SINGLE STRAND, LOOPS, RNA 1yfg nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2tra nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 2z9q nuc 11.70 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 3tra nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPARTIC ACID AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 486d nuc 7.50 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 5tra nuc model 5-METHYLCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA 6tna nuc 2.70 5-METHYLCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1c2w nuc 7.50 5-METHYLURIDINE 5'-MONOPHOSPHATE 4(C10 H15 N2 O9 P) 23S RRNA STRUCTURE FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP ANGSTROMS RESOLUTION 23S RIBOSOMAL RNA RIBOSOME 23S RRNA, RIBOSOME, LARGE RIBOSOMAL SUBUNIT, ATOMIC PROTEIN BIOSYNTHESIS, RIBONUCLEIC ACID, EM-RECONSTRUCTION, 3D ARRAN FITTING 1ehz nuc 1.93 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 5-METHYLURIDINE 5'-MONOPHOSPHATE 5(C10 H15 N2 O9 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1i9v nuc 2.60 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P CRYSTAL STRUCTURE ANALYSIS OF A TRNA-NEOMYCIN COMPLEX PHENYLALANINE TRANSFER RNA RNA AMINO-ACID TRANSPORT, YEAST, PHE-TRNA,PHENYLALANINE, TRANSFER RNA, AMINOGLYCOSIDE, NEOMYCIN B 1ipl nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1ipx nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID TRNA-TRNA INTERACTION 1ipz nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE TRNA-TRNA INTERACTION 1k7n nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1kos nuc NMR 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P SOLUTION NMR STRUCTURE OF AN ANALOG OF THE YEAST TRNA PHE T STEM LOOP CONTAINING RIBOTHYMIDINE AT ITS NATURALLY OCCURRING POSITION 5'-R(*CP*UP*GP*UP*GP*(5MU)P*UP*CP*GP*AP*UP*(CH) P*CP*AP*CP*AP*G)- 3': TPSIC DOMAIN OF TRNA RNA TRNA, T STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, RNA FOLDING 1ks1 nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1q49 nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1vtq nuc 3.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P THREE-DIMENSIONAL STRUCTURE OF YEAST T-RNA-ASP. I. STRUCTURE DETERMINATION TRNAASP RNA T-RNA, SINGLE STRAND, LOOPS, RNA 2tra nuc 3.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 2z9q nuc 11.70 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 3bbv nuc 10.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P THE TRNA(PHE) FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF 50S.NC-TRNA.HSP15 COMPLEX TRNA(PHE) RIBOSOME PHE, TRNA, RESCUE STALLED RIBOSOME, RIBOSOME 3cw5 nuc 3.10 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 3cw6 nuc 3.30 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 3tra nuc 3.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPARTIC ACID AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 486d nuc 7.50 5-METHYLURIDINE 5'-MONOPHOSPHATE 3(C10 H15 N2 O9 P) X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 5l4o nuc 2.80 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P STRUCTURE OF AN E.COLI INITIATOR TRNAFMET A1-U72 VARIANT TRNA (76-MER) TRANSLATION TRNA-TRANSLATION INITIATION, TRANSLATION 5tra nuc model 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA 6tna nuc 2.70 5-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 2mo2 nuc NMR 2'-DEOXY-5-HYDROXYCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H14 N3 O8 P) SOLUTION NMR STRUCTURE OF DNA DODECAMER CONTAINING THE 5- HYDROXYCYTOSINE DNA_(5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5OC)P*GP*CP*G CHAIN: A, B DNA DNA, 5-HYDROXYCYTOSINE 4f3u nuc 1.40 2'-DEOXY-5-HYDROXYCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H14 N3 O8 P) CRYSTAL STRUCTURE OF 5-HYDROXY-2'-DEOXYCYTIDINE BASE PAIRED DEOXYGUANOSINE IN DICKERSON DREW DODECAMER DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5OC)P*GP*CP*G CHAIN: A, B DNA 5-HYDROXY-DC, MODIFIED DICKERSON, 5-HYDROXY-2'-DEOXYCYTIDINE
Code Class Resolution Description 1nts nuc NMR 5(1-PROPYNYL)-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE 4(C12 H16 N3 O7 P) 5'(DCCPUPCPCPUPUP)3':3'(RAGGAGGAAA)5', WHERE P=PROPYNYL 5'-D(*(5PC)P*(5PC)P*(PDU)P*(5PC)P*(5PC)P*(PDU) P*(PDU))-3', 5'-R(*AP*AP*AP*GP*GP*AP*GP*GP*A)-3' RNA/DNA DNA, RNA, HYBRID, PROPYNYL, RNA/DNA COMPLEX 1ntt nuc NMR 5(1-PROPYNYL)-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE 3(C12 H16 N3 O7 P) 5'(DCPCPUPCPCPUPUP)3':(RAGGAGGAAA)5', WHERE P=PROPYNYL 5'-D(*CP*(5PC)P*(PDU)P*(5PC)P*(5PC)P*(PDU) P*(PDU))-3', 5'-R(*AP*AP*AP*GP*GP*AP*GP*GP*A)-3' RNA/DNA DNA, RNA, HYBRID, PROPYNYL, RNA/DNA COMPLEX 1oo7 nuc NMR 5(1-PROPYNYL)-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE 3(C12 H16 N3 O7 P) DNA.RNA HYBRID DUPLEX CONTAINING A 5-PROPYNE DNA STRAND AND PURINE-RICH RNA STRAND, NMR, 4 STRUCTURES 5'-D(*GP*(5PC)P*(PDU)P*(PDU)P*(5PC)P*(PDU) P*(5PC)P*(PDU)P*(PDU)P*C)-3', 5'-R(*GP*AP*AP*GP*AP*GP*AP*AP*GP*C)-3' DNA-RNA HYBRID DNA.RNA HYBRID, PURINE/PYRIMIDINE-RICH STRANDS, ANTISENSE, DNA/RNA COMPLEX, DNA-RNA HYBRID
Code Class Resolution Description
3fx8 nuc 2.44 4,4'-SULFANEDIYLBIS{N-[(1E)-PYRIDIN-2- YLMETHYLIDENE]ANILINE} 2(C24 H18 N4 S) DISTINCT RECOGNITION OF THREE-WAY DNA JUNCTIONS BY A THIOESTER VARIANT OF A METALLO-SUPRAMOLECULAR CYLINDER ('HELICATE') (5'-D(*CP*GP*TP*AP*CP*G)-3' DNA SELF-ASSEMBLY, DNA-BASED NANOMATERIAL, DNA
Code Class Resolution Description 2irl nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,2-BIS[5-(2-IMIDAZOLINYL)-2-BENZIMIDAZOLYL]ETHANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 3ijn nuc 1.80 2'-DEOXY-5-(METHYLSELANYL)CYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H16 N3 O7 P SE 5-SEME-CYTIDINE MODIFIED DNA 8MER 5'-D(*GP*(UMS)P*GP*TP*AP*(5SE)P*AP*C)-3' DNA SELENIUM, DNA, 5-SEME-CYTIDINE
Code Class Resolution Description
5hix nuc 2.48 4-(3-AMINOPROPOXY)-8-({[4-(3-AMINOPROPOXY)-8-({[4-(3- AMINOPROPOXY)-8-({[4-(3-AMINOPROPOXY)-8-NITROQUINOLIN- 2-YL]CARBONYL}AMINO)QUINOLIN-2-YL]CARBONYL}AMINO) QUINOLIN-2-YL]CARBONYL}AMINO)QUINOLINE-2-CARBOXYLIC ACID C52 H52 N12 O11 COCRYSTAL STRUCTURE OF AN ANTI-PARALLEL DNA G-QUADRUPLEX AND QUINOLINE FOLDAMER DIMERIC G-QUADRUPLEX DNA DNA G-QUADRUPLEX, FOLDAMER, FOLDAMER-QUADRUPLEX, G-QUADRUPLE LIGANDS, DNA
Code Class Resolution Description 2kd9 nuc NMR (6S)-3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-HYDROXY-5,6,7,8- TETRAHYDROPYRIMIDO[1,2-A]PURIN-10(3H)-ONE C13 H18 N5 O8 P SOLUTION STRUCTURE OF DNA CONTAINING ALPHA-OH-PDG: THE MUTAGENIC ADDUCT PRODUCED BY ACROLEIN 5'-D(*CP*GP*TP*AP*CP*(63G)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3' DNA ACROLEIN LESIONS, DNA DAMAGED, DNA STRUCTURE, EXOCYCLIC, PROPANO-DG LESIONS 2lt0 nuc NMR (6S)-3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-HYDROXY-5,6,7,8- TETRAHYDROPYRIMIDO[1,2-A]PURIN-10(3H)-ONE C13 H18 N5 O8 P NMR STRUCTURE OF DUPLEX DNA CONTAINING THE BETA-OH-PDG DA BA MUTAGENIC INTERMEDIATE OF ACROLEIN DNA (5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3'), DNA (5'-D(*CP*GP*TP*AP*CP*(63G)P*CP*AP*TP*GP*C)-3 CHAIN: B DNA ACROLEIN ADDUCTS, DNA LESIONS, DAMAGED DNA STRUCTURE, DNA
Code Class Resolution Description 2kda nuc NMR (6R)-3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-HYDROXY-5,6,7,8- TETRAHYDROPYRIMIDO[1,2-A]PURIN-10(3H)-ONE C13 H18 N5 O8 P SOLUTION STRUCTURE OF DNA CONTAINING ALPHA-OH-PDG: THE MUTAGENIC ADDUCT PRODUCED BY ACROLEIN 5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3', 5'-D(*CP*GP*TP*AP*CP*(63H)P*CP*AP*TP*GP*C)-3' DNA ACROLEIN LESIONS, DNA DAMAGED, DNA STRUCTURE, EXOCYCLIC, PROPANO-DG LESIONS 2lsz nuc NMR (6R)-3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-HYDROXY-5,6,7,8- TETRAHYDROPYRIMIDO[1,2-A]PURIN-10(3H)-ONE C13 H18 N5 O8 P NMR STRUCTURE OF DUPLEX DNA CONTAINING THE ALPHA-OH-PDG DA B A MUTAGENIC INTERMEDIATE OF ACROLEIN DNA (5'-D(*CP*GP*TP*AP*CP*(63H)P*CP*AP*TP*GP*C)-3 CHAIN: B, DNA (5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3') DNA ACROLEIN ADDUCTS, DNA LESIONS, DAMAGED DNA STRUCTURE, DNA
Code Class Resolution Description 5hqf nuc NMR [(2R,3S)-3-HYDROXY-5-OXOTETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN PHOSPHATE (NON-PREFERRED NAME) C5 H9 O7 P DNA DUPLEX CONTAINING A RIBONOLACTONE LESION DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B, DNA (5'-D(*CP*GP*CP*TP*CP*(RIB)P*CP*AP*CP*GP*C)-3 CHAIN: A DNA DNA LESION, CLUSTER 8-OXO-GUANINE RIBONOLACTONE, DNA 5hqq nuc NMR [(2R,3S)-3-HYDROXY-5-OXOTETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN PHOSPHATE (NON-PREFERRED NAME) C5 H9 O7 P DNA DUPLEX CONTAINING A RIBONOLACTONE LESION DNA (5'-D(*CP*GP*CP*TP*CP*(RIB)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*(8OG)P*TP*GP*GP*GP*AP*GP*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER 8-OXO-GUANINE RIBONOLACTONE, DNA
Code Class Resolution Description 1cfl nuc NMR 5-HYDROXY-THYMIDINE-5'-MONOPHOSPHATE C10 H17 N2 O9 P DNA DECAMER DUPLEX CONTAINING T5-T6 PHOTOADDUCT DNA (5'-D(*GP*CP*GP*TP*GP*AP*TP*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*AP*(64T)P*TP*AP*CP*GP*C)-3') DNA NMR, DNA PHOTOPRODUCT, (6-4) ADDUCT, MUTAGENESIS, DEOXYRIBONUCLEIC ACID 1qkg nuc NMR 5-HYDROXY-THYMIDINE-5'-MONOPHOSPHATE C10 H17 N2 O9 P DNA DECAMER DUPLEX CONTAINING T-T DEWAR PHOTOPRODUCT DNA (5'-D(*CP*GP*CP*AP*(HYD)TP*+TP*AP*CP*GP*C)- 3'), DNA (5'-D(*GP*CP*GP*TP*GP*AP*TP*GP*CP*G)-3') DNA DEOXYRIBONUCLEIC ACID, DNA PHOTOPRODUCT, DEWAR PRODUCT, (6-4) ADDUCT, MUTAGENESIS, TRANSLESION REPLICATION
Code Class Resolution Description 2b57 nuc 2.15 9H-PURINE-2,6-DIAMINE C5 H6 N6 GUANINE RIBOSWITCH C74U MUTANT BOUND TO 2,6-DIAMINOPURINE 65-MER: G-BOX RNA RNA RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLES, BASE QUADRUPLES, MRNA, PURINE 4feo nuc 1.60 9H-PURINE-2,6-DIAMINE C5 H6 N6 CRYSTAL STRUCTURE OF THE AU25A/A46G/C74U MUTANT XPT-PBUX GUA RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH 2,6-DIAMINOPURINE U25A/A46G/C74U MUTANT OF THE B. SUBTILIS XPT-PBUX RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, 2,6-DIAMINOPURINE, RNA 4fep nuc 1.65 9H-PURINE-2,6-DIAMINE C5 H6 N6 CRYSTAL STRUCTURE OF THE A24U/U25A/A46G/C74U MUTANT XPT-PBUX RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH 2,6-DIAMINOPURINE A24U/U25A/A46G/C74U MUTANT OF THE B. SUBTILIS XPT GUANINE RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, 2,6-DIAMINOPURINE, RNA 4lvz nuc 1.77 9H-PURINE-2,6-DIAMINE C5 H6 N6 STRUCTURE OF THE THF RIBOSWITCH BOUND TO 2,6-DIAMINOPURINE THF RIBOSWITCH RNA APTAMERS, NUCLEOTIDE, BACILLUS SUBTILIS, BACTERIAL PROTEINS, SEQUENCE, BINDING SITES, CALORIMETRY, FOLIC ACID, GENE EXPR REGULATION, BACTERIAL, GUANINE, LEUCOVORIN, LIGANDS, MAGNES MOLECULAR SEQUENCE DATA, NUCLEIC ACID CONFORMATION, POINT M PROTEIN BINDING, PROTEIN STRUCTURE, SECONDARY, RNA, RIBOSWI ADENOSYLMETHIONINE, STREPTOCOCCUS MUTANS, TERMINATOR REGION GENETIC, TETRAHYDROFOLATES, THERMODYNAMICS, TRANSCRIPTION, JUNCTION, PSEUDOKNOT, REGULATION, NCRNA, 2,6-DIAMINOPURINE,
Code Class Resolution Description 5j02 nuc 3.49 3'-DEOXY-5-METHYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H15 N2 O8 P STRUCTURE OF THE LARIAT FORM OF A CHIMERIC DERIVATIVE OF THE OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE PRESENCE OF MG2+ AND AN INACTIVE 5' EXON. GROUP II INTRON LARIAT, 5' EXON ANALOG (5'-R(*CP*UP*GP*UP*UP*AP*(5MU))-3' CHAIN: B RNA GROUP II INTRON, LARIAT, 2'-5' PHOSPHODIESTER BOND, RIBOZYME CATALYSIS, SELF-SPLICING, RNA
Code Class Resolution Description 4nlf nuc 1.00 2'-TRIFLUOROMETHYLTHIO-2'-DEOXYCYTIDINE C10 H15 F3 N3 O7 P S 2'-TRIFLUOROMETHYLTHIO-2'-DEOXYCYTIDINE-MODIFIED SRL 23S RIBOSOMAL RNA SARCIN RICIN LOOP RNA RNA HAIRPIN, STRUCTURAL, RNA
Code Class Resolution Description 4nmg nuc 1.01 2'-TRIFLUOROMETHYLTHIO-2'-DEOXYURIDINE C10 H14 F3 N2 O8 P S 2'-TRIFLUOROMETHYLTHIO-2'-DEOXYURIDINE-MODIFIED SRL 23S RIBOSOMAL RNA SARCIN RICIN LOOP RNA RNA HAIRPIN, STRUCTURAL, RNA 4nxh nuc 1.16 2'-TRIFLUOROMETHYLTHIO-2'-DEOXYURIDINE C10 H14 F3 N2 O8 P S 2'-TRIFLUOROMETHYLTHIOURIDINE-MODIFIED E. COLI 23S RRNA SARC LOOP 23S RIBOSOMAL RNA SARCIN RICIN LOOP RNA HAIRPIN, STRUCTURAL, RNA
Code Class Resolution Description 3fo6 nuc 1.90 6-O-METHYLGUANINE C6 H7 N5 O CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH BOUND TO 6-O- METHYLGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, 6-O-METHYLGUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 3ges nuc 2.15 6-O-METHYLGUANINE C6 H7 N5 O CRYSTAL STRUCTURE OF THE GUANINE RIBOSWITCH C74U MUTANT BOUND TO 6-O-METHYLGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE
Code Class Resolution Description 3fo4 nuc 1.90 6-CHLOROGUANINE C5 H4 CL N5 CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH C74U MUTANT BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH C74U MUTANT RNA MRNA, RIBOSWITCH, 6-CHLOROGUANINE, ADENINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 3ger nuc 1.70 6-CHLOROGUANINE C5 H4 CL N5 GUANINE RIBOSWITCH BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 3gog nuc 2.10 6-CHLOROGUANINE C5 H4 CL N5 GUANINE RIBOSWITCH A21G,U75C MUTANT BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE
Code Class Resolution Description 1d7z nuc 2.21 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(ADENIN-9-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C11 H16 N5 O6 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 2.2 A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX 1ejz nuc NMR 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(ADENIN-9-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL C11 H16 N5 O6 P SOLUTION STRUCTURE OF A HNA-RNA HYBRID DNA (5'-H(*(6HG)P*(6HC)P*(6HG)P*(6HT)P*(6HA) P*(6HG)P*(6HC)P*(6HG))-3'), RNA (5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3') RNA HNA-RNA COMPLEX, DOUBLE HELIX, A-TYPE CONFORMATION 2bj6 nuc 2.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(ADENIN-9-YL)- 6'-O-PHOSPHORYL-D-ARABINO-HEXITOL 8() CRYSTAL STRUCTURE OF A DECAMERIC HNA-RNA HYBRID SYNTHETIC HNA, 5'-R(*GP*GP*CP*AP*UP*UP*AP*CP*GP*GP)-3' NUCLEIC ACID (HNA/RNA) NUCLEIC ACID (HNA/RNA), DNA, RNA, HNA, HEXITOL NUCLEIC ACID, HYBRID, DUPLEX, MODIFIED NUCLEIC ACID, ANTISENSE, BACKBONE MODIFICATION 481d nuc 1.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(ADENIN-9-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C11 H16 N5 O6 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 1.6A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX
Code Class Resolution Description 2mnx nuc NMR 2'-DEOXY-N-[(2S)-2-HYDROXYBUT-3-EN-1-YL]ADENOSINE 5'- (DIHYDROGEN PHOSPHATE) C14 H20 N5 O7 P MAJOR GROOVE ORIENTATION OF THE (2S)-N6-(2-HYDROXY-3-BUTEN-1 DEOXYADENOSINE DNA ADDUCT INDUCED BY 1,2-EPOXY-3-BUTENE 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3', 5'-D(*CP*GP*GP*AP*CP*(6HB)P*AP*GP*AP*AP*G)-3' DNA B-FORM, 11-MER, DNA
Code Class Resolution Description 1d7z nuc 2.21 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(CYTOSIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 2.2 A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX 1ec4 nuc NMR 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(CYTOSIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 8(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A HEXITOL NUCLEIC ACID DUPLEX WITH FOUR CONSECUTIVE T:T BASE PAIRS HEXITOL DODECANUCLEOTIDE DNA DOUBLE HELIX, ANTISENSE, HEXITOL NUCLEIC ACID, DNA 1ejz nuc NMR 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(CYTOSIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C10 H16 N3 O7 P) SOLUTION STRUCTURE OF A HNA-RNA HYBRID DNA (5'-H(*(6HG)P*(6HC)P*(6HG)P*(6HT)P*(6HA) P*(6HG)P*(6HC)P*(6HG))-3'), RNA (5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3') RNA HNA-RNA COMPLEX, DOUBLE HELIX, A-TYPE CONFORMATION 2bj6 nuc 2.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(CYTOSIN-1-YL) -6'-O-PHOSPHORYL-D-ARABINO-HEXITOL 16() CRYSTAL STRUCTURE OF A DECAMERIC HNA-RNA HYBRID SYNTHETIC HNA, 5'-R(*GP*GP*CP*AP*UP*UP*AP*CP*GP*GP)-3' NUCLEIC ACID (HNA/RNA) NUCLEIC ACID (HNA/RNA), DNA, RNA, HNA, HEXITOL NUCLEIC ACID, HYBRID, DUPLEX, MODIFIED NUCLEIC ACID, ANTISENSE, BACKBONE MODIFICATION 481d nuc 1.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(CYTOSIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 1.6A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX
Code Class Resolution Description 1d7z nuc 2.21 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(GUANIN-9-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 2.2 A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX 1ec4 nuc NMR 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(GUANIN-9-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 8(C11 H16 N5 O7 P) SOLUTION STRUCTURE OF A HEXITOL NUCLEIC ACID DUPLEX WITH FOUR CONSECUTIVE T:T BASE PAIRS HEXITOL DODECANUCLEOTIDE DNA DOUBLE HELIX, ANTISENSE, HEXITOL NUCLEIC ACID, DNA 1ejz nuc NMR 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(GUANIN-9-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 4(C11 H16 N5 O7 P) SOLUTION STRUCTURE OF A HNA-RNA HYBRID DNA (5'-H(*(6HG)P*(6HC)P*(6HG)P*(6HT)P*(6HA) P*(6HG)P*(6HC)P*(6HG))-3'), RNA (5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3') RNA HNA-RNA COMPLEX, DOUBLE HELIX, A-TYPE CONFORMATION 2bj6 nuc 2.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(GUANIN-9-YL)- 6'-O-PHOSPHORYL-D-ARABINO-HEXITOL 8() CRYSTAL STRUCTURE OF A DECAMERIC HNA-RNA HYBRID SYNTHETIC HNA, 5'-R(*GP*GP*CP*AP*UP*UP*AP*CP*GP*GP)-3' NUCLEIC ACID (HNA/RNA) NUCLEIC ACID (HNA/RNA), DNA, RNA, HNA, HEXITOL NUCLEIC ACID, HYBRID, DUPLEX, MODIFIED NUCLEIC ACID, ANTISENSE, BACKBONE MODIFICATION 481d nuc 1.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(GUANIN-9-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 1.6A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX
Code Class Resolution Description
4gpw nuc 3.00 (1S,2S,3R,4S,6R)-4,6-DIAMINO-3-{[(2S,3R)-3-AMINO-6- (HYDROXYMETHYL)-3,4-DIHYDRO-2H-PYRAN-2-YL]OXY}-2- HYDROXYCYCLOHEXYL 3-DEOXY-4-C-METHYL-3-(METHYLAMINO)- BETA-L-ARABINOPYRANOSIDE 2(C19 H36 N4 O8) CRYSTAL STRUCTURE OF THE PROTOZOAL CYTOPLASMIC RIBOSOMAL DEC IN COMPLEX WITH 6'-HYDROXYSISOMICIN (P21212 FORM) RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RIBOSOME, AMINOGLYCOSIDE, RNA-ANTIBIOTIC COMPLEX, ANTIPROTOZ ACTIVITY, ANTIBACTERIAL ACTIVITY
4gpx nuc 2.60 (1S,2S,3R,4S,6R)-4,6-DIAMINO-3-{[(2S,3R)-3-AMINO-6- (HYDROXYMETHYL)-3,4-DIHYDRO-2H-PYRAN-2-YL]OXY}-2- HYDROXYCYCLOHEXYL 3-DEOXY-4-C-METHYL-3-(METHYLAMINO)- BETA-L-ARABINOPYRANOSIDE 2(C19 H36 N4 O8) CRYSTAL STRUCTURE OF THE PROTOZOAL CYTOPLASMIC RIBOSOMAL DEC IN COMPLEX WITH 6'-HYDROXYSISOMICIN (P212121 FORM) RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RIBOSOME, AMINOGLYCOSIDE, RNA-ANTIBIOTIC COMPLEX, ANTIPROTOZ ACTIVITY, ANTIBACTERIAL ACTIVITY
4gpy nuc 2.80 (1S,2S,3R,4S,6R)-4,6-DIAMINO-3-{[(2S,3R)-3-AMINO-6- (HYDROXYMETHYL)-3,4-DIHYDRO-2H-PYRAN-2-YL]OXY}-2- HYDROXYCYCLOHEXYL 3-DEOXY-4-C-METHYL-3-(METHYLAMINO)- BETA-L-ARABINOPYRANOSIDE 2(C19 H36 N4 O8) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH 6'-HYDROXYSISOMICIN RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RIBOSOME, AMINOGLYCOSIDE, RNA-ANTIBIOTIC COMPLEX, ANTIPROTOZ ACTIVITY, ANTIBACTERIAL ACTIVITY
Code Class Resolution Description 1d7z nuc 2.21 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(THYMIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C11 H17 N2 O8 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 2.2 A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX 1ec4 nuc NMR 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(THYMIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 8(C11 H17 N2 O8 P) SOLUTION STRUCTURE OF A HEXITOL NUCLEIC ACID DUPLEX WITH FOUR CONSECUTIVE T:T BASE PAIRS HEXITOL DODECANUCLEOTIDE DNA DOUBLE HELIX, ANTISENSE, HEXITOL NUCLEIC ACID, DNA 1ejz nuc NMR 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(THYMIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL C11 H17 N2 O8 P SOLUTION STRUCTURE OF A HNA-RNA HYBRID DNA (5'-H(*(6HG)P*(6HC)P*(6HG)P*(6HT)P*(6HA) P*(6HG)P*(6HC)P*(6HG))-3'), RNA (5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3') RNA HNA-RNA COMPLEX, DOUBLE HELIX, A-TYPE CONFORMATION 2bj6 nuc 2.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(THYMIN-1-YL)- 6'-O-PHOSPHORYL-D-ARABINO-HEXITOL 8() CRYSTAL STRUCTURE OF A DECAMERIC HNA-RNA HYBRID SYNTHETIC HNA, 5'-R(*GP*GP*CP*AP*UP*UP*AP*CP*GP*GP)-3' NUCLEIC ACID (HNA/RNA) NUCLEIC ACID (HNA/RNA), DNA, RNA, HNA, HEXITOL NUCLEIC ACID, HYBRID, DUPLEX, MODIFIED NUCLEIC ACID, ANTISENSE, BACKBONE MODIFICATION 481d nuc 1.60 1',5'-ANHYDRO-2',3'-DIDEOXY-2'-(THYMIN-1-YL)-6'-O- PHOSPHORYL-D-ARABINO-HEXITOL 2(C11 H17 N2 O8 P) CRYSTAL STRUCTURE OF A HEXITOL NUCLEIC ACID (HNA) DUPLEX AT 1.6A RESOLUTION 5'-H(*(6HG)P*(6HT)P*(6HG)P*(6HT)P*(6HA)P*(6HC) P*(6HA)P*(6HC))-3' DNA HEXITOL NUCLEIC ACID, DNA ANALOGUE, DOUBLE HELIX
Code Class Resolution Description 2lbq nuc NMR N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE C15 H24 N5 O7 P NMR STRUCTURE OF I6A37_TYRASL RNA (5'-R(*GP*GP*GP*GP*AP*CP*UP*GP*UP*AP*(6IA) P*AP*UP*CP*CP*CP*C)-3') RNA TYROSYL-TRNA, RNA 2lbr nuc NMR N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE C15 H24 N5 O7 P CONFORMATION EFFECTS OF BASE MODIFICATION ON THE ANTICODON S OF BACILLUS SUBTILIS TRNATYR RNA (5'-R(*GP*GP*GP*GP*AP*CP*UP*GP*UP*AP*(6IA)P*A P*CP*CP*CP*C)-3') RNA TYROSYL-TRNA, RNA 5tra nuc model N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE C15 H24 N5 O7 P SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA
Code Class Resolution Description 1da3 nuc 2.00 N6-METHYL-DEOXY-ADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O6 P) THE CRYSTAL STRUCTURE OF THE TRIGONAL DECAMER C-G-A-T-C-G- 6MEA-T-C-G: A B-DNA HELIX WITH 10.6 BASE-PAIRS PER TURN DNA (5'-D(*CP*GP*AP*TP*CP*GP*(6MA)P*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 1oq2 nuc NMR N6-METHYL-DEOXY-ADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O6 P NMR STRUCTURE OF HEMIMETHYLATED GATC SITE 5'-D(*GP*CP*GP*AP*GP*AP*TP*CP*TP*GP*CP*G)-3', 5'-D(*CP*GP*CP*AP*GP*(6MA)P*TP*CP*TP*CP*GP*C)-3' DNA GATC, AGATCT, HEMIMETHYLATION, SEQA, MUTH, N6-METHYL, DAM (DNA ADENINE METHYLTRANSFERASE), DNA 1uab nuc NMR N6-METHYL-DEOXY-ADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O6 P NMR STRUCTURE OF HEMIMETHYLATED GATC SITE DNA (5'-D(*GP*CP*GP*AP*GP*AP*TP*CP*TP*GP*CP*G)- 3'), DNA (5'-D(*CP*GP*CP*AP*GP*(6MA) P*TP*CP*TP*CP*GP*C)-3') DNA GATC, AGATCT, HEMIMETHYLATION, SEQA, MUTH, N6-METHYL, DAM (DNA ADENINE METHYLTRANSFERASE) 2kal nuc NMR N6-METHYL-DEOXY-ADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O6 P) NMR STRUCTURE OF FULLY METHYLATED GATC SITE 5'-D(*DGP*DCP*DGP*DAP*DGP*(6MA) P*DTP*DCP*DTP*DGP*DCP*DG)-3', 5'-D(*DCP*DGP*DCP*DAP*DGP*(6MA) P*DTP*DCP*DTP*DCP*DGP*DC)-3' DNA GATC, N6-METHYLATED ADENINE, DNA 4dnb nuc 2.00 N6-METHYL-DEOXY-ADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O6 P) METHYLATION OF THE ECORI RECOGNITION SITE DOES NOT ALTER DNA CONFORMATION. THE CRYSTAL STRUCTURE OF D(CGCGAM6ATTCGCG) AT 2.0 ANGSTROMS RESOLUTION DNA (5'-D(*CP*GP*CP*GP*AP*(6MA) P*TP*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
Code Class Resolution Description 2jrg nuc NMR N6-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF E. COLI TRNA-VAL3 MODIFICATIONS (CMO5U34 M6A37) 5'-R(*CP*CP*UP*CP*CP*CP*UP*(CM0)P*AP*CP*(6MZ) P*AP*GP*GP*AP*GP*G)-3' RNA E.COLI, VALINE, TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA URIDINE 5-OXYACETIC ACID, CMO5U, N6-METHYLADENOSINE, M6A, R 2jsg nuc NMR N6-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF E.COLI TRNA-VAL3 MODIFICATION (M6A37) 5'-R(*CP*CP*UP*CP*CP*CP*UP*UP*AP*CP*(6MZ) P*AP*GP*GP*AP*GP*G)-3' RNA E.COLI, VALINE, TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA N6-METHYLADENOSINE, M6A, RNA 2mvs nuc NMR N6-METHYLADENOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) N6-METHYLADENOSINE RNA N-6_METHYL_ADENOSINE_RNA RNA N6-METHYL ADENOSINE, RNA
Code Class Resolution Description 5jvw nuc 2.00 PLICAMYCIN, MITHRAMYCIN ANALOGUE MTM SA-TRP 4(C61 H82 N2 O24) CRYSTAL STRUCTURE OF MITHRAMYCIN ANALOGUE MTM SA-TRP IN COMP 10-MER DNA AGAGGCCTCT. DNA (5'-D(*AP*GP*AP*GP*GP*CP*CP*TP*CP*T)-3') DNA/ANTIBIOTIC ANTI-CANCER AGENT, EWING SARCOMA, TRANSCRIPTION FACTOR, MINO DNA BINDING, DNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 5jw0 nuc 2.40 PLICAMYCIN, MITHRAMYCIN ANALOGUE MTM SA-PHE 4(C59 H81 N O24) CRYSTAL STRUCTURE OF MITHRAMYCIN ANALOGUE MTM SA-PHE IN COMP 10-MER DNA AGGGTACCCT DNA (5'-D(P*AP*GP*GP*GP*TP*AP*CP*CP*CP*T)-3') DNA/ANTIBIOTIC ANTI-CANCER AGENT, DNA BINDING, NATURAL PRODUCT, TRANSCRIPTI FACTOR, EWING SARCOMA, DNA-ANTIBIOTIC COMPLEX 5jw2 nuc 3.10 PLICAMYCIN, MITHRAMYCIN ANALOGUE MTM SA-PHE 4(C59 H81 N O24) CRYSTAL STRUCTURE OF MITHRAMYCIN ANALOGUE MTM SA-PHE IN COMP 10-MER DNA AGGGATCCCT DNA (5'-D(*AP*GP*GP*GP*AP*TP*CP*CP*CP*T)-3') DNA/ANTIBIOTIC ANTI-CANCER AGENT, DNA BINDING, NATURAL PRODUCT, TRANSCRIPTI FACTOR, EWING SARCOMA, DNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 153d nuc 2.90 6-O-METHYL GUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF A MISPAIRED DODECAMER, D(CGAGAATTC(O6ME)GCG)2, CONTAINING A CARCINOGENIC O6- METHYLGUANINE DNA (5'-D(*CP*GP*AP*GP*AP*AP*TP*TP*CP*(6OG) P*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED 1d24 nuc 1.90 6-O-METHYL GUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) CRYSTAL AND MOLECULAR STRUCTURE OF A DNA DUPLEX CONTAINING THE CARCINOGENIC LESION O6-METHYLGUANINE DNA (5'-D(*CP*GP*CP*(6OG)P*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1d27 nuc 2.00 6-O-METHYL GUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) HIGH-RESOLUTION STRUCTURE OF A MUTAGENIC LESION IN DNA DNA (5'-D(*CP*GP*CP*(6OG) P*AP*AP*TP*TP*TP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED 218d nuc 2.25 6-O-METHYL GUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) THE STRUCTURE OF A NEW CRYSTAL FORM OF A DNA DODECAMER CONTAINING T.(O6ME)G BASE PAIRS DNA (5'-D(*CP*GP*TP*GP*AP*AP*TP*TP*CP*(6OG) P*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED
Code Class Resolution Description 2gy0 nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,4-BIS[5-(2-AMIDINO)-2-BENZIMIDAZOLYL]BUTANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gxo nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-IMIDAZOLINYL)-2-(4-ETHOXYPHENYL)BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 5lig nuc NMR 8,12-BIS(2-MORPHOLINOETHYL)-8H-BENZO[IJ]XANTHENO[1,9,8- CDEF][2,7]NAPHTHYRIDIN-12-IUMHEXAFLUOROPHOSPHATE 2(C31 H34 N4 O3 1+) G-QUADRUPLEX FORMED AT THE 5'-END OF NHEIII_1 ELEMENT IN HUM PROMOTER BOUND TO TRIANGULENIUM BASED FLUORESCENCE PROBE DA DNA (5'- D(*TP*AP*GP*GP*GP*AP*GP*GP*GP*TP*AP*GP*GP*GP*AP*GP*GP*GP*T) CHAIN: A DNA DNA, G-QUADRUPLEX, C-MYC PROMOTER, LIGAND, DAOTA-M2
Code Class Resolution Description
5kx9 nuc 2.90 2-[(3~{S})-1-[(2-METHOXYPYRIMIDIN-5-YL) METHYL]PIPERIDIN-3-YL]-6-THIOPHEN-2-YL-1~{H}- PYRIMIDIN-4-ONE C19 H21 N5 O2 S SELECTIVE SMALL MOLECULE INHIBITION OF THE FMN RIBOSWITCH FMN RIBOSWITCH, FMN RIBOSWITCH RNA/INHIBITOR RNA, TRANSLATION, RNA-INHIBITOR COMPLEX
Code Class Resolution Description 1fir nuc 3.30 5-(O-METHYLACETO)-2-THIO-2-DEOXY-URIDINE-5'- MONOPHOSPHATE C12 H17 N2 O10 P S CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 2l9e nuc NMR 5-(O-METHYLACETO)-2-THIO-2-DEOXY-URIDINE-5'- MONOPHOSPHATE C12 H17 N2 O10 P S SOLUTION STRUCTURE OF THE HUMAN ANTI-CODON STEM AND LOOP(HAS TRANSFER RNA LYSINE 3 (TRNALYS3) RNA (5'-R(*GP*CP*AP*GP*AP*CP*UP*(70U)P*UP*UP*(12A P*AP*UP*CP*UP*GP*C)-3') RNA RNA
Code Class Resolution Description
5v3f nuc 1.70 4-{[(2S)-3-{2,16-DIOXO-20-[(3AS,4S,6AR)-2-OXOHEXAHYDRO- 1H-THIENO[3,4-D]IMIDAZOL-4-YL]-6,9,12-TRIOXA-3,15- DIAZAICOSAN-1-YL}-2,3-DIHYDRO-1,3-BENZOTHIAZOL-2- YL]METHYL}-1-METHYLQUINOLIN-1-IUM 2(C38 H51 N6 O6 S2 1+) CO-CRYSTAL STRUCTURE OF THE FLUOROGENIC RNA MANGO RNA (31-MER) RNA QUADRUPLEX FLUORESCENT RNA, RNA
Code Class Resolution Description 1rqy nuc 1.55 9-AMINO-N-[3-(DIMETHYLAMINO)PROPYL]ACRIDINE-4- CARBOXAMIDE 3(C19 H22 N4 O) 9-AMINO-[N-(2-DIMETHYLAMINO)PROPLY]-ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 5'-D(CP*GP*TP*AP*CP*G)-3' DNA B-DNA, CYTOSINE EXCHANGE, QUADRUPLEX, ACRIDINE, UNUSUAL INTERCALATION
Code Class Resolution Description 4nfq nuc 1.70 1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL)-3-(1H-1,2,3- TRIAZOL-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE 3(C12 H15 N8 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE 16MER GCAGNCUUAAGUCUGC CON TRIAZOLYL-8-AZA-7-DEAZAADENOSINE GCAG(7AT)CUUAAGUCUGC RNA RNA 16MER OLIGO, 7-TRIAZOLYL-8-AZA-7-DEAZAADENOSINE, POSITIO
Code Class Resolution Description 3opi nuc 1.10 7-DEAZA-2'-DEOXYADENOSINE-5'-MONOPHOSPHATE 2(C11 H15 N4 O6 P) 7-DEAZA-2'-DEOXYADENOSINE MODIFICATION IN B-FORM DNA DNA (5'-D(*CP*GP*CP*GP*AP*(7DA)P*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA, DODECAMER, 7-DEAZA-DEOXYADENOSINE, 7-DEAZA-DA, DNA
Code Class Resolution Description 4lvw nuc 1.77 7-DEAZAGUANINE 2(C6 H6 N4 O) STRUCTURE OF THE THF RIBOSWITCH BOUND TO 7-DEAZAGUANINE THF RIBOSWITCH RNA APTAMERS, NUCLEOTIDE, BACILLUS SUBTILIS, BACTERIAL PROTEINS, SEQUENCE, BINDING SITES, CALORIMETRY, FOLIC ACID, GENE EXPR REGULATION, BACTERIAL, GUANINE, LEUCOVORIN, LIGANDS, MAGNES MOLECULAR SEQUENCE DATA, NUCLEIC ACID CONFORMATION, POINT M PROTEIN BINDING, PROTEIN STRUCTURE, SECONDARY, RNA, RIBOSWI ADENOSYLMETHIONINE, STREPTOCOCCUS MUTANS, TERMINATOR REGION GENETIC, TETRAHYDROFOLATES, THERMODYNAMICS, TRANSCRIPTION, JUNCTION, PSEUDOKNOT, REGULATION, NCRNA, MRNA
Code Class Resolution Description 2mms nuc NMR 7-DEAZA-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C11 H15 N4 O7 P AG(7-DEAZA)G FAPY MODIFIED DUPLEX DNA_(5'-D(*CP*TP*AP*AP*(FAG)P*(7GU)P*TP*TP*CP*A)- CHAIN: A, DNA_(5'-D(*TP*GP*AP*AP*CP*CP*TP*TP*AP*G)-3') DNA AFLATOXIN B1, FAPY, FORMAMIDOPYRIMIDINE, INTERCALATION, DNA DEOXYRIBONUCLEIC ACID, HYDROGEN BOND, SEQUENCE DEPENDENCE, DEAZA)G, DNA 2qef nuc 1.60 7-DEAZA-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C11 H15 N4 O7 P) X-RAY STRUCTURE OF 7-DEAZA-DG AND Z3DU MODIFIED DUPLEX CGCGAATXCZCG DNA (5'-D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*(ZDU) P*DCP*(7GU)P*DCP*DG)-3') DNA B-DNA, Z3DU, 7-DEAZA-DG 2qeg nuc 1.60 7-DEAZA-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C11 H15 N4 O7 P) B-DNA WITH 7-DEAZA-DG MODIFICATION DNA (5'- D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*DTP*DCP*(7GU)P*DCP*DG)-3') DNA B-DNA, 7-DEAZA-DG
Code Class Resolution Description 1c2w nuc 7.50 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 3(C11 H18 N5 O8 P) 23S RRNA STRUCTURE FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP ANGSTROMS RESOLUTION 23S RIBOSOMAL RNA RIBOSOME 23S RRNA, RIBOSOME, LARGE RIBOSOMAL SUBUNIT, ATOMIC PROTEIN BIOSYNTHESIS, RIBONUCLEIC ACID, EM-RECONSTRUCTION, 3D ARRAN FITTING 1ehz nuc 1.93 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 5(C11 H18 N5 O8 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1fir nuc 3.30 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 1k7n nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1nrt nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 3(C11 H18 N5 O8 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1q49 nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE 2(C11 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1yfg nuc 3.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2z9q nuc 11.70 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 3bbv nuc 10.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P THE TRNA(PHE) FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF 50S.NC-TRNA.HSP15 COMPLEX TRNA(PHE) RIBOSOME PHE, TRNA, RESCUE STALLED RIBOSOME, RIBOSOME 486d nuc 7.50 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 6tna nuc 2.70 7N-METHYL-8-HYDROGUANOSINE-5'-MONOPHOSPHATE C11 H18 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 2gy1 nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,4-BIS[5-(2- IMIDAZOLINYL)-2-BENZIMIDAZOLYL]BUTANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gxp nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-PYRIMIDINYL)-2-(4-HYDROXYPHENYL)BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 3u05 nuc 1.27 6-(1,4,5,6-TETRAHYDROPYRIMIDIN-2-YL)-2-[4'-(1,4,5,6- TETRAHYDROPYRIMIDIN-2-YL)BIPHENYL-4-YL]-1H-INDOLE C28 H27 N5 CRYSTAL STRUCTURE OF DB1804-D(CGCGAATTCGCG)2 COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA A2T2, DICKERSON AND DREW DODECAMER, DOUBLE HELIX, DNA MINOR LIGAND COMPLEX, DNA MINOR GROOVE BINDER, DB1804, MG2+, DNA
Code Class Resolution Description
3oie nuc 1.90 N',N''-{FURAN-2,5-DIYLBIS[3-(PIPERIDIN-4-YLOXY)BENZENE- 4,1-DIYL]}DIPYRIDINE-2-CARBOXIMIDAMIDE C38 H40 N8 O3 CRYSTAL STRUCTURE OF THE DB1880-D(CGCGAATTCGCG)2 COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, DNA MINOR GR BINDER, DNA MINOR GROOVE-LIGAND COMPLEX, DB1880, A2T2, DICK DREW DODECAMER, CRYSTAL STRUCTURE OF B-DNA, DNA-DRUG COMPLE MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM, DNA HYDRATION
Code Class Resolution Description 1fn1 nuc 1.60 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL)ACRIDINE-4- CARBOXAMIDE C20 H24 N4 O CRYSTAL STRUCTURE OF 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL) ACRIDINE-4-CARBOXAMIDE BOUND TO D(CG(5BR)UACG)2 DNA (5'-D(P*GP*(BRO)UP*AP*CP*G)-3'), DNA (5'-D(*CP*GP*(BRO)UP*AP*CP*G)-3') DNA 9-AMINOACRIDINE-4-CARBOAMIDE, HEXANUCLEOTIDE, X-RAY CRYSTALLOGRAPHY, INTERCALATION, QUADRUPLEX, DNA 1fn2 nuc 1.60 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL)ACRIDINE-4- CARBOXAMIDE C20 H24 N4 O 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL)ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 DNA (5'-D(*CP*GP*TP*AP*CP*G)-3'), DNA (5'-D(P*GP*TP*AP*CP*G)-3') DNA DNA, ACRIDINE-4-CARBOXAMIDE, INTERCALATION, QUADRUPLEX
Code Class Resolution Description 1r4d nuc NMR 8-METHYL-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) SOLUTION STRUCTURE OF THE CHIMERIC L/D DNA OLIGONUCLEOTIDE D(C8METGCGC(L)G(L)CGCG)2 5'-D(*CP*(8MG)P*CP*GP*(0DC)P*(0DG)P*CP*GP*CP*G)-3 CHAIN: A, B DNA DNA POLYMORPHISM, L ENANTIOMERY, ANTISENSE, HYBRID ZBZ DNA, 1tne nuc NMR 8-METHYL-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) NMR STUDY OF Z-DNA AT PHYSIOLOGICAL SALT CONDITIONS, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*GP*CP*(8MG)P*CP*G)-3') DNA Z-DNA
Code Class Resolution Description 178d nuc 2.50 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 8- HYDROXYDEOXYGUANINE.ADENINE BASE-PAIRS DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*(8OG) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED 183d nuc 1.60 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P X-RAY STRUCTURE OF A DNA DECAMER CONTAINING 7, 8-DIHYDRO-8- OXOGUANINE DNA (5'-D(*CP*CP*AP*(8OG)P*CP*GP*CP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 1fyi nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P 11-MER DNA DUPLEX CONTAINING A 2'-DEOXYARISTEROMYCIN 8-OXO- GUANINE BASE PAIR; 5'-D(*GP*TP*GP*AP*CP*(8OG)P*CP*AP*CP*TP*G)-3', 5'-D(*CP*AP*GP*TP*GP*(2AR)P*GP*TP*CP*AP*C)-3' DNA 2'-DEOXYARISTEROMYCIN, 8-OXO-GUANINE, DNA 1n2w nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) SOLUTION STRUCTURE OF 8OG:G MISMATCH CONTAINING DUPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(8OG)P*GP*CP*G)-3' DNA 8OG, G:G MISMATCH, OXIDATIVE DAMAGE, DNA 2m3p nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ALPHA ANOMER DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B, DNA (5'-D(*CP*GP*CP*TP*CP*(ORP)P*CP*AP*CP*GP*C)-3 CHAIN: A DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2m3y nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ANOMER DNA (5'-D(*CP*GP*CP*TP*CP*(AAB)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2m40 nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND THF LESION DNA (5'-D(*CP*GP*CP*TP*CP*(3DR)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER, 8-OXO-GUANINE, THF, DNA 2m43 nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ALPHA ANOMER (AP6, 8OG 14) DNA (5'-D(*CP*GP*CP*TP*CP*(ORP)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*(8OG)P*TP*GP*GP*GP*AP*GP*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2m44 nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ANOMER (6AP, 8OG14) DNA (5'-D(*GP*CP*(8OG)P*TP*GP*GP*GP*AP*GP*CP*G)-3 CHAIN: B, DNA (5'-D(*CP*GP*CP*TP*CP*(AAB)P*CP*AP*CP*GP*C)-3 CHAIN: A DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2mwz nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P XANTHINE AND 8-OXOGUANINE IN G-QUADRUPLEXES: FORMATION OF A TETRAD DNA (5'-D(*TP*TP*GP*GP*GP*TP*TP*AP*(8OG) P*GP*GP*TP*TP*AP*GP*GP*(3ZO)P*TP*TP*AP*GP*GP*GP*A)-3') DNA XANTHOSINE, DNA 5hqf nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P DNA DUPLEX CONTAINING A RIBONOLACTONE LESION DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B, DNA (5'-D(*CP*GP*CP*TP*CP*(RIB)P*CP*AP*CP*GP*C)-3 CHAIN: A DNA DNA LESION, CLUSTER 8-OXO-GUANINE RIBONOLACTONE, DNA 5hqq nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P DNA DUPLEX CONTAINING A RIBONOLACTONE LESION DNA (5'-D(*CP*GP*CP*TP*CP*(RIB)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*(8OG)P*TP*GP*GP*GP*AP*GP*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER 8-OXO-GUANINE RIBONOLACTONE, DNA 5iv1 nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) SOLUTION STRUCTURE OF DNA DODECAMER WITH 8-OXOGUANINE AT 4TH DNA (5'-D(*CP*GP*CP*(8OG)P*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DREW-DICKERSON, DNA, DODECAMER, NON-CANONICAL, MODIFIED DNA, DNA, DNA DAMAGE, DNA ADDUCT, LESION 5izp nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) SOLUTION STRUCTURE OF DNA DODECAMER WITH 8-OXOGUANINE AT 10T DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*(8OG)P*CP*G CHAIN: A, B DNA DREW-DICKERSON, DNA, DODECAMER, NON-CANONICAL, MODIFIED DNA, DNA, DNA DAMAGE, DNA ADDUCT, LESION 5uz1 nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE POSITION AND 8-OXOGUANINE AT THE 10TH POSITION DNA (5'-D(*CP*GP*(DMC)P*GP*AP*AP*TP*TP*CP*(8OG)P* CHAIN: A, B DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, 8-OXOGUANINE, OXIDIZED DNA, CPG SITE 5uz2 nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE AND 9TH POSITION AND 8-OXOGUANINE AT THE 10TH POSITION DNA (5'-D(*CP*GP*(DMC)P*GP*AP*AP*TP*TP*(DMC)P*(8O 3') DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, 8-OXOGUANINE, OXIDIZED DNA, CPG SITE 5uz3 nuc NMR 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) SOLUTION STRUCTURE OF A DNA DODECAMER WITH 5-METHYLCYTOSINE POSITION AND 8-OXOGUANINE AT THE 10TH POSITION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(DMC)P*(8OG)P* CHAIN: A, B DNA DREW-DICKERSON, DNA, NON-CANONICAL, MODIFIED DNA, METHYLATED EPIGENETICS, CPG SITE, 8-OXOGUANINE, 5-METHYLCYTOSINE
Code Class Resolution Description 5v0h nuc 1.90 5'-O-[(S)-HYDROXY(4-METHYL-1H-IMIDAZOL-5-YL) PHOSPHORYL]GUANOSINE 2(C14 H18 N7 O7 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-ONE BINDING SITE RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA, ANALOGUE 5v0j nuc 1.50 5'-O-[(S)-HYDROXY(4-METHYL-1H-IMIDAZOL-5-YL) PHOSPHORYL]GUANOSINE 4(C14 H18 N7 O7 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA 5v0k nuc 1.60 5'-O-[(S)-HYDROXY(4-METHYL-1H-IMIDAZOL-5-YL) PHOSPHORYL]GUANOSINE 2(C14 H18 N7 O7 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA
Code Class Resolution Description 2gy2 nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,2-BIS[5-(5-(2-IMIDAZOLINYL)-2 BENZIMIDAZOLYL)-2- BENZIMIDAZOLYL]ETHANE LIGAND 1,2-BIS[5-(5 -(2-IMIDAZOLINYL)-2 BENZIMIDAZOLYL)-2-BENZIMIDAZOLYL]ETHANE MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gxr nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-IMIDAZOLINYL)-2-(4-(2-IMIDAZOLINYL)PHENYL) BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 452d nuc 1.60 9-AMINO-(N-(2-DIMETHYLAMINO)ETHYL)ACRIDINE-4- CARBOXAMIDE 2(C18 H20 N4 O) ACRIDINE BINDING TO DNA DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA INTERCALATION, GROOVE BINDING, DNA 465d nuc 1.60 9-AMINO-(N-(2-DIMETHYLAMINO)ETHYL)ACRIDINE-4- CARBOXAMIDE 2(C18 H20 N4 O) STRUCTURE OF THE TOPOISOMERASE II POISON BOUND TO DNA DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA TOPOISOMERASE II POISON, HEXANUCLEOTIDE, D(CGTACG)2, 9- AMINO-DACA, DNA
Code Class Resolution Description 2gy3 nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,4-BIS[5-(5-(2-AMIDINO)-2 BENZIMIDAZOLYL)-2- BENZIMIDAZOLYL]BUTANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2gxt nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2- PYRIMIDINYL)-2-(4-(2- PYRIMIDINYL)PHENYL) BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 1fdg nuc 1.60 1,4-BIS-[2-(2-HYDROXY-ETHYLAMINO)-ETHYLAMINO]- ANTHRAQUINONE C14 H8 O2 BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (AMETANTRONE COMPLEX) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA HIGH RESOLUTION CRYSTAL STRUCTURE, INTERCALATION PLATFORM, MAD, ANTICANCER DRUG, DRUG-DNA COMPLEX, METAL IONS, TERTIARY BASE PAIRS
Code Class Resolution Description 5lfx nuc 1.56 RU(PHEN)2(DPPZ-11,12-ME2) C44 H30 N8 RU 6+ LAMBDA-[RU(PHEN)2(DPPZ-11,12-ME)]2+ BOUND TO A SHORT SUBSTIT SEQUENCE DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, LIGHT-SWITCH, INTERCALATION
Code Class Resolution Description 1d4r nuc 2.00 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 29-MER FRAGMENT OF HUMAN SRP RNA HELIX 6 29-MER OF MODIFIED SRP RNA HELIX 6: NON-NATIVE DUPLEX, 29-MER OF MODIFIED SRP RNA HELIX 6: NON-NATIVE DUPLEX RNA A-RNA HELIX, GGAG/GAGG BULGE, AC/CA TANDEM MISMATCH, GU WOBBLE BASE PAIRS, 2'3' -CYCLIC PHOSPHATE 2gcs nuc 2.10 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME AMINO RNA INHIBITOR, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 2gcv nuc 2.10 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME PRODUCT OLIGONUCLEOTIDE, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 2h0s nuc 2.35 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME DEOXY RNA INHIBITOR, GLMS RIBOZYME RNA RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX 2h0w nuc 2.40 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME PRODUCT OLIGONUCLEOTIDE, GLMS RIBOZYME RNA RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX 2h0x nuc 2.30 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME RNA, GLMS RIBOZYME AMINO RNA INHIBITOR RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX 2ho6 nuc 2.80 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 2ho7 nuc 2.90 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSE-6-PHOSPHATE GLMS RIBOZYME RNA, GLMS RIBOZYME SUBSTRATE RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 2hoj nuc 2.50 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, MANGANESE IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 3b4a nuc 2.70 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 T. TENGCONGENSIS GLMS RIBOZYME WITH G40A MUTATION, BOUND TO GLUCOSAMINE-6-PHOSPHATE GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA 3t4b nuc 3.55 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 CRYSTAL STRUCTURE OF THE HCV IRES PSEUDOKNOT DOMAIN HCV IRES PSEUDOKNOT DOMAIN PLUS CRYSTALLIZATION M CHAIN: A: PSEUDOKNOT DOMAIN, RESIDUES 220-270 RNA PSEUDOKNOT, FOUR-WAY JUNCTION, HCV IRES CENTRAL DOMAIN, RNA 4nyb nuc 3.10 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (1,2,3-THIADIAZOL-4-YL)PHENYL)METHANAMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4nyc nuc 3.15 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX THIENO[2,3-B]PYRAZIN-7-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4nyd nuc 2.90 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX HYPOXANTHINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4nyg nuc 3.05 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX THIAMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4p5j nuc 1.99 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C10 H13 N5 O9 P2 CRYSTAL STRUCTURE OF THE TRNA-LIKE STRUCTURE FROM TURNIP YEL VIRUS (TYMV), A TRNA MIMICKING RNA TURNIP YELLOW MOSAIC VIRUS MRNA FOR THE COAT PROT CHAIN: A RNA TRNA-MIMIC VIRAL RNA PSEUDOKNOT MULTIFUNCTIONAL, RNA 4plx nuc 3.10 ADENOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 3(C10 H13 N5 O9 P2) CRYSTAL STRUCTURE OF THE TRIPLE-HELICAL STABILITY ELEMENT AT END OF MALAT1 CORE ENE HAIRPIN AND A-RICH TRACT FROM MALAT1 RNA TRIPLE HELIX, RNA STABILITY ELEMENT, MALAT1, LONG NONCODING
Code Class Resolution Description 3got nuc 1.95 2-FLUOROADENINE C5 H4 F N5 GUANINE RIBOSWITCH C74U MUTANT BOUND TO 2-FLUOROADENINE. GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLE, THREE-WAY JUNCTION
Code Class Resolution Description 1xv6 nuc NMR 3'-O-METHYOXYETHYL-ADENOSINE 5'-MONOPHOSPHATE 2(C13 H20 N5 O8 P) THE SOLUTION STRUCTURE OF 2',5'-LINKED 3'-O-(2- METHOXYETHYL)-RNA HAIRPIN 5'-R(*(C2L)P*(G2L)P*(C2L)P*(G2L)P*(A2L)P*(A2L) P*(U2L)P*(U2L)P*(C2L)P*(G2L)P*(C2L)P*(G2L))-2' RNA HAIRPIN, (2',5')-RNA, 3'-O-(2-METHOXYETHYL) RIBOSE
Code Class Resolution Description 168d nuc 2.00 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 2(C11 H16 N5 O7 P) STABILIZING EFFECTS OF THE RNA 2'-SUBSTITUENT: CRYSTAL STRUC OLIGODEOXYNUCLEOTIDE DUPLEX CONTAINING 2'-O-METHYLATED ADEN DNA/RNA (5'-D(*GP*CP*GP*TP*)-R(*(A2M)P*)-D(*TP*AP 3') DNA/RNA HYBRID A-DNA/RNA, DOUBLE HELIX, MODIFIED, DNA-RNA HYBRID COMPLEX 1l3m nuc NMR 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 6(C11 H16 N5 O7 P) THE SOLUTION STRUCTURE OF [D(CGC)R(AMAMAM)D(TTTGCG)]2 5'-D(*CP*GP*C)-R(P*(A39)P*(A39)P*(A39))- D(P*TP*TP*TP*GP*CP*G)-3' DNA/RNA DNA/RNA HYBRID,CHIMERIC DUPLEX,2'O-METHYL, DNA-RNA COMPLEX 1x9c nuc 2.19 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P AN ALL-RNA HAIRPIN RIBOZYME WITH MUTATION U39C 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, JUNCT LOW SALT, S-TURN, E-LOOP, CATALYTIC RNA, 2'-OME, RNA 1zft nuc 2.33 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P THE CRYSTAL STRUCTURE OF AN ALL-RNA MINIMAL HAIRPIN RIBOZYME MUTANT G8I AT THE CLEAVAGE SITE 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*CP*GP*GP*UP*GP*AP*IP*AP*AP*GP*GP*G)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3' RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, INOSI JUNCTIONLESS, LOW SALT, S-TURN, E-LOOP, RIBOSE ZIPPER, CATA RNA, 2'-OME, RNA 2d2k nuc 2.65 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P CRYSTAL STRUCTURE OF A MINIMAL, NATIVE (U39) ALL-RNA HAIRPIN 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*UP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, S-TURN, DUAL CONFORMATION, RNA 2d2l nuc 2.50 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P CRYSTAL STRUCTURE OF A MINIMAL, ALL-RNA HAIRPIN RIBOZYME WIT LINKER (C3) AT POSITION U39 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*(P1P) P*AP*UP*UP*AP*CP*CP*UP*GP*CP*C)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, PROPYL LINKER, RNA 2fij nuc 1.19 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 2(C11 H16 N5 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE A-DNA DECAMER GCGT-2'OMEA- WITH INCORPORATED 2'-O-METHYLATED-ADENOSINE (2'OMEA) AND AR URIDINE (AU) 5'-D(*GP*CP*GP*TP*(A2M)P*(UAR)P*AP*CP*GP*C)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, A-FORM DNA, DNA 2fil nuc 1.69 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 4(C11 H16 N5 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE A-DNA DECAMER GCGT-2'OMEA- WITH INCORPORATED 2'-O-METHYLATED-ADENOSINE (2'OMEA) AND 2' FLUOROARABINO-THYMIDINE (FAT) 5'-D(*GP*CP*GP*TP*(A2M)P*(TAF)P*AP*CP*GP*C)-3' DNA 2'-FLUOROARABINO ACID, SUGAR MODIFICATIONS, A-FORM DNA, DNA 2kwg nuc NMR 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 5(C11 H16 N5 O7 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 2oue nuc 2.05 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P CRYSTAL STRUCTURE OF A JUNCTIONLESS ALL-RNA HAIRPIN RIBOZYME ANGSTROMS RESOLUTION SUBSTRATE STRAND - MINIMAL JUNCTIONLESS HAIRPIN R CHAIN: A, LOOP B S-TURN STRAND, LOOP B RIBOZYME STRAND, LOOP A RIBOZYME STRAND RNA RNA, HAIRPIN RIBOZYME, ALL-RNA, MUTATION, LOW SALT, S-TURN, RIBOSE ZIPPER, CATALYTIC RNA 3b5a nuc 2.35 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P CRYSTAL STRUCTURE OF A MINIMALLY HINGED HAIRPIN RIBOZYME INC A38G MUTATION WITH A 2'OME MODIFICATION AT THE ACTIVE SITE LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND29-MER LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2'O-METHYL, RIBOZYME, RNA 3b5s nuc 2.25 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES A38DAP MUTATI O-METHYL MODIFICATION AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; RNA; 2, 6 DIAMINOPURINE; 2'-O-METHYL, RNA 3bbi nuc 2.35 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATING A38(2AP) 2'-O-ME MODIFICATIONS NEAR ACTIVE SITE LOOP A SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2-AMINOPURINE, 2'O-METHYL, PHOSPHORYL TRAN RNA, LINKER 3bbm nuc 2.65 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38C AND MODIFICATION AT ACTIVE SITE LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME, PHOSPHORYL TRANSFER, 2'O-METHYL, RNA, SMAL RIBOZYME 3cr1 nuc 2.25 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P CRYSTAL STRUCTURE OF A MINIMAL, MUTANT, ALL-RNA HAIRPIN RIBO (A38C, A-1OMA) GROWN FROM MGCL2 RNA (5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*C CHAIN: A, LOOP A AND B RIBOZYME STRAND, RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*CP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) CHAIN: C RNA RIBOZYME, A38, RNA 3i2q nuc 2.90 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH 2'OME SUBSTRA AND N1-DEAZAADENOSINE AT POSITION A9 DNA/RNA (30-MER), 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2s nuc 2.75 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2'OME SUBST N1-DEAZAADENOSINE AT POSITION A10 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', DNA/RNA (30-MER) RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 4g6p nuc 2.64 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P MINIMAL HAIRPIN RIBOZYME IN THE PRECATALYTIC STATE WITH A38P LOOP A SUBSTRATE STRAND, LOOP B OF THE RIBOZYME STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4rbz nuc 1.18 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P X-RAY STRUCTURE OF RNA CONTAINING ADENOSINE PHOSPHORODITHIOA 5'-R(*CP*GP*CP*GP*(A2M)P*(ADS)P*UP*UP*AP*GP*CP*G) CHAIN: A RNA PHOSPHORODITHIOATE RNA, ADENOSINE PHOSPHORODITHIOATE, PHOSPHOROTHIOATE, ADENOSINE ANALOGUE, HYDROPHOBIC, BACKBONE 4rc0 nuc 1.13 2'-O-METHYLADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P X-RAY STRUCTURE OF RNA CONTAINING GUANOSINE PHOSPHORODITHIOA 5'-R(*CP*GP*CP*GP*AP*AP*UP*UP*(A2M)P*(2SG)P*CP*G) CHAIN: A RNA PHOSPHORODITHIOATE RNA, GUANOSINE PHOSPHORODITHIOATE, PHOSPHOROTHIOATE, GUANOSINE ANALOGUE, HYDROPHOBIC, BACKBONE
Code Class Resolution Description 1d75 nuc 2.80 8-OXY DEOXYADENOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O7 P) CONFORMATION OF THE GUANINE.8-OXOADENINE BASE PAIRS IN THE CRYSTAL STRUCTURE OF D(CGCGAATT(O8A)GCG) DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(A38) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED 1fjb nuc NMR 8-OXY DEOXYADENOSINE-5'-MONOPHOSPHATE C10 H14 N5 O7 P NMR STUDY OF AN 11-MER DNA DUPLEX CONTAINING 7,8-DIHYDRO-8- OXOADENINE (AOXO) OPPOSITE THYMINE DNA (5'-D(*CP*GP*TP*AP*CP*(A38)P*CP*AP*TP*GP*C)- 3'), DNA (5'-D(*GP*CP*AP*TP*GP*TP*GP*TP*AP*CP*G)-3') DNA DNA
Code Class Resolution Description 1s0t nuc NMR 2'DEOXY-ALPHA-ANOMERIC-ADENOSINE-5'-PHOSPHATE C10 H14 N5 O6 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING AN ALPHA- ANOMERIC ADENOSINE: INSIGHTS INTO SUBSTRATE RECOGNITION BY ENDONUCLEASE IV 5'-D(*GP*TP*CP*CP*(A3A)P*CP*GP*AP*CP*G)-3', 5'-D(*CP*GP*TP*CP*GP*TP*GP*GP*AP*C)-3' DNA DNA DOUBLE HELIX WITH ENLARGED MINER GROOVE AND HELICAL KINK 1s74 nuc NMR 2'DEOXY-ALPHA-ANOMERIC-ADENOSINE-5'-PHOSPHATE C10 H14 N5 O6 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING AN ALPHA- ANOMERIC ADENOSINE: INSIGHTS INTO SUBSTRATE RECOGNITION BY ENDONUCLEASE IV 5'-D(*GP*TP*CP*CP*(A3A)P*CP*GP*AP*CP*G)-3', 5'-D(*CP*GP*TP*CP*GP*TP*GP*GP*AP*C)-3' DNA DNA DOUBLE HELIX WITH ENLARGED MINER GROOVE AND HELICAL KINK 1s75 nuc NMR 2'DEOXY-ALPHA-ANOMERIC-ADENOSINE-5'-PHOSPHATE C10 H14 N5 O6 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING AN ALPHA- ANOMERIC ADENOSINE: INSIGHTS INTO SUBSTRATE RECOGNITION BY ENDONUCLEASE IV 5'-D(*CP*GP*TP*CP*GP*TP*GP*GP*AP*C)-3', 5'-D(*GP*TP*CP*CP*(A3A)P*CP*GP*AP*CP*G)-3' DNA DNA DOUBLE HELIX WITH ENLARGED MINER GROOVE AND HELICAL KINK 2lib nuc NMR 2'DEOXY-ALPHA-ANOMERIC-ADENOSINE-5'-PHOSPHATE C10 H14 N5 O6 P DNA SEQUENCE CONTEXT CONCEALS ALPHA ANOMERIC LESION DNA (5'-D(*CP*GP*TP*CP*CP*TP*GP*GP*AP*C)-3'), DNA (5'-D(*GP*TP*CP*CP*(A3A)P*GP*GP*AP*CP*G)-3') DNA ALPHA ANOMERIC ADENOSINE, DNA DAMAGE, FLANKING SEQUENCE EFFE STRUCTURAL PERTURBATION, STRUCTURAL DISTORTION, MINOR GROOV DISTORTION, ENDONUCLEASE IV, ENZYME RECOGNITION, HELICAL AX ENZYME MODULATION, DNA REPAIR, DNA PERTURBATION, DNA
Code Class Resolution Description 1d35 nuc 1.30 N2-METHYL 2'-DEOXYADENOSINE 5'-MONOPHOSPHATE C11 H17 N6 O6 P FACILE FORMATION OF A CROSSLINKED ADDUCT BETWEEN DNA AND THE DAUNORUBICIN DERIVATIVE MAR70 MEDIATED BY FORMALDEHYDE: MOLECULAR STRUCTURE OF THE MAR70-D(CGTNACG) COVALENT ADDUC DNA (5'-D(*CP*GP*TP*(A40)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 2d34 nuc 1.40 N2-METHYL 2'-DEOXYADENOSINE 5'-MONOPHOSPHATE C11 H17 N6 O6 P FORMALDEHYDE CROSS-LINKS DAUNORUBICIN AND DNA EFFICIENTLY: HPLC AND X-RAY DIFFRACTION STUDIES 5'-D(*CP*GP*TP*(A35)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 363d nuc 2.00 3'-AMINO DEOXYADENOSINE 5'-MONOPHOSPHATE 12(C10 H15 N6 O5 P) HIGH-RESOLUTION CRYSTAL STRUCTURE OF A FULLY MODIFIED N3'-> PHOSPHORAMIDATE DNA DODECAMER DUPLEX 5'-D(*(C42)P*(G38)P*(C42)P*(G38)P*(A43)P*(A43)P*( P*(NYM)P*(C42)P*(G38)P*(C42)P*DG)-3' DNA A-DNA, MODIFIED, DNA
Code Class Resolution Description 2m39 nuc NMR 2'-O-METHYOXYETHYL-ADENOSINE 5'-MONOPHOSPHATE 4(C13 H20 N5 O8 P) THE SOLUTION STRUCTURE OF 3',5'-LINKED 2'-O-(2-METHOXYETHYL) DUPLEX RNA (5'-R(*(C5L)P*(G48)P*(C5L)P*(G48)P*(A44)P*(A4 P*(T39)P*(C5L)P*(G48)P*(C5L)P*DG)-3') RNA DUPLEX, (3',5')-RNA, 2'-O-(2-METHOXYETHYL) RIBOSE, RNA 468d nuc 1.80 2'-O-METHYOXYETHYL-ADENOSINE 5'-MONOPHOSPHATE 4(C13 H20 N5 O8 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 469d nuc 1.70 2'-O-METHYOXYETHYL-ADENOSINE 5'-MONOPHOSPHATE 4(C13 H20 N5 O8 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RNA 470d nuc 1.95 2'-O-METHYOXYETHYL-ADENOSINE 5'-MONOPHOSPHATE 4(C13 H20 N5 O8 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 471d nuc 2.70 2'-O-METHYOXYETHYL-ADENOSINE 5'-MONOPHOSPHATE 4(C13 H20 N5 O8 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA
Code Class Resolution Description 1edr nuc 1.60 N6-METHOXY ADENOSINE 5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATTCGCG) AT 1.6 ANGSTROM 5'-D(*CP*GP*CP*GP*(A47)AP*AP*TP*TP*CP*GP*CP*G)- 3' DNA B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID, MODIFIED NUCLEOTIDE, METHOXYADENOSINE, DAMAGED DNA 456d nuc 1.60 N6-METHOXY ADENOSINE 5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATCCGCG): THE WATSON-CRICK TYPE N6-METHOXYADENOSINE/CYTIDINE BASE-PAIRS IN B-DNA DNA (5'-D(*CP*GP*CP*GP*(A47) P*AP*TP*CP*CP*GP*CP*G)-3') DNA MODIFIED NUCLEOTIDE, MISMATCH, METHOXYADENOSINE, DNA DAMAGE, B-DNA, DOUBLE HELIX 457d nuc 2.00 N6-METHOXY ADENOSINE 5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATTCGCG): N6- METHOXYADENOSINE/ THYMIDINE BASE-PAIRS IN B-DNA DNA (5'-D(*CP*GP*CP*GP*(A47) P*AP*TP*TP*CP*GP*CP*G)-3') DNA MODIFIED NUCLEOTIDE, METHOXYADENOSINE, DNA DAMAGE, B-DNA, DOUBLE HELIX
Code Class Resolution Description 2lgm nuc NMR [1,3]BENZODIOXOLO[6,5,4-CD]BENZO[F]INDOL-5(6H)-ONE C16 H9 N O3 STRUCTURE OF DNA CONTAINING AN ARISTOLACTAM II-DA LESION DNA (5'-D(*CP*GP*TP*AP*CP*AP*CP*AP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*TP*GP*TP*GP*TP*AP*CP*G)-3') DNA DUPLEX STABILITY, NER RECOGNITION, DNA
Code Class Resolution Description
2gb9 nuc 1.70 9,9'-(HEXANE-1,6-DIYLDIIMINO)BIS{N-[2-(DIMETHYLAMINO) ETHYL]ACRIDINE-4-CARBOXAMIDE} 2(C42 H50 N8 O2) D(CGTACG)2 CROSSLINKED BIS-ACRIDINE COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA DUPLEX CROSSLINKING
2gwa nuc 1.75 9,9'-(HEXANE-1,6-DIYLDIIMINO)BIS{N-[2-(DIMETHYLAMINO) ETHYL]ACRIDINE-4-CARBOXAMIDE} C42 H50 N8 O2 CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN THE DNA HOLLIDAY JUNCTION AND A BIS-ACRIDINE MOLECULE. 5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3' DNA DNA HOLLIDAY JUNCTION BIS-ACRIDINE
Code Class Resolution Description
1xcs nuc 1.40 9-[(5-(ACETYLAMINO)-6-{[(1S,4R)-8-AMINO-4-[((2R)-6- AMINO-2-{2-[(1S)-5-AMINO-1- FORMYLPENTYL]HYDRAZINO}HEXANOYL)AMINO]-1-(4- AMINOBUTYL)-2,3-DIOXOOCTYL]AMINO}-6-OXOHEXYL)AMINO]-6- CHLORO-2-METHOXYACRIDINIUM C46 H73 CL N11 O7 1+ STRUCTURE OF OLIGONUCLEOTIDE/DRUG COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX, CO2+, DNA
Code Class Resolution Description 2kp4 nuc NMR 9-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)-9H-PURIN-6-AMINE 3(C10 H13 F N5 O6 P) STRUCTURE OF 2'F-ANA/RNA HYBRID DUPLEX DNA (5'-D(*(GFL)P*(CFL)P*(TAF)P*(A5L)P*(TAF)P*(A5 P*(TAF)P*(GFL)P*(GFL))-3'), RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3') DNA/RNA 2-DEOXY-2-FLUORO-D-ARABINOSE, FANA, NUCLEIC ACID STRUCTURE, NMR/MD/TI, HYBRID DUPLEX, DNA-RNA COMPLEX
Code Class Resolution Description 1yrm nuc 2.50 2'-AMINE-CYTIDINE-5'-MONOPHOSPHATE 3(C9 H15 N4 O7 P) CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING SITE SPECIFIC SUBSTITUTIONS AT A C-A MISMATCH DNA/RNA (5'-R(*GP*CP*AP*GP*A)-D(P*(A5M))- R(P*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3') RNA 2'-AMINE, RNA, DUPLEX, MISMATCH 1yy0 nuc 3.20 2'-AMINE-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H15 N4 O7 P) CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING A 2'-AMINE SUB AND A 2'-AMIDE PRODUCT PRODUCED BY IN-CRYSTAL ACYLATION AT MISMATCH 5'-R(*GP*CP*AP*GP*AP*(A5M)P*UP*UP*AP*AP*AP*UP*CP* 3', 5'-R(*GP*CP*AP*GP*AP*(M5M)P*UP*UP*AP*AP*AP*UP*CP* 3' RNA 2'-AMINE, RNA, DUPLEX, MISMATCH, 2-AMIDE, IN-CRYSTAL REACTIO 1yzd nuc 2.35 2'-AMINE-CYTIDINE-5'-MONOPHOSPHATE 3(C9 H15 N4 O7 P) CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING A SITE SPECIFI SUBSTITUTION AT A C-G WATSON-CRICK BASE PAIR RNA 5'-R(*GP*CP*AP*GP*AP*(A5M) P*UP*UP*AP*AP*GP*UP*CP*UP*GP*C)-3' RNA 2'-AMINE, RNA, DUPLEX 1z79 nuc 2.55 2'-AMINE-CYTIDINE-5'-MONOPHOSPHATE 3(C9 H15 N4 O7 P) CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING SITE SPECIFIC SUBSTITUTION AT A C-A MISMATCH (AT PH 5) RNA 5'-R(*GP*CP*AP*GP*AP*(A5M) P*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3' RNA 2'-AMINE, RNA, DUPLEX, MISMATCH
Code Class Resolution Description 2kp3 nuc NMR ADENINE ARABINOSE-5'-PHOSPHATE 3(C10 H14 N5 O7 P) STRUCTURE OF ANA-RNA HYBRID DUPLEX RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3'), RNA (5'-R(*(GAO)P*(CAR)P*(UAR)P*(A5O)P*(UAR)P*(A5 P*(UAR)P*(GAO)P*(GAO))-3') RNA ANA, ARABINONUCLEIC ACID, NUCLEIC ACID STRUCTURE, NMR/MD/TI, DUPLEX, RNA 2lsc nuc NMR ADENINE ARABINOSE-5'-PHOSPHATE 4(C10 H14 N5 O7 P) SOLUTION STRUCTURE OF 2'F-ANA AND ANA SELF-COMPLEMENTARY DUP DNA (5'-D(*(CFL)P*(GFL)P*(CFL)P*(GFL)P*(A5O)P*(A5 P*(UAR)P*(CFL)P*(GFL)P*(CFL)P*(GFL))-3') DNA DNA, DICKERSON DREW DODECAMER
Code Class Resolution Description 1nr8 nuc 1.66 2-AMINOETHYLLYSINE-CARBONYLMETHYLENE-ADENINE C15 H24 N8 O3 THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX
Code Class Resolution Description 3ok2 nuc 1.96 2-(6-AMINO-9H-PURIN-9-YL)-1,5-ANHYDRO-2-DEOXY-6-O- PHOSPHONO-D-ALTRITOL 6(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER WITHOUT LATTICE TRA DEFECTS (A6C)(A6C)(A6G)(A6U)(A6A)(A6A)(A6U)(A6G)(A6C)(A6C CHAIN: A, C, E, GGCAUUACGG RNA RNA, HYBRID, ANA, SUGAR MODIFICATION, ALTRITOL SUGAR RINGS 3ok4 nuc 1.15 2-(6-AMINO-9H-PURIN-9-YL)-1,5-ANHYDRO-2-DEOXY-6-O- PHOSPHONO-D-ALTRITOL 30(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER SUFFERING FROM LATT TRANSLOCATION DEFECTS ANA, RNA RNA ALTRITOL, SUGAR MODIFICATION, RNA, LATTICE TRANSLOCATION DEF
Code Class Resolution Description 3ok2 nuc 1.96 2-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)-1,5-ANHYDRO-2- DEOXY-6-O-PHOSPHONO-D-ALTRITOL 12(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER WITHOUT LATTICE TRA DEFECTS (A6C)(A6C)(A6G)(A6U)(A6A)(A6A)(A6U)(A6G)(A6C)(A6C CHAIN: A, C, E, GGCAUUACGG RNA RNA, HYBRID, ANA, SUGAR MODIFICATION, ALTRITOL SUGAR RINGS 3ok4 nuc 1.15 2-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)-1,5-ANHYDRO-2- DEOXY-6-O-PHOSPHONO-D-ALTRITOL 60(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER SUFFERING FROM LATT TRANSLOCATION DEFECTS ANA, RNA RNA ALTRITOL, SUGAR MODIFICATION, RNA, LATTICE TRANSLOCATION DEF
Code Class Resolution Description 3ok2 nuc 1.96 2-(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)-1,5- ANHYDRO-2-DEOXY-6-O-PHOSPHONO-D-ALTRITOL 6(C11 H16 N5 O8 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER WITHOUT LATTICE TRA DEFECTS (A6C)(A6C)(A6G)(A6U)(A6A)(A6A)(A6U)(A6G)(A6C)(A6C CHAIN: A, C, E, GGCAUUACGG RNA RNA, HYBRID, ANA, SUGAR MODIFICATION, ALTRITOL SUGAR RINGS 3ok4 nuc 1.15 2-(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)-1,5- ANHYDRO-2-DEOXY-6-O-PHOSPHONO-D-ALTRITOL 30(C11 H16 N5 O8 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER SUFFERING FROM LATT TRANSLOCATION DEFECTS ANA, RNA RNA ALTRITOL, SUGAR MODIFICATION, RNA, LATTICE TRANSLOCATION DEF
Code Class Resolution Description 3ok2 nuc 1.96 1,5-ANHYDRO-2-DEOXY-2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL)-6-O-PHOSPHONO-D-ALTRITOL 6(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER WITHOUT LATTICE TRA DEFECTS (A6C)(A6C)(A6G)(A6U)(A6A)(A6A)(A6U)(A6G)(A6C)(A6C CHAIN: A, C, E, GGCAUUACGG RNA RNA, HYBRID, ANA, SUGAR MODIFICATION, ALTRITOL SUGAR RINGS 3ok4 nuc 1.15 1,5-ANHYDRO-2-DEOXY-2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL)-6-O-PHOSPHONO-D-ALTRITOL 30(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER SUFFERING FROM LATT TRANSLOCATION DEFECTS ANA, RNA RNA ALTRITOL, SUGAR MODIFICATION, RNA, LATTICE TRANSLOCATION DEF
Code Class Resolution Description 2dyw nuc 1.13 (6-AMINOHEXYLAMINE)(TRIAMMINE) PLATINUM(II) COMPLEX 3(C6 H25 N5 PT) A BACKBONE BINDING DNA COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA PLATINUM, PHOSPHATE CLAMP, ANTICANCER DRUG, DNA
Code Class Resolution Description 2dyw nuc 1.13 TRANS-BIS(HEXYLAMINE)-(DIAMMINE) PLATINUM(II) COMPLEX C12 H36 N4 PT A BACKBONE BINDING DNA COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA PLATINUM, PHOSPHATE CLAMP, ANTICANCER DRUG, DNA
Code Class Resolution Description 4nfp nuc 1.85 3-ETHYNYL-1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL)-1H- PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE 3(C12 H14 N5 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE 16MER GCAGNCUUAAGUCUGC CON AZA-7-DEAZA-7-ETHYNYL ADENOSINE GCAG(A7E)CUUAAGUCUGC RNA RNA 16MER OLIGO, 8-AZA-7-DEAZA-7-ETHYNYLADENOSINE, POSITION
Code Class Resolution Description 1a9g nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P APURINIC DNA WITH BOUND WATER AT THE DAMAGED SITE AND N3 OF BETA FORM, NMR, 1 STRUCTURE DNA (5'-D(*CP*GP*CP*GP*AP*AABP*AP*CP*GP*CP*C)-3') CHAIN: A, DNA (5'-D(*GP*GP*CP*GP*TP*CP*TP*CP*GP*CP*G)-3') DNA DAMAGED DNA, APURINIC DNA, WATER, DNA 1a9h nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P APURINIC DNA WITH BOUND WATER AT THE DAMAGED SITE AND O2 OF BETA FORM, NMR, 1 STRUCTURE DNA (5'-D(*CP*GP*CP*GP*AP*AABP*AP*CP*GP*CP*C)-3') CHAIN: A, DNA (5'-D(*GP*GP*CP*GP*TP*CP*TP*CP*GP*CP*G)-3') DNA DAMAGED DNA, APURINIC DNA, WATER, DNA 1a9i nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P APYRIMIDINIC DNA WITH BOUND WATER AT THE DAMAGED SITE, ALPHA NMR, 1 STRUCTURE DNA (5'-D(*CP*GP*CP*GP*AP*AABP*AP*CP*GP*CP*C)-3') CHAIN: A, DNA (5'-D(*GP*GP*CP*GP*TP*AP*TP*CP*GP*CP*G)-3') DNA DAMAGED DNA, APYRIMIDINIC DNA, WATER, DNA 1a9j nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P APYRIMIDINIC DNA WITH BOUND WATER AT THE DAMAGED SITE, BETA 1 STRUCTURE DNA (5'-D(*GP*GP*CP*GP*TP*AP*TP*CP*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*GP*AP*AABP*AP*CP*GP*CP*C)-3') CHAIN: A DNA DAMAGED DNA, APYRIMIDINIC DNA, WATER, DNA 1g5e nuc NMR 2-DEOXY-5-PHOSPHORIBOSE GROUP C5 H11 O7 P NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: BETA ANOMER 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*TP*GP*GP*G)- 3' DNA DAMAGED DNA, APYRIMIDINIC SITE 1gj0 nuc NMR 2-DEOXY-5-PHOSPHORIBOSE GROUP C5 H11 O7 P NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: BETA ANOMER 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*TP*GP*GP*G)- 3', 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3' DNA DAMAGED DNA, APYRIMIDINIC SITE 1sjl nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P A DUPLEX DNA WITH AN ABASIC SITE IN A DA TRACT, BETA FORM, N MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*GP*CP*AP*AP*AP*AP*AP*TP*GP*CP*G)-3' CHAIN: A, DNA (5'-D(*CP*GP*CP*AP*TP*TP*(AAB)P*TP*TP*GP*CP*G CHAIN: B DNA DUPLEX DNA WITH AN ABASIC SITE IN A DA TRACT, DAMAGED DNA, A DNA, DEOXYRIBONUCLEIC ACID, DNA 2hsr nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P 13MER DUPLEX DNA CONTAINING AN ABASIC SITE WITH BETA ANOMER 5'-D(*CP*CP*CP*GP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*CP*GP*GP*G)- CHAIN: A DNA ABASIC SITE, DNA DAMAGE, BASE EXCISION REPAIR, APE1, DNA 2hss nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P 13MER DUPLEX DNA CONTAING AN ABASIC SITE WITH BETA ANOMER, A STRUCTURE 5'-D(*CP*CP*CP*GP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*CP*GP*GP*G)- CHAIN: A DNA ABASIC SITE, DNA DAMAGE, BASE EXCISION REPAIR, APE1, DNA 2m3y nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ANOMER DNA (5'-D(*CP*GP*CP*TP*CP*(AAB)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2m44 nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ANOMER (6AP, 8OG14) DNA (5'-D(*GP*CP*(8OG)P*TP*GP*GP*GP*AP*GP*CP*G)-3 CHAIN: B, DNA (5'-D(*CP*GP*CP*TP*CP*(AAB)P*CP*AP*CP*GP*C)-3 CHAIN: A DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2o7x nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P DUPLEX DNA CONTAINING AN ABASIC SITE WITH AN OPPOSITE G (BET IN 5'-G_AC-3' (10 STRUCTURE ENSEMBLE AND AVERAGED STRUCTURE 5'-D(*CP*CP*CP*GP*GP*TP*GP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*CP*GP*GP*G)- CHAIN: A DNA DNA DAMAGE, APE1, ABASIC, AMBER, MOLECULAR DYNAMICS, DNA 2o7z nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P DUPLEX DNA CONTAINING AN ABASIC SITE WITH AN OPPOSITE T (BET IN 5'-G_AC-3' (10 STRUCTURE ENSEMBLE AND AVERAGED STRUCTURE 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*CP*GP*GP*G)- CHAIN: A, 5'-D(*CP*CP*CP*GP*GP*TP*TP*CP*TP*TP*TP*GP*G)-3' DNA DNA DAMAGE, APE1, ABASIC, AMBER, MOLECULAR DYNAMICS, DNA 2o82 nuc NMR 2'-DEOXY-RIBOFURANOSE-5'-MONOPHOSPHATE C5 H11 O7 P DUPLEX DNA CONTAINING AN ABASIC SITE WITH AN OPPOSITE DC (BE IN 5'-G_AC-3' (10 STRUCTURE ENSEMBLE AND AVERAGED STRUCTURE 5'-D(*CP*CP*CP*GP*GP*TP*CP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*CP*GP*GP*G)- CHAIN: A DNA DNA DAMAGE, APE1, ABASIC, AMBER, MOLECULAR DYNAMICS, DNA
Code Class Resolution Description 1db6 nuc NMR ARGININEAMIDE C6 H16 N5 O 1+ SOLUTION STRUCTURE OF THE DNA APTAMER 5'- CGACCAACGTGTCGCCTGGTCG-3' COMPLEXED WITH ARGININAMIDE DNA DNA APTAMER, ARGININE, ARGININAMIDE, SINGLE-STRAND, HAIRPIN, NMR, SELEX, DNA
Code Class Resolution Description
2f4u nuc 2.60 (2R)-4-AMINO-N-((1R,2S,3R,4R,5S)-5-AMINO-4-[(2-AMINO- 2-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-2-{2-[(3- AMINOPROPYL)AMINO]ETHOXY}-3-HYDROXYCYCLOHEXYL)-2- HYDROXYBUTANAMIDE C21 H44 N6 O9 ASITE RNA + DESIGNER ANTIBIOTIC 5'- R(*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP*CP *GP*C)-3' RNA ASITE RNA, DESIGNER ANTIBIOTIC
Code Class Resolution Description
2f4t nuc 3.00 (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-2-{2-[(2- AMINOETHYL)AMINO]ETHOXY}-4-[(2,6-DIAMINO-2,6-DIDEOXY- ALPHA-D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}-2- HYDROXYBUTANAMIDE C20 H43 N7 O8 ASITE RNA + DESIGNER ANTIBIOTIC 5'- R(*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP*CP *GP*C)-3', 5'- R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP *UP*CP*GP*C)-3' RNA ASITE RNA, DESIGNER ANTIBIOTIC
Code Class Resolution Description 1k5e nuc NMR (R)-(N-PHENYL-2-HYDROXY-ETHYL)-2'-DEOXY-ADENOSINE-5'- MONOPHOSPHATE C18 H22 N5 O7 P SOLUTION STRUCTURE OF R-STYRENE ADDUCT IN THE RAS61 SEQUENCE 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3', 5'-D(*CP*GP*GP*AP*CP*(ABR)P*AP*GP*AP*AP*G)-3' DNA STYRENE, DNA ADDUCT, SOLUTION STRUCTURE OF DNA
Code Class Resolution Description 1k5f nuc NMR (S)-(N-PHENYL-2-HYDROXY-ETHYL)-2'-DEOXY-ADENOSINE-5'- MONOPHOSPHATE C18 H22 N5 O7 P SOLUTION STRUCTURE OF THE S-STYRENE ADDUCT IN THE RAS61 SEQUENCE 5'-D(*CP*GP*GP*AP*CP*(ABS)P*AP*GP*AP*AP*G)-3', 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3' DNA STYRENE, DNA ADDUCT, SOLUTION STRUCTURE OF DNA
Code Class Resolution Description 4erj nuc 3.00 6-AMINOHEXANOIC ACID C6 H13 N O2 CRYSTAL STRUCTURE OF THE LYSINE RIBOSWITCH BOUND TO A 6-AMIN ACID LYSINE RIBOSWITCH RNA: LYSINE RIBOSWITCH APTAMER DOMAIN TRANSCRIPTION RIBOSWITCH APTAMER DOMAIN, REGULATORY MRNA, TRANSLATION, TRANSCRIPTION
Code Class Resolution Description 258d nuc 1.58 ACETATE ION 2(C2 H3 O2 1-) FACTORS AFFECTING SEQUENCE SELECTIVITY ON NOGALAMYCIN INTERCALATION: THE CRYSTAL STRUCTURE OF D(TGTACA)- NOGALAMYCIN DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 2b57 nuc 2.15 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH C74U MUTANT BOUND TO 2,6-DIAMINOPURINE 65-MER: G-BOX RNA RNA RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLES, BASE QUADRUPLES, MRNA, PURINE 2ees nuc 1.75 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH A21U, U75A MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, GUANINE, HYPOXANTHINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 2eet nuc 1.95 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH A21G, U75C MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, HYPOXANTHINE, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 2eeu nuc 1.95 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH U22A, A52U MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, GUANINE, HYPOXANTHINE, RNA-LIGAND COMPLEX, THREE-WAY JUNCTION, DOUBLE HELIX 2eev nuc 1.95 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH U22C, A52G MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, HYPOXANTHINE, GUANINE, THREE-WAY JUNCTION, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLE 2eew nuc 2.25 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH U47C MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, RNA-LIGAND COMPLEX, THREE-WAY JUNCTION, HYPOXANTHINE, GUANINE, BASE TRIPLE 2g9c nuc 1.70 ACETATE ION C2 H3 O2 1- MODIFIED PYRIMIDINES SPECIFICALLY BIND THE PURINE RIBOSWITCH GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, TRIAMINOPYRIMIDINE, RNA-LIGAND COMPLEX 2xnw nuc 1.50 ACETATE ION C2 H3 O2 1- XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO A TRIAZOLO-TRIAZOLE-DIAMINE LIGAND IDENTIFIED BY VIRTUAL SCRE GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 2xnz nuc 1.59 ACETATE ION C2 H3 O2 1- XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO ACETOGUAN IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA, APTAMER, RNA-LIGAND COMPLEX, MRNA 2xo0 nuc 1.70 ACETATE ION 2(C2 H3 O2 1-) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO 24-DIAMINO-1,3,5-TRIAZINE IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 2xo1 nuc 1.60 ACETATE ION C2 H3 O2 1- XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO N6-METHYL GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 3ds7 nuc 1.85 ACETATE ION 2(C2 H3 O2 1-) STRUCTURE OF AN RNA-2'-DEOXYGUANOSINE COMPLEX 67-MER RNA RNA, RNA-LIGAND COMPLEX, RIBOSWITCH 3fo4 nuc 1.90 ACETATE ION C2 H3 O2 1- CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH C74U MUTANT BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH C74U MUTANT RNA MRNA, RIBOSWITCH, 6-CHLOROGUANINE, ADENINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 3fo6 nuc 1.90 ACETATE ION C2 H3 O2 1- CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH BOUND TO 6-O- METHYLGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, 6-O-METHYLGUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 3g4m nuc 2.40 ACETATE ION C2 H3 O2 1- CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH BOUND TO 2- AMINOPURINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, 2-AMINOPURINE, GUANINE, THREE-WAY JUNCTION, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE-TRIPLE. 3gao nuc 1.90 ACETATE ION C2 H3 O2 1- CRYSTAL STRUCTURE OF THE GUANINE RIBOSWITCH BOUND TO XANTHINE. GUANINE RIBOSWITCH RNA RIBOSWITCH, GUANINE, XANTHINE, MRNA, RNA_LIGAND COMPLEX, THREE-WAY JUNCTION 3ger nuc 1.70 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 3ges nuc 2.15 ACETATE ION C2 H3 O2 1- CRYSTAL STRUCTURE OF THE GUANINE RIBOSWITCH C74U MUTANT BOUND TO 6-O-METHYLGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 3gog nuc 2.10 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH A21G,U75C MUTANT BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 3got nuc 1.95 ACETATE ION C2 H3 O2 1- GUANINE RIBOSWITCH C74U MUTANT BOUND TO 2-FLUOROADENINE. GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLE, THREE-WAY JUNCTION 3rg5 nuc 2.00 ACETATE ION 2(C2 H3 O2 1-) CRYSTAL STRUCTURE OF MOUSE TRNA(SEC) TRNA(SEC) RNA METAL BINDING BY RNA, RNA HYDRATION, STRUCTURAL FLEXIBILITY, TRNA FOLD, TRANSLATION, SERRS, SECS, PSTK, RNA 3sj2 nuc 1.36 ACETATE ION 2(C2 H3 O2 1-) A CRYSTAL STRUCTURE OF A MODEL OF THE REPEATING R(CGG) TRANS FOUND IN FRAGILE X SYNDROME RNA (5'- R(*UP*UP*GP*GP*GP*CP*CP*GP*GP*CP*GP*GP*CP*GP*GP*GP*UP*CP*C) CHAIN: A, RNA (5'- R(P*GP*GP*GP*CP*CP*GP*GP*CP*GP*GP*CP*GP*GP*GP*UP*CP*C)-3') RNA TRINUCLEOTIDE DISORDERS, FRAGILE X-SYNDROME, RNA 4fe5 nuc 1.32 ACETATE ION 2(C2 H3 O2 1-) CRYSTAL STRUCTURE OF THE XPT-PBUX GUANINE RIBOSWITCH APTAMER COMPLEX WITH HYPOXANTHINE XPT-PBUX GUANINE RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENE RE ELEMENT, HYPOXANTHINE, RNA 4fej nuc 1.50 ACETATE ION 2(C2 H3 O2 1-) CRYSTAL STRUCTURE OF THE A24U MUTANT XPT-PBUX GUANINE RIBOSW APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE A24U MUTANT OF THE B. SUBTILIS XPT-PBUX GUANINE R APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, HYPOXANTHINE, RNA 4fel nuc 1.60 ACETATE ION C2 H3 O2 1- CRYSTAL STRUCTURE OF THE U25A/A46G MUTANT OF THE XPT-PBUX GU RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE U25A/A46G MUTANT OF THE B. SUBTILIS XPT-PBUX GUAN RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, HYPOXANTHINE, RNA 4fen nuc 1.35 ACETATE ION C2 H3 O2 1- CRYSTAL STRUCTURE OF THE A24U/U25A/A46G MUTANT XPT-PBUX GUAN RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE A24U/U25A/A46G MUTANT OF THE B. SUBTILIS XPT-PBUX RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, RNA 4phy nuc 3.10 ACETATE ION 2(C2 H3 O2 1-) FUNCTIONAL CONSERVATION DESPITE STRUCTURAL DIVERGENCE IN LIG RESPONSIVE RNA SWITCHES RNA (26-MER), RNA (5'- R(*GP*CP*AP*GP*GP*AP*AP*CP*CP*GP*AP*GP*AP*GP*GP*CP*AP*CP*GP CHAIN: B RNA VIRAL GENOME, INTERNAL RIBOSOME ENTRY SITE, TRANSLATION, RNA
Code Class Resolution Description 1y26 nuc 2.10 ADENINE C5 H5 N5 A-RIBOSWITCH-ADENINE COMPLEX VIBRIO VULNIFICUS A-RIBOSWITCH: SEQUENCE DATABASE RESIDUES 202511-202580 RNA A-RIBOSWITCH ADENINE RECOGNITION, RNA 4lw0 nuc 1.89 ADENINE C5 H5 N5 STRUCTURE OF THE THF RIBOSWITCH BOUND TO ADENINE THF RIBOSWITCH RNA APTAMERS, NUCLEOTIDE, BACILLUS SUBTILIS, BACTERIAL PROTEINS, SEQUENCE, BINDING SITES, CALORIMETRY, FOLIC ACID, GENE EXPR REGULATION, BACTERIAL, GUANINE, LEUCOVORIN, LIGANDS, MAGNES MOLECULAR SEQUENCE DATA, NUCLEIC ACID CONFORMATION, POINT M PROTEIN BINDING, PROTEIN STRUCTURE, SECONDARY, RNA, RIBOSWI ADENOSYLMETHIONINE, STREPTOCOCCUS MUTANS, TERMINATOR REGION GENETIC, TETRAHYDROFOLATES, THERMODYNAMICS, TRANSCRIPTION, JUNCTION, PSEUDOKNOT, REGULATION, NCRNA, ADENINE BINDING, M 4tzx nuc 2.01 ADENINE C5 H5 N5 VIBRIO VULNIFICUS ADENINE RIBOSWITCH VARIANT, GROWN IN MG2+ VIBRIO VULNIFICUS ADENINE RIBOSWITCH RNA RIBOSWITCH, ADENINE, RNA, GENE REGULATION 4tzy nuc 2.57 ADENINE C5 H5 N5 VIBRIO VULNIFICUS ADENINE RIBOSWITCH VARIANT, GROWN IN BOTH MG2+ VIBRIO VULNIFICUS ADENINE RIBOSWITCH RNA RNA, RIBOSWITCH, GENE REGULATION, ADENINE 4xnr nuc 2.21 ADENINE C5 H5 N5 VIBRIO VULNIFICUS ADENINE RIBOSWITCH APTAMER DOMAIN, SYNTHES POSITION-SELECTIVE LABELING OF RNA (PLOR), IN COMPLEX WITH VIBRIO VULNIFICUS ADENINE RIBOSWITCH RNA RNA, RIBOSWITCH 5swd nuc 2.50 ADENINE C5 H5 N5 STRUCTURE OF THE ADENINE RIBOSWITCH APTAMER DOMAIN IN AN INT BOUND STATE VIBRIO VULNIFICUS STRAIN 93U204 CHROMOSOME II, AD RIBOSWITCH APTAMER DOMAIN RNA ADENINE RIBOSWITCH, PURINE RIBOSWITCH, LIGAND MIXING, INTERM STATE, RNA, GENE REGULATION, X-RAY FREE ELECTRON LASER 5swe nuc 3.00 ADENINE C5 H5 N5 LIGAND-BOUND STRUCTURE OF ADENINE RIBOSWITCH APTAMER DOMAIN IN CRYSTAL FROM ITS LIGAND-FREE STATE USING LIGAND MIXING S FEMTOSECOND CRYSTALLOGRAPHY VIBRIO VULNIFICUS STRAIN 93U204 CHROMOSOME II, AD RIBOSWITCH APTAMER DOMAIN RNA ADENINE RIBOSWITCH, PURINE RIBOSWITCH, LIGAND MIXING, RNA, G REGULATION, X-RAY FREE ELECTRON LASER
Code Class Resolution Description 1auf nuc model O-3-AMINO-3-DEOXY-ALPHA-D-GLUCOPYRANOSE C6 H14 N O5 1+ THEORETICAL MODEL OF THE REV BINDING ELEMENT (RBE, 30 RIBONUCLEOTIDE FRAGMENT) OF HUMAN IMMUNODEFICIENCY VIRUS-1 COMPLEXED WITH TOBRAMYCIN REV BINDING ELEMENT: 30 RIBONUCLEOTIDE FRAGMENT RIBONUCLEIC ACID RNA/AMINOGLYCOSIDE COMPLEX, MRNA TRANSPORT, INHIBITION OF VIRAL REPLICATION, RIBONUCLEIC ACID
Code Class Resolution Description 1auf nuc model 2,6-DIAMINO-2,3,6-TRIDEOXY-ALPHA-D-RIBO-HEXOPYRANOSYL C6 H14 N2 O2 THEORETICAL MODEL OF THE REV BINDING ELEMENT (RBE, 30 RIBONUCLEOTIDE FRAGMENT) OF HUMAN IMMUNODEFICIENCY VIRUS-1 COMPLEXED WITH TOBRAMYCIN REV BINDING ELEMENT: 30 RIBONUCLEOTIDE FRAGMENT RIBONUCLEIC ACID RNA/AMINOGLYCOSIDE COMPLEX, MRNA TRANSPORT, INHIBITION OF VIRAL REPLICATION, RIBONUCLEIC ACID
Code Class Resolution Description 4rbz nuc 1.18 ADENOSINE-5'-(DITHIO)PHOSPHATE C10 H14 N5 O5 P S2 X-RAY STRUCTURE OF RNA CONTAINING ADENOSINE PHOSPHORODITHIOA 5'-R(*CP*GP*CP*GP*(A2M)P*(ADS)P*UP*UP*AP*GP*CP*G) CHAIN: A RNA PHOSPHORODITHIOATE RNA, ADENOSINE PHOSPHORODITHIOATE, PHOSPHOROTHIOATE, ADENOSINE ANALOGUE, HYDROPHOBIC, BACKBONE
Code Class Resolution Description 1ax6 nuc NMR 2-AMINOFLUORENE C13 H11 N SOLUTION STRUCTURE OF THE [AF]-C8-DG ADDUCT OPPOSITE A-2 DELETION SITE IN THE NARI HOT SPOT SEQUENCE CONTEXT; NMR, 6 STRUCTURES DNA DUPLEX D(CTCGGC-[AF]G-CCATC)D(GATGGCCGAG), DNA DUPLEX D(CTCGGC-[AF]G-CCATC)D(GATGGCCGAG) DNA DNA DUPLEX, AMINOFLUORENE ADDUCT, CARCINOGEN ADDUCT, HOT SPOT SEQUENCE 1ax7 nuc NMR 2-AMINOFLUORENE C13 H11 N SOLUTION STRUCTURE OF THE [AF]-C8-DG ADDUCT POSITIONED AT A TEMPLATE-PRIMER JUNCTION, NMR, 6 STRUCTURES DNA DUPLEX D(AAC-[AF]G-CTACCATCC)D(GGATGGTAG), DNA DUPLEX D(AAC-[AF]G-CTACCATCC)D(GGATGGTAG) DNA DNA DUPLEX, AMINOFLUORENE ADDUCT, CARCINOGEN ADDUCT, TEMPLATE-PRIMER JUNCTION 1c0y nuc NMR 2-AMINOFLUORENE C13 H11 N SOLUTION STRUCTURE OF THE [AF]-C8-DG ADDUCT POSITIONED OPPOSITE DA AT A TEMPLATE-PRIMER JUNCTION DNA (5'- D(*AP*AP*CP*GP*CP*TP*AP*CP*CP*AP*TP*CP*C)-3'), DNA (5'-D(*GP*GP*AP*TP*GP*GP*TP*AP*GP*C)-3') DNA DNA DUPLEX, AMINOFLUORENE ADDUCT, CARCINOGEN ADDUCT, TEMPLATE-PRIMER JUNCTION
Code Class Resolution Description 2kwg nuc NMR 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 8(C10 H13 F N5 O6 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 2m84 nuc NMR 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 4(C10 H13 F N5 O6 P) STRUCTURE OF 2'F-RNA/2'F-ANA CHIMERIC DUPLEX 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA 2'F-RNA/2'F-ANA CHIMERIC DUPLEX, A-FORM, 12-MER, DICKERSON D DODECAMER, MODIFIED NUCLEOTIDES, DNA, RNA 2m8a nuc NMR 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 4(C10 H13 F N5 O6 P) 2'F-ANA/2'F-RNA ALTERNATED SEQUENCES 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA A-FORM, 12-MER, DICKERSON DREW DODECAMER, MODIFIED NUCLEOTID RNA 3p4a nuc 1.20 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 12(C10 H13 F N5 O6 P) 2'FLUORO MODIFIED RNA OCTAMER FA2U2 2'FLUORO MODIFIED RNA 8-MER RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, 2'-FLUORO 2'- DEOXYADENOSINE, 2'-FLUORO 2'-DEOXYURIDINE, SIRNA 3p4b nuc 1.45 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 6(C10 H13 F N5 O6 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-P3 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA 3p4c nuc 1.15 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 F N5 O6 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-R32 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA 5do5 nuc 1.20 2'-DEOXY-2'-FLUOROADENOSINE 5'-(DIHYDROGEN PHOSPHATE) C10 H13 F N5 O6 P CRYSTAL STRUCTURE OF 2'-FLUORO-RNA BEARING A PHOSPHORODITHIO RNA (5'-R(*CP*GP*CP*GP*AP*AP*UP*UP*(AF2)P*(2SG)P* CHAIN: A RNA RNA, 2'-FLUORO-RNA, PHOSPHORODITHIOATE RNA, PS2-RNA
Code Class Resolution Description
2gxh nuc model 2,4-BIS{[4-(N-ISOPORPYL)DIAMINOMETHYL]PHENYL}FURAN C24 H32 N4 O MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 2,4-BIS{[4-(N-ISOPROPYL)DIAMINOMETHYL]PHENYL}FURAN DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, FURAN DERIVATIVE
Code Class Resolution Description 2ge2 nuc NMR 2-ACETYLAMINOFLUORENE-3-YL C15 H13 N O SOLUTION STRUCTURE OF THE DUPLEX DNA CONTAINING THE 3- (DEOXYGUANOSIN-N2-YL)-2-ACETOAMINOFLUORENE 5'-D(*CP*GP*TP*AP*CP*GP*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3' DNA DNA, ACETYLAMINOFLUOREN (AAF)
Code Class Resolution Description 1n1n nuc NMR 8,9-DIHYDRO-9-HYDROXY-AFLATOXIN B1 C17 H14 O7 STRUCTURE OF MISPAIRING OF THE DEOXYCYTOSINE WITH DEOXYADENOSINE 5' TO THE 8,9-DIHYDRO-8-(N7-GUANYL)-9- HYDROXY-AFLATOXIN B1 ADDUCT 5'-D(*AP*CP*AP*TP*CP*GP*AP*TP*CP*T)-3', 5'-D(*AP*GP*AP*TP*CP*AP*AP*TP*GP*T)-3' DNA AFLATOXIN B1 ADDUCT 5' TO AC MISMATCH, MAJOR CONFORMATION, DNA
Code Class Resolution Description 2gxd nuc model 2,4-BIS(4-AMIDINOPHENYL)FURAN C18 H16 N4 O MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 2,4-BIS(4-AMIDINO)FURAN. DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, FURAN DERIVATIVE
Code Class Resolution Description 2ke8 nuc NMR SILVER ION 3(AG 1+) NMR SOLUTION STRUCTURE OF METAL-MODIFIED DNA DNA (5'-D(*TP*TP*AP*AP*TP*TP*TP*(D33)P*(D33)P*(D3 P*AP*AP*AP*TP*TP*AP*A)-3') DNA DNA, ARTIFICIAL NUCLEOBASE, IMIDAZOLE NUCLEOSIDE, AG+ 2m54 nuc NMR SILVER ION 3(AG 1+) REFINED NMR SOLUTION STRUCTURE OF METAL-MODIFIED DNA DNA (5'-D(*TP*TP*AP*AP*TP*TP*TP*(D33)P*(D33)P*(D3 P*AP*AP*AP*TP*TP*AP*A)-3') DNA DNA, ARTIFICIAL NUCLEOBASE, IMIDAZOLE NUCLEOSIDE 2rvp nuc NMR SILVER ION AG 1+ SOLUTION STRUCTURE OF DNA CONTAINING METALLO-BASE-PAIR DNA (5'-D(*TP*AP*AP*TP*TP*AP*AP*CP*TP*AP*TP*AP*TP 3'), DNA (5'-D(*TP*AP*AP*TP*AP*TP*AP*CP*TP*TP*AP*AP*TP 3') DNA DNA, METALLO-DNA, METALLO-BASE-PAIR, C-AG(I)-C BASE-PAIR 5ay2 nuc 1.30 SILVER ION 4(AG 1+) CRYSTAL STRUCTURE OF RNA DUPLEX CONTAINING C-AG(I)-C BASE PA RNA (5'-R(*GP*GP*AP*CP*UP*(CBR)P*GP*AP*CP*UP*CP*C CHAIN: A, B, C, D RNA RNA, METALLO BASE PAIR, AG(I)
Code Class Resolution Description 5nex nuc 1.72 AGMATINE C5 H14 N4 THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH AGMATINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA,
Code Class Resolution Description 5neq nuc 1.69 AMINOGUANIDINE C H6 N4 THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH AMINOGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, AMINOGUANIDINE, RNA
Code Class Resolution Description
1rmx nuc NMR N-[3-(DIMETHYLAMINO)PROPYL]-2-({[4-({[4-(FORMYLAMINO)- 1-METHYL-1H-PYRROL-2-YL]CARBONYL}AMINO)-1-METHYL-1H- PYRROL-2-YL]CARBONYL}AMINO)-5-ISOPROPYL-1,3-THIAZOLE- 4-CARBOXAMIDE 2(C25 H34 N8 O4 S) A SHORT LEXITROPSIN THAT RECOGNIZES THE DNA MINOR GROOVE AT 5'-ACTAGT-3': UNDERSTANDING THE ROLE OF ISOPROPYL-THIAZOLE 5'-D(*CP*GP*AP*CP*TP*AP*GP*TP*CP*G)-3' DNA MINOR-GROOVE-DNA COMPLEX, SIDE-BY-SIDE BINDING, DNA RECOGNITION
Code Class Resolution Description 4p20 nuc 2.70 (2S)-N-[(1R,2S,3S,4R,5S)-4-[(2R,3R,4S,5S,6R)-6- (AMINOMETHYL)-3,4,5-TRIS(OXIDANYL)OXAN-2-YL]OXY-5- AZANYL-2-[(2S,3R,4S,5S,6R)-4-AZANYL-6-(HYDROXYMETHYL)- 3,5-BIS(OXIDANYL)OXAN-2-YL]OXY-3-OXIDANYL-CYCLOHEXYL]- 4-AZANYL-2-OXIDANYL-BUTANAMIDE 2(C22 H43 N5 O13) CRYSTAL STRUCTURES OF THE BACTERIAL RIBOSOMAL DECODING SITE WITH AMIKACIN 5'-R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*U *GP*UP*CP*GP*C)-3' RNA/ANTIBIOTIC AMINOGLYCOSIDE, HABA GROUP, RIBOSOMAL DECODING SITE, X-RAY A RNA, AMIKACIN
Code Class Resolution Description 1yrj nuc 2.70 APRAMYCIN 2(C21 H41 N5 O11) CRYSTAL STRUCTURE OF APRAMYCIN BOUND TO A RIBOSOMAL RNA A SI OLIGONUCLEOTIDE BACTERIAL 16 S RIBOSOMAL RNA A SITE OLIGONUCLEOTI CHAIN: A, B RNA RNA COMPLEX, APRAMYCIN-RNA COMPLEX, MOLECULAR RECOGNITION, R 2g5k nuc 2.80 APRAMYCIN 2(C21 H41 N5 O11) CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING SITE COMPLEXED WITH APRAMYCIN 5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3' RNA AMINOGLYCOSIDE, ANTIBIOTICS, APRAMYCIN, RIBOSOME, DECODING SITE, HOMO SAPIENS, CYTOPLASM, RNA 2m4q nuc NMR APRAMYCIN C21 H41 N5 O11 NMR STRUCTURE OF E. COLI RIBOSOMELA DECODING SITE WITH APRAM RNA (27-MER) RNA/ANTIBIOTIC RNA, ANTIBIOTIC, DECODING SITE, AMINOGLYCOSIDE, APRAMYCIN, R ANTIBIOTIC COMPLEX 2oe5 nuc 1.51 APRAMYCIN C21 H41 N5 O11 1.5 A X-RAY CRYSTAL STRUCTURE OF APRAMYCIN COMPLEX WITH RNA GGCGUCGCUAGUACCG/GGUACUAAAAGUCGCCC CONTAINING THE HUMAN RIB DECODING A SITE: RNA CONSTRUCT WITH 3'-OVERHANG RNA (5'-R(*GP*GP*CP*GP*UP*CP*GP*CP*UP*AP*GP*UP*AP 3'), RNA (5'- R(*GP*GP*UP*AP*CP*UP*AP*AP*AP*AP*GP*UP*CP*GP*CP*CP*C)-3') RNA AMINOGLYCOSIDE ANTIBIOTICS, APRAMYCIN, RIBOSOMAL DECODING SI SITE, HOMO SAPIENS, RNA DUPLEX, RNA 2oe8 nuc 1.80 APRAMYCIN C21 H41 N5 O11 1.8 A X-RAY CRYSTAL STRUCTURE OF APRAMYCIN COMPLEX WITH RNA GGGCGUCGCUAGUACC/CGGUACUAAAAGUCGCC CONTAINING THE HUMAN RIB DECODING A SITE: RNA CONSTRUCT WITH 5'-OVERHANG RNA (5'- R(*CP*GP*GP*UP*AP*CP*UP*AP*AP*AP*AP*GP*UP*CP*GP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*CP*GP*UP*CP*GP*CP*UP*AP*GP*UP 3') RNA AMINOGLYCOSIDE ANTIBIOTICS, APRAMYCIN, RIBOSOMAL DECODING SI SITE, HOMO SAPIENS, RNA DUPLEX, RNA 4k31 nuc 1.42 APRAMYCIN 4(C21 H41 N5 O11) CRYSTAL STRUCTURE OF APRAMYCIN BOUND TO THE LEISHMANIAL RRNA RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*UP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RRNA DUPLEX, RIBOSOMAL A-SITE, AMINOGLYCOSIDE, RIBOSOME, RNA ANTIBIOTIC COMPLEX
Code Class Resolution Description 1am0 nuc NMR ADENOSINE MONOPHOSPHATE C10 H14 N5 O7 P AMP RNA APTAMER COMPLEX, NMR, 8 STRUCTURES RNA APTAMER RNA COMPLEX (RIBONUCLEIC ACID/AMP), RNA APTAMER, GNRA MOTIF, G(DOT)G MISMATCH, G(DOT)A MISMATCH, RIBONUCLEIC ACID 1aw4 nuc NMR ADENOSINE MONOPHOSPHATE 2(C10 H14 N5 O7 P) STRUCTURAL BASIS OF DNA FOLDING AND RECOGNITION IN AMP-DNA APTAMER COMPLEX, NMR, 7 STRUCTURES ATP-BINDING DNA APTAMER DNA ADAPTIVE BINDING, AMP BINDING, DNA APTAMER, DNA BINDING, DNA RECOGNITION, AMP-DNA APTAMER COMPLEX 1raw nuc NMR ADENOSINE MONOPHOSPHATE C10 H14 N5 O7 P ATP BINDING RNA APTAMER IN COMPLEX WITH AMP, NMR, 10 STRUCTURES RNA APTAMER: ATP-BINDING, RESIDUES 1 - 36 RNA RIBONUCLEIC ACID, UUCG TETRALOOP, RNA
Code Class Resolution Description 4xw7 nuc 2.50 AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE C9 H15 N4 O8 P CRYSTAL STRUCTURE OF THE ZMP RIBOSWITCH AT 2.50 ANGSTROM PFL RNA RNA RNA, RIBOSWITCH, ZMP, AICAR 4xwf nuc 1.80 AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE C9 H15 N4 O8 P CRYSTAL STRUCTURE OF THE ZMP RIBOSWITCH AT 1.80 ANGSTROM PFL RNA RNA RNA, RIBOSWITCH, ZMP, AICAR 4znp nuc 2.94 AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE 2(C9 H15 N4 O8 P) THE STRUCTURE OF A PFI RIBOSWITCH BOUND TO ZMP PFI RIBOSWITCH RNA ZMP, RIBOSWITCH, RNA, ONE CARBON MECHANISM, AICAR, ZTP, COMP 5btp nuc 2.82 AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE 2(C9 H15 N4 O8 P) FUSOBACTERIUM ULCERANS ZTP RIBOSWITCH BOUND TO ZMP RNA (62-MER) RNA RNA
Code Class Resolution Description 1xcu nuc 2.00 1,5-BIS[3-(DIETHYLAMINO)PROPIONAMIDO]ANTHRACENE-9,10- DIONE 2(C28 H36 N4 O4) OLIGONUCLEOTID/DRUG COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, ANTHRAQUINONE, CO2+
Code Class Resolution Description 274d nuc 2.30 ANTHRAMYCIN C16 H17 N3 O4 CRYSTAL STRUCTURE OF A COVALENT DNA-DRUG ADDUCT: ANTHRAMYCIN BOUND TO C-C-A-A-C-G-T-T-G-G, AND A MOLECULAR EXPLANATION OF SPECIFICITY DNA (5'-D(*CP*CP*AP*AP*CP*GP*TP*TP*(DRUG)GP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 1axu nuc NMR N-1-AMINOPYRENE C16 H11 N SOLUTION NMR STRUCTURE OF THE [AP]DG ADDUCT OPPOSITE DA IN A DNA DUPLEX, NMR, 9 STRUCTURES DNA DUPLEX D(CCATC-[AP]G-CTACC)D(GGTAGAGATGG), DNA DUPLEX D(CCATC-[AP]G-CTACC)D(GGTAGAGATGG) DNA DNA DUPLEX, AMINOPYRENE ADDUCT, CARCINOGEN ADDUCT
Code Class Resolution Description 2rrc nuc NMR N1-PROTONATED ADENOSINE-5'-MONOPHOSPHATE C10 H15 N5 O7 P 1+ SOLUTION STRUCTURE OF RNA APTAMER AGAINST AML1 RUNT DOMAIN 5'-R(P*GP*GP*AP*CP*CP*CP*(AP7) P*CP*CP*AP*CP*GP*GP*CP*GP*AP*GP*GP*UP*CP*CP*A)-3' RNA RNA APTAMER, AML1/RUNX1, MOLECULAR MIMICRY, RNA 5lwj nuc NMR N1-PROTONATED ADENOSINE-5'-MONOPHOSPHATE C10 H15 N5 O7 P 1+ SOLUTION NMR STRUCTURE OF THE GTP BINDING CLASS II RNA APTAM COMPLEX CONTAINING A PROTONATED ADENINE NUCLEOTIDE WITH A H SHIFTED PKA. GTP CLASS II RNA (34-MER) RNA RNA STRUCTURE, APTAMER, PROTONATED ADENINE, GTP, RNA
Code Class Resolution Description 176d nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-ADENINE 2(C11 H16 N7 O3 1+) NMR SOLUTION STRUCTURE OF A PEPTIDE NUCLEIC ACID COMPLEXED W DNA (5'-D(*GPN*APN*APN*CPN*TPN*CPN)-3'), RNA (5'-R(P*GP*AP*GP*UP*UP*C)-3') PEPTIDE NUCLEIC ACID/RNA RNA, PNA, DOUBLE HELIX, PEPTIDE NUCLEIC ACID-RNA COMPLEX 1nr8 nuc 1.66 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-ADENINE 2(C11 H16 N7 O3 1+) THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX 1pdt nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-ADENINE C11 H16 N7 O3 1+ PD235, PNA-DNA DUPLEX, NMR, 8 STRUCTURES DNA (5'-D(*GP*AP*CP*AP*TP*AP*GP*C)-3', PEPTIDE NUCLEIC ACID (COOH-P(*G*C*T*A*T*G*T*C)-NH CHAIN: B PEPTIDE NUCLEIC ACID/DNA COMPLEX (PEPTIDE NUCLEIC ACID-DNA), NUCLEIC ACID COMPLEX, DU HYBRID, PEPTIDE NUCLEIC ACID-DNA COMPLEX 5emf nuc 1.14 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-ADENINE 2(C11 H16 N7 O3 1+) CRYSTAL STRUCTURE OF RNA R(GCUGCUGC) WITH ANTISENSE PNA P(GC RNA (5'-R(*GP*CP*UP*GP*CP*UP*GP*C)-3'), ANTISENSE PNA P(GCAGCAGC) RNA CUG REPEATS, RNA/PNA DUPLEX, ANTISENSE PNA, MYOTONIC DYSTROP 1, RNA
Code Class Resolution Description 2kk5 nuc NMR 9,10-DIOXO-9,10-DIHYDROANTHRACENE-2-CARBOXAMIDE 2(C15 H9 N O3) HIGH FIDELITY BASE PAIRING AT THE 3'-TERMINUS 5'-D(*AP*CP*GP*CP*GP*(2AU))-3' DNA ANTHRAQUINONE-LINKED DNA
Code Class Resolution Description 386d nuc 1.80 N,N-BIS(3-AMINOPROPYL)-2-ANTHRAQUINONESULFONAMIDE C20 H25 N3 O4 S 2+ THREE-DIMENSIONAL STRUCTURE AND REACTIVITY OF A PHOTOCHEMICAL CLEAVAGE AGENT BOUND TO DNA DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description
1b0s nuc NMR (2-{[4-({4-[(4-FORMYLAMINO-1-METHYL-1H-IMIDAZOLE-2- CARBONYL)-AMINO]-1-METHYL-1H-IMIDAZOLE-2-CARBONYL}- AMINO)-1-METHYL-1H-IMIDAZOLE-2-CARBONYL]-AMINO}- ETHYL)-DIMETHYL-AMMONIUM 2(C20 H28 N11 O4 1+) BINDING OF AR-1-144, A TRI-IMIDAZOLE DNA MINOR GROOVE BINDER, TO CCGG SEQUENCE ANALYZED BY NMR SPECTROSCOPY DNA (5'-D(*GP*AP*AP*CP*CP*GP*GP*TP*TP*C)-3') DNA ANTICANCER DRUG, DRUG DESIGN, DNA STRUCTURE, SEQUENCE SPECIFIC RECOGNITION
1cyz nuc NMR (2-{[4-({4-[(4-FORMYLAMINO-1-METHYL-1H-IMIDAZOLE-2- CARBONYL)-AMINO]-1-METHYL-1H-IMIDAZOLE-2-CARBONYL}- AMINO)-1-METHYL-1H-IMIDAZOLE-2-CARBONYL]-AMINO}- ETHYL)-DIMETHYL-AMMONIUM 2(C20 H28 N11 O4 1+) NMR STRUCTURE OF THE GAACTGGTTC/TRI-IMIDAZOLE POLYAMIDE COMPLEX 5'-D(*GP*AP*AP*CP*TP*GP*GP*TP*TP*C)-3' DNA T:G RECOGNIZED BY IM/IM PAIR IN THE DNA MINOR GROOVE
Code Class Resolution Description 4nfp nuc 1.85 FORMAMIDE 3(C H3 N O) CRYSTAL STRUCTURE ANALYSIS OF THE 16MER GCAGNCUUAAGUCUGC CON AZA-7-DEAZA-7-ETHYNYL ADENOSINE GCAG(A7E)CUUAAGUCUGC RNA RNA 16MER OLIGO, 8-AZA-7-DEAZA-7-ETHYNYLADENOSINE, POSITION
Code Class Resolution Description 1aju nuc NMR ARGININE C6 H15 N4 O2 1+ HIV-2 TAR-ARGININAMIDE COMPLEX, NMR, 20 STRUCTURES TAR RNA RNA COMPLEX (RIBONUCLEIC ACID/LIGAND), NMR, TRANSCRIPTIONAL ACTIVATION, PROTEIN-RNA INTERACTIONS 1akx nuc NMR ARGININE C6 H15 N4 O2 1+ HIV-2 TRANS ACTIVATING REGION RNA COMPLEX WITH ARGININAMIDE, NMR, MINIMIZED AVERAGE STRUCTURE TAR RNA RNA TRANSCRIPTIONAL ACTIVATION, NMR, COMPLEX (RNA/LIGAND), PROTEIN-RNA INTERACTIONS 1arj nuc NMR ARGININE C6 H15 N4 O2 1+ ARG-BOUND TAR RNA, NMR TAR RNA RNA NMR PEPTIDE-BOUND STRUCTURE, NUCLEIC ACIDS, COMPLEX (RNA/PEPTIDE) 1koc nuc NMR ARGININE C6 H15 N4 O2 1+ RNA APTAMER COMPLEXED WITH ARGININE, NMR RNA (5'-R(P*AP*GP*AP*AP*GP*GP*AP*GP*CP*GP*U)-3'), RNA (5'- R(P*AP*CP*AP*GP*GP*UP*AP*GP*GP*UP*CP*GP*CP*U)-3') RNA COMPLEX (RNA APTAMER/PEPTIDE), IN VITRO SELECTED RNA, RNA APTAMER 2kx8 nuc NMR ARGININE C6 H15 N4 O2 1+ NMR STRUCTURE OF STEM-LOOP 4 FROM THE HUMAN 7SK SNRNA IN COM ARGININE 7SK RNA SNRNA, RNA 2l8h nuc NMR ARGININE C6 H15 N4 O2 1+ CHEMICAL PROBE BOUND TO HIV TAR RNA HIV TAR RNA RNA RNA 5kvj nuc 2.26 ARGININE C6 H15 N4 O2 1+ CRYSTAL STRUCTURE OF THE 16-MER DOUBLESTRANDED RNA. NORTHEAS STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET RNA1 RNA (5'- R(P*CP*GP*CP*CP*UP*GP*UP*AP*GP*AP*GP*GP*AP*UP*GP*G)-3'), RNA (5'- R(P*CP*CP*AP*UP*CP*CP*UP*CP*UP*AP*CP*AP*GP*GP*CP*G)-3') RNA DOUBLE STRANDED RNA, DSRNA, NORTHEAST STRUCTURAL GENOMICS CO NESG, PSI-BIOLOGY, RNA
Code Class Resolution Description 1d83 nuc NMR [O4]-ACETOXY-2,3-DIDEOXYFUCOSE 2(C8 H14 O4) STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION DNA (5'-D(*AP*AP*GP*GP*CP*CP*TP*T)-3') DNA DNA, NMR, DOUBLE HELIX, CHROMOMYCIN 1vaq nuc 2.00 [O4]-ACETOXY-2,3-DIDEOXYFUCOSE 4(C8 H14 O4) CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA) 2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION 5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3' DNA CHROMOMYCIN A3, X-RAY DIFFRACTION, MAD, DNA DUPLEX, GGCC SITE, DNA KINK, CD SPECTRA 5erz nuc 1.75 [O4]-ACETOXY-2,3-DIDEOXYFUCOSE 2(C8 H14 O4) CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX 5es0 nuc 2.10 [O4]-ACETOXY-2,3-DIDEOXYFUCOSE 2(C8 H14 O4) CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX
Code Class Resolution Description 1old nuc NMR DEOXY-METHYL-ARGININE C7 H16 N4 O NMR STRUCTURE OF 24-MER DEOXYRIBONUCLEIC ACID, 7 STRUCTURES DNA (GATCGAAACGTAGCGCCTTCGATC) DNA DEOXYRIBONUCLEIC ACID, DNA 2arg nuc NMR DEOXY-METHYL-ARGININE C7 H16 N4 O FORMATION OF AN AMINO ACID BINDING POCKET THROUGH ADAPTIVE ZIPPERING-UP OF A LARGE DNA HAIRPIN LOOP, NMR, 9 STRUCTURES DNA APTAMER [5'-D (*TP*GP*AP*CP*CP*AP*GP*GP*GP*CP*AP*AP*AP*CP*GP*GP*TP*AP* GP*GP*TP*GP*AP*GP*TP*GP*GP*TP*CP*A)-3'] DNA ADAPTIVE DNA STRUCTURAL TRANSITIONS, L-ARGININAMIDE BINDING POCKET, MOLECULAR RECOGNITION OF AN AMINO ACID, MINOR GROOVE RECOGNITION, BASE ENCAPSULATION WITHIN MINOR GROOVE, DNA APTAMER, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1d14 nuc 1.50 2-DEOXY-ADENOSINE -5'-THIO-MONOPHOSPHATE C10 H14 N5 O5 P S STRUCTURE OF 11-DEOXYDAUNOMYCIN BOUND TO DNA CONTAINING A PHOSPHOROTHIOATE DNA (5'-D(*CP*GP*TP*(AS)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1d21 nuc 1.70 2-DEOXY-ADENOSINE -5'-THIO-MONOPHOSPHATE 2(C10 H14 N5 O5 P S) BINDING OF THE ANTITUMOR DRUG NOGALAMYCIN AND ITS DERIVATIVE STRUCTURAL COMPARISON DNA (5'-D(*(5CM)P*GP*TP*(AS)P*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE 1d22 nuc 1.80 2-DEOXY-ADENOSINE -5'-THIO-MONOPHOSPHATE 2(C10 H14 N5 O5 P S) BINDING OF THE ANTITUMOR DRUG NOGALAMYCIN AND ITS DERIVATIVES TO DNA: STRUCTURAL COMPARISON DNA (5'-D(*(5CM)P*GP*TP*(AS)P*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 8psh nuc NMR 2-DEOXY-ADENOSINE -5'-THIO-MONOPHOSPHATE C10 H14 N5 O5 P S HIGH RESOLUTION NMR STRUCTURE OF THE STEREOREGULAR (ALL-RP)- PHOSPHOROTHIOATE-DNA/RNA HYBRID D (G*PS*C*PS*G*PS*T*PS*C*PS*A*PS*G*PS*G)R(CCUGACGC), MINIMIZED AVERAGE STRUCTURE RNA (5'-R(*CP*CP*UP*GP*AP*CP*GP*C)-3'), DNA (5'-D(*DGP*(SC)P*(GS)P*(PST)P*(SC)P*(AS) P*(GS)P*(GS))-3') DNA-RNA HYBRID OLIGONUCLEOTIDE, DNA-RNA HYBRID, PHOSPHOROTHIOATE, THIONUCLEOTIDE, ANTISENSE
Code Class Resolution Description 3s8u nuc 1.20 2'-DEOXY-2'-TRIAZA-1,2-DIEN-2-IUM-1-YL-ADENINE-5'- MONOPHOSPHATE C10 H14 N8 O6 P 1+ CRYSTAL STRUCTURE OF A 2-AZIDO-ADENINE-MODIFIED RNA ECOLI 23 S RRNA SARCIN RICIN LOOP RNA HAIRPIN RNA, RNA LABELLING,2'-AZIDO-ADENINE, RNA
Code Class Resolution Description 1bx5 nuc NMR THYMIDINE-3'-PHOSPHATE 2(C10 H15 N2 O8 P) NMR SOLUTION STRUCTURE OF [D(GCGAAT-3'-3'-ALPHAT-5'-5'-CGC) 2] DNA (5'-D(*GP*CP*GP*AP*AP*TP*(ATD)P*CP*GP*C)-3') DNA ALPHA ANOMERIC, POLARITY REVERSALS, DNA
Code Class Resolution Description 1gv6 nuc NMR [(1S,3R,4S,7R)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H15 N2 O9 P) SOLUTION STRUCTURE OF ALFA-L-LNA:DNA DUPLEX 5- D(*CP*(ATL)P*GP*CP*(ATL)P*(ATL)P*CP*(ATL)P* GP*C) -3, 5- D(*GP*CP*AP*GP*AP*AP*GP*CP*AP*G) -3 LOCKED NUCLEIC ACID LOCKED NUCLEIC ACID, LNA, DNA, NMR 1okf nuc NMR [(1S,3R,4S,7R)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H15 N2 O9 P) NMR STRUCTURE OF AN ALPHA-L-LNA:RNA HYBRID 5'-R(*GP*CP*AP*UP*AP*UP*CP*AP*GP)-3', 5'-D(*CP*ATLP*GP*AP*ATLP*AP*ATLP*GP*CP)-3' DNA-RNA HYBRID DNA-RNA HYBRID, DNA/RNA HYBRID, ALPHA-L-LNA, LNA, RNA, NMR, RNASE H, LOCKED NUCLEIC ACID
Code Class Resolution Description 5ktj nuc 2.97 ADENOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O13 P3) CRYSTAL STRUCTURE OF PISTOL, A CLASS OF SELF-CLEAVING RIBOZY RNA (5'-R(*UP*CP*UP*GP*CP*UP*CP*UP*CP*GP*UP*CP*CP 3'), PISTOL (50-MER) RNA RIBOZYME, SELF-CLEAVAGE, INTERNAL TRANSESTERIFICATION, RNA
Code Class Resolution Description 5lys nuc 2.32 GOLD ION 2(AU 1+) THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - GOLD DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
Code Class Resolution Description 2oij nuc 2.31 GOLD 3+ ION 2(AU 3+) HIV-1 SUBTYPE B DIS RNA EXTENDED DUPLEX AUCL3 SOAKED 5'-R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*C *GP*CP*AP*AP*G)-3' RNA HIV-1, METAL IONS, RNA, BULGES
Code Class Resolution Description 5mvb nuc NMR BIS(M2-OXO)-BIS(2-METHYL-2,2'-BIPYRIDINE)-DI-GOLD(III) C24 H24 AU2 N4 O2 4+ SOLUTION STRUCTURE OF A HUMAN G-QUADRUPLEX HYBRID-2 FORM IN WITH A GOLD-LIGAND DNA (26-MER) DNA G-QUADRUPLEX HYBRID, 2 AUOXO6, DNA
Code Class Resolution Description 2p7e nuc 2.05 ADENOSINE-5'-MONOPHOSPHATE-2',3'-VANADATE C10 H13 N5 O9 P V VANADATE AT THE ACTIVE SITE OF A SMALL RIBOZYME SUGGESTS A ROLE FOR WATER IN TRANSITION-STATE STABILIZATION 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, RIBOZYME STRAND I, RIBOZYME STRAND II, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; VANADATE; REACTION INTERMEDIATE; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA
Code Class Resolution Description
2n9q nuc NMR 4-{(E)-[4-(HYDROXYMETHYL)PHENYL]DIAZENYL}BENZYL DIHYDROGEN PHOSPHATE 4(C14 H15 N2 O5 P) PHOTOSWITCHABLE G-QUADRUPLEX DNA (5'-D(*GP*GP*(AZW)P*GP*G)-3') DNA QUADRUPLEX, PHOTOSWITCH, DNA
Code Class Resolution Description 1ddy nuc 3.00 COBALAMIN 4(C62 H89 CO N13 O14 P 2+) MOLECULAR RECOGNITION BY THE VITAMIN B12 RNA APTAMER VITAMIN B12 BINDING RNA RNA RNA, TRIPLEX, VITAMIN B12, APTAMER
Code Class Resolution Description 4gma nuc 3.94 ADENOSYLCOBALAMIN C72 H101 CO N18 O17 P CRYSTAL STRUCTURE OF THE ADENOSYLCOBALAMIN RIBOSWITCH ADENOSYLCOBALAMIN RIBOSWITCH RNA ADENOSYLCOBALAMIN, RIBOSWITCH, ADOCBL, RNA 4gxy nuc 3.05 ADENOSYLCOBALAMIN 2(C72 H101 CO N18 O17 P) RNA STRUCTURE ADENOSYLCOBALAMIN RIBOSWITCH RNA RNA, RIBOSWITCH, ADENOSYLCOBALAMIN
Code Class Resolution Description 3gjh nuc 2.90 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN- 2(3H)-ONE 2(C12 H16 N3 O7 P) CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(B7C)P*GP*CP*G)-3' DNA DNA DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE, DNA 3gjj nuc 2.90 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN- 2(3H)-ONE 2(C12 H16 N3 O7 P) CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*AP*TP*(B7C)P*CP*GP*CP*G)-3' DNA DNA, DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE 3gjk nuc 2.20 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN- 2(3H)-ONE C12 H16 N3 O7 P CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*A)-3', 5'-D(P*TP*TP*(B7C)P*GP*CP*G)-3' DNA DNA, DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE 3gjl nuc 1.92 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN- 2(3H)-ONE C12 H16 N3 O7 P CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*A)-3', 5'-D(P*TP*TP*(B7C)P*GP*CP*G)-3' DNA DNA, DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE 3n4n nuc 1.92 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN- 2(3H)-ONE C12 H16 N3 O7 P INSIGHTS INTO THE STABILIZING CONTRIBUTIONS OF A BICYCLIC CY ANALOGUE: CRYSTAL STRUCTURES OF DNA DUPLEXES CONTAINING 7,8 DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*A)-3', 5'-D(P*TP*TP*(B7C)P*GP*CP*G)-3' DNA BICYCLIC CYTOSINE, DNA 3n4o nuc 2.90 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN- 2(3H)-ONE 2(C12 H16 N3 O7 P) INSIGHTS INTO THE STABILIZING CONTRIBUTIONS OF A BICYCLIC CY ANALOGUE: CRYSTAL STRUCTURES OF DNA DUPLEXES CONTAINING 7,8 DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*AP*TP*(B7C)P*CP*GP*CP*G)-3' DNA BICYCLIC CYTOSINE, DNA
Code Class Resolution Description 1fd5 nuc 1.10 MACROCYCLIC-BIS-9-AMINO-ACRIDINE C46 H58 N8 O2 S2 BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (BISACRIDINE COMPLEX) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA HIGH RESOLUTION CRYSTAL STRUCTURE, INTERCALATION PLATFORM, MAD, ANTICANCER DRUG, DRUG-DNA COMPLEX, METAL IONS, TERTIARY BASE PAIRS
Code Class Resolution Description
1i0f nuc 1.60 BARIUM ION BA 2+ 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-AMINOOXYETHYL THYMINE IN PLACE OF T6, BA-FORM 5'-D(*GP*CP*GP*TP*AP*(127)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA
1ihh nuc 2.40 BARIUM ION BA 2+ 2.4 ANGSTROM CRYSTAL STRUCTURE OF AN OXALIPLATIN 1,2-D(GPG) INTRASTRAND CROSS-LINK IN A DNA DODECAMER DUPLEX 5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3', 5'-D(*CP*CP*TP*CP*TP*GP*GP*TP*CP*TP*CP*C)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, OXALIPLATIN, MODIFIED, DEOXYNUCLEIC ACID
1j6s nuc 1.40 BARIUM ION 8(BA 2+) CRYSTAL STRUCTURE OF AN RNA TETRAPLEX (UGAGGU)4 WITH A- TETRADS, G-TETRADS, U-TETRADS AND G-U OCTADS 5'-R(*(BRUP*GP*AP*GP*GP*U)-3' RNA RNA, TETRAPLEX, G-U OCTADS, A-TETRADS, U-TETRADS, G-TETRADS
1kd4 nuc 1.85 BARIUM ION 2(BA 2+) THE CRYSTAL STRUCTURE OF R(GGUCACAGCCC)2, BARIUM FORM 5'-R(*GP*GP*UP*CP*AP*CP*AP*GP*CP*CP*C)-3' RNA RNA DUPLEX, METAL BINDING
1nta nuc 2.90 BARIUM ION 3(BA 2+) 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RNA-APTAMER 5'-R(*CP*GP*GP*CP*AP*CP*CP*AP*CP*GP*GP*UP*CP*GP*G -3', 5'-R(*GP*GP*AP*UP*CP*GP*CP*AP*UP*UP*UP*GP*GP*AP*C *UP*GP*CP*C)-3' RNA STREPTOMYCIN RNA-APTAMER, BARIUM FORM, RNA
1qyk nuc 1.40 BARIUM ION 2(BA 2+) GCATGCT + BARIUM 5'-D(*GP*CP*AP*TP*GP*CP*T)-3' DNA QUADRUPLEX DNA, DNA
1u9s nuc 2.90 BARIUM ION 21(BA 2+) CRYSTAL STRUCTURE OF THE SPECIFICITY DOMAIN OF RIBONUCLEASE P OF THE A-TYPE RIBONUCLEASE P RNA RNASE P, RIBONUCLEASE P RNA, P RNA, SPECIFICITY DOMAIN, S- DOMAIN, RIBOZYME, TRNA, PRE-TRNA, THERMUS THERMOPHILUS
1xcs nuc 1.40 BARIUM ION BA 2+ STRUCTURE OF OLIGONUCLEOTIDE/DRUG COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX, CO2+, DNA
1xcu nuc 2.00 BARIUM ION BA 2+ OLIGONUCLEOTID/DRUG COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, ANTHRAQUINONE, CO2+
1y6s nuc 2.90 BARIUM ION 6(BA 2+) HIV-1 DIS(MAL) DUPLEX BA-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, METAL IONS
1y7f nuc 1.60 BARIUM ION BA 2+ CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- [HYDROXY(METHYLENEAMINO)OXY]ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(2NT)P*AP*CP*GP*C)-3') DNA A-DNA, MODIFIED
220d nuc 2.00 BARIUM ION BA 2+ INFLUENCE OF COUNTER-IONS ON THE CRYSTAL STRUCTURES OF DNA DECAMERS: BINDING OF [CO(NH3)6]3+ AND BA2+ TO A-DNA DNA (5'-D(*AP*CP*CP*CP*GP*CP*GP*GP*GP*T)-3') DNA A-DNA, DOUBLE HELIX
284d nuc 1.10 BARIUM ION 11(BA 2+) THE BI-LOOP, A NEW GENERAL FOUR-STRANDED DNA MOTIF DNA (5'-CD(*P*AP*TP*TP*CP*AP*TP*TP*C)-3') DNA CYCLIC B-DNA, QUADRUPLE HELIX, BI-LOOP
2dqo nuc 2.30 BARIUM ION 2(BA 2+) CRYSTAL STRUCTURE OF D(CXCTXCTTC):R(GAAGAAGAG) WHERE X IS 5- (N-AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID
2gpx nuc 1.60 BARIUM ION BA 2+ 2'-ME-SE AND BR DERIVITATION OF A-DNA OCTAMER G(UMS)G(BRU) ACAC 5'-D(*GP*(UMS)P*GP*(BRU)P*AP*CP*AP*C)-3' DNA 2'-METHYLSELENO-URIDINE, SE-DNA, SE-BR-DNA, SELENIUM DERIVATIZATION
2hol nuc 2.90 BARIUM ION 9(BA 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, BARIUM IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH
2ydh nuc 2.90 BARIUM ION 5(BA 2+) CRYSTAL STRUCTURE OF THE SAM-I RIBOSWITCH A94G U34 G18U G19U VARIANT IN COMPLEX WITH SAM SAM-I RIBOSWITCH RNA RNA, K-TURN
3f2w nuc 3.45 BARIUM ION 16(BA 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, BA2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, BARIUM, RNA
3fqb nuc 1.67 BARIUM ION BA 2+ BARIUM INTERACTIONS WITH Z-DNA 5'-D(*CP*GP*CP*GP*TP*G)-3', 5'-D(*CP*AP*CP*GP*CP*G)-3' DNA Z-DNA DOUBLE HELIX
3goj nuc 2.60 BARIUM ION 4(BA 2+) BARIUM BOUND TO THE HOLLIDAY SEQUENCE D(CCGGCGCCGG)4 5'-D(*CP*CP*GP*GP*CP*GP*CP*CP*GP*G)-3' DNA HOLLIDAY JUNCTION STRUCTURE, DNA
3gom nuc 2.30 BARIUM ION 5(BA 2+) BARIUM BOUND TO THE HOLLIDAY JUNCTION SEQUENCE D(TCGGCGCCGA) 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA HOLLIDAY JUNCTION STRUCTURE, DNA
3iqn nuc 2.70 BARIUM ION 5(BA 2+) FREE-STATE STRUCTURAL TRANSITIONS OF THE SAM-I RIBOSWITCH SAM-I RIBOSWITCH RNA RIBOSWITCH, SAM, KINK-TURN, PSUEDOKNOT, RNA
3iqp nuc 2.90 BARIUM ION 10(BA 2+) SAM-I RIBOSWITCH FROM T. TENCONGENSIS VARIANT A94G APO FORM SAM-I RIBOSWITCH RNA RIBOSWITCH, SAM, KINK-TURN, PSUEDOKNOT, RNA
3iqr nuc 2.55 BARIUM ION 9(BA 2+) SAM-I RIBOSWITCH FROM T. TENCONGENSIS VARIANT A94G BOUND WIT SAM-I RIBOSWITCH RNA RIBOSWITCH, SAM, KINK-TURN, PSUEDOKNOT, RNA
3oxj nuc 3.20 BARIUM ION 24(BA 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN BA2+ DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3p4b nuc 1.45 BARIUM ION 2(BA 2+) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-P3 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA
3qf8 nuc 1.73 BARIUM ION BA 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D BOUND TO D(TCGGCGCCGA) AT MEDIUM RESOLUTION 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA B-DNA, INTERCALATION, KINK, FLIPPED OUT BASE, DNA
3qrn nuc 1.10 BARIUM ION BA 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D BOUND TO D(TCGGCGCCGA)AT HIGH RESOLUTION 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA INTERCALATION, SEMI-INTERCALATION, B-DNA, DNA
3u38 nuc 2.13 BARIUM ION BA 2+ INTERCALATION OF LAMBDA-[RU(PHEN)2(DPPZ)]2+ INTO D(CCGGTACCG 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA B-DNA, RUTHENIUM, DNA
3uyb nuc 1.50 BARIUM ION BA 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D BOUND TO D(TCGGTACCGA) 5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3' DNA DNA-RUTHENIUM COMPLEX, SEMIINTERCALATION, INTERCALATION, MIN INTERACTION, DNA
439d nuc 1.60 BARIUM ION BA 2+ 5'-R(*CP*UP*GP*GP*GP*CP*GP*G)-3', 5'- R(*CP*CP*GP*CP*CP*UP*GP*G)-3' RNA (5'-R(*CP*CP*GP*CP*CP*UP*GP*G)-3'), RNA (5'-R(*CP*UP*GP*GP*GP*CP*GP*G)-3') RNA FRAGMENT OF 5S RRNA, A-RNA
4aob nuc 2.95 BARIUM ION 15(BA 2+) SAM-I RIBOSWITCH CONTAINING THE T. SOLENOPSAE KT-23 IN COMPL S-ADENOSYL METHIONINE SAM-I RIBOSWITCH TRANSLATION TRANSLATION, K-TURN, RNA
4b5r nuc 2.95 BARIUM ION 12(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI K-T-7 SAM-I RIBOSWITCH: APTAMER DOMAIN, RESIDUES 1-94 RNA RNA, RIBOSWITCH, K-TURN
4e1u nuc 0.92 BARIUM ION 2(BA 2+) [RU(BPY)2 DPPZ]2+ BOUND TO DNA 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*AP*CP*CP*G)-3' DNA MISMATCH, SMALL MOLECULE, DNA
4e2r nuc 1.67 BARIUM ION BA 2+ INTERACTIONS OF BA2+ WITH A NON-SELF-COMPLEMENTARY Z-TYPE DN DNA (5'-D(*CP*AP*CP*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*GP*TP*G)-3') DNA Z-TYPE DNA DOUBLE HELICES, BARIUM IONS, DNA
4e4o nuc 1.72 BARIUM ION BA 2+ INTERACTIONS OF BA2+ WITH A NON-SELF-COMPLEMENTARY Z-TYPE DN DNA (5'-D(*CP*AP*CP*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*GP*TP*G)-3') DNA Z-TYPE DNA DOUBLE HELICES, BARIUM IONS, DNA
4e60 nuc 1.86 BARIUM ION BA 2+ INTERACTIONS OF BA2+ WITH A NON-SELF-COMPLEMENTARY Z-TYPE DN DNA (5'-D(P*TP*G)-3'), DNA (5'-D(*CP*GP*CP*GP*TP*G)-3'), DNA (5'-D(*CP*AP*CP*GP*CP*G)-3') DNA Z-TYPE DNA DOUBLE HELICES, BARIUM IONS, DNA
4e7y nuc 1.70 BARIUM ION BA 2+ LAMBDA-[RU(PHEN)2(DPPZ)]2+ BOUND TO CCGGATCCGG 5'-D(*CP*CP*GP*GP*AP*TP*CP*CP*GP*G)-3' DNA INTERCALATION, DNA, LAMBDA-[RU(PHEN)2(DPPZ)]2+
4e8s nuc 1.24 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ{ME2}2)]2+ BOUND TO TCGGCGCCGA AT HIGH 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA INTERCALATION, PHOTOREACTIVE, DNA, RUTHENIUM COMPLEX
4e8v nuc 4.00 BARIUM ION 42(BA 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND BA2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION,
4e8x nuc 2.18 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ-(ME)2)]2+ BOUND TO D(CCGGCGCCGG)2 5'-D(*CP*CP*GP*GP*CP*GP*CP*CP*GP*G)-3' DNA INTERCALATION, PHOTOREACTIVE, LAMBDA-[RU(TAP)2(DPPZ-(ME)2)]2
4e95 nuc 1.94 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ-(ME)2)]2+ BOUND TO CCGGATCCGG 5'-D(*CP*CP*GP*GP*AP*TP*CP*CP*GP*G)-3' DNA INTERCALATION, PHOTOREACTIVE, LAMBDA-[RU(TAP)2(DPPZ-(ME)2]2+
4frn nuc 3.43 BARIUM ION 12(BA 2+) CRYSTAL STRUCTURE OF THE COBALAMIN RIBOSWITCH REGULATORY ELE COBALAMIN RIBOSWITCH APTAMER DOMAIN RNA COBALAMIN, RIBOSWITCH, B12, RNA
4iii nuc 1.02 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(11-CL-DPPZ)] WITH A DNA DECAMER AT ATOMIC R 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA DUPLEX, RUTHENIUM, DNA
4ltf nuc 1.50 BARIUM ION BA 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY(1/7) DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4ltg nuc 1.18 BARIUM ION BA 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (2/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4lth nuc 1.60 BARIUM ION BA 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY (3/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4lti nuc 1.41 BARIUM ION BA 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (4/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4ltj nuc 1.80 BARIUM ION BA 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY (5/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4ltk nuc 1.45 BARIUM ION BA 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (6/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4ltl nuc 2.07 BARIUM ION BA 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY (7/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4ly2 nuc 2.10 BARIUM ION BA 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(PHEN)2( BOUND TO D(TCGGTACCGA) DNA DNA INTERCALATION, SEMI-INTERCALATION, SYMMETRICAL INTERCALATION BINDING, LIGHT-SWITCH COMPOUNDS, DNA DAMAGE AGENT, GUANINE OXIDATION, DNA
4m3i nuc 2.10 BARIUM ION BA 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D {ME2})]2+ BOUND TO D(CCGGTACCGG) SYNTHETIC DNA CCGGTACCGG DNA INTERCALATION, SEMI-INTERCALATION, MINOR-GROOVE BINDER, LIGH BENDING, KINKING, DNA
4m3v nuc 2.05 BARIUM ION BA 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D {ME2})]2+ BOUND TO D(TCGGTACCGA) DNA DECAMER SEQUENCE DNA MINOR-GROOVE, SEMI-INTERCALATION, INTERCALATION, BENDING, KI SYMMETRICAL INTERCALATION, DNA LIGHT-SWITCH COMPOUND, DNA
4mj9 nuc 0.97 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ-10-ME)]2+ BOUND TO A SYNTHETIC DNA OLI DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA METHYL-SUBSTITUTED, INTERCALATION, RUTHENIUM, ASYMMETRIC SUBSTITUTION, DNA
4ms5 nuc 2.23 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ-11,12-(F)2)]2+ BOUND TO CCGGATCCGG DNA DNA INTERCALATION, SEMI-INTERCALATION, DNA, RUTHENIUM
4o5y nuc 1.75 BARIUM ION BA 2+ O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA
4o5z nuc 1.75 BARIUM ION BA 2+ O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA
4qio nuc 0.95 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(TCGGCGCCIA) AT HIGH RES 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*IP*A)-3' DNA INTERCALATION, RUTHENIUM COMPLEX, INOSINE, DNA
4r8j nuc 1.21 BARIUM ION BA 2+ D(TCGGCGCCGA) WITH LAMBDA-[RU(TAP)2(DPPZ)]2+ SOAKED IN D2O DNA (5'-D(*(THM)P*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA KINKING, INFRA-RED, RUTHENIUM, DNA
4re7 nuc 2.18 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(TCIGCGCCGA) 5'-D(*TP*CP*IP*GP*CP*GP*CP*CP*GP*A)-3' DNA INOSINE, KINKING, RUTHENIUM, DNA
4ts0 nuc 2.80 BARIUM ION BA 2+ CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH BARIUM IONS SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT, SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA
4u92 nuc 1.50 BARIUM ION 6(BA 2+) CRYSTAL STRUCTURE OF A DNA/BA2+ G-QUADRUPLEX CONTAINING A WA MEDIATED C-TETRAD DNA (5'-D(*CP*CP*AP*KP*GP*CP*GP*TP*GP*G)-3') DNA DNA QUADRUPLEX BARIUM C-TETRAD, DNA
4x18 nuc 1.05 BARIUM ION BA 2+ [RU(TAP)2(DPPZ-11-ME)]2+ BOUND TO D(TCGGCGCCGA) DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA RUTHENIUM, DNA, SUBSTITUTION, DUPLEX
4x1a nuc 0.89 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ-10,12-ME)]2+ BOUND TO D(TCGGCGCCGA) DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA RUTHENIUM, DNA, POLYPYRIDYL
4xk0 nuc 1.08 BARIUM ION 3(BA 2+) CRYSTAL STRUCTURE OF A TETRAMOLECULAR RNA G-QUADRUPLEX IN PO RNA (5'-(*UP*GP*GP*GP*GP*U)-3') RNA RNA, RNA G-QUADRUPLEX, TETRAMOLECULAR G-QUADRUPLEX, INTERMOL QUADRUPLEX
4y1i nuc 2.85 BARIUM ION 19(BA 2+) LACTOCOCCUS LACTIS YYBP-YKOY MN RIBOSWITCH BOUND TO MN2+ LACTOCOCCUS LACTIS YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE-BINDING, RNA
4ymc nuc 1.88 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(CCGGATCCGG)2 DNA (5'-D(*CP*CP*GP*GP*AP*TP*CP*CP*GP*G)-3') DNA RUTHENIUM, COMPLEX, DNA, INTERCALATION
5ebi nuc 1.09 BARIUM ION 16(BA 2+) CRYSTAL STRUCTURE OF A DNA-RNA CHIMERA IN COMPLEX WITH BA2+ CASE OF UNUSUAL MULTI-DOMAIN TWINNING DNA/RNA (5'-D(*C)-R(P*G)-D(P*C)-R(P*G)-D(P*C)-R(P CHAIN: A, B, C, D, E, F, G, H DNA/RNA CHIMERA DNA-RNA CHIMERA COMPLEX; Z-DNA; Z-RNA; SELF-COMPLEMENTARY DU LEFT-HANDED Z-TYPE DUPLEX; MULTI-DOMAIN TWINNING; DETECTION PSEUDOSYMMETRY, DNA-RNA CHIMERA COMPLEX
5et2 nuc 1.39 BARIUM ION BA 2+ LAMBDA-RU(TAP)2(DPPZ)]2+ BOUND TO D(TTGGCGCCAA) DNA (5'-D(*(THM)P*TP*GP*GP*CP*GP*CP*CP*AP*A)-3') DNA RUTHENIUM INTERCALATION DNA PHOTOACTIVE, DNA
5et9 nuc 1.83 BARIUM ION 2(BA 2+) RACEMIC CRYSTAL STRUCTURES OF PRIBNOW BOX CONSENSUS PROMOTER (P21/N) PRIBNOW BOX NON-TEMPLATE STRAND, PRIBNOW BOX CONSENSUS SEQUENCE- TEMPLATE STRAND DNA RACEMIC DNA CRYSTALLOGRAPHY, PRIBNOW BOX, BACTERIAL PROMOTER DNA
5ew7 nuc 1.75 BARIUM ION BA 2+ CRYSTAL STRUCTURE OF C9ORF72 ANTISENSE CCCCGG REPEAT RNA ASS WITH LOU GEHRIG'S DISEASE AND FRONTOTEMPORAL DEMENTIA, CRYS WITH BA2+ RNA (5'- R(*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP 3') RNA REPEAT EXPANSION DISORDER, GENETIC DISEASE, RNA
5fjc nuc 1.71 BARIUM ION 21(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT C- SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fk1 nuc 2.50 BARIUM ION 12(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fk2 nuc 2.60 BARIUM ION 11(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fk3 nuc 2.50 BARIUM ION 15(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fk4 nuc 2.43 BARIUM ION 17(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-93 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fk5 nuc 3.32 BARIUM ION 12(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-93 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fk6 nuc 2.50 BARIUM ION 12(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS CA SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fkd nuc 3.00 BARIUM ION 13(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS UA SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fke nuc 2.80 BARIUM ION 16(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS GU SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fkf nuc 2.80 BARIUM ION 12(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS UC SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fkg nuc 2.95 BARIUM ION 13(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN (1-94) RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5fkh nuc 2.65 BARIUM ION 12(BA 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5ip8 nuc 1.76 BARIUM ION 2(BA 2+) LAMBDA-RU(TAP)2DPPZ BOUND TO D(CCGGCTCCGG) DNA (5'-D(*CP*CP*GP*GP*AP*GP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*CP*TP*CP*CP*GP*G)-3') DNA SEQUENCE SPECIFIC, DNA, RUTHENIUM, PHOTOOXIDISING
5iwj nuc 1.88 BARIUM ION BA 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(CCGGGCCCGG DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*CP*GP*G)-3') DNA RUTHENIUM, PHOTOOXIDISING, DNA, INTERCALATION
5jeu nuc 0.97 BARIUM ION BA 2+ DEL-[RU(PHEN)2(DPPZ)]2+ BOUND TO D(TCGGCGCCGA) WITH BA2+ DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA, RUTHENIUM, LIGHT-SWITCH, SEMI-INTERCALATION
5lfs nuc 1.85 BARIUM ION BA 2+ LAMBDA-[RU(BPY)2(DPPZ)]2+ BOUND TO BROMINATED DNA DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, INTERCALATION, LIGHT-SWITCH
5lfw nuc 1.28 BARIUM ION BA 2+ LAMBDA-[RU(PHEN)2(DPPZ)]2+ BOUND TO A SHORT SUBSTITUTED DNA DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, INTERCALATION, LIGHT-SWITCH
5lfx nuc 1.56 BARIUM ION BA 2+ LAMBDA-[RU(PHEN)2(DPPZ-11,12-ME)]2+ BOUND TO A SHORT SUBSTIT SEQUENCE DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, LIGHT-SWITCH, INTERCALATION
5wss nuc 1.45 BARIUM ION BA 2+ CRYSTAL STRUCTURE OF T-HG-T PAIR CONTAINING DNA DUPLEX IN TH BA2+ DNA (5'-D(*GP*GP*TP*CP*GP*TP*CP*C)-3') DNA DNA DUPLEX, T-HG-T PAIR, DNA
Code Class Resolution Description 1axl nuc NMR 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE C20 H16 O3 SOLUTION CONFORMATION OF THE (-)-TRANS-ANTI-[BP]DG ADDUCT OPPOSITE A DELETION SITE IN DNA DUPLEX D(CCATC-[BP]G- CTACC)D(GGTAG--GATGG), NMR, 6 STRUCTURES DNA DUPLEX D(CCATC-[BP]G-CTACC)D(GGTAG--GATGG), DNA DUPLEX D(CCATC-[BP]G-CTACC)D(GGTAG--GATGG) DNA DEOXYRIBONUCLEIC ACID, DNA, BENZO[A]PYRENE, CARCINOGEN 1axo nuc NMR 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE C20 H16 O3 STRUCTURAL ALIGNMENT OF THE (+)-TRANS-ANTI-[BP]DG ADDUCT POSITIONED OPPOSITE DC AT A DNA TEMPLATE-PRIMER JUNCTION, NMR, 6 STRUCTURES DNA DUPLEX D(AAC-[BP]G-CTACCATCC)D(GGATGGTAGC), DNA DUPLEX D(AAC-[BP]G-CTACCATCC)D(GGATGGTAGC) DNA DEOXYRIBONUCLEIC ACID, DNA, BENZO[A]PYRENE, CARCINOGEN 1axv nuc NMR 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE C20 H16 O3 SOLUTION NMR STRUCTURE OF THE [BP]DA ADDUCT OPPOSITE DT IN A DNA DUPLEX, 6 STRUCTURES DNA DUPLEX D(CTCTC-[BP]A-CTTCC)D(GGAAGTGAGAG), DNA DUPLEX D(CTCTC-[BP]A-CTTCC)D(GGAAGTGAGAG) DNA DNA DUPLEX, BENZO[A]PYRENE ADDUCT, CARCINOGEN ADDUCT 1bps nuc NMR 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE C20 H16 O3 MINOR CONFORMER OF A BENZO[A]PYRENE DIOL EPOXIDE ADDUCT OF DA IN DUPLEX DNA DNA (5'-D(*GP*GP*TP*CP*(BAP)AP*CP*GP*AP*G)-3'), DNA (5'-D(*CP*TP*CP*GP*GP*GP*AP*CP*C)-3') DNA DEOXYRIBONUCLEIC ACID, BENZO[A]PYRENE DIOL EPOXIDE ADDUCT, DUPLEX DNA 1dxa nuc NMR 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE C20 H16 O3 BENZO[A]PYRENE DIOL EPOXIDE ADDUCT OF DA IN DUPLEX DNA DNA (5'-D(*CP*TP*CP*GP*GP*GP*AP*CP*C)-3'), DNA (5'-D(*GP*GP*TP*CP*AP*CP*GP*AP*G)-3') DNA NMR, DOUBLE HELIX, BENZO[A]PYRENE DIOL EPOXIDE ADDUCT, DUPLEX DNA, NON-WATSON-CRICK BASE PAIR 1fyy nuc NMR 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE C20 H16 O3 HPRT GENE MUTATION HOTSPOT WITH A BPDE2(10R) ADDUCT 5'-D(*TP*GP*CP*CP*CP*TP*TP*GP*AP*CP*TP*A)-3', HPRT DNA WITH BENZO[A]PYRENE-ADDUCTED DA7 DNA DNA LESIONS, BENZO[A]PYRENE, HPRT GENE, DIOL EPOXIDE ADDUCTS, SYN-ANTI INTERCONVERSION 1y9h nuc NMR 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE C20 H16 O3 METHYLATION OF CYTOSINE AT C5 IN A CPG SEQUENCE CONTEXT CAUSES A CONFORMATIONAL SWITCH OF A BENZO[A]PYRENE DIOL EPOXIDE-N2-GUANINE ADDUCT IN DNA FROM A MINOR GROOVE ALIGNMENT TO INTERCALATION WITH BASE DISPLACEMENT 5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3', 5'-D(*CP*CP*AP*TP*(5CM)P*(BPG)P*CP*TP*AP*CP*C)- 3' DNA CONFORMATIONAL SWITCH, CYTOSINE METHYLATION, P53 MUTATION HOT SPOT, DNA ADDUCT, BENZO[A]PYRENE, BPDE
Code Class Resolution Description 1qv8 nuc 2.50 2'-(4-DIMETHYLAMINOPHENYL)-5-(4-METHYL-1-PIPERAZINYL)- 2,5'-BI-BENZIMIDAZOLE C27 H29 N7 B-DNA DODECAMER D(CGCGAATTCGCG)2 COMPLEXED WITH PROAMINE 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA, MINOR GROOVE BINDER 447d nuc 2.20 2'-(4-DIMETHYLAMINOPHENYL)-5-(4-METHYL-1-PIPERAZINYL)- 2,5'-BI-BENZIMIDAZOLE C27 H29 N7 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING
Code Class Resolution Description 1cr3 nuc NMR BENZO[G]CHRYSENE C22 H18 O3 SOLUTION CONFORMATION OF THE (+)TRANS-ANTI-BENZO[G]CHRYSENE- DA ADDUCT OPPOSITE DT IN A DNA DUPLEX DNA (5'-D(*CP*TP*CP*TP*CP*AP*CP*TP*TP*CP*C)-3'), DNA (5'-D(*GP*GP*AP*AP*GP*TP*GP*AP*GP*AP*G)-3') DNA DNA DUPLEX, BENZO[G]CHRYSENE ADDUCT, CARCINOGEN ADDUCT
Code Class Resolution Description 1agl nuc 2.20 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] C62 H66 N2 O20 2+ STRUCTURE OF A DNA-BISDAUNOMYCIN COMPLEX DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1al9 nuc NMR 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] C62 H66 N2 O20 2+ NMR STUDY OF DNA (5'-D(*AP*CP*GP*TP*AP*CP*GP*T)-3') SELF- COMPLEMENTARY DUPLEX COMPLEXED WITH A BIS-DAUNORUBICIN, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*AP*CP*GP*TP*AP*CP*GP*T)-3') DNA COMPLEX (DEOXYRIBONUCLEIC ACID/DRUG), BIS-INTERCALATOR, DAUNORUBICIN, DNA, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1k2l nuc 2.40 BIS-(9-OCTYLAMINO(2-DIMETHYLAMINOETHYL)ACRIDINE-4- CARBOXAMIDE C44 H54 N8 O2 STRUCTURAL CHARACTERIZATION OF BISINTERCALATION IN HIGHER- ORDER DNA AT A JUNCTION-LIKE QUADRUPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA STRAND EXCHANGE, QUADRUPLEX, BISINTERCALATION
Code Class Resolution Description 1at8 nuc model O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSE C6 H14 N2 O4 THEORETICAL MODEL OF THE REV BINDING ELEMENT (RBE, 30 RIBONUCLEOTIDE FRAGMENT) OF HUMAN IMMUNODEFICIENCY VIRUS-1 COMPLEXED WITH NEOMYCIN B REV BINDING ELEMENT: 30 RIBONUCLEOTIDE FRAGMENT RIBONUCLEIC ACID RNA/AMINOGLYCOSIDE COMPLEX, MRNA TRANSPORT, INHIBITION OF VIRAL REPLICATION, RIBONUCLEIC ACID 1nem nuc NMR O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSE C6 H14 N2 O4 SACCHARIDE-RNA RECOGNITION IN THE NEOMYCIN B / RNA APTAMER COMPLEX 5'- R(*GP*GP*AP*CP*UP*GP*GP*GP*CP*GP*AP*GP*AP*AP*GP*UP*UP*UP*AP *GP*UP*CP*C)-3' RNA RNA APTAMER, AMINOGLYCOSIDE, ANTIBIOTIC 1o9m nuc 2.40 O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D- GLUCOPYRANOSE C6 H14 N2 O4 THE COMPLEX OF A NOVEL ANTIBIOTIC WITH THE AMINOACYL SITE OF THE BACTERIAL RIBOSOME REVEALED BY X-RAY CRYSTALLOGRAPHY. EUBACTERIAL A-SITE ANTIBIOTIC/RNA ANTIBIOTIC/RNA, RNA-ANTIBIOTIC INTERACTIONS, A-SITE 1qd3 nuc NMR O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSE C6 H14 N2 O4 HIV-1 TAR RNA/NEOMYCIN B COMPLEX HIV-1 TAR RNA: RESIDUES 17-45 RNA NMR, HIV-1, AMINOGLYCOSIDE-RNA-COMPLEX, MINOR GROOVE BINDING
Code Class Resolution Description 1at8 nuc model BETA-D-RIBOFURANOSYL C5 H10 O5 THEORETICAL MODEL OF THE REV BINDING ELEMENT (RBE, 30 RIBONUCLEOTIDE FRAGMENT) OF HUMAN IMMUNODEFICIENCY VIRUS-1 COMPLEXED WITH NEOMYCIN B REV BINDING ELEMENT: 30 RIBONUCLEOTIDE FRAGMENT RIBONUCLEIC ACID RNA/AMINOGLYCOSIDE COMPLEX, MRNA TRANSPORT, INHIBITION OF VIRAL REPLICATION, RIBONUCLEIC ACID 1nem nuc NMR BETA-D-RIBOFURANOSYL C5 H10 O5 SACCHARIDE-RNA RECOGNITION IN THE NEOMYCIN B / RNA APTAMER COMPLEX 5'- R(*GP*GP*AP*CP*UP*GP*GP*GP*CP*GP*AP*GP*AP*AP*GP*UP*UP*UP*AP *GP*UP*CP*C)-3' RNA RNA APTAMER, AMINOGLYCOSIDE, ANTIBIOTIC 1pbr nuc NMR BETA-D-RIBOFURANOSYL C5 H10 O5 STRUCTURE OF 16S RIBOSOMAL RNA, NMR, MINIMIZED AVERAGE STRUC 16S RIBOSOMAL RNA RNA AMINOGLYCOSIDE, RIBOSOMAL RNA, RNA TRANSCRIPT, ANTIBIOTIC, RIBONUCLEIC ACID, RNA 1qxb nuc NMR BETA-D-RIBOFURANOSYL 2(C5 H10 O5) NMR STRUCTURE DETERMINATION OF THE SELF COMPLEMENTARY DNA DODECAMER CGCGAATT*CGCG IN WHICH A RIBOSE IS INSERTED BETWEEN THE 3'-OH OF T8 AND THE 5'-PHOSPHATE GROUP OF C9 5'-D(CPGPCPGPAPAPTPTPCPGPCPG)-3' DNA DISACCHARIDE NUCLEOTIDE, BACKBONE MODIFICATION, B-HELIX, RIBOSE, DNA
Code Class Resolution Description 3np6 nuc 2.30 BERBERINE C20 H18 N O4 1+ THE CRYSTAL STRUCTURE OF BERBERINE BOUND TO DNA D(CGTACG) 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX, B-DNA, DNA 3r6r nuc 2.40 BERBERINE 4(C20 H18 N O4 1+) STRUCTURE OF THE COMPLEX OF AN INTRAMOLECULAR HUMAN TELOMERI BERBERINE FORMED IN K+ SOLUTION DNA (22-MER) DNA/ANTIBIOTIC DNA-DRUG COMPLEX, G-QUADRUPLEX, HUMAN TELOMERIC DNA, DNA, DN ANTIBIOTIC COMPLEX
Code Class Resolution Description 1eg6 nuc 2.00 9-BROMO-PHENAZINE-1-CARBOXYLIC ACID (2-DIMETHYLAMINO- ETHYL)-AMIDE C17 H17 BR N4 O CRYSTAL STRUCTURE ANALYSIS OF D(CG(5-BRU)ACG) COMPLEXES TO A PHENAZINE 5'-D(*CP*GP*(BRO)UP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, INTERCALATION, MAJOR GROOVE BINDING, DOUBLE HELIX
Code Class Resolution Description 2hoo nuc 3.00 S-BENZOYLTHIAMINE O-MONOPHOSPHATE C19 H25 N4 O6 P S CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO BENFOTIAMINE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH; BENFOTIAMINE
Code Class Resolution Description 308d nuc 1.50 BETA-D-GLUCOSE 2(C6 H12 O6) BINDING OF DAUNOMYCIN TO B-D-GLUCOSYLATED DNA FOUND IN PROTOZOA TRYPANOSOMA BRUCEI STUDIED BY X-RAY CRYSTALLOGRAPH DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 227d nuc 2.20 2,5-BIS(4-GUANYLPHENYL)FURAN C18 H18 N4 O 2+ A CRYSTALLOGRAPHIC AND SPECTROSCOPIC STUDY OF THE COMPLEX BETWEEN D(CGCGAATTCGCG)2 AND 2,5-BIS(4-GUANYLPHENYL)FURAN, AN ANALOGUE OF BERENIL. STRUCTURAL ORIGINS OF ENHANCED DNA- BINDING AFFINITY DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1mdg nuc 1.50 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H13 BR N5 O7 P AN ALTERNATING ANTIPARALLEL OCTAPLEX IN AN RNA CRYSTAL STRUC 5'-R(*UP*(BGM)GP*AP*GP*GP*U)-3' RNA TETRAPLEX, BASE TETRADS, BASE OCTADS, RNA 1n7a nuc 1.20 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 8(C10 H13 BR N5 O7 P) RIP-RADIATION-DAMAGE INDUCED PHASING RNA/DNA (5'-R(*U)-D(P*(BGM))-R(P*AP*GP*GP*U)-3') DNA, RNA DNA, RNA 1n7b nuc 1.40 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 8(C10 H13 BR N5 O7 P) RIP-RADIATION-DAMAGE INDUCED PHASING RNA/DNA (5'-R(*U)-D(P*(BGM))-R(P*AP*GP*GP*U)-3') DNA, RNA DNA, RNA 2awe nuc 2.10 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 8(C10 H13 BR N5 O7 P) BASE-TETRAD SWAPPING RESULTS IN DIMERIZATION OF RNA QUADRUPLEXES: IMPLICATIONS FOR FORMATION OF I-MOTIF RNA OCTAPLEX 5'-R(*UP*(BGM)P*GP*UP*GP*U)-3' RNA RNA, TETRAPLEX, OCTAPLEX 2e4i nuc NMR 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 5(C10 H13 BR N5 O7 P) HUMAN TELOMERIC DNA MIXED-PARALLEL/ANTIPARALLEL QUADRUPLEX UNDER PHYSIOLOGICAL IONIC CONDITIONS STABILIZED BY PROPER INCORPORATION OF 8-BROMOGUANOSINES DNA (5'-D(*DAP*(BGM)P*DGP*DGP*DTP*DTP*DAP*(BGM) P*DGP*DGP*DTP*DTP*DAP*(BGM)P*(BGM)P*DGP*DTP*DTP*DAP*(BGM) P*DGP*DG)-3') DNA TELOMERE, QUADRUPLEX, MIXED-PARALLEL/ANTIPARALLEL, NMR, DNA, STRUCTURE 2jsk nuc NMR 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H13 BR N5 O7 P MONOMERIC HUMAN TELOMERE DNA TETRAPLEX WITH 3+1 STRAND FOLD TOPOLOGY, TWO EDGEWISE LOOPS AND DOUBLE-CHAIN REVERSAL LOOP, 16 G FORM 1, NMR, 10 STRUCTURES HUMAN TELOMERE DNA DNA G-TETRAD, 3+1 STRAND FOLDING, EDGEWISE, DOUBLE-CHAIN REVERSAL LOOPS, NMR, FORM 1 16BRG, 10 STRUCTURES, DNA 2jsq nuc NMR 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H13 BR N5 O7 P MONOMERIC HUMAN TELOMERE DNA TETRAPLEX WITH 3+1 STRAND FOLD TOPOLOGY, TWO EDGEWISE LOOPS AND DOUBLE-CHAIN REVERSAL LOOP, FORM 2 15BRG, NMR, 10 STRUCTURES HUMAN TELOMERE DNA DNA G-TETRAD, 3+1 STRAND FOLDING, EDGEWISE, DOUBLE-CHAIN REVERSAL LOOPS, NMR, 10 STRUCTURES, 15BRG FORM 2, DNA 2kf7 nuc NMR 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H13 BR N5 O7 P STRUCTURE OF A TWO-G-TETRAD BASKET-TYPE INTRAMOLECULAR G- QUADRUPLEX FORMED BY HUMAN TELOMERIC REPEATS IN K+ SOLUTION (WITH G7-TO-BRG SUBSTITUTION) HUMAN TELOMERE DNA DNA ANTICANCER TARGETS, HUMAN TELOMERE, INTRAMOLECULAR G- QUADRUPLEXES, DNA 2mbj nuc NMR 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H13 BR N5 O7 P STRUCTURE OF AN ANTIPARALLEL (2+2) G-QUADRUPLEX FORMED BY HU TELOMERIC REPEATS IN NA+ SOLUTION (WITH G22-TO-BRG SUBSTITU DNA_(27-MER) DNA ANTICANCER TARGETS, G-QUADRUPLEX, HUMAN TELOMERE, DNA 2n2d nuc NMR 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H13 BR N5 O7 P STRUCTURE OF DNA G-QUADRUPLEX ADOPTED BY ALS AND FTD RELATED REPEAT WITH G21 TO BR-G21 SUBSTITUTION DNA (5'- D(*GP*GP*GP*GP*CP*CP*GP*GP*GP*GP*CP*CP*GP*GP*GP*GP*CP*CP*GP P*G)-3') DNA DNA, G-QUADRUPLEX, ANTIPARALLEL 4xsn nuc 1.45 8-BROMO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C10 H13 BR N5 O7 P) COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCGCG) DNA (5'-D(*CP*(BGM)P*CP*GP*CP*GP)-3') DNA Z-DNA, COPPER(II), DNA
Code Class Resolution Description 2lar nuc NMR [[(2R,3S,5R)-5-(2-AZANYL-6-OXO-1H-PURIN-9-YL)-3- HYDROXY-OXOLAN-2-YL]METHOXY-HYDROXY- PHOSPHORYL]BORANUIDE C10 H16 B N5 O6 P 1- DNA / RNA HYBRID CONTAINING A CENTRAL STEREO SPECIFIC RP BOR PHOSPHATE LINKAGE DNA_(5'-D(*AP*TP*GP*GP*TP*BGR*CP*TP*C)-3')_, RNA_(5'-R(*GP*AP*GP*CP*AP*CP*CP*AP*U)-3')_ DNA/RNA NUCLEIC ACID HETERODUPLEX, RNASE H1 ACTIVITY, DNA-RNA COMPLE 2lb4 nuc NMR [[(2R,3S,5R)-5-(2-AZANYL-6-OXO-1H-PURIN-9-YL)-3- HYDROXY-OXOLAN-2-YL]METHOXY-HYDROXY- PHOSPHORYL]BORANUIDE C10 H16 B N5 O6 P 1- DNA / RNA HYBRID CONTAINING A CENTRAL STEREO SPECIFIC SP BOR PHOSPHATE LINKAGE RNA_(5'-R(*GP*AP*GP*CP*AP*CP*CP*AP*U)-3')_, DNA_(5'-D(*AP*TP*GP*GP*TP*BGR*CP*TP*C)-3')_ DNA/RNA NUCLEIC ACID HETERODUPLEX, RNASE H1 ACTIVITY, DNA-RNA COMPLE
Code Class Resolution Description 226d nuc NMR BIZELESIN C43 H38 N8 O5 SOLUTION CONFORMATION OF A BIZELESIN A-TRACT DUPLEX ADDUCT, NMR, 1 STRUCTURE DNA (5'-D(*CP*GP*TP*TP*TP*TP*TP*AP*CP*G)-3'), DNA (5'-D(*CP*GP*TP*AP*AP*AP*AP*AP*CP*G)-3') DNA DNA, NMR, DNA-LIGAND, ADDUCT, BIZELESIN
Code Class Resolution Description 1g5l nuc NMR BLEOMYCIN B2 C55 H85 N20 O21 S2 1+ CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1gj2 nuc NMR BLEOMYCIN B2 C55 H85 N20 O21 S2 1+ CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION
Code Class Resolution Description 1mtg nuc NMR BLEOMYCIN A2 C55 H85 N17 O21 S3 NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GAGCTC 5'-D(*GP*AP*GP*CP*TP*C)-3' DNA DRUG-DNA COMPLEX, COBALT(III), DNA 1mxk nuc NMR BLEOMYCIN A2 C55 H85 N17 O21 S3 NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GGAAGCTTCC)(2) 5'-D(*GP*GP*AP*AP*GP*CP*TP*TP*CP*C)-3' DNA DRUG-DNA COMPLEX, COBALT(III)
Code Class Resolution Description 2gjb nuc 2.20 N-ACRIDIN-9-YL-N'-[3-(ACRIDIN-9-YLAMINO) PROPYL]PROPANE-1,3-DIAMINE C32 H31 N5 CROSSLINKING OF DNA DUPLEXES: X-RAY CRYSTAL STRUCTURE OF AN UNSUBSTITUTED BISACRIDINE WITH THE OLIGONUCLEOTIDE D(CGTACG) 5'-D(*CP*GP*TP*AP*CP*GP*)-3' DNA DNA DUPLEX, BIS-INTERCALATOR
Code Class Resolution Description 1amd nuc NMR BIS-DAUNORUBICIN C62 H66 N2 O20 2+ NMR STUDY OF DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') SELF- COMPLEMENTARY DUPLEX COMPLEXED WITH A BIS-DAUNORUBICIN WP- 652, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA COMPLEX (DEOXYRIBONUCLEIC ACID/DRUG), BIS-INTERCALATOR, DAUNORUBICIN, DNA, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1ybc nuc 1.80 2'-O-[2-(BENZYLOXY)ETHYL] THYMIDINE-5'-MONOPHOSPHATE 2(C19 H25 N2 O10 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (BENZYLOXY)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(BOE)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER
Code Class Resolution Description 1jdg nuc NMR 7S,8R,9R-TRIHYDROXY-7,8,9,10-TETRAHYDRO BENZO[A]PYRENE C20 H16 O3 SOLUTION STRUCTURE OF A TRANS-OPENED (10S)-DA ADDUCT OF (+)- (7S,8R,9S,10R)-7,8-DIHYDROXY-9,10-EPOXY-7,8,9,10- TETRAHYDROBENZO[A]PYRENE IN A FULLY COMPLEMENTARY DNA DUPLEX 5'-D(*CP*CP*TP*CP*GP*TP*GP*AP*CP*CP*G)-3', 5'-D(*CP*GP*GP*TP*CP*(BPA)AP*CP*GP*AP*GP*G)-3' DNA SYN GLYCOSIDIC TORSION ANGLE, BENZO[A]PYRENE DIOL EPOXIDE, DA ADDUCT, DNA
Code Class Resolution Description
360d nuc 1.85 N,N'-(FURAN-2,5-DIYLBIS{BENZENE-4,1-DIYL[(Z)- AMINOMETHYLYLIDENE]})DIETHANAMINIUM C22 H26 N4 O 2+ STRUCTURE OF 2,5-BIS{[4-(N-ETHYLAMIDINO)PHENYL]}FURAN COMPLE D(CPGPCPGPAPAPTPTPCPGPCPG)-3'. A MINOR GROOVE DRUG COMPLEX, PATTERNS OF GROOVE HYDRATION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
Code Class Resolution Description 1hwv nuc NMR (1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4- TRIOL C18 H16 O3 MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DNA ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY 5'-D(*CP*CP*AP*TP*CP*GP*CP*TP*AP*CP*C)-3', 5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3' DNA CARCINOGEN-DNA ADDUCT, BENZO[C]PHENANTHRENE DNA ADDUCT
Code Class Resolution Description 1hx4 nuc NMR (1R)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4- TRIOL C18 H16 O3 MOLECULAR TOPOLOGY OF POLYCYCLIC AROMATIC CARCINOGENS DETERMINES DNA ADDUCT CONFORMATION: A LINK TO TUMORIGENIC ACTIVITY 5'-D(*CP*CP*AP*TP*CP*GP*CP*TP*AP*CP*C)-3', 5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3' DNA 1R-TRANS-ANTI-BPH-N2-G ADDUCT, CARCINOGEN-DNA ADDUCT, BENZO[C]PHENANTHRENE DNA ADDUCT 2rou nuc NMR (1R)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4- TRIOL C18 H16 O3 STEREOSPECIFIC CONFORMATIONS OF N2-DG 1R-TRANS-ANTI- BENZO[C]PHENANTHRENE DNA ADDUCTS: 3'-INTERCALATION OF THE 1R ADDUCT AND 5'-MINOR GROOVE ORIENTATION OF THE 1S ADDUCT IN AN ITERATED (CG)3 REPEAT DNA (5'- D(*DCP*DAP*DTP*DGP*DCP*DCP*DGP*DCP*DGP*DCP*DGP*DAP*DT)-3'), DNA (5'- D(*DAP*DTP*DCP*DGP*DCP*DGP*DCP*DGP*DGP*DCP*DAP*DTP*DG)-3') DNA N2-DG 1R-TRANS-ANTI-BENZO[C]PHENANTHRENE, DNA
Code Class Resolution Description 1au6 nuc NMR BIS(TRANS-PLATINUM ETHYLENEDIAMINE DIAMINE CHLORO) COMPLEX C4 H24 CL2 N6 PT2 SOLUTION STRUCTURE OF DNA D(CATGCATG) INTERSTRAND- CROSSLINKED BY BISPLATIN COMPOUND (1,1/T,T), NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*AP*TP*GP*CP*AP*TP*G)-3') DNA BISPLATINUM COMPOUND (1,1/T,T), DNA, INTERSTRAND CROSSLINK, DUMBBELL STRUCTURE, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1eg6 nuc 2.00 BROMIDE ION 2(BR 1-) CRYSTAL STRUCTURE ANALYSIS OF D(CG(5-BRU)ACG) COMPLEXES TO A PHENAZINE 5'-D(*CP*GP*(BRO)UP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, INTERCALATION, MAJOR GROOVE BINDING, DOUBLE HELIX 1mhk nuc 2.50 BROMIDE ION BR 1- CRYSTAL STRUCTURE ANALYSIS OF A 26MER RNA MOLECULE, REPRESENTING A NEW RNA MOTIF, THE HOOK-TURN RNA 12-MER BCH12: FRAGMENT OF 5S RRNA LOOP E, RNA 14-MER BCH12: FRAGMENT OF 5S RRNA LOOP E RNA HELIX, 180 DEGREE TURN, RNA 367d nuc 1.20 BROMIDE ION 2(BR 1-) 1.2 A STRUCTURE DETERMINATION OF THE D(CG(5-BRU)ACG)2/5- BROMO-9-AMINO-DACA COMPLEX 5'-D(*CP*GP*(BRU)P*AP*CP*G)-3' DNA DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 3ivn nuc 2.80 BROMIDE ION 2(BR 1-) STRUCTURE OF THE U65C MUTANT A-RIBOSWITCH APTAMER FROM THE B SUBTILIS PBUE OPERON A-RIBOSWITCH RNA APTAMER, RNA, A-RIBOSWITCH 3r1d nuc 1.45 BROMIDE ION 2(BR 1-) CRYSTAL STRUCTURE OF GC(8BRG)GCGGCGGC DUPLEX RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*CP*GP*GP*C)-3 CHAIN: A, B, C, D, E RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, 8-BROMOGUANOSINE, 3r1e nuc 0.97 BROMIDE ION 2(BR 1-) CRYSTAL STRUCTURE OF GC(8BRG)GCGGC DUPLEX RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*C)-3') RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, 8-BROMOGUANOSINE,
Code Class Resolution Description 3ce5 nuc 2.50 9-[4-(N,N-DIMETHYLAMINO)PHENYLAMINO]-3,6-BIS(3- PYRROLIDINOPROPIONAMIDO) ACRIDINE C35 H43 N7 O2 A BIMOLECULAR PARALLEL-STRANDED HUMAN TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6,9-TRISUBSTITUTED ACRIDINE MOLECULE BRACO19 DNA (5'- D(*DTP*DAP*DGP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DGP*DT)-3') DNA BIMOLECULAR, PARALLEL, HUMAN, TELOMERE, QUADRUPLEX, COMPLEX, TRISUBSTITUTED, ACRIDINE, BRACO19, DNA
Code Class Resolution Description 1d63 nuc 2.00 BERENIL C14 H15 N7 CRYSTAL STRUCTURE OF A BERENIL-D(CGCAAATTTGCG) COMPLEX; AN EXAMPLE OF DRUG-DNA RECOGNITION BASED ON SEQUENCE- DEPENDENT STRUCTURAL FEATURES DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 268d nuc 2.02 BERENIL C14 H15 N7 STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA 2dbe nuc 2.50 BERENIL C14 H15 N7 CRYSTAL STRUCTURE OF A BERENIL-DODECANUCLEOTIDE COMPLEX: THE ROLE OF WATER IN SEQUENCE-SPECIFIC LIGAND BINDING DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 2gvr nuc 1.65 BERENIL C14 H15 N7 CRYSTAL STRUCTURE OF THE BERENIL-D(CGCGAATTCGCG)2 COMPLEX AT 1.65 A RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, CRYSTAL STRUCTURE OF B-DNA, DNA MINOR GROOVE BINDER, DICKERSON AND DREW DODECAMER, D(CGCGAATTCGCG)2, A2T2, DNA MINOR GROOVE- LIGAND COMPLEX, DNA-DRUG COMPLEX, DNA HYDRATION, BERENIL AND DNA, BERENIL-DNA COMPLEX, MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM COMPLEX.
Code Class Resolution Description 115d nuc 1.70 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O8 P) ORDERED WATER STRUCTURE IN AN A-DNA OCTAMER AT 1.7 ANGSTROMS RESOLUTION DNA (5'-D(*GP*GP*(BRU)P*AP*(BRU)P*AP*CP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 165d nuc 1.55 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) THE STRUCTURE OF A MISPAIRED RNA DOUBLE HELIX AT 1.6 ANGSTROMS RESOLUTION AND IMPLICATIONS FOR THE PREDICTION OF RNA SECONDARY STRUCTURE DNA/RNA (5'-R(*GP*CP*UP*UP*CP*GP*GP*CP*)- D(*(BRU))-3') DNA-RNA HYBRID A-DNA/RNA, DOUBLE HELIX, OVERHANGING BASES, MODIFIED, MISMATCHED, DNA-RNA HYBRID 1aio nuc 2.60 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DNA CONTAINING THE MA OF THE ANTICANCER DRUG CISPLATIN DNA (5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3' CHAIN: B, D, DNA (5'-D(*CP*CP*(BRU)P*CP*TP*[PT(NH3)2(GP*GP) ]*TP*CP*TP*CP*C)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE 1cs7 nuc 3.20 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O8 P) SYNTHETIC DNA HAIRPIN WITH STILBENEDIETHER LINKER 5'-D(GP*(BRU)P*TP*TP*TP*GP*(S02) *CP*AP*AP*AP*AP*C)-3' DNA DNA HAIRPIN 1d3r nuc 1.80 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF TRIPLEX DNA DNA (5'-D(*CP*GP*CP*GP*CP*GP*GP*AP*G)-3'), DNA (5'-D(*CP*(BRU)P*CP*CP*(BRU) P*CP*CP*GP*CP*GP*CP*G)-3') DNA TRIPLEX DNA AND ITS JUNCTION WITH A DUPLEX DNA 1d9r nuc 1.50 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G-A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*(BRU)P*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DEOXYRIBONUCLEIC ACID, DNA 1da1 nuc 2.25 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) STRUCTURAL CHARACTERISATION OF THE BROMOURACIL-GUANINE BASE PAIR MISMATCH IN A Z-DNA FRAGMENT DNA (5'-D(*(BRU)P*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED 1dcr nuc 1.60 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G-A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*(BRU)P*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DEOXYRIBONUCLEIC ACID, DNA 1fn1 nuc 1.60 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL) ACRIDINE-4-CARBOXAMIDE BOUND TO D(CG(5BR)UACG)2 DNA (5'-D(P*GP*(BRO)UP*AP*CP*G)-3'), DNA (5'-D(*CP*GP*(BRO)UP*AP*CP*G)-3') DNA 9-AMINOACRIDINE-4-CARBOAMIDE, HEXANUCLEOTIDE, X-RAY CRYSTALLOGRAPHY, INTERCALATION, QUADRUPLEX, DNA 1gqu nuc 2.50 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF AN ALTERNATING A-T OLIGONUCLEOTIDE FRAGMENT WITH HOOGSTEEN BASE PAIRING DNA (5'(*AP*TP*AP*UP*AP*T)-3') DNA DNA, DNA/RNA, NEW DNA STRUCTURE, HOOGSTEEN BASE PAIRING 1iha nuc 1.60 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[BR]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(BRU))-3' DNA/RNA RNA/DNA HYBRID, BROMO URACIL, RHODIUM(III) HEXAMMINE, C-U G- U MISMATCH, DNA/RNA COMPLEX 1j6s nuc 1.40 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF AN RNA TETRAPLEX (UGAGGU)4 WITH A- TETRADS, G-TETRADS, U-TETRADS AND G-U OCTADS 5'-R(*(BRUP*GP*AP*GP*GP*U)-3' RNA RNA, TETRAPLEX, G-U OCTADS, A-TETRADS, U-TETRADS, G-TETRADS 1jpq nuc 1.60 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF THE OXYTRICHA TELOMERIC DNA AT 1.6A 5'-D(*GP*GP*GP*GP*(BRU)P*TP*TP*TP*GP*GP*GP*G)-3' DNA OXYTRICHA, G-QUARTETS, DNA 1k8p nuc 2.40 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O8 P) STRUCTURE OF THE HUMAN G-QUADRUPLEX REVEALS A NOVEL TOPOLOGY 5'-D(*(BRU)P*AP*GP*GP*GP*(BRU) P*TP*AP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, DOUBLE CHAIN REVERSAL LOOP, DIMERIC QUADRUPLEX, HUMAN TELOMERE SEQUENCE, G(ANTI).G(ANTI) .G(ANTI).G(ANTI), PARALLEL STRANDED 1p1y nuc 2.10 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P CRYSTAL STRUCTURE OF A CONTINUOUS THREE-DIMENSIONAL DNA LATT D(GGACAGATGGGAG) 5'-D(*GP*GP*AP*(CBR)P*AP*GP*AP*(BRU)P*GP*GP*GP*AP CHAIN: X DNA CONTINUOUS THREE-DIMENSIONAL DNA LATTICE, PARALLEL-STRANDED PAIRS, DNA 1p54 nuc 1.90 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DNA HOL JUNCTIONS 5'-D(*CP*CP*AP*GP*TP*AP*CP*(BRU)P*GP*G)-3' DNA DNA HOLLIDAY JUNCTION, FOUR-WAY JUNCTION, STACKED-X JUNCTION BROMINATED URACIL, DNA 1sm5 nuc 2.00 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF A DNA DECAMER CONTAINING A THYMINE- DIMER 5'-D(*CP*GP*AP*AP*TP*TP*AP*AP*GP*C)-3', 5'-D(*GP*CP*(BRU)P*TP*AP*AP*TP*(BRU)P*CP*G)-3' DNA UV-DAMAGED DNA, THYMINE DIMER, DNA DECAMER 2avj nuc 2.39 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 6(C9 H12 BR N2 O8 P) G4(BR)UTTG4 DIMERIC QUADRUPLEX 5'-D(*GP*GP*GP*GP*(BRU)P*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, LOOP, DNA 2dlj nuc 1.50 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P 2'-ME-SE AND BR DERIVITATION OF A-DNA OCTAMER G(UMS)G(BRU) ACAC 5'-D(*GP*(UMS)P*GP*(BRU)P*AP*CP*AP*C)-3' DNA 2'-METHYLSELENO-URIDINE, SE-DNA, SE-BR-DNA, SELENIUM DERIVATIZATION 2gpx nuc 1.60 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P 2'-ME-SE AND BR DERIVITATION OF A-DNA OCTAMER G(UMS)G(BRU) ACAC 5'-D(*GP*(UMS)P*GP*(BRU)P*AP*CP*AP*C)-3' DNA 2'-METHYLSELENO-URIDINE, SE-DNA, SE-BR-DNA, SELENIUM DERIVATIZATION 2h05 nuc 1.80 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P BR DERIVITATION OF A-DNA OCTAMER GTG(UBR)ACAC 5'-D(*GP*TP*GP*(BRU)P*AP*CP*AP*C)-3' DNA BR-DNA, SE-DNA, SE-BR-DNA 2obz nuc 1.10 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF THE THE BROMINATED Z-DNA DUPLEX D(CGCG[BRU]G) 5'-D(*CP*GP*CP*GP*(BRU)P*G)-3' DNA BROMINATED DNA Z-DNA 2orf nuc 1.85 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P DIRECTING MACROMOLECULAR CONFORMATION THROUGH HALOGEN BONDS DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*TP*AP*(BRU)P*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND 2org nuc 2.00 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P DIRECTING MACROMOLECULAR CONFORMATION THROUGH HALOGEN BONDS DNA (5'-D(*CP*CP*GP*GP*TP*AP*(BRU)P*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND 344d nuc 1.46 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P DETERMINATION BY MAD-DM OF THE STRUCTURE OF THE DNA DUPLEX D(ACGTACG(5-BRU))2 AT 1.46A AND 100K DNA (5'-D(*AP*CP*GP*TP*AP*CP*GP*(BRU))-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 366d nuc 1.30 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P 1.3 A STRUCTURE DETERMINATION OF THE D(CG(5-BRU)ACG)2/6- BROMO-9-AMINO-DACA COMPLEX DNA (5'-D(*CP*GP*(BRU)P*AP*CP*G)-3') DNA DNA, DRUG INTERCALATION, MAJOR GROOVE BINDING 3gdd nuc 2.80 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) AN INVERTED ANTHRAQUINONE-DNA CRYSTAL STRUCTURE 5'-D(*(BRU)P*AP*GP*G)-3' DNA ANTHRAQUINONE, TELOMERE DNA SEQUENCE, DRUG-DNA COMPLEX, DNA 3qsc nuc 2.40 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C9 H12 BR N2 O8 P THE FIRST CRYSTAL STRUCTURE OF A HUMAN TELOMERIC G-QUADRUPLE BOUND TO A METAL-CONTAINING LIGAND (A COPPER COMPLEX) 5'-D(*AP*GP*GP*GP*TP*(BRU)P*AP*GP*GP*GP*TP*T)-3' DNA PARALLEL, TELOMERE, QUADRUPLEX, DRUG, DNA, METAL COMPLEX, CO COMPLEX 3qxr nuc 1.62 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF THE BROMINATED CKIT-1 PROTO-ONCOGENE PR QUADRUPLEX DNA 5'-D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*(BRU) P*GP*GP*GP*AP*GP*GP*AP*GP*GP*G)-3' DNA DNA QUADRUPLEX, REGULATION, CKIT-1, DNA 4rip nuc 2.10 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) BROMOURACIL SUBSTITUTED STRUCTURE OF INTERCALATION-LOCKED DN TETRAPLEX DNA (5'-D(*AP*CP*(BRU)P*CP*GP*GP*AP*(BRU)P*GP*AP* CHAIN: A DNA BROMOURACIL, HOMODUPLEX, INTERCALATION-LOCKED DNA TETRAPLEX, 4xno nuc 1.99 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF 5'-CTTATPPPZZZATAAG DNA (5'-D(*CP*TP*(BRU)P*AP*TP*(1WA)P*(1WA)P*(1WA) P*(1W5)P*(1W5)P*AP*TP*AP*AP*G)-3') DNA A-FORM DNA, NON-NATURAL NUCLEOBASE PAIR, SYNTHETIC BIOLOGY, 5mvl nuc 1.41 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 BR N2 O8 P) CRYSTAL STRUCTURE OF AN A-DNA DODECAMER CONTAINING 5-BROMOUR BROMINATED DNA DODECAMER DNA A-DNA, 5-BROMOURACIL, CPG, DNA
Code Class Resolution Description 1f27 nuc 1.30 BIOTIN C10 H16 N2 O3 S CRYSTAL STRUCTURE OF A BIOTIN-BINDING RNA PSEUDOKNOT RNA (5'-R(*AP*AP*AP*AP*AP*GP*UP*CP*CP*UP*C)-3'), RNA (5'- R(*AP*CP*CP*GP*UP*CP*AP*GP*AP*GP*GP*AP*CP*AP*CP*GP*GP*UP*U) -3') RNA RNA APTAMER, PSEUDOKNOT, BIOTIN-BINDING RNA
Code Class Resolution Description 1dl4 nuc NMR 1R,2S,3R,4S-TETRAHYDRO-BENZO[A]ANTHRACENE-2,3,4-TRIOL C18 H16 O3 THE SOLUTION STRUCTURE OF A BAY-REGION 1S-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE DNA (5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3'), DNA (5'-D(*CP*GP*GP*AP*CP*(BZA)AP*AP*GP*AP*AP*G)- 3') DNA BENZ[A]ANTHRACENE-DNA DUPLEX 1i7v nuc NMR 1R,2S,3R,4S-TETRAHYDRO-BENZO[A]ANTHRACENE-2,3,4-TRIOL C18 H16 O3 THE SOLUTION STRUCTURE OF A BAY REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3', 5'-D(*CP*GP*GP*AP*CP*AP*(BZA)AP*GP*AP*AP*G)-3' DNA BENZ[A]ANTHRACENE-DNA DUPLEX 1qby nuc NMR 1R,2S,3R,4S-TETRAHYDRO-BENZO[A]ANTHRACENE-2,3,4-TRIOL C18 H16 O3 THE SOLUTION STRUCTURE OF A BAY-REGION 1R-BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N-RAS CODON 61 SEQUENCE 5'-D(*CP*GP*GP*AP*CP*(BZA)AP*AP*GP*AP*AP*G)-3', 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP* G)-3' DNA BENZ[A]ANTHRACENE-DNA DUPLEX, INTERCALATION
Code Class Resolution Description 4hqi nuc 1.70 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-9H-PURIN-2-AMINE 2(C17 H20 N5 O7 P) STRUCTURE OF O6-BENZYL-2'-DEOXYGUANOSINE OPPOSITE PERIMIDINO SYNTHETIC NUCLEOSIDE IN DNA DUPLEX SHORT MODIFIED NUCLEIC ACIDS DNA B-FORM DNA, O6-BENZYL-2'-DEOXYGUANOSINE, DPER, PERIMIDINONE- NUCLEOSIDE, DICKERSON-DREW DODECAMER, DNA
Code Class Resolution Description 1mxj nuc NMR 1S,2R,3S,4R-TETRAHYDRO-BENZO[A]ANTHRACENE-2,3,4-TRIOL C18 H16 O3 NMR SOLUTION STRUCTURE OF BENZ[A]ANTHRACENE-DG IN RAS CODON 12,2; GGCAGXTGGTG 5'-D(*CP*AP*CP*CP*AP*CP*CP*TP*GP*CP*C)-3', 5'-D(*GP*GP*CP*AP*GP*GP*TP*GP*GP*TP*G)-3' DNA DNA ADDUCT, B-LIKE DNA
Code Class Resolution Description 3q3z nuc 2.51 9,9'-[(2R,3R,3AS,5S,7AR,9R,10R,10AS,12S,14AR)-3,5,10, 12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3, 2-D:3',2'-J][1,3,7,9,2, 8]TETRAOXADIPHOSPHACYCLODODECINE-2,9-DIYL]BIS(2-AMINO- 1,9-DIHYDRO-6H-PURIN-6-ONE) 4(C20 H24 N10 O14 P2) STRUCTURE OF A C-DI-GMP-II RIBOSWITCH FROM C. ACETOBUTYLICUM C-DI-GMP C-DI-GMP-II RIBOSWITCH RNA RIBOSWITCH, C-DI-GMP, RNA 4yb0 nuc 2.12 9,9'-[(2R,3R,3AS,5S,7AR,9R,10R,10AS,12S,14AR)-3,5,10, 12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3, 2-D:3',2'-J][1,3,7,9,2, 8]TETRAOXADIPHOSPHACYCLODODECINE-2,9-DIYL]BIS(2-AMINO- 1,9-DIHYDRO-6H-PURIN-6-ONE) 2(C20 H24 N10 O14 P2) 3',3'-CGAMP RIBOSWITCH BOUND WITH C-DI-GMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP,
Code Class Resolution Description 1xv6 nuc NMR 5-METHYL-3'-O-METHOXYETHYL CYTIDINE 5'-MONOPHOSPHATE 4(C13 H22 N3 O9 P) THE SOLUTION STRUCTURE OF 2',5'-LINKED 3'-O-(2- METHOXYETHYL)-RNA HAIRPIN 5'-R(*(C2L)P*(G2L)P*(C2L)P*(G2L)P*(A2L)P*(A2L) P*(U2L)P*(U2L)P*(C2L)P*(G2L)P*(C2L)P*(G2L))-2' RNA HAIRPIN, (2',5')-RNA, 3'-O-(2-METHOXYETHYL) RIBOSE
Code Class Resolution Description 1k8l nuc NMR CYTIDINE-5'-DITHIOPHOSPHORATE 3(C9 H14 N3 O5 P S2) XBY6: AN ANALOG OF CK14 CONTAINING 6 DITHIOPHOSPHATE GROUPS FIRST STRAND OF CK14 DNA DUPLEX: DITHIOATED AT T10, C11, SECOND STRAND OF CK14 DNA DUPLEX: DITHIOATED AT G17, C22, C24, G27 DNA XBY6, CK14, CK1, PHOSPHORODITHIOATE, NF-KB, DNA 1k8n nuc NMR CYTIDINE-5'-DITHIOPHOSPHORATE 2(C9 H14 N3 O5 P S2) NMR STRUCTURE OF THE XBY2 DNA DUPLEX, AN ANALOG OF CK14 CONTAINING PHOSPHORODITHIOATE GROUPS AT C22 AND C24 FIRST STRAND OF CK14 DNA DUPLEX, SECOND STRAND OF CK14 DNA DUPLEX: DITHIOATED AT C22 AND C24 DNA PHOSPHORODITHIOATE, CK14, CK1, NF-KB, XBY6, XBY2, THIOPHOSPHATE, DNA
Code Class Resolution Description 133d nuc 1.80 N4-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O7 P) THE CRYSTAL STRUCTURE OF N4-METHYLCYTOSINE.GUANOSIN BASE- PAIRS IN THE SYNTHETIC HEXANUCLEOTIDE D(CGCGM(4)CG) DNA (5'-D(*CP*GP*CP*GP*(C34)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 2oks nuc 1.65 N4-METHYL-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O7 P X-RAY STRUCTURE OF A DNA REPAIR SUBSTRATE CONTAINING AN ALKY INTERSTRAND CROSSLINK AT 1.65 RESOLUTION 5'-D(*CP*CP*AP*AP*(C34)P*GP*TP*TP*GP*G)-3' DNA INTERSTRAND CROSSLINK, DNA, DNA DAMAGE
Code Class Resolution Description 1ana nuc 2.00 5-IODO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 I N3 O7 P) HELIX GEOMETRY AND HYDRATION IN AN A-DNA TETRAMER. IC-C-G-G DNA (5'-D(*(C38)P*CP*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED, DNA 1ue2 nuc 1.40 5-IODO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 I N3 O7 P CRYSTAL STRUCTURE OF D(GC38GAAAGCT) 5'-D(*GP*(C38)P*GP*AP*AP*AP*GP*CP*T)-3' DNA DNA, BASE-INTERCALATED DUPLEX, MINI-HAIRPIN STRUCTURE, SHEAR PAIR, ZIPPER-LIKE DUPLEX 1v3o nuc 1.70 5-IODO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 I N3 O7 P) CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DNA QUADRUPLEX STRUCTU FROM THE OCTAPLEX 5'-D(*GP*(C38)P*GP*AP*GP*AP*GP*C)-3' DNA OCTAPLEX, QUADRUPLEX, G-DUET, BASE-INTERCALATED DUPLEX, BASE INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DEOXYRIBONUCLEIC RAY ANALYSIS 1v3p nuc 2.30 5-IODO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 I N3 O7 P) CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DNA OCTAPLEX STRUCTURE WITH I-MOTIF OF G-QUARTET 5'-D(*GP*(C38)P*GP*AP*GP*AP*GP*C)-3' DNA OCTAPLEX, QUADRUPLEX, G-QUARTET, I-MOTIF, I-MOTIF OF G- QUARTET, BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DEOXYRIBONUCLEIC ACID, X-RAY ANALYSIS, CRYSTAL STRUCTURE 3i5l nuc 1.18 5-IODO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 I N3 O7 P) ALLOSTERIC MODULATION OF DNA BY SMALL MOLECULES 5'-D(*CP*CP*AP*GP*GP*(C38)P*CP*TP*GP*G)-3' DNA CYCLIC POLYAMIDE, DNA BINDER, MINOR GROOVE BINDER, PYIM POLYAMIDE 3omj nuc 0.95 5-IODO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 I N3 O7 P) STRUCTURAL BASIS FOR CYCLIC PY-IM POLYAMIDE ALLOSTERIC INHIB NUCLEAR RECEPTOR BINDING 5'-D(*CP*(C38)P*AP*GP*TP*AP*CP*TP*GP*G)-3' DNA CYCLIC PY-IM POLYAMIDE, DNA
Code Class Resolution Description 363d nuc 2.00 3'-AMINO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 24(C9 H15 N4 O6 P) HIGH-RESOLUTION CRYSTAL STRUCTURE OF A FULLY MODIFIED N3'-> PHOSPHORAMIDATE DNA DODECAMER DUPLEX 5'-D(*(C42)P*(G38)P*(C42)P*(G38)P*(A43)P*(A43)P*( P*(NYM)P*(C42)P*(G38)P*(C42)P*DG)-3' DNA A-DNA, MODIFIED, DNA
Code Class Resolution Description 468d nuc 1.80 2'-O-METHYOXYETHYL-CYTIDINE-5'-MONOPHOSPHATE 8(C12 H20 N3 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 469d nuc 1.70 2'-O-METHYOXYETHYL-CYTIDINE-5'-MONOPHOSPHATE 8(C12 H20 N3 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RNA 470d nuc 1.95 2'-O-METHYOXYETHYL-CYTIDINE-5'-MONOPHOSPHATE 8(C12 H20 N3 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 471d nuc 2.70 2'-O-METHYOXYETHYL-CYTIDINE-5'-MONOPHOSPHATE 8(C12 H20 N3 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA
Code Class Resolution Description 1da2 nuc 1.70 N4-METHOXY-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO4CG): N4- METHOXYCYTOSINE/GUANINE BASE-PAIRS IN Z-DNA DNA (5'-D(*CP*GP*CP*GP*(C45)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1i3t nuc 1.60 N4-METHOXY-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATT(MO4)CGCG): THE WATSON-CRICK TYPE AND WOBBLE N4- METHOXYCYTIDINE/GUANOSINE BASE PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(C45)P*GP*CP*GP)- 3' DNA N4-METHOXYCYTOSINE, DAMAGED DNA, B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID 1i47 nuc 2.10 N4-METHOXY-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATT(MO4)CGCG): THE WATSON-CRICK TYPE AND WOBBLE N4- METHOXYCYTIDINE/GUANOSINE BASE PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(C45)P*GP*CP*GP)- 3' DNA N4-METHOXYCYTOSINE, DAMAGED DNA, B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID 1j8l nuc 1.60 N4-METHOXY-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCAAATTMO4CGCG): THE WATSON-CRICK TYPE N4-METHOXYCYTIDINE/ADENOSINE BASE PAIR IN B-DNA DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*(C45) P*GP*CP*G)-3') DNA N4-METHOXYCYTOSINE, DNA DAMAGE, B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 223d nuc 1.70 6H,8H-3,4-DIHYDROPYRIMIDO[4,5-C][1,2]OXAZIN-7- 0NE(CYTIDINE)-5'-MONOPHOSPHATE 2(C11 H16 N3 O8 P) DIRECT OBSERVATION OF TWO BASE-PAIRING MODES OF A CYTOSINE- THYMINE ANALOGUE WITH GUANINE IN A DNA Z-FORM DUPLEX: SIGNIFICANCE FOR BASE ANALOGUE MUTAGENESIS DNA (5'-D(*CP*GP*CP*GP*(C46)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 417d nuc 1.50 6H,8H-3,4-DIHYDROPYRIMIDO[4,5-C][1,2]OXAZIN-7- 0NE(CYTIDINE)-5'-MONOPHOSPHATE 2(C11 H16 N3 O8 P) A THYMINE-LIKE BASE ANALOGUE FORMS WOBBLE PAIRS WITH ADENINE DNA (5'-D(*CP*AP*CP*GP*(C46)P*G)-3') DNA P.A BASE-PAIRS, PYRIMIDINE ANALOGUE, Z-DNA
Code Class Resolution Description 2loa nuc NMR 4-(1,4,7,10-TETRAAZACYCLODODECAN-1-YLMETHYL)QUINOLINE C18 H27 N5 STRUCTURAL BASIS FOR BIFUNCTIONAL ZN(II) MACROCYCLIC COMPLEX RECOGNITION OF THYMINE BULGES IN DNA DNA (5'-D(*GP*CP*CP*GP*CP*AP*GP*TP*GP*C)-3') DNA THYMINE BULGE, BIFUNCTIONAL ZN(II) MACROCYCLIC COMPLEX, DNA,
Code Class Resolution Description 2rmq nuc NMR 2'-DEOXY-4'-THIOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 8(C9 H14 N3 O6 P S) SOLUTION STRUCTURE OF FULLY MODIFIED 4'-THIODNA WITH THE SEQUENCE OF D(CGCGAATTCGCG) DNA (5'-D(*(C4S)P*(S4G)P*(C4S)P*(S4G)P*(S4A) P*(S4A)P*(T49)P*(T49)P*(C4S)P*(S4G)P*(C4S)P*(S4G))-3') DNA 4'-THIODNA, A-FORM
Code Class Resolution Description 2m39 nuc NMR 2'-O-(2-METHOXYETHYL)-5-METHYLCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 8(C13 H22 N3 O9 P) THE SOLUTION STRUCTURE OF 3',5'-LINKED 2'-O-(2-METHOXYETHYL) DUPLEX RNA (5'-R(*(C5L)P*(G48)P*(C5L)P*(G48)P*(A44)P*(A4 P*(T39)P*(C5L)P*(G48)P*(C5L)P*DG)-3') RNA DUPLEX, (3',5')-RNA, 2'-O-(2-METHOXYETHYL) RIBOSE, RNA
Code Class Resolution Description 1me0 nuc NMR CYTIDINE-5'-MONOPHOSPHATE C9 H14 N3 O8 P CHIMERIC HAIRPIN WITH 2',5'-LINKED RNA LOOP AND DNA STEM DNA/RNA (5'-D(*GP*GP*AP*C)-R(P*(U25)P*(U25)P*(C25 D(P*GP*TP*CP*C)-3') DNA, RNA HAIRPIN, (2',5')-RNA, DNA, RNA 1me1 nuc NMR CYTIDINE-5'-MONOPHOSPHATE C9 H14 N3 O8 P CHIMERIC HAIRPIN WITH 2',5'-LINKED RNA LOOP AND RNA STEM 5'-R(*GP*GP*AP*CP*(U25)P*(U25)P*(C25)P*(5GP)P*GP* 3' RNA HAIRPIN, (2',5')-RNA, RNA
Code Class Resolution Description 1nr8 nuc 1.66 2-AMINOETHYLLYSINE-CARBONYLMETHYLENE-CYTOSINE C14 H24 N6 O4 THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX
Code Class Resolution Description 4ij0 nuc 1.54 6-(CARBOXYMETHOXY)-9-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-9H-PURIN-2-AMINE 2(C12 H16 N5 O9 P) STRUCTURES OF DNA DUPLEXES CONTAINING O6-CARBOXYMETHYLGUANIN LESION ASSOCIATED WITH GASTROINTESTINAL CANCER, REVEAL A ME FOR INDUCING TRANSITION MUTATION DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, MUTAGENESIS, DNA 4itd nuc 1.94 6-(CARBOXYMETHOXY)-9-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-9H-PURIN-2-AMINE 2(C12 H16 N5 O9 P) STRUCTURES OF DNA DUPLEXES CONTAINING O6-CARBOXYMETHYLGUANIN LESION ASSOCIATED WITH GASTROINTESTINAL CANCER, REVEAL A ME FOR INDUCING TRANSITION MUTATION DNA (5'-D(*CP*GP*CP*GP*(C6G)P*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, MUTAGENESIS, DNA 4o5w nuc 1.60 6-(CARBOXYMETHOXY)-9-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-9H-PURIN-2-AMINE 2(C12 H16 N5 O9 P) O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 4o5x nuc 1.60 6-(CARBOXYMETHOXY)-9-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-9H-PURIN-2-AMINE 2(C12 H16 N5 O9 P) O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE. DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 4o5y nuc 1.75 6-(CARBOXYMETHOXY)-9-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-9H-PURIN-2-AMINE 2(C12 H16 N5 O9 P) O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 4o5z nuc 1.75 6-(CARBOXYMETHOXY)-9-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-9H-PURIN-2-AMINE 2(C12 H16 N5 O9 P) O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA
Code Class Resolution Description
3co3 nuc 2.16 CIS-DIAMMINE(PYRIDINE)CHLOROPLATINUM(II) C5 H11 CL N3 PT 2+ X-RAY CRYSTAL STRUCTURE OF A MONOFUNCTIONAL PLATINUM-DNA ADDUCT, CIS-{PT(NH3)2(PYRIDINE)}2+ BOUND TO DEOXYGUANOSINE IN A DODECAMER DUPLEX 5'- D(*DCP*DCP*DTP*DCP*DTP*DCP*DGP*DTP*DCP*DTP*DCP*DC)-3', 5'- D(*DGP*DGP*DAP*DGP*DAP*DCP*DGP*DAP*DGP*DAP*DGP*DG)-3' DNA PLATINUM-DNA DUPLEX, CISPLATIN, MONOFUNCTIONAL PT COMPOUND
Code Class Resolution Description 158d nuc 1.90 CALCIUM ION 2(CA 2+) CRYSTALLOGRAPHIC ANALYSIS OF C-C-A-A-G-C-T-T-G-G AND ITS IMPLICATIONS FOR BENDING IN B-DNA DNA (5'-D(*CP*CP*AP*AP*GP*CP*TP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX 196d nuc 1.70 CALCIUM ION 6(CA 2+) CRYSTAL STRUCTURE OF C-T-C-T-C-G-A-G-A-G: IMPLICATIONS FOR THE STRUCTURE OF THE HOLLIDAY JUNCTION DNA (5'-D(*CP*TP*CP*TP*CP*GP*AP*GP*AP*G)-3') DNA B-DNA, DOUBLE HELIX 1cw9 nuc 1.55 CALCIUM ION CA 2+ DNA DECAMER WITH AN ENGINEERED CROSSLINK IN THE MINOR GROOVE 5'-D(*CP*CP*AP*GP*(G47)P*CP*CP*TP*GP*G)-3' DNA CROSSLINKED DOUBLE-HELICAL DNA, BASE-PAIR OPENING, PARTIAL B FLIPPING., DNA 1d56 nuc 1.70 CALCIUM ION CA 2+ ALTERNATIVE STRUCTURES FOR ALTERNATING POLY(DA-DT) TRACTS: THE STRUCTURE OF THE B-DNA DECAMER C-G-A-T-A-T-A-T-C-G DNA (5'-D(*CP*GP*AP*TP*AP*TP*AP*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX 1d61 nuc 1.30 CALCIUM ION CA 2+ THE STRUCTURE OF THE B-DNA DECAMER C-C-A-A-C-I-T-T-G-G: MONO FORM DNA (5'-D(*CP*CP*AP*AP*CP*IP*TP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA 1d8g nuc 0.74 CALCIUM ION 4(CA 2+) ULTRAHIGH RESOLUTION CRYSTAL STRUCTURE OF B-DNA DECAMER D(CC 5'-D(*CP*CP*AP*GP*TP*AP*CP*TP*GP*GP*)-3' DNA B-DNA, ALTERNATE CONFORMATION, ULTRAHIGH RESOLUTION, TRP REP POLYAMIDE, DNA 1dqf nuc 2.20 CALCIUM ION 2(CA 2+) CRYSTAL STRUCTURE OF HELIX II OF THE X. LAEVIS SOMATIC 5S RR CYTOSINE BULGE IN TWO CONFORMATIONS RNA (5'-R(*GP*CP*CP*AP*CP*CP*CP*UP*G)-3'): HELIX II OF 5S RRNA, RNA (5'-R(*CP*AP*GP*GP*GP*UP*CP*GP*GP*C)-3') RNA DOUBLE HELIX, CYTOSINE BULGE, RNA 1en8 nuc 0.98 CALCIUM ION 4(CA 2+) 1 A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM DNA (5'-D(*CP*CP*AP*AP*CP*GP*TP*TP*GP*G)-3') DNA DIVALENT CATIONS, DNA SEQUENCE-SPECIFIC BINDING, SHELXDNA, B-DNA 1ene nuc 0.98 CALCIUM ION 5(CA 2+) 1A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM. DNA (5'-D(*CP*CP*AP*GP*CP*GP*CP*TP*GP*G)-3') DNA DIVALENT CATIONS, DNA SEQUENCE-SPECIFIC BINDING, SHELXDNA, B-DNA 1fhy nuc 2.20 CALCIUM ION CA 2+ PSORALEN CROSS-LINKED D(CCGCTAGCGG) FORMS HOLLIDAY JUNCTION DNA (5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3') DNA PSORALEN, CROSS-LINKED DNA, HOLLIDAY JUNCTION, 4-WAY JUNCTION, DNA-DRUG COMPLEX 1g2j nuc 1.97 CALCIUM ION 2(CA 2+) RNA OCTAMER R(CCCP*GGGG) CONTAINING PHENYL RIBONUCLEOTIDE 5'-R(*CP*CP*CP*(PYY)P*GP*GP*GP*G)-3' RNA RNA DUPLEX, PHENYL-RIBONUCLEOTIDE 1g4q nuc 1.15 CALCIUM ION 3(CA 2+) RNA/DNA HYBRID DECAMER OF CAAAGAAAAG/CTTTTCTTTG 5'-R(*CP*AP*AP*AP*GP*AP*AP*AP*AP*G)-3': POLYPURINE TRACT OF HIV-1, 5'-D(*CP*TP*TP*TP*TP*CP*TP*TP*TP*G)-3' DNA-RNA HYBRID RNA/DNA HYBRID, POLYPURINE TRACT OF HIV-1, DIRECT METHODS, DNA/RNA COMPLEX, DNA-RNA HYBRID 1j8g nuc 0.61 CALCIUM ION 3(CA 2+) X-RAY ANALYSIS OF A RNA TETRAPLEX R(UGGGGU)4 AT ULTRA-HIGH R 5'-R(*UP*GP*GP*GP*GP*U)-3' RNA RNA TETRAPLEX, SR IONS, U TETRAD, OCTAPLEX, RNA 1j9h nuc 1.40 CALCIUM ION 4(CA 2+) CRYSTAL STRUCTURE OF AN RNA DUPLEX WITH URIDINE BULGES 5'-R(*GP*UP*GP*UP*CP*GP*(CBR)P*AP*C)-3' RNA URIDINE BULGE, RNA DUPLEX, A-FORM, KINK, METAL BINDING 1l4j nuc 1.85 CALCIUM ION 4(CA 2+) HOLLIDAY JUNCTION TCGGTACCGA WITH NA AND CA BINDING SITES. 5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3' DNA HOLLIDAY JUNCTION, DNA 1l6b nuc 1.50 CALCIUM ION CA 2+ CRYSTAL STRUCTURE ANALYSIS OF THE ALL DNA HOLLIDAY JUNCTION STRUCTURE OF CCGGTACM5CGG 5'-D(*CP*CP*GP*GP*TP*AP*CP*(5CM)P*GP*G)-3' DNA HOLLIDAY JUNCTION, DNA FOUR-WAY JUNCTION, CYTOSINE METHYLATION 1lnt nuc 1.70 CALCIUM ION 3(CA 2+) CRYSTAL STRUCTURE OF THE HIGHLY CONSERVED RNA INTERNAL LOOP 5'-R(*GP*CP*GP*UP*CP*AP*GP*GP*UP*CP*(CBV)P*G)-3', 5'-R(*CP*GP*GP*AP*AP*GP*CP*AP*GP*(CBV)P*GP*C)-3' RNA SRP, INTERNAL LOOP, MISPAIR, RNA 1nqs nuc 1.97 CALCIUM ION CA 2+ STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION FORMED BY THE SEQUENCE D(TCGGTACCGA) AT 1.97 A 5'-D(TPCPGPGPTPAPCPCPGPA)-3' DNA HOLLIDAY JUNCTION, CALCIUM ION, DNA 1nt8 nuc 2.00 CALCIUM ION 2(CA 2+) STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION FORMED BY THE SEQUENCE CCGGTACCGG AT 2.00 A 5'-D(CPCPGPGPTPAPCPCPGPG)-3' DNA HOLLIDAY JUNCTION, CALCIUM ION, DNA 1nvn nuc 1.80 CALCIUM ION 2(CA 2+) STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION FORMED BY THE SEQUENCE CCGGTACCGG AT 1.8 A 5'-D(CPCPGPGPTPAPCPCPGPG)-3' DNA HOLLIDAY JUNCTION, CALCIUM ION, DNA 1p54 nuc 1.90 CALCIUM ION CA 2+ EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DNA HOL JUNCTIONS 5'-D(*CP*CP*AP*GP*TP*AP*CP*(BRU)P*GP*G)-3' DNA DNA HOLLIDAY JUNCTION, FOUR-WAY JUNCTION, STACKED-X JUNCTION BROMINATED URACIL, DNA 1pjg nuc 1.15 CALCIUM ION 4(CA 2+) RNA/DNA HYBRID DECAMER OF CAAAGAAAAG/CTTTTCTTTG 5'-D(*CP*TP*TP*TP*TP*CP*TP*TP*TP*G)-3', 5'-R(*CP*AP*AP*AP*GP*AP*AP*AP*AP*G)-3': POLYPURINE TRACT OF HIV-1 DNA-RNA HYBRID RNA/DNA HYBRID; POLYPURINE TRACT OF HIV-1; MOLEUCLAR REPLACE SUGAR CONFORMATION, DNA-RNA COMPLEX, DNA-RNA HYBRID 1s1k nuc 1.90 CALCIUM ION 2(CA 2+) INFLUENCE OF GROOVE INTERACTIONS ON DNA HOLLIDAY JUNCTION FORMATION 5'-D(*CP*CP*(1AP)P*GP*TP*AP*CP*TP*GP*G)-3' DNA B-DNA, DOUBLE HELIX, 2, 6-DIAMINOPURINE, MINOR GROOVE INTERACTIONS 1sgs nuc 1.60 CALCIUM ION 6(CA 2+) CRYSTAL STRUCTURE OF A FREE KB DNA KB DNA DNA FREE KB DNA, CALCIUM BINDING, NF-KB BINDING, DNA 1sk5 nuc 0.89 CALCIUM ION 8(CA 2+) THE ULTRA-HIGH RESOLUTION STRUCTURE OF D(CTTTTAAAAG)2: MODULATION OF BENDING BY T-A STEPS AND ITS ROLE IN DNA RECOGNITION 5'-D(*CP*TP*TP*TP*TP*AP*AP*AP*AP*G)-3' DNA DNA/DNA DOUBLE HELIX; POPYPURINE TRACT SEQUENCE OF HIV-1 1yy0 nuc 3.20 CALCIUM ION 2(CA 2+) CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING A 2'-AMINE SUB AND A 2'-AMIDE PRODUCT PRODUCED BY IN-CRYSTAL ACYLATION AT MISMATCH 5'-R(*GP*CP*AP*GP*AP*(A5M)P*UP*UP*AP*AP*AP*UP*CP* 3', 5'-R(*GP*CP*AP*GP*AP*(M5M)P*UP*UP*AP*AP*AP*UP*CP* 3' RNA 2'-AMINE, RNA, DUPLEX, MISMATCH, 2-AMIDE, IN-CRYSTAL REACTIO 1yzd nuc 2.35 CALCIUM ION CA 2+ CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING A SITE SPECIFI SUBSTITUTION AT A C-G WATSON-CRICK BASE PAIR RNA 5'-R(*GP*CP*AP*GP*AP*(A5M) P*UP*UP*AP*AP*GP*UP*CP*UP*GP*C)-3' RNA 2'-AMINE, RNA, DUPLEX 1z79 nuc 2.55 CALCIUM ION CA 2+ CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING SITE SPECIFIC SUBSTITUTION AT A C-A MISMATCH (AT PH 5) RNA 5'-R(*GP*CP*AP*GP*AP*(A5M) P*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3' RNA 2'-AMINE, RNA, DUPLEX, MISMATCH 1zez nuc 2.00 CALCIUM ION CA 2+ ACC HOLLIDAY JUNCTION 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, M STRUCTURE, DNA 1zf0 nuc 1.50 CALCIUM ION 4(CA 2+) B-DNA 5'-D(*CP*CP*GP*TP*TP*AP*AP*CP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zf3 nuc 1.84 CALCIUM ION CA 2+ ATC FOUR-STRANDED DNA HOLLIDAY JUNCTION 5'-D(*CP*CP*GP*AP*TP*AP*TP*CP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, M STRUCTURE, DNA 1zf6 nuc 1.50 CALCIUM ION 3(CA 2+) TGG DUPLEX A-DNA 5'-D(*CP*CP*CP*CP*AP*TP*GP*GP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zf7 nuc 1.05 CALCIUM ION 3(CA 2+) GAC DUPLEX B-DNA 5'-D(*CP*CP*GP*TP*CP*GP*AP*CP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zf8 nuc 1.48 CALCIUM ION CA 2+ GGT DUPLEX A-DNA 5'-D(*CP*CP*AP*CP*CP*GP*GP*TP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zfa nuc 1.56 CALCIUM ION CA 2+ GGA DUPLEX A-DNA 5'-D(*CP*CP*TP*CP*CP*GP*GP*AP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zfb nuc 1.65 CALCIUM ION 2(CA 2+) GGC DUPLEX B-DNA 5'-D(*CP*CP*GP*CP*CP*GP*GP*CP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 244d nuc 1.20 CALCIUM ION 9(CA 2+) THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL- STRANDED GUANINE TETRAPLEX DNA (5'-D(*TP*GP*GP*GP*GP*T)-3') DNA UNUSUAL DNA, QUADRUPLE HELIX, PARALLEL-STRANDED TETRAPLEX 249d nuc 2.25 CALCIUM ION CA 2+ STRUCTURAL COMPARISON BETWEEN THE D(CTAG) SEQUENCE IN OLIGONUCLEOTIDES AND TRP AND MET REPRESSOR-OPERATOR COMPLEXES DNA (5'-D(*CP*GP*CP*TP*CP*TP*AP*GP*AP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX 2b2b nuc 1.50 CALCIUM ION 2(CA 2+) STRUCTURAL DISTORTIONS IN PSORALEN CROSS-LINKED DNA 5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3' DNA RECOMBINATION, PSORALEN, NUCLEIC ACID STRUCTURE, DNA 2fza nuc 3.60 CALCIUM ION 2(CA 2+) CRYSTAL STRUCTURE OF D(GCGGGAGC): THE BASE-INTERCALATED DUPLEX 5'-D(*GP*(CBR)P*GP*GP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DNA HEXAPLEX, DEOXYRIBONUCLEIC ACID 2gw0 nuc 1.55 CALCIUM ION 8(CA 2+) A D(TGGGGT)- SODIUM AND CALCIUM COMPLEX. 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA DNA, QUADRUPLEX, G-QUADRUPLEX, TETRAPLEX, G-TETRAPLEX, QUADRUPLE HELIX, PARALLEL-STRANDED, D(TGGGGT), HYDRATED CALCIUM ION, CALCIUM, CALCIUM ION, SODIUM, SODIUM ION. 2hok nuc 3.20 CALCIUM ION 7(CA 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, CALCIUM IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 2hol nuc 2.90 CALCIUM ION 4(CA 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, BARIUM IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 2hom nuc 2.89 CALCIUM ION 2(CA 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE MONOPHOSPHATE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 2hoo nuc 3.00 CALCIUM ION 7(CA 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO BENFOTIAMINE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH; BENFOTIAMINE 2hop nuc 3.30 CALCIUM ION CA 2+ CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO PYRITHIAMINE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 2oks nuc 1.65 CALCIUM ION 3(CA 2+) X-RAY STRUCTURE OF A DNA REPAIR SUBSTRATE CONTAINING AN ALKY INTERSTRAND CROSSLINK AT 1.65 RESOLUTION 5'-D(*CP*CP*AP*AP*(C34)P*GP*TP*TP*GP*G)-3' DNA INTERSTRAND CROSSLINK, DNA, DNA DAMAGE 2zy6 nuc 1.75 CALCIUM ION 7(CA 2+) CRYSTAL STRUCTURE OF A TRUNCATED TRNA, TPHE39A PHENYLALANYL TRANSFER RNA RNA TRUNCATED TRNA 333d nuc 2.52 CALCIUM ION CA 2+ THE CRYSTAL STRUCTURE OF AN RNA OLIGOMER INCORPORATING TANDEM ADENOSINE-INOSINE MISMATCHES RNA (5'-R(*CP*GP*CP*AP*IP*GP*CP*G)-3') RNA A-RNA, DOUBLE HELIX, INTERNAL LOOP, MISMATCHED 334d nuc 1.80 CALCIUM ION CA 2+ DEFINING GC-SPECIFICITY IN THE MINOR GROOVE: SIDE-BY-SIDE BINDING OF THE DI-IMIDAZOLE LEXITROPSIN TO C-A-T-G-G-C-C-A- T-G DNA (5'-D(*CP*AP*TP*GP*GP*CP*CP*AP*TP*G)-3') DNA B-DNA, DOUBLE HELIX 352d nuc 0.95 CALCIUM ION 9(CA 2+) THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL- STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION DNA (5'-D(*TP*GP*GP*GP*GP*T)-3') DNA U-DNA, QUADRUPLE HELIX, PARALLEL-STRANDED 397d nuc 1.30 CALCIUM ION 4(CA 2+) A 1.3 A RESOLUTION CRYSTAL STRUCTURE OF THE HIV-1 TRANS- ACTIVATION RESPONSE REGION RNA STEM REVEALS A METAL ION- DEPENDENT BULGE CONFORMATION RNA (5'-R(*GP*CP*UP*CP*UP*CP*UP*GP*GP*CP*CP*C)- 3'), RNA (5'- R(*GP*GP*CP*CP*AP*GP*AP*UP*CP*UP*GP*AP*GP*CP*G)-3') RNA DOUBLE HELIX, OVERHANGING BASES, RNA 3bse nuc 1.60 CALCIUM ION 12(CA 2+) CRYSTAL STRUCTURE ANALYSIS OF A 16-BASE-PAIR B-DNA DNA (5'- D(*DA*DCP*DAP*DCP*DTP*DAP*DCP*DAP*DAP*DTP*DGP*DTP*DTP*DGP*D CP*DAP*DAP*DT)-3'), DNA (5'- D(*DG*DTP*DAP*DTP*DTP*DGP*DCP*DAP*DAP*DCP*DAP*DTP*DTP*DGP*D TP*DAP*DGP*DT)-3') DNA DM DOMAIN, DNA STRUCTURE, DOUBLESEX, PROTEIN-DNA RECOGNITION, SEX DETERMINATION 3fu2 nuc 2.85 CALCIUM ION 9(CA 2+) COCRYSTAL STRUCTURE OF A CLASS-I PREQ1 RIBOSWITCH PREQ1 RIBOSWITCH RNA RNA; APTAMER; RIBOSWITCH; QUEUOSINE; PREQ1 3gnk nuc 2.10 CALCIUM ION 2(CA 2+) CALCIUM BOUND TO THE HOLLIDAY JUNCTION SEQUENCE D(TCGGCGCCGA)4 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA HOLLIDAY JUNCTION CALCIUM ION CA2+, DNA 3i5e nuc 0.98 CALCIUM ION 2(CA 2+) ALLOSTERIC MODULATION OF DNA BY SMALL MOLECULES 5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G)-3' DNA DOUBLE STRANDED DNA, POLYAMIDE, DOUBLE HELIX 3i5l nuc 1.18 CALCIUM ION 5(CA 2+) ALLOSTERIC MODULATION OF DNA BY SMALL MOLECULES 5'-D(*CP*CP*AP*GP*GP*(C38)P*CP*TP*GP*G)-3' DNA CYCLIC POLYAMIDE, DNA BINDER, MINOR GROOVE BINDER, PYIM POLYAMIDE 3k1v nuc 2.20 CALCIUM ION 4(CA 2+) COCRYSTAL STRUCTURE OF A MUTANT CLASS-I PREQ1 RIBOSWITCH PREQ1 RIBOSWITCH RNA RNA; APTAMER; RIBOSWITCH; QUEUOSINE; PREQ1 3np6 nuc 2.30 CALCIUM ION CA 2+ THE CRYSTAL STRUCTURE OF BERBERINE BOUND TO DNA D(CGTACG) 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX, B-DNA, DNA 3nx5 nuc 2.31 CALCIUM ION CA 2+ THE CRYSTAL STRUCTURE OF SANGUINARINE BOUND TO DNA D(CGTACG) 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX, DNA 3omj nuc 0.95 CALCIUM ION 4(CA 2+) STRUCTURAL BASIS FOR CYCLIC PY-IM POLYAMIDE ALLOSTERIC INHIB NUCLEAR RECEPTOR BINDING 5'-D(*CP*(C38)P*AP*GP*TP*AP*CP*TP*GP*G)-3' DNA CYCLIC PY-IM POLYAMIDE, DNA 3r1e nuc 0.97 CALCIUM ION 2(CA 2+) CRYSTAL STRUCTURE OF GC(8BRG)GCGGC DUPLEX RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*C)-3') RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, 8-BROMOGUANOSINE, 3t86 nuc 1.90 CALCIUM ION CA 2+ D(GCATGCT) + CALCIUM DNA (5'-D(*GP*CP*AP*TP*GP*CP*T)-3') DNA QUADRUPLEX, LOOP, DNA 3t8p nuc 2.35 CALCIUM ION CA 2+ CRYSTAL STRUCTURE OF D(CGGGTACCCG)4 AS A FOUR-WAY HOLLIDAY J DNA (5'-D(*CP*GP*GP*GP*TP*AP*CP*CP*CP*G)-3') DNA DNA FOUR-WAY HOLLIDAY JUNCTION, RECOMBINATION, DNA 426d nuc 3.00 CALCIUM ION CA 2+ THE STRUCTURE OF MOST STUDIED DNA FRAGMENT CHANGES UNDER THE INFLUENCE OF IONS: A NEW PACKING OF D(CGCGAATTCGCG) 5'-D(CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DNA 463d nuc 1.45 CALCIUM ION 4(CA 2+) CALCIUM FORM OF D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA CA2+ BINDING, DICKERSON-DREW DODECAMER, DNA 476d nuc 1.30 CALCIUM ION 6(CA 2+) CALCIUM FORM OF B-DNA UNDECAMER GCGAATTCGCG 5'-D(*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA DODECAMER, CALCIUM FORM 477d nuc 1.70 CALCIUM ION 4(CA 2+) CALCIUM FORM OF THE B-DNA DODECAMER GGCGAATTCGCG 5'-D(*GP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA DODECAMER, CALCIUM FORM, DNA 478d nuc 2.20 CALCIUM ION 3(CA 2+) CRYSTAL STRUCTURE OF THE B-DNA DODECAMER 5'-D(CGCGAA(TAF)TCG TAF IS 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE 5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*TP*CP*GP*CP*G)-3' DNA B-DNA DODECAMER DUPLEX, CALCIUM CRYSTAL FORM, DNA 4d9x nuc 2.44 CALCIUM ION CA 2+ THE CRYSTAL STRUCTURE OF COPTISINE BOUND TO DNA D(CGTACG) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA DRUG-DNA COMPLEX, DOUBLE HELIX, DNA 4d9y nuc 2.10 CALCIUM ION CA 2+ THE CRYSTAL STRUCTURE OF CHELERYTHRINE BOUND TO DNA D(CGTACG DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA DRUG-DNA COMPLEX, DOUBLE HELIX, DNA 4e8k nuc 3.03 CALCIUM ION 26(CA 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND A NON-HYDROLYZED OLIGONUCLEOTIDE SUBSTRATE GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*CP*G*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, RNA 4e8t nuc 3.34 CALCIUM ION 25(CA 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND AN OLIGONUCLEOTIDE FRAGMENT SUBSTRATE (LOW DATASET) GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4faq nuc 3.11 CALCIUM ION 24(CA 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND 5'-EXON GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fs6 nuc 1.30 CALCIUM ION 5(CA 2+) CRYSTAL STRUCTURE OF THE Z-DNA HEXAMER CGCGCG AT 500 MM CACL DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, CA2+ BINDING, DNA 4meh nuc 3.12 CALCIUM ION 9(CA 2+) IN VITRO EVOLVED GLMS RIBOZYME TRIPLE MUTANT, CALCIUM ION CO GLMS TRIPLE MUTANT RIBOZYME, (122-MER) RIBOZYME RNA GLMS RIBOZYME FOLD, SELF-CLEAVAGE, TRANSESTERIFICATION, METALLORIBOZYME, RNA 4p43 nuc 2.00 CALCIUM ION 2(CA 2+) CRYSTAL STRUCTURE OF THE BACTERIAL A1408U-MUTANT RIBOSOMAL D SITE (C2 FORM 2) 5'-R(*UP*UP*GP*CP*GP*UP*CP*UP*CP*GP*UP*CP*GP*AP*C *GP*UP*CP*GP*C)-3' RNA RIBOSOME, ANTIBIOTIC-RESISTANCE, AMINOGLYCOSIDE, DECODING, R 4p97 nuc 1.86 CALCIUM ION 2(CA 2+) FUNCTIONAL CONSERVATION DESPITE STRUCTURAL DIVERGENCE IN LIG RESPONSIVE RNA SWITCHES RNA (5'-R(*CP*GP*AP*GP*AP*GP*GP*AP*CP*GP*G)-3'), RNA (5'-R(*CP*GP*UP*CP*UP*AP*CP*CP*CP*AP*CP*CP*UP 3') RNA VIRAL GENOME, INTERNAL RIBOSOME ENTRY SITE, TRANSLATION, RNA 4r48 nuc 2.33 CALCIUM ION CA 2+ RACEMIC CRYSTAL STRUCTURE OF A CALCIUM-BOUND DNA FOUR-WAY JU 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4r49 nuc 1.28 CALCIUM ION 7(CA 2+) RACEMIC CRYSTAL STRUCTURE OF A CALCIUM-BOUND B-DNA DUPLEX 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4rj1 nuc 0.92 CALCIUM ION 3(CA 2+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4rkv nuc 0.88 CALCIUM ION 2(CA 2+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4rne nuc 1.01 CALCIUM ION 8(CA 2+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4u3l nuc 1.48 CALCIUM ION 3(CA 2+) OCTAMERIC RNA DUPLEX CO-CRYSTALLIZED IN CALCIUM(II)CHLORIDE RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3') RNA RNA, DUPLEX, DI- AND TRIVALENT METAL IONS 4u78 nuc 1.50 CALCIUM ION 2(CA 2+) OCTAMERIC RNA DUPLEX SOAKED IN COPPER(II)CHLORIDE RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3') RNA RNA, DUPLEX, DIVALENT METAL IONS 4xqz nuc 2.15 CALCIUM ION 2(CA 2+) CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY CHLORIDE AND MES DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA 5dsa nuc 1.69 CALCIUM ION 2(CA 2+) CRYSTAL STRUCTURE OF HOLLIDAY JUNCTIONS STABILIZED BY 5-METH IN GCC JUNCTION CORE 5'-D(*CP*CP*GP*GP*CP*GP*5CMP*CP*GP*G)-3' DNA HOLLIDAY JUNCTION, 5-METHYLCYTOSINE, DNA 5dsb nuc 1.50 CALCIUM ION CA 2+ CRYSTAL STRUCTURE OF HOLLIDAY JUNCTIONS STABILIZED BY 5- HYDROXYMETHYLCYTOSINE IN GCC JUNCTION CORE 5'-D(*CP*CP*GP*GP*CP*GP*5HCP*CP*GP*G)-3' DNA HOLLIDAY JUNCTION, 5-HYDROXYMETHYLCYTOSINE, DNA 5ezf nuc 1.65 CALCIUM ION 2(CA 2+) RACEMIC CRYSTAL STRUCTURES OF PRIBNOW BOX CONSENSUS PROMOTER (PBCA) PRIBNOW BOX TEMPLATE STRAND, COMPLEMENTARY STRAND DNA PRIBNOW BOX CONSENSUS SEQUENCE, -10 ELEMENT, TRANSCRIPTION INITIATION, B-DNA DOUBLE HELIX, DNA DOUBLE HELIX, DNA 5i4s nuc 2.46 CALCIUM ION 8(CA 2+) NON-NATURAL DNA PAIR Z (6-AMINO-5-NITRO-2[1H] PYRIDONE HETER GUANOSINE DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(D8Z)P*GP*CP*G)- CHAIN: A, B DNA NON-NATURAL NUCLEOTIDE BASE, SYNTHETIC BIOLOGY, 6-AMINO-5-NI PYRIDONE HETEROCYCLE), DNA 5ihd nuc 1.57 CALCIUM ION 2(CA 2+) CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY L-LACTATE AND SUCCINATE DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA 5ktv nuc 2.35 CALCIUM ION 9(CA 2+) MIS-PAIRING OF UNNATURAL BASE Z-G DNA DUPLEX AT PH 8.5 DNA (5'-D(P*GP*CP*GP*AP*AP*TP*TP*(1W5)P*GP*CP*G)- CHAIN: A, B DNA UNNATURAL DNA BASES, SYNTHETIC BIOLOGY, DNA 5lj4 nuc 2.17 CALCIUM ION 4(CA 2+) CRYSTAL STRUCTURE OF DNA DUPLEX CONTAINING ZP BASE PAIR ODN2 DNA SYNTHETIC NUCLEOTIDE, DNA
Code Class Resolution Description 1d61 nuc 1.30 CACODYLATE ION C2 H6 AS O2 1- THE STRUCTURE OF THE B-DNA DECAMER C-C-A-A-C-I-T-T-G-G: MONO FORM DNA (5'-D(*CP*CP*AP*AP*CP*IP*TP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA 2a2t nuc 3.10 CACODYLATE ION 6(C2 H6 AS O2 1-) CRYSTAL STRUCTURE OF D(AAATATTT) 5'-D(*AP*AP*AP*TP*AP*TP*TP*T)-3' DNA AT, MN, CACODYLATE, HASO, DNA 2avj nuc 2.39 CACODYLATE ION 2(C2 H6 AS O2 1-) G4(BR)UTTG4 DIMERIC QUADRUPLEX 5'-D(*GP*GP*GP*GP*(BRU)P*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, LOOP, DNA 2x2q nuc 1.90 CACODYLATE ION C2 H6 AS O2 1- CRYSTAL STRUCTURE OF AN 'ALL LOCKED' LNA DUPLEX AT 1.9 ANGST RESOLUTION LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX, LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX DNA DNA, MODIFIED NUCLEIC ACID, LOCKED NUCLEIC ACID, THERMOSTABI 3gsk nuc 1.60 CACODYLATE ION C2 H6 AS O2 1- A BULKY RHODIUM COMPLEX BOUND TO AN ADENOSINE-ADENOSINE DNA 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*AP*CP*CP*G)-3' DNA DNA MISMATCH, METALLOINTERCALATOR, DNA RECOGNITION, DNA 4xwf nuc 1.80 CACODYLATE ION C2 H6 AS O2 1- CRYSTAL STRUCTURE OF THE ZMP RIBOSWITCH AT 1.80 ANGSTROM PFL RNA RNA RNA, RIBOSWITCH, ZMP, AICAR 5kek nuc 3.10 CACODYLATE ION 2(C2 H6 AS O2 1-) STRUCTURE DETERMINATION OF A SELF-ASSEMBLING DNA CRYSTAL DNA (5'-D(P*GP*GP*TP*CP*TP*GP*C)-3'), DNA (5'- D(*GP*AP*GP*CP*AP*GP*AP*CP*CP*TP*GP*AP*CP*GP*AP*CP*AP*CP*TP 3'), DNA (5'-D(P*CP*GP*TP*CP*A)-3'), DNA (5'-D(*TP*CP*TP*GP*AP*GP*TP*GP*T)-3') DNA STRUCTURAL DNA NANOECHNOLOGY, SELF-ASSEMBLED CRYSTALS, SELF- DNA 5keo nuc 3.15 CACODYLATE ION 2(C2 H6 AS O2 1-) STRUCTURE DETERMINATION OF A SELF-ASSEMBLING DNA CRYSTAL DNA (5'- D(*GP*AP*GP*CP*AP*GP*AP*CP*CP*TP*GP*AP*CP*GP*AP*CP*AP*CP*TP 3'), DNA (5'-D(P*GP*GP*TP*CP*TP*GP*C)-3'), DNA (5'-D(P*CP*GP*TP*CP*A)-3'), DNA (5'-D(*TP*CP*TP*GP*AP*GP*TP*GP*T)-3') DNA STRUCTURAL DNA NANOECHNOLOGY, SELF-ASSEMBLED CRYSTALS, SELF- DNA
Code Class Resolution Description 170d nuc NMR CYTOSINE ARABINOSE-5'-PHOSPHATE 2(C9 H14 N3 O8 P) SOLUTION STRUCTURE OF A DNA DODECAMER CONTAINING THE ANTI- NEOPLASTIC AGENT ARABINOSYLCYTOSINE: COMBINED USE OF NMR, RESTRAINED MOLECULAR DYNAMICS AND FULL RELAXATION MATRIX REFINEMENT DNA/RNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*T)-R(P*CAR)- D(P*GP*CP*G)-3') DNA DNA 1ho6 nuc NMR CYTOSINE ARABINOSE-5'-PHOSPHATE 2(C9 H14 N3 O8 P) CHIMERIC ARABINONUCLEIC ACID (ANA) HAIRPIN WITH ANA/RNA HYBRID STEM DNA/RNA (5'-R(*GP*GP*AP*C)-D(P*TP*TP*CP*G)- (P*(GAO)P*(UAR)P*(CAR)P*(CAR)-3') DNA, RNA ARABINONUCLEIC ACID, RNA, HAIRPIN, DNA 2kp3 nuc NMR CYTOSINE ARABINOSE-5'-PHOSPHATE C9 H14 N3 O8 P STRUCTURE OF ANA-RNA HYBRID DUPLEX RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3'), RNA (5'-R(*(GAO)P*(CAR)P*(UAR)P*(A5O)P*(UAR)P*(A5 P*(UAR)P*(GAO)P*(GAO))-3') RNA ANA, ARABINONUCLEIC ACID, NUCLEIC ACID STRUCTURE, NMR/MD/TI, DUPLEX, RNA
Code Class Resolution Description 101d nuc 2.25 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) REFINEMENT OF NETROPSIN BOUND TO DNA: BIAS AND FEEDBACK IN ELECTRON DENSITY MAP INTERPRETATION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 154d nuc 2.50 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) DNA DISTORTION IN BIS-INTERCALATED COMPLEXES DNA (5'-D(*(CBR)P*GP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1dn4 nuc 1.60 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 6(C9 H13 BR N3 O7 P) SOLVATION OF THE LEFT-HANDED HEXAMER D(5BRC-G-5BRC-G-5BRC- G) IN CRYSTALS GROWN AT TWO TEMPERATURES DNA (5'-D(*(CBR)P*GP*(CBR)P*GP*(CBR)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1dn5 nuc 1.40 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 6(C9 H13 BR N3 O7 P) SOLVATION OF THE LEFT-HANDED HEXAMER D(5BRC-G-5BRC-G-5BRC- G) IN CRYSTALS GROWN AT TWO TEMPERATURES DNA (5'-D(*(CBR)P*GP*(CBR)P*GP*(CBR)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1em0 nuc 0.90 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C9 H13 BR N3 O7 P) COMPLEX OF D(CCTAGG) WITH TETRA-[N-METHYL-PYRIDYL] PORPHYRIN DNA (5'-D(*(CBR)P*CP*TP*AP*GP*G)-3') DNA PORPHYRIN, RUFFLING, DNA DISTORTION, GROOVE BINDING 1f6j nuc 2.25 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF THE E-DNA HEXAMER GGCGBR5CC DNA (5'-D(*GP*GP*CP*GP*(CBR)P*C)-3') DNA E-DNA, DOUBLE HELIX, METHYLATION 1fuf nuc 1.70 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF A 14BP RNA OLIGONUCLEOTIDE CONTAINING DOUBLE UU BULGES: A NOVEL INTRAMOLECULAR U*(AU) BASE TRIPLE (5'-R(*GP*GP*UP*AP*UP*UP*UP*CP*GP*GP*UP*AP*(CBR) P*C)-3') RNA BULGE, BASE TRIPLE, RNA, CRYSTAL 1ih2 nuc 2.80 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF GGBR5CGBR5CC 5'-D(*GP*GP*(CBR)P*GP*(CBR)P*C)-3' DNA B TO A DNA TRANSITION, DNA TRANSITION, STRUCTURAL TRANSITION 1ih6 nuc 1.45 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 8(C9 H13 BR N3 O7 P) MULTI-CONFORMATION CRYSTAL STRUCTURE OF GGBR5CGCC 5'-D(*GP*GP*(CBR)P*GP*CP*C)-3' DNA B TO A DNA TRANSITION, DNA TRANSITION, STRUCTURAL TRANSITION 1ik5 nuc 1.80 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF A 14MER RNA CONTAINING DOUBLE UU BULGES IN TWO CRYSTAL FORMS: A NOVEL U*(AU) INTRAMOLECULAR BASE TRIPLE 5'-R(*GP*GP*UP*AP*UP*UP*UP*UP*GP*GP*UP*AP*(CBR) P*C)-3', 5'-R(*GP*GP*UP*AP*UP*UP*UP*CP*GP*GP*UP*AP*(CBR) P*C)-3' RNA X-RAY STRUCTURE, RNA DUPLEX, UU-BULGES, BASE TRIPLE, KINK 1j9h nuc 1.40 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF AN RNA DUPLEX WITH URIDINE BULGES 5'-R(*GP*UP*GP*UP*CP*GP*(CBR)P*AP*C)-3' RNA URIDINE BULGE, RNA DUPLEX, A-FORM, KINK, METAL BINDING 1p1y nuc 2.10 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P CRYSTAL STRUCTURE OF A CONTINUOUS THREE-DIMENSIONAL DNA LATT D(GGACAGATGGGAG) 5'-D(*GP*GP*AP*(CBR)P*AP*GP*AP*(BRU)P*GP*GP*GP*AP CHAIN: X DNA CONTINUOUS THREE-DIMENSIONAL DNA LATTICE, PARALLEL-STRANDED PAIRS, DNA 1uhx nuc 2.00 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P CRYSTAL STRUCTURE OF D(GCGAGAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID 1uhy nuc 1.70 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P CRYSTAL STRUCTURE OF D(GCGATAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*TP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID 1v3n nuc 1.80 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DNA QUADRUPLEX STRUCTURE SPLIT FROM THE OCTAPLEX 5'-D(*GP*(CBR)P*GP*AP*GP*AP*GP*C)-3' DNA OCTAPLEX, QUADRUPLEX, G-DUET, BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DEOXYRIBONUCLEIC ACID, X-RAY ANALYSIS, CRYSTAL STRUTURE 1vtf nuc 2.00 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C9 H13 BR N3 O7 P) STRUCTURE OF 5'-D(*(BRO)CP*GP*(BRO)CP*G)-3' IN COMPLEX WITH DNA (5'-D(*(BRO)CP*GP*(BRO)CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE DEOXYRIBONUCLEIC ACID, DNA 238d nuc 2.00 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P CRYSTAL STRUCTURE OF THE DNA DECAMER D(AGG(BR)CATGCCT): COMPARISON WITH D(AGGCATGCCT) AND IMPLICATIONS FOR COBALT HEXAMMINE BINDING TO DNA DNA (5'-D(*AP*GP*GP*(CBR)P*AP*TP*GP*CP*CP*T)-3') DNA A-DNA, DOUBLE HELIX, FLIPPED-OUT BASES, BASE TRIPLET 242d nuc 1.65 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) MAD PHASING STRATEGIES EXPLORED WITH A BROMINATED OLIGONUCLEOTIDE CRYSTAL AT 1.65 A RESOLUTION. DNA (5'-D(*CP*GP*CP*GP*(CBR)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 2fza nuc 3.60 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF D(GCGGGAGC): THE BASE-INTERCALATED DUPLEX 5'-D(*GP*(CBR)P*GP*GP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DNA HEXAPLEX, DEOXYRIBONUCLEIC ACID 2g91 nuc 1.50 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE AN RNA NONAMER R(GGUGCGC) D(BRC)R(C) 5'-R(*GP*GP*UP*GP*CP*GP*CP*(CBR)P*C-3' RNA RNA DOUBLE HELIX 2got nuc 2.60 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF D(GCGAACGC): TWO TYPES OF BULGE- CONTAINING DUPLEXES DNA (5'-D(*DGP*(CBR)P*DGP*DAP*DAP*DCP*DGP*DC)- 3') DNA INTRA-DUPLEX AND INTER-DUPLEX HAND-IN-POCKET MOTIFS, BULGE- CONTAINING DUPLEX, BASE-INTERCALATED DUPLEX, SINGLE STRANDED DNA, DNA, X-RAY STRUCTURE, CRYSTAL STRUCTURE 2gun nuc 2.80 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P RNA-BINDING AFFINITIES AND CRYSTAL STRUCTURE OF OLIGONUCLEOTIDES CONTAINING FIVE-ATOM AMIDE-BASED BACKBONE STRUCTURES 5'-D(*TP*TP*CP*(T2T)P*(CBR)P*TP*TP*C)-3', 5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*A)-3' DNA/RNA DNA:RNA HYBRID, AMIDE BEARING DNA, THYMIDINE DIMERS, INTERNUCLEOSIDIC AMIDE LINKAGE, DNA, RNA, DNA/RNA COMPLEX 2pis nuc 2.80 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 12(C9 H13 BR N3 O7 P) EFFORTS TOWARD EXPANSION OF THE GENETIC ALPHABET: STRUCTURE AND REPLICATION OF UNNATURAL BASE PAIRS DNA (5'-D(*CP*GP*(CBR)P*GP*AP*AP*(FFD) P*TP*TP*CP*GP*CP*G)-3') DNA NUCLEIC ACID, DUPLEX, REPLICATION, UNNATURAL BASE, DNA 318d nuc 2.00 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURES OF D(CCGGGCC(BR)5CGG)-HEXAGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*(CBR)P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 319d nuc 2.20 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURES OF D(CCGGG(BR)5CCCGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*(CBR)P*CP*CP*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 358d nuc 2.50 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF THE 2:1 NETROPSIN-DNA DECAMER D(CBRCCCCIIIII) COMPLEX WITH END-TO-END BINDING DNA (5'-D(*CP*(CBR)P*CP*CP*CP*IP*IP*IP*IP*I)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 365d nuc 2.00 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) STRUCTURAL BASIS FOR G C RECOGNITION IN THE DNA MINOR GROOVE DNA (5'-D(*CP*CP*AP*GP*GP*(CBR)P*CP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 376d nuc 2.10 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P A ZIPPER-LIKE DNA DUPLEX D(GCGAAAGCT) DNA (5'-D(*GP*(CBR)P*GP*AP*AP*AP*GP*CP*T)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, OVERHANGING BASE, MODIFIED, MISMATCHED 380d nuc 2.00 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) BINDING OF THE MODIFIED DAUNORUBICIN WP401 ADJACENT TO A T-G INDUCES THE REVERSE WATSON-CRICK CONFORMATION: CRYSTAL STRU THE WP401-TGGCCG AND WP401-CGG[BR5C]CG COMPLEXES DNA (5'-D(*CP*GP*(G49)P*(CBR)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, MODIFIED, DNA 3bna nuc 3.00 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) REVERSIBLE BENDING AND HELIX GEOMETRY IN A B-DNA DODECAMER: CGCGAATTBRCGCG DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 421d nuc 1.80 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P 5'-D(*TP*TP*CP*TP*TP*(BRO)CP*TP*TP*C)-3', 5'- R(*GP*AP*AP*GP*AP*AP*GP*AP*A)-3' RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*A)-3'), DNA (5'-D(*TP*TP*CP*TP*TP*(CBR)P*TP*TP*C)-3') DNA-RNA HYBRID DNA:RNA HYBRID DUPLEX, DNA-RNA COMPLEX, DNA-RNA HYBRID 458d nuc 2.30 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P DNA MINOR-GROOVE RECOGNITION OF A TRIS-BENZIMIDAZOLE DRUG BY A NON-SELF-COMPLEMENTARY AT-RICH SEQUENCE DNA (5'-D(*CP*GP*(CBR) P*AP*TP*AP*TP*TP*TP*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*AP*TP*GP*CP*G)- 3') DNA B-DNA, DEOXYRIBONUCLEIC ACID 459d nuc 2.30 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE C9 H13 BR N3 O7 P DNA MINOR-GROOVE RECOGNITION OF A TRIS-BENZIMIDAZOLE DRUG DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*AP*TP*GP*CP*G)- 3'), DNA (5'-D(*CP*GP*(CBR) P*AP*TP*AP*TP*TP*TP*GP*CP*G)-3') DNA MINOR GROOVE BINDING, B-DNA, COMPLEXED WITH TRIS- BENZIMIDAZOLE, DEOXYRIBONUCLEIC ACID 474d nuc 2.40 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C9 H13 BR N3 O7 P) A NOVEL END-TO-END BINDING OF TWO NETROPSINS TO THE DNA DECAMER D(CCCCCIIIII)2 DNA (5'-D(*CP*CP*CP*(CBR)P*CP*IP*IP*IP*IP*I)-3') DNA B-DNA/RNA, DOUBLE HELIX, DOUBLE DRUG IN MINOR GROOVE, COMPLEXED WITH DRUG, MODIFIED, MISMATCHED 4bna nuc 2.30 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) REVERSIBLE BENDING AND HELIX GEOMETRY IN A B-DNA DODECAMER: CGCGAATTBRCGCG DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 4l26 nuc 1.40 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF DNA DUPLEX CONTAINING CONSECUTIVE T-T M (BR-DERIVATIVE) DNA (5'-D(*CP*GP*(CBR)P*GP*AP*TP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA T-T MISPAIR, A-T-T TRIPLET, NON-HELICAL DNA DUPLEX, DNA 5ay2 nuc 1.30 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 4(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF RNA DUPLEX CONTAINING C-AG(I)-C BASE PA RNA (5'-R(*GP*GP*AP*CP*UP*(CBR)P*GP*AP*CP*UP*CP*C CHAIN: A, B, C, D RNA RNA, METALLO BASE PAIR, AG(I) 5ay3 nuc 1.20 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF RNA DUPLEX CONTAINING C-C BASE PAIRS RNA (5'-R(*GP*GP*AP*CP*UP*(CBR)P*GP*A*CP*UP*CP*C) CHAIN: A, B RNA RNA, X-RAY ANALYSIS, METALLO BASE PAIR, AG(I) 5ay4 nuc 1.70 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) CRYSTAL STRUCTURE OF RNA DUPLEX CONTAINING C-C BASE PAIRS OB THE PRESENCE OF HG(II) RNA (5'-R(*GP*GP*AP*CP*UP*(CBR)P*GP*AP*CP*UP*CP*C CHAIN: A, B RNA RNA, X-RAY ANALYSIS, METALLO BASE PAIR, AG(I), HG(II) 6bna nuc 2.21 5-BROMO-2'-DEOXY-CYTIDINE-5'-MONOPHOSPHATE 2(C9 H13 BR N3 O7 P) BINDING OF AN ANTITUMOR DRUG TO DNA. NETROPSIN AND C-G-C-G- A-A-T-T-BRC-G-C-G DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 1lnt nuc 1.70 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H13 BR N3 O8 P) CRYSTAL STRUCTURE OF THE HIGHLY CONSERVED RNA INTERNAL LOOP 5'-R(*GP*CP*GP*UP*CP*AP*GP*GP*UP*CP*(CBV)P*G)-3', 5'-R(*CP*GP*GP*AP*AP*GP*CP*AP*GP*(CBV)P*GP*C)-3' RNA SRP, INTERNAL LOOP, MISPAIR, RNA 1qbp nuc 2.10 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 12(C9 H13 BR N3 O8 P) CRYSTAL STRUCTURE OF A BROMINATED RNA HELIX WITH FOUR MISMATCHED BASE PAIRS 5'-R(*UP*GP*(CBV)P*(CBV) P*AP*GP*UP*UP*CP*GP*CP*UP*GP*GP*C)-3' RNA BROMINATED CYTOSINE, MISMATCHED BASE PAIRS, RNA 430d nuc 2.10 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 BR N3 O8 P STRUCTURE OF SARCIN/RICIN LOOP FROM RAT 28S RRNA SARCIN/RICIN LOOP FROM RAT 28S R-RNA RNA U-RNA, DOUBLE HELIX, HAIRPIN, BLUNT STEM, TETRALOOP MISMATCH TRIPLE, RIBONUCLEIC ACID, RNA 5d8t nuc 1.20 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H13 BR N3 O8 P) RNA OCTAMER CONTAINING (S)-5' METHYL, 2'-F U. RNA OLIGONUCLEOTIDE CONTAINING (S)-C5'-ME-2'-FU RNA RNA, MODIFIED BASE 5ndh nuc 1.81 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 4(C9 H13 BR N3 O8 P) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P2 RNA (5'-R(*GP*(CBV) P*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*GP*C)-3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA 5ndi nuc 2.57 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 4(C9 H13 BR N3 O8 P) THE STRUCTURE OF THE E.COLI GUANIDINE II RIBOSWITCH P1 STEM- RNA (5'- R(*UP*UP*UP*GP*CP*AP*GP*GP*AP*CP*GP*AP*CP*CP*UP*GP*(CBV)P*A 3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA 5nef nuc 1.91 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 BR N3 O8 P THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5neo nuc 1.69 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 BR N3 O8 P THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5nep nuc 1.60 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 BR N3 O8 P THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH METHYLGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, METHYLGUANIDINE, RNA 5neq nuc 1.69 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 BR N3 O8 P THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH AMINOGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, AMINOGUANIDINE, RNA 5nex nuc 1.72 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 BR N3 O8 P THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH AGMATINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA, 5nom nuc 1.93 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 BR N3 O8 P THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5t5a nuc 2.00 5-BROMOCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H13 BR N3 O8 P) CRYSTAL STRUCTURE OF THE TWISTER SISTER (TS) RIBOZYME AT 2.0 DNA/RNA (71-MER) RNA RNA JUNCTION CATALYSIS, RNA
Code Class Resolution Description 2gdi nuc 2.05 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWI COMPLEX WITH THIAMINE PYROPHOSPHATE TPP RIBOSWITCH: SENSING DOMAIN RNA RIBOSWITCH, THIAMINE PYROPHOSPHATE, RNA 2quw nuc 2.20 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) HAMMERHEAD RIBOZYME G12A MUTANT AFTER CLEAVAGE HAMMERHEAD RIBOZYME, CLEAVED FRAGMENT, HAMMERHEAD RIBOZYME, CLEAVED FRAGMENT RNA HAMMERHEAD RIBOZYME, RIBOZYME, CATALYTIC RNA, RIBOZYME-PRODU COMPLEX, RNA 3dig nuc 2.80 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO S-(2-AMINOETHYL)-L-CYSTEINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dil nuc 1.90 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dim nuc 2.90 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, CS+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dio nuc 2.40 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO LYSINE, IRIDIUM HEXAMINE SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diq nuc 2.70 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO HOMOARGININE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dir nuc 2.90 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH N6-1-IMINOETHYL-L-LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dis nuc 3.10 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH FORM RNA (174-MER) RNA FREE FORM, RIBOSWITCH, RNA 3dix nuc 2.90 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, K+ ANOMALOUS DATA RNA (174-MER) RNA RIBOSWITCH, LYSINE, POTASSIUM CATION, RNA 3diy nuc 2.71 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, MN2+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diz nuc 2.85 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE IN THE ABSENCE OF MG2+ RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dj0 nuc 2.50 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH L-4-OXALYSINE RNA (174-MER) RNA LYSINE RIBSOWITCH, OXALYSINE, RNA 3dj2 nuc 2.50 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, TL+ SOAK RNA (174-MER) RNA LYSINE, RIBOSWITCH, RNA 3f2q nuc 2.95 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2t nuc 3.00 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, IRIDIU SOAK. FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2w nuc 3.45 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, BA2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, BARIUM, RNA 3f2x nuc 3.11 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, CS+ SO FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, CESIUM, RNA 3f2y nuc 3.20 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, MN2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, MANGANESE, RNA 3f30 nuc 3.15 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, COBALT SOAK. FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, COBALT HEXAMINE, RNA 3owi nuc 2.85 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oww nuc 2.80 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3owz nuc 2.95 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN IRIDIUM DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION, GLYCINE RIBOSWITCH, RNA 3ox0 nuc 3.05 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, UNBOUND STATE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxb nuc 2.95 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH WITH SINGLE MUTATION DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxd nuc 3.00 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH WITH TWO MUTATIONS DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxe nuc 2.90 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, MN2+ SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxj nuc 3.20 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN BA2+ DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxm nuc 2.95 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, TL-ACETATE SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3ski nuc 2.30 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE RNA (68-MER), RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skl nuc 2.90 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, IRIDIUM HEXAMMINE SOAK RNA (66-MER) RNA THREE WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skr nuc 3.10 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, COBALT HEXAMMINE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skt nuc 3.10 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, MANGANESE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY-GUANOSINE, RNA 3skw nuc 2.95 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, CESIUM SOAK RNA (66-MER) RNA THREE-WAY RNA JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3skz nuc 2.60 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slm nuc 2.70 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slq nuc 2.50 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3suh nuc 2.65 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THF RIBOSWITCH, BOUND WITH 5-FORMYL-THF RIBOSWITCH RNA THREE-WAY JUNCTION, PSEUDOKNOT, GENE REGULATOR, THF, RNA 3sux nuc 2.90 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THF RIBOSWITCH, BOUND WITH THF RIBOSWITCH RNA THREE-WAY JUNCTION, PSEUDOKNOT, GENE REGULATOR, THF, RNA 3suy nuc 3.21 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CRYSTAL STRUCTURE OF THF RIBOSWITCH, UNBOUND STATUS RIBOSWITCH RNA THREE-WAY JUNCTION, PSEUDOKNOT, GENE REGULATOR, RNA 488d nuc 3.10 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 CATALYTIC RNA ENZYME-PRODUCT COMPLEX SECOND RNA FRAGMENT OF CLEAVED SUBSTRATE, FIRST RNA FRAGMENT OF CLEAVED SUBSTRATE, RNA RIBOZYME STRAND, UNCLEAVED RNA SUBSTRATE RNA CATALYTIC RNA, RIBOZYME, ENZYME-PRODUCT COMPLEX, CRYSTAL LATTICE TRAPPING 4gxy nuc 3.05 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 RNA STRUCTURE ADENOSYLCOBALAMIN RIBOSWITCH RNA RNA, RIBOSWITCH, ADENOSYLCOBALAMIN 4nya nuc 2.65 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (AZIDOMETHYL)-2-METHYLPYRIMIDIN-4-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4ts0 nuc 2.80 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH BARIUM IONS SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT, SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA 4ts2 nuc 2.88 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH MAGNESIUM IONS SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT, SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA 4wfl nuc 2.49 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE C9 H13 N3 O10 P2 STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN RNA: RESIDUES 3-81,RESIDUES 3-81 RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST 4wfm nuc 3.10 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN BACILLUS SUBTILIS SMALL CYTOPLASMIC RNA (SCRNA),R CHAIN: A, B RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST 5lys nuc 2.32 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - GOLD DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA 5lyu nuc 2.20 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) THE NATIVE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN RNA (58-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA 5lyv nuc 2.35 CYTIDINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE 2(C9 H13 N3 O10 P2) THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - OSMIUM DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
Code Class Resolution Description 1qms nuc NMR CALICHEAMICIN GAMMA-1-OLIGOSACCHARIDE 2(C38 H61 I N2 O17 S) HEAD-TO-TAIL DIMER OF CALICHEAMICIN GAMMA-1-I OLIGOSACCHARIDE BOUND TO DNA DUPLEX, NMR, 9 STRUCTURES DNA (5'-D(*GP*CP*AP*CP*CP*TP*TP*CP*CP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*GP*GP*AP*AP*GP*GP*TP*GP*C)-3') DNA DEOXYRIBONUCLEIC ACID/CALICHEAMICIN, CALICHEAMICIN, HEAD-TO-TAIL DIMER, DNA, MINOR GROOVE BINDING, ANTITUMOR AGENT, LIGAND-DNA COMPLEX, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1ykq nuc 3.50 CADMIUM ION 5(CD 2+) CRYSTAL STRUCTURE OF DIELS-ALDER RIBOZYME DIELS-ALDER RIBOZYME, DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND, CATALYTIC MECHANISM, RNA CRYSTAL STRUCTU DIELS-ALDER REACTION, RIBOZYME, RNA 488d nuc 3.10 CADMIUM ION 8(CD 2+) CATALYTIC RNA ENZYME-PRODUCT COMPLEX SECOND RNA FRAGMENT OF CLEAVED SUBSTRATE, FIRST RNA FRAGMENT OF CLEAVED SUBSTRATE, RNA RIBOZYME STRAND, UNCLEAVED RNA SUBSTRATE RNA CATALYTIC RNA, RIBOZYME, ENZYME-PRODUCT COMPLEX, CRYSTAL LATTICE TRAPPING
Code Class Resolution Description 1d83 nuc NMR 2,3-DIDEOXYFUCOSE 4(C6 H12 O3) STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION DNA (5'-D(*AP*AP*GP*GP*CP*CP*TP*T)-3') DNA DNA, NMR, DOUBLE HELIX, CHROMOMYCIN 1vaq nuc 2.00 2,3-DIDEOXYFUCOSE 8(C6 H12 O3) CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA) 2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION 5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3' DNA CHROMOMYCIN A3, X-RAY DIFFRACTION, MAD, DNA DUPLEX, GGCC SITE, DNA KINK, CD SPECTRA 5erz nuc 1.75 2,3-DIDEOXYFUCOSE 4(C6 H12 O3) CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX 5es0 nuc 2.10 2,3-DIDEOXYFUCOSE 4(C6 H12 O3) CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX
Code Class Resolution Description 1fc8 nuc NMR 4-AMINO-1-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE 2(C9 H13 F N3 O7 P) NMR SOLUTION STRUCTURE OF A CHIMERIC OLIGONUCLEOTIDE HAIRPIN R(GGAC)D(TTCG)2'F-A(GTCC) 5'-R(*GP*GP*AP*CP)D(*TP*TP*CP*GP*(GFL)P*(TAF) P*(CFL)P*(CFL))-3' RNA/DNA CHIMERA 2'F-ARABINONUCLEIC ACID, RNA, DNA, HYBRID DUPLEX, HAIRPIN, RNA/DNA CHIMERA COMPLEX 2kp4 nuc NMR 4-AMINO-1-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE C9 H13 F N3 O7 P STRUCTURE OF 2'F-ANA/RNA HYBRID DUPLEX DNA (5'-D(*(GFL)P*(CFL)P*(TAF)P*(A5L)P*(TAF)P*(A5 P*(TAF)P*(GFL)P*(GFL))-3'), RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3') DNA/RNA 2-DEOXY-2-FLUORO-D-ARABINOSE, FANA, NUCLEIC ACID STRUCTURE, NMR/MD/TI, HYBRID DUPLEX, DNA-RNA COMPLEX 2lsc nuc NMR 4-AMINO-1-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE 8(C9 H13 F N3 O7 P) SOLUTION STRUCTURE OF 2'F-ANA AND ANA SELF-COMPLEMENTARY DUP DNA (5'-D(*(CFL)P*(GFL)P*(CFL)P*(GFL)P*(A5O)P*(A5 P*(UAR)P*(CFL)P*(GFL)P*(CFL)P*(GFL))-3') DNA DNA, DICKERSON DREW DODECAMER 2m84 nuc NMR 4-AMINO-1-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE 4(C9 H13 F N3 O7 P) STRUCTURE OF 2'F-RNA/2'F-ANA CHIMERIC DUPLEX 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA 2'F-RNA/2'F-ANA CHIMERIC DUPLEX, A-FORM, 12-MER, DICKERSON D DODECAMER, MODIFIED NUCLEOTIDES, DNA, RNA 2m8a nuc NMR 4-AMINO-1-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE 4(C9 H13 F N3 O7 P) 2'F-ANA/2'F-RNA ALTERNATED SEQUENCES 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA A-FORM, 12-MER, DICKERSON DREW DODECAMER, MODIFIED NUCLEOTID RNA 2n89 nuc NMR 4-AMINO-1-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE 8(C9 H13 F N3 O7 P) TETRAMERIC I-MOTIF STRUCTURE OF DT-DC-DC-CFL-CFL-DC AT ACIDI DNA (5'-D(*TP*CP*CP*(CFL)P*(CFL)P*C)-3') DNA 2'F-ARAC, I-MOTIF, 2'F-ANA, MODIFIED NUCLEOTIDES, DNA
Code Class Resolution Description 2kwg nuc NMR 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H13 F N3 O7 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 2m84 nuc NMR 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 4(C9 H13 F N3 O7 P) STRUCTURE OF 2'F-RNA/2'F-ANA CHIMERIC DUPLEX 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA 2'F-RNA/2'F-ANA CHIMERIC DUPLEX, A-FORM, 12-MER, DICKERSON D DODECAMER, MODIFIED NUCLEOTIDES, DNA, RNA 2m8a nuc NMR 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 4(C9 H13 F N3 O7 P) 2'F-ANA/2'F-RNA ALTERNATED SEQUENCES 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA A-FORM, 12-MER, DICKERSON DREW DODECAMER, MODIFIED NUCLEOTID RNA 3p4a nuc 1.20 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 12(C9 H13 F N3 O7 P) 2'FLUORO MODIFIED RNA OCTAMER FA2U2 2'FLUORO MODIFIED RNA 8-MER RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, 2'-FLUORO 2'- DEOXYADENOSINE, 2'-FLUORO 2'-DEOXYURIDINE, SIRNA 3p4b nuc 1.45 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 12(C9 H13 F N3 O7 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-P3 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA 3p4c nuc 1.15 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 4(C9 H13 F N3 O7 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-R32 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA 3p4d nuc 1.85 2'-DEOXY-2'-FLUOROCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 4(C9 H13 F N3 O7 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RC4G4 5'-R(*(CFZ)P*CP*(CFZ)P*CP*(GF2)P*GP*(GF2)P*G)-3' RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, SIRNA
Code Class Resolution Description 1m6f nuc 1.78 3-[C-[N'-(3-CARBAMIMIDOYL-BENZYLIDENIUM)-HYDRAZINO]- [[AMINOMETHYLIDENE]AMINIUM]-IMINOMETHYL]-BENZAMIDINIUM C17 H22 N9 3+ STRONG BINDING IN THE DNA MINOR GROOVE BY AN AROMATIC DIAMIDINE WITH A SHAPE THAT DOES NOT MATCH THE CURVATURE OF THE GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA NUCLEIC ACIDS, MINOR GROOVE BINDER, DOUBLE HELIX, DNA-DRUG COMPLEX
Code Class Resolution Description 1kos nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ SOLUTION NMR STRUCTURE OF AN ANALOG OF THE YEAST TRNA PHE T STEM LOOP CONTAINING RIBOTHYMIDINE AT ITS NATURALLY OCCURRING POSITION 5'-R(*CP*UP*GP*UP*GP*(5MU)P*UP*CP*GP*AP*UP*(CH) P*CP*AP*CP*AP*G)- 3': TPSIC DOMAIN OF TRNA RNA TRNA, T STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, RNA FOLDING 1kpy nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ PEMV-1 P1-P2 FRAMESHIFTING PSEUDOKNOT, 15 LOWEST ENERGY STRUCTURES P1-P2 FRAMESHIFTING PSEUDOKNOT RNA PSEUDOKNOT, NMR, FRAMESHIFTING, LUTEOVIRUS, TRIPLE HELIX, PROTONATED CYTIDINE, RIBONUCLEIC ACID, RNA 1kpz nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ PEMV-1 P1-P2 FRAMESHIFTING PSEUDOKNOT REGULARIZED AVERAGE STRUCTURE P1-P2 FRAMESHIFTING PSEUDOKNOT RNA PSEUDOKNOT, NMR, FRAMESHIFTING, LUTEOVIRUS, TRIPLE HELIX, PROTONATED CYTIDINE, RIBONUCLEIC ACID, RNA 1yg3 nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ SOLUTION STRUCTURE OF THE SCYLV P1-P2 FRAMESHIFTING PSEUDOKNOT, 20 LOWEST ENERGY STRUCTURES SCYLV RNA PSEUDOKNOT RNA RNA PSEUDOKNOT; RIBOSOMAL FRAMESHIFTING; PROTONATED CYTIDINE 1yg4 nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ SOLUTION STRUCTURE OF THE SCYLV P1-P2 FRAMESHIFTING PSEUDOKNOT, REGULARIZED AVERAGE STRUCTURE SCYLV RNA PSEUDOKNOT RNA RNA PSEUDOKNOT; RIBOSOMAL FRAMESHIFTING; PROTONATED CYTIDINE 2ap0 nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ SOLUTION STRUCTURE OF THE C27A SCYLV P1-P2 FRAMESHIFTING PSEUDOKNOT, 20 LOWEST ENERGY STRUCTURES C27A SUGARCANE YELLOW LEAF VIRUS RNA PSEUDOKNOT RNA RNA PSEUDOKNOT; FRAMESHIFTING 2ap5 nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ SOLUTION STRUCTURE OF THE C27A SCYLV P1-P2 FRAMESHIFTING PSEUDOKNOT, AVERAGE STRUCTURE C27A SUGARCANE YELLOW LEAF VIRUS RNA PSEUDOKNOT RNA RNA PSEUDOKNOT; FRAMESHIFTING 2rp0 nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ REFINED SOLUTION STRUCTURE OF THE PEMV-1 MRNA PSEUDOKNOT, 28 LOWEST ENERGY STRUCTURES PEMV-1 MRNA PSEUDOKNOT RNA RNA PSEUDOKNOT, FRAMESHIFTING 2rp1 nuc NMR N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O8 P 1+ REFINED SOLUTION STRUCTURE OF THE PEMV-1 MRNA PSEUDOKNOT, REGULARIZED AVERAGE STRUCTURE PEMV-1 MRNA PSEUDOKNOT RNA RNA PSEUDOKNOT, FRAMESHIFTING
Code Class Resolution Description 1on5 nuc NMR CHOLIC ACID 2(C24 H40 O5) SOLUTION STRUCTURE OF A CHOLIC ACID-CAPPED DNA DUPLEX STEROID-DNA HYBRID DNA DNA, STEROID, SYNTHETIC HYBRID
Code Class Resolution Description 1kod nuc NMR CITRULLINE C6 H13 N3 O3 RNA APTAMER COMPLEXED WITH CITRULLINE, NMR RNA (5'-R(P*AP*GP*AP*AP*GP*GP*AP*GP*UP*GP*U)-3'), RNA (5'- R(P*AP*CP*GP*GP*UP*UP*AP*GP*GP*UP*CP*GP*CP*U)-3') RNA IN VITRO SELECTED RNA, RNA APTAMER
Code Class Resolution Description
1da3 nuc 2.00 CHLORIDE ION CL 1- THE CRYSTAL STRUCTURE OF THE TRIGONAL DECAMER C-G-A-T-C-G- 6MEA-T-C-G: A B-DNA HELIX WITH 10.6 BASE-PAIRS PER TURN DNA (5'-D(*CP*GP*AP*TP*CP*GP*(6MA)P*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
1enn nuc 0.89 CHLORIDE ION CL 1- SOLVENT ORGANIZATION IN AN OLIGONUCLEOTIDE CRYSTAL: THE STRUCTURE OF D(GCGAATTCG)2 AT ATOMIC RESOLUTION DNA (5'-D(*GP*CP*GP*AP*AP*TP*TP*CP*G)-3') DNA B-DNA, ATOMIC RESOLUTION, IONS, HYDRATION, BASE TRIPLET
1icg nuc 1.53 CHLORIDE ION 2(CL 1-) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[F]U IN PRESENCE OF IR(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UFP))-3' DNA/RNA RNA/DNA HYBRID, FLUORO-URACIL, C-U MISMATCH, G-U MISMATCH, RHODIUM HEXAMMINE, IRIDIUM HEXAMMINE, DNA/RNA COMPLEX
1id9 nuc 1.60 CHLORIDE ION 2(CL 1-) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[F]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UFP))-3' DNA/RNA RNA/DNA HYBRID, FLUORO URACIL, RHODIUM(III) HEXAMMINE, C-U MISMATCH, G-U MISMATCH, DNA/RNA COMPLEX
1idw nuc 1.80 CHLORIDE ION 2(CL 1-) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[CL]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UCL))-3' DNA/RNA RNA/DNA HYBRID, RHODIUM HEXAMMINE, C-U MISMATCH, G-U MISMATCH, DNA/RNA COMPLEX
1iha nuc 1.60 CHLORIDE ION 2(CL 1-) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[BR]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(BRU))-3' DNA/RNA RNA/DNA HYBRID, BROMO URACIL, RHODIUM(III) HEXAMMINE, C-U G- U MISMATCH, DNA/RNA COMPLEX
1ue2 nuc 1.40 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF D(GC38GAAAGCT) 5'-D(*GP*(C38)P*GP*AP*AP*AP*GP*CP*T)-3' DNA DNA, BASE-INTERCALATED DUPLEX, MINI-HAIRPIN STRUCTURE, SHEAR PAIR, ZIPPER-LIKE DUPLEX
1ue3 nuc 2.15 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF D(GCGAAAGC) CONTAINING HEXAAMMINECOBALT 5'-D(*GP*CP*GP*AP*AP*AP*GP*C)-3' DNA DNA, BASE-INTERCALATED DUPLEX, MINI-HAIRPIN STRUCTURE, SHEARED G:A PAIR, ZIPPER-LIKE DUPLEX
1uhx nuc 2.00 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF D(GCGAGAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID
1uhy nuc 1.70 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF D(GCGATAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*TP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID
1xpe nuc 1.94 CHLORIDE ION CL 1- HIV-1 SUBTYPE B GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1
2fcx nuc 2.00 CHLORIDE ION CL 1- HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEAMINE HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS
2fcy nuc 2.20 CHLORIDE ION CL 1- HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS
2fd0 nuc 1.80 CHLORIDE ION CL 1- HIV-1 DIS KISSING-LOOP IN COMPLEX WITH LIVIDOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS
2fij nuc 1.19 CHLORIDE ION CL 1- CRYSTAL STRUCTURE ANALYSIS OF THE A-DNA DECAMER GCGT-2'OMEA- WITH INCORPORATED 2'-O-METHYLATED-ADENOSINE (2'OMEA) AND AR URIDINE (AU) 5'-D(*GP*CP*GP*TP*(A2M)P*(UAR)P*AP*CP*GP*C)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, A-FORM DNA, DNA
2zy6 nuc 1.75 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF A TRUNCATED TRNA, TPHE39A PHENYLALANYL TRANSFER RNA RNA TRUNCATED TRNA
363d nuc 2.00 CHLORIDE ION 12(CL 1-) HIGH-RESOLUTION CRYSTAL STRUCTURE OF A FULLY MODIFIED N3'-> PHOSPHORAMIDATE DNA DODECAMER DUPLEX 5'-D(*(C42)P*(G38)P*(C42)P*(G38)P*(A43)P*(A43)P*( P*(NYM)P*(C42)P*(G38)P*(C42)P*DG)-3' DNA A-DNA, MODIFIED, DNA
3c44 nuc 2.00 CHLORIDE ION 2(CL 1-) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO PAROMOMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC, PAROMOMYCIN, EXTENDED DUPLEX
3dvv nuc 2.00 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO RIBOSTAMYCIN (U267OME) HIV-1 GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC, AMINOGLYCOSIDE
3gsj nuc 1.80 CHLORIDE ION CL 1- A BULKY RHODIUM COMPLEX BOUND TO AN ADENOSINE-ADENOSINE DNA MISMATCH 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*AP*CP*CP*G)-3' DNA DNA MISMATCH, METALLOINTERCALATOR, DNA RECOGNITION
4e8s nuc 1.24 CHLORIDE ION CL 1- LAMBDA-[RU(TAP)2(DPPZ{ME2}2)]2+ BOUND TO TCGGCGCCGA AT HIGH 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA INTERCALATION, PHOTOREACTIVE, DNA, RUTHENIUM COMPLEX
4fp6 nuc 1.28 CHLORIDE ION CL 1- DNA OCTAMER D(GTGGCCAC) WITH 2'-SE MODIFICATION DNA (5'-D(*GP*(2ST)P*GP*GP*CP*CP*AP*C)-3') DNA 2'-SE-THYMIDINE DNA, DNA
4fs5 nuc 1.30 CHLORIDE ION 4(CL 1-) CRYSTAL STRUCTURE OF THE Z-DNA HEXAMER CGCGCG AT 500 MM MGCL DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, MG2+ BINDING, DNA
4fs6 nuc 1.30 CHLORIDE ION 2(CL 1-) CRYSTAL STRUCTURE OF THE Z-DNA HEXAMER CGCGCG AT 500 MM CACL DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, CA2+ BINDING, DNA
4hif nuc 0.85 CHLORIDE ION CL 1- ULTRAHIGH-RESOLUTION CRYSTAL STRUCTURE OF Z-DNA IN COMPLEX W IONS DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA SELF-COMPLEMENTARY DNA, DNA, Z-DNA
4k27 nuc 2.35 CHLORIDE ION 6(CL 1-) MYOTONIC DYSTROPHY TYPE 2 RNA: STRUCTURAL STUDIES AND DESIGN MOLECULES THAT MODULATE RNA FUNCTION MYOTONIC DYSTROPHY TYPE 2 RNA RNA A-FORM RNA, MYOTONIC DYSTROPHY TYPE 2, UNKNOWN, RNA
4ltg nuc 1.18 CHLORIDE ION CL 1- DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (2/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4lti nuc 1.41 CHLORIDE ION CL 1- DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (4/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4ltk nuc 1.45 CHLORIDE ION CL 1- DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (6/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA
4mj9 nuc 0.97 CHLORIDE ION CL 1- LAMBDA-[RU(TAP)2(DPPZ-10-ME)]2+ BOUND TO A SYNTHETIC DNA OLI DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA METHYL-SUBSTITUTED, INTERCALATION, RUTHENIUM, ASYMMETRIC SUBSTITUTION, DNA
4pco nuc 1.32 CHLORIDE ION 3(CL 1-) CRYSTAL STRUCTURE OF DOUBLE-STRANDED RNA WITH FOUR TERMINAL BASE PAIRS RNA (5'-D(*GP*GP*UP*GP*GP*CP*UP*GP*UP*U)-3') RNA GU WOBBLE BASE PAIR MOTIF, RNA
4qio nuc 0.95 CHLORIDE ION CL 1- LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(TCGGCGCCIA) AT HIGH RES 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*IP*A)-3' DNA INTERCALATION, RUTHENIUM COMPLEX, INOSINE, DNA
4r8j nuc 1.21 CHLORIDE ION CL 1- D(TCGGCGCCGA) WITH LAMBDA-[RU(TAP)2(DPPZ)]2+ SOAKED IN D2O DNA (5'-D(*(THM)P*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA KINKING, INFRA-RED, RUTHENIUM, DNA
4x18 nuc 1.05 CHLORIDE ION CL 1- [RU(TAP)2(DPPZ-11-ME)]2+ BOUND TO D(TCGGCGCCGA) DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA RUTHENIUM, DNA, SUBSTITUTION, DUPLEX
4xqz nuc 2.15 CHLORIDE ION 7(CL 1-) CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY CHLORIDE AND MES DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA
4ymc nuc 1.88 CHLORIDE ION CL 1- LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(CCGGATCCGG)2 DNA (5'-D(*CP*CP*GP*GP*AP*TP*CP*CP*GP*G)-3') DNA RUTHENIUM, COMPLEX, DNA, INTERCALATION
5cnr nuc 2.59 CHLORIDE ION CL 1- CRYSTAL STRUCTURE-GUIDED DESIGN OF SELF-ASSEMBLING RNA NANO RNA (5'-R(*AP*GP*AP*GP*GP*AP*CP*GP*GP*CP*G)-3'), RNA (5'-R(*GP*UP*CP*UP*AP*CP*CP*CP*AP*CP*CP*UP*CP 3') RNA SENECA VALLEY VIRUS, NANOTRIANGLE, SELF-ASSEMBLY, RNA
5eme nuc 1.15 CHLORIDE ION 2(CL 1-) COMPLEX OF RNA R(GCAGCAGC) WITH ANTISENSE PNA P(CTGCTGC) ANTISENSE PNA STRAND, RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3') RNA CAG REPEATS, RNA/PNA, PNA ANTISENSE OLIGOMER, POLY-Q DIESEAS
5emf nuc 1.14 CHLORIDE ION 2(CL 1-) CRYSTAL STRUCTURE OF RNA R(GCUGCUGC) WITH ANTISENSE PNA P(GC RNA (5'-R(*GP*CP*UP*GP*CP*UP*GP*C)-3'), ANTISENSE PNA P(GCAGCAGC) RNA CUG REPEATS, RNA/PNA DUPLEX, ANTISENSE PNA, MYOTONIC DYSTROP 1, RNA
5ew4 nuc 1.47 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF C9ORF72 ANTISENSE CCCCGG REPEAT RNA ASS WITH LOU GEHRIG'S DISEASE AND FRONTOTEMPORAL DEMENTIA, CRYS WITH SR2+ RNA (5'- R(*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP 3') RNA REPEAT EXPANSION DISORDER, GENETIC DISEASE, RNA
5jeu nuc 0.97 CHLORIDE ION CL 1- DEL-[RU(PHEN)2(DPPZ)]2+ BOUND TO D(TCGGCGCCGA) WITH BA2+ DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA, RUTHENIUM, LIGHT-SWITCH, SEMI-INTERCALATION
5ju4 nuc 2.00 CHLORIDE ION CL 1- CRYSTAL STRUCTURE OF A DNA SEQUENCE D(CGTGAATTCACG) AT 130K DNA (5'-D(*CP*GP*TP*GP*AP*AP*TP*TP*CP*AP*CP*G)-3' CHAIN: A, B DNA DNA
5lfs nuc 1.85 CHLORIDE ION CL 1- LAMBDA-[RU(BPY)2(DPPZ)]2+ BOUND TO BROMINATED DNA DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, INTERCALATION, LIGHT-SWITCH
5lyu nuc 2.20 CHLORIDE ION 2(CL 1-) THE NATIVE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN RNA (58-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
5lyv nuc 2.35 CHLORIDE ION CL 1- THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - OSMIUM DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
Code Class Resolution Description 2jrg nuc NMR 5-(CARBOXYMETHOXY) URIDINE-5'-MONOPHOSPHATE C11 H15 N2 O12 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF E. COLI TRNA-VAL3 MODIFICATIONS (CMO5U34 M6A37) 5'-R(*CP*CP*UP*CP*CP*CP*UP*(CM0)P*AP*CP*(6MZ) P*AP*GP*GP*AP*GP*G)-3' RNA E.COLI, VALINE, TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA URIDINE 5-OXYACETIC ACID, CMO5U, N6-METHYLADENOSINE, M6A, R 2jrq nuc NMR 5-(CARBOXYMETHOXY) URIDINE-5'-MONOPHOSPHATE C11 H15 N2 O12 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF E. COLI TRNA- VAL3 WITH 1 MODIFICATION (CMO5U34) 5'-R(*CP*CP*UP*CP*CP*CP*UP*(CM0) P*AP*CP*AP*AP*GP*GP*AP*GP*G)-3' RNA E.COLI, VALINE, TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, URIDINE 5-OXYACETIC ACID, CMO5U
Code Class Resolution Description 236d nuc 1.80 3'-DESAMINO-3'-(3-CYANO-4-MORPHOLINYL)-DOXORUBICIN C32 H34 N2 O12 CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1k1h nuc NMR 2'-DEOXY-CYTIDINE-5'-RP-MONOMETHYLPHOSPHONATE 2(C10 H16 N3 O6 P) HETERODUPLEX OF CHIRALLY PURE METHYLPHOSPHONATE/DNA DUPLEX 5'-D(*TP*GP*TP*TP*TP*GP*GP*C)-3', 5'-D(*CP*(CMR)P*(RMP)P*(RMP)P*(SMP)P*(CMR) P*(RMP))-3' DNA METHYL PHOSPHONATE, ANTI SENSE, DNA 1k1r nuc NMR 2'-DEOXY-CYTIDINE-5'-RP-MONOMETHYLPHOSPHONATE 2(C10 H16 N3 O6 P) HETERODUPLEX OF CHIRALLY PURE R-METHYLPHOSPHONATE/DNA DUPLEX 5'-D(*TP*GP*TP*TP*TP*GP*GP*C)-3', 5'-D(*CP*(CMR)P*(RMP)P*(RMP)P*(RMP)P*(CMR) P*(RMP))-3' DNA METHYL PHOSPHONATE, MODIFIED DNA, ANTI SENSE, APTAMERS
Code Class Resolution Description 2dp7 nuc 1.55 (6-AMINOHEXYL)CARBAMIC ACID 2(C7 H16 N2 O2) CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-DEOXYURIDINE DNA (5'- D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*DUP*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'- DEOXYURIDINE, B-DNA 2dpb nuc 1.50 (6-AMINOHEXYL)CARBAMIC ACID 2(C7 H16 N2 O2) CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-DEOXYURIDINE DNA (5'- D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*DUP*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'- DEOXYURIDINE, B-DNA 2dpc nuc 1.55 (6-AMINOHEXYL)CARBAMIC ACID 2(C7 H16 N2 O2) CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE DNA (5'-D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*(OMU) P*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, B-DNA 2dqo nuc 2.30 (6-AMINOHEXYL)CARBAMIC ACID 2(C7 H16 N2 O2) CRYSTAL STRUCTURE OF D(CXCTXCTTC):R(GAAGAAGAG) WHERE X IS 5- (N-AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID 2dqp nuc 2.10 (6-AMINOHEXYL)CARBAMIC ACID 2(C7 H16 N2 O2) STRUCTURAL ANALYSES OF DNA:DNA AND RNA:DNA DUPLEXES CONTAINING 5-(N-AMINOHEXYL)CARBAMOYL MODIFIED URIDINES RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID 2dqq nuc 2.00 (6-AMINOHEXYL)CARBAMIC ACID 2(C7 H16 N2 O2) CRYSTAL STRUCTURE OF D(CXCTXCTTC):R(GAAGAAGAG) WHERE X IS 5- (N-AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3'), RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID
Code Class Resolution Description 1et4 nuc 2.30 CO-CYANOCOBALAMIN 5(C63 H88 CO N14 O14 P 1+) CRYSTAL STRUCTURE OF A VITAMIN B12 BINDING RNA APTAMER WITH 2.3 A RNA APTAMER, 35-MER RNA B12 BINDING RNA, VITAMIN B12, COBALAMIN, RNA
Code Class Resolution Description 1zz5 nuc 3.00 13,15-DIAMINO-2-(AMINOMETHYL)-3,4,9,12- TETRAHYDROXYHEXADECAHYDRO-2H-7,10-EPOXYPYRANO[2,3- B][1,10,4]BENZODIOXAZACYCLODODECIN-8-YL 2,6-DIAMINO-2, 6-DIDEOXYHEXOPYRANOSIDE 4(C23 H44 N6 O12) MOLECULAR RECOGNITION OF RNA BY NEOMYCIN AND A RESTRICTED NEOMYCIN DERIVATIVE 5'- R(*GP*UP*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*CP*GP*G)-3': RIBOSOMAL RNA A-SITE, 5'-R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*AP*CP*C)- 3': RIBOSOMAL RNA A-SITE RNA RIBOSOME, RNA, A-SITE. DOUBLE HELIX, RESTRICTED NEOMYCIN, CYCLICNEO, NEOCYCLIC
Code Class Resolution Description 1ekh nuc NMR COBALT (II) ION CO 2+ NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND CO DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1eki nuc NMR COBALT (II) ION CO 2+ AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMY COBALT DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1fd5 nuc 1.10 COBALT (II) ION 2(CO 2+) BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (BISACRIDINE COMPLEX) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA HIGH RESOLUTION CRYSTAL STRUCTURE, INTERCALATION PLATFORM, MAD, ANTICANCER DRUG, DRUG-DNA COMPLEX, METAL IONS, TERTIARY BASE PAIRS 1fdg nuc 1.60 COBALT (II) ION 2(CO 2+) BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (AMETANTRONE COMPLEX) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA HIGH RESOLUTION CRYSTAL STRUCTURE, INTERCALATION PLATFORM, MAD, ANTICANCER DRUG, DRUG-DNA COMPLEX, METAL IONS, TERTIARY BASE PAIRS 1fn1 nuc 1.60 COBALT (II) ION 2(CO 2+) CRYSTAL STRUCTURE OF 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL) ACRIDINE-4-CARBOXAMIDE BOUND TO D(CG(5BR)UACG)2 DNA (5'-D(P*GP*(BRO)UP*AP*CP*G)-3'), DNA (5'-D(*CP*GP*(BRO)UP*AP*CP*G)-3') DNA 9-AMINOACRIDINE-4-CARBOAMIDE, HEXANUCLEOTIDE, X-RAY CRYSTALLOGRAPHY, INTERCALATION, QUADRUPLEX, DNA 1fn2 nuc 1.60 COBALT (II) ION 2(CO 2+) 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL)ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 DNA (5'-D(*CP*GP*TP*AP*CP*G)-3'), DNA (5'-D(P*GP*TP*AP*CP*G)-3') DNA DNA, ACRIDINE-4-CARBOXAMIDE, INTERCALATION, QUADRUPLEX 1k2l nuc 2.40 COBALT (II) ION 2(CO 2+) STRUCTURAL CHARACTERIZATION OF BISINTERCALATION IN HIGHER- ORDER DNA AT A JUNCTION-LIKE QUADRUPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA STRAND EXCHANGE, QUADRUPLEX, BISINTERCALATION 1nyi nuc 2.85 COBALT (II) ION 4(CO 2+) CROSSLINKED HAMMERHEAD RIBOZYME INITIAL STATE 5'- R(P*GP*UP*GP*GP*UP*CP*UP*GP*AP*UP*GP*AP*GP*GP*CP*C)-3', 5'- R(*GP*CP*CP*GP*AP*AP*AP*CP*UP*CP*GP*UP*AP*AP*GP*AP*GP*UP*CP *AP*CP*CP*AP*C)-3' RNA HAMMERHEAD RIBOZYME CROSSLINK CONFORMATIONAL CHANGE, RNA 1o55 nuc 1.04 COBALT (II) ION CO 2+ MOLECULAR STRUCTURE OF TWO CRYSTAL FORMS OF CYCLIC TRIADENYLIC ACID AT 1 ANGSTROM RESOLUTION DNA (5'-CD(*AP*AP*AP)-3') DNA CYCLIC TRINUCLEOTIDE, DNA 1p24 nuc 3.02 COBALT (II) ION 5(CO 2+) CRYSTAL STRUCTURE OF COBALT(II)-D(GGCGCC)2 DNA (5'-D(*GP*GP*CP*GP*CP*C)-3') DNA B-DNA, COBALT BINDING 1q29 nuc 3.00 COBALT (II) ION 5(CO 2+) HAMMERHEAD RIBOZYME WITH 5'-5' G-G LINKAGE: CONFORMATIONAL CHANGE EXPERIMENT 5'- R(*GP*GP*UP*GP*GP*UP*CP*UP*GP*AP*UP*GP*AP*GP*GP*CP*C)-3', RIBOZYME RNA HAMMERHEAD RIBOZYME, RNA 1qzl nuc 2.85 COBALT (II) ION CO 2+ GCATGCT + COBALT 5'-D(*GP*CP*AP*TP*GP*CP*T)-3' DNA DNA QUADRUPLEX 1rqy nuc 1.55 COBALT (II) ION 2(CO 2+) 9-AMINO-[N-(2-DIMETHYLAMINO)PROPLY]-ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 5'-D(CP*GP*TP*AP*CP*G)-3' DNA B-DNA, CYTOSINE EXCHANGE, QUADRUPLEX, ACRIDINE, UNUSUAL INTERCALATION 1s23 nuc 1.60 COBALT (II) ION CO 2+ CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DECAMER CGCAATTGCG 5'-D(*CP*GP*CP*AP*AP*TP*TP*GP*CP*G)-3' DNA DEOXYOLIGONUCLEOTIDE, COBALT, VARIABILITY, DNA 1wvd nuc 2.93 COBALT (II) ION 8(CO 2+) HIV-1 DIS(MAL) DUPLEX COCL2-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, BULGE, METAL IONS 1xcs nuc 1.40 COBALT (II) ION 2(CO 2+) STRUCTURE OF OLIGONUCLEOTIDE/DRUG COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX, CO2+, DNA 1xcu nuc 2.00 COBALT (II) ION 3(CO 2+) OLIGONUCLEOTID/DRUG COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, ANTHRAQUINONE, CO2+ 1z3f nuc 1.50 COBALT (II) ION 3(CO 2+) STRUCTURE OF ELLIPTICINE IN COMPLEX WITH A 6-BP DNA 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA ANTICANCER, DNA BINDING, DRUG DESIGN, ELLIPTICINE, INTERCALATOR 2dpc nuc 1.55 COBALT (II) ION 3(CO 2+) CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE DNA (5'-D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*(OMU) P*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, B-DNA 379d nuc 3.10 COBALT (II) ION 8(CO 2+) THE STRUCTURAL BASIS OF HAMMERHEAD RIBOZYME SELF-CLEAVAGE RNA (5'- R(*GP*UP*GP*GP*UP*CP*UP*GP*AP*UP*GP*AP*GP*GP*CP*C)-3'), RNA (5'- R(*GP*GP*CP*CP*GP*AP*AP*AP*CP*UP*CP*GP*UP*AP*AP*GP*A P*GP*UP*CP*AP*CP*CP*AP*C)-3') RIBOZYME RNA HAMMERHEAD RIBOZYME, CATALYTIC RNA, LOOP 3far nuc 2.40 COBALT (II) ION 2(CO 2+) CATION-DEPENDENT SELF-CLEAVAGE ACTIVITY IN THE DUPLEX FORM OF THE SUBTYPE-B HIV-1 RNA DIMERIZATION INITIATION SITE RNA (5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3') RNA HIV-1, RNA, METAL IONS, CATALYTIC RNA 3ixn nuc 2.87 COBALT (II) ION 3(CO 2+) CRYSTAL STRUCTURE OF D(CCGGTACCGG) AS B-DNA DUPLEX DNA (5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3') DNA B-DNA, DNA 3r86 nuc 2.80 COBALT (II) ION 3(CO 2+) CRYSTAL STRUCTURE OF D(CCGGTACCGG)2 AS B-DNA DUPLEX GROWN WI COCL2 DNA (5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3') DNA DUPLEX, DNA 4mnb nuc 1.40 COBALT (II) ION CO 2+ CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE MARINE ANTICANCER VARIOLIN B AND DNA 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA DUPLEX, INTERCALATION, DRUG BINDING, NUCLEUS, DNA 4pzq nuc 2.24 COBALT (II) ION 2(CO 2+) CRYSTAL STRUCTURE OF CCG DNA REPEATS DNA (5'-D(*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*A)-3') DNA I-MOTIF, HEMIPROTONATED CC+ PAIRS, CCG TRIPLET REPEAT, DNA 4qno nuc 1.66 COBALT (II) ION 2(CO 2+) CRYSTAL STRUCTURE OF CCG DNA REPEATS AT 1.66 ANGSTROM RESOLU DNA (5'-D(*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*A)-3') DNA I-MOTIF, HEMIPROTONATED CC+ PAIRS, CCG TRIPLET REPEAT, HIGH RESOLUTION STRUCTURE, DNA 4r4a nuc 1.49 COBALT (II) ION 5(CO 2+) RACEMIC CRYSTAL STRUCTURE OF A COBALT-BOUND B-DNA DUPLEX 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4rum nuc 2.64 COBALT (II) ION 4(CO 2+) CRYSTAL STRUCTURE OF THE NICO TRANSITION-METAL RIBOSWITCH BO COBALT NICO RIBOSWITCH RNA RNA RNA HELIX, LIGAND SENSOR, COBALT AND NICKEL BINDING, RNA, RI 4rzn nuc 2.58 COBALT (II) ION 7(CO 2+) CRYSTAL STRUCTURE OF D(GTGGAATGGAAC) 5'-D(*GP*TP*GP*GP*AP*AP*TP*GP*GP*AP*AP*C)-3' DNA (GGA) MOTIF, DNA EXPANSION IN SCA31 PATIENT, DNA 4u3r nuc 1.70 COBALT (II) ION 3(CO 2+) OCTAMERIC RNA DUPLEX CO-CRYSTALLIZED WITH COBALT(II)CHLORIDE RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3') RNA RNA, DUPLEX, DI- AND TRIVALENT METAL IONS 4zkk nuc 1.80 COBALT (II) ION 3(CO 2+) THE NOVEL DOUBLE-FOLD STRUCTURE OF D(GCATGCATGC) DNA (5'-D(*GP*CP*AP*TP*GP*CP*AP*TP*GP*C)-3') DNA FOLDED, MINOR-GROOVE TETRAD, BI-LOOP, TRIPLET, DNA 5cki nuc 2.99 COBALT (II) ION 4(CO 2+) CRYSTAL STRUCTURE OF 9DB1* DEOXYRIBOZYME (COBALT HEXAMMINE S CRYSTALS) DNA (44-MER), RNA (5'-R(P*GP*CP*AP*CP*UP*AP*GP*AP*UP*CP*GP*GP*A 3') DNA DEOXYRIBOZYME, RNA-LIGASE, CATALYTIC DNA, DNA 5es0 nuc 2.10 COBALT (II) ION 3(CO 2+) CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX 5fhj nuc 1.68 COBALT (II) ION 7(CO 2+) EXTENSIVE AMPHIMORPHISM IN DNA: THREE STABLE CONFORMATIONS F DECADEOXYNUCLEOTIDE D(GCATGCATGC) DNA (5'-D(*GP*CP*AP*TP*GP*CP*AP*TP*GP*C)-3') DNA DNA, AMPHIMORPHISM, DOUBLE-FOLDED, B-TYPE HELIX
Code Class Resolution Description 1d83 nuc NMR 1,8-DIHYDROXY-7-METHYL-3-(1,3,4-TRIHYDROXY-2-OXO- PENTYL)-3,10-DIHYDRO-2H-ANTHRACEN-9-ONE 2(C21 H24 O7) STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION DNA (5'-D(*AP*AP*GP*GP*CP*CP*TP*T)-3') DNA DNA, NMR, DOUBLE HELIX, CHROMOMYCIN 1ekh nuc NMR 1,8-DIHYDROXY-7-METHYL-3-(1,3,4-TRIHYDROXY-2-OXO- PENTYL)-3,10-DIHYDRO-2H-ANTHRACEN-9-ONE 2(C21 H24 O7) NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND CO DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1eki nuc NMR 1,8-DIHYDROXY-7-METHYL-3-(1,3,4-TRIHYDROXY-2-OXO- PENTYL)-3,10-DIHYDRO-2H-ANTHRACEN-9-ONE 2(C21 H24 O7) AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMY COBALT DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1vaq nuc 2.00 1,8-DIHYDROXY-7-METHYL-3-(1,3,4-TRIHYDROXY-2-OXO- PENTYL)-3,10-DIHYDRO-2H-ANTHRACEN-9-ONE 4(C21 H24 O7) CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA) 2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION 5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3' DNA CHROMOMYCIN A3, X-RAY DIFFRACTION, MAD, DNA DUPLEX, GGCC SITE, DNA KINK, CD SPECTRA 5erz nuc 1.75 (1S)-5-DEOXY-1-O-METHYL-1-C-[(2R,3S)-3,5,7,10- TETRAHYDROXY-6-METHYL-4-OXO-1,2,3,4- TETRAHYDROANTHRACEN-2-YL]-D-XYLULOSE 2(C21 H24 O9) CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX 5es0 nuc 2.10 (1S)-5-DEOXY-1-O-METHYL-1-C-[(2R,3S)-3,5,7,10- TETRAHYDROXY-6-METHYL-4-OXO-1,2,3,4- TETRAHYDROANTHRACEN-2-YL]-D-XYLULOSE 2(C21 H24 O9) CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX
Code Class Resolution Description 176d nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-CYTOSINE 2(C10 H16 N5 O4 1+) NMR SOLUTION STRUCTURE OF A PEPTIDE NUCLEIC ACID COMPLEXED W DNA (5'-D(*GPN*APN*APN*CPN*TPN*CPN)-3'), RNA (5'-R(P*GP*AP*GP*UP*UP*C)-3') PEPTIDE NUCLEIC ACID/RNA RNA, PNA, DOUBLE HELIX, PEPTIDE NUCLEIC ACID-RNA COMPLEX 1nr8 nuc 1.66 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-CYTOSINE C10 H16 N5 O4 1+ THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX 1pdt nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-CYTOSINE 2(C10 H16 N5 O4 1+) PD235, PNA-DNA DUPLEX, NMR, 8 STRUCTURES DNA (5'-D(*GP*AP*CP*AP*TP*AP*GP*C)-3', PEPTIDE NUCLEIC ACID (COOH-P(*G*C*T*A*T*G*T*C)-NH CHAIN: B PEPTIDE NUCLEIC ACID/DNA COMPLEX (PEPTIDE NUCLEIC ACID-DNA), NUCLEIC ACID COMPLEX, DU HYBRID, PEPTIDE NUCLEIC ACID-DNA COMPLEX 5eme nuc 1.15 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-CYTOSINE 3(C10 H16 N5 O4 1+) COMPLEX OF RNA R(GCAGCAGC) WITH ANTISENSE PNA P(CTGCTGC) ANTISENSE PNA STRAND, RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3') RNA CAG REPEATS, RNA/PNA, PNA ANTISENSE OLIGOMER, POLY-Q DIESEAS 5emf nuc 1.14 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-CYTOSINE 3(C10 H16 N5 O4 1+) CRYSTAL STRUCTURE OF RNA R(GCUGCUGC) WITH ANTISENSE PNA P(GC RNA (5'-R(*GP*CP*UP*GP*CP*UP*GP*C)-3'), ANTISENSE PNA P(GCAGCAGC) RNA CUG REPEATS, RNA/PNA DUPLEX, ANTISENSE PNA, MYOTONIC DYSTROP 1, RNA
Code Class Resolution Description 1a2e nuc 1.63 CISPLATIN CL2 H6 N2 PT CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DNA DECAMER CONTAININ CISPLATIN INTERSTRAND CROSS-LINK ADDUCT DNA (5'-D(*CP*CP*TP*CP*GP*CP*TP*CP*TP*C)-3'), DNA (5'-D(*GP*AP*GP*AP*GP*CP*GP*AP*GP*G)-3') DNA ANTITUMOR DRUG, CIS-DDP, INTERSTRAND CROSS-LINK, DNA 1a84 nuc NMR CISPLATIN CL2 H6 N2 PT NMR SOLUTION STRUCTURE OF A DNA DODECAMER DUPLEX CONTAINING DIAMMINEPLATINUM(II) D(GPG) INTRASTRAND CROSS-LINK, THE MAJ OF THE ANTICANCER DRUG CISPLATIN, 1 STRUCTURE DNA D(GGAGACCAGAGG), DNA D(CCTCTG*G*TCTCC) DNA DEOXYRIBONUCLEIC ACID, CISPLATIN, DNA, DUPLEX, DODECAMER, HM INTERACTION 1aio nuc 2.60 CISPLATIN 2(CL2 H6 N2 PT) CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DNA CONTAINING THE MA OF THE ANTICANCER DRUG CISPLATIN DNA (5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3' CHAIN: B, D, DNA (5'-D(*CP*CP*(BRU)P*CP*TP*[PT(NH3)2(GP*GP) ]*TP*CP*TP*CP*C)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE 1au5 nuc NMR CISPLATIN CL2 H6 N2 PT SOLUTION STRUCTURE OF INTRASTRAND CISPLATIN-CROSSLINKED DNA D(CCTG*G*TCC):D(GGACCAGG), NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*GP*GP*AP*CP*CP*AP*GP*G)-3'), DNA (5'-D(*CP*CP*TP*GP*GP*TP*CP*C)-3') DNA INTRASTRAND, CISPLATIN, DNA, DEOXYRIBONUCLEIC ACID 1da4 nuc NMR CISPLATIN CL2 H6 N2 PT SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING THE CIS-PT(NH3 )-N7-(G)-N7(G)N7(G)]ADDUCT AS DETERMINED WITH HIGH FIELD NM MOLECULAR MECHANICS/DYNAMICS DNA (5'-D(P*GP*TP*GP*AP*GP*CP*AP*CP*TP*AP*GP*AP*G CHAIN: B, DNA (5'-D(P*CP*TP*CP*TP*AP*GP*TP*GP*CP*TP*CP*AP*C CHAIN: A DNA DNA 1da5 nuc NMR CISPLATIN CL2 H6 N2 PT SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING THE CIS-PT(NH3 )-N7-(G)-N7(G)N7(G)]ADDUCT AS DETERMINED WITH HIGH FIELD NM MOLECULAR MECHANICS/DYNAMICS DNA (5'-D(P*GP*TP*GP*AP*GP*CP*AP*CP*TP*AP*GP*AP*G CHAIN: B, DNA (5'-D(P*CP*TP*CP*TP*AP*GP*TP*GP*CP*TP*CP*AP*C CHAIN: A DNA DNA 1ddp nuc NMR CISPLATIN CL2 H6 N2 PT SOLUTION STRUCTURE OF A CISPLATIN-INDUCED [CATAGCTATG]2 INTE CROSS-LINK DNA (5'-D(*CP*AP*TP*AP*GP*CP*TP*AP*TP*G)-3') DNA DNA, DOUBLE HELIX, ANTITUMOR DRUG, CIS-DDP, INTERSTRAND CROS 1i1p nuc 1.63 CISPLATIN CL2 H6 N2 PT REFINEMENT INCLUDING EXPERIMENTAL MAD PHASES ALLOWS AN EXHAU STUDY OF ORDERED SOLVENT MOLECULES FOR A PLATINATED DECANUC 5'-D(*CP*CP*TP*CP*GP*CP*TP*CP*TP*C)-3', 5'-D(*GP*AP*GP*AP*GP*CP*GP*AP*GP*G)-3' DNA ANTITUMOR DRUG, CIS-DDP, INTERSTRAND CROSS-LINK, DEOXYRIBONU ACID, SPERMINE, DNA 1ksb nuc NMR CISPLATIN CL2 H6 N2 PT RELATIONSHIP OF SOLUTION AND PROTEIN-BOUND STRUCTURES OF DNA WITH THE MAJOR INTRASTRAND CROSS-LINK LESIONS FORMED ON CIS BINDING TO DNA 5'-D(*AP*GP*GP*CP*CP*GP*GP*AP*G)-3', 5'-D(*CP*TP*CP*CP*GP*GP*CP*CP*T)-3' DNA DEOXYRIBONUCLEIC ACID, CISPLATIN, DNA, DUPLEX, 9-MER, INTRAS CROSS-LINK, MODEL J 2npw nuc NMR CISPLATIN CL2 H6 N2 PT SOLUTION STRUCTURES OF A DNA DODECAMER DUPLEX WITH A CISPLAT D(GG) INTRASTRAND CROSS-LINK 5'-D(*CP*CP*TP*CP*AP*GP*GP*CP*CP*TP*CP*C)-3', 5'-D(*GP*GP*AP*GP*GP*CP*CP*TP*GP*AP*GP*G)-3' DNA DEOXYRIBONUCLEIC ACID, CISPLATIN, DNA, DUPLEX, DODECAMER 2nq0 nuc NMR CISPLATIN CL2 H6 N2 PT SOLUTION STRUCTURES OF A DNA DODECAMER DUPLEX WITH A CISPLAT D(GG) INTRASTRAND CROSS-LINK 5'-D(*CP*CP*TP*CP*AP*GP*GP*CP*CP*TP*CP*C)-3', 5'-D(*GP*GP*AP*GP*GP*CP*CP*TP*GP*AP*GP*G)-3' DNA DEOXYRIBONUCLEIC ACID, CISPLATIN, DNA, DUPLEX, DODECAMER 3lpv nuc 1.77 CISPLATIN 2(CL2 H6 N2 PT) X-RAY CRYSTAL STRUCTURE OF DUPLEX DNA CONTAINING A CISPLATIN D(GPG) INTRASTRAND CROSS-LINK 5'-D(*CP*CP*TP*CP*TP*GP*GP*TP*CP*TP*CP*C)-3', 5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3' DNA CISPLATIN, DNA
Code Class Resolution Description 4r15 nuc 0.97 CHROMIUM ION 3(CR 3+) HIGH-RESOLUTION CRYSTAL STRUCTURE OF Z-DNA IN COMPLEX WITH C CATIONS DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA SELF-COMPLEMENTARY DNA, Z-DNA, DNA
Code Class Resolution Description 146d nuc NMR 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4- DIHYDROXYPENTYL)-8,9-DIHYROXY-7-METHYLANTHRACENE 2(C21 H24 O7) SOLUTION STRUCTURE OF THE MITHRAMYCIN DIMER-DNA COMPLEX DNA (5'-D(*TP*CP*GP*CP*GP*A)-3') DNA DNA, NMR, MITHRAMYCIN DIMER 207d nuc NMR 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4- DIHYDROXYPENTYL)-8,9-DIHYROXY-7-METHYLANTHRACENE 4(C21 H24 O7) SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA DNA (5'-D(*TP*AP*GP*CP*TP*AP*GP*CP*TP*A)-3') DNA DNA, NMR, DOUBLE HELIX, MITHRAMYCIN
Code Class Resolution Description 1i0j nuc 1.06 CESIUM ION 3(CS 1+) 1.06 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE (T23) THYMINE IN PLACE OF T6, HIGH CS-SALT 5'-D(*GP*CP*GP*TP*AP*(T23)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0k nuc 1.05 CESIUM ION 3(CS 1+) 1.05 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM CS-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 2qwy nuc 2.80 CESIUM ION 2(CS 1+) SAM-II RIBOSWITCH BOUND TO S-ADENOSYLMETHIONINE SAM-II RIBOSWITCH RNA MRNA, RIBOSWITCH, SAM, S-ADENOSYLMETHIONINE, ADOMET, RNA- LIGAND COMPLEX, DOUBLE HELIX, PSEUDOKNOT, BASE TRIPLE 3dim nuc 2.90 CESIUM ION 2(CS 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, CS+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3f2x nuc 3.11 CESIUM ION 4(CS 1+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, CS+ SO FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, CESIUM, RNA 3skw nuc 2.95 CESIUM ION 6(CS 1+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, CESIUM SOAK RNA (66-MER) RNA THREE-WAY RNA JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 4e8r nuc 3.36 CESIUM ION 35(CS 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF CS+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4ena nuc 2.85 CESIUM ION 5(CS 1+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, SOAKED IN CS+ FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4jf2 nuc 2.28 CESIUM ION 15(CS 1+) STRUCTURE OF A CLASS II PREQ1 RIBOSWITCH REVEALS LIGAND RECO A NEW FOLD PREQ1-II RIBOSWITCH RNA RIBOSWITCH, H-TYPE PSEUDOKNOT, RNA 5d5l nuc 2.50 CESIUM ION 32(CS 1+) PREQ1-II RIBOSWITCH WITH AN ENGINEERED G-U WOBBLE PAIR BOUND PREQ1-II RIBOSWITCH RNA GU WOBBLE, PSEUDOKNOT, SHINE-DALGARNO SEQUENCE, RNA
Code Class Resolution Description 1yls nuc 3.00 (D)-2'-METHYLSELENYL-2'-DEOXYCYTIDINE-5'-PHOSPHATE 6(C10 H16 N3 O7 P SE) CRYSTAL STRUCTURE OF SELENIUM-MODIFIED DIELS-ALDER RIBOZYME WITH THE PRODUCT OF THE REACTION BETWEEN N-PENTYLMALEIMIDE COVALENTLY ATTACHED 9-HYDROXYMETHYLANTHRACENE RNA DIELS-ALDER RIBOZYME, RNA DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND FORMATION, CATALYTIC MECHANISM, DIELS-ALD REACTION, RIBOZYME, RNA 4ys5 nuc 1.65 (D)-2'-METHYLSELENYL-2'-DEOXYCYTIDINE-5'-PHOSPHATE C10 H16 N3 O7 P SE DNA SEQUENCE CONTAINING 2'-SE-DC MODIFICATION DNA (5'-D(*GP*TP*GP*GP*(2SC)P*CP*AP*C)-3') DNA DNA, SELENIUM
Code Class Resolution Description
3uke nuc 1.68 1-{2,5-ANHYDRO-6-O-METHYL-4-[(PHOSPHONOOXY)METHYL]- ALPHA-L-MANNOFURANOSYL}PYRIMIDINE-2,4(1H,3H)-DIONE 2(C12 H17 N2 O10 P) (S)-CMOE-BNA DECAMER STRUCTURE DNA (5'-D(*GP*CP*GP*TP*AP*(CSM)P*AP*CP*GP*C)-3') DNA A-FORM DNA, BICYCLIC NUCLEIC ACID, BNA, DNA, C-MOE-BNA, ANTI OLIGONUCLEOTIDES
Code Class Resolution Description 2kh5 nuc NMR (5R,6S)-5,6-DIHYDRO-5,6-DIHYDROXYTHYMIDINE-5'- MONOPHOSPHATE C10 H17 N2 O10 P SOLUTION STRUCTURE OF CIS-5R,6S-THYMINE GLYCOL OPPOSITE COMPLEMENTARY ADENINE IN DUPLEX DNA 5'-D(*AP*CP*AP*AP*AP*CP*AP*CP*GP*CP*AP*C)-3', 5'-D(*GP*TP*GP*CP*GP*(CTG)P*GP*TP*TP*TP*GP*T)-3' DNA THYMINE GLYCOL, DNA 2kh6 nuc NMR (5R,6S)-5,6-DIHYDRO-5,6-DIHYDROXYTHYMIDINE-5'- MONOPHOSPHATE C10 H17 N2 O10 P SOLUTION STRUCTURE OF CIS-5R,6S-THYMINE GLYCOL OPPOSITE COMPLEMENTARY ADENINE IN DUPLEX DNA 5'-D(*GP*TP*GP*CP*GP*(CTG)P*GP*TP*TP*TP*GP*T)-3', 5'-D(*AP*CP*AP*AP*AP*CP*AP*CP*GP*CP*AP*C)-3' DNA THYMINE GLYCOL, DNA 2kh7 nuc NMR (5R,6S)-5,6-DIHYDRO-5,6-DIHYDROXYTHYMIDINE-5'- MONOPHOSPHATE C10 H17 N2 O10 P SOLUTION STRUCTURE OF CIS-5R,6S-THYMINE GLYCOL OPPOSITE COMPLEMENTARY GUANINE IN DUPLEX DNA 5'-D(*AP*CP*AP*AP*AP*CP*GP*CP*GP*CP*AP*C)-3', 5'-D(*GP*TP*GP*CP*GP*(CTG)P*GP*TP*TP*TP*GP*T)-3' DNA THYMINE GLYCOL, NMR, DNA 2kh8 nuc NMR (5R,6S)-5,6-DIHYDRO-5,6-DIHYDROXYTHYMIDINE-5'- MONOPHOSPHATE C10 H17 N2 O10 P SOLUTION STRUCTURE OF CIS-5R,6S-THYMINE GLYCOL OPPOSITE COMPLEMENTARY GUANINE IN DUPLEX DNA 5'-D(*AP*CP*AP*AP*AP*CP*GP*CP*GP*CP*AP*C)-3', 5'-D(*GP*TP*GP*CP*GP*(CTG)P*GP*TP*TP*TP*GP*T)-3' DNA THYMINE GLYCOL, DNA, NMR
Code Class Resolution Description 4d9y nuc 2.10 1,2-DIMETHOXY-12-METHYL[1,3]BENZODIOXOLO[5,6- C]PHENANTHRIDIN-12-IUM C21 H18 N O4 1+ THE CRYSTAL STRUCTURE OF CHELERYTHRINE BOUND TO DNA D(CGTACG DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA DRUG-DNA COMPLEX, DOUBLE HELIX, DNA
Code Class Resolution Description 1d39 nuc 1.20 COPPER (II) ION 6(CU 2+) COVALENT MODIFICATION OF GUANINE BASES IN DOUBLE STRANDED DNA: THE 1.2 ANGSTROMS Z-DNA STRUCTURE OF D(CGCGCG) IN THE PRESENCE OF CUCL2 DNA (5'-D(*CP*(CU)GP*CP*(CU)GP*CP*(CU)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1d40 nuc 1.30 COPPER (II) ION 3(CU 2+) BASE SPECIFIC BINDING OF COPPER(II) TO Z-DNA: THE 1.3- ANGSTROMS SINGLE CRYSTAL STRUCTURE OF D(M5CGUAM5CG) IN THE PRESENCE OF CUCL2 DNA (5'-D(*(5CM)P*(CU)GP*UP*AP*(5CM)P*(CU)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1jes nuc 1.50 COPPER (II) ION 2(CU 2+) CRYSTAL STRUCTURE OF A COPPER-MEDIATED BASE PAIR IN DNA 5'-D(*CP*GP*CP*GP*(DPY)P*AP*TP*(DRP) P*CP*GP*CP*G)-3' DNA CU, COPPER, DNA, METAL, Z-DNA, DODECAMER, DUPLEX, UNNATURAL, DESIGNED 2jja nuc 1.30 COPPER (II) ION CU 2+ CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA 4u78 nuc 1.50 COPPER (II) ION 2(CU 2+) OCTAMERIC RNA DUPLEX SOAKED IN COPPER(II)CHLORIDE RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3') RNA RNA, DUPLEX, DIVALENT METAL IONS 4xqz nuc 2.15 COPPER (II) ION 6(CU 2+) CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY CHLORIDE AND MES DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA 4xsn nuc 1.45 COPPER (II) ION CU 2+ COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCGCG) DNA (5'-D(*CP*(BGM)P*CP*GP*CP*GP)-3') DNA Z-DNA, COPPER(II), DNA 5ihd nuc 1.57 COPPER (II) ION 4(CU 2+) CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY L-LACTATE AND SUCCINATE DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA
Code Class Resolution Description
3qsc nuc 2.40 [2,2'-{(4,5-DIFLUOROBENZENE-1,2-DIYL)BIS[(NITRILO- KAPPAN)METHYLYLIDENE]}BIS{5-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOLATO-KAPPAO}(2-)]COPPER (II) C34 H38 CU F2 N4 O4 THE FIRST CRYSTAL STRUCTURE OF A HUMAN TELOMERIC G-QUADRUPLE BOUND TO A METAL-CONTAINING LIGAND (A COPPER COMPLEX) 5'-D(*AP*GP*GP*GP*TP*(BRU)P*AP*GP*GP*GP*TP*T)-3' DNA PARALLEL, TELOMERE, QUADRUPLEX, DRUG, DNA, METAL COMPLEX, CO COMPLEX
Code Class Resolution Description 1d40 nuc 1.30 COPPER (II) CHLORIDE CL2 CU BASE SPECIFIC BINDING OF COPPER(II) TO Z-DNA: THE 1.3- ANGSTROMS SINGLE CRYSTAL STRUCTURE OF D(M5CGUAM5CG) IN THE PRESENCE OF CUCL2 DNA (5'-D(*(5CM)P*(CU)GP*UP*AP*(5CM)P*(CU)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED
Code Class Resolution Description
5eao nuc 2.99 [(1~{R},5~{R},6~{R},8~{R})-6-(4-AZANYL-2-OXIDANYLIDENE- PYRIMIDIN-1-YL)-3,3-BIS(OXIDANYL)-2,4,7-TRIOXA- 3$L^{4}-VANADABICYCLO[3.3.0]OCTAN-8-YL]METHYL DIHYDROGEN PHOSPHATE C9 H14 N3 O10 P V TWO ACTIVE SITE DIVALENT ION IN THE CRYSTAL STRUCTURE OF THE HAMMERHEAD RIBOZYME BOUND TO A TRANSITION STATE ANALOG-MG2+ RNA (5'-R(*GP*GP*GP*CP*GP*U*(CVC) *UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3'), RNA (48-MER) RNA RIBOZYME, HAMMERHEAD, RNA
5eaq nuc 3.20 [(1~{R},5~{R},6~{R},8~{R})-6-(4-AZANYL-2-OXIDANYLIDENE- PYRIMIDIN-1-YL)-3,3-BIS(OXIDANYL)-2,4,7-TRIOXA- 3$L^{4}-VANADABICYCLO[3.3.0]OCTAN-8-YL]METHYL DIHYDROGEN PHOSPHATE C9 H14 N3 O10 P V TWO ACTIVE SITE DIVALENT ION IN THE CRYSTAL STRUCTURE OF THE HAMMERHEAD RIBOZYME BOUND TO A TRANSITION STATE ANALOG-MN2+ RNA (48-MER), RNA (5'-R(*GP*GP*GP*CP*GP*U*(CVC) *UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3') RNA RIBOZYME, HAMMERHEAD, RNA
Code Class Resolution Description 1pqq nuc NMR 45-(3-AMINOPROPYL)-5,11,22,28,34-PENTAMETHYL-3,9,15, 20,26,32,38,43-OCTAOXO-2,5,8,14,19,22,25,28,31,34,37, 42,45,48-TETRADECAAZA-11-AZONIAHEPTACYCLO[42.2.1.1~4, 7~.1~10,13~.1~21,24~.1~27,30~.1~33,36~]DOPENTACONTA- 1(46),4(52),6,10(51),12,21(50),23,27(49), C45 H55 N16 O8 1+ NMR STRUCTURE OF A CYCLIC POLYAMIDE-DNA COMPLEX 5'-D(*CP*GP*CP*TP*AP*AP*CP*AP*GP*GP*C)-3', 5'-D(*GP*CP*CP*TP*GP*TP*TP*AP*GP*CP*G)-3' DNA DNA
Code Class Resolution Description 1at8 nuc model 2-DEOXYSTREPTAMINE C6 H14 N2 O3 THEORETICAL MODEL OF THE REV BINDING ELEMENT (RBE, 30 RIBONUCLEOTIDE FRAGMENT) OF HUMAN IMMUNODEFICIENCY VIRUS-1 COMPLEXED WITH NEOMYCIN B REV BINDING ELEMENT: 30 RIBONUCLEOTIDE FRAGMENT RIBONUCLEIC ACID RNA/AMINOGLYCOSIDE COMPLEX, MRNA TRANSPORT, INHIBITION OF VIRAL REPLICATION, RIBONUCLEIC ACID 1auf nuc model 2-DEOXYSTREPTAMINE C6 H14 N2 O3 THEORETICAL MODEL OF THE REV BINDING ELEMENT (RBE, 30 RIBONUCLEOTIDE FRAGMENT) OF HUMAN IMMUNODEFICIENCY VIRUS-1 COMPLEXED WITH TOBRAMYCIN REV BINDING ELEMENT: 30 RIBONUCLEOTIDE FRAGMENT RIBONUCLEIC ACID RNA/AMINOGLYCOSIDE COMPLEX, MRNA TRANSPORT, INHIBITION OF VIRAL REPLICATION, RIBONUCLEIC ACID 1pbr nuc NMR 2-DEOXYSTREPTAMINE C6 H14 N2 O3 STRUCTURE OF 16S RIBOSOMAL RNA, NMR, MINIMIZED AVERAGE STRUC 16S RIBOSOMAL RNA RNA AMINOGLYCOSIDE, RIBOSOMAL RNA, RNA TRANSCRIPT, ANTIBIOTIC, RIBONUCLEIC ACID, RNA 1qd3 nuc NMR 2-DEOXYSTREPTAMINE C6 H14 N2 O3 HIV-1 TAR RNA/NEOMYCIN B COMPLEX HIV-1 TAR RNA: RESIDUES 17-45 RNA NMR, HIV-1, AMINOGLYCOSIDE-RNA-COMPLEX, MINOR GROOVE BINDING
Code Class Resolution Description 1n4b nuc NMR 2'-DEOXY-N-ETHYLCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C11 H18 N3 O7 P SOLUTION STRUCTURE OF THE UNDECAMER CGAAAC*TTTCG 5'-D(*CP*GP*AP*AP*AP*D00*TP*TP*TP*CP*G)-3', 5'-D(*CP*GP*AP*AP*AP*CP*TP*TP*TP*CP*G)-3' DNA INTERSTRAND CROSS-LINK, ALKYLATED DNA, MODIFIED CYTOSINE, AL CYTOSINE, DNA
Code Class Resolution Description
298d nuc 2.20 2,5-BIS{[4-(N-ISOPROPYL)DIAMINOMETHYL]PHENYL}FURAN C24 H32 N4 O TARGETING THE MINOR GROOVE OF DNA: CRYSTAL STRUCTURES OF TWO COMPLEXES BETWEEN FURAN DERIVATIVES OF BERENIL AND THE DNA DODECAMER D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description
289d nuc 2.20 2,5-BIS{[4-(N-CYCLOPROPYLDIAMINOMETHYL)PHENYL]}FURAN C24 H28 N4 O TARGETING THE MINOR GROOVE OF DNA: CRYSTAL STRUCTURES OF TWO COMPLEXES BETWEEN FURAN DERIVATIVES OF BERENIL AND THE DNA DODECAMER D(CGCGAATTCGCG)2 DNA (5'-R(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description
1vzk nuc 1.77 2-(5-{4-[AMINO(IMINO)METHYL]PHENYL}-2- THIENYL)-1H-BENZIMIDAZOLE-6- CARBOXIMIDAMIDE DIHYDROCHLORIDE C19 H16 N6 S A THIOPHENE BASED DIAMIDINE FORMS A "SUPER" AT BINDING MINOR GROOVE AGENT 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP *CP*G)-3' NUCLEIC ACID NUCLEIC ACID, NUCLEIC ACIDS, MINOR GROOVE BINDER, DOUBLE HELIX, DNA-DRUG COMPLEX, MAGNESIUM-WATER COMPLEX, DNA HYDRATION
Code Class Resolution Description 1eel nuc 2.40 2,5-BIS-[4-[CYCLOPENTA-1,3-DIEN-5-YLAMINO-1- AMINOMETHYL]-PHEN-1-YL]FURAN C28 H28 N4 O STRUCTURE OF A COMPLEX BETWEEN THE DNA SEQUENCE DCGCGAATTCGCG AND BIS[PIPERIDINO-ETHYL]-FURAMIDINE 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA MINOR GROOVE BINDING LIGAND, B-DNA, BULKY SIDE-CHAINS
Code Class Resolution Description 2b0k nuc 1.64 2-(4'-AMIDINOBIPHENYL-4-YL)-1H-BENZIMIDAZOLE-5-AMIDINE C21 H18 N6 CRYSTAL STRUCTURE OF THE DB921-D(CGCGAATTCGCG)2 COMPLEX. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, DNA MINOR GROOVE BINDER, DNA MINOR GROOVE-LIGAND COMPLEX, DB921, A2T2 DICKERSON AND DREW DNA, CRYSTAL STRUCTURE OF B-DNA, DNA- DRUG COMPLEX, MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM, DNA HYDRATION. 4ah1 nuc 1.42 2-(4'-AMIDINOBIPHENYL-4-YL)-1H-BENZIMIDAZOLE- 5-AMIDINE C21 H18 N6 CRYSTAL STRUCTURE OF THE DB 921-D(CGCAAATTTGCG)2 COMPLEX AT 1.42 A RESOLUTION 5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*GP)-3' DNA DNA, DNA DOUBLE HELIX, MINOR GROOVE, DODECAMER, A3T3, DNA-DR COMPLEX, DNA HYDRATION,
Code Class Resolution Description
3d2x nuc 2.50 3-[(4-HYDROXY-2-METHYLPYRIMIDIN-5-YL)METHYL]-5-(2- {[(R)-HYDROXY(PHOSPHONOOXY)PHOSPHORYL]OXY}ETHYL)-4- METHYL-1,3-THIAZOL-3-IUM 2(C12 H18 N3 O8 P2 S 1+) STRUCTURE OF THE THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWITCH BOUND TO OXYTHIAMINE PYROPHOSPHATE TPP-SPECIFIC RIBOSWITCH RNA RNA, STRUCTURE, RIBOSWITCH, THIAMINE PYROPHOSPHATE, OXYTHIAMINE PYROPHOSPHATE, ANTIBIOTIC, DRUGS, COMPLEX
Code Class Resolution Description 1wan nuc NMR 1-(2-DEOXY-BETA-D-RIBOFURANOSYL)-4-(3-BENZAMIDO) PHENYLIMIDAZOLE C21 H22 N3 O7 P DNA DTA TRIPLEX, NMR, 7 STRUCTURES DNA (5'- D(*AP*GP*AP*TP*AP*GP*AP*AP*CP*CP*CP*CP*TP*TP*CP*TP*AP*TP*CP *TP*TP*AP*TP*AP*TP*CP*TP*(D3)P*TP*CP*TP*T)-3') DNA TRIPLEX, INTERCALATOR, DEOXYRIBONUCLEIC ACID, DNA
Code Class Resolution Description 2k67 nuc NMR 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-1H-IMIDAZOLE 3(C8 H13 N2 O6 P) NMR SOLUTION STRUCTURE OF MODIFIED DNA CONTAINING IMIDAZOLE NUCLEOSIDES AT ACIDIC PH DNA (5'-D(*DTP*DTP*DAP*DAP*DTP*DTP*DTP*(D33)P*(D3 P*DAP*DAP*DAP*DTP*DTP*DAP*DA)-3') DNA DNA 17-MER, HAIRPIN, ARTIFICIAL NUCLEOBASE, IMIDAZOLE NUCLEO SHIFTED PKA, DNA 2k68 nuc NMR 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-1H-IMIDAZOLE 3(C8 H13 N2 O6 P) NMR SOLUTION STRUCTURE OF MODIFIED DNA CONTAINING IMIDAZOLE NUCLEOSIDES AT NEUTRAL PH DNA (5'-D(*DTP*DTP*DAP*DAP*DTP*DTP*DTP*(D33) P*(D33)P*(D33)P*DAP*DAP*DAP*DTP*DTP*DAP*DA)-3') DNA DNA 17-MER, HAIRPIN, ARTIFICIAL NUCLEOBASE, IMIDAZOLE NUCLEOSIDE, SHIFTED PKA, NMR 2k69 nuc NMR 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-1H-IMIDAZOLE 3(C8 H13 N2 O6 P) NMR SOLUTION STRUCTURE OF MODIFIED DNA CONTAINING IMIDAZOLE NUCLEOSIDES AT BASIC PH DNA (5'-D(*DTP*DTP*DAP*DAP*DTP*DTP*DTP*(D33) P*(D33)P*(D33)P*DAP*DAP*DAP*DTP*DTP*DAP*DA)-3') DNA DNA 17-MER, HAIRPIN, ARTIFICIAL NUCLEOBASE, IMIDAZOLE NUCLEOSIDE, SHIFTED PKA, NMR 2ke8 nuc NMR 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-1H-IMIDAZOLE 6(C8 H13 N2 O6 P) NMR SOLUTION STRUCTURE OF METAL-MODIFIED DNA DNA (5'-D(*TP*TP*AP*AP*TP*TP*TP*(D33)P*(D33)P*(D3 P*AP*AP*AP*TP*TP*AP*A)-3') DNA DNA, ARTIFICIAL NUCLEOBASE, IMIDAZOLE NUCLEOSIDE, AG+ 2m54 nuc NMR 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-1H-IMIDAZOLE 6(C8 H13 N2 O6 P) REFINED NMR SOLUTION STRUCTURE OF METAL-MODIFIED DNA DNA (5'-D(*TP*TP*AP*AP*TP*TP*TP*(D33)P*(D33)P*(D3 P*AP*AP*AP*TP*TP*AP*A)-3') DNA DNA, ARTIFICIAL NUCLEOBASE, IMIDAZOLE NUCLEOSIDE
Code Class Resolution Description
1fmq nuc 2.00 2,5-BIS{[4-(N-CYCLOBUTYLDIAMINOMETHYL)PHENYL]}FURAN C26 H32 N4 O CYCLO-BUTYL-BIS-FURAMIDINE COMPLEXED WITH DCGCGAATTCGCG 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DNA-DRUG MINOR GROOVE COMPLEX
Code Class Resolution Description
1fms nuc 1.90 2,5-BIS{[4-(N-CYCLOHEXYLDIAMINOMETHYL)PHENYL]}FURAN C30 H40 N4 O STRUCTURE OF COMPLEX BETWEEN CYCLOHEXYL-BIS-FURAMIDINE AND D(CGCGAATTCGCG) 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DNA-DRUG MINOR GROOVE COMPLEX
Code Class Resolution Description 2m11 nuc NMR 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-1H-PERIMIDIN-2(3H)-ONE 2(C16 H17 N2 O7 P) STRUCTURE OF PERIMIDINONE-DERIVED SYNTHETIC NUCLEOSIDE PAIRE GUANINE IN DNA DUPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(D3N)P*GP*CP*G CHAIN: A, B DNA B-FORM DNA, DPER, PERIMIDINONE-DERIVED NUCLEOSIDE, DICKERSON DODECAMER, DNA 4hqi nuc 1.70 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-1H-PERIMIDIN-2(3H)-ONE 2(C16 H17 N2 O7 P) STRUCTURE OF O6-BENZYL-2'-DEOXYGUANOSINE OPPOSITE PERIMIDINO SYNTHETIC NUCLEOSIDE IN DNA DUPLEX SHORT MODIFIED NUCLEIC ACIDS DNA B-FORM DNA, O6-BENZYL-2'-DEOXYGUANOSINE, DPER, PERIMIDINONE- NUCLEOSIDE, DICKERSON-DREW DODECAMER, DNA
Code Class Resolution Description 3u08 nuc 1.25 4'-(5-CARBAMIMIDOYL-1H-BENZIMIDAZOL-2-YL)BIPHENYL-4- CARBOXAMIDE C21 H17 N5 O CRYSTAL STRUCTURE OF DB1963-D(CGCGAATTCGCG)2 COMPLEX AT 1.25 RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DNA MINOR GROOVE-LIGAND BINDER, DB1963, DNA
Code Class Resolution Description 3u0u nuc 1.24 2-(4'-CARBAMIMIDOYLBIPHENYL-4-YL)-1H-INDOLE-6- CARBOXIMIDAMIDE C22 H19 N5 CRYSTAL STRUCTURE OF THE DB1883-D(CGCGAATTCGCG)2 COMPLEX AT RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, MINOR GROOVE, DNA MINOR GROOVE BINDER, DB1883, DNA
Code Class Resolution Description 4agz nuc 1.25 2-(4'-CARBAMIMIDOYL-2'-HYDROXYBIPHENYL-4-YL)- 1H-BENZIMIDAZOLE-5-CARBOXIMIDAMIDE C21 H18 N6 O CRYSTAL STRUCTURE OF THE DB 985-D(CGCGAATTCGCG)2 COMPLEX AT RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*GP)-3' DNA DNA, DNA DOUBLE HELIX, DNA-DRUG COMPLEX, DNA HYDRATION 4ah0 nuc 1.20 2-(4'-CARBAMIMIDOYL-2'-HYDROXYBIPHENYL-4-YL)- 1H-BENZIMIDAZOLE-5-CARBOXIMIDAMIDE C21 H18 N6 O CRYSTAL STRUCTURE OF THE DB 985-D(CGCAAATTTGCG)2 COMPLEX AT RESOLUTION 5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*GP)-3' DNA DNA, MINOR GROOVE, DODECAMER, A3T3, DNA-DRUG COMPLEX, DNA HY HYDRATED MAGNESIUM
Code Class Resolution Description 367d nuc 1.20 5-BROMO-9-AMINO-N-ETHYL(DIAMINOMETHYL)ACRIDINE-4- CARBOXAMIDE 3(C18 H21 BR N4 O 2+) 1.2 A STRUCTURE DETERMINATION OF THE D(CG(5-BRU)ACG)2/5- BROMO-9-AMINO-DACA COMPLEX 5'-D(*CP*GP*(BRU)P*AP*CP*G)-3' DNA DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 366d nuc 1.30 6-BROMO-9-AMINO-N-ETHYL(DIAMINOMETHYL)ACRIDINE-4- CARBOXAMIDE 2(C18 H21 BR N4 O 2+) 1.3 A STRUCTURE DETERMINATION OF THE D(CG(5-BRU)ACG)2/6- BROMO-9-AMINO-DACA COMPLEX DNA (5'-D(*CP*GP*(BRU)P*AP*CP*G)-3') DNA DNA, DRUG INTERCALATION, MAJOR GROOVE BINDING
Code Class Resolution Description 1dl8 nuc 1.55 5-FLUORO-9-AMINO-(N-(2-DIMETHYLAMINO)ETHYL)ACRIDINE-4- CARBOXAMIDE 2(C18 H19 F N4 O) CRYSTAL STRUCTURE OF 5-F-9-AMINO-(N-(2-DIMETHYLAMINO)ETHYL) ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA INTERCALATION, DNA, ACRIDINE
Code Class Resolution Description 1pik nuc NMR 4,6-DIDEOXY-4-AMINO-BETA-D-GLUCOPYRANOSIDE C6 H13 N O4 ESPERAMICIN A1-DNA COMPLEX, NMR, 4 STRUCTURES DNA (5'-D(C*GP*GP*AP*TP*CP*CP*GP)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, DNA 2pik nuc NMR 4,6-DIDEOXY-4-AMINO-BETA-D-GLUCOPYRANOSIDE C6 H13 N O4 CALICHEAMICIN GAMMA1I-DNA COMPLEX, NMR, 6 STRUCTURES DNA(5'-D(C*AP*CP*TP*CP*CP*TP*GP*GP*TP*TP*TP*TP* TP*GP*TP*GP*AP*GP*GP*AP*CP*CP)-3') DNA DEOXYRIBONUCLEIC ACID, CALICHEAMICIN GAMMA1I - DNA COMPLEX, ENEDIYNE ALIGNMENT IN MINOR GROOVE, SACCHARIDE DNA MINOR GROOVE INTERACTIONS, INTERMOLECULAR DRUG IODINE-GUANINE AMINO PROTON INTERACTIONS, SPECIFICITY AND CLEAVAGE PROCESS
Code Class Resolution Description 1ykv nuc 3.30 (3AS,9AS)-2-PENTYL-4-HYDROXYMETHYL-3A,4,9,9A- TETRAHYDRO-4,9[1',2']-BENZENO-1H-BENZ[F]ISOINDOLE-1, 3(2H)-DIONE 2(C24 H25 N O3) CRYSTAL STRUCTURE OF THE DIELS-ALDER RIBOZYME COMPLEXED WITH PRODUCT OF THE REACTION BETWEEN N-PENTYLMALEIMIDE AND COVAL ATTACHED 9-HYDROXYMETHYLANTHRACENE DIELS-ALDER RIBOZYME, DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND, CATALYTIC MECHANISM, DIELS-ALDER REACTIO RIBOZYME, RNA 1yls nuc 3.00 (3AS,9AS)-2-PENTYL-4-HYDROXYMETHYL-3A,4,9,9A- TETRAHYDRO-4,9[1',2']-BENZENO-1H-BENZ[F]ISOINDOLE-1, 3(2H)-DIONE 2(C24 H25 N O3) CRYSTAL STRUCTURE OF SELENIUM-MODIFIED DIELS-ALDER RIBOZYME WITH THE PRODUCT OF THE REACTION BETWEEN N-PENTYLMALEIMIDE COVALENTLY ATTACHED 9-HYDROXYMETHYLANTHRACENE RNA DIELS-ALDER RIBOZYME, RNA DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND FORMATION, CATALYTIC MECHANISM, DIELS-ALD REACTION, RIBOZYME, RNA
Code Class Resolution Description 1jo1 nuc NMR DECARBAMOYL-2,7-DIAMINOMITOSENE 2(C13 H16 N3 O2 1+) N7-GUANINE ADDUCT OF 2,7-DIAMINOMITOSENE WITH DNA 5'-D(*GP*TP*GP*(DAJ)GP*TP*AP*TP*AP*CP*CP*AP*C)- 3' DNA DOUBLE HELIX, MAJOR GROOVE BINDING DRUG, GUANINE-N7- ALKYLATOR, DNA
Code Class Resolution Description 1d30 nuc 2.40 6-AMIDINE-2-(4-AMIDINO-PHENYL)INDOLE C16 H15 N5 THE STRUCTURE OF DAPI BOUND TO DNA DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 3ajl nuc 2.70 6-AMIDINE-2-(4-AMIDINO-PHENYL)INDOLE C16 H15 N5 CRYSTAL STRUCTURE OF D(CGCGGATF5UCGCG): 5-FORMYLURIDINE:GUAN BASE-PAIR IN B-DNA WITH DAPI 5'-D(*CP*GP*CP*GP*GP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DNA 3gjh nuc 2.90 6-AMIDINE-2-(4-AMIDINO-PHENYL)INDOLE C16 H15 N5 CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(B7C)P*GP*CP*G)-3' DNA DNA DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE, DNA 432d nuc 1.89 6-AMIDINE-2-(4-AMIDINO-PHENYL)INDOLE C16 H15 N5 D(GGCCAATTGG) COMPLEXED WITH DAPI DNA (5'-D(*GP*GP*CP*CP*AP*AP*TP*TP*GP*G)-3') DNA DEOXYRIBONUCLEIC ACID, DNA-DRUG COMPLEX, TRIPLET FORMATION, 4',6-DIAMIDINO-2-PHENYL INDOLE, DAPI, MINOR GROOVE BINDER
Code Class Resolution Description 2kmj nuc NMR D-ARGININE 4(C6 H15 N4 O2 1+) HIGH RESOLUTION NMR SOLUTION STRUCTURE OF A COMPLEX OF HIV-2 TAR RNA AND A SYNTHETIC TRIPEPTIDE IN A 1:2 STOICHIOMETRY PYRIMIDINYLPEPTIDE, RNA (28-MER) RNA/PEPTIDE RNA-LIGAND COMPLEX, BINDING STOICHIOMETRY, HIV-2 TAR, RNA/PEPTIDE COMPLEX
Code Class Resolution Description 1m69 nuc 1.10 5-BROMO-N[2-(DIMETHYLAMINO)ETHYL]-9-AMINOACRIDINE-4- CARBOXAMIDE 2(C18 H21 BR N4 O 2+) ATOMIC RESOLUTION STRUCTURE OF 5BR-9AMINO-DACA WITH D[CGTACG 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA ATOMIC RESOLUTION, ADENINE-THYMINE DISORDER, TOPOISOMERASE I DNA
Code Class Resolution Description
2nlm nuc 2.05 2-{4'-[AMINO(IMINO)METHYL]BIPHENYL-3-YL}-1H- BENZIMIDAZOLE-6-CARBOXIMIDAMIDE C21 H18 N6 CRYSTAL STRUCTURE OF THE DB 911- D(CGCGAATTCGCG)2 COMPLEX AT 2.05 A RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DNA DODECAMER WITH COMPOUND DB 911.
Code Class Resolution Description
2b3e nuc 1.36 6-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-2-{5-[4-(4,5-DIHYDRO- 1H-IMIDAZOL-2-YL)PHENYL]THIEN-2-YL}-1H-BENZIMIDAZOLE C23 H20 N6 S CRYSTAL STRUCTURE OF DB819-D(CGCGAATTCGCG)2 COMPLEX. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, DNA MINOR, GROOVE BINDER, DNA MINOR GROOVE-LIGAND COMPLEX, DB819, A2T2 DICKERSON AND DREW DODECAMER, CRYSTAL STRUCTURE OF B-DNA, DNA-DRUG COMPLEX, MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM, DNA HYDRATION.
Code Class Resolution Description 1p3x nuc NMR 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE 2(C9 H14 N3 O7 P) INTRAMOLECULAR DNA TRIPLEX WITH 1-PROPYNYL DEOXYURIDINE IN THE THIRD STRAND, NMR, 10 STRUCTURES DNA (5'-D(*AP*GP*AP*GP*AP*GP*AP*A)-3'), DNA (5'-D(*TP*TP*CP*TP*CP*TP*CP*T)-3') DNA OLIGONUCLEOTIDE, TRIPLEX, PROPYNE, DNA 3zd4 nuc 2.20 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C9 H14 N3 O7 P FULL-LENGTH HAMMERHEAD RIBOZYME WITH G12A SUBSTITUTION AT THE GENERAL BASE POSITION HAMMERHEAD RIBOZYME, ENZYME STRAND, HAMMERHEAD RIBOZYME, SUBSTRATE STRAND RNA RNA, GENERAL BASE CATALYSIS 3zd5 nuc 2.20 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C9 H14 N3 O7 P THE 2.2 A STRUCTURE OF A FULL-LENGTH CATALYTICALLY ACTIVE HAMMERHEAD RIBOZYME HAMMERHEAD RIBOZYME, ENZYME STRAND, HAMMERHEAD RIBOZYME, SUBSTRATE STRAND RNA CATALYTIC RNA, IN-LINE ATTACK, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, RNA
Code Class Resolution Description 1p3x nuc NMR 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C9 H14 N3 O7 P INTRAMOLECULAR DNA TRIPLEX WITH 1-PROPYNYL DEOXYURIDINE IN THE THIRD STRAND, NMR, 10 STRUCTURES DNA (5'-D(*AP*GP*AP*GP*AP*GP*AP*A)-3'), DNA (5'-D(*TP*TP*CP*TP*CP*TP*CP*T)-3') DNA OLIGONUCLEOTIDE, TRIPLEX, PROPYNE, DNA 3g2r nuc 2.15 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C9 H14 N3 O7 P CRYSTAL STRUCTURE OF D(CACGCG).D(CGCGTG) COCRYSTALLIZED WITH MNCL2 5'-D(*CP*GP*TP*GP*CP*G)-3' DNA DUPLEX Z-FORM DNA WITH WATSON-CRICK BASE PAIRING
Code Class Resolution Description 3qba nuc 1.53 2'-DEOXYCYTIDINE 2(C9 H13 N3 O4) REINTRODUCING ELECTROSTATICS INTO MACROMOLECULAR CRYSTALLOGR REFINEMENT: Z-DNA (X-RAY) Z-DNA DNA Z-DNA, DNA
Code Class Resolution Description 146d nuc NMR 2,6-DIDEOXY-BETA-D-GLUCOSE 6(C6 H12 O4) SOLUTION STRUCTURE OF THE MITHRAMYCIN DIMER-DNA COMPLEX DNA (5'-D(*TP*CP*GP*CP*GP*A)-3') DNA DNA, NMR, MITHRAMYCIN DIMER 1bp8 nuc NMR 2,6-DIDEOXY-BETA-D-GLUCOSE 12(C6 H12 O4) 4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX 5'-D(*AP*CP*CP*CP*GP*GP*GP*T)-3' DNA MITHRAMYCIN, DNA, OLIGONUCLEOTIDE, NMR 1cp8 nuc NMR 2,6-DIDEOXY-BETA-D-GLUCOSE 6(C6 H12 O4) NMR STRUCTURE OF DNA (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9 DNA (5'-D(P*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DNA 1ekh nuc NMR 2,6-DIDEOXY-BETA-D-GLUCOSE 4(C6 H12 O4) NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND CO DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1eki nuc NMR 2,6-DIDEOXY-BETA-D-GLUCOSE 4(C6 H12 O4) AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMY COBALT DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 207d nuc NMR 2,6-DIDEOXY-BETA-D-GLUCOSE 12(C6 H12 O4) SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA DNA (5'-D(*TP*AP*GP*CP*TP*AP*GP*CP*TP*A)-3') DNA DNA, NMR, DOUBLE HELIX, MITHRAMYCIN
Code Class Resolution Description 1p96 nuc NMR SPIRO[NAPHTHALENE-2(3H),3'(10'H)-PENTALENO[1,2- B]NAPHTHALENE]-3,10'-DIONE, 2'-[(2-AMINO-2-DEOXY-B-D- GULOPYRANOSYL)OXY]-1,1',2',3'A,4,10'A-HEXAHYDRO-,(2'R, 3'AS,10'AR)-(9CI) C31 H31 N O7 SOLUTION STRUCTURE OF A WEDGE-SHAPED SYNTHETIC MOLECULE AT A TWO-BASE BULGE SITE IN DNA 5'-D(*GP*TP*CP*CP*GP*AP*TP*GP*CP*GP*TP*G)-3', 5'-D(*CP*AP*CP*GP*CP*AP*GP*TP*TP*CP*GP*GP*AP*C)- 3' DNA WEDGE-SHAPED SYNTHETIC DRUG-BULGED DNA COMPLEX 1r4e nuc NMR SPIRO[NAPHTHALENE-2(3H),3'(10'H)-PENTALENO[1,2- B]NAPHTHALENE]-3,10'-DIONE, 2'-[(2-AMINO-2-DEOXY-B-D- GULOPYRANOSYL)OXY]-1,1',2',3'A,4,10'A-HEXAHYDRO-,(2'R, 3'AS,10'AR)-(9CI) C31 H31 N O7 SOLUTION STRUCTURE OF THE COMPLEX FORMED BETWEEN A LEFT-HAND SHAPED SPIROCYCLIC MOLECULE AND BULGED DNA 5'-D(*GP*TP*CP*CP*GP*AP*TP*GP*CP*GP*TP*G)-3', 5'-D(*CP*AP*CP*GP*CP*AP*GP*TP*TP*CP*GP*GP*AP*C)-3 CHAIN: A DNA WEDGE-SHAPED SPIROCYCLIC ENANTIOMER-BULGED DNA COMPLEX, DNA
Code Class Resolution Description 146d nuc NMR 2,6-DIDEOXY-BETA-D-GALACTOSE 2(C6 H12 O4) SOLUTION STRUCTURE OF THE MITHRAMYCIN DIMER-DNA COMPLEX DNA (5'-D(*TP*CP*GP*CP*GP*A)-3') DNA DNA, NMR, MITHRAMYCIN DIMER 1bp8 nuc NMR 2,6-DIDEOXY-BETA-D-GALACTOSE 4(C6 H12 O4) 4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX 5'-D(*AP*CP*CP*CP*GP*GP*GP*T)-3' DNA MITHRAMYCIN, DNA, OLIGONUCLEOTIDE, NMR 1cp8 nuc NMR 2,6-DIDEOXY-BETA-D-GALACTOSE 2(C6 H12 O4) NMR STRUCTURE OF DNA (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9 DNA (5'-D(P*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DNA 207d nuc NMR 2,6-DIDEOXY-BETA-D-GALACTOSE 4(C6 H12 O4) SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA DNA (5'-D(*TP*AP*GP*CP*TP*AP*GP*CP*TP*A)-3') DNA DNA, NMR, DOUBLE HELIX, MITHRAMYCIN
Code Class Resolution Description 1bw7 nuc NMR 1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE- 5'MONOPHOSPHATE C12 H15 F2 O6 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING A REPLICABLE DIFLUOROTOLUENE-ADENINE PAIR DNA (5'-D(*CP*GP*CP*AP*TP*(DFT)P*GP*TP*TP*AP*CP*C CHAIN: ADNA (5'-D(*GP*GP*TP*AP*AP*CP*AP*AP*TP*GP*CP*G)-3' CHAIN: B DNA DNA, DIFLUOROTOLUENE 1eek nuc NMR 1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL- BENZENE-5'MONOPHOSPHATE C12 H15 F2 O6 P SOLUTION STRUCTURE OF A NONPOLAR, NON HYDROGEN BONDED BASE PAIR SURROGATE IN DNA. 5'-D(*GP*GP*TP*AP*AP*CP*(MBZ)P*AP*TP*GP*CP*G)-3', 5'-D(*CP*GP*CP*AP*TP*(DFT)P*GP*TP*TP*AP*CP*C)-3' DNA DNA, NONPOLAR, ISOSTERIC, DNA BASE ANALOGS
Code Class Resolution Description 3slm nuc 2.70 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O7 P) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA
Code Class Resolution Description 334d nuc 1.80 DIIMIDAZOLE LEXITROPSIN 2(C14 H20 N9 O3 1+) DEFINING GC-SPECIFICITY IN THE MINOR GROOVE: SIDE-BY-SIDE BINDING OF THE DI-IMIDAZOLE LEXITROPSIN TO C-A-T-G-G-C-C-A- T-G DNA (5'-D(*CP*AP*TP*GP*GP*CP*CP*AP*TP*G)-3') DNA B-DNA, DOUBLE HELIX
Code Class Resolution Description 1d32 nuc 1.70 DITERCALINIUM C46 H50 N6 O2 2+ DRUG-INDUCED DNA REPAIR: X-RAY STRUCTURE OF A DNA- DITERCALINIUM COMPLEX DNA (5'-D(*CP*GP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1pik nuc NMR 2-DEOXY-ALPHA-L-FUCOPYRANOSIDE C6 H12 O4 ESPERAMICIN A1-DNA COMPLEX, NMR, 4 STRUCTURES DNA (5'-D(C*GP*GP*AP*TP*CP*CP*GP)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, DNA
Code Class Resolution Description 110d nuc 1.90 DAUNOMYCIN C27 H29 N O10 ANTHRACYCLINE-DNA INTERACTIONS AT UNFAVOURABLE BASE BASE- PAIR TRIPLET-BINDING SITES: STRUCTURES OF D(CGGCCG) /DAUNOMYCIN AND D(TGGCCA)/ADRIAMYCIN COMPL DNA (5'-D(*CP*GP*GP*CP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 152d nuc 1.40 DAUNOMYCIN C27 H29 N O10 DIVERSITY OF WATER RING SIZE AT DNA INTERFACES: HYDRATION AND DYNAMICS OF DNA-ANTHRACYCLINE COMPLEXES DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d10 nuc 1.50 DAUNOMYCIN C27 H29 N O10 STRUCTURAL COMPARISON OF ANTICANCER DRUG-DNA COMPLEXES. ADRIAMYCIN AND DAUNOMYCIN DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d11 nuc 1.18 DAUNOMYCIN C27 H29 N O10 INTERACTIONS BETWEEN AN ANTHRACYCLINE ANTIBIOTIC AND DNA MOL STRUCTURE OF DAUNOMYCIN COMPLEXED TO D(CPGPTPAPCPG) AT 1.2- RESOLUTION DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1d33 nuc 1.50 DAUNOMYCIN C27 H29 N O10 FORMALDEHYDE CROSS-LINKS DAUNORUBICIN AND DNA EFFICIENTLY: HPLC AND X-RAY DIFFRACTION STUDIES 5'-D(*CP*GP*CP*(G49)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1da0 nuc 1.50 DAUNOMYCIN C27 H29 N O10 DNA-DRUG INTERACTIONS: THE CRYSTAL STRUCTURE OF D(CGATCG) COMPLEXED WITH DAUNOMYCIN DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1jo2 nuc 1.50 DAUNOMYCIN C27 H29 N O10 CRYSTAL STRUCTURE OF THE B-DNA HEXAMER (CGATCG).DAUNOMYCIN COMPLEX CONTAINING A RIBOSE AT THE INTERCALATION SITE 5'-D(*C)-R(P*G)-D(P*AP*TP*CP*G)-3' DNA, RNA INTERCALATION, DNA/RNA CHIMER, DNA, RNA 1o0k nuc 1.17 DAUNOMYCIN 3(C27 H29 N O10) STRUCTURE OF THE FIRST PARALLEL DNA QUADRUPLEX-DRUG COMPLEX 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA G-4 QUADRUPLEX DRUG COMPLEX, PARALLEL QUADRUPLEX, DNA 1vth nuc 1.60 DAUNOMYCIN C27 H29 N O10 DNA-DRUG INTERACTIONS: THE CRYSTAL STRUCTURES OF D(TGTACA) C WITH DAUNOMYCIN DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1vti nuc 1.70 DAUNOMYCIN C27 H29 N O10 DNA-DRUG INTERACTIONS: THE CRYSTAL STRUCTURES OF D(TGATCA) C WITH DAUNOMYCIN DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 2d34 nuc 1.40 DAUNOMYCIN C27 H29 N O10 FORMALDEHYDE CROSS-LINKS DAUNORUBICIN AND DNA EFFICIENTLY: HPLC AND X-RAY DIFFRACTION STUDIES 5'-D(*CP*GP*TP*(A35)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 308d nuc 1.50 DAUNOMYCIN 2(C27 H29 N O10) BINDING OF DAUNOMYCIN TO B-D-GLUCOSYLATED DNA FOUND IN PROTOZOA TRYPANOSOMA BRUCEI STUDIED BY X-RAY CRYSTALLOGRAPH DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 3tvb nuc 1.08 DAUNOMYCIN 4(C27 H29 N O10) A HIGHLY SYMMETRIC DNA G-4 QUADRUPLEX/DRUG COMPLEX DNA (5'-D(*GP*GP*GP*G)-3') DNA/ANTIBIOTIC G-4 QUADRUPLEX, DAUNOMYCIN, DNA-DRUG COMPLEX, DNA-ANTIBIOTIC 427d nuc 1.10 DAUNOMYCIN C27 H29 N O10 5'-D(*CP*GP*CP*(CH2-DM1)GP*CP*G)-3' DNA (5'-D(*CP*GP*CP*(G49)P*CP*G)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, FORMALDEHYDE CROSS- LINK, ATOMIC RESOLUTION, DOUBLE BACKBONE CONFORMATION, DNA
Code Class Resolution Description 151d nuc 1.40 DOXORUBICIN C27 H29 N O11 DIVERSITY OF WATER RING SIZE AT DNA INTERFACES: HYDRATION AND DYNAMICS OF DNA-ANTHRACYCLINE COMPLEXES DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d12 nuc 1.70 DOXORUBICIN C27 H29 N O11 STRUCTURAL COMPARISON OF ANTICANCER DRUG-DNA COMPLEXES. ADRIAMYCIN AND DAUNOMYCIN DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1da9 nuc 1.70 DOXORUBICIN C27 H29 N O11 ANTHRACYCLINE-DNA INTERACTIONS AT UNFAVOURABLE BASE BASE- PAIR TRIPLET-BINDING SITES: STRUCTURES OF D(CGGCCG) /DAUNOMYCIN AND D(TGGCCA)/ADRIAMYCIN COMPL DNA (5'-D(*TP*GP*GP*CP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1p20 nuc 1.34 DOXORUBICIN C27 H29 N O11 SURPRISING ROLES OF ELECTROSTATIC INTERACTIONS IN DNA- LIGAND COMPLEXES 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA ADRIAMYCIN, INTERCALATION, ELECTROSTATICS, THALLIUM, DNA
Code Class Resolution Description 1d14 nuc 1.50 6-DEOXYDAUNOMYCIN C27 H29 N O9 STRUCTURE OF 11-DEOXYDAUNOMYCIN BOUND TO DNA CONTAINING A PHOSPHOROTHIOATE DNA (5'-D(*CP*GP*TP*(AS)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 1d37 nuc 1.80 1-O-DEMETHYL-6-DEOXYDOXORUBICIN C26 H27 N O10 INFLUENCE OF AGLYCONE MODIFICATIONS ON THE BINDING OF ANTHRACYCLINE DRUGS TO DNA: THE MOLECULAR STRUCTURE OF IDARUBICIN AND 4-O-DEMETHYL-11-DEOXYDOXORUBICIN COMPLEXED TO D(CGATCG) DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 198d nuc 1.97 IDARUBICIN 4(C26 H27 N O9) A TRIGONAL FORM OF THE IDARUBICIN-D(CGATCG) COMPLEX: CRYSTAL AND MOLECULAR STRUCTURE AT 2.0 ANGSTROMS RESOLUTION DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d38 nuc 1.70 IDARUBICIN C26 H27 N O9 INFLUENCE OF AGLYCONE MODIFICATIONS ON THE BINDING OF ANTHRACYCLINE DRUGS TO DNA: THE MOLECULAR STRUCTURE OF IDARUBICIN AND 4-O-DEMETHYL-11-DEOXYDOXORUBICIN COMPLEXED TO D(CGATCG) DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d67 nuc 1.60 IDARUBICIN C26 H27 N O9 THE MOLECULAR STRUCTURE OF AN IDARUBICIN-D(TGATCA) COMPLEX AT HIGH RESOLUTION DNA (5'-D(*TP*GP*AP*TP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1d15 nuc 1.50 4'-EPIDOXORUBICIN C27 H30 N O11 1+ TERNARY INTERACTIONS OF SPERMINE WITH DNA: 4'-EPIADRIAMYCIN AND OTHER DNA: ANTHRACYCLINE COMPLEXES DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d54 nuc 1.40 4'-EPIDOXORUBICIN C27 H30 N O11 1+ ANTHRACYCLINE BINDING TO DNA: HIGH RESOLUTION STRUCTURE OF D(TGTACA) COMPLEXED WITH 4'-EPIADRIAMYCIN DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d58 nuc 1.70 4'-EPIDOXORUBICIN C27 H30 N O11 1+ THE MOLECULAR STRUCTURE OF A 4'-EPIADRIAMYCIN COMPLEX WITH D(TGATCA) AT 1.7 ANGSTROM RESOLUTION-COMPARISON WITH THE STRUCTURE OF 4'-EPIADRIAMYCIN D(TGTACA) AND D(CGATCG) COMPLEXES DNA (5'-D(*TP*GP*AP*TP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1qda nuc 1.60 4'-EPIDOXORUBICIN C27 H30 N O11 1+ CRYSTAL STRUCTURE OF EPIDOXORUBICIN-FORMALDEHYDE VIRTUAL CRO DNA 5' -D(CP*GP*CP*(G49)P*CP*GP)-3' DNA DOUBLE HELIX, DRUG-DNA COMPLEX, DNA
Code Class Resolution Description 1imr nuc 1.60 4'-DEOXY-4'-IODODOXORUBICIN C27 H29 I N O10 1+ MOLECULAR STRUCTURE OF THE HALOGENATED ANTI-CANCER DRUG IODODOXORUBICIN COMPLEXED WITH D(TGTACA) AND D(CGATCG) DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1ims nuc 1.50 4'-DEOXY-4'-IODODOXORUBICIN C27 H29 I N O10 1+ MOLECULAR STRUCTURE OF THE HALOGENATED ANTI-CANCER DRUG IODODOXORUBICIN COMPLEXED WITH D(TGTACA) AND D(CGATCG) DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 276d nuc 1.80 2'-BROMO-4'-EPIDAUNORUBICIN C27 H28 BR N O10 SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 277d nuc 1.80 2'-BROMO-4'-EPIDAUNORUBICIN C27 H28 BR N O10 SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY 5'-D(*CP*GP*CP*(G49)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 278d nuc 1.80 2'-BROMO-4'-EPIDAUNORUBICIN C27 H28 BR N O10 SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY DNA (5'-D(*CP*GP*(G49)P*CP*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 288d nuc 1.80 2'-BROMO-4'-EPIDAUNORUBICIN C27 H28 BR N O10 SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 380d nuc 2.00 2'-BROMO-4'-EPIDAUNORUBICIN 2(C27 H28 BR N O10) BINDING OF THE MODIFIED DAUNORUBICIN WP401 ADJACENT TO A T-G INDUCES THE REVERSE WATSON-CRICK CONFORMATION: CRYSTAL STRU THE WP401-TGGCCG AND WP401-CGG[BR5C]CG COMPLEXES DNA (5'-D(*CP*GP*(G49)P*(CBR)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, MODIFIED, DNA 381d nuc 2.10 2'-BROMO-4'-EPIDAUNORUBICIN 2(C27 H28 BR N O10) BINDING OF THE MODIFIED DAUNORUBICIN WP401 ADJACENT TO A T-G INDUCES THE REVERSE WATSON-CRICK CONFORMATION: CRYSTAL STRU THE WP401-TGGCCG AND WP401-CGG[BR5C]CG COMPLEXES DNA (5'-D(*TP*GP*(G49)P*CP*CP*G)-3'), DNA (5'-D(*TP*GP*GP*CP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE MISMATCHED, DNA
Code Class Resolution Description 482d nuc 1.54 N-HYDROXYMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN C31 H39 N O12 RELEASE OF THE CYANO MOIETY IN THE CRYSTAL STRUCTURE OF N- CYANOMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN COMPLEXED WITH D(CGATCG) 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 215d nuc 1.70 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN C32 H37 N O13 CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 234d nuc 1.80 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN C32 H37 N O13 CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 235d nuc 1.80 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN C32 H37 N O13 CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 2des nuc 1.50 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN 2(C32 H37 N O13) INTERACTIONS BETWEEN MORPHOLINYL ANTHRACYCLINES AND DNA: THE CRYSTAL STRUCTURE OF A MORPHOLINO DOXORUBICIN BOUND TO D(CGTACG) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 159d nuc 1.80 DISTAMYCIN A C22 H27 N9 O4 SIDE BY SIDE BINDING OF TWO DISTAMYCIN A DRUGS IN THE MINOR GROOVE OF AN ALTERNATING B-DNA DUPLEX DNA (5'-D(*IP*CP*IP*CP*IP*CP*IP*C)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1jtl nuc 1.85 DISTAMYCIN A C22 H27 N9 O4 THE CRYSTAL STRUCTURE OF D(GGCCAATTGG) COMPLEXED WITH DISTAMYCIN 5'-D(*GP*GP*CP*CP*AP*AP*TP*TP*GP*G)-3' DNA B-DNA DOUBLE HELIX, BASE TRIPLETS, MINOR GROOVE BINDING, DRUG, DISTAMYCIN 1jux nuc 1.60 DISTAMYCIN A C22 H27 N9 O4 1.6A RESOLUTION CRYSTAL STRUCTURES OF THE DNA OCTAMERS D(IUATATAC) AND D(ITITACAC):BINDING OF TWO DISTAMYCIN DRUGS SIDE-BY-SIDE 5'-D(*IP*TP*IP*TP*AP*CP*AP*C)-3' DNA DNA, OCTAMER, DISTAMYCIN, SIDE-BY-SIDE 1k2z nuc 2.38 DISTAMYCIN A C22 H27 N9 O4 THE CRYSTAL STRUCTURE OF D(GGCCAATTGG) COMPLEXED WITH DISTAMYCIN. 5'-D(*GP*GP*CP*CP*AP*AP*TP*TP*GP*G)-3' DNA B-DNA DOUBLE HELIX, BASE TRIPLETS, MINOR GROOVE BINDING, DRUG, DISTAMYCIN 216d nuc 1.73 DISTAMYCIN A C22 H27 N9 O4 CRYSTAL STRUCTURES OF THE B-FORM DNA-RNA CHIMER (5'-D(*IP*)- R(*CP*)-D(*IP*CP*IP*CP*IP*C)-3') COMPLEXED WITH DISTAMYCIN DNA/RNA (5'-D(*IP*)-R(*CP*)-D(*IP*CP*IP*CP*IP*C)- 3') DNA-RNA HYBRID B-DNA/RNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED, DNA- RNA HYBRID 217d nuc 1.70 DISTAMYCIN A C22 H27 N9 O4 CRYSTAL STRUCTURES OF THE B-FORM DNA-RNA CHIMER (5'-D(*IP*)- R(*CP*)-D(*IP*)-R(*CP*)-D(*IP*CP*IP*C)-3') COMPLEXED WITH DISTAMYCIN DNA/RNA (5'-D(*IP*)-R(*CP*)-D(*IP*)-R(*CP*)- D(*IP*CP*IP*C)-3') DNA-RNA HYBRID B-DNA/RNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED, DNA- RNA HYBRID 267d nuc 2.00 DISTAMYCIN A C22 H27 N9 O4 STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA 2dnd nuc 2.20 DISTAMYCIN A C22 H27 N9 O4 A BIFURCATED HYDROGEN-BONDED CONFORMATION IN THE D(A.T) BASE PAIRS OF THE DNA DODECAMER D(CGCAAATTTGCG) AND ITS COMPLEX WITH DISTAMYCIN DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 2jt7 nuc NMR DISTAMYCIN A 4(C22 H27 N9 O4) NMR SOLUTION STRUCTURE OF THE 4:1 DISTAMYCIN A/[D(TGGGGT)]4 COMPLEX DNA (5'-D(*DTP*DGP*DGP*DGP*DGP*DT)-3') DNA QUADRUPLEX, DISTAMYCIN A, TGGGGT, COMPLEX, TELOMERE, DNA 304d nuc 1.90 DISTAMYCIN A C22 H27 N9 O4 SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICATATIC) IN THE MONOCLINIC FORM DNA (5'-D(*IP*CP*AP*TP*AP*TP*IP*C)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DOUBLE DRUG IN THE MINOR GROOVE 305d nuc 2.17 DISTAMYCIN A C22 H27 N9 O4 SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICATATIC) IN THE TETRAGONAL FORM DNA (5'-D(*IP*CP*AP*TP*AP*TP*IP*C)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DOUBLE DRUG IN THE MINOR GROOVE 306d nuc 1.60 DISTAMYCIN A C22 H27 N9 O4 SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICITACIC) DNA (5'-D(*IP*CP*IP*TP*AP*CP*IP*C)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DOUBLE DRUG IN THE MINOR GROOVE 378d nuc 2.40 DISTAMYCIN A 4(C22 H27 N9 O4) STRUCTURE OF THE SIDE-BY-SIDE BINDING OF DISTAMYCIN TO DNA DNA (5'-D(*GP*TP*AP*TP*AP*TP*AP*C)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, DOUBLE DRUG IN MINOR GROOVE
Code Class Resolution Description 1ihh nuc 2.40 1R,2R-DIAMINOCYCLOHEXANE C6 H14 N2 2.4 ANGSTROM CRYSTAL STRUCTURE OF AN OXALIPLATIN 1,2-D(GPG) INTRASTRAND CROSS-LINK IN A DNA DODECAMER DUPLEX 5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3', 5'-D(*CP*CP*TP*CP*TP*GP*GP*TP*CP*TP*CP*C)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, OXALIPLATIN, MODIFIED, DEOXYNUCLEIC ACID
Code Class Resolution Description 1laq nuc NMR 2'-DEOXY-N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O7 P 1+ SOLUTION STRUCTURE OF THE B-DNA DUPLEX CGCGGTXTCCGCG (X=PDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT WITH THE DEOXYRIBOSE AT C20 OPPOSITE PDG IN THE C2' ENDO CONFORMATION. 5'-D(*CP*GP*CP*GP*GP*AP*(DNR)P*AP*CP*CP*GP*CP*G)- 3', 5'-D(*CP*GP*CP*GP*GP*TP*(P)P*TP*CP*CP*GP*CP*G)- 3' DNA DNA, B-TYPE, NMR, PROPANODEOXYGUANOSINE 1las nuc NMR 2'-DEOXY-N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE C9 H15 N3 O7 P 1+ SOLUTION STRUCTURE OF THE B-DNA DUPLEX CGCGGTXTCCGCG (X=PDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT WITH THE DEOXYRIBOSE AT C20 OPPOSITE PDG IN THE C3' ENDO CONFORMATION. 5'-D(*CP*GP*CP*GP*GP*AP*(DNR)P*AP*CP*CP*GP*CP*G)- 3', 5'-D(*CP*GP*CP*GP*GP*TP*(P)P*TP*CP*CP*GP*CP*G)- 3' DNA DNA, B-TYPE, NMR, PROPANODEOXYGUANOSINE 1r2l nuc NMR 2'-DEOXY-N3-PROTONATED CYTIDINE-5'-MONOPHOSPHATE 4(C9 H15 N3 O7 P 1+) A PARALLEL STRANDED DNA DUPLEX WITH AN A-G MISMATCH BASE- PAIR DNA (5'-D(P*(DNR)P*(DNR) P*DAP*DTP*DAP*DAP*DTP*DTP*DTP*DAP*(DNR)P*(DNR))-3'), 5'-D(P*CP*CP*TP*AP*TP*GP*AP*AP*AP*TP*CP*C)-3' DNA PS-DNA, A:G MISMATCH, PARALLEL DNA DUPLEX
Code Class Resolution Description 1pik nuc NMR 4,5-DIMETHOXY-N-(2'-METHOXYPROPENOYL ANTHRANILATE) C13 H15 N O5 ESPERAMICIN A1-DNA COMPLEX, NMR, 4 STRUCTURES DNA (5'-D(C*GP*GP*AP*TP*CP*CP*GP)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, DNA
Code Class Resolution Description 1jes nuc 1.50 2-DEOXYRIBOFURANOSYL-PYRIDINE-2,6-DICARBOXYLIC ACID- 5'-MONOPHOSPHATE 2(C12 H14 N O10 P) CRYSTAL STRUCTURE OF A COPPER-MEDIATED BASE PAIR IN DNA 5'-D(*CP*GP*CP*GP*(DPY)P*AP*TP*(DRP) P*CP*GP*CP*G)-3' DNA CU, COPPER, DNA, METAL, Z-DNA, DODECAMER, DUPLEX, UNNATURAL, DESIGNED
Code Class Resolution Description 1k9g nuc 1.40 5-METHYL-5H-INDOLO[3,2-B]QUINOLINE 2(C16 H12 N2) CRYSTAL STRUCTURE OF THE COMPLEX OF CRYPTOLEPINE-D(CCTAGG)2 5'-D(*CP*CP*TP*AP*GP*G)-3' DNA DNA INTERCALATOR COMPLEX
Code Class Resolution Description 1kci nuc 1.80 9-AMINO-N-[2-(4-MORPHOLINYL)ETHYL]-4- ACRIDINECARBOXAMIDE 2(C20 H22 N4 O2) CRYSTAL STRUCTURE OF 9-AMINO-N-[2-(4-MORPHOLINYL)ETHYL]-4- ACRIDINECARBOXAMIDE BOUND TO D(CGTACG)2 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA, INTERCALATOR, AMINOACRIDINECARBOXAMIDE
Code Class Resolution Description 1cp8 nuc NMR 4-O-METHYL-2,6-DIDEOXY-BETA-D-GLUCOSE 2(C7 H14 O4) NMR STRUCTURE OF DNA (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9 DNA (5'-D(P*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DNA
Code Class Resolution Description 1jes nuc 1.50 2-DEOXYRIBOFURANOSYL-PYRIDINE-5'-MONOPHOSPHATE 2(C10 H14 N O6 P) CRYSTAL STRUCTURE OF A COPPER-MEDIATED BASE PAIR IN DNA 5'-D(*CP*GP*CP*GP*(DPY)P*AP*TP*(DRP) P*CP*GP*CP*G)-3' DNA CU, COPPER, DNA, METAL, Z-DNA, DODECAMER, DUPLEX, UNNATURAL, DESIGNED
Code Class Resolution Description 1dsa nuc NMR 4-HYDROXY-8-METHYL-6-(4,5,6-TRIMETHOXY-1H-INDOLE-2- CARBONYL)-3,6,7,8-TETRAHYDRO-3,6-DIAZA-AS-INDACENE-2- CARBOXYLIC ACID METHYL ESTER C25 H25 N3 O7 (+)-DUOCARMYCIN SA COVALENTLY LINKED TO DUPLEX DNA, NMR, 20 STRUCTURES DNA (5'-D(*GP*AP*CP*TP*AP*AP*TP*TP*GP*AP*C)-3', 5'-D(*GP*TP*CP*AP*AP*TP*TP*AP*GP*TP*C)-3'), DNA (5'-D(*GP*AP*CP*TP*AP*AP*TP*TP*GP*AP*C)-3', 5'-D(*GP*TP*CP*AP*AP*TP*TP*AP*GP*TP*C)-3') DNA DUOCARMYCIN, DNA, MINOR GROOVE BINDING, ANTITUMOR AGENT, DRUG-DNA COMPLEX, DEOXYRIBONUCLEIC ACID 1dsm nuc NMR 4-HYDROXY-8-METHYL-6-(4,5,6-TRIMETHOXY-1H-INDOLE-2- CARBONYL)-3,6,7,8-TETRAHYDRO-3,6-DIAZA-AS-INDACENE-2- CARBOXYLIC ACID METHYL ESTER C25 H25 N3 O7 (-)-DUOCARMYCIN SA COVALENTLY LINKED TO DUPLEX DNA 5'-D(*GP*AP*CP*TP*AP*AP*TP*TP*GP*AP*C)-3', 5'-D(*GP*TP*CP*AP*AP*TP*TP*AP*GP*TP*C)-3' DNA DUOCARMYCIN, DNA, MINOR GROOVE BINDING, ANTITUMOR AGENT, DRUG-DNA COMPLEX
Code Class Resolution Description 1dsi nuc NMR 4-HYDROXY-6-(1H-INDOLE-2-CARBONYL)-8-METHYL-3,6,7,8- TETRAHYDRO-3,6-DIAZA-AS-INDACENE-2-CARBOXYLIC ACID METHYL ESTER C22 H19 N3 O4 SOLUTION STRUCTURE OF A DUOCARMYCIN SA-INDOLE-ALKYLATED DNA DUPLEX DNA (5'-D(*GP*TP*CP*AP*AP*TP*TP*AP*GP*TP*C)-3'), DNA (5'-D(*GP*AP*CP*TP*AP*AP*TP*TP*GP*AP*C)-3') DNA DEOXYRIBONUCLEIC ACID, DUOCARMYCIN, DNA, MINOR GROOVE BINDING, ANTITUMOR AGENT, LIGAND-DNA COMPLEX
Code Class Resolution Description 2pik nuc NMR 2,6-DIDEOXY-4-THIO-BETA-D-ALLOSEPYRANOSIDE C6 H12 O3 S CALICHEAMICIN GAMMA1I-DNA COMPLEX, NMR, 6 STRUCTURES DNA(5'-D(C*AP*CP*TP*CP*CP*TP*GP*GP*TP*TP*TP*TP* TP*GP*TP*GP*AP*GP*GP*AP*CP*CP)-3') DNA DEOXYRIBONUCLEIC ACID, CALICHEAMICIN GAMMA1I - DNA COMPLEX, ENEDIYNE ALIGNMENT IN MINOR GROOVE, SACCHARIDE DNA MINOR GROOVE INTERACTIONS, INTERMOLECULAR DRUG IODINE-GUANINE AMINO PROTON INTERACTIONS, SPECIFICITY AND CLEAVAGE PROCESS
Code Class Resolution Description 107d nuc NMR 4-HYDROXY-2,8-DIMETHYL-1-OXO-6-(4,5,6-TRIMETHOXY-1H- INDOLE-2-CARBONYL)-1,2,3,6,7,8-HEXAHYDRO-3,6-DIAZA-AS- INDACENE-2-CARBOXYLIC ACID METHYL ESTER C26 H27 N3 O8 SOLUTION STRUCTURE OF THE COVALENT DUOCARMYCIN A-DNA DUPLEX COMPLEX DNA (5'-D(*CP*CP*TP*TP*TP*TP*C)-3'), DNA (5'-D(*GP*AP*AP*AP*AP*GP*G)-3') DNA DNA, NMR, DOUBLE HELIX
Code Class Resolution Description 3rkf nuc 2.50 2-AMINO-1,9-DIHYDRO-6H-PURINE-6-THIONE 4(C5 H5 N5 S) CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH C61U/G37A DOUBLE MUT TO THIO-GUANINE GUANINE RIBOSWITCH RNA THREE-WAY JUNCTION, RIBOSWITCH, M-RNA, THIOGUANINE, RNA
Code Class Resolution Description 1cp8 nuc NMR 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4- DIHYDROXYPENTYL)-8,9-DIHYDROXY-7-(SEC-BUTYL)- ANTHRACENE 2(C24 H30 O7) NMR STRUCTURE OF DNA (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9 DNA (5'-D(P*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DNA
Code Class Resolution Description 1bp8 nuc NMR 1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4- DIHYDROXYPENTYL)-8,9-DIHYDROXY-7-METHYL-ANTHRACENE 4(C21 H24 O7) 4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX 5'-D(*AP*CP*CP*CP*GP*GP*GP*T)-3' DNA MITHRAMYCIN, DNA, OLIGONUCLEOTIDE, NMR
Code Class Resolution Description 1xcy nuc NMR (1S,3S,4R)-4-(PHOSPHOOXYMETHYL)-CYCLOPENTANE-1,3-DIOL C6 H13 O6 P STRUCTURE OF DNA CONTAINING THE ALPHA-ANOMER OF A CARBOCYCLIC ABASIC SITE 5'-D(*CP*GP*TP*AP*CP*(DXD)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3' DNA DOUBLE HELIX, ABASIC SITE, DNA 1xcz nuc NMR (1S,3S,4R)-4-(PHOSPHOOXYMETHYL)-CYCLOPENTANE-1,3-DIOL C6 H13 O6 P STRUCTURE OF DNA CONTAINING THE BETA-ANOMER OF A CARBOCYCLIC ABASIC SITE 5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3', 5'-D(*CP*GP*TP*AP*CP*(DXD)P*CP*AP*TP*GP*C)-3' DNA DOUBLE HELIX, ABASIC SITE, DNA
Code Class Resolution Description 1agu nuc NMR N-((-)-(7S,8R,9S,10R)[7,8,9-TRIHYDROXY-7,8,9,10-TETRA HYDROBENZO[A]PYREN-10-YL])-2'-DEOXY-ADENOSINE-5'- MONOPHOSPHATE C30 H28 N5 O9 P THE SOLUTION NMR STRUCTURE OF THE C10R ADDUCT OF BENZO[A]PYRENE-DIOL-EPOXIDE AT THE N6 POSITION OF ADENINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 60-62 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3'), DNA (5'-D(*CP*GP*GP*AP*CP*EP*AP*GP*AP*AP*G)-3') DNA DNA DUPLEX, HUMAN N-RAS GENE, CODON 61 SEQUENCE, C10R-BPDE ADDUCT, INTERCALATION, N6-ADENINE ADDUCT, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description
453d nuc 1.80 4-{[4-HYDROXY-PHENYL]-1H-BENZIMIDAZOLE-5-YL}- BENZIMIDAZOLE-2-YL-[4-HYDROXY-BENZENE] C26 H18 N4 O2 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3'-BENZIMIDAZOLE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA MINOR GROOVE BINDING, DNA
Code Class Resolution Description
1ftd nuc 2.00 [3-(4-{2'-[4-(3-DIMETHYLAMINO-PROPOXY)-PHENYL]-3H,3'H- [5,5']BIBENZOIMIDAZOLYL-2-YL}-PHENOXY)-PROPYL]- DIMETHYL-AMINE C36 H40 N6 O2 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3'-SYMMETRIC BIS- BENZIMIDAZOLE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA MINOR GROOVE BINDING, DNA
Code Class Resolution Description 1ez5 nuc model ECTEINASCIDIN 743 C39 H43 N3 O11 S COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN D(TAAAGCTTA) AND ANTITUMOR DRUG ECTEINASCIDIN 743 DNA (5'-D(*TP*AP*AP*GP*CP*TP*TP*TP*A)-3'), DNA (5'-D(*TP*AP*AP*AP*GP*CP*TP*TP*A)-3') DEOXYRIBONUCLEIC ACID ANTICANCER, DNA, ECTEINASCIDIN, DEOXYRIBONUCLEIC ACID 1ezh nuc model ECTEINASCIDIN 743 C39 H43 N3 O11 S COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN D(TAACGGTTA) AND ANTITUMOR DRUG ECTEINASCIDIN 743 DNA (5'-D(*TP*AP*AP*CP*GP*GP*TP*TP*A)-3'), DNA (5'-D(*TP*AP*AP*CP*CP*GP*TP*TP*A)-3') DEOXYRIBONUCLEIC ACID ANTICANCER, DNA, ECTEINASCIDIN, DEOXYRIBONUCLEIC ACID, DNA BENDING 1kml nuc model ECTEINASCIDIN 743 3(C39 H43 N3 O11 S) COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN D(GTGGCGGCGGCC) AND THREE MOLECULES OF ANTITUMOR DRUG ECTEINASCIDIN 743 5'-D(*GP*GP*CP*CP*GP*CP*CP*GP*CP*CP*AP*C)-3', 5'-D(*GP*TP*GP*GP*CP*GP*GP*CP*GP*GP*CP*C)-3' DEOXYRIBONUCLEIC ACID ANTICANCER, DNA, ECTEINASCIDIN, DEOXYRIBONUCLEIC ACID 2b0i nuc model ECTEINASCIDIN 743 2(C39 H43 N3 O11 S) COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN D(GTATGGCCATAC) AND TWO MOLECULES OF ANTITUMOR DRUG TRABECTEDIN. 5'-D(*GP*TP*AP*TP*GP*GP*CP*CP*AP*TP*AP*C)-3' DEOXYRIBONUCLEIC ACID ANTICANCER, DNA, ECTEINASCIDINS, TRABECTEDIN, DEOXYRIBONUCLE
Code Class Resolution Description 150d nuc 2.25 3-[2-DEOXY-RIBOFURANOSYL]-3H-1,3,4,5A,8-PENTAAZA-AS- INDACENE-5'-MONOPHOSPHATE 2(C12 H14 N5 O6 P) GUANINE.1,N6-ETHENOADENINE BASE-PAIRS IN THE CRYSTAL STRUCTURE OF D(CGCGAATT(EDA)GCG) DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(EDA) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED
Code Class Resolution Description 1b5k nuc NMR N3,N4-ETHENO-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C11 H14 N3 O7 P 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE THYMIDINE IN AN 11-MER SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS DNA (5'-D(*CP*GP*TP*AP*CP*EDCP*CP*AP*TP*GP*C)-3') CHAIN: A, DNA (5'-D(*GP*CP*AP*TP*GP*TP*GP*TP*AP*CP*G)-3') DNA ETHENODC, EDC, EXOCYCLIC LESION, DNA 1b60 nuc NMR N3,N4-ETHENO-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C11 H14 N3 O7 P 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE CYTIDINE IN AN 11-MER SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS DNA (5'-D(*CP*GP*TP*AP*CP*(EDC)P*CP*AP*TP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3') DNA ETHENODC, EDC, EXOCYCLIC LESION, DNA 1b6x nuc NMR N3,N4-ETHENO-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C11 H14 N3 O7 P 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE GUANINE IN AN 11-MER D SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS, 4 STRUC 5'-D(*CP*GP*TP*AP*CP*(EDC)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*GP*GP*TP*AP*CP*G)-3' DNA DEOXYRIBONUCLEIC ACID, ETHENODC, EDC, EXOCYCLIC LESION, DNA 1b6y nuc NMR N3,N4-ETHENO-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C11 H14 N3 O7 P 3,N4-ETHENO-2'-DEOXYCYTIDINE OPPOSITE ADENINE IN AN 11-MER D SOLUTION STRUCTURE FROM NMR AND MOLECULAR DYNAMICS, 2 STRUC 5'-D(*CP*GP*TP*AP*CP*(EDC)P*CP*AP*TP*GP*C)-3', 5'-D(*GP*CP*AP*TP*GP*AP*GP*TP*AP*CP*G)-3' DNA DEOXYRIBONUCLEIC ACID, ETHENODC, EDC, EXOCYCLIC LESION, DNA 1n5c nuc 1.79 N3,N4-ETHENO-2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE C11 H14 N3 O7 P CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAATT(E 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(EDC)P*GP*CP*G)-3' DNA B FORM DOUBLE HELIX, 3, N4-ETHENO-2'-CYTIDINE MODIFICATION O G, DNA
Code Class Resolution Description 2mh6 nuc NMR 2'-DEOXY-1-(2-IODOETHYL)INOSINE C12 H16 I N4 O7 P SOLUTION STRUCTURE OF DNA DUPLEX CONTAINING N3T-ETHYLENE-N1I INTERSTRAND CROSS-LINK 5'-D(*TP*GP*GP*AP*IP*CP*TP*G)-3', 5'-D(*CP*AP*GP*TP*TP*CP*CP*A)-3' DNA DNA DUPLEX, INTERSTRAND CROSS-LINK, DNA
Code Class Resolution Description 3e5f nuc 2.70 [(3S)-3-AMINO-4-HYDROXY-4-OXO-BUTYL]-[[(2S,3S,4R,5R)- 5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2- YL]METHYL]-METHYL-SELANIUM C15 H23 N6 O5 SE 1+ CRYSTAL STRUCTURES OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SE-SAM SMK BOX (SAM-III) RIBOSWITCH FOR RNA RNA SMK SAM RIBOSWITCH SHINE-DELGARNO TRANSLATION REGULATION, RNA
Code Class Resolution Description 1y84 nuc 1.60 ((3R,4R,5R)-4-(2-(1H-IMIDAZOL-1-YL)ETHOXY)-3-HYDROXY- 5-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)- TETRAHYDROFURAN-2-YL)METHYL DIHYDROGEN PHOSPHATE 2(C15 H21 N4 O9 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (IMIDAZOLYL)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(EIT)P*AP*CP*GP*C)-3' DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER.
Code Class Resolution Description 1z3f nuc 1.50 ELLIPTICINE 2(C17 H15 N2 1+) STRUCTURE OF ELLIPTICINE IN COMPLEX WITH A 6-BP DNA 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA ANTICANCER, DNA BINDING, DRUG DESIGN, ELLIPTICINE, INTERCALATOR
Code Class Resolution Description 2pik nuc NMR 2,4-DIDEOXY-4-(ETHYLAMINO)-3-O-METHYL ALPHA-L-THREO- PENTOPYRANOSIDE C8 H17 N O3 CALICHEAMICIN GAMMA1I-DNA COMPLEX, NMR, 6 STRUCTURES DNA(5'-D(C*AP*CP*TP*CP*CP*TP*GP*GP*TP*TP*TP*TP* TP*GP*TP*GP*AP*GP*GP*AP*CP*CP)-3') DNA DEOXYRIBONUCLEIC ACID, CALICHEAMICIN GAMMA1I - DNA COMPLEX, ENEDIYNE ALIGNMENT IN MINOR GROOVE, SACCHARIDE DNA MINOR GROOVE INTERACTIONS, INTERMOLECULAR DRUG IODINE-GUANINE AMINO PROTON INTERACTIONS, SPECIFICITY AND CLEAVAGE PROCESS
Code Class Resolution Description 1en8 nuc 0.98 ETHANOL 4(C2 H6 O) 1 A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM DNA (5'-D(*CP*CP*AP*AP*CP*GP*TP*TP*GP*G)-3') DNA DIVALENT CATIONS, DNA SEQUENCE-SPECIFIC BINDING, SHELXDNA, B-DNA 1ene nuc 0.98 ETHANOL 3(C2 H6 O) 1A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM. DNA (5'-D(*CP*CP*AP*GP*CP*GP*CP*TP*GP*G)-3') DNA DIVALENT CATIONS, DNA SEQUENCE-SPECIFIC BINDING, SHELXDNA, B-DNA
Code Class Resolution Description 4e8k nuc 3.03 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 5(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND A NON-HYDROLYZED OLIGONUCLEOTIDE SUBSTRATE GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*CP*G*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, RNA 4e8m nuc 3.50 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 6(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8n nuc 2.96 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 4(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF NH4+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8p nuc 3.28 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 6(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF RB+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYMES, SELF-SPLICING, RETROTRANSPOSITION, 4e8q nuc 2.84 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 5(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF TL+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8r nuc 3.36 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 5(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF CS+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8t nuc 3.34 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 6(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND AN OLIGONUCLEOTIDE FRAGMENT SUBSTRATE (LOW DATASET) GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8v nuc 4.00 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 6(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND BA2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4faq nuc 3.11 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 6(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND 5'-EXON GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4far nuc 2.86 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 5(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND 5'-EXON GRUUP IIC INTRON: DOMAINS 1-5, GROUP IIC INTRON: 5'-EXON RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fau nuc 2.87 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 3(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF LI+, MG2+ AND 5'-EXON GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4faw nuc 2.70 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 4(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND A HYDROLYZED OLIGONUCLEOTIDE FRAGMENT GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*A*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fax nuc 3.10 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 3(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF NA+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fb0 nuc 3.22 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID 5(C8 H18 N2 O4 S) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON C377G A LIGAND-FREE STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN
Code Class Resolution Description 1d83 nuc NMR 4-O-ACETYL-2,6-DIDEOXY-3-C-METHYL-BETA-L-ARABINO- HEXOPYRANOSE 2(C9 H16 O5) STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION DNA (5'-D(*AP*AP*GP*GP*CP*CP*TP*T)-3') DNA DNA, NMR, DOUBLE HELIX, CHROMOMYCIN 1ekh nuc NMR 4-O-ACETYL-2,6-DIDEOXY-3-C-METHYL-BETA-L-ARABINO- HEXOPYRANOSE 2(C9 H16 O5) NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND CO DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1eki nuc NMR 4-O-ACETYL-2,6-DIDEOXY-3-C-METHYL-BETA-L-ARABINO- HEXOPYRANOSE 2(C9 H16 O5) AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMY COBALT DNA (5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DRUG BOUND IN THE MINOR GROOVE OF DNA, DNA 1vaq nuc 2.00 4-O-ACETYL-2,6-DIDEOXY-3-C-METHYL-BETA-L-ARABINO- HEXOPYRANOSE 4(C9 H16 O5) CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA) 2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION 5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3' DNA CHROMOMYCIN A3, X-RAY DIFFRACTION, MAD, DNA DUPLEX, GGCC SITE, DNA KINK, CD SPECTRA 5erz nuc 1.75 4-O-ACETYL-2,6-DIDEOXY-3-C-METHYL-BETA-L-ARABINO- HEXOPYRANOSE 2(C9 H16 O5) CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX 5es0 nuc 2.10 4-O-ACETYL-2,6-DIDEOXY-3-C-METHYL-BETA-L-ARABINO- HEXOPYRANOSE 2(C9 H16 O5) CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX
Code Class Resolution Description
2o43 nuc 3.60 (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-AMINO-6- {[(2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6- METHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-14-ETHYL-7,12,13- TRIHYDROXY-4-{[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6- DIMETHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY}-3,5,7,9,11 C37 H70 N2 O12 STRUCTURE OF 23S RRNA OF THE LARGE RIBOSOMAL SUBUNIT FROM DE RADIODURANS IN COMPLEX WITH THE MACROLIDE ERYTHROMYCYLAMINE 23S RRNA RNA RIBOSOME, MACROLIDES, RNA
Code Class Resolution Description 1ess nuc NMR O3-PHOSPHONOESTRONE 2(C18 H23 O5 P) STEROID TETHERED DNA, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(P*TP*CP*CP*A)-3'), DNA (5'-D(P*CP*AP*GP*C)-3'), DNA (5'-D(P*TP*GP*GP*AP*GP*CP*TP*G)-3') DNA DEOXYRIBONUCLEIC ACID, ESTRONE, DNA, NMR, STEROID TETHERED
Code Class Resolution Description 1bub nuc NMR EUROPIUM ION 2(EU 2+) DETERMINATION OF INTERNUCLEAR ANGLES OF DNA USING PARAMAGNETIC ASSISTED MAGNETIC ALIGNMENT DNA (5'- D(*GP*GP*TP*TP*GP*GP*TP*GP*TP*GP*GP*TP*TP*GP*G)-3'): TELOMERE DNA QUDRAPLEX DNA, DUPLEX, EU BINDING DNA, TELOMERE DNA
Code Class Resolution Description 3ot0 nuc 1.70 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-8-HYDROXY-7,7,9,9-TETRAMETHYL-7,8,9, 11-TETRAHYDROPYRIMIDO[4',5':5,6][1,4]OXAZINO[2,3- F]ISOINDOL-2(3H)-ONE RADICAL 2(C21 H26 N4 O9 P) CRYSTAL STRUCTURE OF A DNA CONTAINING THE RIGID NITROXIDE SP NUCLEOTIDE C-SPIN SPIN-LABELED DNA DNA NITROXIDE, SPIN-LABEL, EPR SPECTROSCOPY, FLUORESCENCE SPECTR MODIFIED NUCLEIC ACID, C-SPIN, DEOXYCYTOSINE ANALOG, PHENOX SPECTROSCOPIC PROBE, PELDOR, 2'-O-METHYL U, DNA
Code Class Resolution Description 3vrs nuc 2.60 FLUORIDE ION F 1- CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, SOAKED IN MN2+ FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4en5 nuc 2.96 FLUORIDE ION F 1- CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, TL-ACETATE SOAKED FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4ena nuc 2.85 FLUORIDE ION F 1- CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, SOAKED IN CS+ FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4enb nuc 2.30 FLUORIDE ION F 1- CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, BOUND TO IRIDIUM FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4enc nuc 2.27 FLUORIDE ION F 1- CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA
Code Class Resolution Description 3q61 nuc 1.56 1,5-ANHYDRO-2,3-DIDEOXY-3-FLUORO-2-(5-METHYL-2,4-DIOXO- 3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-6-O-PHOSPHONO-D- ALTRITOL 2(C11 H16 F N2 O8 P) 3'-FLUORO HEXITOL NUCLEIC ACID DNA STRUCTURE DNA (5'-D(*GP*CP*GP*TP*AP*(F3H)P*AP*CP*GP*C)-3') DNA A-FORM DNA, 3'-FLUORO HEXITOL NUCLEIC ACID, FHNA, ANTISENSE OLIGONUCLEOTIDES, DNA
Code Class Resolution Description 3sd8 nuc 1.67 1,5-ANHYDRO-2,3-DIDEOXY-3-FLUORO-2-(5-METHYL-2,4-DIOXO- 3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-6-O-PHOSPHONO-D- MANNITOL 2(C11 H16 F N2 O8 P) CRYSTAL STRUCTURE OF ARA-FHNA DECAMER DNA 5'-D(*GP*CP*GP*TP*AP*(F4H)P*AP*CP*GP*C)-3' DNA A-FORM DNA, ARA-3'-FLUORO HEXITOL NUCLEIC ACID, ARA-FHNA, AN OLIGONUCLEOTIDES, DNA
Code Class Resolution Description 3v06 nuc 1.53 3,7-ANHYDRO-1,5,6-TRIDEOXY-5-FLUORO-6-(5-METHYL-2,4- DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-2-O-PHOSPHONO-D- GLYCERO-L-ALTRO-HEPTITOL 2(C12 H18 F N2 O8 P) CRYSTAL STRUCTURE OF S-6'-ME-3'-FLUORO HEXITOL NUCLEIC ACID DNA (5'-D(*GP*CP*GP*TP*AP*(F5H)P*AP*CP*GP*C)-3') DNA A-FORM DNA, 3'-FLUORO HEXITOL NUCLEIC ACID, FHNA, S-6'-ME-FH ANTISENSE OLIGONUCLEOTIDES, DNA
Code Class Resolution Description 3v07 nuc 1.24 3,7-ANHYDRO-1,5,6-TRIDEOXY-5-FLUORO-6-(5-METHYL-2,4- DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-2-O-PHOSPHONO-D- GLYCERO-L-ALLO-HEPTITOL 2(C12 H18 F N2 O8 P) CRYSTAL STRUCTURE OF R-6'-ME-3'-FLUORO HEXITOL NUCLEIC ACID DNA (5'-D(*GP*CP*GP*TP*AP*(F6H)P*AP*CP*GP*C)-3') DNA A-FORM DNA, 3'-FLUORO HEXITOL NUCLEIC ACID, FHNA, R-6'-ME-FH ANTISENSE OLIGONUCLEOTIDES, DNA
Code Class Resolution Description 1pwf nuc 1.16 5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXYTETRAHYDROFURAN-3- YL DIHYDROGEN PHOSPHATE 2(C9 H12 N5 O6 P) ONE SUGAR PUCKER FITS ALL: PAIRING VERSATILITY DESPITE CONFORMATIONAL UNIFORMITY IN TNA 5'-D(*GP*CP*GP*TP*AP*(2MU)P*(FA2)P*CP*GP*C)-3' DNA A-DNA, HYDROGEN BONDING, NUCLEIC ACID ETIOLOGY, TETROSE, FOUR CARBON SUGAR, X-RAY CRYSTALLOGRAPHY, NUCLEIC ACID ANALOGUE
Code Class Resolution Description 1hm1 nuc NMR [1',2'-DIDEOXY[2-AMINO-5-([9-HYDROXY-AFLATOXINB2-8- YL]-FORMYL-AMINO)-6-OXO-1,6-IHYDRO-PYRIMIDIN-4- YLAMINO]-RIBOFURANOSE]-5-MONOPHOSPHATE GROUP C27 H28 N5 O15 P THE SOLUTION NMR STRUCTURE OF A THERMALLY STABLE FAPY ADDUCT OF AFLATOXIN B1 IN AN OLIGODEOXYNUCLEOTIDE DUPLEX REFINED FROM DISTANCE RESTRAINED MOLECULAR DYNAMICS SIMULATED ANNEALING, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(TP*GP*AP*AP*TP*CP*AP*TP*AP*G)-3'), DNA (5'-D(*CP*TP*AP*TP*(FAG)P*AP*TP*TP*CP*A)-3') DNA AFLATOXIN B1, FAPY, FORMAMIDOPYRIMIDINE, INTERCALATION, DNA DUPLEX, NMR, SOLUTION STRUCTURE, DNA ADDUCT, DEOXYRIBONUCLEIC ACID 2kh3 nuc NMR [1',2'-DIDEOXY[2-AMINO-5-([9-HYDROXY-AFLATOXINB2-8-YL]- FORMYL-AMINO)-6-OXO-1,6-IHYDRO-PYRIMIDIN-4-YLAMINO]- RIBOFURANOSE]-5-MONOPHOSPHATE GROUP C27 H28 N5 O15 P NMR STRUCTURE OF AFLATOXIN FORMAMIDOPYRIMIDINE ALPHA-ANOMER IN DUPLEX DNA 5'-D(*CP*TP*AP*TP*(FAG)P*AP*TP*TP*CP*A)-3', 5'-D(*TP*GP*AP*AP*TP*CP*AP*TP*AP*G)-3' DNA DNA, AFLATOXIN, FORMAMIDOPYRIMIDINE, ALPHA ANOMER 2kh4 nuc NMR [1',2'-DIDEOXY[2-AMINO-5-([9-HYDROXY-AFLATOXINB2-8-YL]- FORMYL-AMINO)-6-OXO-1,6-IHYDRO-PYRIMIDIN-4-YLAMINO]- RIBOFURANOSE]-5-MONOPHOSPHATE GROUP C27 H28 N5 O15 P AFLATOXIN FORMAMIDOPYRIMIDINE ALPHA ANOMER IN SINGLE STRAND DNA 5'-D(*CP*TP*(FAG)P*A)-3' DNA AFLATOXIN, FORMAMIDOPYRIMIDINE, ALPHA ANOMER, DNA 2mmf nuc NMR [1',2'-DIDEOXY[2-AMINO-5-([9-HYDROXY-AFLATOXINB2-8-YL]- FORMYL-AMINO)-6-OXO-1,6-IHYDRO-PYRIMIDIN-4-YLAMINO]- RIBOFURANOSE]-5-MONOPHOSPHATE GROUP C27 H28 N5 O15 P SOLUTION STRUCTURE OF AGA MODIFIED DNA_(5'-D(*TP*GP*AP*AP*TP*CP*TP*TP*AP*G)-3'), DNA_(5'-D(*CP*TP*AP*AP*(FAG)P*AP*TP*TP*CP*A)-3') DNA AFLATOXIN B1, FAPY, FORMAMIDOPYRIMIDINE, INTERCALATION, DNA DNA ADDUCT, SEQUENCE DEPENDENCE, DNA 2mmq nuc NMR [1',2'-DIDEOXY[2-AMINO-5-([9-HYDROXY-AFLATOXINB2-8-YL]- FORMYL-AMINO)-6-OXO-1,6-IHYDRO-PYRIMIDIN-4-YLAMINO]- RIBOFURANOSE]-5-MONOPHOSPHATE GROUP C27 H28 N5 O15 P SOLUTION STRUCTURE OF AGT FAPY MODIFIED DUPLEX DNA_(5'-D(*CP*TP*AP*AP*(FAG)P*TP*TP*TP*CP*A)-3'), DNA_(5'-D(*TP*GP*AP*AP*AP*CP*TP*TP*AP*G)-3') DNA AFLATOXIN B1, FAPY, FORMAMIDOPYRIMIDINE, INTERCALATION, DNA DEOXYRIBONUCLEIC ACID, HYDROGEN BOND, SEQUENCE DEPENDENCE, 2mmr nuc NMR [1',2'-DIDEOXY[2-AMINO-5-([9-HYDROXY-AFLATOXINB2-8-YL]- FORMYL-AMINO)-6-OXO-1,6-IHYDRO-PYRIMIDIN-4-YLAMINO]- RIBOFURANOSE]-5-MONOPHOSPHATE GROUP C27 H28 N5 O15 P AGC FAPY MODIFIED DUPLEX MAJOR ISOMER DNA_(5'-D(*TP*GP*AP*AP*GP*CP*TP*TP*AP*G)-3'), DNA_(5'-D(*CP*TP*AP*AP*(FAG)P*CP*TP*TP*CP*A)-3') DNA AFLATOXIN B1, FAPY, FORMAMIDOPYRIMIDINE, INTERCALATION, DNA DEOXYRIBONUCLEIC ACID, HYDROGEN BOND, SEQUENCE DEPENDENCE, MAJOR ISOMER, DNA 2mms nuc NMR [1',2'-DIDEOXY[2-AMINO-5-([9-HYDROXY-AFLATOXINB2-8-YL]- FORMYL-AMINO)-6-OXO-1,6-IHYDRO-PYRIMIDIN-4-YLAMINO]- RIBOFURANOSE]-5-MONOPHOSPHATE GROUP C27 H28 N5 O15 P AG(7-DEAZA)G FAPY MODIFIED DUPLEX DNA_(5'-D(*CP*TP*AP*AP*(FAG)P*(7GU)P*TP*TP*CP*A)- CHAIN: A, DNA_(5'-D(*TP*GP*AP*AP*CP*CP*TP*TP*AP*G)-3') DNA AFLATOXIN B1, FAPY, FORMAMIDOPYRIMIDINE, INTERCALATION, DNA DEOXYRIBONUCLEIC ACID, HYDROGEN BOND, SEQUENCE DEPENDENCE, DEAZA)G, DNA
Code Class Resolution Description
2et0 nuc 1.70 FE (II) ION 6(FE 2+) THE STRUCTURE OF A THREE-WAY DNA JUNCTION IN COMPLEX WITH A SUPRAMOLECULAR HELICATE REVEALS A NEW TARGET FOR DRUGS 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, 3-WAY JUNCTION, DNA STRUCTURE RECOGNITION,
3fx8 nuc 2.44 FE (II) ION 4(FE 2+) DISTINCT RECOGNITION OF THREE-WAY DNA JUNCTIONS BY A THIOESTER VARIANT OF A METALLO-SUPRAMOLECULAR CYLINDER ('HELICATE') (5'-D(*CP*GP*TP*AP*CP*G)-3' DNA SELF-ASSEMBLY, DNA-BASED NANOMATERIAL, DNA
3i1d nuc 2.50 FE (II) ION 6(FE 2+) DISTINCT RECOGNITION OF THREE-WAY DNA JUNCTIONS BY THE TWO E OF A METALLO-SUPRAMOLECULAR CYLINDER ('HELICATE') 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, 3-WAY JUNCTION, DNA STRUCTURE RECOGNITION,
4jiy nuc 1.91 FE (II) ION 4(FE 2+) RNA THREE-WAY JUNCTION STABILIZED BY A SUPRAMOLECULAR DI-IRO CYLINDER DRUG 5'-(CGUACG)-3' RNA RNA, THREE-WAY JUNCTION, DRUG-RNA COMPLEX, RNA STRUCTURE REC CYLINDER, SUPRAMOLECULE
Code Class Resolution Description 2pis nuc 2.80 (1R)-1,4-ANHYDRO-2-DEOXY-1-(3-FLUOROPHENYL)-5-O- PHOSPHONO-D-ERYTHRO-PENTITOL 12(C11 H14 F O6 P) EFFORTS TOWARD EXPANSION OF THE GENETIC ALPHABET: STRUCTURE AND REPLICATION OF UNNATURAL BASE PAIRS DNA (5'-D(*CP*GP*(CBR)P*GP*AP*AP*(FFD) P*TP*TP*CP*GP*CP*G)-3') DNA NUCLEIC ACID, DUPLEX, REPLICATION, UNNATURAL BASE, DNA
Code Class Resolution Description
3suh nuc 2.65 N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-3,4,5,6,7,8- HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L- GLUTAMIC ACID C20 H23 N7 O7 CRYSTAL STRUCTURE OF THF RIBOSWITCH, BOUND WITH 5-FORMYL-THF RIBOSWITCH RNA THREE-WAY JUNCTION, PSEUDOKNOT, GENE REGULATOR, THF, RNA
4lvv nuc 2.10 N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-3,4,5,6,7,8- HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L- GLUTAMIC ACID 2(C20 H23 N7 O7) STRUCTURE OF THE THF RIBOSWITCH THF RIBOSWITCH RNA APTAMERS, NUCLEOTIDE, BACTERIAL PROTEINS, BASE SEQUENCE, BIN SITES, CALORIMETRY, FOLIC ACID, GENE EXPRESSION REGULATION, BACTERIAL, GUANINE, LEUCOVORIN, LIGANDS, MAGNESIUM, MOLECUL SEQUENCE DATA, NUCLEIC ACID CONFORMATION, POINT MUTATION, P BINDING, S-ADENOSYLMETHIONINE, STREPTOCOCCUS MUTANS, TERMIN REGIONS, GENETIC, TETRAHYDROFOLATES, THERMODYNAMICS, TRANSC THREE-WAY JUNCTION, PSEUDOKNOT, REGULATION, NCRNA, THF BIND MRNA, RNA
Code Class Resolution Description 154d nuc 2.50 BIS-(N-ETHYLPYRIDINIUM-(3-METHOXYCARBAZOLE))HEXANE-1, 6-DIAMINE C42 H48 N6 O2 4+ DNA DISTORTION IN BIS-INTERCALATED COMPLEXES DNA (5'-D(*(CBR)P*GP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 1fmn nuc NMR FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P SOLUTION STRUCTURE OF FMN-RNA APTAMER COMPLEX, NMR, 5 STRUCTURES RNA (5'-R(*GP*GP*CP*GP*UP*GP*UP*AP*GP*GP *AP*UP*AP*UP*GP*CP*UP*UP*CP*GP*GP*CP*AP*GP*AP*AP*GP *GP*AP*CP*AP*CP*GP*CP*C)-3') RNA FMN-RNA COMPLEX, FMN-ADENINE PAIRING, FMN INTERCALATION, BASE TRIPLE PLATFORM, BASE PAIR MISMATCHES 2yie nuc 2.94 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF A F. NUCLEATUM FMN RIBOSWITCH BOUND TO FMN RIBOSWITCHFMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2495-2544APTAMER DOMAIN, RESIDUES 2550-2601 RNA RNA 3f2q nuc 2.95 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2t nuc 3.00 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, IRIDIU SOAK. FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2w nuc 3.45 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, BA2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, BARIUM, RNA 3f2x nuc 3.11 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, CS+ SO FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, CESIUM, RNA 3f2y nuc 3.20 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, MN2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, MANGANESE, RNA 3f30 nuc 3.15 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, COBALT SOAK. FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, COBALT HEXAMINE, RNA 3f4e nuc 3.05 FLAVIN MONONUCLEOTIDE C17 H21 N4 O9 P CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, SPLIT FMN RIBOSWITCH, FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, RNA
Code Class Resolution Description
3sd3 nuc 1.95 N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8- HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L- GLUTAMIC ACID C20 H23 N7 O7 THE STRUCTURE OF THE TETRAHYDROFOLATE RIBOSWITCH CONTAINING MUTATION TETRAHYDROFOLATE RIBOSWITCH RNA TETRAHYDROFOLATE RNA RIBOSWITCH, RNA
Code Class Resolution Description 1nyi nuc 2.85 GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P CROSSLINKED HAMMERHEAD RIBOZYME INITIAL STATE 5'- R(P*GP*UP*GP*GP*UP*CP*UP*GP*AP*UP*GP*AP*GP*GP*CP*C)-3', 5'- R(*GP*CP*CP*GP*AP*AP*AP*CP*UP*CP*GP*UP*AP*AP*GP*AP*GP*UP*CP *AP*CP*CP*AP*C)-3' RNA HAMMERHEAD RIBOZYME CROSSLINK CONFORMATIONAL CHANGE, RNA 1y27 nuc 2.40 GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O8 P G-RIBOSWITCH-GUANINE COMPLEX BACILLUS SUBTILIS XPT: SEQUENCE DATABASE RESIDUES 185-252 RNA G-RIBOSWITCH GUANINE RECOGNITION, RNA 5l00 nuc 1.25 GUANOSINE-5'-MONOPHOSPHATE 4(C10 H14 N5 O8 P) SELF-COMPLIMENTARY RNA 15MER BINDING WITH GMP MONOMERS RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA
Code Class Resolution Description
2juk nuc NMR (1S,2R,3S,4R,6S)-4,6-BIS{[AMINO(IMINIO)METHYL]AMINO}-2- {[3-O-(2,6-BIS{[AMINO(IMINIO)METHYL]AMINO}-2,6- DIDEOXY-BETA-L-GLUCOPYRANOSYL)-BETA-D- ARABINOFURANOSYL]OXY}-3-HYDROXYCYCLOHEXYL 2,6- BIS{[AMINO(IMINIO)METHYL]AMINO}-2,6-DIDEOXY-BETA-L- GLUCOPYRANOSI C29 H64 N18 O13 6+ GUANIDINO NEOMYCIN B RECOGNITION OF AN HIV-1 RNA HELIX HIV-1 FRAMESHIFT SITE RNA RNA HIV-1, RNA-LIGAND INTERACTIONS, GUANIDINOGLYCOSIDES, NMR, RNA
Code Class Resolution Description 1xv6 nuc NMR 3'-O-METHYOXYETHYL-GUANOSINE-5'-MONOPHOSPHATE 4(C13 H20 N5 O9 P) THE SOLUTION STRUCTURE OF 2',5'-LINKED 3'-O-(2- METHOXYETHYL)-RNA HAIRPIN 5'-R(*(C2L)P*(G2L)P*(C2L)P*(G2L)P*(A2L)P*(A2L) P*(U2L)P*(U2L)P*(C2L)P*(G2L)P*(C2L)P*(G2L))-2' RNA HAIRPIN, (2',5')-RNA, 3'-O-(2-METHOXYETHYL) RIBOSE
Code Class Resolution Description 1k8l nuc NMR GUANOSINE-5'-DITHIOPHOSPHORATE 2(C10 H14 N5 O5 P S2) XBY6: AN ANALOG OF CK14 CONTAINING 6 DITHIOPHOSPHATE GROUPS FIRST STRAND OF CK14 DNA DUPLEX: DITHIOATED AT T10, C11, SECOND STRAND OF CK14 DNA DUPLEX: DITHIOATED AT G17, C22, C24, G27 DNA XBY6, CK14, CK1, PHOSPHORODITHIOATE, NF-KB, DNA
Code Class Resolution Description 1d26 nuc 2.12 3'-METHYL-2',3'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O6 P EFFECT OF A SINGLE 3'-METHYLENE PHOSPHONATE LINKAGE ON THE CONFORMATION OF AN A-DNA OCTAMER DOUBLE HELIX DNA (5'-D(*GP*CP*CP*CP*(G31)P*GP*GP*C)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED
Code Class Resolution Description 128d nuc 2.50 O6-ETHYL-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O7 P) MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG) COMPLEXED WITH HOECHST 33258 DNA (5'-D(*CP*GP*CP*(G36) P*AP*AP*TP*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 130d nuc 2.50 O6-ETHYL-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O7 P) MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG) COMPLEXED WITH HO 33342 DNA (5'-D(*CP*GP*CP*(G36)P*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED, DNA 144d nuc 2.25 O6-ETHYL-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O7 P) MINOR GROOVE BINDING OF SN6999 TO AN ALKYLATED DNA: MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG)-SN6999 COMPLEX DNA (5'-D(*CP*GP*CP*(G36) P*AP*AP*TP*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1d85 nuc 2.50 O6-ETHYL-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O7 P) STRUCTURAL CONSEQUENCES OF A CARCINOGENIC ALKYLATION LESION ON DNA: EFFECT OF O6-ETHYL-GUANINE ON THE MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG)-NETROPSIN COMPLEX DNA (5'-D(*CP*GP*CP*(G36) P*AP*AP*TP*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 363d nuc 2.00 3'-AMINO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 18(C10 H15 N6 O6 P) HIGH-RESOLUTION CRYSTAL STRUCTURE OF A FULLY MODIFIED N3'-> PHOSPHORAMIDATE DNA DODECAMER DUPLEX 5'-D(*(C42)P*(G38)P*(C42)P*(G38)P*(A43)P*(A43)P*( P*(NYM)P*(C42)P*(G38)P*(C42)P*DG)-3' DNA A-DNA, MODIFIED, DNA
Code Class Resolution Description 354d nuc 1.50 GUANOSINE-5'-MONOTHIOPHOSPHATE C10 H14 N5 O7 P S STRUCTURE OF LOOP E FROM E. COLI 5S RRNA RNA (5'-R(*CP*CP*GP*AP*UP*GP*GP*UP*AP*GP*UP*G)-3' CHAIN: A, RNA-DNA (5'-R(*GP*CP*GP*AP*GP*AP*GP*UP*AP*)-D(*DG R(*GP*C)-3') RNA U-RNA, DOUBLE HELIX, INTERNAL LOOP, OVERHANGING BASE, MISMAT
Code Class Resolution Description 1cw9 nuc 1.55 N2-ETHANETHIOL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 4(C12 H18 N5 O7 P S) DNA DECAMER WITH AN ENGINEERED CROSSLINK IN THE MINOR GROOVE 5'-D(*CP*CP*AP*GP*(G47)P*CP*CP*TP*GP*G)-3' DNA CROSSLINKED DOUBLE-HELICAL DNA, BASE-PAIR OPENING, PARTIAL B FLIPPING., DNA
Code Class Resolution Description 2m39 nuc NMR 2'-O-METHYOXYETHYL-GUANOSINE-5'-MONOPHOSPHATE 6(C13 H20 N5 O9 P) THE SOLUTION STRUCTURE OF 3',5'-LINKED 2'-O-(2-METHOXYETHYL) DUPLEX RNA (5'-R(*(C5L)P*(G48)P*(C5L)P*(G48)P*(A44)P*(A4 P*(T39)P*(C5L)P*(G48)P*(C5L)P*DG)-3') RNA DUPLEX, (3',5')-RNA, 2'-O-(2-METHOXYETHYL) RIBOSE, RNA 468d nuc 1.80 2'-O-METHYOXYETHYL-GUANOSINE-5'-MONOPHOSPHATE 8(C13 H20 N5 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 469d nuc 1.70 2'-O-METHYOXYETHYL-GUANOSINE-5'-MONOPHOSPHATE 8(C13 H20 N5 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RNA 470d nuc 1.95 2'-O-METHYOXYETHYL-GUANOSINE-5'-MONOPHOSPHATE 8(C13 H20 N5 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 471d nuc 2.70 2'-O-METHYOXYETHYL-GUANOSINE-5'-MONOPHOSPHATE 8(C13 H20 N5 O9 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA
Code Class Resolution Description 1d33 nuc 1.50 N2-METHYL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P FORMALDEHYDE CROSS-LINKS DAUNORUBICIN AND DNA EFFICIENTLY: HPLC AND X-RAY DIFFRACTION STUDIES 5'-D(*CP*GP*CP*(G49)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1qda nuc 1.60 N2-METHYL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P CRYSTAL STRUCTURE OF EPIDOXORUBICIN-FORMALDEHYDE VIRTUAL CRO DNA 5' -D(CP*GP*CP*(G49)P*CP*GP)-3' DNA DOUBLE HELIX, DRUG-DNA COMPLEX, DNA 277d nuc 1.80 N2-METHYL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY 5'-D(*CP*GP*CP*(G49)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 278d nuc 1.80 N2-METHYL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY DNA (5'-D(*CP*GP*(G49)P*CP*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 380d nuc 2.00 N2-METHYL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O7 P) BINDING OF THE MODIFIED DAUNORUBICIN WP401 ADJACENT TO A T-G INDUCES THE REVERSE WATSON-CRICK CONFORMATION: CRYSTAL STRU THE WP401-TGGCCG AND WP401-CGG[BR5C]CG COMPLEXES DNA (5'-D(*CP*GP*(G49)P*(CBR)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, MODIFIED, DNA 381d nuc 2.10 N2-METHYL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P BINDING OF THE MODIFIED DAUNORUBICIN WP401 ADJACENT TO A T-G INDUCES THE REVERSE WATSON-CRICK CONFORMATION: CRYSTAL STRU THE WP401-TGGCCG AND WP401-CGG[BR5C]CG COMPLEXES DNA (5'-D(*TP*GP*(G49)P*CP*CP*G)-3'), DNA (5'-D(*TP*GP*GP*CP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE MISMATCHED, DNA 427d nuc 1.10 N2-METHYL-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O7 P 5'-D(*CP*GP*CP*(CH2-DM1)GP*CP*G)-3' DNA (5'-D(*CP*GP*CP*(G49)P*CP*G)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, FORMALDEHYDE CROSS- LINK, ATOMIC RESOLUTION, DOUBLE BACKBONE CONFORMATION, DNA
Code Class Resolution Description 2h0z nuc 2.70 ALPHA-D-GLUCOSE-6-PHOSPHATE C6 H13 O9 P PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSE-6-PHOSPHATE GLMS RIBOZYME RNA, GLMS RIBOZYME DEOXY RNA INHIBITOR RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX 2ho7 nuc 2.90 ALPHA-D-GLUCOSE-6-PHOSPHATE C6 H13 O9 P PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSE-6-PHOSPHATE GLMS RIBOZYME RNA, GLMS RIBOZYME SUBSTRATE RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 2z74 nuc 2.20 ALPHA-D-GLUCOSE-6-PHOSPHATE C6 H13 O9 P T. TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSE-6-PHOSPHATE GLMS RIBOZYME RNA, GLMS RIBOZYME SUBSTRATE RNA DNA, RNA RIBOZYME, RIBOSWITCH, GLUCOSE-6-PHOSPHATE, GLUCOSAMINE-6- PHOSPHATE, DNA, RNA
Code Class Resolution Description 5ndh nuc 1.81 GUANIDINE 4(C H5 N3) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P2 RNA (5'-R(*GP*(CBV) P*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*GP*C)-3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA 5ndi nuc 2.57 GUANIDINE 4(C H5 N3) THE STRUCTURE OF THE E.COLI GUANIDINE II RIBOSWITCH P1 STEM- RNA (5'- R(*UP*UP*UP*GP*CP*AP*GP*GP*AP*CP*GP*AP*CP*CP*UP*GP*(CBV)P*A 3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA 5nef nuc 1.91 GUANIDINE C H5 N3 THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5nom nuc 1.93 GUANIDINE C H5 N3 THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5t83 nuc 2.71 GUANIDINE C H5 N3 STRUCTURE OF A GUANIDINE-I RIBOSWITCH FROM S. ACIDOPHILUS RNA (95-MER) RNA RIBOSWITCH, GUANIDINE, S-TURN, A-MINOR, RNA 5u3g nuc 2.30 GUANIDINE C H5 N3 STRUCTURE OF THE DICKEYA DADANTII YKKC RIBOSWITCH BOUND TO G YKKC RIBOSWITCH RNA RIBOSWITCH, YKKC, GUANIDINE, GUANIDINIUM, RNA
Code Class Resolution Description 1ho6 nuc NMR GUANINE ARABINOSE-5'-PHOSPHATE C10 H14 N5 O8 P CHIMERIC ARABINONUCLEIC ACID (ANA) HAIRPIN WITH ANA/RNA HYBRID STEM DNA/RNA (5'-R(*GP*GP*AP*C)-D(P*TP*TP*CP*G)- (P*(GAO)P*(UAR)P*(CAR)P*(CAR)-3') DNA, RNA ARABINONUCLEIC ACID, RNA, HAIRPIN, DNA 2kp3 nuc NMR GUANINE ARABINOSE-5'-PHOSPHATE 3(C10 H14 N5 O8 P) STRUCTURE OF ANA-RNA HYBRID DUPLEX RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3'), RNA (5'-R(*(GAO)P*(CAR)P*(UAR)P*(A5O)P*(UAR)P*(A5 P*(UAR)P*(GAO)P*(GAO))-3') RNA ANA, ARABINONUCLEIC ACID, NUCLEIC ACID STRUCTURE, NMR/MD/TI, DUPLEX, RNA
Code Class Resolution Description 1kgk nuc 1.00 PHOSPHORIC ACID 9-(2-GUANIDINOETHOXY-3-(2-DEOXY-BETA- D-ERYTHROPENTOFURANOSYL))-3H-PYRIMIDO-[5,4-B][1,4]- BENZOOXAZIN-2-ONE]-5'-ESTER 2(C18 H24 N6 O9 P 1+) DIRECT OBSERVATION OF A CYTOSINE ANALOG THAT FORMS FIVE HYDROGEN BONDS TO GUANOSINE; GUANYL G-CLAMP 5'-D(*GP*(GCK)P*GP*TP*AP*TP*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, CYTOSINE ANALOGUE, DNA
Code Class Resolution Description 1d4r nuc 2.00 GUANOSINE-5'-DIPHOSPHATE 3(C10 H15 N5 O11 P2) 29-MER FRAGMENT OF HUMAN SRP RNA HELIX 6 29-MER OF MODIFIED SRP RNA HELIX 6: NON-NATIVE DUPLEX, 29-MER OF MODIFIED SRP RNA HELIX 6: NON-NATIVE DUPLEX RNA A-RNA HELIX, GGAG/GAGG BULGE, AC/CA TANDEM MISMATCH, GU WOBBLE BASE PAIRS, 2'3' -CYCLIC PHOSPHATE 1y27 nuc 2.40 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 G-RIBOSWITCH-GUANINE COMPLEX BACILLUS SUBTILIS XPT: SEQUENCE DATABASE RESIDUES 185-252 RNA G-RIBOSWITCH GUANINE RECOGNITION, RNA 3diy nuc 2.71 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, MN2+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3owi nuc 2.85 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oww nuc 2.80 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3owz nuc 2.95 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN IRIDIUM DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION, GLYCINE RIBOSWITCH, RNA 3ox0 nuc 3.05 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, UNBOUND STATE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxb nuc 2.95 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH WITH SINGLE MUTATION DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxd nuc 3.00 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH WITH TWO MUTATIONS DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxe nuc 2.90 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, MN2+ SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxj nuc 3.20 GUANOSINE-5'-DIPHOSPHATE 2(C10 H15 N5 O11 P2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN BA2+ DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxm nuc 2.95 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, TL-ACETATE SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3zd4 nuc 2.20 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 FULL-LENGTH HAMMERHEAD RIBOZYME WITH G12A SUBSTITUTION AT THE GENERAL BASE POSITION HAMMERHEAD RIBOZYME, ENZYME STRAND, HAMMERHEAD RIBOZYME, SUBSTRATE STRAND RNA RNA, GENERAL BASE CATALYSIS 3zd5 nuc 2.20 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 THE 2.2 A STRUCTURE OF A FULL-LENGTH CATALYTICALLY ACTIVE HAMMERHEAD RIBOZYME HAMMERHEAD RIBOZYME, ENZYME STRAND, HAMMERHEAD RIBOZYME, SUBSTRATE STRAND RNA CATALYTIC RNA, IN-LINE ATTACK, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, RNA 3zp8 nuc 1.55 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 HIGH-RESOLUTION FULL-LENGTH HAMMERHEAD RIBOZYME HAMMERHEAD RIBOZYME, SUBSTRATE STRAND, HAMMERHEAD RIBOZYME, ENZYME STRAND RNA RNA, CATALYTIC RNA 4r4p nuc 3.07 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF THE VS RIBOZYME-A756G MUTANT VS RIBOZYME RNA RNA NA, DIMER, RNA 4r4v nuc 3.07 GUANOSINE-5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF THE VS RIBOZYME - G638A MUTANT VS RIBOZYME RNA RNA NA, DIMER, RNA 4yb0 nuc 2.12 GUANOSINE-5'-DIPHOSPHATE 2(C10 H15 N5 O11 P2) 3',3'-CGAMP RIBOSWITCH BOUND WITH C-DI-GMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP,
Code Class Resolution Description 1byj nuc NMR 3,4-DIDEOXY-2,6-AMINO-ALPHA-D GALACTOPYRANOSE C6 H14 N2 O2 GENTAMICIN C1A A-SITE COMPLEX RNA (16S RNA): DECODING REGION RNA COMPLEX (AMINOGLYCOSIDE/RIBOSOMAL RNA)
Code Class Resolution Description 1byj nuc NMR 3,5-DIAMINO-CYCLOHEXANOL C6 H14 N2 O GENTAMICIN C1A A-SITE COMPLEX RNA (16S RNA): DECODING REGION RNA COMPLEX (AMINOGLYCOSIDE/RIBOSOMAL RNA)
Code Class Resolution Description 1byj nuc NMR 5-METHYL-4-METHYLAMINO-TETRAHYDRO-PYRAN-2,3,5-TRIOL C7 H15 N O4 GENTAMICIN C1A A-SITE COMPLEX RNA (16S RNA): DECODING REGION RNA COMPLEX (AMINOGLYCOSIDE/RIBOSOMAL RNA)
Code Class Resolution Description 1mwl nuc 2.40 GENETICIN 2(C20 H40 N4 O10) CRYSTAL STRUCTURE OF GENETICIN BOUND TO THE EUBACTERIAL 16S SITE 5'-R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*G *UP*CP*GP*C)-3' RNA AMINOGLYCOSIDE ANTIBIOTIC, GENETICIN-A-SITE COMPLEX, 16S RIB RNA, BULGED ADENINES, UOU PAIRS, RNA 3td1 nuc 2.10 GENETICIN 2(C20 H40 N4 O10) CRYSTAL STRUCTURE OF THE BACTERIAL A1408G-MUTANT AND THE PRO CYTOPLASMIC RIBOSOMAL DECODING SITE IN COMPLEX WITH GENETIC RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA/ANTIBIOTIC DECODING, RIBOSOME, RNA-ANTIBIOTIC COMPLEX 4k32 nuc 2.50 GENETICIN 2(C20 H40 N4 O10) CRYSTAL STRUCTURE OF GENETICIN BOUND TO THE LEISHMANIAL RRNA RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*UP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RRNA DUPLEX, RIBOSOMAL A-SITE, AMINOGLYCOSIDE, LEISHMANIAL R RNA, RNA-ANTIBIOTIC COMPLEX 4p3s nuc 2.30 GENETICIN 3(C20 H40 N4 O10) CRYSTAL STRUCTURE OF THE BACTERIAL A1408C-MUTANT RIBOSOMAL D SITE IN COMPLEX WITH GENETICIN 5'-R(*UP*UP*GP*CP*GP*UP*CP*CP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3' RNA/ANTIBIOTIC RIBOSOME, ANTIBIOTIC-RESISTANCE, AMINOGLYCOSIDE, DECODING, R ANTIBIOTIC COMPLEX 4wcq nuc 2.10 GENETICIN 2(C20 H40 N4 O10) CRYSTAL STRUCTURE OF THE BACTERIAL A1408ME1A-MUTANT RIBOSOMA SITE IN COMPLEX WITH GENETICIN RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*(1MA) P*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA RIBOSOME, RNA, AMINOGLYCOSIDE, ANTIBIOTIC-RESISTANCE
Code Class Resolution Description 5mcr nuc NMR 2'-DEOXY-2'-FLUOROGUANOSINE C10 H12 F N5 O4 QUADRUPLEX WITH FLIPPED TETRAD FORMED BY AN ARTIFICIAL SEQUE ARTIFICIAL QUADRUPLEX WITH PROPELLER, DIAGONAL AN LOOP DNA G-QUADRUPLEX, DNA
Code Class Resolution Description 2kwg nuc NMR 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 4(C10 H13 F N5 O7 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 2m84 nuc NMR 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 4(C10 H13 F N5 O7 P) STRUCTURE OF 2'F-RNA/2'F-ANA CHIMERIC DUPLEX 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA 2'F-RNA/2'F-ANA CHIMERIC DUPLEX, A-FORM, 12-MER, DICKERSON D DODECAMER, MODIFIED NUCLEOTIDES, DNA, RNA 2m8a nuc NMR 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 8(C10 H13 F N5 O7 P) 2'F-ANA/2'F-RNA ALTERNATED SEQUENCES 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA A-FORM, 12-MER, DICKERSON DREW DODECAMER, MODIFIED NUCLEOTID RNA 3p4a nuc 1.20 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 12(C10 H13 F N5 O7 P) 2'FLUORO MODIFIED RNA OCTAMER FA2U2 2'FLUORO MODIFIED RNA 8-MER RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, 2'-FLUORO 2'- DEOXYADENOSINE, 2'-FLUORO 2'-DEOXYURIDINE, SIRNA 3p4d nuc 1.85 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 4(C10 H13 F N5 O7 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RC4G4 5'-R(*(CFZ)P*CP*(CFZ)P*CP*(GF2)P*GP*(GF2)P*G)-3' RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, SIRNA 5mbr nuc NMR 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 3(C10 H13 F N5 O7 P) QUADRUPLEX WITH FLIPPED TETRAD FORMED BY A HUMAN TELOMERIC S G-QUADRUPLEX FORMED BY A HUMAN TELOMERIC SEQUENCE WITH 2'-FLUORO-2'-DEOXYRIBOGUANOSINE DNA G-QUADRUPLEX, DNA, HUMAN TELOMERE 5mcr nuc NMR 2'-DEOXY-2'-FLUOROGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 F N5 O7 P) QUADRUPLEX WITH FLIPPED TETRAD FORMED BY AN ARTIFICIAL SEQUE ARTIFICIAL QUADRUPLEX WITH PROPELLER, DIAGONAL AN LOOP DNA G-QUADRUPLEX, DNA
Code Class Resolution Description 1fc8 nuc NMR 2-AMINO-9-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE C10 H13 F N5 O7 P NMR SOLUTION STRUCTURE OF A CHIMERIC OLIGONUCLEOTIDE HAIRPIN R(GGAC)D(TTCG)2'F-A(GTCC) 5'-R(*GP*GP*AP*CP)D(*TP*TP*CP*GP*(GFL)P*(TAF) P*(CFL)P*(CFL))-3' RNA/DNA CHIMERA 2'F-ARABINONUCLEIC ACID, RNA, DNA, HYBRID DUPLEX, HAIRPIN, RNA/DNA CHIMERA COMPLEX 2kp4 nuc NMR 2-AMINO-9-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE 3(C10 H13 F N5 O7 P) STRUCTURE OF 2'F-ANA/RNA HYBRID DUPLEX DNA (5'-D(*(GFL)P*(CFL)P*(TAF)P*(A5L)P*(TAF)P*(A5 P*(TAF)P*(GFL)P*(GFL))-3'), RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3') DNA/RNA 2-DEOXY-2-FLUORO-D-ARABINOSE, FANA, NUCLEIC ACID STRUCTURE, NMR/MD/TI, HYBRID DUPLEX, DNA-RNA COMPLEX 2lsc nuc NMR 2-AMINO-9-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE 8(C10 H13 F N5 O7 P) SOLUTION STRUCTURE OF 2'F-ANA AND ANA SELF-COMPLEMENTARY DUP DNA (5'-D(*(CFL)P*(GFL)P*(CFL)P*(GFL)P*(A5O)P*(A5 P*(UAR)P*(CFL)P*(GFL)P*(CFL)P*(GFL))-3') DNA DNA, DICKERSON DREW DODECAMER 2m1g nuc NMR 2-AMINO-9-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE 2(C10 H13 F N5 O7 P) PARALLEL HUMAN TELOMERIC QUADRUPLEX CONTAINING 2'F-ANA SUBST 5'-D(*TP*AP*GP*GP*GP*TP*TP*AP*(GFL)P*GP*GP*T)-3' DNA PARALLEL G-QUADRUPLEX, HUMAN TELOMERIC SEQUENCE, FLUORO-ARAB MOLECULAR INTERACTIONS, DNA 2m84 nuc NMR 2-AMINO-9-(2-DEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ARABINOFURANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE 4(C10 H13 F N5 O7 P) STRUCTURE OF 2'F-RNA/2'F-ANA CHIMERIC DUPLEX 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA 2'F-RNA/2'F-ANA CHIMERIC DUPLEX, A-FORM, 12-MER, DICKERSON D DODECAMER, MODIFIED NUCLEOTIDES, DNA, RNA
Code Class Resolution Description 3c2j nuc 1.78 TRIOXACARCIN A 2(C42 H52 O20) CRYSTAL STRUCTURE ANALYSIS OF TRIOXACARCIN A COVALENTLY BOUN D(AACCGGTT) DNA (5'-D(*DAP*DAP*DCP*DCP*DGP*DGP*DTP*DT)-3') DNA DNA-DRUG COMPLEX, BASE FLIPPING, B-DNA, DNA
Code Class Resolution Description 2hkc nuc NMR 3-METHYL-3H-IMIDAZO[4,5-F]QUINOLIN-2-AMINE C11 H10 N4 NMR STRUCTURE OF THE IQ-MODIFIED DODECAMER CTCGGC[IQ]GCCATC 5'-D(*GP*AP*TP*GP*GP*CP*GP*CP*CP*GP*AP*G)-3', 5'-D(*CP*TP*CP*GP*GP*CP*GP*CP*CP*AP*TP*C)-3' DNA NMR STRUCTURE, NAR1IQ3, RMD CALCULATIONS, ANNEAL, NOESY, COSY, REFINEMENT, IQ, ADDUCT, HCA, DNA 2z2g nuc NMR 3-METHYL-3H-IMIDAZO[4,5-F]QUINOLIN-2-AMINE C11 H10 N4 NMR STRUCTURE OF THE IQ-MODIFIED DODECAMER CTC[IQ]GGCGCCATC DNA (5'- D(*DCP*DTP*DCP*DGP*DGP*DCP*DGP*DCP*DCP*DAP*DTP*DC)-3'), DNA (5'- D(*DGP*DAP*DTP*DGP*DGP*DCP*DGP*DCP*DCP*DGP*DAP*DG)-3') DNA NMR STRUCTURE, NAR1IQ1, RMD CALCULATIONS, NOESY, COSY, REFINEMENT, IQ, ADDUCT, DNA 2z2h nuc NMR 3-METHYL-3H-IMIDAZO[4,5-F]QUINOLIN-2-AMINE C11 H10 N4 NMR STRUCTURE OF THE IQ-MODIFIED DODECAMER CTCG[IQ]GCGCCATC DNA (5'- D(*DGP*DAP*DTP*DGP*DGP*DCP*DGP*DCP*DCP*DGP*DAP*DG)-3'), DNA (5'- D(*DCP*DTP*DCP*DGP*DGP*DCP*DGP*DCP*DCP*DAP*DTP*DC)-3') DNA NMR, NAR1IQ2, RMD, NOESY, COSY, IQ, DNA
Code Class Resolution Description 2z75 nuc 1.70 GLUCOSAMINE 6-PHOSPHATE C6 H14 N O8 P T. TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSAMINE-6- PHOSPHATE GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA DNA, RNA RIBOZYME, RIBOSWITCH, GLUCOSE-6-PHOSPHATE, GLUCOSAMINE-6- PHOSPHATE, DNA, RNA 3b4a nuc 2.70 GLUCOSAMINE 6-PHOSPHATE C6 H14 N O8 P T. TENGCONGENSIS GLMS RIBOZYME WITH G40A MUTATION, BOUND TO GLUCOSAMINE-6-PHOSPHATE GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA 3b4b nuc 2.70 GLUCOSAMINE 6-PHOSPHATE C6 H14 N O8 P T. TENGCONGENSIS GLMS RIBOZYME WITH G40A MUTATION, BOUND TO GLUCOSAMINE-6-PHOSPHATE AND A SUBSTRATE RNA WITH A 2'5'- PHOSPHODIESTER LINKAGE GLMS RIBOZYME SUBSTRATE WITH 2'5'-PHOSPHODIESTER LINKAGE, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA 3b4c nuc 3.00 GLUCOSAMINE 6-PHOSPHATE C6 H14 N O8 P T. TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSAMINE-6- PHOSPHATE AND A SUBSTRATE RNA WITH A 2'5'-PHOSPHODIESTER LINKAGE GLMS RIBOZYME SUBSTRATE WITH A 2'5'- PHOSPHODIESTER LINKAGE, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA
Code Class Resolution Description 3owi nuc 2.85 GLYCINE 2(C2 H5 N O2) CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oww nuc 2.80 GLYCINE 2(C2 H5 N O2) CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3owz nuc 2.95 GLYCINE 2(C2 H5 N O2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN IRIDIUM DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION, GLYCINE RIBOSWITCH, RNA 3oxe nuc 2.90 GLYCINE 2(C2 H5 N O2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, MN2+ SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxj nuc 3.20 GLYCINE 2(C2 H5 N O2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN BA2+ DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3oxm nuc 2.95 GLYCINE 2(C2 H5 N O2) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, TL-ACETATE SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 4erl nuc 3.00 GLYCINE C2 H5 N O2 CRYSTAL STRUCTURE OF THE LYSINE RIBOSWITCH BOUND TO A LYSINE DIPEPTIDE LYSINE RIBOSWITCH RNA: LYSINE RIBOSWITCH APTAMER DOMAIN TRANSCRIPTION RIBOSWITCH APTAMER DOMAIN, REGULATORY MRNA, TRANSCRIPTION
Code Class Resolution Description 2gbh nuc NMR GUANOSINE C10 H13 N5 O5 NMR STRUCTURE OF STEM REGION OF HELIX-35 OF 23S E.COLI RIBOSOMAL RNA (RESIDUES 736-760) 5'-R(*(GMP)P*GP*GP*CP*UP*AP*AP*UP*GP*(PSU) P*UP*GP*AP*AP*AP*AP*AP*UP*UP*AP*GP*CP*CP*C)-3' RNA NMR, RDC, RCSA, RNA 3skz nuc 2.60 GUANOSINE 2(C10 H13 N5 O5) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 4a4r nuc NMR GUANOSINE C10 H13 N5 O5 UNAC TETRALOOPS: TO WHAT EXTENT CAN THEY MIMIC GNRA TETRALOO 5'-R(*GMP*GP*AP*CP*CP*CP*GP*GP*CP*UP*AP*AP*CP*GP *CP*UP*GP*GP*GP*UP*CP*C)-3' RNA RNA, EVOLUTION, UMAC TETRALOOP
Code Class Resolution Description 1vro nuc 1.10 2'-DEOXYGUANOSINE-5'-MONOSELENOPHOSPHATE 2(C10 H14 N5 O6 P SE) SELENIUM-ASSISTED NUCLEIC ACID CRYSTALLOGRAPHY: USE OF PHOSPHOROSELENOATES FOR MAD PHASING OF A DNA STRUCTURE 5'-D(*CP*(GMS)P*CP*GP*CP*G)-3' DNA LEFT-HANDED Z-DNA, PHOSPHOROSELENOATE, MULTIWAVELENGTH ANOMALOUS DISPERSION (MAD), COVALENT MODIFICATION OF OLIGONUCLEOTIDES, OLIGONUCLEOTIDE ANALOGUE, PHASING STRATEGY, SYNCHROTRON
Code Class Resolution Description 1r3g nuc 1.16 2'-O-[(2-GUANIDINIUM)ETHYL]-5-METHYLURIDINE 5'- MONOPHOSPHATE 2(C13 H24 N5 O9 P) 1.16A X-RAY STRUCTURE OF THE SYNTHETIC DNA FRAGMENT WITH THE INCORPORATED 2'-O-[(2-GUANIDINIUM)ETHYL]-5-METHYLURIDINE RESIDUES 5'-D(*GP*CP*GP*TP*AP*(GMU)P*AP*CP*GP*C)-3') DNA DNA
Code Class Resolution Description 1gn7 nuc NMR N7-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O7 P NMR STRUCTURE OF AN INTRAMOLECULAR DNA TRIPLEX CONTAINING AN N7-GLYCOSYLATED GUANINE, 8 STRUCTURES DNA (5'-D (*AP*GP*AP*GP*AP*GP*AP*AP*CP*CP*CP*CP*TP*TP*CP*TP*CP*TP* CP*TP*TP*AP*TP*AP*TP*CP*TP*GN7*TP*CP*TP*T)-3') DNA DEOXYRIBONUCLEIC ACID, TRIPLEX, N7-GUANINE, DNA
Code Class Resolution Description 1nbk nuc NMR 2-AMINO-5-GUANIDINO-PENTANOIC ACID 2(C6 H15 N4 O2 1+) THE STRUCTURE OF RNA APTAMER FOR HIV TAT COMPLEXED WITH TWO ARGININAMIDE MOLECULES RNA APTAMER RNA RNA-LIGANDS COMPLEX, BASE TRIPLE, RNA APTAMER, HIV TAT
Code Class Resolution Description 2k1y nuc NMR 1,N2-ETHENOGUANINE C12 H14 N5 O7 P SOLUTION STRUCTURE OF DUPLEX DNA CONTAINING THE MUTAGENIC LESION: 1,N2-ETHENO-2'-DEOXYGUANINE 5'- D(*DGP*DCP*DAP*DTP*DGP*DCP*DGP*DTP*DAP*DCP*DG)-3', 5'-D(*DCP*DGP*DTP*DAP*DCP*(GNE) P*DCP*DAP*DTP*DGP*DC)-3' DNA DAMAGED DNA STRUCTURE, EXOCYCLIC DNA LESIONS, EXTRAHELICAL BASE, BER RECOGNITION 2ktp nuc NMR 1,N2-ETHENOGUANINE C12 H14 N5 O7 P STRUCTURE OF THE 1,N2-ETHENODEOXYGUANOSINE LESION OPPOSITE A DELETION IN DUPLEX DNA DNA (5'-D(*GP*GP*AP*TP*TP*CP*AP*TP*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*AP*TP*(GNE)P*GP*AP*AP*TP*CP*C CHAIN: A DNA ETHENOGUANINE, ONE-BASE DELETION, DNA
Code Class Resolution Description 3ds7 nuc 1.85 2'-DEOXY-GUANOSINE 2(C10 H13 N5 O4) STRUCTURE OF AN RNA-2'-DEOXYGUANOSINE COMPLEX 67-MER RNA RNA, RNA-LIGAND COMPLEX, RIBOSWITCH 3ski nuc 2.30 2'-DEOXY-GUANOSINE 2(C10 H13 N5 O4) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE RNA (68-MER), RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skl nuc 2.90 2'-DEOXY-GUANOSINE 2(C10 H13 N5 O4) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, IRIDIUM HEXAMMINE SOAK RNA (66-MER) RNA THREE WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skr nuc 3.10 2'-DEOXY-GUANOSINE 2(C10 H13 N5 O4) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, COBALT HEXAMMINE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skt nuc 3.10 2'-DEOXY-GUANOSINE 2(C10 H13 N5 O4) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, MANGANESE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY-GUANOSINE, RNA 3skw nuc 2.95 2'-DEOXY-GUANOSINE 2(C10 H13 N5 O4) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, CESIUM SOAK RNA (66-MER) RNA THREE-WAY RNA JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA
Code Class Resolution Description 2w89 nuc 2.00 GLYCEROL C3 H8 O3 CRYSTAL STRUCTURE OF THE E.COLI TRNAARG AMINOACYL STEM ISSOACCEPTOR RR-1660 AT 2.0 ANGSTROEM RESOLUTION 5'-R(*GP*CP*AP*UP*CP*CP*GP)-3': AMINOACYL STEM, RESIDUES 901-907, 5'-R(*CP*GP*GP*AP*UP*GP*CP)-3': AMINOACYL STEM, RESIDUES 966-972 RNA TRNA ACCEPTOR STEM, RNA, TRNAARG, HYDRATION, TRNA IDENTITY 3dvz nuc 1.00 GLYCEROL C3 H8 O3 CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA RNA RNA, SARCIN RICIN LOOP 3dw4 nuc 0.97 GLYCEROL C3 H8 O3 CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 U2650-OCH3 MODIFIED SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA RNA RNA, SARCIN RICIN LOOP 3dw6 nuc 1.00 GLYCEROL C3 H8 O3 CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 U2650-SECH3 MODIFIED SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA RNA RNA, SARCIN RICIN LOOP 3glp nuc 1.23 GLYCEROL C3 H8 O3 1.23 A RESOLUTION X-RAY STRUCTURE OF (GCUGCUGC)2 5'-R(*GP*CP*UP*GP*CP*UP*GP*C)-3' RNA STRETCHED U-U WOBBLE, RNA, MYOTONIC DYSTROPHY, CUG REPEATS 3r1e nuc 0.97 GLYCEROL C3 H8 O3 CRYSTAL STRUCTURE OF GC(8BRG)GCGGC DUPLEX RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*C)-3') RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, 8-BROMOGUANOSINE, 3rg5 nuc 2.00 GLYCEROL 2(C3 H8 O3) CRYSTAL STRUCTURE OF MOUSE TRNA(SEC) TRNA(SEC) RNA METAL BINDING BY RNA, RNA HYDRATION, STRUCTURAL FLEXIBILITY, TRNA FOLD, TRANSLATION, SERRS, SECS, PSTK, RNA 4l0a nuc 1.70 GLYCEROL 3(C3 H8 O3) X-RAY STRUCTURE OF AN ALL LNA QUADRUPLEX DNA/RNA (5'-R(*(TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN)) CHAIN: A, B, C, D, E, F, G, H DNA, RNA PARALLEL G-QUADRUPLEX, LOCKED NUCLEIC ACID (LNA), DNA, RNA 4nxh nuc 1.16 GLYCEROL C3 H8 O3 2'-TRIFLUOROMETHYLTHIOURIDINE-MODIFIED E. COLI 23S RRNA SARC LOOP 23S RIBOSOMAL RNA SARCIN RICIN LOOP RNA HAIRPIN, STRUCTURAL, RNA 4rum nuc 2.64 GLYCEROL C3 H8 O3 CRYSTAL STRUCTURE OF THE NICO TRANSITION-METAL RIBOSWITCH BO COBALT NICO RIBOSWITCH RNA RNA RNA HELIX, LIGAND SENSOR, COBALT AND NICKEL BINDING, RNA, RI 5d99 nuc 0.97 GLYCEROL C3 H8 O3 3DW4 REDETERMINED BY DIRECT METHODS STARTING FROM RANDOM PHA RNA (27-MER) HAIRPIN FROM SARCIN-RICIN DOMAIN OF 23S RRNA RNA AB INITIO DIRECT METHODS STRUCTURE DETERMINATION, HAIRPIN RN
Code Class Resolution Description 176d nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-GUANINE C11 H16 N7 O4 1+ NMR SOLUTION STRUCTURE OF A PEPTIDE NUCLEIC ACID COMPLEXED W DNA (5'-D(*GPN*APN*APN*CPN*TPN*CPN)-3'), RNA (5'-R(P*GP*AP*GP*UP*UP*C)-3') PEPTIDE NUCLEIC ACID/RNA RNA, PNA, DOUBLE HELIX, PEPTIDE NUCLEIC ACID-RNA COMPLEX 1nr8 nuc 1.66 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-GUANINE 2(C11 H16 N7 O4 1+) THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX 1pdt nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-GUANINE 2(C11 H16 N7 O4 1+) PD235, PNA-DNA DUPLEX, NMR, 8 STRUCTURES DNA (5'-D(*GP*AP*CP*AP*TP*AP*GP*C)-3', PEPTIDE NUCLEIC ACID (COOH-P(*G*C*T*A*T*G*T*C)-NH CHAIN: B PEPTIDE NUCLEIC ACID/DNA COMPLEX (PEPTIDE NUCLEIC ACID-DNA), NUCLEIC ACID COMPLEX, DU HYBRID, PEPTIDE NUCLEIC ACID-DNA COMPLEX 5eme nuc 1.15 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-GUANINE 3(C11 H16 N7 O4 1+) COMPLEX OF RNA R(GCAGCAGC) WITH ANTISENSE PNA P(CTGCTGC) ANTISENSE PNA STRAND, RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3') RNA CAG REPEATS, RNA/PNA, PNA ANTISENSE OLIGOMER, POLY-Q DIESEAS 5emf nuc 1.14 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-GUANINE 3(C11 H16 N7 O4 1+) CRYSTAL STRUCTURE OF RNA R(GCUGCUGC) WITH ANTISENSE PNA P(GC RNA (5'-R(*GP*CP*UP*GP*CP*UP*GP*C)-3'), ANTISENSE PNA P(GCAGCAGC) RNA CUG REPEATS, RNA/PNA DUPLEX, ANTISENSE PNA, MYOTONIC DYSTROP 1, RNA
Code Class Resolution Description 3r1d nuc 1.45 8-BROMOGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 5(C10 H13 BR N5 O8 P) CRYSTAL STRUCTURE OF GC(8BRG)GCGGCGGC DUPLEX RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*CP*GP*GP*C)-3 CHAIN: A, B, C, D, E RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, 8-BROMOGUANOSINE, 3r1e nuc 0.97 8-BROMOGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 BR N5 O8 P) CRYSTAL STRUCTURE OF GC(8BRG)GCGGC DUPLEX RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*C)-3') RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, 8-BROMOGUANOSINE,
Code Class Resolution Description 5j3f nuc NMR GUANOSINE-5'-THIO-MONOPHOSPHATE 2(C10 H14 N5 O6 P S) NMR SOLUTION STRUCTURE OF [RP, RP]-PT DSDNA DNA (5'-D(*TP*CP*GP*GP*CP*GP*(RSG)P*CP*CP*G)-3'), DNA (5'-D(*CP*GP*(RSG)P*CP*CP*GP*CP*CP*GP*A)-3') DNA DNA, [RP, RP]-PT DSDNA 5j3i nuc NMR GUANOSINE-5'-THIO-MONOPHOSPHATE 2(C10 H14 N5 O6 P S) NMR SOLUTION STRUCTURE OF [SP, SP]-PT DSDNA DNA (5'-D(*CP*GP*(SSG)P*CP*CP*GP*CP*CP*GP*A)-3'), DNA (5'-D(*TP*CP*GP*GP*CP*GP*(SSG)P*CP*CP*G)-3') DNA DNA, [SP, SP]-PT DSDNA 8psh nuc NMR GUANOSINE-5'-THIO-MONOPHOSPHATE 3(C10 H14 N5 O6 P S) HIGH RESOLUTION NMR STRUCTURE OF THE STEREOREGULAR (ALL-RP)- PHOSPHOROTHIOATE-DNA/RNA HYBRID D (G*PS*C*PS*G*PS*T*PS*C*PS*A*PS*G*PS*G)R(CCUGACGC), MINIMIZED AVERAGE STRUCTURE RNA (5'-R(*CP*CP*UP*GP*AP*CP*GP*C)-3'), DNA (5'-D(*DGP*(SC)P*(GS)P*(PST)P*(SC)P*(AS) P*(GS)P*(GS))-3') DNA-RNA HYBRID OLIGONUCLEOTIDE, DNA-RNA HYBRID, PHOSPHOROTHIOATE, THIONUCLEOTIDE, ANTISENSE
Code Class Resolution Description 1af1 nuc NMR 2'-DEOXY-N2-(R)STYRENE OXIDE GUANOSINE MONOPHOSPHATE C18 H22 N5 O8 P THE SOLUTION NMR STRUCTURE OF AN R-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*GP*GP*CP*AP*GP*GSRP*TP*GP*GP*TP*G)- 3'), DNA (5'-D(*CP*AP*CP*CP*AP*CP*CP*TP*GP*CP*C)-3') DNA DNA DUPLEX, HUMAN N-RAS GENE, CODON 12 SEQUENCE, R-STYRENE OXIDE, MINOR GROOVE ADDUCT, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1ap1 nuc NMR 2'-DEOXY-N2-(S)STYRENE OXIDE GUANOSINE MONOPHOSPHATE C18 H22 N5 O8 P THE SOLUTION NMR STRUCTURE OF AN S-STYRENE OXIDE ADDUCT AT THE N2 POSITION OF GUANINE OF AN 11 BASE-PAIR OLIGONUCLEOTIDE SEQUENCE CODING FOR AMINO ACIDS 11-13 OF THE PRODUCT OF THE N-RAS PROTOONCOGENE, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*GP*GP*CP*AP*GSSP*GP*TP*GP*GP*TP*G)- 3'), DNA (5'-D(*CP*AP*CP*CP*AP*CP*CP*TP*GP*CP*C)-3') DNA DNA DUPLEX, HUMAN N-RAS GENE, CODON 12 SEQUENCE, S-STYRENE OXIDE, MINOR GROOVE ADDUCT, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1l2x nuc 1.25 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 ATOMIC RESOLUTION CRYSTAL STRUCTURE OF A VIRAL RNA PSEUDOKNOT RNA PSEUDOKNOT RNA PSEUDOKNOT, FRAMESHIFTING, ATOMIC RESOLUTION, VIRAL RNA, METAL IONS, FLEXIBILITY 1l3d nuc 2.85 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 LOW RESOLUTION CRYSTAL STRUCTURE OF A VIRAL RNA PSEUDOKNOT RNA PSEUDOKNOT RNA PSEUDOKNOT, FRAMESHIFTING, VIRAL RNA, FLEXIBILITY 1xjr nuc 2.70 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 THE STRUCTURE OF A RIGOROUSLY CONSERVED RNA ELEMENT WITHIN THE SARS VIRUS GENOME S2M RNA RNA RNA, GNRA, 530-LIKE LOOP, S2M, STEM-LOOP, PURINE BULGE, SARS 2au4 nuc NMR GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CLASS I GTP APTAMER CLASS I RNA APTAMER TO GTP RNA RNA, APTAMER 2gdi nuc 2.05 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWI COMPLEX WITH THIAMINE PYROPHOSPHATE TPP RIBOSWITCH: SENSING DOMAIN RNA RIBOSWITCH, THIAMINE PYROPHOSPHATE, RNA 2m58 nuc NMR GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 STRUCTURE OF 2'-5' AG1 LARIAT FORMING RIBOZYME IN ITS INACTI RNA (59-MER) RNA RNA, LARIAT, 2'-5' BRANCHING 2oeu nuc 2.00 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 FULL-LENGTH HAMMERHEAD RIBOZYME WITH MN(II) BOUND HAMMERHEAD RIBOZYME, 5'-R(*GP*GP*CP*GP*UP*(OMC)P*CP*UP*GP*GP*(5BU) P*AP*UP*CP*CP*AP*AP*UP*CP*(DC))-3' RNA RIBOZYME, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, MANGANESE, MN 2qus nuc 2.40 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) HAMMERHEAD RIBOZYME G12A MUTANT PRE-CLEAVAGE HAMMERHEAD RIBOZYME RNA HAMMERHEAD RNA, HAMMERHEAD RIBOZYME, CATALYTIC RNA, SATELLIT RNA, RIBOZYME, RNA 2quw nuc 2.20 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) HAMMERHEAD RIBOZYME G12A MUTANT AFTER CLEAVAGE HAMMERHEAD RIBOZYME, CLEAVED FRAGMENT, HAMMERHEAD RIBOZYME, CLEAVED FRAGMENT RNA HAMMERHEAD RIBOZYME, RIBOZYME, CATALYTIC RNA, RIBOZYME-PRODU COMPLEX, RNA 2yie nuc 2.94 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF A F. NUCLEATUM FMN RIBOSWITCH BOUND TO FMN RIBOSWITCHFMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2495-2544APTAMER DOMAIN, RESIDUES 2550-2601 RNA RNA 2yif nuc 3.30 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF A F. NUCLEATUM FMN RIBOSWITCH - FREE STATE FMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2495-2544, FMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2550-2601 RNA RNA, TRANSLATION 3dir nuc 2.90 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH N6-1-IMINOETHYL-L-LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3e5c nuc 2.25 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SAM SMK BOX (SAM-III) RIBOSWITCH RNA SAM RIBOSWITCH SMK SAM-III TRANSLATION REGULATION SD, RNA 3e5e nuc 2.90 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURES OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SAH SMK BOX (SAM-III) RIBOSWITCH FOR RNA RNA SMK SAM RIBOSWITCH SHINE-DELGARNO TRANSLATION REGULATION, RNA 3e5f nuc 2.70 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURES OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SE-SAM SMK BOX (SAM-III) RIBOSWITCH FOR RNA RNA SMK SAM RIBOSWITCH SHINE-DELGARNO TRANSLATION REGULATION, RNA 3f2q nuc 2.95 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2t nuc 3.00 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, IRIDIU SOAK. FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2w nuc 3.45 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, BA2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, BARIUM, RNA 3f2x nuc 3.11 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, CS+ SO FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, CESIUM, RNA 3f2y nuc 3.20 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, MN2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, MANGANESE, RNA 3f30 nuc 3.15 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, COBALT SOAK. FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, COBALT HEXAMINE, RNA 3p22 nuc 2.50 GUANOSINE-5'-TRIPHOSPHATE 4(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE ENE, A VIRAL RNA STABILITY ELEMENT, COMPLEX WITH A9 RNA OLIGO(A)9 RNA, CORE ENE HAIRPIN FROM KSHV PAN RNA: HAIRPIN FROM KSHV PAN RNA RNA MAJOR GROOVE TRIPLE HELIX, VIRAL NON-CODING RNA, STABILITY E NUCLEUS, RNA 3q3z nuc 2.51 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) STRUCTURE OF A C-DI-GMP-II RIBOSWITCH FROM C. ACETOBUTYLICUM C-DI-GMP C-DI-GMP-II RIBOSWITCH RNA RIBOSWITCH, C-DI-GMP, RNA 3ski nuc 2.30 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE RNA (68-MER), RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skl nuc 2.90 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, IRIDIUM HEXAMMINE SOAK RNA (66-MER) RNA THREE WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skr nuc 3.10 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, COBALT HEXAMMINE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skt nuc 3.10 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, MANGANESE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY-GUANOSINE, RNA 3skw nuc 2.95 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, CESIUM SOAK RNA (66-MER) RNA THREE-WAY RNA JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3skz nuc 2.60 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slm nuc 2.70 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slq nuc 2.50 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 437d nuc 1.60 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF AN RNA PSEUDOKNOT FROM BEET WESTERN YEL INVOLVED IN RIBOSOMAL FRAMESHIFTING RNA PSEUDOKNOT RNA PSEUDOKNOT, RNA, TRIPLEX, VIRAL FRAMESHIFTING 4ena nuc 2.85 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, SOAKED IN CS+ FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4enb nuc 2.30 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, BOUND TO IRIDIUM FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4gxy nuc 3.05 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 RNA STRUCTURE ADENOSYLCOBALAMIN RIBOSWITCH RNA RNA, RIBOSWITCH, ADENOSYLCOBALAMIN 4jf2 nuc 2.28 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 STRUCTURE OF A CLASS II PREQ1 RIBOSWITCH REVEALS LIGAND RECO A NEW FOLD PREQ1-II RIBOSWITCH RNA RIBOSWITCH, H-TYPE PSEUDOKNOT, RNA 4jrc nuc 2.67 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) DISTAL STEM I REGION FROM G. KAUSTOPHILUS GLYQS T BOX RNA DISTAL STEM I REGION OF THE GLYQS T BOX LEADER RN CHAIN: A, B RNA T BOX RNA, REGULATORY RNA LEADER SEQUENCE, TRNA BINDING, RNA 4mgn nuc 3.20 GUANOSINE-5'-TRIPHOSPHATE 4(C10 H16 N5 O14 P3) CO-CRYSTAL STRUCTURE OF THE G. KAUSTOPHILUS GLYQS T BOX RIBO STEM I IN COMPLEX WITH TRNA TRNA-GLYCINE, GLYQS T BOX RIBOSWITCH RNA RNA-RNA COMPLEX, BASE STACKING, T-LOOP, RNA BINDING, RNA 4nya nuc 2.65 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (AZIDOMETHYL)-2-METHYLPYRIMIDIN-4-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4plx nuc 3.10 GUANOSINE-5'-TRIPHOSPHATE 3(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE TRIPLE-HELICAL STABILITY ELEMENT AT END OF MALAT1 CORE ENE HAIRPIN AND A-RICH TRACT FROM MALAT1 RNA TRIPLE HELIX, RNA STABILITY ELEMENT, MALAT1, LONG NONCODING 4qjd nuc 3.10 GUANOSINE-5'-TRIPHOSPHATE 4(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF TWISTER WITH THE NUCLEOTIDE 5'- TO THE SITE DISORDERED AT 3.1 A RESOLUTION TWISTER RNA SEQUENCE, TWISTER RNA SEQUENCE RNA SELF-CLEAVING RIBOZYME, 2' DEOXY SUBSITUTION, NUCLEOTIDE 5 ( 4qjh nuc 3.88 GUANOSINE-5'-TRIPHOSPHATE 3(C10 H16 N5 O14 P3) CRYSTAL STRUCTURE OF THE TWISTER RIBOZYME WITH THE NUCLEOTID THE CLEAVAGE SITE ORDERED AT 4.1 A RESOLUTION TWISTER RIBOZYME, TWISTER RIBOZYME RNA SMALL SELF-CLEAVING RIBOZYME, RNA 4qk8 nuc 3.05 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 THERMOANAEROBACTER PSEUDETHANOLICUS C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qka nuc 3.20 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 C-DI-AMP RIBOSWITCH FROM THERMOANAEROBACTER PSEUDETHANOLICUS HEXAMINE SOAK C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4rum nuc 2.64 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF THE NICO TRANSITION-METAL RIBOSWITCH BO COBALT NICO RIBOSWITCH RNA RNA RNA HELIX, LIGAND SENSOR, COBALT AND NICKEL BINDING, RNA, RI 4rzd nuc 2.75 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 CRYSTAL STRUCTURE OF A PREQ1 RIBOSWITCH PREQ1-III RIBOSWITCH (CLASS 3) RNA THREE-WAY HELICAL JUNCTION, HL(OUT)-TYPE PSEUDOKNOT, TRANSLA REGULATION, RNA 4wfl nuc 2.49 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN RNA: RESIDUES 3-81,RESIDUES 3-81 RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST 4wfm nuc 3.10 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN BACILLUS SUBTILIS SMALL CYTOPLASMIC RNA (SCRNA),R CHAIN: A, B RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST 4y1i nuc 2.85 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) LACTOCOCCUS LACTIS YYBP-YKOY MN RIBOSWITCH BOUND TO MN2+ LACTOCOCCUS LACTIS YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE-BINDING, RNA 4y1j nuc 2.24 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) LACTOCOCCUS LACTIS YYBP-YKOY MN RIBOSWITCH A41U BINDING SITE PRESENCE OF MN2+ YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE-BINDING, MUTANT, RNA 4y1m nuc 3.00 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) AN ESCHERICHIA COLI YYBP-YKOY MN RIBOSWITCH IN THE MN2+-FREE E. COLI YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE, FREE STATE, RNA 4yaz nuc 2.00 GUANOSINE-5'-TRIPHOSPHATE 2(C10 H16 N5 O14 P3) 3',3'-CGAMP RIBOSWITCH BOUND WITH 3',3'-CGAMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP, 5d5l nuc 2.50 GUANOSINE-5'-TRIPHOSPHATE 4(C10 H16 N5 O14 P3) PREQ1-II RIBOSWITCH WITH AN ENGINEERED G-U WOBBLE PAIR BOUND PREQ1-II RIBOSWITCH RNA GU WOBBLE, PSEUDOKNOT, SHINE-DALGARNO SEQUENCE, RNA 5fjc nuc 1.71 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT C- SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5lwj nuc NMR GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 SOLUTION NMR STRUCTURE OF THE GTP BINDING CLASS II RNA APTAM COMPLEX CONTAINING A PROTONATED ADENINE NUCLEOTIDE WITH A H SHIFTED PKA. GTP CLASS II RNA (34-MER) RNA RNA STRUCTURE, APTAMER, PROTONATED ADENINE, GTP, RNA 5u3g nuc 2.30 GUANOSINE-5'-TRIPHOSPHATE C10 H16 N5 O14 P3 STRUCTURE OF THE DICKEYA DADANTII YKKC RIBOSWITCH BOUND TO G YKKC RIBOSWITCH RNA RIBOSWITCH, YKKC, GUANIDINE, GUANIDINIUM, RNA
Code Class Resolution Description 1ehz nuc 1.93 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 10(C9 H15 N2 O9 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1fir nuc 3.30 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 3(C9 H15 N2 O9 P) CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 1ipl nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1ipx nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID TRNA-TRNA INTERACTION 1ipz nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE TRNA-TRNA INTERACTION 1k7n nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1nrt nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 6(C9 H15 N2 O9 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1q49 nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 4(C9 H15 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1vtq nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) THREE-DIMENSIONAL STRUCTURE OF YEAST T-RNA-ASP. I. STRUCTURE DETERMINATION TRNAASP RNA T-RNA, SINGLE STRAND, LOOPS, RNA 1yfg nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2mn0 nuc NMR 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE C9 H15 N2 O9 P D LOOP OF TRNA(MET) 5'-R(*GP*GP*AP*GP*AP*GP*(H2U)P*GP*GP*AP*AP*CP*UP* CHAIN: A RNA TRNA, D ARM, H2U, RNA 2tra nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 2z9q nuc 11.70 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 3bbv nuc 10.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) THE TRNA(PHE) FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF 50S.NC-TRNA.HSP15 COMPLEX TRNA(PHE) RIBOSOME PHE, TRNA, RESCUE STALLED RIBOSOME, RIBOSOME 3cw5 nuc 3.10 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE C9 H15 N2 O9 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 3cw6 nuc 3.30 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE C9 H15 N2 O9 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 3tra nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPARTIC ACID AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 486d nuc 7.50 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 6(C9 H15 N2 O9 P) X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 5l4o nuc 2.80 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE C9 H15 N2 O9 P STRUCTURE OF AN E.COLI INITIATOR TRNAFMET A1-U72 VARIANT TRNA (76-MER) TRANSLATION TRNA-TRANSLATION INITIATION, TRANSLATION 5tra nuc model 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 3(C9 H15 N2 O9 P) SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA 6tna nuc 2.70 5,6-DIHYDROURIDINE-5'-MONOPHOSPHATE 2(C9 H15 N2 O9 P) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 4lvx nuc 1.90 5,6,7,8-TETRAHYDROBIOPTERIN 2(C9 H15 N5 O3) STRUCTURE OF THE THF RIBOSWITCH BOUND TO TETRAHYDROBIOPTERIN THF RIBOSWITCH RNA APTAMERS, NUCLEOTIDE, BACILLUS SUBTILIS, BACTERIAL PROTEINS, SEQUENCE, BINDING SITES, CALORIMETRY, FOLIC ACID, GENE EXPR REGULATION, BACTERIAL, GUANINE, LEUCOVORIN, LIGANDS, MAGNES MOLECULAR SEQUENCE DATA, NUCLEIC ACID CONFORMATION, POINT M PROTEIN BINDING, PROTEIN STRUCTURE, SECONDARY, RNA, RIBOSWI ADENOSYLMETHIONINE, STREPTOCOCCUS MUTANS, TERMINATOR REGION GENETIC, TETRAHYDROFOLATES, THERMODYNAMICS, TRANSCRIPTION, JUNCTION, PSEUDOKNOT, REGULATION, NCRNA, TETRAHYDROBIOPTERI BINDING, MRNA
Code Class Resolution Description 1jhi nuc NMR HEDAMYCIN C41 H52 N2 O11 2+ SOLUTION STRUCTURE OF A HEDAMYCIN-DNA COMPLEX 5'-D(*AP*CP*CP*(HEH)GP*GP*T)-3' DNA DUPLEX DNA, HEDAMYCIN
Code Class Resolution Description 1kxs nuc NMR 3-(2-HYDROXYETHYL)-2'-DEOXYURIDINE-5'-MONOPHOSPHATE C11 H17 N2 O9 P NMR STUDY OF B-DNA CONTAINING A MODIFIED BASE PAIR: THE 2'- DEOXYADENOSINE 3-(2-HYDROXYETHYL-2'-DEOXYURIDINE) 5'-D(*CP*GP*TP*TP*TP*TP*AP*GP*AP*CP*TP*TP*GP*C)- 3', 5'-D(*GP*CP*AP*AP*GP*TP*CP*(HEU) P*AP*AP*AP*AP*CP*G)-3' DNA MODIFIED BASE, MUTAGENESIS, DEOXYRIBONUCLEIC ACID, DNA
Code Class Resolution Description 5tpy nuc 2.81 HEXANE-1,6-DIOL C6 H14 O2 CRYSTAL STRUCTURE OF AN EXONUCLEASE RESISTANT RNA FROM ZIKA RNA (71-MER) RNA ZIKA RNA EXONUCLEASE RESISTANCE, RNA
Code Class Resolution Description 2rt8 nuc NMR MERCURY (II) ION 2(HG 2+) STRUCTURE OF METALLO-DNA IN SOLUTION DNA (5'-D(*CP*GP*CP*GP*TP*TP*GP*TP*CP*C)-3'), DNA (5'-D(*GP*GP*AP*CP*TP*TP*CP*GP*CP*G)-3') DNA DNA, METALLO-BASE-PAIR, T-HG(II)-T BASE-PAIR 357d nuc 3.50 MERCURY (II) ION HG 2+ 3.5 A STRUCTURE OF FRAGMENT I FROM E. COLI 5S RRNA RNA-DNA (5'-R(*UP*GP*DCP)-D(*CP(S)*)- R(*UP*GP*GP*CP*GP*GP*C)-3'), RNA (5'- R(*CP*CP*GP*AP*UP*GP*GP*UP*AP*GP*UP*GP*UP*GP*GP*GP*G*UP*C)- 3'), RNA (5'- R(*CP*CP*CP*CP*AP*UP*GP*CP*GP*AP*GP*AP*GP*UP*AP*GP*G P*GP*AP*AP*CP*UP* GP*CP*CP*AP*GP*GP*CP*AP*U)-3') RNA U-RNA, DOUBLE HELIX, KINKED, INTERNAL LOOP, OVERHANGING BASE, MODIFIED, MISMATCHED 4l24 nuc 2.70 MERCURY (II) ION 2(HG 2+) CRYSTAL STRUCTURE OF METALLO-DNA DUPLEX CONTAINING CONSECUTI HG(II)-T BASE PAIRS DNA (5'-D(*CP*GP*CP*GP*AP*TP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA METALLO-DNA DUPLEX, B-FORM DNA DUPLEX, T-HG(II)-T BASE PAIR, DOUBLE HELIX, HG(II), DNA 4r6m nuc 2.36 MERCURY (II) ION 6(HG 2+) CRYSTAL STRUCTURE OF DNA DUPLEX CONTAINING TWO CONSECUTIVE M MEDIATED BASE PAIRS DNA (5'-D(P*GP*GP*AP*CP*TP*TP*CP*GP*CP*G)-3'), DNA (5'-D(P*CP*GP*CP*GP*TP*TP*GP*TP*CP*C)-3') DNA B DOUBLE HELIX, METALLO DNA DUPLEX, DNA 5gsk nuc 1.05 MERCURY (II) ION HG 2+ CRYSTAL STRUCTURE OF DUPLEX DNA3 IN COMPLEX WITH HG(II) AND DNA (5'-D(*GP*GP*TP*CP*GP*TP*CP*C)-3') DNA METALLO-BASE PAIR, T-HG(II)-T, DNA 5wsq nuc 1.05 MERCURY (II) ION 2(HG 2+) CRYSTAL STRUCTURE OF C-HG-T PAIR CONTAINING DNA DUPLEX DNA (5'-D(*GP*CP*CP*CP*GP*TP*GP*C)-3') DNA DNA DUPLEX, C-HG-T PAIR, DNA 5wsr nuc 1.50 MERCURY (II) ION HG 2+ CRYSTAL STRUCTURE OF T-HG-T PAIR CONTAINING DNA DUPLEX DNA (5'-D(*GP*GP*TP*CP*GP*TP*CP*C)-3') DNA DNA DUPLEX, T-HG-T PAIR, DNA 5wss nuc 1.45 MERCURY (II) ION HG 2+ CRYSTAL STRUCTURE OF T-HG-T PAIR CONTAINING DNA DUPLEX IN TH BA2+ DNA (5'-D(*GP*GP*TP*CP*GP*TP*CP*C)-3') DNA DNA DUPLEX, T-HG-T PAIR, DNA
Code Class Resolution Description 2pik nuc NMR 4-HYDROXY-5-IODO-2,3-DIMETHOXY-6-METHYLBENZOIC ACID C10 H11 I O5 CALICHEAMICIN GAMMA1I-DNA COMPLEX, NMR, 6 STRUCTURES DNA(5'-D(C*AP*CP*TP*CP*CP*TP*GP*GP*TP*TP*TP*TP* TP*GP*TP*GP*AP*GP*GP*AP*CP*CP)-3') DNA DEOXYRIBONUCLEIC ACID, CALICHEAMICIN GAMMA1I - DNA COMPLEX, ENEDIYNE ALIGNMENT IN MINOR GROOVE, SACCHARIDE DNA MINOR GROOVE INTERACTIONS, INTERMOLECULAR DRUG IODINE-GUANINE AMINO PROTON INTERACTIONS, SPECIFICITY AND CLEAVAGE PROCESS
Code Class Resolution Description 2k8t nuc NMR (2S,5R)-5-PENTYLTETRAHYDROFURAN-2-OL C9 H18 O2 SOLUTION NMR STRUCTURE OF TRANS-4-HYDROXYNONENAL DERIVED DG ADDUCT OF (6R,8S,11R)-CONFIGURATION OPPOSITE DC 5'- D(*DGP*DCP*DTP*DAP*DGP*DCP*DGP*DAP*DGP*DTP*DCP*DC)-3', 5'- D(*DGP*DGP*DAP*DCP*DTP*DCP*DGP*DCP*DTP*DAP*DGP*DC)-3' DNA HNE-DG (6R,8S,11R), HNE DERIVED DG ADDUCT, TRANS-4- HYDROXYNONENAL, DNA 2k8u nuc NMR (2S,5R)-5-PENTYLTETRAHYDROFURAN-2-OL C9 H18 O2 SOLUTION NMR STRUCTURE OF TRANS-4-HYDROXYNONENAL DERIVED DG ADDUCT OF (6S,8R,11S)-CONFIGURATION MATCHED WITH DC 5'- D(*DGP*DGP*DAP*DCP*DTP*DCP*DGP*DCP*DTP*DAP*DGP*DC)-3', 5'- D(*DGP*DCP*DTP*DAP*DGP*DCP*DGP*DAP*DGP*DTP*DCP*DC)-3' DNA HNE-DG (6S,8R,11S), HNE DERIVED DG ADDUCT, TRANS-4- HYDROXYNONENAL, DNA
Code Class Resolution Description 2kar nuc NMR (4S)-NONANE-1,4-DIOL C9 H20 O2 HNE-DG ADDUCT MISMATCHED WITH DA IN ACIDIC SOLUTION 5'- D(*DGP*DGP*DAP*DCP*DTP*DAP*DGP*DCP*DTP*DAP*DGP*DC)-3', 5'- D(*DGP*DCP*DTP*DAP*DGP*DCP*DGP*DAP*DGP*DTP*DCP*DC)-3' DNA HNE-DG, MISMATCH, HYDROXYNONENAL, DNA 2kas nuc NMR (4S)-NONANE-1,4-DIOL C9 H20 O2 HNE-DG ADDUCT MISMATCHED WITH DA IN BASIC SOLUTION 5'- D(*DGP*DCP*DTP*DAP*DGP*DCP*DGP*DAP*DGP*DTP*DCP*DC)-3', 5'- D(*DGP*DGP*DAP*DCP*DTP*DAP*DGP*DCP*DTP*DAP*DGP*DC)-3' DNA HNE-DG, MISMATCH, HYDROXYNONENAL, DNA 2lbi nuc NMR (4S)-NONANE-1,4-DIOL C9 H20 O2 N2-DG:N2-DG INTERSTRAND CROSS-LINK INDUCED BY TRANS-4-HYDROX DNA (5'-D(*GP*GP*AP*CP*TP*CP*GP*CP*TP*AP*GP*C)-3' CHAIN: B, DNA (5'-D(*GP*CP*TP*AP*GP*CP*GP*AP*GP*TP*CP*C)-3' CHAIN: A DNA TRANS-4-HYDROXYNONENAL, INTERSTRAND CROSS-LINK, DNA 2lg3 nuc NMR (4S)-NONANE-1,4-DIOL C9 H20 O2 STRUCTURE OF THE DUPLEX CONTAINING HNE DERIVED (6S,8R,11S) G PDG WHEN PLACED OPPOSITE DT DNA (5'-D(*GP*CP*TP*AP*GP*CP*GP*AP*GP*TP*CP*C)-3' CHAIN: A, DNA (5'-D(*GP*GP*AP*CP*TP*TP*GP*CP*TP*AP*GP*C)-3' CHAIN: B DNA TRANS-4-HYDROXYNONENAL, GAMMA-HO-PDG, DNA
Code Class Resolution Description 2kh0 nuc NMR 7-NITRO-9H-FLUOREN-2-OL C13 H9 N O3 2-HYDROXY-7-NITROFLUORENE COVALENTLY LINKED INTO A 13MER DNA DUPLEX - SOLUTION STRUCTURE OF THE FACE-DOWN ORIENTATION 5'-D(*GP*CP*TP*GP*CP*AP*(3DR)P*AP*CP*GP*TP*CP*G)- 3', 5'-D(*CP*GP*AP*CP*GP*TP*(3DR)P*TP*GP*CP*AP*GP*C)- 3' DNA DNA, SOLUTION STRUCTURE, BASE PAIR MIMIC, CONFORMATIONAL FLEXIBILITY 2kh1 nuc NMR 7-NITRO-9H-FLUOREN-2-OL C13 H9 N O3 2-HYDROXY-7-NITROFLUORENE COVALENTLY LINKED INTO A 13MER DNA DUPLEX - SOLUTION STRUCTURE OF THE FACE-UP ORIENTATION 5'-D(*GP*CP*TP*GP*CP*AP*(3DR)P*AP*CP*GP*TP*CP*G)- 3', 5'-D(*CP*GP*AP*CP*GP*TP*(3DR)P*TP*GP*CP*AP*GP*C)- 3' DNA DNA, SOLUTION STRUCTURE, BASE PAIR MIMIC, CONFORMATIONAL FLEXIBILITY
Code Class Resolution Description 1ssj nuc NMR BETA-CHOLEST-5-EN-3-YL 3-[(2-DEOXY-5-O-PHOSPHONO-ALPHA- D-GLYCERO-PENTOFURANOSYL)OXY]PROPYLCARBAMATE C36 H62 N O8 P A DNA DUPLEX CONTAINING A CHOLESTEROL ADDUCT (BETA-ANOMER) 5'-D(*CP*CP*AP*CP*(HOB)P*GP*GP*AP*AP*C)-3', 5'-D(GP*TP*TP*CP*CP*GP*GP*TP*GP*G)-3' DNA DOUBLE HELIX, MODIFIED DNA, CHOLESTEROL ADDUCT, DNA LESION,
Code Class Resolution Description 1sp6 nuc NMR ALPHA-CHOLEST-5-EN-3-YL 3-[(2-DEOXY-5-O-PHOSPHONO- ALPHA-D-GLYCERO-PENTOFURANOSYL)OXY]PROPYLCARBAMATE C36 H62 N O9 P A DNA DUPLEX CONTAINING A CHOLESTEROL ADDUCT (ALPHA-ANOMER) 5'-D(GP*TP*TP*CP*CP*GP*GP*TP*GP*G)-3', 5'-D(*CP*CP*AP*CP*(HOL)P*GP*GP*AP*AP*C)-3' DNA DOUBLE HELIX, MODIFIED DNA, CHOLESTEROL ADDUCT, DNA LESION,
Code Class Resolution Description 407d nuc 2.20 IMIDAZOLE-PYRROLE-HYDROXYPYRROLE POLYAMIDE 2(C31 H40 N11 O6 1+) STRUCTURAL BASIS FOR RECOGNITION OF A-T AND T-A BASE PAIRS I MINOR GROOVE OF B-DNA DNA (5'-D(*CP*CP*AP*GP*TP*AP*CP*TP*GP*G)-3') DNA DRUGS IN THE DNA MINOR GROOVE, DNA
Code Class Resolution Description 1cvx nuc 2.27 HYDROXYPYRROLE-IMIDAZOLE-PYRROLE POLYAMIDE 2(C31 H41 N11 O6) CRYSTAL STRUCTURE OF POLYAMIDE DIMER (IMPYHPPYBETADP)2 BOUND TO B-DNA DECAMER CCAGATCTGG 5'-D(*CP*CP*AP*GP*AP*TP*CP*TP*GP*G)-3' DNA POLYAMIDE, MINOR GROOVE RECOGNITION, TA RECOGNITION, DOUBLE DRUG IN MINOR GROOVE, DNA
Code Class Resolution Description 2lzv nuc NMR HEPTANE C7 H16 DNA DUPLEX CONTAINING MISPAIR-ALIGNED O4U-HEPTYLENE-O4U INTE CROSS-LINK DNA (5'-D(*CP*GP*AP*AP*AP*UP*TP*TP*TP*CP*G)-3') DNA INTERSTRAND CROSS-LINK, DNA 2lzw nuc NMR HEPTANE C7 H16 DNA DUPLEX CONTAINING MISPAIR-ALIGNED O6G-HEPTYLENE-O6G INTE CROSS-LINK DNA (5'-D(*CP*GP*AP*AP*AP*GP*TP*TP*TP*CP*G)-3') DNA INTERSTRAND CROSS-LINK, DNA
Code Class Resolution Description 2ees nuc 1.75 HYPOXANTHINE C5 H4 N4 O GUANINE RIBOSWITCH A21U, U75A MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, GUANINE, HYPOXANTHINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 2eet nuc 1.95 HYPOXANTHINE C5 H4 N4 O GUANINE RIBOSWITCH A21G, U75C MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, HYPOXANTHINE, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 2eeu nuc 1.95 HYPOXANTHINE C5 H4 N4 O GUANINE RIBOSWITCH U22A, A52U MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, GUANINE, HYPOXANTHINE, RNA-LIGAND COMPLEX, THREE-WAY JUNCTION, DOUBLE HELIX 2eev nuc 1.95 HYPOXANTHINE C5 H4 N4 O GUANINE RIBOSWITCH U22C, A52G MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, HYPOXANTHINE, GUANINE, THREE-WAY JUNCTION, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLE 2eew nuc 2.25 HYPOXANTHINE C5 H4 N4 O GUANINE RIBOSWITCH U47C MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, RNA-LIGAND COMPLEX, THREE-WAY JUNCTION, HYPOXANTHINE, GUANINE, BASE TRIPLE 4fe5 nuc 1.32 HYPOXANTHINE C5 H4 N4 O CRYSTAL STRUCTURE OF THE XPT-PBUX GUANINE RIBOSWITCH APTAMER COMPLEX WITH HYPOXANTHINE XPT-PBUX GUANINE RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENE RE ELEMENT, HYPOXANTHINE, RNA 4fej nuc 1.50 HYPOXANTHINE C5 H4 N4 O CRYSTAL STRUCTURE OF THE A24U MUTANT XPT-PBUX GUANINE RIBOSW APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE A24U MUTANT OF THE B. SUBTILIS XPT-PBUX GUANINE R APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, HYPOXANTHINE, RNA 4fel nuc 1.60 HYPOXANTHINE C5 H4 N4 O CRYSTAL STRUCTURE OF THE U25A/A46G MUTANT OF THE XPT-PBUX GU RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE U25A/A46G MUTANT OF THE B. SUBTILIS XPT-PBUX GUAN RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, HYPOXANTHINE, RNA 4fen nuc 1.35 HYPOXANTHINE C5 H4 N4 O CRYSTAL STRUCTURE OF THE A24U/U25A/A46G MUTANT XPT-PBUX GUAN RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE A24U/U25A/A46G MUTANT OF THE B. SUBTILIS XPT-PBUX RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, RNA 4nyd nuc 2.90 HYPOXANTHINE C5 H4 N4 O CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX HYPOXANTHINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 5c7u nuc 3.05 HYPOXANTHINE C5 H4 N4 O 5'-MONOPHOSPHATE WT GUANINE RIBOSWITCH BOUND TO HYPOXANTHINE 5'-MONOPHOSPHATE WT GUANINE RIBOSWITCH RNA EXPANDED RNA; RIBOSWITCH; UNNATURAL BASE PAIR, RNA 5c7w nuc 3.22 HYPOXANTHINE C5 H4 N4 O 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH BOUND TO HYPOXANTHIN 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH RNA EXPANDED RNA; RIBOSWITCH; UNNATURAL BASE PAIR, RNA
Code Class Resolution Description 3diq nuc 2.70 L-HOMOARGININE C7 H16 N4 O2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO HOMOARGININE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA
Code Class Resolution Description 127d nuc 2.00 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3') COMPLEXED WITH HOECHST 33258 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 128d nuc 2.50 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG) COMPLEXED WITH HOECHST 33258 DNA (5'-D(*CP*GP*CP*(G36) P*AP*AP*TP*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1d43 nuc 2.00 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: C, PIPERAZINE UP DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1d44 nuc 2.00 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: C, PIPERAZINE DOWN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1d45 nuc 1.90 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: DEGREES C, PIPERAZINE DOWN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1d46 nuc 2.00 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: DEGREES C, PIPERAZINE DOWN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1dnh nuc 2.25 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O THE MOLECULAR STRUCTURE OF THE COMPLEX OF HOECHST 33258 AND DODECAMER D(CGCGAATTCGCG) DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1qsx nuc NMR 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE 2(C25 H24 N6 O) SOLUTION NMR STRUCTURE OF THE 2:1 HOECHST 33258- D(CTTTTGCAAAAG)2 COMPLEX 5'-D(CP*TP*TP*TP*TP*GP*CP*AP*AP*AP*AP*G)-3' DNA DRUG-DNA COMPLEX, HOECHST 33258, DEOXYRIBONUCLEIC ACID, MINOR GROOVE RECOGNITION, DOUBLE HELIX, NMR SPECTROSCOPY 264d nuc 2.44 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O THREE-DIMENSIONAL CRYSTAL STRUCTURE OF THE A-TRACT DNA DODEC D(CGCAAATTTGCG) COMPLEXED WITH THE MINOR-GROOVE-BINDING DRU 33258 DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 269d nuc 2.15 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA 296d nuc 2.25 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O SEQUENCE-DEPENDENT EFFECTS IN DRUG-DNA INTERACTION: THE CRYSTAL STRUCTURE OF HOECHST 33258 BOUND TO THE D(CGCAAATTTGCG)2 DUPLEX DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 3ajk nuc 1.95 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O CRYSTAL STRUCTURE OF D(CGCGGATF5UCGCG): 5-FORMYLURIDINE:GUAN BASE-PAIR IN B-DNA WITH HOECHST33258 5'-D(*CP*GP*CP*GP*GP*AP*TP*(UFR)P*CP*GP*CP*G*)-3' CHAIN: A, B DNA DOUBLE HELIX, DNA 3gjj nuc 2.90 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*AP*TP*(B7C)P*CP*GP*CP*G)-3' DNA DNA, DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE 3n4o nuc 2.90 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O INSIGHTS INTO THE STABILIZING CONTRIBUTIONS OF A BICYCLIC CY ANALOGUE: CRYSTAL STRUCTURES OF DNA DUPLEXES CONTAINING 7,8 DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*AP*TP*(B7C)P*CP*GP*CP*G)-3' DNA BICYCLIC CYTOSINE, DNA 4ij0 nuc 1.54 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O STRUCTURES OF DNA DUPLEXES CONTAINING O6-CARBOXYMETHYLGUANIN LESION ASSOCIATED WITH GASTROINTESTINAL CANCER, REVEAL A ME FOR INDUCING TRANSITION MUTATION DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, MUTAGENESIS, DNA 4itd nuc 1.94 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O STRUCTURES OF DNA DUPLEXES CONTAINING O6-CARBOXYMETHYLGUANIN LESION ASSOCIATED WITH GASTROINTESTINAL CANCER, REVEAL A ME FOR INDUCING TRANSITION MUTATION DNA (5'-D(*CP*GP*CP*GP*(C6G)P*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, MUTAGENESIS, DNA 4o5w nuc 1.60 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 4o5x nuc 1.60 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE. DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 8bna nuc 2.20 2'-(4-HYDROXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C25 H24 N6 O BINDING OF HOECHST 33258 TO THE MINOR GROOVE OF B-DNA DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
Code Class Resolution Description 129d nuc 2.25 2'-(4-ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C27 H28 N6 O DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3') COMPLEXED WITH HOECHST 33342 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 130d nuc 2.50 2'-(4-ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE C27 H28 N6 O MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG) COMPLEXED WITH HO 33342 DNA (5'-D(*CP*GP*CP*(G36)P*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED, DNA 403d nuc 1.40 2'-(4-ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'- BI-BENZIMIDAZOLE C27 H28 N6 O 5'-D(*CP*GP*CP*(HYD)AP*AP*AP*TP*TP*TP*GP*CP*G)-3', 2'-(4- ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE DNA (5'-D(*CP*GP*CP*(IGU) P*AP*AP*TP*TP*TP*GP*CP*G)-3') DNA DNA/DRUG COMPLEX, B-DNA DOUBLE HELIX
Code Class Resolution Description 311d nuc 2.20 5-AMIDINO-2-[2-(4-AMIDINOPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE C22 H18 N8 THE ROLE OF HYDROGEN BONDING IN MINOR-GROOVE DRUG-DNA RECOGNITION. STRUCTURE OF A BIS-AMIDINIUM DERIVATIVE OF HOECHST 33258 COMPLEXED TO THE DODECANUCLEOTIDE D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description
2ky7 nuc NMR 2-{2-[4-(3-{[(11AS)-7-METHOXY-5-OXO-2,3,5,10,11,11A- HEXAHYDRO-1H-PYRROLO[2,1-C][1,4]BENZODIAZEPIN-8- YL]OXY}PROPYL)PIPERAZIN-1-YL]ETHYL}-1H- BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE C34 H39 N5 O5 NMR STRUCTURAL STUDIES ON THE COVALENT DNA BINDING OF A PYRROLOBENZODIAZEPINE-NAPHTHALIMIDE CONJUGATE 5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3' DNA DNA DUPLEX, PYRROLOBENZODIAZEPINE, PBD-NAPHTHALIMIDE HYBRID, COMPLEX, DNA
Code Class Resolution Description 4frg nuc 2.95 HYDROXOCOBALAMIN 2(C62 H88 CO N13 O15 P) CRYSTAL STRUCTURE OF THE COBALAMIN RIBOSWITCH APTAMER DOMAIN COBALAMIN RIBOSWITCH APTAMER DOMAIN RNA COBALAMIN, RIBOSWITCH, B12, RNA 4frn nuc 3.43 HYDROXOCOBALAMIN 2(C62 H88 CO N13 O15 P) CRYSTAL STRUCTURE OF THE COBALAMIN RIBOSWITCH REGULATORY ELE COBALAMIN RIBOSWITCH APTAMER DOMAIN RNA COBALAMIN, RIBOSWITCH, B12, RNA
Code Class Resolution Description 443d nuc 1.60 2'-(3-IODOPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE C25 H24 I N6 1+ 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3'/ BENZIMIDAZOLE DERIVATIVE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING 445d nuc 2.60 2'-(3-IODOPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE C25 H24 I N6 1+ 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3', BENZIMIDAZOLE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, MINOR GROOVE BINDING, DNA 449d nuc 2.10 2'-(3-IODOPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE C25 H24 I N6 1+ 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING
Code Class Resolution Description 442d nuc 1.60 2'-(3-IODO-4-METHOXYPHENYL)-5-(4-METHYL-1- PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE C26 H26 I N6 O 1+ 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING 444d nuc 2.40 2'-(3-IODO-4-METHOXYPHENYL)-5-(4-METHYL-1- PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE C26 H26 I N6 O 1+ 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING 448d nuc 2.20 2'-(3-IODO-4-METHOXYPHENYL)-5-(4-METHYL-1- PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE C26 H26 I N6 O 1+ 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING
Code Class Resolution Description 109d nuc 2.00 5-(2-IMIDAZOLINYL)-2-[2-(4-HYDROXYPHENYL)-5- BENZIMIDAZOLYL]BENZIMIDAZOLE C23 H20 N6 O VARIABILITY IN DNA MINOR GROOVE WIDTH RECOGNISED BY LIGAND BINDING: THE CRYSTAL STRUCTURE OF A BIS-BENZIMIDAZOLE COMPOUND BOUND TO THE DNA DUPLEX D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1g3a nuc NMR ISOCYTIDINE-5'-MONOPHOSPHATE 2(C9 H14 N3 O8 P) STRUCTURE OF RNA DUPLEXES (CIGCGICG)2 5'-R(*CP*(IG)P*CP*GP*(IC)P*G)-3' RNA DOUBLE HELIX, RNA 2o81 nuc NMR ISOCYTIDINE-5'-MONOPHOSPHATE 2(C9 H14 N3 O8 P) THE STRUCTURE OF TANDEM GA RNA PAIRS WHEN FLANKING PAIRS ARE ISOG-ISOC PAIRS 5'-R(*GP*CP*(IG)P*GP*AP*(IC)P*GP*CP*A)-3' RNA RNA, THERMODYNAMICS, SECONDARY STRUCTURE PREDICTION, SHEARED GA PAIR, ISOGUANOSINE, ISOCYTIDINE 2o83 nuc NMR ISOCYTIDINE-5'-MONOPHOSPHATE 2(C9 H14 N3 O8 P) THE STRUCTURE OF TANDEM GA RNA PAIRS WHEN FLANKING PAIRS ARE ISOG-ISOC PAIRS 5'-R(*GP*GP*(IC)P*GP*AP*(IG)P*CP*CP*A)-3' RNA RNA, THERMODYNAMICS, SECONDARY STRUCTURE PREDICTION, IMINO GA PAIR, ISOGUANOSINE, ISOCYTIDINE
Code Class Resolution Description 1at8 nuc model O-2,6-DIAMINO-2,6-DIDEOXY-BETA-L-IDOPYRANOSE C6 H14 N2 O4 THEORETICAL MODEL OF THE REV BINDING ELEMENT (RBE, 30 RIBONUCLEOTIDE FRAGMENT) OF HUMAN IMMUNODEFICIENCY VIRUS-1 COMPLEXED WITH NEOMYCIN B REV BINDING ELEMENT: 30 RIBONUCLEOTIDE FRAGMENT RIBONUCLEIC ACID RNA/AMINOGLYCOSIDE COMPLEX, MRNA TRANSPORT, INHIBITION OF VIRAL REPLICATION, RIBONUCLEIC ACID 1nem nuc NMR O-2,6-DIAMINO-2,6-DIDEOXY-BETA-L-IDOPYRANOSE C6 H14 N2 O4 SACCHARIDE-RNA RECOGNITION IN THE NEOMYCIN B / RNA APTAMER COMPLEX 5'- R(*GP*GP*AP*CP*UP*GP*GP*GP*CP*GP*AP*GP*AP*AP*GP*UP*UP*UP*AP *GP*UP*CP*C)-3' RNA RNA APTAMER, AMINOGLYCOSIDE, ANTIBIOTIC 1pbr nuc NMR O-2,6-DIAMINO-2,6-DIDEOXY-BETA-L-IDOPYRANOSE C6 H14 N2 O4 STRUCTURE OF 16S RIBOSOMAL RNA, NMR, MINIMIZED AVERAGE STRUC 16S RIBOSOMAL RNA RNA AMINOGLYCOSIDE, RIBOSOMAL RNA, RNA TRANSCRIPT, ANTIBIOTIC, RIBONUCLEIC ACID, RNA 1qd3 nuc NMR O-2,6-DIAMINO-2,6-DIDEOXY-BETA-L-IDOPYRANOSE C6 H14 N2 O4 HIV-1 TAR RNA/NEOMYCIN B COMPLEX HIV-1 TAR RNA: RESIDUES 17-45 RNA NMR, HIV-1, AMINOGLYCOSIDE-RNA-COMPLEX, MINOR GROOVE BINDING
Code Class Resolution Description 3dir nuc 2.90 N~6~-[(1Z)-ETHANIMIDOYL]-L-LYSINE C8 H17 N3 O2 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH N6-1-IMINOETHYL-L-LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA
Code Class Resolution Description 1g3a nuc NMR ISOGUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) STRUCTURE OF RNA DUPLEXES (CIGCGICG)2 5'-R(*CP*(IG)P*CP*GP*(IC)P*G)-3' RNA DOUBLE HELIX, RNA 2o81 nuc NMR ISOGUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) THE STRUCTURE OF TANDEM GA RNA PAIRS WHEN FLANKING PAIRS ARE ISOG-ISOC PAIRS 5'-R(*GP*CP*(IG)P*GP*AP*(IC)P*GP*CP*A)-3' RNA RNA, THERMODYNAMICS, SECONDARY STRUCTURE PREDICTION, SHEARED GA PAIR, ISOGUANOSINE, ISOCYTIDINE 2o83 nuc NMR ISOGUANOSINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O8 P) THE STRUCTURE OF TANDEM GA RNA PAIRS WHEN FLANKING PAIRS ARE ISOG-ISOC PAIRS 5'-R(*GP*GP*(IC)P*GP*AP*(IG)P*CP*CP*A)-3' RNA RNA, THERMODYNAMICS, SECONDARY STRUCTURE PREDICTION, IMINO GA PAIR, ISOGUANOSINE, ISOCYTIDINE
Code Class Resolution Description 1be5 nuc NMR 2'-DEOXYISOGUANINE-5'-MONOPHOSPHATE 3(C10 H14 N5 O7 P) STRUCTURAL STUDIES OF A STABLE PARALLEL-STRANDED DNA DUPLEX INCORPORATING ISOGUANINE:CYTOSINE AND ISOCYTOSINE:GUANINE BASE PAIRS BY NMR, MINIMIZED AVERAGE STRUCTURE DNA DUPLEX (TGCACGGACT), DNA DUPLEX (TGCACGGACT) DNA DNA STRUCTURE, NOVEL DNA BASES, ANTISENSE OLIGONUCLEOTIDES, INTERCALATOR BINDING, REVERSE WATSON-CRICK BASE PAIRS, DEOXYRIBONUCLEIC ACID 1bhr nuc NMR 2'-DEOXYISOGUANINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O7 P) 2'-DEOXY-ISOGUANOSINE BASE PAIRED TO THYMIDINE, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*GP*CP*IGUP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA DEOXYRIBONUCLEIC ACID, ISOGUANOSINE-THYMIDINE MISMATCH, DNA 2luj nuc NMR 2'-DEOXYISOGUANINE-5'-MONOPHOSPHATE 20(C10 H14 N5 O7 P) SOLUTION STRUCTURE OF A PARALLEL-STRANDED OLIGOISOGUANINE DN PENTAPLEX FORMED BY D(T(IG)4T) IN THE PRESENCE OF CS IONS DNA (5'-D(*TP*(IGU)P*(IGU)P*(IGU)P*(IGU)P*T)-3') DNA PENTAPLEX, ISOGUANINE, PARALLEL-STRANDED, DNA 403d nuc 1.40 2'-DEOXYISOGUANINE-5'-MONOPHOSPHATE 2(C10 H14 N5 O7 P) 5'-D(*CP*GP*CP*(HYD)AP*AP*AP*TP*TP*TP*GP*CP*G)-3', 2'-(4- ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE DNA (5'-D(*CP*GP*CP*(IGU) P*AP*AP*TP*TP*TP*GP*CP*G)-3') DNA DNA/DRUG COMPLEX, B-DNA DOUBLE HELIX
Code Class Resolution Description 365d nuc 2.00 IMIDAZOLE-PYRROLE POLYAMIDE 2(C30 H41 N12 O5 1+) STRUCTURAL BASIS FOR G C RECOGNITION IN THE DNA MINOR GROOVE DNA (5'-D(*CP*CP*AP*GP*GP*(CBR)P*CP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
Code Class Resolution Description 1lex nuc 2.25 MONOIMIDAZOLE LEXITROPSIN C17 H27 N11 O3 2+ STRUCTURE OF A DICATIONIC MONOIMIDAZOLE LEXITROPSIN BOUND TO DNA (ORIENTATION 1) DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1ley nuc 2.25 MONOIMIDAZOLE LEXITROPSIN C17 H27 N11 O3 2+ STRUCTURE OF A DICATIONIC MONOIMIDAZOLE LEXITROPSIN BOUND TO DNA (ORIENTATION 2) DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1be5 nuc NMR N1-[2-DEOXY-RIBOFURANOSYL]-[2-AMINO-5-METHYL-4-OXO-4H- PYRIMIDINE]-5'-MONOPHOSPHATE 3(C10 H16 N3 O7 P) STRUCTURAL STUDIES OF A STABLE PARALLEL-STRANDED DNA DUPLEX INCORPORATING ISOGUANINE:CYTOSINE AND ISOCYTOSINE:GUANINE BASE PAIRS BY NMR, MINIMIZED AVERAGE STRUCTURE DNA DUPLEX (TGCACGGACT), DNA DUPLEX (TGCACGGACT) DNA DNA STRUCTURE, NOVEL DNA BASES, ANTISENSE OLIGONUCLEOTIDES, INTERCALATOR BINDING, REVERSE WATSON-CRICK BASE PAIRS, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 3cgp nuc 1.57 IODIDE ION 3(I 1-) X-RAY STRUCTURE OF A PSEUDOURIDINE-CONTAINING YEAST SPLICEOSOMAL U2 SNRNA-INTRON BRANCH SITE DUPLEX BOUND TO IODIDE IONS RNA (5'-R(*GP*CP*GP*CP*GP*(PSU) P*AP*GP*UP*AP*GP*C)-3'), RNA (5'- R(*CP*GP*CP*UP*AP*CP*UP*AP*AP*CP*GP*CP*G)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING
Code Class Resolution Description 3dig nuc 2.80 ISOPROPYL ALCOHOL C3 H8 O CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO S-(2-AMINOETHYL)-L-CYSTEINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dil nuc 1.90 ISOPROPYL ALCOHOL C3 H8 O CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dim nuc 2.90 ISOPROPYL ALCOHOL C3 H8 O CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, CS+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dis nuc 3.10 ISOPROPYL ALCOHOL C3 H8 O CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH FORM RNA (174-MER) RNA FREE FORM, RIBOSWITCH, RNA 3dj2 nuc 2.50 ISOPROPYL ALCOHOL C3 H8 O CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, TL+ SOAK RNA (174-MER) RNA LYSINE, RIBOSWITCH, RNA
Code Class Resolution Description 2gym nuc model MODEL STRUCTURE OF DNA DODECAMER D(GCCTGTTAGCG) BOUND TO HAIRPIN POLYAMIDE IM-PY-PY-GAMMA-PY-PY-PY-BETA-DP DNA 5'-D(*GP*CP*CP*TP*GP*TP*TP*AP*GP*CP*G)-3', DNA 5'-D(*CP*GP*CP*TP*AP*AP*CP*AP*GP*GP*C)-3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, HAIRPIN POLYAMIDE, IMIDAZOLE PYRROLE POLYAMIDE 2gyn nuc model MODEL STRUCTURE OF DNA DODECAMER D(GCCTATTAGCG) BOUND TO HAIRPIN POLYAMIDE IM-PY-PY-GAMMA-PY-PY-PY-BETA-DP DNA 5'-D(*GP*CP*CP*TP*AP*TP*TP*AP*GP*CP*G)-3', DNA 5'-D(*CP*GP*CP*TP*AP*AP*TP*AP*GP*GP*C)-3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, HAIRPIN POLYAMIDE, IMIDAZOLE PYRROLE POLYAMIDE
Code Class Resolution Description 1cvy nuc 2.15 IMIDAZOLE-PYRROLE POLYAMIDE 2(C31 H42 N11 O5 1+) CRYSTAL STRUCTURE OF POLYAMIDE DIMER (IMPYPYPYBETADP)2 BOUND CCAGATCTGG 5'-D(*CP*CP*AP*GP*AP*TP*CP*TP*GP*G)-3' DNA IMIDAZOLE-PYRROLE POLYAMIDE, DOUBLE DRUG IN MINOR GROOVE, MI GROOVE RECOGNITION, DNA 408d nuc 2.10 IMIDAZOLE-PYRROLE POLYAMIDE 2(C31 H42 N11 O5 1+) STRUCTURAL BASIS FOR RECOGNITION OF A-T AND T-A BASE PAIRS IN THE MINOR GROOVE OF B-DNA DNA (5'-D(*CP*CP*AP*GP*TP*AP*CP*TP*GP*G)-3') DNA DRUG IN THE DNA MINOR GROOVE
Code Class Resolution Description 2mav nuc NMR N-(2-AMINO-3-METHYL-3H-IMIDAZO[4,5-F]QUINOLIN-5-YL)-2'- DEOXYGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) C21 H22 N9 O7 P NMR STRUCTURE OF N2-IQ-DG AT THE G3 POSITION IN THE NARI REC SEQUENCE DNA_(5'-D(*GP*AP*TP*GP*GP*CP*GP*CP*CP*GP*AP*G)-3' CHAIN: B, DNA_(5'-D(*CP*TP*CP*GP*GP*CP*GP*CP*CP*AP*TP*C)-3' CHAIN: A DNA HETEROCYCLIC AMINE, N2-IQ, DNA ADDUCTS, NARI, OLIGODEOXYRIBONUCLEOTIDES, QUINOLINES, DNA 2n0q nuc NMR N-(2-AMINO-3-METHYL-3H-IMIDAZO[4,5-F]QUINOLIN-5-YL)-2'- DEOXYGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) C21 H22 N9 O7 P N2-DG-IQ MODIFIED DNA AT THE G1 POSITION OF THE NARI RECOGNI SEQUENCE DNA_(5'-D(*CP*TP*CP*(IQG)P*GP*CP*GP*CP*CP*AP*TP*C CHAIN: A, DNA_(5'-D(*GP*AP*TP*GP*GP*CP*GP*CP*CP*GP*AP*G)-3' CHAIN: B DNA HETEROCYCLIC AMINE, BASE-DISPLACED INTERCATED, DNA
Code Class Resolution Description 486d nuc 7.50 IRIDIUM ION 4(IR 4+) X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME
Code Class Resolution Description 4frg nuc 2.95 IRIDIUM (III) ION 17(IR 3+) CRYSTAL STRUCTURE OF THE COBALAMIN RIBOSWITCH APTAMER DOMAIN COBALAMIN RIBOSWITCH APTAMER DOMAIN RNA COBALAMIN, RIBOSWITCH, B12, RNA
Code Class Resolution Description 1icg nuc 1.53 IRIDIUM HEXAMMINE ION 2(H18 IR N6 3+) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[F]U IN PRESENCE OF IR(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UFP))-3' DNA/RNA RNA/DNA HYBRID, FLUORO-URACIL, C-U MISMATCH, G-U MISMATCH, RHODIUM HEXAMMINE, IRIDIUM HEXAMMINE, DNA/RNA COMPLEX 2gis nuc 2.90 IRIDIUM HEXAMMINE ION 4(H18 IR N6 3+) STRUCTURE OF THE S-ADENOSYLMETHIONINE RIBOSWITCH MRNA REGULATORY ELEMENT SAM-I RIBOSWITCH RNA MRNA, RIBOSWITCH, S-ADENOSYLMETHIONINE, SAM, RNA-LIGAND COMPLEX 3b31 nuc 2.40 IRIDIUM HEXAMMINE ION 3(H18 IR N6 3+) CRYSTAL STRUCTURE OF DOMAIN III OF THE CRICKET PARALYSIS VIRUS IRES RNA RNA (5'- R(P*UP*AP*AP*GP*AP*AP*AP*UP*UP*UP*AP*CP*CP*U)-3'): RESIDUES 6203-6216, RNA (29-MER): RESIDUES 6174-6202 RNA IRES, RNA STRUCTURE, TRANSLATION INITIATION, TRNA ANTICODON, HYBRID STATE, TRNA MIMICRY 3d0u nuc 2.80 IRIDIUM HEXAMMINE ION 3(H18 IR N6 3+) CRYSTAL STRUCTURE OF LYSINE RIBOSWITCH BOUND TO LYSINE LYSINE RIBOSWITCH RNA: LIGAND BINDING DOMAIN RNA RNA-LIGAND COMPLEX, RIBOSWITCH 3dio nuc 2.40 IRIDIUM HEXAMMINE ION 16(H18 IR N6 3+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO LYSINE, IRIDIUM HEXAMINE SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3f2t nuc 3.00 IRIDIUM HEXAMMINE ION 11(H18 IR N6 3+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, IRIDIU SOAK. FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3owz nuc 2.95 IRIDIUM HEXAMMINE ION 23(H18 IR N6 3+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN IRIDIUM DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION, GLYCINE RIBOSWITCH, RNA 3sd3 nuc 1.95 IRIDIUM HEXAMMINE ION 5(H18 IR N6 3+) THE STRUCTURE OF THE TETRAHYDROFOLATE RIBOSWITCH CONTAINING MUTATION TETRAHYDROFOLATE RIBOSWITCH RNA TETRAHYDROFOLATE RNA RIBOSWITCH, RNA 3skl nuc 2.90 IRIDIUM HEXAMMINE ION 10(H18 IR N6 3+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, IRIDIUM HEXAMMINE SOAK RNA (66-MER) RNA THREE WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 4enb nuc 2.30 IRIDIUM HEXAMMINE ION 4(H18 IR N6 3+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, BOUND TO IRIDIUM FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4gxy nuc 3.05 IRIDIUM HEXAMMINE ION 7(H18 IR N6 3+) RNA STRUCTURE ADENOSYLCOBALAMIN RIBOSWITCH RNA RNA, RIBOSWITCH, ADENOSYLCOBALAMIN 4p5j nuc 1.99 IRIDIUM HEXAMMINE ION 12(H18 IR N6 3+) CRYSTAL STRUCTURE OF THE TRNA-LIKE STRUCTURE FROM TURNIP YEL VIRUS (TYMV), A TRNA MIMICKING RNA TURNIP YELLOW MOSAIC VIRUS MRNA FOR THE COAT PROT CHAIN: A RNA TRNA-MIMIC VIRAL RNA PSEUDOKNOT MULTIFUNCTIONAL, RNA 4p9r nuc 2.70 IRIDIUM HEXAMMINE ION 10(H18 IR N6 3+) SPECIATION OF A GROUP I INTRON INTO A LARIAT CAPPING RIBOZYM ATOM DERIVATIVE) RNA (189-MER) RNA CATALYTIC RNA, LARIAT-CAPPING RIBOZYME, BRANCHING REACTION, FOLD, RNA 4qka nuc 3.20 IRIDIUM HEXAMMINE ION 5(H18 IR N6 3+) C-DI-AMP RIBOSWITCH FROM THERMOANAEROBACTER PSEUDETHANOLICUS HEXAMINE SOAK C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4r0d nuc 3.68 IRIDIUM HEXAMMINE ION 38(H18 IR N6 3+) CRYSTAL STRUCTURE OF A EUKARYOTIC GROUP II INTRON LARIAT LIGATED EXONS, GROUP IIB INTRON LARIAT RNA LARIAT, RIBOZYME, 2'-5' PHOSPHODIESTER, RNA 4xw7 nuc 2.50 IRIDIUM HEXAMMINE ION 4(H18 IR N6 3+) CRYSTAL STRUCTURE OF THE ZMP RIBOSWITCH AT 2.50 ANGSTROM PFL RNA RNA RNA, RIBOSWITCH, ZMP, AICAR 4xwf nuc 1.80 IRIDIUM HEXAMMINE ION 4(H18 IR N6 3+) CRYSTAL STRUCTURE OF THE ZMP RIBOSWITCH AT 1.80 ANGSTROM PFL RNA RNA RNA, RIBOSWITCH, ZMP, AICAR 4y1n nuc 3.00 IRIDIUM HEXAMMINE ION 28(H18 IR N6 3+) OCEANOBACILLUS IHEYENSIS GROUP II INTRON DOMAIN 1 WITH IRIDI HEXAMINE GROUP II INTRON, DOMAIN 1 RNA, TRANSFERASE GROUP II INTRON, DOMAIN 1, RNA, IRIDIUM HEXAMINE, TRANSFERAS 5k7d nuc 2.68 IRIDIUM HEXAMMINE ION 2(H18 IR N6 3+) THE STRUCTURE OF NATIVE PISTOL RIBOZYME, BOUND TO IRIDIUM RNA 47-MER, DNA/RNA 11-MER RNA/DNA RIBOZYME, RNA STRUCTURE, PISTOL, RNA-DNA COMPLEX 5kpy nuc 2.00 IRIDIUM HEXAMMINE ION 12(H18 IR N6 3+) STRUCTURE OF A 5-HYDROXYTRYPTOPHAN APTAMER 5-HYDROXYTRYPTOPHAN RNA APTAMER RNA RNA, APTAMER, RIBOSWITCH, 5-HYDROXYTRYPTOPHAN 5t83 nuc 2.71 IRIDIUM HEXAMMINE ION 3(H18 IR N6 3+) STRUCTURE OF A GUANIDINE-I RIBOSWITCH FROM S. ACIDOPHILUS RNA (95-MER) RNA RIBOSWITCH, GUANIDINE, S-TURN, A-MINOR, RNA
Code Class Resolution Description 2ktz nuc NMR (7R)-7-[(DIMETHYLAMINO)METHYL]-1-[3-(DIMETHYLAMINO) PROPYL]-7,8-DIHYDRO-1H-FURO[3,2-E]BENZIMIDAZOL-2-AMINE C17 H27 N5 O INHIBITOR INDUCED STRUCTURAL CHANGE IN THE HCV IRES DOMAIN I HCV IRES DOMAIN IIA RNA RNA HEPATITIS C VIRUS, RNA STRUCTURE, ANTIVIRAL, RNA
Code Class Resolution Description 2ku0 nuc NMR (7S)-7-[(DIMETHYLAMINO)METHYL]-1-[3-(DIMETHYLAMINO) PROPYL]-7,8-DIHYDRO-1H-FURO[3,2-E]BENZIMIDAZOL-2-AMINE C17 H27 N5 O INHIBITOR INDUCED STRUCTURAL CHANGE IN THE HCV IRES DOMAIN I HCV IRES DOMAIN IIA RNA RNA HEPATITIS C VIRUS, RNA STRUCTURE, ANTIVIRAL, RNA
Code Class Resolution Description 2h0s nuc 2.35 5-IODOURIDINE-5'-MONOPHOSPHATE C9 H12 I N2 O9 P PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME DEOXY RNA INHIBITOR, GLMS RIBOZYME RNA RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX 464d nuc 1.23 5-IODOURIDINE-5'-MONOPHOSPHATE 2(C9 H12 I N2 O9 P) DISORDER AND TWIN REFINEMENT OF RNA HEPTAMER DOUBLE HELIX RNA (5'-R(*UP*AP*GP*CP*UP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*GP*CP*(IU)P*A)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM, DOUBLE HELIX, RIBONUCLEIC ACID, DISORDERED MODEL
Code Class Resolution Description 2rrq nuc NMR 2'-DEOXY-5-ETHYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) C11 H17 N2 O8 P DNA OLIGOMER CONTAINING PROPYLENE CROSS-LINKED CYCLIC 2'- DEOXYURIDYLATE DIMER DNA (5'-D(*GP*GP*AP*TP*GP*TP*AP*AP*TP*GP*AP*AP*GP CHAIN: B, DNA (5'-D(*CP*CP*TP*TP*CP*AP*(JDT)P*TP*AP*CP*AP*T 3') DNA DNA, NUCLEIC ACID, DEOXYURIDYLATE, BENT DNA
Code Class Resolution Description
2o44 nuc 3.30 (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R, 10S,12E,14Z,16R)-4-(ACETYLOXY)-10-HYDROXY-5-METHOXY-9, 16-DIMETHYL-2-OXO-7-(2-OXOETHYL)OXACYCLOHEXADECA-12, 14-DIEN-6-YL]OXY}-4-(DIMETHYLAMINO)-5-HYDROXY-2- METHYLTETRAHYDRO-2H-PYRAN-3-YL]OXY}-4-HYDR C42 H69 N O15 STRUCTURE OF 23S RRNA OF THE LARGE RIBOSOMAL SUBUNIT FROM DE RADIODURANS IN COMPLEX WITH THE MACROLIDE JOSAMYCIN 23S RRNA RNA RIBOSOME, MACROLIDES, RNA
Code Class Resolution Description 2bee nuc 2.60 (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R, 5S)-4-(2-(3-AMINOPROPYLAMINO)ETHOXY)-5-((1R,2R,3S,5R, 6S)-3,5-DIAMINO-2-((2S,3R,4R,5S,6R)-3-AMINO-4,5- DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2- YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(HYDROXYMETHY 2(C28 H57 N7 O14) COMPLEX BETWEEN PAROMOMYCIN DERIVATIVE JS4 AND THE 16S-RRNA A SITE 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES
Code Class Resolution Description 2be0 nuc 2.63 (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R, 5S)-5-((1R,2R,3S,5R,6S)-3,5-DIAMINO-2-((2S,3R,4R,5S, 6R)-3-AMINO-4,5-DIHYDROXY-6-(HYDROXYMETHYL)- TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)- 2-(HYDROXYMETHYL)-4-(2-((R)-PIPERIDIN-3- YLMETHY 2(C31 H61 N7 O14) COMPLEX BETWEEN PAROMOMYCIN DERIVATIVE JS5-39 AND THE 16S- RRNA A-SITE. 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES
Code Class Resolution Description
3s4p nuc 2.56 (1R,2R,3S,4R,6S)-4,6-DIAMINO-2-{[3-O-(2,6-DIAMINO-2,6- DIDEOXY-BETA-L-IDOPYRANOSYL)-2-O-{2-[(2-PHENYLETHYL) AMINO]ETHYL}-BETA-D-RIBOFURANOSYL]OXY}-3- HYDROXYCYCLOHEXYL 2-AMINO-2-DEOXY-ALPHA-D- GLUCOPYRANOSIDE 2(C33 H58 N6 O14) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE C WITH AN AMPHIPHILIC PAROMOMYCIN O2''-ETHER ANALOGUE RNA (5'- R(P*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP*C 3') RNA/ANTIBIOTIC AMINOGLYCOSIDE, ANTIBIOTICS, RIBOSOME, DECODING SITE, RNA, R ANTIBIOTIC COMPLEX
Code Class Resolution Description 1c35 nuc NMR POTASSIUM ION 20(K 1+) SOLUTION STRUCTURE OF A QUADRUPLEX FORMING DNA AND ITS INTERMIDIATE DNA (5'- D(*GP*GP*TP*TP*GP*GP*TP*GP*TP*GP*GP*TP*TP*GP*G)-3') DNA APTAMER, THROMBIN BINDING, POTASSIUM, METAL BINDING SITES, QUADRUPLEX, INTERMEDIATE, DNA 1c38 nuc NMR POTASSIUM ION 20(K 1+) SOLUTION STRUCTURE OF A QUADRUPLEX FORMING DNA AND ITS INTERMEDIATE DNA (5'- D(*GP*GP*TP*TP*GP*GP*TP*GP*TP*GP*GP*TP*TP*GP*G)-3') DNA APTAMER, THROMBIN BINDING, POTASSIUM, METAL ION BINDING SITES, QUADRUPLEX, INTERMEDIATE, DNA 1g75 nuc 1.57 POTASSIUM ION K 1+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG): 5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE,B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID 1i0o nuc 2.00 POTASSIUM ION 3(K 1+) 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE THYMINE IN PLACE OF T6, HIGH K-SALT 5'-D(*GP*CP*GP*TP*AP*(T23)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0p nuc 1.30 POTASSIUM ION 3(K 1+) 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)], MEDIUM K-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1jpq nuc 1.60 POTASSIUM ION 5(K 1+) CRYSTAL STRUCTURE OF THE OXYTRICHA TELOMERIC DNA AT 1.6A 5'-D(*GP*GP*GP*GP*(BRU)P*TP*TP*TP*GP*GP*GP*G)-3' DNA OXYTRICHA, G-QUARTETS, DNA 1jrn nuc 2.00 POTASSIUM ION 10(K 1+) ORTHORHOMBIC FORM OF OXYTRICHA TELOMERIC DNA AT 2.0A 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA OXYTRICHA, G-QUARTETS, DNA 1k8p nuc 2.40 POTASSIUM ION 2(K 1+) STRUCTURE OF THE HUMAN G-QUADRUPLEX REVEALS A NOVEL TOPOLOGY 5'-D(*(BRU)P*AP*GP*GP*GP*(BRU) P*TP*AP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, DOUBLE CHAIN REVERSAL LOOP, DIMERIC QUADRUPLEX, HUMAN TELOMERE SEQUENCE, G(ANTI).G(ANTI) .G(ANTI).G(ANTI), PARALLEL STRANDED 1kf1 nuc 2.10 POTASSIUM ION 3(K 1+) STRUCTURE AND PACKING OF HUMAN TELOMERIC DNA 5'- D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP *GP*GP*G)-3 DNA QUADRUPLEX DNA, DOUBLE CHAIN REVERSAL LOOP, HUMAN TELOMERE SEQUENCE, G(ANTI).G(ANTI).G(ANTI), PARALLEL STRANDED 1l1h nuc 1.75 POTASSIUM ION 4(K 1+) CRYSTAL STRUCTURE OF THE QUADRUPLEX DNA-DRUG COMPLEX 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA G-QUADRUPLEX, OXYTRICHA, FOUR-STRANDED DNA 1l2x nuc 1.25 POTASSIUM ION K 1+ ATOMIC RESOLUTION CRYSTAL STRUCTURE OF A VIRAL RNA PSEUDOKNOT RNA PSEUDOKNOT RNA PSEUDOKNOT, FRAMESHIFTING, ATOMIC RESOLUTION, VIRAL RNA, METAL IONS, FLEXIBILITY 1n7a nuc 1.20 POTASSIUM ION 9(K 1+) RIP-RADIATION-DAMAGE INDUCED PHASING RNA/DNA (5'-R(*U)-D(P*(BGM))-R(P*AP*GP*GP*U)-3') DNA, RNA DNA, RNA 1n7b nuc 1.40 POTASSIUM ION 9(K 1+) RIP-RADIATION-DAMAGE INDUCED PHASING RNA/DNA (5'-R(*U)-D(P*(BGM))-R(P*AP*GP*GP*U)-3') DNA, RNA DNA, RNA 1nzm nuc NMR POTASSIUM ION 2(K 1+) NMR STRUCTURE OF THE PARALLEL-STRANDED DNA QUADRUPLEX D(TTAGGGT)4 COMPLEXED WITH THE TELOMERASE INHIBITOR RHPS4 5'-D(*TP*TP*AP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, TELOMERES, TELOMERASE INHIBITION, NMR SPECTROSCOPY, MOLECULAR DYNAMICS, DRUG-DNA INTERACTION, TTAGGGT REPEAT 1p79 nuc 1.10 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF A BULGED RNA TETRAPLEX: IMPLICATIONS FOR A NOVEL BINDING SITE IN RNA TETRAPLEX 5'-R(*UP*GP*UP*GP*GP*U)-3' RNA RNA, TETRAPLEX, BULGE 1v3n nuc 1.80 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DNA QUADRUPLEX STRUCTURE SPLIT FROM THE OCTAPLEX 5'-D(*GP*(CBR)P*GP*AP*GP*AP*GP*C)-3' DNA OCTAPLEX, QUADRUPLEX, G-DUET, BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DEOXYRIBONUCLEIC ACID, X-RAY ANALYSIS, CRYSTAL STRUTURE 1v3o nuc 1.70 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DNA QUADRUPLEX STRUCTU FROM THE OCTAPLEX 5'-D(*GP*(C38)P*GP*AP*GP*AP*GP*C)-3' DNA OCTAPLEX, QUADRUPLEX, G-DUET, BASE-INTERCALATED DUPLEX, BASE INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DEOXYRIBONUCLEIC RAY ANALYSIS 1v3p nuc 2.30 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF D(GCGAGAGC): THE DNA OCTAPLEX STRUCTURE WITH I-MOTIF OF G-QUARTET 5'-D(*GP*(C38)P*GP*AP*GP*AP*GP*C)-3' DNA OCTAPLEX, QUADRUPLEX, G-QUARTET, I-MOTIF, I-MOTIF OF G- QUARTET, BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DEOXYRIBONUCLEIC ACID, X-RAY ANALYSIS, CRYSTAL STRUCTURE 1xav nuc NMR POTASSIUM ION 2(K 1+) MAJOR G-QUADRUPLEX STRUCTURE FORMED IN HUMAN C-MYC PROMOTER, MONOMERIC PARALLEL-STRANDED QUADRUPLEX 5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*G *GP*TP*AP*A)-3' DNA C-MYC PROMOTER DNA, PARALLEL STRANDED GUANINE-QUADRUPLEX,NMR STRUCTURE, DNA 1y3s nuc 2.25 POTASSIUM ION 3(K 1+) HIV-1 DIS RNA SUBTYPE F- MPD FORM 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1yrj nuc 2.70 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF APRAMYCIN BOUND TO A RIBOSOMAL RNA A SI OLIGONUCLEOTIDE BACTERIAL 16 S RIBOSOMAL RNA A SITE OLIGONUCLEOTI CHAIN: A, B RNA RNA COMPLEX, APRAMYCIN-RNA COMPLEX, MOLECULAR RECOGNITION, R 1zci nuc 1.65 POTASSIUM ION 4(K 1+) HIV-1 DIS RNA SUBTYPE F- MONOCLINIC FORM 5'-R(*CP*(5BU) P*UP*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP* AP*G)-3' RNA HIV-1, RNA, LOOP-LOOP COMPLEX, METAL IONS 2avh nuc 1.50 POTASSIUM ION 4(K 1+) G4T3G4 DIMERIC QUADRUPLEX STRUCTURE 5'-D(*GP*GP*GP*GP*TP*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, LOOP, DNA 2avj nuc 2.39 POTASSIUM ION 14(K 1+) G4(BR)UTTG4 DIMERIC QUADRUPLEX 5'-D(*GP*GP*GP*GP*(BRU)P*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, LOOP, DNA 2awe nuc 2.10 POTASSIUM ION 11(K 1+) BASE-TETRAD SWAPPING RESULTS IN DIMERIZATION OF RNA QUADRUPLEXES: IMPLICATIONS FOR FORMATION OF I-MOTIF RNA OCTAPLEX 5'-R(*UP*(BGM)P*GP*UP*GP*U)-3' RNA RNA, TETRAPLEX, OCTAPLEX 2dp7 nuc 1.55 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-DEOXYURIDINE DNA (5'- D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*DUP*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'- DEOXYURIDINE, B-DNA 2dpb nuc 1.50 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-DEOXYURIDINE DNA (5'- D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*DUP*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'- DEOXYURIDINE, B-DNA 2fcx nuc 2.00 POTASSIUM ION 3(K 1+) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEAMINE HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2fcy nuc 2.20 POTASSIUM ION 6(K 1+) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2fcz nuc 2.01 POTASSIUM ION 4(K 1+) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH RIBOSTAMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2fd0 nuc 1.80 POTASSIUM ION 4(K 1+) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH LIVIDOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2gdi nuc 2.05 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWI COMPLEX WITH THIAMINE PYROPHOSPHATE TPP RIBOSWITCH: SENSING DOMAIN RNA RIBOSWITCH, THIAMINE PYROPHOSPHATE, RNA 2gjb nuc 2.20 POTASSIUM ION K 1+ CROSSLINKING OF DNA DUPLEXES: X-RAY CRYSTAL STRUCTURE OF AN UNSUBSTITUTED BISACRIDINE WITH THE OLIGONUCLEOTIDE D(CGTACG) 5'-D(*CP*GP*TP*AP*CP*GP*)-3' DNA DNA DUPLEX, BIS-INTERCALATOR 2grb nuc 1.40 POTASSIUM ION 11(K 1+) CRYSTAL STRUCTURE OF AN RNA QUADRUPLEX CONTAINING INOSINE- TETRAD 5'-R(*(U33)P*GP*IP*GP*GP*U)-3' RNA RNA QUADRUPLEX 2gwe nuc 2.20 POTASSIUM ION 30(K 1+) CRYSTAL STRUCTURE OF D(G4T4G4) WITH SIX QUADRUPLEXES IN THE ASYMMETRIC UNIT. 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA OXYTRICHA, G-QUARTET, G-QUADRUPLEX, G-TETRAD, G-TETRAPLEX, SIX QUADRUPLEXES, ASYMMETRIC UNIT., DNA 2gwq nuc 2.00 POTASSIUM ION 20(K 1+) CRYSTAL STRUCTURE OF D(G4T4G4) WITH FOUR QUADRUPLEXES IN THE ASYMMETRIC UNIT. 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA OXYTRICHA, G-QUARTET, G-QUADRUPLEX, G-TETRAD, G-TETRAPLEX, FOUR QUADRUPLEXES, ASYMMETRIC UNIT., DNA 2hri nuc 2.09 POTASSIUM ION 3(K 1+) A PARALLEL STRANDED HUMAN TELOMERIC QUADRUPLEX IN COMPLEX WI PORPHYRIN TMPYP4 5'-D(*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3': TELOMERE DNA QUADRUPLEX, DNA, PROPELLER, DIMERIC, HUMAN TELOMERE PARALLEL STRANDED, LIGAND, COMPLEX 2kaz nuc NMR POTASSIUM ION 2(K 1+) FOLDING TOPOLOGY OF A BIMOLECULAR DNA QUADRUPLEX CONTAINING A STABLE MINI-HAIRPIN MOTIF WITHIN THE CONNECTING LOOP 5'- D(*DGP*DGP*DGP*DAP*DCP*DGP*DTP*DAP*DGP*DTP*DGP*DGP*DG)-3' DNA BIMOLECULAR DNA QUADRUPLEX, DNA HAIRPINS, DNA, QUADRUPLEX 2kqg nuc NMR POTASSIUM ION 2(K 1+) A G-RICH SEQUENCE WITHIN THE C-KIT ONCOGENE PROMOTER FORMS A PARALLEL G-QUADRUPLEX HAVING ASYMMETRIC G-TETRAD DYNAMICS 5'- D(*CP*GP*GP*GP*CP*GP*GP*GP*CP*AP*CP*GP*AP*GP*GP*GP*AP*GP*GP *GP*T)-3' DNA C-KIT2, ONCOGENE, PROMOTER, G-QUADRUPLEX, DNA 2kqh nuc NMR POTASSIUM ION 2(K 1+) A G-RICH SEQUENCE WITHIN THE C-KIT ONCOGENE PROMOTER FORMS A PARALLEL G-QUADRUPLEX HAVING ASYMMETRIC G-TETRAD DYNAMICS 5'- D(*CP*GP*GP*GP*CP*GP*GP*GP*CP*GP*CP*GP*AP*GP*GP*GP*AP*GP*GP *GP*T)-3' DNA C-KIT2, ONCOGENE, PROMOTER, G-QUADRUPLEX, DNA 2l7v nuc NMR POTASSIUM ION 2(K 1+) QUINDOLINE/G-QUADRUPLEX COMPLEX DNA (5'- D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP 3') DNA/INHIBITOR C-MYC PROMOTER, DNA-INHIBITOR COMPLEX, C-MYC PROMOTER G-QUAD 2mko nuc NMR POTASSIUM ION K 1+ G-TRIPLEX STRUCTURE AND FORMATION PROPENSITY DNA_(5'-D(*GP*GP*TP*TP*GP*GP*TP*GP*TP*GP*G)-3') DNA G-TRIPLEX, G-TRIAD, DNA 2n9q nuc NMR POTASSIUM ION 3(K 1+) PHOTOSWITCHABLE G-QUADRUPLEX DNA (5'-D(*GP*GP*(AZW)P*GP*G)-3') DNA QUADRUPLEX, PHOTOSWITCH, DNA 2oij nuc 2.31 POTASSIUM ION 2(K 1+) HIV-1 SUBTYPE B DIS RNA EXTENDED DUPLEX AUCL3 SOAKED 5'-R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*C *GP*CP*AP*AP*G)-3' RNA HIV-1, METAL IONS, RNA, BULGES 2oiy nuc 1.60 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF THE DUPLEX FORM OF THE HIV-1(LAI) RNA DIMERIZATION INITIATION SITE 5'-R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*C *GP*CP*AP*AP*G)-3' RNA HIV-1, DIS, RNA, DIMERIZATION 2oj0 nuc 2.60 POTASSIUM ION 5(K 1+) CRYSTAL STRUCTURE OF THE DUPLEX FORM OF THE HIV-1(LAI) RNA DIMERIZATION INITIATION SITE MN SOAKED 5'-R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*C *GP*CP*AP*AP*G)-3' RNA HIV-1, DIS, RNA, DIMERIZATION, METAL IONS 2qbz nuc 2.60 POTASSIUM ION 4(K 1+) STRUCTURE OF THE M-BOX RIBOSWITCH APTAMER DOMAIN M-BOX RNA, YKOK RIBOSWITCH APTAMER RNA RNA, RIBOSWITCH, YKOK, M-BOX, RNA SENSOR, NONCODING RNA 2qek nuc 1.80 POTASSIUM ION 3(K 1+) HIV-1 SUBTYPE F DIS RNA EXTENDED DUPLEX FORM HIV-1 SUBTYPE F DIS GENOMIC RNA RNA HIV RNA BULGED-ADENINE 2xnw nuc 1.50 POTASSIUM ION K 1+ XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO A TRIAZOLO-TRIAZOLE-DIAMINE LIGAND IDENTIFIED BY VIRTUAL SCRE GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 2xnz nuc 1.59 POTASSIUM ION 6(K 1+) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO ACETOGUAN IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA, APTAMER, RNA-LIGAND COMPLEX, MRNA 2xo0 nuc 1.70 POTASSIUM ION 5(K 1+) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO 24-DIAMINO-1,3,5-TRIAZINE IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 2xo1 nuc 1.60 POTASSIUM ION 3(K 1+) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO N6-METHYL GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 2ygh nuc 2.60 POTASSIUM ION K 1+ SAM-I RIBOSWITCH WITH A G2NA MUTATION IN THE KINK TURN IN CO WITH S-ADENOSYLMETHIONINE SAM-I RIBOSWITCH RNA RNA 2yie nuc 2.94 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF A F. NUCLEATUM FMN RIBOSWITCH BOUND TO FMN RIBOSWITCHFMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2495-2544APTAMER DOMAIN, RESIDUES 2550-2601 RNA RNA 2yif nuc 3.30 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF A F. NUCLEATUM FMN RIBOSWITCH - FREE STATE FMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2495-2544, FMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2550-2601 RNA RNA, TRANSLATION 3bnp nuc 2.70 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE (A1555G MUTANT) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, A CHAIN, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, B CHAIN RNA RIBOSOME, DECODING SITE, RNA 3bnq nuc 2.00 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF SRCL2 (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, B CHAIN, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, A CHAIN RNA RIBOSOME, DECODING SITE, RNA 3bnr nuc 2.10 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF NONSPECIFICALLY BOUND PAROMOMYCIN (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN THREE, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN TWO, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN ONE RNA RIBOSOME, DECODING SITE, RNA 3bns nuc 1.90 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMA SITE (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN TWO CHAIN: B, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN THR CHAIN: D, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN THR CHAIN: A, C RNA RIBOSOME, DECODING SITE, RNA 3bwp nuc 3.10 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF A SELF-SPLICED GROUP II INTRON GROUP IIC INTRON RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II 3c44 nuc 2.00 POTASSIUM ION 4(K 1+) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO PAROMOMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC, PAROMOMYCIN, EXTENDED DUPLEX 3c5d nuc 1.80 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO LIVIDOMYCIN 'HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, AMINOGLYCOSIDE,LIVIDOMYCIN, EXTENDED DUPLEX 3c7r nuc 1.70 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO NEOMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, NEOMYCIN, EXTENDED DUPLEX 3cco nuc 2.20 POTASSIUM ION 3(K 1+) STRUCTURAL ADAPTATION AND CONSERVATION IN QUADRUPLEX-DRUG RECOGNITION DNA (5'- D(*DTP*DAP*DGP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DGP*DT)-3') DNA QUADRUPLEX, DNA, PROPELLER, DIMERIC, HUMAN TELOMERE PARALLEL STRANDED, LIGAND, COMPLEX, NAPHTHALENE DIIMIDINE 3cdm nuc 2.10 POTASSIUM ION 4(K 1+) STRUCTURAL ADAPTATION AND CONSERVATION IN QUADRUPLEX-DRUG RECOGNITION DNA (5'- D(*DT*DAP*DGP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DGP*DTP*DTP*DAP*D GP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DG)-3') DNA QUADRUPLEX, DNA, PROPELLER, INTRAMOLECULAR, HUMAN TELOMERE PARALLEL STRANDED, LIGAND, COMPLEX 3ce5 nuc 2.50 POTASSIUM ION 2(K 1+) A BIMOLECULAR PARALLEL-STRANDED HUMAN TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6,9-TRISUBSTITUTED ACRIDINE MOLECULE BRACO19 DNA (5'- D(*DTP*DAP*DGP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DGP*DT)-3') DNA BIMOLECULAR, PARALLEL, HUMAN, TELOMERE, QUADRUPLEX, COMPLEX, TRISUBSTITUTED, ACRIDINE, BRACO19, DNA 3dig nuc 2.80 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO S-(2-AMINOETHYL)-L-CYSTEINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dil nuc 1.90 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dio nuc 2.40 POTASSIUM ION K 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO LYSINE, IRIDIUM HEXAMINE SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diq nuc 2.70 POTASSIUM ION K 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO HOMOARGININE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dir nuc 2.90 POTASSIUM ION K 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH N6-1-IMINOETHYL-L-LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dix nuc 2.90 POTASSIUM ION K 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, K+ ANOMALOUS DATA RNA (174-MER) RNA RIBOSWITCH, LYSINE, POTASSIUM CATION, RNA 3diy nuc 2.71 POTASSIUM ION K 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, MN2+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diz nuc 2.85 POTASSIUM ION K 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE IN THE ABSENCE OF MG2+ RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dj0 nuc 2.50 POTASSIUM ION K 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH L-4-OXALYSINE RNA (174-MER) RNA LYSINE RIBSOWITCH, OXALYSINE, RNA 3dvv nuc 2.00 POTASSIUM ION 4(K 1+) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO RIBOSTAMYCIN (U267OME) HIV-1 GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC, AMINOGLYCOSIDE 3em2 nuc 2.30 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6038 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6038, BSU6038, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, G-QUADRUPLEX, DNA 3eog nuc 3.39 POTASSIUM ION 11(K 1+) CO-CRYSTALLIZATION SHOWING EXON RECOGNITION BY A GROUP II INTRON GROUP IIC INTRON, 5'-R(*UP*UP*AP*UP*UP*A)-3' RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II, EXON 3eoh nuc 3.12 POTASSIUM ION 9(K 1+) REFINED GROUP II INTRON STRUCTURE GROUP IIC INTRON, 5'-R(*UP*UP*AP*UP*UP*A)-3' RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II, EXON 3eqw nuc 2.20 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6042 IN SMALL UNIT CELL 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6042, BSU6042, ANTI- PARALLEL, BIMOLECULAR, MACROMLECULE, DNA, G-QUADRUPLEX, TELOMERE 3eru nuc 2.00 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6045 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6045, BSU6045, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, G-QUADRUPLEX, TELOMERE, DNA 3es0 nuc 2.20 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6048 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6048, BSU6048, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX 3et8 nuc 2.45 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6054 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6054, BSU6054, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX 3eui nuc 2.20 POTASSIUM ION 8(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6042 IN A LARGE UNIT CELL 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6042, BSU6042, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX 3eum nuc 1.78 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6066 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXTYRICHA NOVA, BSU-6066, BSU6066, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX 3f2q nuc 2.95 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2t nuc 3.00 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, IRIDIU SOAK. FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA 3f2y nuc 3.20 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, MN2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, MANGANESE, RNA 3f30 nuc 3.15 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, COBALT SOAK. FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, COBALT HEXAMINE, RNA 3f4e nuc 3.05 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, SPLIT FMN RIBOSWITCH, FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, RNA 3f4g nuc 3.01 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO RIBOFLAVIN. FMN RIBOSWITCH, FMN RIBOSWITCH RNA RIBOFLAVIN, FMN, RIBOSWITCH, TRANSCRIPTION, RNA 3f4h nuc 3.00 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO ROSEOFLAVIN FMN RIBOSWITCH, FMN RIBOSWITCH RNA ROSEOFLAVIN, FMN, RIBOSWITCH, TRANSCRIPTION, RNA 3far nuc 2.40 POTASSIUM ION 3(K 1+) CATION-DEPENDENT SELF-CLEAVAGE ACTIVITY IN THE DUPLEX FORM OF THE SUBTYPE-B HIV-1 RNA DIMERIZATION INITIATION SITE RNA (5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3') RNA HIV-1, RNA, METAL IONS, CATALYTIC RNA 3ftm nuc 2.70 POTASSIUM ION 2(K 1+) CLASS II LIGASE RIBOZYME PRODUCT-TEMPLATE DUPLEX, STRUCTURE 1 5'-R(*CP*CP*AP*GP*UP*CP*GP*GP*AP*AP*CP*A)-3', 5'-R(*GP*UP*GP*UP*GP*AP*GP*GP*CP*UP*G)-3' RNA RIBOZYME, LIGASE, 2'-5', 2-5, 2P5, RNA 3g78 nuc 2.80 POTASSIUM ION 26(K 1+) INSIGHT INTO GROUP II INTRON CATALYSIS FROM REVISED CRYSTAL GROUP II INTRON, LIGATED EXON PRODUCT: UNKNOWN EXON PRODUCT RNA REVISED CRYSTAL STRUCTURE, REVISION, RNA 3gjk nuc 2.20 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*A)-3', 5'-D(P*TP*TP*(B7C)P*GP*CP*G)-3' DNA DNA, DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE 3gx3 nuc 2.70 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF THE T. TENGCONGENSIS SAM-I RIBOSWITCH VARIANT U34C/A94G BOUND WITH SAH RNA (94-MER) RNA KINK-TURN, FOUR-WAY JUNCTION, PSEUDOKNOT, RIBOSWITCH, RNA 3gx5 nuc 2.40 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF T. TENCONGENSIS SAM-I RIBOSWITCH VARIANT A94G/U34 BOUND WITH SAM RNA (94-MER) RNA KINK-TURN, PSEUDOKNOT, FOUR-WAY JUNCTION, RIBOSWITCH, RNA 3ibk nuc 2.20 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF A TELOMERIC RNA QUADRUPLEX RNA (5'-R(*(5BU)P*AP*GP*GP*GP*UP*UP*AP*GP*GP*GP*U CHAIN: A, B RNA RNA QUADRUPLEX, BIMOLECULAR QUADRUPLEX, PARALLEL STRANDED, R 3igi nuc 3.12 POTASSIUM ION 22(K 1+) TERTIARY ARCHITECTURE OF THE OCEANOBACILLUS IHEYENSIS GROUP 5'-R(*CP*GP*CP*UP*CP*UP*AP*CP*UP*CP*UP*AP*U)-3', GROUP IIC INTRON RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II, EXON 3iqn nuc 2.70 POTASSIUM ION 6(K 1+) FREE-STATE STRUCTURAL TRANSITIONS OF THE SAM-I RIBOSWITCH SAM-I RIBOSWITCH RNA RIBOSWITCH, SAM, KINK-TURN, PSUEDOKNOT, RNA 3l0u nuc 3.00 POTASSIUM ION K 1+ THE CRYSTAL STRUCTURE OF UNMODIFIED TRNAPHE FROM ESCHERICHIA UNMODIFIED TRNAPHE RNA TRANSFER RNA, TRNA, TRANSCRIPT, UNMODIFIED, RNA 3mij nuc 2.60 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF A TELOMERIC RNA G-QUADRUPLEX COMPLEXED ACRIDINE-BASED LIGAND. RNA (5'-R(*UP*AP*GP*GP*GP*UP*UP*AP*GP*GP*GP*U)-3' CHAIN: A RNA QUADRUPLEX, RNA-LIGAND COMPLEX, RNA, TELOMERIC 3nd3 nuc 1.37 POTASSIUM ION K 1+ UHELIX 16-MER DSRNA 5'-R(*AP*GP*AP*GP*AP*AP*GP*AP*UP*UP*UP*UP*UP*UP*U CHAIN: A RNA DOUBLE-STRANDED RNA, RNA, U-HELIX, OLIGO-U TAIL, POLYU RNA 3nd4 nuc 1.52 POTASSIUM ION K 1+ WATSON-CRICK 16-MER DSRNA 5'-R(*AP*GP*AP*GP*AP*AP*GP*AP*UP*CP*UP*UP*CP*UP*C CHAIN: A RNA DOUBLE-STRANDED RNA, RNA, 16 BASE PAIR RNA 3nyp nuc 1.18 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERI QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE LIG CONTAINING BIS-3-FLUOROPYRROLIDINE END SIDE CHAINS 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, OXTYRICHA NOVA, BSU-6039, BSU6039, ANTI-PARALLEL BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX, TELOMERE, AC 3nz7 nuc 1.10 POTASSIUM ION 4(K 1+) A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERI QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE LIG CONTAINING BIS-3-FLUOROPYRROLIDINE END SIDE CHAINS 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, OXTYRICHA NOVA, BSU-6039, BSU6039, ANTI-PARALLEL BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX, TELOMERE, AC FLUORINATION 3pdr nuc 1.85 POTASSIUM ION 6(K 1+) CRYSTAL STRUCTURE OF MANGANESE BOUND M-BOX RNA M-BOX RIBOSWITCH RNA RNA MANGANESE-RNA COMPLEX, RNA 3qcr nuc 3.20 POTASSIUM ION 2(K 1+) INCOMPLETE STRUCTURAL MODEL OF A HUMAN TELOMERIC DNA QUADRUP ACRIDINE COMPLEX. HUMAN TELOMERIC REPEAT DEOXYRIBONUCLEIC ACID DNA QUADRUPLEX, ACRIDINE LIGAND-COMPLEX, TELOMERE, DNA 3qsc nuc 2.40 POTASSIUM ION 3(K 1+) THE FIRST CRYSTAL STRUCTURE OF A HUMAN TELOMERIC G-QUADRUPLE BOUND TO A METAL-CONTAINING LIGAND (A COPPER COMPLEX) 5'-D(*AP*GP*GP*GP*TP*(BRU)P*AP*GP*GP*GP*TP*T)-3' DNA PARALLEL, TELOMERE, QUADRUPLEX, DRUG, DNA, METAL COMPLEX, CO COMPLEX 3qsf nuc 2.40 POTASSIUM ION 3(K 1+) THE FIRST CRYSTAL STRUCTURE OF A HUMAN TELOMERIC G-QUADRUPLE BOUND TO A METAL-CONTAINING LIGAND (A NICKEL COMPLEX) 5'-D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*T)-3' DNA PARALLEL, TELOMERE, NICKEL, DRUG, DNA, METAL COMPLEX 3qxr nuc 1.62 POTASSIUM ION 9(K 1+) CRYSTAL STRUCTURE OF THE BROMINATED CKIT-1 PROTO-ONCOGENE PR QUADRUPLEX DNA 5'-D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*(BRU) P*GP*GP*GP*AP*GP*GP*AP*GP*GP*G)-3' DNA DNA QUADRUPLEX, REGULATION, CKIT-1, DNA 3r6r nuc 2.40 POTASSIUM ION 2(K 1+) STRUCTURE OF THE COMPLEX OF AN INTRAMOLECULAR HUMAN TELOMERI BERBERINE FORMED IN K+ SOLUTION DNA (22-MER) DNA/ANTIBIOTIC DNA-DRUG COMPLEX, G-QUADRUPLEX, HUMAN TELOMERIC DNA, DNA, DN ANTIBIOTIC COMPLEX 3s49 nuc 2.30 POTASSIUM ION 3(K 1+) RNA CRYSTAL STRUCTURE WITH 2-SE-URIDINE MODIFICATION RNA (5'-R(*GP*UP*AP*UP*AP*(RUS)P*AP*C)-3') RNA RNA, 2-SE-URIDINE 3sc8 nuc 2.30 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX BOUND BY THE NAPHTHALENE DIIMIDE BMSG-SH-3 HUMAN TELOMERIC REPEAT SEQUENCE DNA G-QUADRUPLEX, INTRAMOLECULAR, LIGAND-COMPLEX, TELOMERIC, DNA 3t5e nuc 2.10 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX BOUND BY THE NAPHTHALENE DIIMIDE BMSG-SH-4 HUMAN TELOMERIC DNA SEQUENCE DNA G-QUADRUPLEX, INTRAMOLECULAR, LIGAND-COMPLEX, TELOMERIC, DNA 3t86 nuc 1.90 POTASSIUM ION K 1+ D(GCATGCT) + CALCIUM DNA (5'-D(*GP*CP*AP*TP*GP*CP*T)-3') DNA QUADRUPLEX, LOOP, DNA 3uyh nuc 1.95 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX BOUND BY THE NAPHTHALENE DIIMIDE COMPOUND, MM41 HUMAN TELOMERIC DNA SEQUENCE DNA INTRAMOLECULAR, LIGAND-COMPLEX, G-QUADRUPLEX, TELOMERE, DNA 3vrs nuc 2.60 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, SOAKED IN MN2+ FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 3wru nuc 2.30 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH SYNTHETIC AMINOGLYCOSIDE WITH F-HABA GROUP RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RIBOSOMAL RNA, AMINOGLYCOSIDE, RNA-ANTIBIOTIC COMPLEX 4aob nuc 2.95 POTASSIUM ION 8(K 1+) SAM-I RIBOSWITCH CONTAINING THE T. SOLENOPSAE KT-23 IN COMPL S-ADENOSYL METHIONINE SAM-I RIBOSWITCH TRANSLATION TRANSLATION, K-TURN, RNA 4b5r nuc 2.95 POTASSIUM ION 7(K 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI K-T-7 SAM-I RIBOSWITCH: APTAMER DOMAIN, RESIDUES 1-94 RNA RNA, RIBOSWITCH, K-TURN 4da3 nuc 2.40 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX 21-MER BOUND BY THE NAPHTHALENE DIIMIDE COMPOUND DNA (5'- D(*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP 3') DNA INTRAMOLECULAR, LIGAND-COMPLEX, G-QUADRUPLEX, TELOMERE, DNA 4daq nuc 2.75 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX 21-MER BOUND BY THE NAPHTHALENE DIIMIDE COMPOUND DNA (5'- D(*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP 3') DNA INTRAMOLECULAR, LIGAND-COMPLEX, G-QUADRUPLEX, DNA 4e48 nuc 2.50 POTASSIUM ION 2(K 1+) STRUCTURE OF 20MER DOUBLE-HELICAL RNA COMPOSED OF CUG/CUG-RE 5'-R(P*GP*CP*UP*GP*CP*UP*GP*CP*UP*GP*CP*UP*GP*CP* P*GP*C)-3' RNA SIRNA, TRINUCLEOTIDE REPEAT EXPANSION, RNA 4e8k nuc 3.03 POTASSIUM ION 18(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND A NON-HYDROLYZED OLIGONUCLEOTIDE SUBSTRATE GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*CP*G*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, RNA 4e8m nuc 3.50 POTASSIUM ION 18(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8t nuc 3.34 POTASSIUM ION 14(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND AN OLIGONUCLEOTIDE FRAGMENT SUBSTRATE (LOW DATASET) GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8v nuc 4.00 POTASSIUM ION 4(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND BA2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4enb nuc 2.30 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, BOUND TO IRIDIUM FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4enc nuc 2.27 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4faq nuc 3.11 POTASSIUM ION 20(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND 5'-EXON GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4far nuc 2.86 POTASSIUM ION 19(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND 5'-EXON GRUUP IIC INTRON: DOMAINS 1-5, GROUP IIC INTRON: 5'-EXON RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4faw nuc 2.70 POTASSIUM ION 19(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND A HYDROLYZED OLIGONUCLEOTIDE FRAGMENT GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*A*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fb0 nuc 3.22 POTASSIUM ION 18(K 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON C377G A LIGAND-FREE STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fxm nuc 1.65 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF THE COMPLEX OF A HUMAN TELOMERIC REPEAT QUADRUPLEX AND N-METHYL MESOPORPHYRIN IX (P21212) DNA (5'- D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP 3') DNA PARALLEL QUADRUPLEX, N-METHYL MESOPORPHYRIN IX, DNA 4g0f nuc 2.15 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF THE COMPLEX OF A HUMAN TELOMERIC REPEAT QUADRUPLEX AND N-METHYL MESOPORPHYRIN IX (P6) DNA (5'- D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP 3') DNA QUADRUPLEX, N-METHYL MESOPORPHYRIN IX, DNA 4glh nuc 1.66 POTASSIUM ION 2(K 1+) DNA DODECAMER CONTAINING 5-HYDROXYMETHYL CYTOSINE DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5HC)P*GP*CP*G CHAIN: A, B DNA B-DNA DODECAMER, EPIGENETICS, 5-HYDROXYMETHYL CYTOSINE, DNA 4h29 nuc 1.99 POTASSIUM ION 6(K 1+) B-RAF DIMER DNA QUADRUPLEX DNA (5'- D(*GP*GP*GP*CP*GP*GP*GP*GP*AP*GP*GP*GP*GP*GP*AP*AP*GP*GP*GP CHAIN: A, B DNA B-RAF QUADRUPLEX DNA, DNA 4hli nuc 1.99 POTASSIUM ION K 1+ DNA DODECAMER CONTAINING 5-HYDROXYMETHYL-CYTOSINE DNA (5'-D(*CP*GP*(5HC)P*GP*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA DODECAMER, EPIGENETICS, 5-HYDROXYMETHYL CYTOSINE, DNA 4jah nuc 1.50 POTASSIUM ION 2(K 1+) CRYSTAL STRUCTURE OF 2-SELENOURIDINE CONTAINING RNA RNA (5'-R(*GP*UP*GP*UP*AP*(RUS)P*AP*C)-3') RNA 2-SELENOURIDINE, HIGH FIDELITY BASE PAIRING, RNA 4jd8 nuc 1.16 POTASSIUM ION K 1+ RACEMIC-[RU(PHEN)2(DPPZ)]2+] BOUND TO SYNTHETIC DNA AT HIGH DNA (5'-D(*AP*TP*GP*CP*AP*T)-3') DNA INTERCALATION, RACEMIC LIGAND-DNA, DNA 4kyy nuc 2.35 POTASSIUM ION 7(K 1+) CRYSTAL STRUCTURE OF RNA 17-MER UUCGGUUUUGAUCCGGA DUPLEX RNA 17-MER RNA RNA DUPLEX, RNA 4l0a nuc 1.70 POTASSIUM ION 6(K 1+) X-RAY STRUCTURE OF AN ALL LNA QUADRUPLEX DNA/RNA (5'-R(*(TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN)) CHAIN: A, B, C, D, E, F, G, H DNA, RNA PARALLEL G-QUADRUPLEX, LOCKED NUCLEIC ACID (LNA), DNA, RNA 4o5y nuc 1.75 POTASSIUM ION K 1+ O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 4p1d nuc 1.55 POTASSIUM ION 2(K 1+) STRUCTURE OF THE COMPLEX OF A BIMOLECULAR HUMAN TELOMERIC DN COPTISINE TELOMERIC DNA DNA DRUG-DNA COMPLEX, G-QUADRUPLEX, DNA 4qk8 nuc 3.05 POTASSIUM ION K 1+ THERMOANAEROBACTER PSEUDETHANOLICUS C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qka nuc 3.20 POTASSIUM ION K 1+ C-DI-AMP RIBOSWITCH FROM THERMOANAEROBACTER PSEUDETHANOLICUS HEXAMINE SOAK C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4r44 nuc 2.69 POTASSIUM ION 14(K 1+) RACEMIC CRYSTAL STRUCTURE OF A TETRAMOLECULAR DNA G-QUADRUPL 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA RACEMIC DNA, RACEMATES, DNA 4r45 nuc 1.90 POTASSIUM ION 5(K 1+) RACEMIC CRYSTAL STRUCTURE OF A BIMOLECULAR DNA G-QUADRUPLEX 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4r47 nuc 1.85 POTASSIUM ION 5(K 1+) RACEMIC CRYSTAL STRUCTURE OF A BIMOLECULAR DNA G-QUADRUPLEX 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4r4v nuc 3.07 POTASSIUM ION 5(K 1+) CRYSTAL STRUCTURE OF THE VS RIBOZYME - G638A MUTANT VS RIBOZYME RNA RNA NA, DIMER, RNA 4rbq nuc 1.05 POTASSIUM ION 5(K 1+) 32 BASE PAIR OLIGO(U) RNA U-HELIX RNA FROM TRYPANOSOME EDITING RNA DOUBLE HELIX, OLIGOU, 3' U-TAIL, ATOMIC RESOLUTION, A-FORM R TRYPANOSOME RNA EDITING SUBSTRATE, MITOCHONDRION, RNA 4rgf nuc 3.20 POTASSIUM ION 14(K 1+) CRYSTAL STRUCTURE OF THE IN-LINE ALIGNED ENV22 TWISTER RIBOZ WITH MN2+ ENV22 TWISTER RIBOZYME RNA PSEUDOKNOT, STEMS, CLEAVAGE, RNA 4rum nuc 2.64 POTASSIUM ION 7(K 1+) CRYSTAL STRUCTURE OF THE NICO TRANSITION-METAL RIBOSWITCH BO COBALT NICO RIBOSWITCH RNA RNA RNA HELIX, LIGAND SENSOR, COBALT AND NICKEL BINDING, RNA, RI 4ts0 nuc 2.80 POTASSIUM ION 10(K 1+) CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH BARIUM IONS SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT, SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA 4ts2 nuc 2.88 POTASSIUM ION 3(K 1+) CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH MAGNESIUM IONS SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT, SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA 4u5m nuc 1.50 POTASSIUM ION 4(K 1+) STRUCTURE OF A LEFT-HANDED DNA G-QUADRUPLEX DNA (28-MER) DNA DNA, QUADRUPLEX 4wo2 nuc 1.82 POTASSIUM ION 6(K 1+) CRYSTAL STRUCTURE OF HUMAN NATIVE CKIT PROTO-ONCOGENE PROMOT QUADRUPLEX DNA DNA (5'- D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*TP*GP*GP*GP*AP*GP*GP*AP 3') DNA DNA QUADRUPLEX, REGULATION, DNA 4wo3 nuc 2.73 POTASSIUM ION 5(K 1+) THE SECOND C-KIT DNA QUADRUPLEX CRYSTAL STRUCTURE DNA (5'- D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*TP*GP*GP*GP*AP*GP*GP*AP 3') DNA DNA G-QUADRUPLEX, C/KIT, DNA 4xk0 nuc 1.08 POTASSIUM ION 9(K 1+) CRYSTAL STRUCTURE OF A TETRAMOLECULAR RNA G-QUADRUPLEX IN PO RNA (5'-(*UP*GP*GP*GP*GP*U)-3') RNA RNA, RNA G-QUADRUPLEX, TETRAMOLECULAR G-QUADRUPLEX, INTERMOL QUADRUPLEX 4y1n nuc 3.00 POTASSIUM ION K 1+ OCEANOBACILLUS IHEYENSIS GROUP II INTRON DOMAIN 1 WITH IRIDI HEXAMINE GROUP II INTRON, DOMAIN 1 RNA, TRANSFERASE GROUP II INTRON, DOMAIN 1, RNA, IRIDIUM HEXAMINE, TRANSFERAS 4y1o nuc 2.95 POTASSIUM ION 2(K 1+) OCEANOBACILLUS IHEYENSIS GROUP II INTRON DOMAIN 1 GROUP II INTRON, DOMAIN 1 RNA, TRANSFERASE GROUP II INTRON, DOMAIN 1, RNA, TRANSFERASE 4yaz nuc 2.00 POTASSIUM ION 3(K 1+) 3',3'-CGAMP RIBOSWITCH BOUND WITH 3',3'-CGAMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP, 4yb0 nuc 2.12 POTASSIUM ION 2(K 1+) 3',3'-CGAMP RIBOSWITCH BOUND WITH C-DI-GMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP, 5btp nuc 2.82 POTASSIUM ION K 1+ FUSOBACTERIUM ULCERANS ZTP RIBOSWITCH BOUND TO ZMP RNA (62-MER) RNA RNA 5c45 nuc 2.93 POTASSIUM ION 6(K 1+) SELECTIVE SMALL MOLECULE INHIBITION OF THE FMN RIBOSWITCH FMN RIBOSWITCH, FMN RIBOSWITCH RNA/INHIBITOR RNA, TRANSLATION, RNA-INHIBITOR COMPLEX 5ccw nuc 1.89 POTASSIUM ION 2(K 1+) STRUCTURE OF THE COMPLEX OF A HUMAN TELOMERIC DNA WITH AU(CA YLIDENE)2 HUMAN TELOMERIC DNA DRUG/DNA DRUG-DNA COMPLEX, G-QUADRUPLEX 5cdb nuc 1.70 POTASSIUM ION 2(K 1+) STRUCTURE OF THE COMPLEX OF A BIMOLECULAR HUMAN TELOMERIC DN 13-DIPHENYLALKYL BERBERINE DERIVATIVE HUMAN TELOMERIC DNA DNA DRUG-DNA COMPLEX, G-QUADRUPLEX, DNA 5da6 nuc 1.05 POTASSIUM ION K 1+ ATOMIC RESOLUTION CRYSTAL STRUCTURE OF DOUBLE-STRANDED RNA 3 PAIRS LONG DETERMINED FROM RANDOM STARTING PHASES ANGLES IN PRESENCE OF PSEUDO TRANSLATIONAL SYMMETRY USING THE DIRECT PROGRAM SIR2014. RNA (32-MER) RNA RNA EDITING SUBSTRATE, DOUBLE-STRANDED RNA, DIRECT METHODS S DETERMINATION, PSEUDO TRANSLATIONAL SYMMETRY, RNA 5dqk nuc 2.71 POTASSIUM ION 4(K 1+) TWO DIVALENT METAL IONS AND CONFORMATIONAL CHANGES PLAY ROLE HAMMERHEAD RIBOZYME CLEAVAGE REACTION-WT RIBOZYME IN MG2+ RNA (5'-R(*GP*GP*GP*CP*GP*U)-D(P*C)- R(P*UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3'), RNA (48-MER) RNA RIBOZYME, HAMMERHEAD, RNA 5dun nuc 2.64 POTASSIUM ION K 1+ THE CRYSTAL STRUCTURE OF OME SUBSTITUTED TWISTER RIBOZYME RNA (54-MER) RNA OME, TWISTER, RNA, RIBOZYME 5dww nuc 2.79 POTASSIUM ION 10(K 1+) STRUCTURAL INSIGHTS INTO THE QUADRUPLEX-DUPLEX 3' INTERFACE FROM A TELOMERIC REPEAT - TTLOOP DNA (25-MER), DNA (5'-D(*TP*AP*AP*CP*GP*CP*TP*A)-3') DNA TELOMERE, QUADRUPLEX, JUNCTION, DUPLEX, DNA 5dwx nuc 2.71 POTASSIUM ION 3(K 1+) STRUCTURAL INSIGHTS INTO THE QUADRUPLEX-DUPLEX 3' INTERFACE FROM A TELOMERIC REPEAT - TLOOP DNA (24-MER), DNA COMPLEMENTARY STRAND DNA TELOMERE, QUADRUPLEX, JUNCTION, DUPLEX, DNA 5ew4 nuc 1.47 POTASSIUM ION 9(K 1+) CRYSTAL STRUCTURE OF C9ORF72 ANTISENSE CCCCGG REPEAT RNA ASS WITH LOU GEHRIG'S DISEASE AND FRONTOTEMPORAL DEMENTIA, CRYS WITH SR2+ RNA (5'- R(*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP 3') RNA REPEAT EXPANSION DISORDER, GENETIC DISEASE, RNA 5ew7 nuc 1.75 POTASSIUM ION 4(K 1+) CRYSTAL STRUCTURE OF C9ORF72 ANTISENSE CCCCGG REPEAT RNA ASS WITH LOU GEHRIG'S DISEASE AND FRONTOTEMPORAL DEMENTIA, CRYS WITH BA2+ RNA (5'- R(*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP 3') RNA REPEAT EXPANSION DISORDER, GENETIC DISEASE, RNA 5fjc nuc 1.71 POTASSIUM ION 4(K 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT C- SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk3 nuc 2.50 POTASSIUM ION 3(K 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk5 nuc 3.32 POTASSIUM ION 2(K 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-93 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk6 nuc 2.50 POTASSIUM ION 3(K 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS CA SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkd nuc 3.00 POTASSIUM ION K 1+ SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS UA SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fke nuc 2.80 POTASSIUM ION K 1+ SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS GU SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkf nuc 2.80 POTASSIUM ION 2(K 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS UC SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkg nuc 2.95 POTASSIUM ION 2(K 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN (1-94) RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkh nuc 2.65 POTASSIUM ION K 1+ SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5hix nuc 2.48 POTASSIUM ION 4(K 1+) COCRYSTAL STRUCTURE OF AN ANTI-PARALLEL DNA G-QUADRUPLEX AND QUINOLINE FOLDAMER DIMERIC G-QUADRUPLEX DNA DNA G-QUADRUPLEX, FOLDAMER, FOLDAMER-QUADRUPLEX, G-QUADRUPLE LIGANDS, DNA 5i2v nuc NMR POTASSIUM ION 2(K 1+) NMR STRUCTURE OF A NEW G-QUADRUPLEX FORMING SEQUENCE WITHIN PROTO-ONCOGENE PROMOTER REGION DNA (5'- D(*AP*GP*GP*GP*CP*GP*GP*TP*GP*TP*GP*GP*GP*AP*AP*TP*AP*GP*GP 3') DNA G-QUADRUPLEX, KRAS, PROTO-ONCOGENE, CANCER TARGET, DNA 5kx9 nuc 2.90 POTASSIUM ION 7(K 1+) SELECTIVE SMALL MOLECULE INHIBITION OF THE FMN RIBOSWITCH FMN RIBOSWITCH, FMN RIBOSWITCH RNA/INHIBITOR RNA, TRANSLATION, RNA-INHIBITOR COMPLEX 5mvb nuc NMR POTASSIUM ION 2(K 1+) SOLUTION STRUCTURE OF A HUMAN G-QUADRUPLEX HYBRID-2 FORM IN WITH A GOLD-LIGAND DNA (26-MER) DNA G-QUADRUPLEX HYBRID, 2 AUOXO6, DNA 5mvp nuc 1.61 POTASSIUM ION K 1+ CRYSTAL STRUCTURE OF AN A-DNA DODECAMER CONTAINING THE GGGCC DNA DNA A-DNA, UNMODIFIED, SELF-COMPLEMENTARY, DNA 5u3g nuc 2.30 POTASSIUM ION K 1+ STRUCTURE OF THE DICKEYA DADANTII YKKC RIBOSWITCH BOUND TO G YKKC RIBOSWITCH RNA RIBOSWITCH, YKKC, GUANIDINE, GUANIDINIUM, RNA 5v3f nuc 1.70 POTASSIUM ION 6(K 1+) CO-CRYSTAL STRUCTURE OF THE FLUOROGENIC RNA MANGO RNA (31-MER) RNA QUADRUPLEX FLUORESCENT RNA, RNA
Code Class Resolution Description 2l13 nuc NMR 12-HYDROXYDODECYL DIHYDROGEN PHOSPHATE C12 H27 O5 P MINI-HAIPIN OF AT BASEPAIRS HAVING A C12-ALKYL LINKER FORMIN REGION DNA (5'-D(*TP*AP*TP*TP*AP*TP*((CH2)12)P*AP*TP*AP* 3') DNA MINI-HAIRPIN, ALKYL CHAIN, C12, DODECYL, SYNTHETIC HYBRID, D
Code Class Resolution Description 2hli nuc NMR 2'-DEOXY-N-[(1S)-1-METHYL-3-OXOPROPYL]GUANOSINE 5'- PHOSPHATE C14 H20 N5 O8 P SOLUTION STRUCTURE OF CROTONALDEHYDE-DERIVED N2-[3-OXO-1(S)- METHYL-PROPYL]-DG DNA ADDUCT IN THE 5'-CPG-3' SEQUENCE DNA DODECAMER, DNA DODECAMER WITH S-CROTONALDEHYDE ADDUCT DNA INTERSTRAND DNA CROSS-LINK; S-CROTONALDEHYDE-DG ADDUCT; 5'- CPG-3' SEQUENCE
Code Class Resolution Description 2esi nuc 3.00 KANAMYCIN A 3(C18 H36 N4 O11) COMPLEX BETWEEN KANAMYCIN A AND THE 16S-RRNA A SITE. 5'- R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP *UP*CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES
Code Class Resolution Description 4d9x nuc 2.44 6,7-DIHYDRO[1,3]DIOXOLO[4,5-G][1,3]DIOXOLO[7, 8]ISOQUINO[3,2-A]ISOQUINOLIN-5-IUM C19 H14 N O4 1+ THE CRYSTAL STRUCTURE OF COPTISINE BOUND TO DNA D(CGTACG) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA DRUG-DNA COMPLEX, DOUBLE HELIX, DNA 4l5k nuc 2.71 6,7-DIHYDRO[1,3]DIOXOLO[4,5-G][1,3]DIOXOLO[7, 8]ISOQUINO[3,2-A]ISOQUINOLIN-5-IUM C19 H14 N O4 1+ CRYSTAL STRUCTURE OF THE COMPLEX OF DNA HEXAMER D(CGATCG) WI COPTISINE DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA DRUG-DNA COMPLEX, ISOQUINOLINE ALKALOID, DNA 4p1d nuc 1.55 6,7-DIHYDRO[1,3]DIOXOLO[4,5-G][1,3]DIOXOLO[7, 8]ISOQUINO[3,2-A]ISOQUINOLIN-5-IUM C19 H14 N O4 1+ STRUCTURE OF THE COMPLEX OF A BIMOLECULAR HUMAN TELOMERIC DN COPTISINE TELOMERIC DNA DNA DRUG-DNA COMPLEX, G-QUADRUPLEX, DNA
Code Class Resolution Description
2kvy nuc NMR 4-AMINO-1-METHYL-N-{1-METHYL-5-[(1-METHYL-5-{[3- (METHYLAMINO)-3-OXOPROPYL]CARBAMOYL}-1H-PYRROL-3-YL) CARBAMOYL]-1H-PYRROL-3-YL}-1H-PYRROLE-2-CARBOXAMIDE 4(C22 H28 N8 O4) NMR SOLUTION STRUCTURE OF THE 4:1 COMPLEX BETWEEN AN UNCHARG DISTAMYCIN A ANALOGUE AND [D(TGGGGT)]4 DNA (5'-D(*TP*GP*GP*GP*GP*T)-3') DNA G-QUADRUPLEX, COULOMBIC INTERACTIONS, NMR TITRATION, DISTAMY STRUCTURE CALCULATIONS, ISOTHERMAL TITRATION CALORIMETRY (I
Code Class Resolution Description 2mb3 nuc NMR (12S,27S)-12,27-BIS(4-AMINOBUTYL)-4,30-DIMETHYL-3,7,14, 18,22,29-HEXAOXA-11,26,31,32,33,34,35,36- OCTAAZAHEPTACYCLO[26.2.1.1~2,5~.1~6,9~.1~13,16~.1~17, 20~.1~21,24~]HEXATRIACONTA-1(30),2(36),4,6(35),8, 13(34),15,17(33),19,21(32),23,28(31)-DODECAENE-10,25- C32 H34 N10 O8 SOLUTION STRUCTURE OF AN INTRAMOLECULAR (3+1) HUMAN TELOMERI QUADRUPLEX BOUND TO A TELOMESTATIN DERIVATIVE DNA_(5'- D(*TP*TP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP GP*A)-3') DNA/DNA INHIBITOR INTRAMOLECULAR G-QUADRUPLEX, HUMAN TELOMERE, ANTICANCER TARG MACROCYCLIC HEXAOXAZOLE, TELOMESTATIN DERIVATIVE, DNA-DNA I COMPLEX
Code Class Resolution Description 2l8h nuc NMR 4-METHOXYNAPHTHALEN-2-AMINE C11 H11 N O CHEMICAL PROBE BOUND TO HIV TAR RNA HIV TAR RNA RNA RNA
Code Class Resolution Description
2l8p nuc NMR ({[(2S)-1-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)-3- HYDROXYPROPAN-2-YL]OXY}METHYL)PHOSPHONIC ACID C8 H14 N3 O6 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING THE POTENT ANT AGENT CIDOFOVIR DNA (5'-D(*CP*GP*CP*AP*TP*GP*(L8P)P*TP*AP*CP*GP*C CHAIN: A, DNA (5'-D(*GP*CP*GP*TP*AP*GP*CP*AP*TP*GP*CP*G)-3' CHAIN: B DNA DNA, POXVIRUS, HPMPC
Code Class Resolution Description
2l94 nuc NMR N'-{(Z)-AMINO[4-(AMINO{[3-(DIMETHYLAMMONIO) PROPYL]IMINIO}METHYL)PHENYL]METHYLIDENE}-N,N- DIMETHYLPROPANE-1,3-DIAMINIUM C18 H36 N6 4+ STRUCTURE OF THE HIV-1 FRAMESHIFT SITE RNA BOUND TO A SMALL INHIBITOR OF VIRAL REPLICATION RNA_(45-MER) RNA/INHIBITOR RNA, INHIBITOR, RNA-INHIBITOR COMPLEX
Code Class Resolution Description 3jq4 nuc 3.52 N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7,13-DIHYDROXY- 1,4,10,19-TETRAMETHYL-17,18-DIOXO-16- OXABICYCLO[13.2.2]NONADECA-3,5,9,11-TETRAEN-2-YL]-2- OXOPROPANAMIDE C25 H33 N O7 THE STRUCTURE OF THE COMPLEX OF THE LARGE RIBOSOMAL SUBUNIT RADIODURANS WITH THE ANTIBIOTIC LANKACIDIN 23S RIBOSOMAL RNA, 5S RIBOSOMAL RNA RNA RIBOSOME STRUCTURE, ANTIBIOTICS, LANKACIDIN, LANKAMYCIN, PRO SYNTHESIS, INHIBITORS, SYNERGISM, MACROLIDE, RNA
Code Class Resolution Description 1h0q nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(ADENIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 N5 O7 P1) NMR SOLUTION STRUCTURE OF A FULLY MODIFIED LOCKED NUCLEIC ACID (LNA) HYBRIDIZED TO RNA 5-R(*GP*CP*AP*UP*AP*UP*CP*AP*G)-3, 5-D(*(LKC)P*(TLN)P*(LCG)P*(LCA)P*(TLN)P*(LCA)P* (TLN)P*(LCG)P*(LCC))-3 DNA-RNA HYBRID DNA-RNA HYBRID, LNA, RNA, LOCKED NUCLEIC ACID, HYBRID, DNA/RNA HYBRID 2oom nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(ADENIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H14 N5 O7 P NMR STRUCTURE OF A KISSING COMPLEX FORMED BETWEEN THE TAR RNA ELEMENT OF HIV-1 AND A LNA/RNA APTAMER TAR RNA ELEMENT OF HIV-1, RNA 16-MER RNA LNA; LOCKED NUCLEIC ACID; NMR; APTAMER; TAR; HIV-1, RNA 2pn9 nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(ADENIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H14 N5 O7 P NMR STRUCTURE OF A KISSING COMPLEX FORMED BETWEEN THE TAR RNA ELEMENT OF HIV-1 AND A LNA MODIFIED APTAMER 5'- R(*GP*GP*AP*GP*CP*CP*UP*GP*GP*GP*AP*GP*CP*UP*CP*C)-3', RNA 16-MER WITH LOCKED RESIDUES 9-10 RNA RNA; LNA; LOCKED NUCLEIC ACID; NMR; APTAMER; TAR; HIV-1; KISSING 2x2q nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(ADENIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O7 P) CRYSTAL STRUCTURE OF AN 'ALL LOCKED' LNA DUPLEX AT 1.9 ANGST RESOLUTION LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX, LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX DNA DNA, MODIFIED NUCLEIC ACID, LOCKED NUCLEIC ACID, THERMOSTABI 5dhc nuc 1.55 [(1R,3R,4R,7S)-7-HYDROXY-3-(ADENIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O7 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA, MONOMER, COOPERATIVITY 5hbx nuc 1.70 [(1R,3R,4R,7S)-7-HYDROXY-3-(ADENIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O7 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA 5v0j nuc 1.50 [(1R,3R,4R,7S)-7-HYDROXY-3-(ADENIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 N5 O7 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA
Code Class Resolution Description 1h0q nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN- 1-YL)-2,5-DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H16 N3 O8 P NMR SOLUTION STRUCTURE OF A FULLY MODIFIED LOCKED NUCLEIC ACID (LNA) HYBRIDIZED TO RNA 5-R(*GP*CP*AP*UP*AP*UP*CP*AP*G)-3, 5-D(*(LKC)P*(TLN)P*(LCG)P*(LCA)P*(TLN)P*(LCA)P* (TLN)P*(LCG)P*(LCC))-3 DNA-RNA HYBRID DNA-RNA HYBRID, LNA, RNA, LOCKED NUCLEIC ACID, HYBRID, DNA/RNA HYBRID 1w86 nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN- 1-YL)-2,5-DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H16 N3 O8 P) SOLUTION STRUCTURE OF AN DSDNA:LNA TRIPLEX INTRAMOLECULAR DSDNA-LNA TRIPLEX, INTRAMOLECULAR DSDNA-LNA TRIPLEX, INTRAMOLECULAR DSDNA-LNA TRIPLEX DNA DNA COMPLEX, LNA, DNA, TRIPLEX, NMR SPECTROSCOPY, STRUCTURE 2x2q nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN- 1-YL)-2,5-DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 10(C11 H16 N3 O8 P) CRYSTAL STRUCTURE OF AN 'ALL LOCKED' LNA DUPLEX AT 1.9 ANGST RESOLUTION LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX, LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX DNA DNA, MODIFIED NUCLEIC ACID, LOCKED NUCLEIC ACID, THERMOSTABI 5dhb nuc 1.80 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H16 N3 O8 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA, COOPERATIVITY, MONOMER 5dhc nuc 1.55 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 8(C11 H16 N3 O8 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA, MONOMER, COOPERATIVITY 5hbw nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H16 N3 O8 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA 5hbx nuc 1.70 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 8(C11 H16 N3 O8 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA 5hby nuc 1.18 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H16 N3 O8 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA 5krg nuc 1.60 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 12(C11 H16 N3 O8 P) RNA 15MER DUPLEX BINDING WITH PZG MONOMER RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA 5l00 nuc 1.25 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 12(C11 H16 N3 O8 P) SELF-COMPLIMENTARY RNA 15MER BINDING WITH GMP MONOMERS RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA 5v0h nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 6(C11 H16 N3 O8 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-ONE BINDING SITE RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA, ANALOGUE 5v0j nuc 1.50 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H16 N3 O8 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA 5v0k nuc 1.60 [(1R,3R,4R,7S)-7-HYDROXY-3-(5-METHYLCYTOSIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H16 N3 O8 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA
Code Class Resolution Description 1h0q nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 N5 O8 P) NMR SOLUTION STRUCTURE OF A FULLY MODIFIED LOCKED NUCLEIC ACID (LNA) HYBRIDIZED TO RNA 5-R(*GP*CP*AP*UP*AP*UP*CP*AP*G)-3, 5-D(*(LKC)P*(TLN)P*(LCG)P*(LCA)P*(TLN)P*(LCA)P* (TLN)P*(LCG)P*(LCC))-3 DNA-RNA HYBRID DNA-RNA HYBRID, LNA, RNA, LOCKED NUCLEIC ACID, HYBRID, DNA/RNA HYBRID 1s9l nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 12(C11 H14 N5 O8 P) NMR SOLUTION STRUCTURE OF A PARALLEL LNA QUADRUPLEX 5'-((TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN))-3' RNA LNA, QUADRUPLEX, RNA 2chj nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 8(C11 H14 N5 O8 P) NMR STRUCTURE OF TGLGLT QUADRUPLEX 5'-D(*TP*G LCGP*G LCGP*TP)-3' NUCLEIC ACID NUCLEIC ACID, QUADRUPLEX, LNA, LOCKED NUCLEIC ACID 2chk nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 16(C11 H14 N5 O8 P) NMR STRUCTURE OF TLLLLT QUADRUPLEX 5'-D(*T LCG LCG LCG LCGP*TP)-3' NUCLEIC ACID QUADRUPLEX, LNA, LOCKED NUCLEIC ACID, NUCLEIC ACID 2m53 nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H14 N5 O8 P) G-RICH VEGF APTAMER WITH LNA MODIFICATIONS G-RICH VEGF APTAMER DNA APTAMER, DNA, G-QUADRUPLEX, LOCKED NUCLEIC ACID, VEGF 2may nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H14 N5 O8 P STRUCTURE OF A G-QUADRUPLEX CONTAINING A SINGLE LNA MODIFICA DNA_(5'- D(*TP*TP*GP*LGP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*T *GP*A)-3') DNA G-QUADRUPLEX, LNA MODIFICATION, BACKBONE, LOOP, DNA 2wcn nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 8(C11 H14 N5 O8 P) SOLUTION STRUCTURE OF AN LNA-MODIFIED QUADRUPLEX DNA (5'-D(*DGP*LCG*DGP*LCG*DTP*DTP*DTP *DTP*DGP*LCG*DGP*LCG)-3') DNA LNA, QUADRUPLEX, FOLDING TOPOLOGY, DNA 2x2q nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 10(C11 H14 N5 O8 P) CRYSTAL STRUCTURE OF AN 'ALL LOCKED' LNA DUPLEX AT 1.9 ANGST RESOLUTION LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX, LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX DNA DNA, MODIFIED NUCLEIC ACID, LOCKED NUCLEIC ACID, THERMOSTABI 4e58 nuc 1.95 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H14 N5 O8 P) CRYSTAL STRUCTURE OF GCC(LCG)CCGC DUPLEX CONTAINING LNA RESI RNA DUPLEX CONTAINING CCG REPEATS RNA CCG REPEATS, 5' SLIPPERY DUPLEXES, X-LINKED MENTAL RETARDATI HUNTINGTON'S DISEASE, MYOTONIC DYSTROPHY TYPE 1, LNA GUANOS 4l0a nuc 1.70 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 24(C11 H14 N5 O8 P) X-RAY STRUCTURE OF AN ALL LNA QUADRUPLEX DNA/RNA (5'-R(*(TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN)) CHAIN: A, B, C, D, E, F, G, H DNA, RNA PARALLEL G-QUADRUPLEX, LOCKED NUCLEIC ACID (LNA), DNA, RNA 4xw0 nuc 1.81 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 N5 O8 P) CRYSTAL STRUCTURE OF (GCCU(G-LNA)CCUGC)2 DUPLEX RNA (5'-R(*GP*CP*CP*UP*(LCG)P*CP*CP*UP*GP*C)-3') RNA CCUG REPEATS, RNA DUPLEX, MYOTONIC DYSTROPHY TYPE 2, TAUTOME RESIDUE, 3' OVERHANGING NUCLEOTIDES, RNA 4xw1 nuc 2.30 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H14 N5 O8 P CRYSTAL STRUCTURE OF (GCCU(G-LNA)CCUG)2 DUPLEX RNA (5'-R(*GP*CP*CP*UP*(LCG)P*CP*CP*UP*G)-3') RNA CCUG REPEATS, RNA DUPLEX, MYOTONIC DYSTROPHY TYPE 2, TAUTOME RESIDUE, 3' OVERHANGING NUCLEOTIDES, RNA 5dhb nuc 1.80 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O8 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA, COOPERATIVITY, MONOMER 5dhc nuc 1.55 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O8 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA, MONOMER, COOPERATIVITY 5hbw nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 N5 O8 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA 5hbx nuc 1.70 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O8 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA 5hby nuc 1.18 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H14 N5 O8 P RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA 5krg nuc 1.60 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O8 P) RNA 15MER DUPLEX BINDING WITH PZG MONOMER RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA 5l00 nuc 1.25 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H14 N5 O8 P) SELF-COMPLIMENTARY RNA 15MER BINDING WITH GMP MONOMERS RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA 5v0h nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 N5 O8 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-ONE BINDING SITE RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA, ANALOGUE 5v0j nuc 1.50 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 N5 O8 P) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA 5v0k nuc 1.60 [(1R,3R,4R,7S)-7-HYDROXY-3-(GUANIN-9-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H14 N5 O8 P RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA
Code Class Resolution Description 1nzm nuc NMR 3,11-DIFLUORO-6,8,13-TRIMETHYL-8H-QUINO[4,3,2- KL]ACRIDIN-13-IUM 2(C22 H17 F2 N2 1+) NMR STRUCTURE OF THE PARALLEL-STRANDED DNA QUADRUPLEX D(TTAGGGT)4 COMPLEXED WITH THE TELOMERASE INHIBITOR RHPS4 5'-D(*TP*TP*AP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, TELOMERES, TELOMERASE INHIBITION, NMR SPECTROSCOPY, MOLECULAR DYNAMICS, DRUG-DNA INTERACTION, TTAGGGT REPEAT
Code Class Resolution Description 1ac9 nuc NMR N9-1-HYDROXY-PROP-2-OXYMETHYL-GUANINE-3'-MONOPHOSPHATE 2(C9 H14 N5 O7 P) SOLUTION STRUCTURE OF A DNA DECAMER CONTAINING THE ANTIVIRAL DRUG GANCICLOVIR: COMBINED USE OF NMR, RESTRAINED MOLECULAR DYNAMICS, AND FULL RELAXATION REFINEMENT, 6 STRUCTURES DNA DNA DNA DECAMER, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 2pwt nuc 1.80 DOUBLY FUNCTIONALIZED PAROMOMYCIN PM-II-162 3(C37 H65 N7 O16) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE COMPLEXED WITH AMINOGLYCOSIDE CONTAINING THE L-HABA GROUP 22-MER OF THE RIBOSOMAL DECODING SITE RNA AMINOGLYCOSIDE; HABA GROUP; RIBOSOMAL DECODING SITE; X-RAY ANALYSIS; RNA
Code Class Resolution Description 2lho nuc NMR 2-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-6-METHYLISOQUINOLINE-1(2H)-THIONE C15 H18 N O6 P S SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING AN UNNATURAL, HYDROPHOBIC BASE PAIR DNA (5'-D(*CP*GP*TP*TP*TP*CP*(LHO)P*TP*TP*CP*TP*C CHAIN: A, DNA (5'-D(*GP*AP*GP*AP*AP*(MM7)P*GP*AP*AP*AP*CP*G CHAIN: B DNA DNA, UNNATURAL BASE PAIR
Code Class Resolution Description 2o4f nuc 1.50 LITHIUM ION LI 1+ STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX CRYSTALLISED WITH MONOVALENT IONS 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA DNA, QUADRUPLE HELIX, PARALLEL-STRANDED
Code Class Resolution Description 2esj nuc 2.20 (2R,3S,4S,5S,6R)-2-((2S,3S,4R,5R,6R)-5-AMINO-2- (AMINOMETHYL)-6-((2R,3S,4R,5S)-5-((1R,2R,3S,5R,6S)-3, 5-DIAMINO-2-((2S,3R,5S,6R)-3-AMINO-5-HYDROXY-6- (HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6- HYDROXYCYCLOHEXYLOXY)-4-HYDROXY-2-(HYDROXYMETHYL)- TETRAH 2(C29 H55 N5 O18) COMPLEX BETWEEN LIVIDOMYCIN A AND THE 16S-RRNA A SITE 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES 2fd0 nuc 1.80 (2R,3S,4S,5S,6R)-2-((2S,3S,4R,5R,6R)-5-AMINO-2- (AMINOMETHYL)-6-((2R,3S,4R,5S)-5-((1R,2R,3S,5R,6S)-3, 5-DIAMINO-2-((2S,3R,5S,6R)-3-AMINO-5-HYDROXY-6- (HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6- HYDROXYCYCLOHEXYLOXY)-4-HYDROXY-2-(HYDROXYMETHYL)- TETRAH 2(C29 H55 N5 O18) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH LIVIDOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 3c5d nuc 1.80 (2R,3S,4S,5S,6R)-2-((2S,3S,4R,5R,6R)-5-AMINO-2- (AMINOMETHYL)-6-((2R,3S,4R,5S)-5-((1R,2R,3S,5R,6S)-3, 5-DIAMINO-2-((2S,3R,5S,6R)-3-AMINO-5-HYDROXY-6- (HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6- HYDROXYCYCLOHEXYLOXY)-4-HYDROXY-2-(HYDROXYMETHYL)- TETRAH 2(C29 H55 N5 O18) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO LIVIDOMYCIN 'HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, AMINOGLYCOSIDE,LIVIDOMYCIN, EXTENDED DUPLEX
Code Class Resolution Description 1h0q nuc NMR 4-AMINO-1-[(1S,3R,4R,7S)-7-HYDROXY-1- (HYDROXYMETHYL)-2,5-DIOXABICYCLO[2.2.1]HEPT-3-YL]-5- METHYLPYRIMIDIN-2(1H)-ONE C11 H15 N3 O5 NMR SOLUTION STRUCTURE OF A FULLY MODIFIED LOCKED NUCLEIC ACID (LNA) HYBRIDIZED TO RNA 5-R(*GP*CP*AP*UP*AP*UP*CP*AP*G)-3, 5-D(*(LKC)P*(TLN)P*(LCG)P*(LCA)P*(TLN)P*(LCA)P* (TLN)P*(LCG)P*(LCC))-3 DNA-RNA HYBRID DNA-RNA HYBRID, LNA, RNA, LOCKED NUCLEIC ACID, HYBRID, DNA/RNA HYBRID
Code Class Resolution Description 2llj nuc NMR 6,22-DIOXA-3,9,19,25-TETRAAZONIAPENTACYCLO[25.5.3.3~11, 17~.0~14,37~.0~30,34~]OCTATRIACONTA-1(33),11(38),12, 14(37),15,17(36),27,29,31,34-DECAENE C32 H44 N4 O2 4+ STRUCTURE OF A BIS-NAPHTHALENE BOUND TO A THYMINE-THYMINE DN DNA (5'-D(*CP*GP*TP*CP*GP*TP*AP*GP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*CP*TP*TP*CP*GP*AP*CP*G)-3') DNA DNA THYMINE MISMATCH, MACROCYLE, BISINTERCALATION, DNA
Code Class Resolution Description 2et3 nuc 2.80 (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R, 3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2- YLOXY)-2-HYDROXYCYCLOHEXYLOXY)-5-METHYL-4- (METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL 2(C19 H39 N5 O7) COMPLEX BETWEEN GENTAMICIN C1A AND THE 16S-RRNA A-SITE 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES
Code Class Resolution Description
1lu5 nuc 2.40 CIS-(AMMINE)(CYCLOHEXYLAMINE)PLATINUM(II) COMPLEX 2(C6 H16 N2 PT 2+) 2.4 ANGSTROM CRYSTAL STRUCTURE OF THE ASYMMETRIC PLATINUM CO {PT(AMMINE)(CYCLOHEXYLAMINE)}2+ BOUND TO A DODECAMER DNA DU 5'-D(*CP*CP*TP*CP*TP*GP*GP*TP*CP*TP*CP*C)-3', 5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3' DNA PLATINUM-DNA COMPLEX, DNA
Code Class Resolution Description
5axe nuc 0.95 [(1R,5R,7R,8S)-7-[5-METHYL-2,4-BIS(OXIDANYLIDENE) PYRIMIDIN-1-YL]-8-OXIDANYL-3,3-BIS(OXIDANYLIDENE)-6- OXA-3$L^{6}-THIA-2-AZABICYCLO[3.2.1]OCTAN-5-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H16 N3 O10 P S) CRYSTAL STRUCTURE ANALYSIS OF DNA DUPLEXES CONTAINING SULFOA BRIDGED NUCLEIC ACID (SUNA-NH) DNA (5'-D(*GP*CP*GP*TP*AP*(LSH)P*AP*CP*GP*C)-3') DNA A-FORM DNA, SULFONAMIDE-BRIDGED NUCLEIC ACID, SUNA[NH], ANTI DNA
Code Class Resolution Description
5axf nuc 1.13 [(1R,5R,7R,8S)-2-METHYL-7-[5-METHYL-2,4- BIS(OXIDANYLIDENE)PYRIMIDIN-1-YL]-8-OXIDANYL-3,3- BIS(OXIDANYLIDENE)-6-OXA-3$L^{6}-THIA-2- AZABICYCLO[3.2.1]OCTAN-5-YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H18 N3 O10 P S) CRYSTAL STRUCTURE ANALYSIS OF DNA DUPLEXES CONTAINING SULFOA BRIDGED NUCLEIC ACID (SUNA-NME) DNA (5'-D(*GP*CP*GP*TP*AP*(LSM)P*AP*CP*GP*C)-3') DNA A-FORM DNA, SULFONAMIDE-BRIDGED NUCLEIC ACID, SUNA[NME], ANT DNA
Code Class Resolution Description 1duh nuc 2.70 LUTETIUM (III) ION LU 3+ CRYSTAL STRUCTURE OF THE CONSERVED DOMAIN IV OF E. COLI 4.5S RNA 4.5S RNA DOMAIN IV: DOMAIN IV RNA 4.5S RNA, DOMAIN IV, HELIX 8, SIGNAL RECOGNITION PARTICLE, SRP, FFH, SRP54, ELONGATION FACTOR G, EF-G, 23S RNA, NON- CANONICAL BASE PAIRS, MISMATCH
Code Class Resolution Description
2lwm nuc NMR [(1R,2S,4R)-4-{[2-AMINO-5-(FORMYLAMINO)-6-OXO-1,6- DIHYDROPYRIMIDIN-4-YL]AMINO}-2- HYDROXYCYCLOPENTYL]METHYL DIHYDROGEN PHOSPHATE C11 H18 N5 O7 P SOLUTION STRUCTURE OF DUPLEX DNA CONTAINING A B-CARBA-FAPY-D DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3'), DNA (5'-D(*CP*GP*TP*AP*C*(LWM)P*CP*AP*TP*GP*C)-3' CHAIN: B DNA OXIDATIVE DAMAGE, DNA
2lwn nuc NMR [(1R,2S,4R)-4-{[2-AMINO-5-(FORMYLAMINO)-6-OXO-1,6- DIHYDROPYRIMIDIN-4-YL]AMINO}-2- HYDROXYCYCLOPENTYL]METHYL DIHYDROGEN PHOSPHATE C11 H18 N5 O7 P SOLUTION STRUCTURE OF DUPLEX DNA CONTAINING A B-CARBA-FAPY-D DNA (5'-D(*CP*GP*TP*AP*C*(LWM)P*CP*AP*TP*GP*C)-3' CHAIN: B, DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3') DNA OXIDATIVE DAMAGE, DNA
2lwo nuc NMR [(1R,2S,4R)-4-{[2-AMINO-5-(FORMYLAMINO)-6-OXO-1,6- DIHYDROPYRIMIDIN-4-YL]AMINO}-2- HYDROXYCYCLOPENTYL]METHYL DIHYDROGEN PHOSPHATE C11 H18 N5 O7 P SOLUTION STRUCTURE OF DUPLEX DNA CONTAINING A B-CARBA-FAPY-D DNA (5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3'), DNA (5'-D(*G*CP*GP*TP*AP*C*(LWM)P*CP*AP*TP*GP*C)- CHAIN: B DNA OXIDATIVE DAMAGE, DNA
Code Class Resolution Description
4lvy nuc 2.00 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID 2(C20 H21 N5 O6) STRUCTURE OF THE THF RIBOSWITCH BOUND TO PEMETREXED THF RIBOSWITCH RNA APTAMERS, NUCLEOTIDE, BACILLUS SUBTILIS, BACTERIAL PROTEINS, SEQUENCE, BINDING SITES, CALORIMETRY, FOLIC ACID, GENE EXPR REGULATION, BACTERIAL, GUANINE, LEUCOVORIN, LIGANDS, MAGNES MOLECULAR SEQUENCE DATA, NUCLEIC ACID CONFORMATION, POINT M PROTEIN BINDING, PROTEIN STRUCTURE, SECONDARY, RNA, RIBOSWI ADENOSYLMETHIONINE, STREPTOCOCCUS MUTANS, TERMINATOR REGION GENETIC, TETRAHYDROFOLATES, THERMODYNAMICS, TRANSCRIPTION, JUNCTION, PSEUDOKNOT, REGULATION, NCRNA, PEMETREXED BINDING
Code Class Resolution Description 3d0u nuc 2.80 LYSINE C6 H15 N2 O2 1+ CRYSTAL STRUCTURE OF LYSINE RIBOSWITCH BOUND TO LYSINE LYSINE RIBOSWITCH RNA: LIGAND BINDING DOMAIN RNA RNA-LIGAND COMPLEX, RIBOSWITCH 3dil nuc 1.90 LYSINE C6 H15 N2 O2 1+ CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dim nuc 2.90 LYSINE C6 H15 N2 O2 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, CS+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dio nuc 2.40 LYSINE C6 H15 N2 O2 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO LYSINE, IRIDIUM HEXAMINE SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dix nuc 2.90 LYSINE C6 H15 N2 O2 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, K+ ANOMALOUS DATA RNA (174-MER) RNA RIBOSWITCH, LYSINE, POTASSIUM CATION, RNA 3diy nuc 2.71 LYSINE C6 H15 N2 O2 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, MN2+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diz nuc 2.85 LYSINE C6 H15 N2 O2 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE IN THE ABSENCE OF MG2+ RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dj2 nuc 2.50 LYSINE C6 H15 N2 O2 1+ CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, TL+ SOAK RNA (174-MER) RNA LYSINE, RIBOSWITCH, RNA 4erl nuc 3.00 LYSINE C6 H15 N2 O2 1+ CRYSTAL STRUCTURE OF THE LYSINE RIBOSWITCH BOUND TO A LYSINE DIPEPTIDE LYSINE RIBOSWITCH RNA: LYSINE RIBOSWITCH APTAMER DOMAIN TRANSCRIPTION RIBOSWITCH APTAMER DOMAIN, REGULATORY MRNA, TRANSCRIPTION
Code Class Resolution Description
2i5a nuc 1.65 2-{3'-[AMINO(IMINO)METHYL]BIPHENYL-4-YL}-1H- BENZIMIDAZOLE-5-CARBOXIMIDAMIDE C21 H18 N6 CRYSTAL STRUCTURE OF A DB1055-D(CGCGAATTCGCG)2 COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DNA DODECAMER WITH COMPOUND DB 1055
Code Class Resolution Description 1k29 nuc NMR 3-(2-DEOXY-BETA-D-RIBOFURANOSYL)-PYRIDO[5,6-A]-PURINE- 10-ONE-5'-MONOPHOSPHATE C13 H14 N5 O7 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING M1G OPPOSITE A 2 BASE PAIR DELETION 5'-D(*AP*TP*CP*GP*CP*(M1G)P*CP*GP*GP*CP*AP*TP*G)- 3', 5'-D(*CP*AP*TP*GP*CP*CP*GP*CP*GP*AP*T)-3' DNA TWO BASE DELETION, DNA ADDUCT, MALONDIALDEHYDE
Code Class Resolution Description 1ehz nuc 1.93 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 5(C12 H18 N5 O8 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1ipl nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1k7n nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1nrt nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 3(C12 H18 N5 O8 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1q49 nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1yfg nuc 3.00 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2z9q nuc 11.70 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 3cjz nuc 1.80 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) EFFECTS OF N2,N2-DIMETHYLGUANOSINE ON RNA STRUCTURE AND STABILITY: CRYSTAL STRUCTURE OF AN RNA DUPLEX WITH TANDEM M22G:A PAIRS RNA (5'-R(*GP*GP*AP*CP*GP*(M2G) P*AP*CP*GP*UP*CP*CP*U)-3') RNA RNA, N2, N2-DIMETHYL GUANOSINE, X-RAY CRYSTAL STRUCTURE, M22G:A PAIR, RRNA, TRNA 486d nuc 7.50 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE 2(C12 H18 N5 O8 P) X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 5tra nuc model N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA 6tna nuc 2.70 N2-DIMETHYLGUANOSINE-5'-MONOPHOSPHATE C12 H18 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1yy0 nuc 3.20 2'-(N-ACETAMIDE)-CYTIDINE-5'-MONOPHOSPHATE C11 H17 N4 O8 P CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING A 2'-AMINE SUB AND A 2'-AMIDE PRODUCT PRODUCED BY IN-CRYSTAL ACYLATION AT MISMATCH 5'-R(*GP*CP*AP*GP*AP*(A5M)P*UP*UP*AP*AP*AP*UP*CP* 3', 5'-R(*GP*CP*AP*GP*AP*(M5M)P*UP*UP*AP*AP*AP*UP*CP* 3' RNA 2'-AMINE, RNA, DUPLEX, MISMATCH, 2-AMIDE, IN-CRYSTAL REACTIO
Code Class Resolution Description 1wts nuc NMR 6N-DIMETHYLADENOSINE-5'-MONOPHOSHATE 2(C12 H18 N5 O7 P) HELIX 45 (16S RRNA) FROM B. STEAROTHERMOPHILUS, NMR, MINIMIZED AVERAGE STRUCTURE RNA (5'- R(*GP*GP*AP*CP*CP*2MGP*GP*MA6P*MA6P*GP*GP*UP*CP*C)-3'): HELIX 45 STEM-LOOP RNA RIBONUCLEIC ACID, RIBOSOME, RNA, 16S, MODIFIED NUCLEOTIDES, TETRALOOP 1wtt nuc NMR 6N-DIMETHYLADENOSINE-5'-MONOPHOSHATE 2(C12 H18 N5 O7 P) HELIX 45 (16S RRNA) FROM B. STEAROTHERMOPHILUS, NMR, 11 STRUCTURES RNA (5'- R(*GP*GP*AP*CP*CP*2MGP*GP*MA6P*MA6P*GP*GP*UP*CP*C)-3'): HELIX 45 STEM-LOOP RNA RIBONUCLEIC ACID, RIBOSOME, RNA, 16S, MODIFIED NUCLEOTIDES, TETRALOOP
Code Class Resolution Description 5uzi nuc NMR 1N-METHYLADENOSINE-5'-MONOPHOSPHATE C11 H17 N5 O6 P 1+ INSIGHTS INTO WATSON-CRICK/HOOGSTEEN BREATHING DYNAMICS AND REPAIR FROM THE SOLUTION STRUCTURE AND DYNAMIC ENSEMBLE OF DUPLEXES CONTAINING M1A - A6-DNAM1A16 STRUCTURE DNA (5'-D(*CP*GP*AP*TP*TP*TP*TP*TP*TP*GP*GP*C)-3' CHAIN: A, DNA (5'-D(*GP*CP*CP*(M1A)P*AP*AP*AP*AP*AP*TP*CP*G CHAIN: B DNA HOOGSTEEN BASE PAIRS, DNA STRUCTURE AND DYNAMICS, N1-METHYLA DAMAGE RECOGNITION AND REPAIR, NMR STRUCTURE AND DYNAMIC EN DNA
Code Class Resolution Description 1d35 nuc 1.30 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN C33 H39 N O13 FACILE FORMATION OF A CROSSLINKED ADDUCT BETWEEN DNA AND THE DAUNORUBICIN DERIVATIVE MAR70 MEDIATED BY FORMALDEHYDE: MOLECULAR STRUCTURE OF THE MAR70-D(CGTNACG) COVALENT ADDUC DNA (5'-D(*CP*GP*TP*(A40)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1d36 nuc 1.50 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN C33 H39 N O13 FACILE FORMATION OF A CROSSLINKED ADDUCT BETWEEN DNA AND THE DAUNORUBICIN DERIVATIVE MAR70 MEDIATED BY FORMALDEHYDE: MOLECULAR STRUCTURE OF THE MAR70-D(CGTNACG) COVALENT ADDUC DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1r68 nuc 1.20 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN C33 H39 N O13 ROLE OF THE AMINO SUGAR IN DNA BINDING OF DISACCHARIDE ANTHRACYCLINES: CRYSTAL STRUCTURE OF MAR70/D(CGATCG) COMPLEX 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, DRUG-DNA COMPLEX
Code Class Resolution Description 1pik nuc NMR 2,4-DIDEOXY-4-[2-(PROPYL)AMINO]-3-O-METHYL ALPHA-L- THREO-PENTOPYRANOSIDE C9 H19 N O3 ESPERAMICIN A1-DNA COMPLEX, NMR, 4 STRUCTURES DNA (5'-D(C*GP*GP*AP*TP*CP*CP*GP)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, DNA
Code Class Resolution Description 1qv4 nuc 2.50 2'-(3-METHYL-4-DIMETHYLAMINOPHENYL)-5-(4-METHYL-1- PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE C28 H31 N7 B-DNA DODECAMER CGTGAATTCACG COMPLEXED WITH MINOR GROOVE BINDER METHYLPROAMINE 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA, MINOR GROOVE BINDER
Code Class Resolution Description
2i2i nuc 1.63 2-(5-{4-[AMINO(IMINO)METHYL]PHENYL}-2-FURYL)-1H- BENZIMIDAZOLE-5-CARBOXIMIDAMIDE C19 H16 N6 O CRYSTAL STRUCTURE OF THE DB293-D(CGCGAATTCGCG)2 COMPLEX. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DNA DODECAMER WITH COMPOUND DB 293.
Code Class Resolution Description 1eek nuc NMR 1-[2-DEOXYRIBOFURANOSYL]-4-METHYL-BENZOIMIDAZOLE-5'- MONOPHOSPHATE C13 H17 N2 O6 P SOLUTION STRUCTURE OF A NONPOLAR, NON HYDROGEN BONDED BASE PAIR SURROGATE IN DNA. 5'-D(*GP*GP*TP*AP*AP*CP*(MBZ)P*AP*TP*GP*CP*G)-3', 5'-D(*CP*GP*CP*AP*TP*(DFT)P*GP*TP*TP*AP*CP*C)-3' DNA DNA, NONPOLAR, ISOSTERIC, DNA BASE ANALOGS
Code Class Resolution Description 106d nuc NMR 5-METHYL-2'-DEOXYCYTIDINE 4(C10 H15 N3 O4) SOLUTION STRUCTURES OF THE I-MOTIF TETRAMERS OF D(TCC), D(5MCCT) AND D(T5MCC). NOVEL NOE CONNECTIONS BETWEEN AMINO PROTONS AND SUGAR PROTONS DNA (5'-D(*MCYP*CP*T)-3') DNA DNA 145d nuc 1.25 5-METHYL-2'-DEOXYCYTIDINE 3(C10 H15 N3 O4) STRUCTURE AND THERMODYNAMICS OF NONALTERNATING C/G BASE PAIRS IN Z-DNA: THE 1.3 ANGSTROMS CRYSTAL STRUCTURE OF THE ASYMMETRIC HEXANUCLEOTIDE D(M(5)CGGGM(5) CG)/D(M(5) CGCCM(5)CG) DNA (5'-D(*(MCY)P*GP*GP*GP*(5CM)P*G)-3'), DNA (5'-D(*(5CM)P*DGP*DGP*DGP*(5CM)P*DG)-3'), DNA (5'-D(*(MCY)P*GP*CP*CP*(5CM)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1a83 nuc NMR 5-METHYL-2'-DEOXYCYTIDINE C10 H15 N3 O4 INTRAMOLECULAR I-MOTIF, NMR, 6 STRUCTURES DNA (5'-(MCY)CTTTCCTTTACCTTTCC-3') DNA DEOXYRIBONUCLEIC ACID, DNA, I-MOTIF, SOLUTION STRUCTURE, TELOMERE, CENTROMERE 1bae nuc NMR 5-METHYL-2'-DEOXYCYTIDINE 2(C10 H15 N3 O4) STRUCTURE OF DNA (5'-D 5MCCTTTACC-3')2, NMR, 1 STRUCTURE DNA (5'-D(*MCYP*CP*TP*TP*TP*AP*CP*C)-3') DNA DEOXYRIBONUCLEIC ACID, DNA DIMER OF 5MCCTTTACC, I-MOTIF, DIMER, NMR 1g22 nuc NMR 5-METHYL-2'-DEOXYCYTIDINE C10 H15 N3 O4 SOLUTION STRUCTURE OF A MODIFIED HUMAN CENTROMERIC FRAGMENT CENTROMERIC SATELLITE III: C-RICH STRAND FRAGMENT DNA DNA SOLUTION STRUCTURE, I-MOTIF, INTERACTING LOOPS, NMR, CENTROMERE, SATELLITE III 1q2t nuc NMR 5-METHYL-2'-DEOXYCYTIDINE 4(C10 H15 N3 O4) SOLUTION STRUCTURE OF D(5MCCTCTCC)4 5'-D(*(MCY)P*CP*TP*CP*TP*CP*C)-3' DNA DNA SOLUTION STRUCTURE; I-MOTIF; PROTONATED CYTIDINE; HEMIPROTONATED BASE-PAIRS 1rme nuc NMR 5-METHYL-2'-DEOXYCYTIDINE 4(C10 H15 N3 O4) DNA (5'-D(MCYP*CP*TP*CP*C)-3') TETRAMER, NMR, 1 STRUCTURE DNA (5'-D(*(MCY)P*CP*TP*CP*C)-3') DNA DEOXYRIBONUCLEIC ACID, I-MOTIF, TETRAMER, DNA 2awv nuc NMR 5-METHYL-2'-DEOXYCYTIDINE 2(C10 H15 N3 O4) NMR STRUCTURAL ANALYSIS OF THE DIMER OF 5MCCTCATCC 5'-D(*(MCY)P*CP*TP*CP*AP*CP*TP*CP*C)-3' DNA I-MOTIF, HEMIPROTONATED CC+ PAIRS, DIMER, DNA 2kkk nuc NMR 5-METHYL-2'-DEOXYCYTIDINE 4(C10 H15 N3 O4) AN I-MOTIF STRUCTURE WITH INTERCALATED T T PAIRS 5'-D(*(MCY)P*CP*TP*CP*TP*CP*TP*CP*C)-3' DNA DNA
Code Class Resolution Description 146d nuc NMR 2,6-DIDEOXY-3 C-METHYL-D-RIBOPYRANOSIDE 2(C7 H14 O4) SOLUTION STRUCTURE OF THE MITHRAMYCIN DIMER-DNA COMPLEX DNA (5'-D(*TP*CP*GP*CP*GP*A)-3') DNA DNA, NMR, MITHRAMYCIN DIMER 1bp8 nuc NMR 2,6-DIDEOXY-3 C-METHYL-D-RIBOPYRANOSIDE 4(C7 H14 O4) 4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX 5'-D(*AP*CP*CP*CP*GP*GP*GP*T)-3' DNA MITHRAMYCIN, DNA, OLIGONUCLEOTIDE, NMR 207d nuc NMR 2,6-DIDEOXY-3 C-METHYL-D-RIBOPYRANOSIDE 4(C7 H14 O4) SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA DNA (5'-D(*TP*AP*GP*CP*TP*AP*GP*CP*TP*A)-3') DNA DNA, NMR, DOUBLE HELIX, MITHRAMYCIN
Code Class Resolution Description 2gcv nuc 2.10 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 2(C6 H13 N O4 S) POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME PRODUCT OLIGONUCLEOTIDE, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 2h0w nuc 2.40 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 2(C6 H13 N O4 S) POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME PRODUCT OLIGONUCLEOTIDE, GLMS RIBOZYME RNA RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX 2ho6 nuc 2.80 2-(N-MORPHOLINO)-ETHANESULFONIC ACID 2(C6 H13 N O4 S) POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX 4p95 nuc 2.50 2-(N-MORPHOLINO)-ETHANESULFONIC ACID C6 H13 N O4 S SPECIATION OF A GROUP I INTRON INTO A LARIAT CAPPING RIBOZYM (CIRCULARLY PERMUTATED RIBOZYME) RNA (192-MER) RNA CATALYTIC RNA, LARIAT-CAPPING RIBOZYME, BRANCHING REACTION, FOLD, RNA 4xqz nuc 2.15 2-(N-MORPHOLINO)-ETHANESULFONIC ACID C6 H13 N O4 S CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY CHLORIDE AND MES DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA
Code Class Resolution Description
101d nuc 2.25 MAGNESIUM ION MG 2+ REFINEMENT OF NETROPSIN BOUND TO DNA: BIAS AND FEEDBACK IN ELECTRON DENSITY MAP INTERPRETATION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
109d nuc 2.00 MAGNESIUM ION MG 2+ VARIABILITY IN DNA MINOR GROOVE WIDTH RECOGNISED BY LIGAND BINDING: THE CRYSTAL STRUCTURE OF A BIS-BENZIMIDAZOLE COMPOUND BOUND TO THE DNA DUPLEX D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
119d nuc 2.25 MAGNESIUM ION MG 2+ CRYSTAL AND MOLECULAR STRUCTURE OF D(CGTAGATCTACG) AT 2.25 ANGSTROMS RESOLUTION DNA (5'-D(*CP*GP*TP*AP*GP*AP*TP*CP*TP*AP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX
146d nuc NMR MAGNESIUM ION MG 2+ SOLUTION STRUCTURE OF THE MITHRAMYCIN DIMER-DNA COMPLEX DNA (5'-D(*TP*CP*GP*CP*GP*A)-3') DNA DNA, NMR, MITHRAMYCIN DIMER
150d nuc 2.25 MAGNESIUM ION MG 2+ GUANINE.1,N6-ETHENOADENINE BASE-PAIRS IN THE CRYSTAL STRUCTURE OF D(CGCGAATT(EDA)GCG) DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(EDA) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED
159d nuc 1.80 MAGNESIUM ION MG 2+ SIDE BY SIDE BINDING OF TWO DISTAMYCIN A DRUGS IN THE MINOR GROOVE OF AN ALTERNATING B-DNA DUPLEX DNA (5'-D(*IP*CP*IP*CP*IP*CP*IP*C)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
184d nuc 1.80 MAGNESIUM ION 2(MG 2+) SELF-ASSOCIATION OF A DNA LOOP CREATES A QUADRUPLEX: CRYSTAL STRUCTURE OF D(GCATGCT) AT 1.8 ANGSTROMS RESOLUTION DNA (5'-D(*GP*CP*AP*TP*GP*CP*T)-3') DNA U-DNA, QUADRUPLE HELIX, TETRAPLEX, LOOP
1bdn nuc 2.60 MAGNESIUM ION 2(MG 2+) CRYSTAL LATTICE PACKING IS IMPORTANT IN DETERMINING THE BEND OF A DNA DODECAMER CONTAINING AN ADENINE TRACT DNA (5'-D(*CP*GP*CP*AP*AP*AP*AP*AP*TP*GP*CP*G)- 3'), DNA (5'-D(*CP*GP*CP*AP*TP*TP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX
1bp8 nuc NMR MAGNESIUM ION 2(MG 2+) 4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX 5'-D(*AP*CP*CP*CP*GP*GP*GP*T)-3' DNA MITHRAMYCIN, DNA, OLIGONUCLEOTIDE, NMR
1cp8 nuc NMR MAGNESIUM ION MG 2+ NMR STRUCTURE OF DNA (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9 DNA (5'-D(P*TP*TP*GP*GP*CP*CP*AP*A)-3') DNA DNA
1d23 nuc 1.50 MAGNESIUM ION 2(MG 2+) THE STRUCTURE OF B-HELICAL C-G-A-T-C-G-A-T-C-G AND COMPARISON WITH C-C-A-A-C-G-T-T-G-G. THE EFFECT OF BASE PAIR REVERSALS DNA (5'-D(*CP*GP*AP*TP*CP*GP*AP*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX
1d33 nuc 1.50 MAGNESIUM ION MG 2+ FORMALDEHYDE CROSS-LINKS DAUNORUBICIN AND DNA EFFICIENTLY: HPLC AND X-RAY DIFFRACTION STUDIES 5'-D(*CP*GP*CP*(G49)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
1d35 nuc 1.30 MAGNESIUM ION MG 2+ FACILE FORMATION OF A CROSSLINKED ADDUCT BETWEEN DNA AND THE DAUNORUBICIN DERIVATIVE MAR70 MEDIATED BY FORMALDEHYDE: MOLECULAR STRUCTURE OF THE MAR70-D(CGTNACG) COVALENT ADDUC DNA (5'-D(*CP*GP*TP*(A40)P*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
1d36 nuc 1.50 MAGNESIUM ION MG 2+ FACILE FORMATION OF A CROSSLINKED ADDUCT BETWEEN DNA AND THE DAUNORUBICIN DERIVATIVE MAR70 MEDIATED BY FORMALDEHYDE: MOLECULAR STRUCTURE OF THE MAR70-D(CGTNACG) COVALENT ADDUC DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
1d38 nuc 1.70 MAGNESIUM ION MG 2+ INFLUENCE OF AGLYCONE MODIFICATIONS ON THE BINDING OF ANTHRACYCLINE DRUGS TO DNA: THE MOLECULAR STRUCTURE OF IDARUBICIN AND 4-O-DEMETHYL-11-DEOXYDOXORUBICIN COMPLEXED TO D(CGATCG) DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
1d41 nuc 1.30 MAGNESIUM ION 2(MG 2+) STABILIZATION OF Z-DNA BY DEMETHYLATION OF THYMINE BASES: 1.3 ANGSTROMS SINGLE-CRYSTAL STRUCTURE OF D(M5CGUAM5CG) DNA (5'-D(*(5CM)P*GP*UP*AP*(5CM)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED
1d43 nuc 2.00 MAGNESIUM ION MG 2+ DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: C, PIPERAZINE UP DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
1d44 nuc 2.00 MAGNESIUM ION MG 2+ DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: C, PIPERAZINE DOWN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
1d45 nuc 1.90 MAGNESIUM ION MG 2+ DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: DEGREES C, PIPERAZINE DOWN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
1d46 nuc 2.00 MAGNESIUM ION MG 2+ DNA DODECAMER C-G-C-G-A-A-T-T-C-G-C-G/HOECHST 33258 COMPLEX: DEGREES C, PIPERAZINE DOWN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
1d49 nuc 1.50 MAGNESIUM ION MG 2+ THE STRUCTURE OF A B-DNA DECAMER WITH A CENTRAL T-A STEP: C- G-A-T-T-A-A-T-C-G DNA (5'-D(*CP*GP*AP*TP*TP*AP*AP*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX
1d4r nuc 2.00 MAGNESIUM ION 5(MG 2+) 29-MER FRAGMENT OF HUMAN SRP RNA HELIX 6 29-MER OF MODIFIED SRP RNA HELIX 6: NON-NATIVE DUPLEX, 29-MER OF MODIFIED SRP RNA HELIX 6: NON-NATIVE DUPLEX RNA A-RNA HELIX, GGAG/GAGG BULGE, AC/CA TANDEM MISMATCH, GU WOBBLE BASE PAIRS, 2'3' -CYCLIC PHOSPHATE
1d57 nuc 2.00 MAGNESIUM ION MG 2+ ALTERNATIVE STRUCTURES FOR ALTERNATING POLY(DA-DT) TRACTS: THE STRUCTURE OF THE B-DNA DECAMER C-G-A-T-A-T-A-T-C-G DNA (5'-D(*CP*GP*AP*TP*AP*TP*AP*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX
1d60 nuc 2.20 MAGNESIUM ION MG 2+ THE STRUCTURE OF THE B-DNA DECAMER C-C-A-A-C-I-T-T-G-G: TRIGONAL FORM DNA (5'-D(*CP*CP*AP*AP*CP*IP*TP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
1d63 nuc 2.00 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A BERENIL-D(CGCAAATTTGCG) COMPLEX; AN EXAMPLE OF DRUG-DNA RECOGNITION BASED ON SEQUENCE- DEPENDENT STRUCTURAL FEATURES DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
1d83 nuc NMR MAGNESIUM ION MG 2+ STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION DNA (5'-D(*AP*AP*GP*GP*CP*CP*TP*T)-3') DNA DNA, NMR, DOUBLE HELIX, CHROMOMYCIN
1d8x nuc 1.20 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*TP*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DNA
1da1 nuc 2.25 MAGNESIUM ION MG 2+ STRUCTURAL CHARACTERISATION OF THE BROMOURACIL-GUANINE BASE PAIR MISMATCH IN A Z-DNA FRAGMENT DNA (5'-D(*(BRU)P*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED
1da3 nuc 2.00 MAGNESIUM ION 2(MG 2+) THE CRYSTAL STRUCTURE OF THE TRIGONAL DECAMER C-G-A-T-C-G- 6MEA-T-C-G: A B-DNA HELIX WITH 10.6 BASE-PAIRS PER TURN DNA (5'-D(*CP*GP*AP*TP*CP*GP*(6MA)P*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
1dcg nuc 1.00 MAGNESIUM ION 4(MG 2+) THE MOLECULAR STRUCTURE OF THE LEFT-HANDED Z-DNA DOUBLE HELIX AT 1.0 ANGSTROM ATOMIC RESOLUTION. GEOMETRY, CONFORMATION, AND IONIC INTERACTIONS OF D(CGCGCG) DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX
1dcr nuc 1.60 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G-A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*(BRU)P*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DEOXYRIBONUCLEIC ACID, DNA
1dj6 nuc 1.00 MAGNESIUM ION MG 2+ COMPLEX OF A Z-DNA HEXAMER, D(CG)3, WITH SYNTHETIC POLYAMINE AT ROOM TEMPERATURE 5'-D(*CP*GP*CP*GP*CP*G)-3' DNA Z-DNA:POLYAMINE COMPLEX, X-RAY CRYSTAL STRUCTURE, POLYAMINE BINDING IN MINOR GROOVE OF Z-DNA
1dnf nuc 1.50 MAGNESIUM ION MG 2+ EFFECTS OF 5-FLUOROURACIL/GUANINE WOBBLE BASE PAIRS IN Z- DNA. MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGFG) DNA (5'-D(*CP*GP*CP*GP*(UFP)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED
1dno nuc 1.40 MAGNESIUM ION 4(MG 2+) A-DNA/RNA DODECAMER R(GCG)D(TATACGC) MG BINDING SITES DNA/RNA (5'-R(*GP*CP*GP)-D(*TP*AP*TP*AP*CP*GP*C)- 3') DNA/RNA HYBRID DNA CONFORMATION, RNA/DNA HYBRID, METAL IONS, DNA/RNA COMPLEX, DNA/RNA HYBRID COMPLEX
1dnt nuc 1.70 MAGNESIUM ION MG 2+ RNA/DNA DODECAMER R(GC)D(GTATACGC) WITH MAGNESIUM BINDING SITES DNA/RNA (5'-R(*GP*CP)-D(*GP*TP*AP*TP*AP*CP*GP*C)- 3') DNA/RNA HYBRID DNA CONFORMATION, RNA/DNA HYBRID, METAL IONS, DNA/RNA COMPLEX, DNA/RNA HYBRID COMPLEX
1dnx nuc 1.70 MAGNESIUM ION MG 2+ RNA/DNA DODECAMER R(G)D(CGTATACGC) WITH MAGNESIUM BINDING SITES DNA/RNA (5'-R(*GP)-D(*CP*GP*TP*AP*TP*AP*CP*GP*C)- 3') DNA-RNA HYBRID DNA CONFORMATION, RNA/DNA HYBRID, METAL IONS, DNA/RNA COMPLEX, DNA-RNA HYBRID
1dnz nuc 1.60 MAGNESIUM ION 2(MG 2+) A-DNA DECAMER ACCGGCCGGT WITH MAGNESIUM BINDING SITES DNA (5'-D(*AP*CP*CP*GP*GP*CP*CP*GP*GP*T)-3') DNA DNA CONFORMATION, METAL IONS
1dou nuc 1.82 MAGNESIUM ION MG 2+ MONOVALENT CATIONS SEQUESTER WITHIN THE A-TRACT MINOR GROOVE OF [D(CGCGAATTCGCG)]2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA DODECAMER, CATION BINDING, DNA
1dpl nuc 0.83 MAGNESIUM ION 2(MG 2+) A-DNA DECAMER GCGTA(T23)TACGC WITH INCORPORATED 2'-METHOXY- 3'-METHYLENEPHOSPHATE-THYMIDINE 5'-D(*GP*CP*GP*TP*AP*(T23)P*AP*CP*GP*C)-3' DNA MODIFIED A-DECAMER AT 0.83 A RESOLUTION, DEOXYRIBONUCLEIC ACID, DNA
1dpn nuc 0.95 MAGNESIUM ION 4(MG 2+) B-DODECAMER CGCGAA(TAF)TCGCG WITH INCORPORATED 2'-DEOXY-2'- FLUORO-ARABINO-FURANOSYL THYMINE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA 0.95 A RESOLUTION STRUCTURE, DNA
1duh nuc 2.70 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE CONSERVED DOMAIN IV OF E. COLI 4.5S RNA 4.5S RNA DOMAIN IV: DOMAIN IV RNA 4.5S RNA, DOMAIN IV, HELIX 8, SIGNAL RECOGNITION PARTICLE, SRP, FFH, SRP54, ELONGATION FACTOR G, EF-G, 23S RNA, NON- CANONICAL BASE PAIRS, MISMATCH
1edr nuc 1.60 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATTCGCG) AT 1.6 ANGSTROM 5'-D(*CP*GP*CP*GP*(A47)AP*AP*TP*TP*CP*GP*CP*G)- 3' DNA B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID, MODIFIED NUCLEOTIDE, METHOXYADENOSINE, DAMAGED DNA
1egk nuc 3.10 MAGNESIUM ION 14(MG 2+) CRYSTAL STRUCTURE OF A NUCLEIC ACID FOUR-WAY JUNCTION RNA (5'- R(*AP*GP*GP*AP*GP*AP*GP*AP*GP*AP*UP*GP*GP*GP*UP*GP*CP*GP*AP *G)-3'), 10-23 DNA ENZYME DNA-RNA HYBRID FOUR-WAY JUNCTION, NUCLEIC ACID, RNA-DNA COMPLEX, 10-23 DNA ENZYME, RIBOZYME, DNA/RNA COMPLEX, DNA-RNA HYBRID
1ehz nuc 1.93 MAGNESIUM ION 6(MG 2+) THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA
1ei4 nuc 1.43 MAGNESIUM ION MG 2+ B-DNA DODECAMER CGCGAAT(TLC)CGCG WITH INCORPORATED [3.3.0]BICYCLO-ARABINO-THYMINE-5'-PHOSPHATE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TLC)P*(TLC) P*CP*GP*CP*G)-3') DNA MODIFIED B-DODECAMER, [3.3.0]BICYCLO-ARABINONUCLEIC ACID, DNA
1em0 nuc 0.90 MAGNESIUM ION 2(MG 2+) COMPLEX OF D(CCTAGG) WITH TETRA-[N-METHYL-PYRIDYL] PORPHYRIN DNA (5'-D(*(CBR)P*CP*TP*AP*GP*G)-3') DNA PORPHYRIN, RUFFLING, DNA DISTORTION, GROOVE BINDING
1en3 nuc 0.98 MAGNESIUM ION 4(MG 2+) 1A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM DNA (5'-D(*CP*CP*AP*AP*CP*GP*TP*TP*GP*G)-3') DNA DIVALENT CATIONS, DNA SEQUENCE-SPECIFIC BINDING, SHELXDNA, B-DNA
1en9 nuc 0.98 MAGNESIUM ION 6(MG 2+) 1A CRYSTAL STRUCTURES OF B-DNA REVEAL SEQUENCE-SPECIFIC BINDING AND GROOVE-SPECIFIC BENDING OF DNA BY MAGNESIUM AND CALCIUM. DNA (5'-D(*CP*CP*AP*GP*CP*GP*CP*TP*GP*G)-3') DNA DIVALENT CATIONS, DNA SEQUENCE-SPECIFIC BINDING, SHELXDNA, B-DNA
1enn nuc 0.89 MAGNESIUM ION 7(MG 2+) SOLVENT ORGANIZATION IN AN OLIGONUCLEOTIDE CRYSTAL: THE STRUCTURE OF D(GCGAATTCG)2 AT ATOMIC RESOLUTION DNA (5'-D(*GP*CP*GP*AP*AP*TP*TP*CP*G)-3') DNA B-DNA, ATOMIC RESOLUTION, IONS, HYDRATION, BASE TRIPLET
1evv nuc 2.00 MAGNESIUM ION 10(MG 2+) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA
1f27 nuc 1.30 MAGNESIUM ION 6(MG 2+) CRYSTAL STRUCTURE OF A BIOTIN-BINDING RNA PSEUDOKNOT RNA (5'-R(*AP*AP*AP*AP*AP*GP*UP*CP*CP*UP*C)-3'), RNA (5'- R(*AP*CP*CP*GP*UP*CP*AP*GP*AP*GP*GP*AP*CP*AP*CP*GP*GP*UP*U) -3') RNA RNA APTAMER, PSEUDOKNOT, BIOTIN-BINDING RNA
1f69 nuc 2.60 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE B-DNA HEXAMER GGCGCC WITH COBALT HEXAMINE DNA (5'-D(*GP*GP*CP*GP*CP*C)-3') DNA B-DNA, E-DNA, DOUBLE HELIX
1fd5 nuc 1.10 MAGNESIUM ION MG 2+ BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (BISACRIDINE COMPLEX) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA HIGH RESOLUTION CRYSTAL STRUCTURE, INTERCALATION PLATFORM, MAD, ANTICANCER DRUG, DRUG-DNA COMPLEX, METAL IONS, TERTIARY BASE PAIRS
1fdg nuc 1.60 MAGNESIUM ION MG 2+ BINDING OF A MACROCYCLIC BISACRIDINE AND AMETANTRONE TO CGTACG INVOLVES SIMILAR UNUSUAL INTERCALATION PLATFORMS (AMETANTRONE COMPLEX) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA HIGH RESOLUTION CRYSTAL STRUCTURE, INTERCALATION PLATFORM, MAD, ANTICANCER DRUG, DRUG-DNA COMPLEX, METAL IONS, TERTIARY BASE PAIRS
1fir nuc 3.30 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA
1fmq nuc 2.00 MAGNESIUM ION MG 2+ CYCLO-BUTYL-BIS-FURAMIDINE COMPLEXED WITH DCGCGAATTCGCG 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DNA-DRUG MINOR GROOVE COMPLEX
1fms nuc 1.90 MAGNESIUM ION MG 2+ STRUCTURE OF COMPLEX BETWEEN CYCLOHEXYL-BIS-FURAMIDINE AND D(CGCGAATTCGCG) 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DNA-DRUG MINOR GROOVE COMPLEX
1fq2 nuc 1.20 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE ANALYSIS OF THE POTASSIUM FORM OF B-DNA DODECAMER CGCGAATTCGCG DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA CATIONS, DICKERSON DODECAMER, DICKERSON-DREW DODECAMER, MINOR GROOVE, DNA
1ftd nuc 2.00 MAGNESIUM ION MG 2+ 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3'-SYMMETRIC BIS- BENZIMIDAZOLE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA MINOR GROOVE BINDING, DNA
1fuf nuc 1.70 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A 14BP RNA OLIGONUCLEOTIDE CONTAINING DOUBLE UU BULGES: A NOVEL INTRAMOLECULAR U*(AU) BASE TRIPLE (5'-R(*GP*GP*UP*AP*UP*UP*UP*CP*GP*GP*UP*AP*(CBR) P*C)-3') RNA BULGE, BASE TRIPLE, RNA, CRYSTAL
1g75 nuc 1.57 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG): 5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE,B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID
1g8n nuc 1.55 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG):5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE,B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID
1gid nuc 2.50 MAGNESIUM ION 24(MG 2+) CRYSTAL STRUCTURE OF A GROUP I RIBOZYME DOMAIN: PRINCIPLES OF RNA PACKING P4-P6 RNA RIBOZYME DOMAIN RIBOZYME RNA, P4-P6 RIBOZYME DOMAIN OF THE TETRAHYMENA GROUP I INTRON
1hr2 nuc 2.25 MAGNESIUM ION 42(MG 2+) CRYSTAL STRUCTURE ANALYSIS OF A MUTANT P4-P6 DOMAIN (DELC209) OF TETRAHYMENA THEMOPHILA GROUP I INTRON. P4-P6 DELC209 MUTANT RNA RIBOZYME DOMAIN RNA RNA, P4-P6, C209, RIBOZYME, TETRAHYMENA, GROUP I INTRON, RIBONUCLEIC ACID
1i3t nuc 1.60 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATT(MO4)CGCG): THE WATSON-CRICK TYPE AND WOBBLE N4- METHOXYCYTIDINE/GUANOSINE BASE PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(C45)P*GP*CP*GP)- 3' DNA N4-METHOXYCYTOSINE, DAMAGED DNA, B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID
1i47 nuc 2.10 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATT(MO4)CGCG): THE WATSON-CRICK TYPE AND WOBBLE N4- METHOXYCYTIDINE/GUANOSINE BASE PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(C45)P*GP*CP*GP)- 3' DNA N4-METHOXYCYTOSINE, DAMAGED DNA, B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID
1i7j nuc 1.19 MAGNESIUM ION 5(MG 2+) CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RNA DUPLEX AT 1.19 A RESOLUTION. 2-METHYL-2,4-PENTANEDIOL AND MAGNESIUM BINDING. 5'-R(*(OMC)P*(OMG)P*(OMC)P*(OMG)P*(OMC)P*(OMG))- 3' RNA X-RAY, 2'-O-MERNA DUPLEX, 2-METHYL-2, 4-PENTANEDIOL, MAGNESIUM, GROOVE HYDRATION AND BINDING
1i9v nuc 2.60 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE ANALYSIS OF A TRNA-NEOMYCIN COMPLEX PHENYLALANINE TRANSFER RNA RNA AMINO-ACID TRANSPORT, YEAST, PHE-TRNA,PHENYLALANINE, TRANSFER RNA, AMINOGLYCOSIDE, NEOMYCIN B
1ick nuc 0.95 MAGNESIUM ION MG 2+ LEFT-HANDED Z-DNA HEXAMER DUPLEX D(CGCGCG)2 5'-D(*CP*GP*CP*GP*CP*G)-3' DNA LEFT-HANDED Z-DNA OLIGOMER
1ih1 nuc 2.00 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE B-DNA HEXAMER GGCGCC WITH COBALT HE RESOLVED TO 2.0 ANGSTROMS 5'-D(*GP*GP*CP*GP*CP*C)-3' DNA B TO A DNA TRANSITION, DNA TRANSITION, STRUCTURAL TRANSITION
1ik5 nuc 1.80 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF A 14MER RNA CONTAINING DOUBLE UU BULGES IN TWO CRYSTAL FORMS: A NOVEL U*(AU) INTRAMOLECULAR BASE TRIPLE 5'-R(*GP*GP*UP*AP*UP*UP*UP*UP*GP*GP*UP*AP*(CBR) P*C)-3', 5'-R(*GP*GP*UP*AP*UP*UP*UP*CP*GP*GP*UP*AP*(CBR) P*C)-3' RNA X-RAY STRUCTURE, RNA DUPLEX, UU-BULGES, BASE TRIPLE, KINK
1ikk nuc 1.60 MAGNESIUM ION 4(MG 2+) INTRINSIC BENDING AND DEFORMABILITY AT THE T-A STEP OF CCTTTAAAGG: A COMPARATIVE ANALYSIS OF T-A AND A-T STEPS WITHIN A-TRACTS 5'-D(*CP*CP*TP*TP*TP*AP*AP*AP*GP*G)-3' DNA B-DNA DOUBLE HELIX, A-TRACT CONTAINING A T-A STEP
1ixj nuc 2.50 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF D(GCGAAAGCT) CONTAINING PARALLEL- STRANDED DUPLEX WITH HOMO BASE PAIRS AND ANTI-PARALLEL DUPLEX WITH WATSON-CRICK BASE PAIRS 5'-D(*GP*CP*GP*AP*AP*AP*GP*CP*T)-3' DNA PARALLEL DNA, HOMO BASE PAIRS, PARALLEL-STRANDED HELIX, PARALLEL DUPLEX
1j8l nuc 1.60 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCAAATTMO4CGCG): THE WATSON-CRICK TYPE N4-METHOXYCYTIDINE/ADENOSINE BASE PAIR IN B-DNA DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*(C45) P*GP*CP*G)-3') DNA N4-METHOXYCYTOSINE, DNA DAMAGE, B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID
1jgr nuc 1.20 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAATTCGCG WITH THALLIUM IONS. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DEOXYRIBONUCLEIC ACID, THALLIUM, DNA
1jzv nuc 1.70 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A BULGED RNA FROM THE SL2 STEM-LOOP OF THE HIV-1 PSI-RNA 5'-R(*GP*GP*CP*GP*AP*CP*(5BU)P*G)-3', 5'-R(*CP*AP*GP*UP*AP*CP*GP*(5IC)P*C)-3' RNA A-BULGE, A-RNA, HIV-1 SL2, X-RAY
1k9w nuc 3.10 MAGNESIUM ION 4(MG 2+) HIV-1(MAL) RNA DIMERIZATION INITIATION SITE HIV-1 DIS(MAL)UU RNA RNA HIV, RNA, HAIRPIN
1kxk nuc 3.00 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF A RNA MOLECULE CONTAINING DOMAIN 5 AND 6 OF THE YEAST AI5G GROUP II SELF-SPLICING INTRON AI5G GROUP II SELF-SPLICING INTRON: DOMAIN 5 AND 6 RNA DOUBLE HELIX, TETRALOOP, TETRALOOP RECEPTOR, TWO-NUCLEOTIDE BULGE, RNA
1l2x nuc 1.25 MAGNESIUM ION 6(MG 2+) ATOMIC RESOLUTION CRYSTAL STRUCTURE OF A VIRAL RNA PSEUDOKNOT RNA PSEUDOKNOT RNA PSEUDOKNOT, FRAMESHIFTING, ATOMIC RESOLUTION, VIRAL RNA, METAL IONS, FLEXIBILITY
1l8v nuc 2.80 MAGNESIUM ION 10(MG 2+) CRYSTAL STRUCTURE OF A MUTANT (C109G,G212C) P4-P6 DOMAIN OF THE GROUP I INTRON FROM TETRAHYMENA THERMOPHILIA P4-P6 RNA RIBOZYME DOMAIN RNA RNA, RIBOZYME DOMAIN, A-MINOR
1ljx nuc 1.64 MAGNESIUM ION 2(MG 2+) THE STRUCTURE OF D(TPGPCPGPCPA)2 AT 293K: COMPARISON OF THE EFFECT OF SEQUENCE AND TEMPERATURE 5'-D(*TP*GP*CP*GP*CP*A)-3' DNA Z-DNA HEXAMER WITH AT BASE PAIRS AT THE TERMINAL
1lnt nuc 1.70 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF THE HIGHLY CONSERVED RNA INTERNAL LOOP 5'-R(*GP*CP*GP*UP*CP*AP*GP*GP*UP*CP*(CBV)P*G)-3', 5'-R(*CP*GP*GP*AP*AP*GP*CP*AP*GP*(CBV)P*GP*C)-3' RNA SRP, INTERNAL LOOP, MISPAIR, RNA
1lp7 nuc 2.40 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A NON-SELF COMPLEMENTARY DNA DODECAMER CONTAINING AN A/T TRACT: ANALYSIS OF THE EFFECT OF CRYSTAL ENVIRONMENT ON LOCAL HELICAL PARAMETERS 5'-D(*CP*GP*CP*TP*TP*AP*TP*AP*TP*GP*CP*G)-3', 5'-D(*CP*GP*CP*AP*TP*AP*TP*AP*AP*GP*CP*G)-3' DNA DNA, A-TRACT, CRYSTAL ENVIRONMENT, LATTICE ENVIRONMENT, B- DNA, DODECAMER, CRYSTAL, DUPLEX
1m6f nuc 1.78 MAGNESIUM ION MG 2+ STRONG BINDING IN THE DNA MINOR GROOVE BY AN AROMATIC DIAMIDINE WITH A SHAPE THAT DOES NOT MATCH THE CURVATURE OF THE GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA NUCLEIC ACIDS, MINOR GROOVE BINDER, DOUBLE HELIX, DNA-DRUG COMPLEX
1n1o nuc 1.20 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A B-FORM DNA DUPLEX CONTAINING (L)- ALPHA-THREOFURANOSYL (3'-2') NUCLEOSIDES: A FOUR-CARBON SUGAR IS EASILY ACCOMMODATED INTO THE BACKBONE OF DNA 5'-D(*CP*GP*CP*GP*AP*AP*(TFT)P*TP*CP*GP*CP*G)-3' DNA B-DNA, HYDROGEN BONDING, NUCLEIC ACID ETIOLOGY, TETROSE, FOUR-CARBON SUGAR, X-RAY CRYSTALLOGRAPHY, NUCLEIC ACID ANALOGUE
1nbs nuc 3.15 MAGNESIUM ION 12(MG 2+) CRYSTAL STRUCTURE OF THE SPECIFICITY DOMAIN OF RIBONUCLEASE P RNA RIBONUCLEASE P RNA: SPECIFICITY-DOMAIN, S-DOMAIN RNA RIBONUCLEASE P RNA, P RNA, S-DOMAIN
1ngt nuc 2.04 MAGNESIUM ION MG 2+ THE ROLE OF MINOR GROOVE FUNCTIONAL GROUPS IN DNA HYDRATION 5'-D(*CP*GP*CP*GP*AP*AP*(MTR)P*TP*CP*GP*CP*G)-3' DNA SPINE OF HYDRATION, DNA CONFORMATION, MODIFIED BASE
1nr8 nuc 1.66 MAGNESIUM ION MG 2+ THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX
1ntb nuc 2.90 MAGNESIUM ION MG 2+ 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RNA-APTAMER COMPLEX 5'- R(*CP*GP*GP*CP*AP*CP*CP*AP*CP*GP*GP*UP*CP*GP*GP*AP*UP*C)- 3', 5'- R(*GP*GP*AP*UP*CP*GP*CP*AP*UP*UP*UP*GP*GP*AP*CP*UP*UP*CP*UP *GP*CP*C)-3' RNA STREPTOMYCIN RNA-APTAMER, MAGNESIUM FORM
1nuj nuc 1.80 MAGNESIUM ION 10(MG 2+) THE LEADZYME STRUCTURE BOUND TO MG(H20)6(II) AT 1.8 A RESOLUTION 5'-R(*CP*GP*GP*AP*CP*CP*GP*AP*GP*CP*CP*AP*G)-3', 5'-R(*GP*CP*UP*GP*GP*GP*AP*GP*UP*CP*C)-3' RNA RIBOZYME, LEADZYME, LEAD-DEPENDENT CLEAVAGE, RNA, MG(H20) 62+, BULGED NUCLEOTIDES, HYDRATED MAGNESIUM, PSEUDOHELICAL PACKING, STICKY ENDS, ALTERNATE CONFORMATION, HOMOPURINE BASE PAIRS
1nuv nuc 1.81 MAGNESIUM ION 10(MG 2+) THE LEADZYME RIBOZYME BOUND TO MG(H2O)6(II) AND SR(II) AT 1.8 A RESOLUTION 5'-R(*GP*CP*UP*GP*GP*GP*AP*GP*UP*CP*C)-3', 5'-R(*CP*GP*GP*AP*CP*CP*GP*AP*GP*CP*CP*AP*G)-3' RNA RIBOZYME, LEADZYME, LEAD-DEPENDENT CLEAVAGE, RNA, MG(H2O) 6(II), BULGED NUCLEOTIDES, HYDRATED MAGNESIUM, SR(II), PSEUDOHELICAL PACKING, STICKY ENDS, ALTERNATE CONFORMATION, HOMOPURINE BASE PAIRS
1nxl nuc model MAGNESIUM ION 10(MG 2+) STRUCTURE OF THE SPECIFICITY DOMAIN OF RIBONUCLEASE P RNA RIBONUCLEASE P RNA: SPECIFICITY DOMAIN, S-DOMAIN RIBONUCLEIC ACID RIBONUCLEASE P RNA, P RNA, S-DOMAIN
1o3z nuc 2.65 MAGNESIUM ION 8(MG 2+) HIV-1 DIS(MAL) DUPLEX RU HEXAMINE-SOAKED HIV-1 DIS(MAL) GENOMIC RNA RNA HIV-1, RNA, METAL IONS, DIS
1p1y nuc 2.10 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A CONTINUOUS THREE-DIMENSIONAL DNA LATT D(GGACAGATGGGAG) 5'-D(*GP*GP*AP*(CBR)P*AP*GP*AP*(BRU)P*GP*GP*GP*AP CHAIN: X DNA CONTINUOUS THREE-DIMENSIONAL DNA LATTICE, PARALLEL-STRANDED PAIRS, DNA
1pjo nuc 1.10 MAGNESIUM ION 6(MG 2+) CRYSTAL STRUCTURE OF AN RNA/DNA HYBRID OF HIV-1 PPT 5'-D(*CP*TP*TP*TP*TP*CP*TP*TP*TP*G)-3', 5'-R(*CP*AP*AP*AP*GP*AP*AP*AP*AP*G)-3': POLYPURINE TRACT OF HIV-1 DNA-RNA HYBRID RNA/DNA HYBRID; POLYPURINE TRACT OF HIV-1; MOLEUCLAR REPLACEMENT; SUGAR CONFORMATION, DNA/RNA COMPLEX, DNA-RNA HYBRID
1puy nuc 1.50 MAGNESIUM ION 5(MG 2+) 1.5 A RESOLUTION STRUCTURE OF A SYNTHETIC DNA HAIRPIN WITH A STILBENEDIETHER LINKER 5'-D(*GP*TP*TP*TP*TP*GP*(S02)P*CP*AP*AP*AP*AP*C)- 3' DNA DNA
1qc1 nuc 2.50 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF THE SELF-FITTED B-DNA DECAMER D(CCGCCGGCGG) 5'-D(*CP*CP*GP*CP*CP*GP*GP*CP*GP*G)-3' DNA B-DNA DOUBLE-HELIX, DNA-DNA RECOGNITION
1qp5 nuc 2.60 MAGNESIUM ION 8(MG 2+) BASE-PAIRING SHIFT IN A DODECAMER CONTAINING A (CA)N TRACT DNA (5'-D(*TP*GP*TP*GP*GP*CP*GP*CP*CP*GP*GP*T)- 3'), DNA (5'-D(*AP*CP*CP*GP*GP*CP*GP*CP*CP*AP*CP*A)- 3') DNA DNA-DNA INTERACTION, DNA SELF-FITTING, BASE PAIR SHIFT, FRAMESHIFT MUTATION, MICROSATELLITE INSTABILITY
1r3g nuc 1.16 MAGNESIUM ION MG 2+ 1.16A X-RAY STRUCTURE OF THE SYNTHETIC DNA FRAGMENT WITH THE INCORPORATED 2'-O-[(2-GUANIDINIUM)ETHYL]-5-METHYLURIDINE RESIDUES 5'-D(*GP*CP*GP*TP*AP*(GMU)P*AP*CP*GP*C)-3') DNA DNA
1rqy nuc 1.55 MAGNESIUM ION 2(MG 2+) 9-AMINO-[N-(2-DIMETHYLAMINO)PROPLY]-ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 5'-D(CP*GP*TP*AP*CP*G)-3' DNA B-DNA, CYTOSINE EXCHANGE, QUADRUPLEX, ACRIDINE, UNUSUAL INTERCALATION
1s45 nuc 2.20 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE ANALYSIS OF THE DNA QUADRUPLEX D(TGGGGT) S1 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, THYMINE TRIADS, THALLIUM
1tn1 nuc 3.00 MAGNESIUM ION 5(MG 2+) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA
1tn2 nuc 3.00 MAGNESIUM ION 5(MG 2+) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
1tra nuc 3.00 MAGNESIUM ION 5(MG 2+) RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
1ue2 nuc 1.40 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(GC38GAAAGCT) 5'-D(*GP*(C38)P*GP*AP*AP*AP*GP*CP*T)-3' DNA DNA, BASE-INTERCALATED DUPLEX, MINI-HAIRPIN STRUCTURE, SHEAR PAIR, ZIPPER-LIKE DUPLEX
1ue3 nuc 2.15 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF D(GCGAAAGC) CONTAINING HEXAAMMINECOBALT 5'-D(*GP*CP*GP*AP*AP*AP*GP*C)-3' DNA DNA, BASE-INTERCALATED DUPLEX, MINI-HAIRPIN STRUCTURE, SHEARED G:A PAIR, ZIPPER-LIKE DUPLEX
1ue4 nuc 1.65 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(GCGAAAGC) 5'-D(*GP*CP*GP*AP*AP*AP*GP*C)-3' DNA DNA, SHEARED G:A PAIR, BULGE-IN DUPLEX, G:AXA:G CROSSING
1uhx nuc 2.00 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(GCGAGAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID
1vaq nuc 2.00 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA) 2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION 5'-D(*TP*TP*GP*GP*CP*CP*AP*A)-3' DNA CHROMOMYCIN A3, X-RAY DIFFRACTION, MAD, DNA DUPLEX, GGCC SITE, DNA KINK, CD SPECTRA
1vro nuc 1.10 MAGNESIUM ION MG 2+ SELENIUM-ASSISTED NUCLEIC ACID CRYSTALLOGRAPHY: USE OF PHOSPHOROSELENOATES FOR MAD PHASING OF A DNA STRUCTURE 5'-D(*CP*(GMS)P*CP*GP*CP*G)-3' DNA LEFT-HANDED Z-DNA, PHOSPHOROSELENOATE, MULTIWAVELENGTH ANOMALOUS DISPERSION (MAD), COVALENT MODIFICATION OF OLIGONUCLEOTIDES, OLIGONUCLEOTIDE ANALOGUE, PHASING STRATEGY, SYNCHROTRON
1vty nuc 1.30 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A Z-DNA FRAGMENT CONTAINING THYMINE/2- AMINOADENINE BASE PAIRS DNA (5'-D(*CP*(NH2)AP*CP*GP*TP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, DNA
1vzk nuc 1.77 MAGNESIUM ION MG 2+ A THIOPHENE BASED DIAMIDINE FORMS A "SUPER" AT BINDING MINOR GROOVE AGENT 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP *CP*G)-3' NUCLEIC ACID NUCLEIC ACID, NUCLEIC ACIDS, MINOR GROOVE BINDER, DOUBLE HELIX, DNA-DRUG COMPLEX, MAGNESIUM-WATER COMPLEX, DNA HYDRATION
1wv5 nuc 2.30 MAGNESIUM ION MG 2+ X-RAY STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2' THYMINE IN PLACE OF T6, MG-FORM 5'-D(*GP*CP*GP*TP*AP*(2BT)P*AP*CP*GP*C)-3' DNA DNA
1x8w nuc 3.80 MAGNESIUM ION 38(MG 2+) STRUCTURE OF THE TETRAHYMENA RIBOZYME: BASE TRIPLE SANDWICH AND METAL ION AT THE ACTIVE SITE TETRAHYMENA RIBOZYME RNA RNA CATALYTIC RNA, RIBOZYME, GROUP I INTRON, CRYSTAL STRUCTURE, GUANOSINE BINDING SITE, METAL IONS, ACTIVE SITE, CATALYTIC MECHANISM, BASE TRIPLES, CONFORMATIONAL CHANGES
1xjr nuc 2.70 MAGNESIUM ION 2(MG 2+) THE STRUCTURE OF A RIGOROUSLY CONSERVED RNA ELEMENT WITHIN THE SARS VIRUS GENOME S2M RNA RNA RNA, GNRA, 530-LIKE LOOP, S2M, STEM-LOOP, PURINE BULGE, SARS
1xp7 nuc 2.50 MAGNESIUM ION 4(MG 2+) HIV-1 SUBTYPE F GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1
1xpe nuc 1.94 MAGNESIUM ION 2(MG 2+) HIV-1 SUBTYPE B GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1
1xpf nuc 2.30 MAGNESIUM ION 3(MG 2+) HIV-1 SUBTYPE A GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1
1y0q nuc 3.60 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF AN ACTIVE GROUP I RIBOZYME-PRODUCT COMPLEX 5'-R(*GP*CP*UP*U)-3': 5'-EXON, GROUP I RIBOZYME: ORF142-I2 INTRON RNA RIBOZYME, RNA-SPLICING, GUANOSINE-BINDING, RNA-FOLDING
1y26 nuc 2.10 MAGNESIUM ION 5(MG 2+) A-RIBOSWITCH-ADENINE COMPLEX VIBRIO VULNIFICUS A-RIBOSWITCH: SEQUENCE DATABASE RESIDUES 202511-202580 RNA A-RIBOSWITCH ADENINE RECOGNITION, RNA
1y3s nuc 2.25 MAGNESIUM ION 2(MG 2+) HIV-1 DIS RNA SUBTYPE F- MPD FORM 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1
1y73 nuc 2.90 MAGNESIUM ION 8(MG 2+) HIV-1 DIS(MAL) DUPLEX PT-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, METAL IONS
1y84 nuc 1.60 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (IMIDAZOLYL)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(EIT)P*AP*CP*GP*C)-3' DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER.
1y8l nuc 1.50 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (TRIFLUORO)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(TFE)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER
1y95 nuc 2.80 MAGNESIUM ION 10(MG 2+) HIV-1 DIS(MAL) DUPLEX PB-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, HIV-1, METAL IONS, BULGE
1y99 nuc 2.40 MAGNESIUM ION 7(MG 2+) HIV-1 SUBTYPE A DIS RNA DUPLEX 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, BULGE, MAGNESIUM
1ykq nuc 3.50 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF DIELS-ALDER RIBOZYME DIELS-ALDER RIBOZYME, DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND, CATALYTIC MECHANISM, RNA CRYSTAL STRUCTU DIELS-ALDER REACTION, RIBOZYME, RNA
1ykv nuc 3.30 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF THE DIELS-ALDER RIBOZYME COMPLEXED WITH PRODUCT OF THE REACTION BETWEEN N-PENTYLMALEIMIDE AND COVAL ATTACHED 9-HYDROXYMETHYLANTHRACENE DIELS-ALDER RIBOZYME, DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND, CATALYTIC MECHANISM, DIELS-ALDER REACTIO RIBOZYME, RNA
1yls nuc 3.00 MAGNESIUM ION 13(MG 2+) CRYSTAL STRUCTURE OF SELENIUM-MODIFIED DIELS-ALDER RIBOZYME WITH THE PRODUCT OF THE REACTION BETWEEN N-PENTYLMALEIMIDE COVALENTLY ATTACHED 9-HYDROXYMETHYLANTHRACENE RNA DIELS-ALDER RIBOZYME, RNA DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND FORMATION, CATALYTIC MECHANISM, DIELS-ALD REACTION, RIBOZYME, RNA
1yrj nuc 2.70 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF APRAMYCIN BOUND TO A RIBOSOMAL RNA A SI OLIGONUCLEOTIDE BACTERIAL 16 S RIBOSOMAL RNA A SITE OLIGONUCLEOTI CHAIN: A, B RNA RNA COMPLEX, APRAMYCIN-RNA COMPLEX, MOLECULAR RECOGNITION, R
1zph nuc 1.80 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE ANALYSIS OF THE MINOR GROOVE BINDING QUINOLINIUM QUATERNARY SALT SN 8315 COMPLEXED WITH CGCGAATTCGCG 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA, DODECAMER, MINOR GROOVE BINDING COMPLEX
1zpi nuc 1.60 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE ANALYSIS OF THE MINOR GROOVE BINDING QUINOLINIUM QUATERNARY SALT SN 8224 COMPLEXED WITH CGCGAATTCGCG 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA, DODECAMER, MINOR GROOVE BINDING COMPLEX
1zz5 nuc 3.00 MAGNESIUM ION 2(MG 2+) MOLECULAR RECOGNITION OF RNA BY NEOMYCIN AND A RESTRICTED NEOMYCIN DERIVATIVE 5'- R(*GP*UP*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*CP*GP*G)-3': RIBOSOMAL RNA A-SITE, 5'-R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*AP*CP*C)- 3': RIBOSOMAL RNA A-SITE RNA RIBOSOME, RNA, A-SITE. DOUBLE HELIX, RESTRICTED NEOMYCIN, CYCLICNEO, NEOCYCLIC
207d nuc NMR MAGNESIUM ION 2(MG 2+) SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA DNA (5'-D(*TP*AP*GP*CP*TP*AP*GP*CP*TP*A)-3') DNA DNA, NMR, DOUBLE HELIX, MITHRAMYCIN
208d nuc 2.05 MAGNESIUM ION 2(MG 2+) HIGH-RESOLUTION STRUCTURE OF A DNA HELIX FORMING (C.G)*G BASE TRIPLETS DNA (5'-D(*GP*CP*GP*AP*AP*TP*TP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, BASE TRIPLET
216d nuc 1.73 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURES OF THE B-FORM DNA-RNA CHIMER (5'-D(*IP*)- R(*CP*)-D(*IP*CP*IP*CP*IP*C)-3') COMPLEXED WITH DISTAMYCIN DNA/RNA (5'-D(*IP*)-R(*CP*)-D(*IP*CP*IP*CP*IP*C)- 3') DNA-RNA HYBRID B-DNA/RNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED, DNA- RNA HYBRID
217d nuc 1.70 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURES OF THE B-FORM DNA-RNA CHIMER (5'-D(*IP*)- R(*CP*)-D(*IP*)-R(*CP*)-D(*IP*CP*IP*C)-3') COMPLEXED WITH DISTAMYCIN DNA/RNA (5'-D(*IP*)-R(*CP*)-D(*IP*)-R(*CP*)- D(*IP*CP*IP*C)-3') DNA-RNA HYBRID B-DNA/RNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED, DNA- RNA HYBRID
253d nuc 2.20 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE B-DNA NONAMER D(GCGTACGCG) WITH A NOVEL D[G*(G.C)] BASE-TRIPLET INVOLVING THE MINOR GROOVE DNA (5'-D(*GP*CP*GP*TP*AP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, BASE TRIPLET
265d nuc 2.01 MAGNESIUM ION MG 2+ STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*(5CM)P*GP*AP*AP*TP*TP*(5CM)P*GP* CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA
266d nuc 2.03 MAGNESIUM ION MG 2+ STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA
267d nuc 2.00 MAGNESIUM ION MG 2+ STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA
268d nuc 2.02 MAGNESIUM ION MG 2+ STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA
269d nuc 2.15 MAGNESIUM ION MG 2+ STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, COMPLEXED WITH DRUG, DNA
270d nuc 2.01 MAGNESIUM ION MG 2+ STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5CM)P*GP*CP*G CHAIN: A, B DNA B-DNA, DOUBLE HELIX, MODIFIED, DNA
271d nuc 2.02 MAGNESIUM ION MG 2+ STRUCTURAL STUDIES ON NUCLEIC ACIDS DNA (5'-D(*CP*GP*CP*GP*AP*AP*UP*UP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, DNA
291d nuc 2.14 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURES OF OLIGODEOXYRIBONUCLEOTIDES CONTAINING 6'-ALPHA-METHYL AND 6'-ALPHA-HYDROXY CARBOCYCLIC THYMIDINES DNA (5'-D(*CP*GP*CP*GP*AP*AP*(T48)P*(T48) P*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, CARBOCYCLUS, ANTISENSE
292d nuc 1.00 MAGNESIUM ION 3(MG 2+) INTERACTION BETWEEN THE LEFT-HANDED Z-DNA AND POLYAMINE:THE CRYSTAL STRUCTURE OF THE D(CG)3 AND N-(2-AMINOETHYL)-1,4- DIAMINOBUTANE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, COMPLEXED WITH N-(2-AMINOETHYL)-1,4- DIAMINOBUTANE
293d nuc 1.00 MAGNESIUM ION 3(MG 2+) INTERACTION BETWEEN THE LEFT-HANDED Z-DNA AND POLYAMINE-2: THE CRYSTAL STRUCTURE OF THE D(CG)3 AND SPERMIDINE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, COMPLEXED WITH SPERMIDINE
2a04 nuc 2.95 MAGNESIUM ION 2(MG 2+) MOLECULAR RECOGNITION OF RNA BY NEOMYCIN AND A RESTRICTED NEOMYCIN DERIVATIVE 5'- R(*GP*UP*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*CP*GP*G)-3': RIBOSOMAL RNA A-SITE, 5'-R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*AP*CP*C)- 3': RIBOSOMAL RNA A-SITE RNA RIBOSOME, RNA, A-SITE. DOUBLE HELIX, NEOMYCIN
2a43 nuc 1.34 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF A LUTEOVIRAL RNA PSEUDOKNOT AND MODEL FOR A MINIMAL RIBOSOMAL FRAMESHIFTING MOTIF RNA PSEUDOKNOT RNA PLRV, POTATO LEAF ROLL VIRUS; BWYV, BEET WESTERN YELLOW VIRUS, PK, PSEUDOKNOT, RNA.
2ao5 nuc 2.10 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF AN RNA DUPLEX R(GGCGBRUGCGCU)2 WITH TERMINAL AND INTERNAL TANDEM G-U BASE PAIRS 5'-R(*GP*GP*CP*GP*(5BU)P*GP*CP*GP*CP*U)-3' RNA G-U BASE PAIR, RNA DUPLEX
2b0k nuc 1.64 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE DB921-D(CGCGAATTCGCG)2 COMPLEX. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, DNA MINOR GROOVE BINDER, DNA MINOR GROOVE-LIGAND COMPLEX, DB921, A2T2 DICKERSON AND DREW DNA, CRYSTAL STRUCTURE OF B-DNA, DNA- DRUG COMPLEX, MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM, DNA HYDRATION.
2b1b nuc 1.90 MAGNESIUM ION MG 2+ 5'-D(*GP*CP*GP*TP*GP*GP*GP*CP*AP*C)-3' ZIF268 BINDING SITE 5'-D(*GP*TP*GP*CP*CP*CP*AP*CP*GP*C)-3', 5'-D(*GP*CP*GP*TP*GP*GP*GP*CP*AP*C)-3' DNA SEQUENCE DEPENDENT DNA DEFORMATION, A FORM DNA, PROTEIN-DNA RECOGNITION
2b1c nuc 2.20 MAGNESIUM ION MG 2+ 5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*CP*C)-3' ZIF268 BINDING SITE 5'-D(*GP*GP*TP*CP*CP*CP*AP*CP*GP*C)-3', 5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*CP*C)-3' DNA SEQUENCE DEPENDENT DNA DEFORMATION, A FORM DNA, PROTEIN-DNA RECOGNITION
2b1d nuc 2.50 MAGNESIUM ION MG 2+ 5'-D(*GP*CP*AP*GP*AP*CP*GP*TP*CP*TP*GP*C)-3' METHIONINE REPR BINDING SITE 5'-D(*GP*CP*AP*GP*AP*CP*GP*TP*CP*TP*GP*C)-3' DNA SEQUENCE DEPENDENT DNA DEFORMABILITY, PROTEIN-DNA RECOGNITIO
2b3e nuc 1.36 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF DB819-D(CGCGAATTCGCG)2 COMPLEX. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, DNA MINOR, GROOVE BINDER, DNA MINOR GROOVE-LIGAND COMPLEX, DB819, A2T2 DICKERSON AND DREW DODECAMER, CRYSTAL STRUCTURE OF B-DNA, DNA-DRUG COMPLEX, MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM, DNA HYDRATION.
2b8r nuc 2.60 MAGNESIUM ION 6(MG 2+) STRUCTURE OF HIV-1(LAI) GENOMIC RNA DIS 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, HAIRPIN
2b8s nuc 2.76 MAGNESIUM ION 6(MG 2+) STRUCTURE OF HIV-1(MAL) GENOMIC RNA DIS 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, HAIRPIN
2cky nuc 2.90 MAGNESIUM ION 10(MG 2+) STRUCTURE OF THE ARABIDOPSIS THALIANA THIAMINE PYROPHOSPHATE RIBOSWITCH WITH ITS REGULATORY LIGAND NUCLEIC ACID NUCLEIC ACID NUCLEIC ACID
2d25 nuc 1.75 MAGNESIUM ION MG 2+ C-C-A-G-G-C-M5C-T-G-G; HELICAL FINE STRUCTURE, HYDRATION, AND COMPARISON WITH C-C-A-G-G-C-C-T-G-G DNA (5'-D(*CP*CP*AP*GP*GP*CP*(5CM)P*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
2d34 nuc 1.40 MAGNESIUM ION MG 2+ FORMALDEHYDE CROSS-LINKS DAUNORUBICIN AND DNA EFFICIENTLY: HPLC AND X-RAY DIFFRACTION STUDIES 5'-D(*CP*GP*TP*(A35)P*CP*G)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
2dcg nuc 0.90 MAGNESIUM ION MG 2+ MOLECULAR STRUCTURE OF A LEFT-HANDED DOUBLE HELICAL DNA FRAGMENT AT ATOMIC RESOLUTION DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX
2des nuc 1.50 MAGNESIUM ION MG 2+ INTERACTIONS BETWEEN MORPHOLINYL ANTHRACYCLINES AND DNA: THE CRYSTAL STRUCTURE OF A MORPHOLINO DOXORUBICIN BOUND TO D(CGTACG) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
2dp7 nuc 1.55 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-DEOXYURIDINE DNA (5'- D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*DUP*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'- DEOXYURIDINE, B-DNA
2dpc nuc 1.55 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE DNA (5'-D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*(OMU) P*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, B-DNA
2dz7 nuc 1.60 MAGNESIUM ION 2(MG 2+) DNA OCTAPLEX FORMATION WITH AN I-MOTIF OF A-QUARTETS: THE REVISED CRYSTAL STRUCTURE OF D(GCGAAAGC) DNA (5'-D(*DGP*DCP*DGP*DAP*DAP*DAP*DGP*DC)-3') DNA A-QUARTET, DNA OCTAPLEX, NON-CODING DNA, VNTR
2elg nuc 1.00 MAGNESIUM ION 3(MG 2+) THE RARE CRYSTALLOGRAPHIC STRUCTURE OF D(CGCGCG)2: THE NATURAL SPERMIDINE MOLECULE BOUND TO THE MINOR GROOVE OF LEFT-HANDED Z-DNA D(CGCGCG)2 AT 10 DEGREE CELSIUS DNA (5'-D(*DCP*DGP*DCP*DGP*DCP*DG)-3') DNA D(CGCGCG)2, LEFT-HANDED Z-DNA, SPERMIDINE, X-RAY CRYSTALLOGRAPHY, POLYAMINE
2fih nuc 1.13 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAA-AU- WITH INCORPORATED ARABINO-URIDINE (AU) 5'-D(*CP*GP*CP*GP*AP*AP*(UAR)P*TP*CP*GP*CP*G)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, B-FORM DNA, DNA
2fii nuc 1.24 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAAT-AU WITH INCORPORATED ARABINO-URIDIN (AU) 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UAR)P*CP*GP*CP*G)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, B-FORM DNA, DNA
2fqn nuc 2.30 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING A SITE 5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3' RNA RNA DUPLEX, RRNA, DECODING SITE, A SITE, HOMO SAPIENS CYTOPLASM
2g3s nuc 1.50 MAGNESIUM ION 2(MG 2+) RNA STRUCTURE CONTAINING GU BASE PAIRS 5'-R(*GP*GP*CP*GP*UP*GP*CP*C)-3' RNA RNA CRYSTAL STRUCTURE, TANDEM GU BASE PAIRS
2g5k nuc 2.80 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING SITE COMPLEXED WITH APRAMYCIN 5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3' RNA AMINOGLYCOSIDE, ANTIBIOTICS, APRAMYCIN, RIBOSOME, DECODING SITE, HOMO SAPIENS, CYTOPLASM, RNA
2g91 nuc 1.50 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE ANALYSIS OF THE AN RNA NONAMER R(GGUGCGC) D(BRC)R(C) 5'-R(*GP*GP*UP*GP*CP*GP*CP*(CBR)P*C-3' RNA RNA DOUBLE HELIX
2gcs nuc 2.10 MAGNESIUM ION 6(MG 2+) PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME AMINO RNA INHIBITOR, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX
2gcv nuc 2.10 MAGNESIUM ION 4(MG 2+) POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME PRODUCT OLIGONUCLEOTIDE, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX
2gdi nuc 2.05 MAGNESIUM ION 6(MG 2+) CRYSTAL STRUCTURE OF THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWI COMPLEX WITH THIAMINE PYROPHOSPHATE TPP RIBOSWITCH: SENSING DOMAIN RNA RIBOSWITCH, THIAMINE PYROPHOSPHATE, RNA
2gis nuc 2.90 MAGNESIUM ION 2(MG 2+) STRUCTURE OF THE S-ADENOSYLMETHIONINE RIBOSWITCH MRNA REGULATORY ELEMENT SAM-I RIBOSWITCH RNA MRNA, RIBOSWITCH, S-ADENOSYLMETHIONINE, SAM, RNA-LIGAND COMPLEX
2gvr nuc 1.65 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE BERENIL-D(CGCGAATTCGCG)2 COMPLEX AT 1.65 A RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, CRYSTAL STRUCTURE OF B-DNA, DNA MINOR GROOVE BINDER, DICKERSON AND DREW DODECAMER, D(CGCGAATTCGCG)2, A2T2, DNA MINOR GROOVE- LIGAND COMPLEX, DNA-DRUG COMPLEX, DNA HYDRATION, BERENIL AND DNA, BERENIL-DNA COMPLEX, MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM COMPLEX.
2gyx nuc 1.86 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF DB884- D(CGCGAATTCGCG)2 COMPLEX AT 1.86 A RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DUPLEX DNA, DOUBLE HELIX, DODECAMER, COMPOUND DB 884.
2gzc nuc model MAGNESIUM ION MG 2+ ACTIVE FOLD OF THE HAMMERHEAD RIBOZYME RNA HAMMERHEAD RIBOZYME STRAND A, RNA HAMMERHEAD RIBOZYME STRAND B RIBONUCLEIC ACID RNA, HAMMERHEAD RIBOZYME, ACTIVE SITE
2h0s nuc 2.35 MAGNESIUM ION 5(MG 2+) PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME DEOXY RNA INHIBITOR, GLMS RIBOZYME RNA RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX
2h0w nuc 2.40 MAGNESIUM ION 4(MG 2+) POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME PRODUCT OLIGONUCLEOTIDE, GLMS RIBOZYME RNA RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX
2h0x nuc 2.30 MAGNESIUM ION 6(MG 2+) PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME RNA, GLMS RIBOZYME AMINO RNA INHIBITOR RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX
2h0z nuc 2.70 MAGNESIUM ION 8(MG 2+) PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSE-6-PHOSPHATE GLMS RIBOZYME RNA, GLMS RIBOZYME DEOXY RNA INHIBITOR RNA RNA, RIBOZYME, PSEUDOKNOT, HELIX
2h9s nuc 1.75 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF HOMO-DNA AND NATURE'S CHOICE OF PENTOSE OVER HEXOSE IN THE GENETIC SYSTEM 5'-D(*(XCT)P*(XGU)P*(XAD)P*(XAD)P*(XTH)P*(XTH) P*(XCT)P*(XGU))-3' DNA HOMO-DNA, HOMO-DNA CRYSTAL STRUCTURE, 2',3'-DI-DEOXY-BETA- D-GLUCOPYRANOSE, HEXOSE NUCLEIC ACID, GLUCOPYRANOSYL NUCLEIC ACID, DIDEOXYGLUCOPYRANOSE OCTAMER
2ho6 nuc 2.80 MAGNESIUM ION 3(MG 2+) POST-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX
2ho7 nuc 2.90 MAGNESIUM ION 4(MG 2+) PRE-CLEAVAGE STATE OF THE THERMOANAEROBACTER TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSE-6-PHOSPHATE GLMS RIBOZYME RNA, GLMS RIBOZYME SUBSTRATE RNA RNA RNA; RIBOZYME; PSEUDOKNOT; HELIX
2hoj nuc 2.50 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, MANGANESE IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH
2hol nuc 2.90 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, BARIUM IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH
2hom nuc 2.89 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE MONOPHOSPHATE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH
2hop nuc 3.30 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO PYRITHIAMINE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH
2i2i nuc 1.63 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE DB293-D(CGCGAATTCGCG)2 COMPLEX. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DNA DODECAMER WITH COMPOUND DB 293.
2i5a nuc 1.65 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A DB1055-D(CGCGAATTCGCG)2 COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DNA DODECAMER WITH COMPOUND DB 1055
2jja nuc 1.30 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA
2mis nuc NMR MAGNESIUM ION 5(MG 2+) NMR LOCALIZATION OF DIVALENT CATIONS AT THE ACTIVE SITE OF T NEUROSPORA VS RIBOZYME PROVIDES INSIGHTS INTO RNA-METAL ION INTERACTIONS VS RIBOZYME RNA RIBOZYME, VS, VARKUD SATELLITE, MAGNESIUM ION, ACTIVE SITE,
2mtk nuc NMR MAGNESIUM ION 6(MG 2+) NMR STRUCTURE OF THE III-IV-V THREE-WAY JUNCTION FROM THE VS AND IDENTIFICATION OF MAGNESIUM-BINDING SITES USING PARAMAG RELAXATION ENHANCEMENT RNA (47-MER) RNA VS RIBOZYME, THREE-WAY JUNCTION, BASE TRIPLE, U-TURN, RIBOSE GAAA TETRALOOP, CUUG TETRALOOP, RNA
2n3r nuc NMR MAGNESIUM ION 8(MG 2+) NMR STRUCTURE OF THE II-III-VI THREE-WAY JUNCTION FROM THE V AND IDENTIFICATION OF MAGNESIUM-BINDING SITES USING PARAMAG RELAXATION ENHANCEMENT RNA (62-MER) RNA RNA, VS RIBOZYME, CATALYSIS, MG2+ IONS
2nlm nuc 2.05 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE DB 911- D(CGCGAATTCGCG)2 COMPLEX AT 2.05 A RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DNA DODECAMER WITH COMPOUND DB 911.
2nok nuc 3.00 MAGNESIUM ION 8(MG 2+) CRYSTAL STRUCTURE OF AN RNA DOMAIN FROM HEPATITIS C VIRUS. 5'- R(*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*UP*CP*UP*UP*CP *AP*CP*GP*CP*C)-3', 5'- R(*GP*CP*GP*UP*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*UP*CP*CP*GP *G)-3' RNA MG BINDING SITE, BENT RNA
2oe5 nuc 1.51 MAGNESIUM ION 2(MG 2+) 1.5 A X-RAY CRYSTAL STRUCTURE OF APRAMYCIN COMPLEX WITH RNA GGCGUCGCUAGUACCG/GGUACUAAAAGUCGCCC CONTAINING THE HUMAN RIB DECODING A SITE: RNA CONSTRUCT WITH 3'-OVERHANG RNA (5'-R(*GP*GP*CP*GP*UP*CP*GP*CP*UP*AP*GP*UP*AP 3'), RNA (5'- R(*GP*GP*UP*AP*CP*UP*AP*AP*AP*AP*GP*UP*CP*GP*CP*CP*C)-3') RNA AMINOGLYCOSIDE ANTIBIOTICS, APRAMYCIN, RIBOSOMAL DECODING SI SITE, HOMO SAPIENS, RNA DUPLEX, RNA
2oiu nuc 2.60 MAGNESIUM ION 7(MG 2+) L1 RIBOZYME LIGASE CIRCULAR ADDUCT L1 RIBOZYME RNA LIGASE RNA LIGASE, RIBOZYME, IN VITRO SELECTION, RNA, ACTIVE SITE
2oiy nuc 1.60 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE DUPLEX FORM OF THE HIV-1(LAI) RNA DIMERIZATION INITIATION SITE 5'-R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*C *GP*CP*AP*AP*G)-3' RNA HIV-1, DIS, RNA, DIMERIZATION
2pis nuc 2.80 MAGNESIUM ION 6(MG 2+) EFFORTS TOWARD EXPANSION OF THE GENETIC ALPHABET: STRUCTURE AND REPLICATION OF UNNATURAL BASE PAIRS DNA (5'-D(*CP*GP*(CBR)P*GP*AP*AP*(FFD) P*TP*TP*CP*GP*CP*G)-3') DNA NUCLEIC ACID, DUPLEX, REPLICATION, UNNATURAL BASE, DNA
2pn3 nuc 2.90 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF HEPATITIS C VIRUS IRES SUBDOMAIN IIA 5'-R(*GP*CP*GP*(5BU) P*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*(5BU)P*CP*CP*GP*G)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 98-117), 5'- R(*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*UP*CP*UP*UP*CP *AP*CP*GP*CP*C)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 47-70) RNA HCV, IRES, LOOP IIA, RNA, MAGNESIUM, CRYSTALLIZATION, CRYSTAL STRUCTURE
2q1r nuc 1.12 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE ANALYSIS OF THE RNA DODECAMER CGCGAAUUAGCG, WITH A G-A MISMATCH. RNA (5'-R(*CP*GP*CP*GP*AP*AP*UP*UP*AP*GP*CP*G)- 3') RNA G-A MISMATCH, RNA, RNAI
2qbz nuc 2.60 MAGNESIUM ION 6(MG 2+) STRUCTURE OF THE M-BOX RIBOSWITCH APTAMER DOMAIN M-BOX RNA, YKOK RIBOSWITCH APTAMER RNA RNA, RIBOSWITCH, YKOK, M-BOX, RNA SENSOR, NONCODING RNA
2qek nuc 1.80 MAGNESIUM ION MG 2+ HIV-1 SUBTYPE F DIS RNA EXTENDED DUPLEX FORM HIV-1 SUBTYPE F DIS GENOMIC RNA RNA HIV RNA BULGED-ADENINE
2qus nuc 2.40 MAGNESIUM ION 16(MG 2+) HAMMERHEAD RIBOZYME G12A MUTANT PRE-CLEAVAGE HAMMERHEAD RIBOZYME RNA HAMMERHEAD RNA, HAMMERHEAD RIBOZYME, CATALYTIC RNA, SATELLIT RNA, RIBOZYME, RNA
2quw nuc 2.20 MAGNESIUM ION 17(MG 2+) HAMMERHEAD RIBOZYME G12A MUTANT AFTER CLEAVAGE HAMMERHEAD RIBOZYME, CLEAVED FRAGMENT, HAMMERHEAD RIBOZYME, CLEAVED FRAGMENT RNA HAMMERHEAD RIBOZYME, RIBOZYME, CATALYTIC RNA, RIBOZYME-PRODU COMPLEX, RNA
2qwy nuc 2.80 MAGNESIUM ION MG 2+ SAM-II RIBOSWITCH BOUND TO S-ADENOSYLMETHIONINE SAM-II RIBOSWITCH RNA MRNA, RIBOSWITCH, SAM, S-ADENOSYLMETHIONINE, ADOMET, RNA- LIGAND COMPLEX, DOUBLE HELIX, PSEUDOKNOT, BASE TRIPLE
2r1s nuc 1.40 MAGNESIUM ION MG 2+ STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.4 A (BR1) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA ASYMMETRY, ELECTROSTATIC, MONOVALENT CATIONS, STRUCTURAL PLASTICITY, RNA
2r20 nuc 1.30 MAGNESIUM ION MG 2+ STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.3 A (BR2) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA ASYMMETRY, METAL ION BINDING, UNSTACKING, ELECTROSTATIC, RNA
2tra nuc 3.00 MAGNESIUM ION MG 2+ RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS
2val nuc 2.00 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF AN ESCHERICHIA COLI TRNAGLY MICROHELIX AT 2.0 ANGSTROM RESOLUTION 5'-R(*GP*CP*GP*GP*GP*AP*AP)-3', 5'-R(*UP*UP*CP*CP*CP*GP*CP)-3' RNA RNA, GLYCYL-TRNA SYNTHETASE (GLYRS) SYSTEM, TRNAGLY ACCEPTOR STEM MICROHELIX, RNA TRNA IDENTITY ELEMENTS, MAGNESIUM BINDING SITES
2wna nuc 0.97 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE GNA 3'-G(BR)CGCGC-2' GNA RNA RNA, GNA, NUCLEIC ACID, GLYCOL NUCLEIC ACID, WATSON-CRICK BASE PAIR
2x2q nuc 1.90 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF AN 'ALL LOCKED' LNA DUPLEX AT 1.9 ANGST RESOLUTION LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX, LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX DNA DNA, MODIFIED NUCLEIC ACID, LOCKED NUCLEIC ACID, THERMOSTABI
2yie nuc 2.94 MAGNESIUM ION 14(MG 2+) CRYSTAL STRUCTURE OF A F. NUCLEATUM FMN RIBOSWITCH BOUND TO FMN RIBOSWITCHFMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2495-2544APTAMER DOMAIN, RESIDUES 2550-2601 RNA RNA
2yif nuc 3.30 MAGNESIUM ION 12(MG 2+) CRYSTAL STRUCTURE OF A F. NUCLEATUM FMN RIBOSWITCH - FREE STATE FMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2495-2544, FMN RIBOSWITCH: APTAMER DOMAIN, RESIDUES 2550-2601 RNA RNA, TRANSLATION
2z74 nuc 2.20 MAGNESIUM ION 8(MG 2+) T. TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSE-6-PHOSPHATE GLMS RIBOZYME RNA, GLMS RIBOZYME SUBSTRATE RNA DNA, RNA RIBOZYME, RIBOSWITCH, GLUCOSE-6-PHOSPHATE, GLUCOSAMINE-6- PHOSPHATE, DNA, RNA
2z75 nuc 1.70 MAGNESIUM ION 9(MG 2+) T. TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSAMINE-6- PHOSPHATE GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA DNA, RNA RIBOZYME, RIBOSWITCH, GLUCOSE-6-PHOSPHATE, GLUCOSAMINE-6- PHOSPHATE, DNA, RNA
2zy6 nuc 1.75 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A TRUNCATED TRNA, TPHE39A PHENYLALANYL TRANSFER RNA RNA TRUNCATED TRNA
301d nuc 3.00 MAGNESIUM ION 5(MG 2+) CAPTURING THE STRUCTURE OF A CATALYTIC RNA INTERMEDIATE: RNA HAMMERHEAD RIBOZYME, MG(II)-SOAKED RNA HAMMERHEAD RIBOZYME, RNA HAMMERHEAD RIBOZYME RIBOZYME RNA HAMMERHEAD RIBOZYME, CATALYTIC RNA, LOOP
302d nuc 2.20 MAGNESIUM ION MG 2+ META-HYDROXY ANALOGUE OF HOECHST 33258 ('HYDROXYL IN' CONFORMATION) BOUND TO D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
303d nuc 2.20 MAGNESIUM ION MG 2+ META-HYDROXY ANALOGUE OF HOECHST 33258 ('HYDROXYL OUT' CONFORMATION) BOUND TO D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
305d nuc 2.17 MAGNESIUM ION MG 2+ SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICATATIC) IN THE TETRAGONAL FORM DNA (5'-D(*IP*CP*AP*TP*AP*TP*IP*C)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DOUBLE DRUG IN THE MINOR GROOVE
306d nuc 1.60 MAGNESIUM ION MG 2+ SIDE-BY-SIDE BINDING OF DISTAMYCIN MOLECULES TO D(ICITACIC) DNA (5'-D(*IP*CP*IP*TP*AP*CP*IP*C)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DOUBLE DRUG IN THE MINOR GROOVE
308d nuc 1.50 MAGNESIUM ION 3(MG 2+) BINDING OF DAUNOMYCIN TO B-D-GLUCOSYLATED DNA FOUND IN PROTOZOA TRYPANOSOMA BRUCEI STUDIED BY X-RAY CRYSTALLOGRAPH DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
310d nuc 1.30 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RNA DUPLEX AT 1.3 A RESOLUTION. HYDRATION PATTERN OF 2'-O-METHYLATED RNA RNA (5'-R(*(OMC)P*(OMG)P*(OMC)P*(OMG)P*(OMC) P*(OMG))-3') RNA A-RNA, DOUBLE HELIX, MODIFIED
312d nuc 1.80 MAGNESIUM ION MG 2+ Z-DNA HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE WATSON- CRICK BASE PAIR DNA (5'-D(*CP*CP*GP*CP*GP*CP*G)-3'), DNA (5'-D(*GP*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, OVERHANGING BASE, FLIPPED-OUT BASE
313d nuc 1.68 MAGNESIUM ION MG 2+ Z-DNA HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE HOOGSTEEN BASE PAIR DNA (5'-D(*GP*(5CM)P*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, OVERHANGING BASE, FLIPPED- OUT BASE
314d nuc 1.90 MAGNESIUM ION MG 2+ Z-DNA HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE WOBBLE BASE PAIR DNA (5'-D(*GP*CP*GP*CP*GP*CP*G)-3'), DNA (5'-D(*TP*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, OVERHANGING BASE, FLIPPED-OUT BASE
335d nuc 2.40 MAGNESIUM ION MG 2+ THE CRYSTAL STRUCTURE OF THE DNA DECAMER D(GGCAATTGCG) CONTAINS BOTH MAJOR AND MINOR GROOVE BINDING G.(G.C) TRIPLETS DNA (5'-D(*GP*GP*CP*AP*AP*TP*TP*GP*CP*G)-3') DNA A-DNA, DOUBLE HELIX, FLIPPED-OUT BASE
336d nuc 1.00 MAGNESIUM ION 2(MG 2+) INTERACTION BETWEEN LEFT-HANDED Z-DNA AND POLYAMINE-3 THE CRYSTAL STRUCTURE OF THE D(CG)3 AND THERMOSPERMINE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX
354d nuc 1.50 MAGNESIUM ION 5(MG 2+) STRUCTURE OF LOOP E FROM E. COLI 5S RRNA RNA (5'-R(*CP*CP*GP*AP*UP*GP*GP*UP*AP*GP*UP*G)-3' CHAIN: A, RNA-DNA (5'-R(*GP*CP*GP*AP*GP*AP*GP*UP*AP*)-D(*DG R(*GP*C)-3') RNA U-RNA, DOUBLE HELIX, INTERNAL LOOP, OVERHANGING BASE, MISMAT
355d nuc 1.40 MAGNESIUM ION MG 2+ THE B-DNA DODECAMER AT HIGH RESOLUTION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, SODIUM FORM, DNA
357d nuc 3.50 MAGNESIUM ION 8(MG 2+) 3.5 A STRUCTURE OF FRAGMENT I FROM E. COLI 5S RRNA RNA-DNA (5'-R(*UP*GP*DCP)-D(*CP(S)*)- R(*UP*GP*GP*CP*GP*GP*C)-3'), RNA (5'- R(*CP*CP*GP*AP*UP*GP*GP*UP*AP*GP*UP*GP*UP*GP*GP*GP*G*UP*C)- 3'), RNA (5'- R(*CP*CP*CP*CP*AP*UP*GP*CP*GP*AP*GP*AP*GP*UP*AP*GP*G P*GP*AP*AP*CP*UP* GP*CP*CP*AP*GP*GP*CP*AP*U)-3') RNA U-RNA, DOUBLE HELIX, KINKED, INTERNAL LOOP, OVERHANGING BASE, MODIFIED, MISMATCHED
360d nuc 1.85 MAGNESIUM ION MG 2+ STRUCTURE OF 2,5-BIS{[4-(N-ETHYLAMIDINO)PHENYL]}FURAN COMPLE D(CPGPCPGPAPAPTPTPCPGPCPG)-3'. A MINOR GROOVE DRUG COMPLEX, PATTERNS OF GROOVE HYDRATION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
364d nuc 3.00 MAGNESIUM ION 12(MG 2+) 3.0 A STRUCTURE OF FRAGMENT I FROM E. COLI 5S RRNA RNA (5'-R(*UP*GP*)-D(*(1SC)P*)- R(*CP*UP*GP*GP*CP*GP*GP*C)-3'), RNA (5'- R(*CP*CP*CP*CP*AP*UP*GP*CP*GP*AP*GP*AP*GP*UP*AP*GP*G P*GP*AP*AP*CP*UP*GP*CP*CP*AP*GP*GP*CP*AP*U)-3'), RNA (5'- R(*CP*CP*GP*AP*UP*GP*GP*UP*AP*GP*UP*GP*UP*GP*GP*GP*G *UP*C)-3') RNA U-RNA, DOUBLE HELIX, KINKED, INTERNAL LOOP, OVERHANGING BASE, MODIFIED, MISMATCHED
370d nuc 1.67 MAGNESIUM ION MG 2+ STRUCTURAL VARIABILITY OF A-DNA IN CRYSTALS OF THE OCTAMER D(PCPCPCPGPCPGPGPG) DNA (5'-D(P*CP*CP*CP*GP*CP*GP*GP*G)-3') DNA A-DNA, DOUBLE HELIX, DNA
382d nuc 2.20 MAGNESIUM ION MG 2+ HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DNA. DNA (5'-D(*CP*CP*GP*CP*CP*GP*GP*CP*GP*G)-3') DNA A-DNA, DOUBLE HELIX, DNA
383d nuc 1.70 MAGNESIUM ION MG 2+ HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DNA DNA (5'-D(*CP*(5CM)P*GP*CP*(5CM)P*GP*GP*(5CM) P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED DEOXYRIBONUCLEIC ACID
384d nuc 2.15 MAGNESIUM ION MG 2+ HYDRATION AND RECOGNITION OF METHYLATED CPG STEPS IN DNA 5'-D(*CP*(5CM)P*GP*CP*(5CM)P*GP*GP*(5CM)P*GP*G)- 3' DNA A-DNA, DOUBLE HELIX, MODIFIED
388d nuc 1.55 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF B-DNA WITH INCORPORATED 2'-DEOXY-2'- FLUORO-ARABINO-FURANOSYL THYMINES: IMPLICATIONS OF CONFORMATIONAL PREORGANIZATION FOR DUPLEX STABILITY DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*(TAF) P*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
389d nuc 1.55 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF B-DNA WITH INCORPORATED 2'-DEOXY-2'- FLUORO-ARABINO-FURANOSYL THYMINES: IMPLICATIONS OF CONFORMATIONAL PREORGANIZATION FOR DUPLEX STABILITY DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED
392d nuc 3.00 MAGNESIUM ION MG 2+ STRUCTURAL VARIABILITY AND NEW INTERMOLECULAR INTERACTIONS OF Z-DNA IN CRYSTALS OF D(PCPGPCPGPCPG) DNA (5'-D(P*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX
3ajk nuc 1.95 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(CGCGGATF5UCGCG): 5-FORMYLURIDINE:GUAN BASE-PAIR IN B-DNA WITH HOECHST33258 5'-D(*CP*GP*CP*GP*GP*AP*TP*(UFR)P*CP*GP*CP*G*)-3' CHAIN: A, B DNA DOUBLE HELIX, DNA
3ajl nuc 2.70 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(CGCGGATF5UCGCG): 5-FORMYLURIDINE:GUAN BASE-PAIR IN B-DNA WITH DAPI 5'-D(*CP*GP*CP*GP*GP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DNA
3b4a nuc 2.70 MAGNESIUM ION 6(MG 2+) T. TENGCONGENSIS GLMS RIBOZYME WITH G40A MUTATION, BOUND TO GLUCOSAMINE-6-PHOSPHATE GLMS RIBOZYME SUBSTRATE RNA, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA
3b4b nuc 2.70 MAGNESIUM ION 3(MG 2+) T. TENGCONGENSIS GLMS RIBOZYME WITH G40A MUTATION, BOUND TO GLUCOSAMINE-6-PHOSPHATE AND A SUBSTRATE RNA WITH A 2'5'- PHOSPHODIESTER LINKAGE GLMS RIBOZYME SUBSTRATE WITH 2'5'-PHOSPHODIESTER LINKAGE, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA
3b4c nuc 3.00 MAGNESIUM ION 4(MG 2+) T. TENGCONGENSIS GLMS RIBOZYME BOUND TO GLUCOSAMINE-6- PHOSPHATE AND A SUBSTRATE RNA WITH A 2'5'-PHOSPHODIESTER LINKAGE GLMS RIBOZYME SUBSTRATE WITH A 2'5'- PHOSPHODIESTER LINKAGE, GLMS RIBOZYME RNA RNA RIBOZYME, RIBOSWITCH, GLUCOSAMINE-6-PHOSPHATE, RNA
3bwp nuc 3.10 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF A SELF-SPLICED GROUP II INTRON GROUP IIC INTRON RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II
3cgs nuc 1.65 MAGNESIUM ION MG 2+ X-RAY STRUCTURE CONTAINING THE PSEUDOURIDYLATED U2 SNRNA AND MAMMALIAN INTRON BRANCH SITE CONSENSUS SEQUENCES RNA (5'-R(*GP*CP*GP*CP*GP*(PSU) P*AP*GP*UP*AP*GP*C)-3'), RNA (5'- R(*CP*GP*CP*UP*AP*CP*UP*GP*AP*CP*GP*CP*G)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING
3cr1 nuc 2.25 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A MINIMAL, MUTANT, ALL-RNA HAIRPIN RIBO (A38C, A-1OMA) GROWN FROM MGCL2 RNA (5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*C CHAIN: A, LOOP A AND B RIBOZYME STRAND, RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*CP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) CHAIN: C RNA RIBOZYME, A38, RNA
3d2g nuc 2.25 MAGNESIUM ION 10(MG 2+) STRUCTURAL BASIS OF THIAMINE PYROPHOSPHATE ANALOGUES BINDING EUKARYOTIC RIBOSWITCH TPP-SPECIFIC RIBOSWITCH RNA RNA, RIBOSWITCH, TPP, THIAMINE ANALOGUES, ANTIBIOTICS, ARABI THALIANA, EUKARYOTE
3d2v nuc 2.00 MAGNESIUM ION 10(MG 2+) STRUCTURE OF THE EUKARYOTIC TPP-SPECIFIC RIBOSWITCH BOUND TO ANTIBACTERIAL COMPOUND PYRITHIAMINE PYROPHOSPHATE TPP-SPECIFIC RIBOSWITCH RNA RNA, RIBOSWITCH, ANTIBIOTIC, THIAMINE PYROPHOSPHATE, PYRITHI PYROPHOSPHATE, COMPLEX
3d2x nuc 2.50 MAGNESIUM ION 13(MG 2+) STRUCTURE OF THE THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWITCH BOUND TO OXYTHIAMINE PYROPHOSPHATE TPP-SPECIFIC RIBOSWITCH RNA RNA, STRUCTURE, RIBOSWITCH, THIAMINE PYROPHOSPHATE, OXYTHIAMINE PYROPHOSPHATE, ANTIBIOTIC, DRUGS, COMPLEX
3dil nuc 1.90 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA
3dnb nuc 1.30 MAGNESIUM ION 3(MG 2+) HELIX GEOMETRY, HYDRATION, AND G.A MISMATCH IN A B-DNA DECAM DNA (5'-D(*CP*CP*AP*AP*GP*AP*TP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, MISMATCHED, DNA
3eog nuc 3.39 MAGNESIUM ION 31(MG 2+) CO-CRYSTALLIZATION SHOWING EXON RECOGNITION BY A GROUP II INTRON GROUP IIC INTRON, 5'-R(*UP*UP*AP*UP*UP*A)-3' RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II, EXON
3eoh nuc 3.12 MAGNESIUM ION 31(MG 2+) REFINED GROUP II INTRON STRUCTURE GROUP IIC INTRON, 5'-R(*UP*UP*AP*UP*UP*A)-3' RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II, EXON
3ey0 nuc 2.52 MAGNESIUM ION MG 2+ A NEW FORM OF DNA-DRUG INTERACTION IN THE MINOR GROOVE OF A COIL 5'-D(*DAP*DTP*DAP*DTP*DAP*DTP*DAP*DTP*DAP*DT)-3' DNA DNA DRUG PENTAMIDINE COILED-COIL ALL-AT, DNA
3f2q nuc 2.95 MAGNESIUM ION 14(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA
3f2t nuc 3.00 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, IRIDIU SOAK. FMN RIBOSWITCH RNA FMN RIBOSWITCH, TRANSCRIPTION, RNA
3f2w nuc 3.45 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, BA2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, BARIUM, RNA
3f2x nuc 3.11 MAGNESIUM ION 13(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, CS+ SO FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, CESIUM, RNA
3f2y nuc 3.20 MAGNESIUM ION 11(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, MN2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, MANGANESE, RNA
3f30 nuc 3.15 MAGNESIUM ION 8(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, COBALT SOAK. FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, COBALT HEXAMINE, RNA
3f4e nuc 3.05 MAGNESIUM ION 13(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, SPLIT FMN RIBOSWITCH, FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, RNA
3f4g nuc 3.01 MAGNESIUM ION 15(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO RIBOFLAVIN. FMN RIBOSWITCH, FMN RIBOSWITCH RNA RIBOFLAVIN, FMN, RIBOSWITCH, TRANSCRIPTION, RNA
3f4h nuc 3.00 MAGNESIUM ION 11(MG 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO ROSEOFLAVIN FMN RIBOSWITCH, FMN RIBOSWITCH RNA ROSEOFLAVIN, FMN, RIBOSWITCH, TRANSCRIPTION, RNA
3fs0 nuc 2.30 MAGNESIUM ION 5(MG 2+) CLASS II LIGASE RIBOZYME PRODUCT-TEMPLATE DUPLEX, STRUCTURE 2 5'-R(*GP*GP*UP*GP*AP*GP*GP*CP*UP*G)-3', 5'-R(*CP*CP*AP*GP*UP*CP*GP*GP*AP*AP*C)-3' RNA RIBOZYME, LIGASE, 2'-5', 2-5, 2P5, RNA
3ftm nuc 2.70 MAGNESIUM ION 9(MG 2+) CLASS II LIGASE RIBOZYME PRODUCT-TEMPLATE DUPLEX, STRUCTURE 1 5'-R(*CP*CP*AP*GP*UP*CP*GP*GP*AP*AP*CP*A)-3', 5'-R(*GP*UP*GP*UP*GP*AP*GP*GP*CP*UP*G)-3' RNA RIBOZYME, LIGASE, 2'-5', 2-5, 2P5, RNA
3g78 nuc 2.80 MAGNESIUM ION 51(MG 2+) INSIGHT INTO GROUP II INTRON CATALYSIS FROM REVISED CRYSTAL GROUP II INTRON, LIGATED EXON PRODUCT: UNKNOWN EXON PRODUCT RNA REVISED CRYSTAL STRUCTURE, REVISION, RNA
3gao nuc 1.90 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE GUANINE RIBOSWITCH BOUND TO XANTHINE. GUANINE RIBOSWITCH RNA RIBOSWITCH, GUANINE, XANTHINE, MRNA, RNA_LIGAND COMPLEX, THREE-WAY JUNCTION
3gdd nuc 2.80 MAGNESIUM ION MG 2+ AN INVERTED ANTHRAQUINONE-DNA CRYSTAL STRUCTURE 5'-D(*(BRU)P*AP*GP*G)-3' DNA ANTHRAQUINONE, TELOMERE DNA SEQUENCE, DRUG-DNA COMPLEX, DNA
3ggi nuc 0.98 MAGNESIUM ION 5(MG 2+) LOCATING MONOVALENT CATIONS IN ONE TURN OF G/C RICH B-DNA 5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G) -3' DNA DNA, CATIONS, DIVALENT CATIONS, MONOVALENT CATIONS, THALLIUM ION
3ggk nuc 0.87 MAGNESIUM ION 5(MG 2+) LOCATING MONOVALENT CATIONS IN ONE TURN OF G/C RICH B-DNA 5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G) -3' DNA DNA, CATIONS, DIVALENT CATIONS, MONOVALENT CATIONS, RUBIDIUM ION
3gvn nuc 1.20 MAGNESIUM ION 2(MG 2+) THE 1.2 ANGSTROEM CRYSTAL STRUCTURE OF AN E.COLI TRNASER ACCEPTOR STEM MICROHELIX REVEALS TWO MAGNESIUM BINDING SITES 5'-R(*GP*GP*UP*GP*AP*GP*G)-3', 5'-R(*CP*CP*UP*CP*AP*CP*C)-3' RNA TRNASER/SERYL-TRNA-SYNTHETASE, TRNA ACCEPTOR STEM MICROHELIX, X-RAY STRUCTURE, IDENTITY ELEMENTS, RNA HYDRATION, MAGNESIUM BINDING SITES
3gx2 nuc 2.90 MAGNESIUM ION 7(MG 2+) TTESAM-I RIBOSWITCH VARIANT A94GU34C BOUND TO SINEFUNGIN RNA (94-MER) RNA KINK-TURN, PSEUDOKNOT, FOUR-WAY JUNCTION, RNA
3gx3 nuc 2.70 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF THE T. TENGCONGENSIS SAM-I RIBOSWITCH VARIANT U34C/A94G BOUND WITH SAH RNA (94-MER) RNA KINK-TURN, FOUR-WAY JUNCTION, PSEUDOKNOT, RIBOSWITCH, RNA
3gx5 nuc 2.40 MAGNESIUM ION 8(MG 2+) CRYSTAL STRUCTURE OF T. TENCONGENSIS SAM-I RIBOSWITCH VARIANT A94G/U34 BOUND WITH SAM RNA (94-MER) RNA KINK-TURN, PSEUDOKNOT, FOUR-WAY JUNCTION, RIBOSWITCH, RNA
3gx7 nuc 2.95 MAGNESIUM ION 6(MG 2+) CRYSTAL STRUCTURE OF THE T. TENGCONGENSIS SAM-I RIBOSWITCH VARIANT U34C/A94G MUTANT A6C/U7G/A87C/U88G BOUND WITH SAM RNA (94-MER) RNA KINK-TURN, FOUR-WAY JUNCTION, PSEUDOKNOT, RIBOSWITCH, RNA
3iff nuc 1.75 MAGNESIUM ION 3(MG 2+) 2'-SEME-A MODIFIED DNA DECAMER DNA (5'-D(*GP*TP*AP*CP*GP*CP*GP*TP*(XUA)P*C)-3') DNA SELENIUM, NUCLEIC ACID, ADENOSINE, DNA
3igi nuc 3.12 MAGNESIUM ION 44(MG 2+) TERTIARY ARCHITECTURE OF THE OCEANOBACILLUS IHEYENSIS GROUP 5'-R(*CP*GP*CP*UP*CP*UP*AP*CP*UP*CP*UP*AP*U)-3', GROUP IIC INTRON RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II, EXON
3iki nuc 1.38 MAGNESIUM ION MG 2+ 5-SME-DU CONTAINING DNA OCTAMER 5'-D(*GP*(UMS)P*GP*(US2)P*AP*CP*AP*C)-3' DNA SELENIUM, NUCLEIC ACID, 5-SME-DEOXYURIDINE, 2'-SEME-DEOXYURI
3ivn nuc 2.80 MAGNESIUM ION 9(MG 2+) STRUCTURE OF THE U65C MUTANT A-RIBOSWITCH APTAMER FROM THE B SUBTILIS PBUE OPERON A-RIBOSWITCH RNA APTAMER, RNA, A-RIBOSWITCH
3jxq nuc 1.45 MAGNESIUM ION 4(MG 2+) X-RAY STRUCTURE OF R[CGCG(5-FLUORO)CG]2 R[CGCG(5-FLUORO)CG]2 RNA RNA, DOUBLE HELIX
3knc nuc 2.50 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE CENA-RNA HYBRID OCTAMER CE(GCGTAGCG :R(CGCUACGC) 5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3', 5'-D(*(XGR)P*(XCR)P*(XGR)P*(XTR)P*(XAR)P*(XGR)P*( P*(XGR)P*(XGR))-3' RNA/CYCLOHEXENE-RNA HYBRID CYCLOHEXENE, SUGAR MODIFICATION, RNA, RNA-CYCLOHEXENE-RNA HY COMPLEX
3kq8 nuc 1.60 MAGNESIUM ION MG 2+ 5-TE-URIDINE DERIVATIZED DNA-8MER 5'-D(*GP*(UMS)P*GP*(TTI)P*AP*CP*AP*C)-3' DNA TELLURIUM DNA, DNA
3l0u nuc 3.00 MAGNESIUM ION 2(MG 2+) THE CRYSTAL STRUCTURE OF UNMODIFIED TRNAPHE FROM ESCHERICHIA UNMODIFIED TRNAPHE RNA TRANSFER RNA, TRNA, TRANSCRIPT, UNMODIFIED, RNA
3la5 nuc 1.70 MAGNESIUM ION 10(MG 2+) X-RAY CRYSTAL STRUCTURE OF MC6 RNA RIBOSWITCH BOUND TO AZACYTOSINE ADENOSINE RIBOSWITCH RNA RNA, RIBOSWITCH, GENE REGULATION, SYNTHETIC BIOLOGY
3loa nuc 2.30 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE ANALYSIS OF THE RNA CONSTRUCT WITH TWO ADJ LIGAND BINDING SITES OF HELIX H44 IN 16S RIBOSOMAL RNA 5'-R(*CP*CP*GP*CP*GP*CP*CP*CP*GP*(5BU) P*CP*AP*CP*AP*CP*CP*AP*CP*CP*CP*G)-3', 5'-R(*GP*GP*GP*(5BU) P*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*UP*AP*AP*CP*GP*CP*GP*GP*C)- CHAIN: B RNA RNA, A-SITE, HYGROMYCIN B BINDING SITE, AMINOGLYCOSIDE
3lpv nuc 1.77 MAGNESIUM ION 4(MG 2+) X-RAY CRYSTAL STRUCTURE OF DUPLEX DNA CONTAINING A CISPLATIN D(GPG) INTRASTRAND CROSS-LINK 5'-D(*CP*CP*TP*CP*TP*GP*GP*TP*CP*TP*CP*C)-3', 5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3' DNA CISPLATIN, DNA
3ltr nuc 1.30 MAGNESIUM ION MG 2+ 5-OME-DU CONTAINING DNA 8MER 5'-D(*GP*(UMS)P*GP*(T5O)P*AP*CP*AP*C)-3' DNA DNA, OLIGONUCLEOTIDE, 2'-SEME, 5-OME, SELENIUM, 5-METHOXY-UR
3mei nuc 1.97 MAGNESIUM ION 5(MG 2+) REGULATORY MOTIF FROM THE THYMIDYLATE SYNTHASE MRNA RNA (5'-R(*CP*CP*GP*CP*CP*GP*CP*GP*CP*CP*AP*(5BU) P*GP*CP*CP*UP*GP*UP*GP*GP*CP*GP*G)-3') RNA S-TURN, C-C BASE PAIR, RNA
3nd4 nuc 1.52 MAGNESIUM ION MG 2+ WATSON-CRICK 16-MER DSRNA 5'-R(*AP*GP*AP*GP*AP*AP*GP*AP*UP*CP*UP*UP*CP*UP*C CHAIN: A RNA DOUBLE-STRANDED RNA, RNA, 16 BASE PAIR RNA
3nkb nuc 1.92 MAGNESIUM ION 10(MG 2+) A 1.9A CRYSTAL STRUCTURE OF THE HDV RIBOZYME PRECLEAVAGE SUG LEWIS ACID AND GENERAL ACID MECHANISMS CONTRIBUTE TO PHOSPH CLEAVAGE DNA/RNA (5'-D(*(DUR))-D(*GP*G)-R(P*CP*UP*UP*GP*CP CHAIN: A, THE HEPATITIS DELTA VIRUS RIBOZYME DNA, RNA CATALYTIC RNA, METAL-MEDIATED CATALYSIS, PHOSPHODIESTER CLEA DNA, RNA
3oie nuc 1.90 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE DB1880-D(CGCGAATTCGCG)2 COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA NUCLEIC ACIDS, DNA, DOUBLE HELIX, MINOR GROOVE, DNA MINOR GR BINDER, DNA MINOR GROOVE-LIGAND COMPLEX, DB1880, A2T2, DICK DREW DODECAMER, CRYSTAL STRUCTURE OF B-DNA, DNA-DRUG COMPLE MAGNESIUM-WATER COMPLEX, HYDRATED MAGNESIUM, DNA HYDRATION
3opi nuc 1.10 MAGNESIUM ION MG 2+ 7-DEAZA-2'-DEOXYADENOSINE MODIFICATION IN B-FORM DNA DNA (5'-D(*CP*GP*CP*GP*AP*(7DA)P*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA, DODECAMER, 7-DEAZA-DEOXYADENOSINE, 7-DEAZA-DA, DNA
3owi nuc 2.85 MAGNESIUM ION 33(MG 2+) CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3oww nuc 2.80 MAGNESIUM ION 33(MG 2+) CRYSTAL STRUCTURE OF THE GLYCINE RIBOSWITCH BOUND TO GLYCINE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3owz nuc 2.95 MAGNESIUM ION 16(MG 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN IRIDIUM DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION, GLYCINE RIBOSWITCH, RNA
3ox0 nuc 3.05 MAGNESIUM ION 28(MG 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, UNBOUND STATE DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3oxb nuc 2.95 MAGNESIUM ION 28(MG 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH WITH SINGLE MUTATION DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3oxd nuc 3.00 MAGNESIUM ION 34(MG 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH WITH TWO MUTATIONS DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3oxe nuc 2.90 MAGNESIUM ION 10(MG 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, MN2+ SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3oxj nuc 3.20 MAGNESIUM ION 21(MG 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, SOAKED IN BA2+ DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3oxm nuc 2.95 MAGNESIUM ION 27(MG 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, TL-ACETATE SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA
3p4a nuc 1.20 MAGNESIUM ION 2(MG 2+) 2'FLUORO MODIFIED RNA OCTAMER FA2U2 2'FLUORO MODIFIED RNA 8-MER RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, 2'-FLUORO 2'- DEOXYADENOSINE, 2'-FLUORO 2'-DEOXYURIDINE, SIRNA
3p59 nuc 2.18 MAGNESIUM ION 2(MG 2+) FIRST CRYSTAL STRUCTURE OF A RNA NANOSQUARE RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*CP*CP*U)-3'), RNA (5'-R(*CP*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP P*G)-3') RNA RNA SQUARE, RNA
3q3z nuc 2.51 MAGNESIUM ION 13(MG 2+) STRUCTURE OF A C-DI-GMP-II RIBOSWITCH FROM C. ACETOBUTYLICUM C-DI-GMP C-DI-GMP-II RIBOSWITCH RNA RIBOSWITCH, C-DI-GMP, RNA
3q51 nuc 2.85 MAGNESIUM ION MG 2+ STRUCTURAL ANALYSIS OF A CLASS I PREQ1 RIBOSWITCH APTAMER IN METABOLITE-FREE STATE. PREQ1 RIBOSWITCH RNA PREQ1, PREQ0, RNA, RIBOSOMAL BINDING SITE, APTAMER, METABOLI PSEUDOKNOT, H-TYPE, RIBOSWITCH
3qxr nuc 1.62 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE BROMINATED CKIT-1 PROTO-ONCOGENE PR QUADRUPLEX DNA 5'-D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*(BRU) P*GP*GP*GP*AP*GP*GP*AP*GP*GP*G)-3' DNA DNA QUADRUPLEX, REGULATION, CKIT-1, DNA
3r4f nuc 3.50 MAGNESIUM ION 9(MG 2+) PROHEAD RNA PRNA RNA PROHEAD RNA, MOTOR, VIRAL PACKAGING, RNA
3ski nuc 2.30 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE RNA (68-MER), RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA
3skl nuc 2.90 MAGNESIUM ION 6(MG 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, IRIDIUM HEXAMMINE SOAK RNA (66-MER) RNA THREE WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA
3skr nuc 3.10 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, COBALT HEXAMMINE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA
3skt nuc 3.10 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, MANGANESE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY-GUANOSINE, RNA
3skw nuc 2.95 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, CESIUM SOAK RNA (66-MER) RNA THREE-WAY RNA JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA
3skz nuc 2.60 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA
3slm nuc 2.70 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA
3ssf nuc 1.60 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF RNA:DNA DODECAMER CORRESPONDING TO HIV- POLYPURINE TRACT, AT 1.6 A RESOLUTION. 5'-R(*UP*AP*AP*AP*AP*GP*AP*AP*AP*AP*GP*G)-3', 5'-D(*CP*CP*TP*TP*TP*TP*CP*TP*TP*TP*TP*A)-3' RNA/DNA POLYPURINE TRACT (PPT) OF HIV-1; RNA-DNA HYBRID; REVERSE TRANSCRIPTION, RNA-DNA COMPLEX
3td0 nuc 1.60 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF THE BACTERIAL A1408G-MUTANT AND THE PRO CYTOPLASMIC RIBOSOMAL DECODING SITE RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*GP*(5BU) P*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA DECODING, RIBOSOME, RNA
3tra nuc 3.00 MAGNESIUM ION MG 2+ RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPARTIC ACID AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS
3tvb nuc 1.08 MAGNESIUM ION 2(MG 2+) A HIGHLY SYMMETRIC DNA G-4 QUADRUPLEX/DRUG COMPLEX DNA (5'-D(*GP*GP*GP*G)-3') DNA/ANTIBIOTIC G-4 QUADRUPLEX, DAUNOMYCIN, DNA-DRUG COMPLEX, DNA-ANTIBIOTIC
3tzr nuc 2.21 MAGNESIUM ION 6(MG 2+) STRUCTURE OF A RIBOSWITCH-LIKE RNA-LIGAND COMPLEX FROM THE H VIRUS INTERNAL RIBOSOME ENTRY SITE 5'-R(*CP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*UP*C *CP*C)-3', 5'-R(*GP*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*UP*CP*G CHAIN: B RNA INTERNAL LOOP, REGULATORY MOTIF, AMINOBENZIMIDAZOLE BINDING,
3u05 nuc 1.27 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF DB1804-D(CGCGAATTCGCG)2 COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA A2T2, DICKERSON AND DREW DODECAMER, DOUBLE HELIX, DNA MINOR LIGAND COMPLEX, DNA MINOR GROOVE BINDER, DB1804, MG2+, DNA
3u08 nuc 1.25 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF DB1963-D(CGCGAATTCGCG)2 COMPLEX AT 1.25 RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DNA MINOR GROOVE-LIGAND BINDER, DB1963, DNA
3u0u nuc 1.24 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF THE DB1883-D(CGCGAATTCGCG)2 COMPLEX AT RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, MINOR GROOVE, DNA MINOR GROOVE BINDER, DB1883, DNA
3u2n nuc 1.25 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF DNA(CGCGAATTCGCG)2 AT 1.25 ANGSTROMS 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, MG2+, DNA
3u89 nuc 0.96 MAGNESIUM ION 5(MG 2+) CRYSTAL STRUCTURE OF ONE TURN OF G/C RICH B-DNA REVISITED 5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G) -3' DNA B-DNA, DNA
403d nuc 1.40 MAGNESIUM ION MG 2+ 5'-D(*CP*GP*CP*(HYD)AP*AP*AP*TP*TP*TP*GP*CP*G)-3', 2'-(4- ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI- BENZIMIDAZOLE DNA (5'-D(*CP*GP*CP*(IGU) P*AP*AP*TP*TP*TP*GP*CP*G)-3') DNA DNA/DRUG COMPLEX, B-DNA DOUBLE HELIX
412d nuc 1.65 MAGNESIUM ION 2(MG 2+) DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O-METHYL- [TRI(OXYETHYL)] RIBONUCLEOSIDE DNA (5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3') DNA DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O-METHYL- [TRI(OXYETHYL)] RIBONUCLEOSIDE, DNA
423d nuc 1.60 MAGNESIUM ION 5(MG 2+) 5'-D(*AP*CP*CP*GP*AP*CP*GP*TP*CP*GP*GP*T)-3' DNA (5'-D(*AP*CP*CP*GP*AP*CP*GP*TP*CP*GP*GP*T)- 3') DNA DOUBLE HELIX, DNA
428d nuc 1.75 MAGNESIUM ION MG 2+ STRUCTURE OF THE POTASSIUM FORM OF CGCGAATTCGCG: DNA DEFORMATION BY ELECTROSTATIC COLLAPSE AROUND SMALL CATIONS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA DOUBLE HELIX, POTASSIUM FORM, DNA
429d nuc 2.70 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF A LEADZYME; METAL BINDING AND IMPLICATIONS FOR CATALYSIS RNA (5'-R(*GP*CP*UP*GP*GP*GP*AP*GP*UP*CP*C)-3'), RNA (5'- R(*CP*GP*GP*AP*CP*CP*GP*AP*GP*CP*CP*AP*G)-3') RNA LEADZYME, LEAD-DEPENDENT CLEAVAGE, TRNA INTERNAL LOOP, RNA, BULGED NUCLEOTIDES
430d nuc 2.10 MAGNESIUM ION 9(MG 2+) STRUCTURE OF SARCIN/RICIN LOOP FROM RAT 28S RRNA SARCIN/RICIN LOOP FROM RAT 28S R-RNA RNA U-RNA, DOUBLE HELIX, HAIRPIN, BLUNT STEM, TETRALOOP MISMATCH TRIPLE, RIBONUCLEIC ACID, RNA
431d nuc 1.15 MAGNESIUM ION 2(MG 2+) 5'-D(*GP*GP*CP*CP*AP*AP*TP*TP*GP*G)-3' DNA (5'-D(*GP*GP*CP*CP*AP*AP*TP*TP*GP*G)-3') DNA DEOXYRIBONUCLEIC ACID, EXTENDED HYDRATION SPINE, TRIPLET FORMATION, ATOMIC RESOLUTION, DOUBLE BACKBONE CONFORMATION, DNA
436d nuc 1.10 MAGNESIUM ION 5(MG 2+) THE DICKERSON-DREW B-DNA DODECAMER REVISITED-AT ATOMIC RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*TP*CP*GP*CP*G)-3' DNA B-DNA DODECAMER, HIGH RESOLUTION
437d nuc 1.60 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF AN RNA PSEUDOKNOT FROM BEET WESTERN YEL INVOLVED IN RIBOSOMAL FRAMESHIFTING RNA PSEUDOKNOT RNA PSEUDOKNOT, RNA, TRIPLEX, VIRAL FRAMESHIFTING
442d nuc 1.60 MAGNESIUM ION 2(MG 2+) 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3', BENZIMIDAZOLE DERIVATIVE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING
443d nuc 1.60 MAGNESIUM ION 2(MG 2+) 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3'/ BENZIMIDAZOLE DERIVATIVE COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, MINOR GROOVE BINDING
455d nuc 1.43 MAGNESIUM ION 3(MG 2+) A6/A18 INTER-STRAND DITHIOBIS(PROPANE)-CROSSLINKED DODECAMER (CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*(SSP) AP*TP*TP*CP*GP*CP*G)-3') DNA INTER-STRAND CROSSLINKING, DODECAMER CGCGAATTCGCG/CGCGAATTCGCG, DEOXYRIBONUCLEIC ACID, DNA
456d nuc 1.60 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATCCGCG): THE WATSON-CRICK TYPE N6-METHOXYADENOSINE/CYTIDINE BASE-PAIRS IN B-DNA DNA (5'-D(*CP*GP*CP*GP*(A47) P*AP*TP*CP*CP*GP*CP*G)-3') DNA MODIFIED NUCLEOTIDE, MISMATCH, METHOXYADENOSINE, DNA DAMAGE, B-DNA, DOUBLE HELIX
457d nuc 2.00 MAGNESIUM ION MG 2+ MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATTCGCG): N6- METHOXYADENOSINE/ THYMIDINE BASE-PAIRS IN B-DNA DNA (5'-D(*CP*GP*CP*GP*(A47) P*AP*TP*TP*CP*GP*CP*G)-3') DNA MODIFIED NUCLEOTIDE, METHOXYADENOSINE, DNA DAMAGE, B-DNA, DOUBLE HELIX
460d nuc 1.20 MAGNESIUM ION 3(MG 2+) A "HYDRAT-ION SPINE" IN A B-DNA MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DODECAMER DUPLEX, TYPE 1 RB+ FORM CRYSTAL
461d nuc 1.50 MAGNESIUM ION 2(MG 2+) A "HYDRAT-ION SPINE" IN A B-DNA MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DODECAMER DUPLEX, TYPE 2 RB+ FORM CRYSTAL
462d nuc 2.30 MAGNESIUM ION 8(MG 2+) CRYSTAL STRUCTURE OF THE HIV-1 GENOMIC RNA DIMERIZATION INITIATION SITE RNA (5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G) -3') RNA HIV, RNA DUPLEX, MISMATCH, BULGES, MAGNESIUM BINDING
468d nuc 1.80 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA
469d nuc 1.70 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RNA
470d nuc 1.95 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA
471d nuc 2.70 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA
4agz nuc 1.25 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF THE DB 985-D(CGCGAATTCGCG)2 COMPLEX AT RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*GP)-3' DNA DNA, DNA DOUBLE HELIX, DNA-DRUG COMPLEX, DNA HYDRATION
4ah0 nuc 1.20 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF THE DB 985-D(CGCAAATTTGCG)2 COMPLEX AT RESOLUTION 5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*GP)-3' DNA DNA, MINOR GROOVE, DODECAMER, A3T3, DNA-DRUG COMPLEX, DNA HY HYDRATED MAGNESIUM
4ah1 nuc 1.42 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE DB 921-D(CGCAAATTTGCG)2 COMPLEX AT 1.42 A RESOLUTION 5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*GP)-3' DNA DNA, DNA DOUBLE HELIX, MINOR GROOVE, DODECAMER, A3T3, DNA-DR COMPLEX, DNA HYDRATION,
4c5x nuc 1.30 MAGNESIUM ION MG 2+ ULTRA HIGH RESOLUTION DICKERSON-DREW DODECAMER B-DNA WITH 5-HYDROXYMETHYL-CYTOSINE MODIFICATION 5'-D(CP*GP*CP*GP*AP*AP*TP*TP*5HCP*GP*CP*GP)-3': DICKERSON-DREW SEQUENCE DODECAMER DNA DNA, CYTOSINE MODIFICATION
4c63 nuc 1.32 MAGNESIUM ION MG 2+ ULTRA HIGH RESOLUTION DICKERSON-DREW DODECAMER B-DNA WITH 5- METHYLCYSTOSINE MODIFICATION 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*5CMP*GP*CP*GP)-3' DNA DNA, CYTOSINE MODIFICATION
4c64 nuc 1.32 MAGNESIUM ION MG 2+ ULTRA HIGH RESOLUTION DICKERSON-DREW DODECAMER B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*GP)-3' DNA DNA
4cs1 nuc 2.00 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF A SIMPLE DUPLEX KINK TURN, HMKT-7 WITH 2 MG BOUND. 5'-(*GP*GP*CP*GP*AP*AP*GP*AP*AP*CP*CP*GP*GP*GP *GP*AP*GP*CP*CP)-3' RNA RNA, KINK TURN, METAL ION
4ds6 nuc 3.64 MAGNESIUM ION 16(MG 2+) CRYSTAL STRUCTURE OF A GROUP II INTRON IN THE PRE-CATALYTIC MUTANT GROUP IIC INTRON RNA RNA, RIBONUCLEIC ACID, INTRON, GROUP II
4e8m nuc 3.50 MAGNESIUM ION 24(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION,
4e8n nuc 2.96 MAGNESIUM ION 31(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF NH4+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION,
4e8p nuc 3.28 MAGNESIUM ION 27(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF RB+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYMES, SELF-SPLICING, RETROTRANSPOSITION,
4e8q nuc 2.84 MAGNESIUM ION 30(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF TL+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION,
4e8r nuc 3.36 MAGNESIUM ION 23(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF CS+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION,
4e8v nuc 4.00 MAGNESIUM ION 5(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND BA2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION,
4en5 nuc 2.96 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, TL-ACETATE SOAKED FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA
4ena nuc 2.85 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, SOAKED IN CS+ FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA
4enb nuc 2.30 MAGNESIUM ION 7(MG 2+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, BOUND TO IRIDIUM FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA
4enc nuc 2.27 MAGNESIUM ION 5(MG 2+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA
4f2y nuc 1.59 MAGNESIUM ION 2(MG 2+) STRUCTURE OF 3'-FLUORO CYCLOHEXENYL NUCLEIC ACID DECAMER 5'-D(*GP*CP*GP*TP*AP*(XTF)P*AP*CP*GP*C)-3' DNA FLUORO CYCLOHEXENYL NUCLEIC ACID, F-CENA, MODIFIED DNA, A-FO DNA
4f3u nuc 1.40 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF 5-HYDROXY-2'-DEOXYCYTIDINE BASE PAIRED DEOXYGUANOSINE IN DICKERSON DREW DODECAMER DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5OC)P*GP*CP*G CHAIN: A, B DNA 5-HYDROXY-DC, MODIFIED DICKERSON, 5-HYDROXY-2'-DEOXYCYTIDINE
4far nuc 2.86 MAGNESIUM ION 30(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND 5'-EXON GRUUP IIC INTRON: DOMAINS 1-5, GROUP IIC INTRON: 5'-EXON RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN
4fau nuc 2.87 MAGNESIUM ION 24(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF LI+, MG2+ AND 5'-EXON GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN
4faw nuc 2.70 MAGNESIUM ION 32(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND A HYDROLYZED OLIGONUCLEOTIDE FRAGMENT GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*A*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN
4fax nuc 3.10 MAGNESIUM ION 21(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF NA+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN
4fb0 nuc 3.22 MAGNESIUM ION 25(MG 2+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON C377G A LIGAND-FREE STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN
4fnj nuc 1.95 MAGNESIUM ION 5(MG 2+) UTILIZING THE GAAA TETRALOOP/RECEPTOR TO FACILITATE CRYSTAL AND STRUCTURE DETERMINATION OF A CUG RNA HELIX RNA (35-MER) RNA CUG REPEAT GAAA TETRALOOP/RECEPTOR, TOXIC RNA, RNA
4frg nuc 2.95 MAGNESIUM ION 16(MG 2+) CRYSTAL STRUCTURE OF THE COBALAMIN RIBOSWITCH APTAMER DOMAIN COBALAMIN RIBOSWITCH APTAMER DOMAIN RNA COBALAMIN, RIBOSWITCH, B12, RNA
4fs5 nuc 1.30 MAGNESIUM ION 10(MG 2+) CRYSTAL STRUCTURE OF THE Z-DNA HEXAMER CGCGCG AT 500 MM MGCL DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, MG2+ BINDING, DNA
4g6r nuc 2.83 MAGNESIUM ION MG 2+ MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH G8I VA LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND, LOOP A RIBOZYME STRAND, LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT
4gju nuc 1.41 MAGNESIUM ION MG 2+ 5-METHYLCYTOSINE MODIFIED DNA OLIGOMER 5-METHYLCYTOSINE MODIFIED DNA OLIGOMER DNA DOUBLE-STRANDED B-DNA, 5-METHYLCYTOSINE, EPIGENETICS, DNA
4gxy nuc 3.05 MAGNESIUM ION 2(MG 2+) RNA STRUCTURE ADENOSYLCOBALAMIN RIBOSWITCH RNA RNA, RIBOSWITCH, ADENOSYLCOBALAMIN
4hli nuc 1.99 MAGNESIUM ION MG 2+ DNA DODECAMER CONTAINING 5-HYDROXYMETHYL-CYTOSINE DNA (5'-D(*CP*GP*(5HC)P*GP*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA DODECAMER, EPIGENETICS, 5-HYDROXYMETHYL CYTOSINE, DNA
4hw1 nuc 3.10 MAGNESIUM ION MG 2+ MULTIPLE CRYSTAL STRUCTURES OF AN ALL-AT DNA DODECAMER STABI WEAK INTERACTIONS. DNA (5'-D(*AP*AP*TP*AP*AP*AP*TP*TP*TP*AP*TP*T)-3' CHAIN: A, B, C, D DNA OLIGONUCLEOTIDE, WEAK INTERACTIONS, B FORM DNA, DNA
4i9v nuc 1.02 MAGNESIUM ION MG 2+ THE ATOMIC STRUCTURE OF 5-HYDROXYMETHYL 2'-DEOXYCITIDINE BAS WITH 2'-DEOXYGUANOSINE IN DICKERSON DREW DODECAMER DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5HC)P*GP*CP*G CHAIN: A, B DNA 5-HYDROXYMETHYL 2' DEOXYCITIDINE, 5-HYDROXYMETHYL-DC ADDUCT, DDD, DODECAMER OF B-DNA, DNA
4itd nuc 1.94 MAGNESIUM ION MG 2+ STRUCTURES OF DNA DUPLEXES CONTAINING O6-CARBOXYMETHYLGUANIN LESION ASSOCIATED WITH GASTROINTESTINAL CANCER, REVEAL A ME FOR INDUCING TRANSITION MUTATION DNA (5'-D(*CP*GP*CP*GP*(C6G)P*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, MUTAGENESIS, DNA
4jf2 nuc 2.28 MAGNESIUM ION 4(MG 2+) STRUCTURE OF A CLASS II PREQ1 RIBOSWITCH REVEALS LIGAND RECO A NEW FOLD PREQ1-II RIBOSWITCH RNA RIBOSWITCH, H-TYPE PSEUDOKNOT, RNA
4jrc nuc 2.67 MAGNESIUM ION 2(MG 2+) DISTAL STEM I REGION FROM G. KAUSTOPHILUS GLYQS T BOX RNA DISTAL STEM I REGION OF THE GLYQS T BOX LEADER RN CHAIN: A, B RNA T BOX RNA, REGULATORY RNA LEADER SEQUENCE, TRNA BINDING, RNA
4k27 nuc 2.35 MAGNESIUM ION 3(MG 2+) MYOTONIC DYSTROPHY TYPE 2 RNA: STRUCTURAL STUDIES AND DESIGN MOLECULES THAT MODULATE RNA FUNCTION MYOTONIC DYSTROPHY TYPE 2 RNA RNA A-FORM RNA, MYOTONIC DYSTROPHY TYPE 2, UNKNOWN, RNA
4kqy nuc 3.02 MAGNESIUM ION 2(MG 2+) BACILLUS SUBTILIS YITJ S BOX/SAM-I RIBOSWITCH YITJ S BOX/SAM-I RIBOSWITCH RNA GENE REGULATION, RNA
4kw0 nuc 1.49 MAGNESIUM ION MG 2+ STRUCTURE OF DICKERSON-DREW DODECAMER WITH 2'-MESE-ARA-G MOD DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*(1TW)P*CP*G CHAIN: A, B DNA B-DNA, 2'-MESE-ARABINOSYL-DEOXYGUANOSINE, DNA
4kwx nuc 1.30 MAGNESIUM ION 10(MG 2+) LINEAR STRUCTURE OF THE HOLLIDAY JUNCTION SEQUENCE (TCGGCGCC 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA LINEAR DNA, PALINDROME SEQUENCE, DNA
4l81 nuc 2.95 MAGNESIUM ION 6(MG 2+) STRUCTURE OF THE SAM-I/IV RIBOSWITCH (ENV87(DELTAU92, DELTAG SAM-I/IV VARIANT RIBOSWITCH APTAMER DOMAIN: APTAMER DOMAIN RNA RIBOSWITCH, GENE REGULATION, SAM BINDING, RNA
4lx5 nuc 2.13 MAGNESIUM ION 4(MG 2+) X-RAY CRYSTAL STRUCTURE OF THE M6" RIBOSWITCH APTAMER BOUND PYRIMIDO[4,5-D]PYRIMIDINE-2,4-DIAMINE (PPDA) MUTATED ADENINE RIBOSWITCH APTAMER RNA RIBOSWITCH, GENE EXPRESSION PLATFORM, RNA
4lx6 nuc 2.15 MAGNESIUM ION 5(MG 2+) X-RAY CRYSTAL STRUCTURE OF THE M6C" RIBOSWITCH APTAMER BOUND AMINOPYRIMIDO[4,5-D]PYRIMIDIN-4(3H)-ONE (PPAO) MUTATED ADENINE RIBOSWITCH APTAMER RNA RIBOSWITCH GENE EXPRESSION PLATFORM, RNA
4meg nuc 3.10 MAGNESIUM ION 16(MG 2+) IN VITRO EVOLVED GLMS RIBOZYME TRIPLE MUTANT, MAGNESIUM ION (121-MER) RIBOZYME, GLMS TRIPLE MUTANT RIBOZYME RNA GLMS RIBOZYME FOLD, RNA, SELF-CLEAVAGE, TRANSESTERIFICATION, METALLORIBOZYME
4mgm nuc 3.20 MAGNESIUM ION 14(MG 2+) CRYSTAL STRUCTURE OF THE IN VITRO TRANSCRIBED G. KAUSTOPHILU TRNA GLYCINE RNA RNA-RNA COMPLEX, BASE STACKING, T-LOOP, RNA BINDING, RNA
4mgn nuc 3.20 MAGNESIUM ION 18(MG 2+) CO-CRYSTAL STRUCTURE OF THE G. KAUSTOPHILUS GLYQS T BOX RIBO STEM I IN COMPLEX WITH TRNA TRNA-GLYCINE, GLYQS T BOX RIBOSWITCH RNA RNA-RNA COMPLEX, BASE STACKING, T-LOOP, RNA BINDING, RNA
4mgw nuc 1.93 MAGNESIUM ION MG 2+ COMPARISON OF THE STRUCTURAL AND DYNAMIC EFFECTS OF 5-METHYL AND 5-CHLOROCYTOSINE IN A CPG DINUCLEOTIDE SEQUENCE CLC CONTAINING DICKERSON-DREW DODECAMER DNA DNA DODECAMER, STRUCTURAL STUDY OF DNA, DNA
4mkw nuc 1.22 MAGNESIUM ION MG 2+ COMPARISON OF THE STRUCTURAL AND DYNAMIC EFFECTS OF 5-METHYL AND 5-CHLOROCYTOSINE IN A CPG DINUCLEOTIDE SEQUENCE 5METHYLC DNA DODECAMER DNA MODIFIED DNA DODECAMER, DNA
4nya nuc 2.65 MAGNESIUM ION 15(MG 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (AZIDOMETHYL)-2-METHYLPYRIMIDIN-4-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
4nyb nuc 3.10 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (1,2,3-THIADIAZOL-4-YL)PHENYL)METHANAMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
4nyc nuc 3.15 MAGNESIUM ION 11(MG 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX THIENO[2,3-B]PYRAZIN-7-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
4nyd nuc 2.90 MAGNESIUM ION 6(MG 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX HYPOXANTHINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
4nyg nuc 3.05 MAGNESIUM ION 6(MG 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX THIAMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
4o5w nuc 1.60 MAGNESIUM ION 2(MG 2+) O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA
4o5x nuc 1.60 MAGNESIUM ION MG 2+ O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE. DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA
4oji nuc 2.30 MAGNESIUM ION 5(MG 2+) CRYSTAL STRUCTURE OF TWISTER RIBOZYME RNA (52-MER) RNA PSEUDOKNOT, SELF-CLEAVAGE, RNA
4oqu nuc 3.20 MAGNESIUM ION 5(MG 2+) STRUCTURE OF THE SAM-I/IV RIBOSWITCH (ENV87(DELTAU92)) SAM-I/IV RIBOSWITCH RNA RIBOSWITCH, APTAMER, PSEUDOKNOT, REGULATION, S-ADENOSYLMETHI RNA
4p5j nuc 1.99 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE TRNA-LIKE STRUCTURE FROM TURNIP YEL VIRUS (TYMV), A TRNA MIMICKING RNA TURNIP YELLOW MOSAIC VIRUS MRNA FOR THE COAT PROT CHAIN: A RNA TRNA-MIMIC VIRAL RNA PSEUDOKNOT MULTIFUNCTIONAL, RNA
4p95 nuc 2.50 MAGNESIUM ION 3(MG 2+) SPECIATION OF A GROUP I INTRON INTO A LARIAT CAPPING RIBOZYM (CIRCULARLY PERMUTATED RIBOZYME) RNA (192-MER) RNA CATALYTIC RNA, LARIAT-CAPPING RIBOZYME, BRANCHING REACTION, FOLD, RNA
4p9r nuc 2.70 MAGNESIUM ION 3(MG 2+) SPECIATION OF A GROUP I INTRON INTO A LARIAT CAPPING RIBOZYM ATOM DERIVATIVE) RNA (189-MER) RNA CATALYTIC RNA, LARIAT-CAPPING RIBOZYME, BRANCHING REACTION, FOLD, RNA
4pcj nuc 1.90 MAGNESIUM ION 5(MG 2+) MODIFICATIONS TO TOXIC CUG RNAS INDUCE STRUCTURAL STABILITY MIS-SPLICING IN MYOTONIC DYSTROPHY TRCUG-3('5) RNA PSEUDOU, CUG REPEATS, TETRALOOP RECEPTOR
4pdq nuc 3.00 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH 4'-DEOXY-4'-FLUORO NEOMYCIN ANALOG RNA (5'- *UP*UP*GP*CP*GP*UP*CP*AP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP*U 3') RNA/ANTIBIOTIC RIBOSOME, AMINOGLYCOSIDE, RNA-ANTIBIOTIC COMPLEX
4phy nuc 3.10 MAGNESIUM ION 2(MG 2+) FUNCTIONAL CONSERVATION DESPITE STRUCTURAL DIVERGENCE IN LIG RESPONSIVE RNA SWITCHES RNA (26-MER), RNA (5'- R(*GP*CP*AP*GP*GP*AP*AP*CP*CP*GP*AP*GP*AP*GP*GP*CP*AP*CP*GP CHAIN: B RNA VIRAL GENOME, INTERNAL RIBOSOME ENTRY SITE, TRANSLATION, RNA
4pqv nuc 2.46 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF AN XRN1-RESISTANT RNA FROM THE 3' UNTRA REGION OF A FLAVIVIRUS (MURRAY VALLEY ENCEPHALITIS VIRUS) XRN1-RESISTANT FLAVIVIRAL RNA RNA FLAVIVIRUS, 3' UNTRANSLATED REGION, SFRNA, PSEUDOKNOT, TYPE THREE-WAY JUNCTION, XRN1 RESISTANT RNA, XRRNA), RESISTS DEG EXONUCLEASE XRN1, SMALL FLAVIVIRAL RNA, RNA
4qjd nuc 3.10 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF TWISTER WITH THE NUCLEOTIDE 5'- TO THE SITE DISORDERED AT 3.1 A RESOLUTION TWISTER RNA SEQUENCE, TWISTER RNA SEQUENCE RNA SELF-CLEAVING RIBOZYME, 2' DEOXY SUBSITUTION, NUCLEOTIDE 5 (
4qjh nuc 3.88 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF THE TWISTER RIBOZYME WITH THE NUCLEOTID THE CLEAVAGE SITE ORDERED AT 4.1 A RESOLUTION TWISTER RIBOZYME, TWISTER RIBOZYME RNA SMALL SELF-CLEAVING RIBOZYME, RNA
4qk8 nuc 3.05 MAGNESIUM ION 4(MG 2+) THERMOANAEROBACTER PSEUDETHANOLICUS C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA
4qk9 nuc 3.05 MAGNESIUM ION 11(MG 2+) THERMOVIRGA LIENII C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA
4qka nuc 3.20 MAGNESIUM ION MG 2+ C-DI-AMP RIBOSWITCH FROM THERMOANAEROBACTER PSEUDETHANOLICUS HEXAMINE SOAK C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA
4qlm nuc 2.72 MAGNESIUM ION 2(MG 2+) YDAO RIBOSWITCH BINDING TO C-DI-AMP RNA (108-MER) RNA SECOND MESSAGE MOLECULE, C-DI-AMP BINDING, RNA
4qln nuc 2.65 MAGNESIUM ION 2(MG 2+) STRUCTURE OF YDAO RIBOSWITCH BINDING WITH C-DI-DAMP RNA (117-MER) RNA YDAO RIBOSWITCH, C-DI-AMP, RNA
4r0d nuc 3.68 MAGNESIUM ION 83(MG 2+) CRYSTAL STRUCTURE OF A EUKARYOTIC GROUP II INTRON LARIAT LIGATED EXONS, GROUP IIB INTRON LARIAT RNA LARIAT, RIBOZYME, 2'-5' PHOSPHODIESTER, RNA
4r47 nuc 1.85 MAGNESIUM ION 3(MG 2+) RACEMIC CRYSTAL STRUCTURE OF A BIMOLECULAR DNA G-QUADRUPLEX 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA
4r4d nuc 1.29 MAGNESIUM ION 8(MG 2+) RACEMIC CRYSTAL STRUCTURE OF A MAGNESIUM-BOUND B-DNA DUPLEX 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA
4r4p nuc 3.07 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE VS RIBOZYME-A756G MUTANT VS RIBOZYME RNA RNA NA, DIMER, RNA
4r4v nuc 3.07 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF THE VS RIBOZYME - G638A MUTANT VS RIBOZYME RNA RNA NA, DIMER, RNA
4rge nuc 2.89 MAGNESIUM ION 27(MG 2+) CRYSTAL STRUCTURE OF THE IN-LINE ALIGNED ENV22 TWISTER RIBOZ ENV22 TWISTER RIBOZYME RNA PSEUDOKNOT, STEM, CLEAVAGE, DEOXYURIDINE MONOPHOSPHATE, RNA
4rgf nuc 3.20 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE IN-LINE ALIGNED ENV22 TWISTER RIBOZ WITH MN2+ ENV22 TWISTER RIBOZYME RNA PSEUDOKNOT, STEMS, CLEAVAGE, RNA
4rhd nuc 1.70 MAGNESIUM ION 2(MG 2+) DNA DUPLEX WITH NOVEL ZP BASE PAIR DNA 9MER NOVEL Z NUCLEOBASE, DNA 9MER NOVEL P NUCLEOBASE DNA MODIFIED NUCLEOBASE Z AND P, DNA
4rnk nuc 2.08 MAGNESIUM ION 2(MG 2+) SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGAAAATTTGGAG) GGAAAATTTGGAG DNA 3D DNA LATTICE, DNA
4ro4 nuc 2.04 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGAAACGTTGGAG) D(GGAAACGTTGGAG) DNA DNA, SELF-ASSEMBLING 3D DNA CRYSTAL
4ro7 nuc 2.03 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGAAAGCTTGGAG) D(GGAAAGCTTGGAG) DNA SYNTHETIC SELF-ASSEMBLED DNA CRYSTAL., DNA
4ro8 nuc 2.08 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGAATCGATGGAG) D(GGAATCGATGGAG) DNA SELF ASSEMBLING 3D DNA CRYSTAL, DNA
4rog nuc 2.08 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGACACGTGGGAG) D(GGACACGTGGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4rok nuc 2.16 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGACAGCTGGGAG) D(GGACAGCTGGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4ron nuc 2.39 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGACCATGGGGAG) D(GGACCATGGGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4roo nuc 2.37 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGACCGCGGGGAG) D(GGACCGCGGGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4roy nuc 2.09 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGACGATCGGGAG) D(GGACGATCGGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4roz nuc 2.08 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGACGGCCGGGAG) D(GGACGGCCGGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4rp0 nuc 2.19 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGATAATTAGGAG) D(GGATAATTAGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4rp1 nuc 2.27 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGATACGTAGGAG) D(GGATACGTAGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4rp2 nuc 2.32 MAGNESIUM ION MG 2+ SEQUENCE AND STRUCTURE OF A SELF-ASSEMBLED 3-D DNA CRYSTAL: D(GGATAGCTAGGAG) D(GGATAGCTAGGAG) DNA SELF-ASSEMBLING 3D DNA CRYSTAL, DNA
4rum nuc 2.64 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF THE NICO TRANSITION-METAL RIBOSWITCH BO COBALT NICO RIBOSWITCH RNA RNA RNA HELIX, LIGAND SENSOR, COBALT AND NICKEL BINDING, RNA, RI
4tna nuc 2.50 MAGNESIUM ION 4(MG 2+) FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
4tra nuc 3.00 MAGNESIUM ION 4(MG 2+) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
4ts2 nuc 2.88 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH MAGNESIUM IONS SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT, SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA
4tzx nuc 2.01 MAGNESIUM ION 9(MG 2+) VIBRIO VULNIFICUS ADENINE RIBOSWITCH VARIANT, GROWN IN MG2+ VIBRIO VULNIFICUS ADENINE RIBOSWITCH RNA RIBOSWITCH, ADENINE, RNA, GENE REGULATION
4tzy nuc 2.57 MAGNESIUM ION 2(MG 2+) VIBRIO VULNIFICUS ADENINE RIBOSWITCH VARIANT, GROWN IN BOTH MG2+ VIBRIO VULNIFICUS ADENINE RIBOSWITCH RNA RNA, RIBOSWITCH, GENE REGULATION, ADENINE
4u5m nuc 1.50 MAGNESIUM ION MG 2+ STRUCTURE OF A LEFT-HANDED DNA G-QUADRUPLEX DNA (28-MER) DNA DNA, QUADRUPLEX
4u8a nuc 1.48 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(CGCGAATTCGCG)2 COMPLEXED WITH BPH-150 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA/ANTIBIOTIC ANTIBACTERIAL AGENTS, BISAMIDINES, MINOR GROOVE BINDERS, MOD MOLECULAR, NUCLEIC ACID CONFORMATION, OLIGODEOXYRIBONUCLEOT
4u8b nuc 1.31 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(CGCGAATTCGCG)2 COMPLEXED WITH BPH-135 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA/ANTIBIOTIC ANTIBACTERIAL AGENTS, BISAMIDINES, MINOR GROOVE BINDERS, MOD MOLECULAR, NUCLEIC ACID CONFORMATION, OLIGODEOXYRIBONUCLEOT DNA-ANTIBIOTIC COMPLEX
4u8c nuc 1.24 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF D(CGCGAATTCGCG)2 COMPLEXED WITH BPH-140 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA/ANTIBIOTIC ANTIBACTERIAL AGENTS, BISAMIDINES, MINOR GROOVE BINDERS, MOD MOLECULAR, NUCLEIC ACID CONFORMATION, OLIGODEOXYRIBONUCLEOT
4u92 nuc 1.50 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF A DNA/BA2+ G-QUADRUPLEX CONTAINING A WA MEDIATED C-TETRAD DNA (5'-D(*CP*CP*AP*KP*GP*CP*GP*TP*GP*G)-3') DNA DNA QUADRUPLEX BARIUM C-TETRAD, DNA
4wfl nuc 2.49 MAGNESIUM ION 3(MG 2+) STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN RNA: RESIDUES 3-81,RESIDUES 3-81 RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST
4wfm nuc 3.10 MAGNESIUM ION MG 2+ STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN BACILLUS SUBTILIS SMALL CYTOPLASMIC RNA (SCRNA),R CHAIN: A, B RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST
4wkj nuc 2.80 MAGNESIUM ION MG 2+ CRYSTALLOGRAPHIC STRUCTURE OF A DODECAMERIC RNA-DNA HYBRID DNA (5'-D(*GP*AP*AP*TP*CP*AP*GP*GP*TP*GP*TP*C)-3' CHAIN: E, B, F, H, RNA (5'-R(*GP*AP*CP*AP*CP*CP*UP*GP*AP*UP*UP*C)-3' CHAIN: D, A, C, G RNA/DNA RNA, DNA, HYBRID, DUPLEX, RNA-DNA COMPLEX
4xnr nuc 2.21 MAGNESIUM ION 6(MG 2+) VIBRIO VULNIFICUS ADENINE RIBOSWITCH APTAMER DOMAIN, SYNTHES POSITION-SELECTIVE LABELING OF RNA (PLOR), IN COMPLEX WITH VIBRIO VULNIFICUS ADENINE RIBOSWITCH RNA RNA, RIBOSWITCH
4xw7 nuc 2.50 MAGNESIUM ION 13(MG 2+) CRYSTAL STRUCTURE OF THE ZMP RIBOSWITCH AT 2.50 ANGSTROM PFL RNA RNA RNA, RIBOSWITCH, ZMP, AICAR
4xwf nuc 1.80 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF THE ZMP RIBOSWITCH AT 1.80 ANGSTROM PFL RNA RNA RNA, RIBOSWITCH, ZMP, AICAR
4y1i nuc 2.85 MAGNESIUM ION 25(MG 2+) LACTOCOCCUS LACTIS YYBP-YKOY MN RIBOSWITCH BOUND TO MN2+ LACTOCOCCUS LACTIS YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE-BINDING, RNA
4y1j nuc 2.24 MAGNESIUM ION 24(MG 2+) LACTOCOCCUS LACTIS YYBP-YKOY MN RIBOSWITCH A41U BINDING SITE PRESENCE OF MN2+ YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE-BINDING, MUTANT, RNA
4y1m nuc 3.00 MAGNESIUM ION 9(MG 2+) AN ESCHERICHIA COLI YYBP-YKOY MN RIBOSWITCH IN THE MN2+-FREE E. COLI YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE, FREE STATE, RNA
4y1n nuc 3.00 MAGNESIUM ION 8(MG 2+) OCEANOBACILLUS IHEYENSIS GROUP II INTRON DOMAIN 1 WITH IRIDI HEXAMINE GROUP II INTRON, DOMAIN 1 RNA, TRANSFERASE GROUP II INTRON, DOMAIN 1, RNA, IRIDIUM HEXAMINE, TRANSFERAS
4y1o nuc 2.95 MAGNESIUM ION 19(MG 2+) OCEANOBACILLUS IHEYENSIS GROUP II INTRON DOMAIN 1 GROUP II INTRON, DOMAIN 1 RNA, TRANSFERASE GROUP II INTRON, DOMAIN 1, RNA, TRANSFERASE
4yaz nuc 2.00 MAGNESIUM ION 5(MG 2+) 3',3'-CGAMP RIBOSWITCH BOUND WITH 3',3'-CGAMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP,
4yb0 nuc 2.12 MAGNESIUM ION 5(MG 2+) 3',3'-CGAMP RIBOSWITCH BOUND WITH C-DI-GMP RNA (84-MER) RNA RIBOSWITCH, 3', 3'-CGAMP, SPINACH, RNA STRUCTURE, C-DI-GMP,
4z4b nuc 1.97 MAGNESIUM ION MG 2+ 2-PYRIDYL HOECHST - A NEW GENERATION DNA-BINDING RADIOPROTEC DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)-3' CHAIN: A, B DNA DNA, HOECHST
4znp nuc 2.94 MAGNESIUM ION 3(MG 2+) THE STRUCTURE OF A PFI RIBOSWITCH BOUND TO ZMP PFI RIBOSWITCH RNA ZMP, RIBOSWITCH, RNA, ONE CARBON MECHANISM, AICAR, ZTP, COMP
4zym nuc 2.53 MAGNESIUM ION 4(MG 2+) STRUCTURAL IMPLICATIONS OF HOMO-PYRIMIDINE BASE PAIRS ON THE STRANDED D(GAY) MOTIF. DNA (5'-D(*AP*CP*TP*CP*GP*GP*AP*CP*GP*AP*T)-3') DNA TETRAPLEX, HOMO-BASE PAIR, PYRIMIDINE SUBSTITUTION., DNA
5ana nuc 2.25 MAGNESIUM ION MG 2+ THE CRYSTAL STRUCTURE OF D(GTACGTAC) AT 2.25 ANGSTROMS RESOLUTION. ARE THE A-DNA'S ALWAYS UNWOUND APPROXIMATELY 10 DEGREES AT THE C-G STEPS DNA (5'-D(*GP*TP*AP*CP*GP*TP*AP*C)-3') DNA A-DNA, DOUBLE HELIX
5btm nuc 2.78 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF AUUCU REPEATING RNA THAT CAUSES SPINOCE ATAXIA TYPE 10 (SCA10) RNA (55-MER) RNA NUCLEIC ACIDS, RNA STRUCTURE, REPEAT EXPANSION DISORDER, GEN DISEASE, RNA
5btp nuc 2.82 MAGNESIUM ION 12(MG 2+) FUSOBACTERIUM ULCERANS ZTP RIBOSWITCH BOUND TO ZMP RNA (62-MER) RNA RNA
5bxw nuc 2.15 MAGNESIUM ION 2(MG 2+) X-RAY CRYSTAL STRUCTURE OF A CONTINUOUSLY HYDROGEN BONDED 14 LATTICE. DNA (5'-D(*GP*GP*AP*AP*AP*GP*CP*TP*TP*GP*GP*AP*GP CHAIN: A DNA 3D DNA LATTICE, 14MER DNA, SELF ASSEMBLY, DNA
5bz7 nuc 2.03 MAGNESIUM ION 2(MG 2+) X-RAY CRYSTAL STRUCTURE OF A CONTINUOUSLY HYDROGEN BONDED 14 LATTICE. DNA (5'-D(*GP*GP*AP*AP*AP*AP*TP*TP*TP*GP*GP*AP*GP CHAIN: A DNA 3D DNA LATTICE, 14MER DNA, SELF ASSEMBLY, DNA
5bz9 nuc 2.10 MAGNESIUM ION 2(MG 2+) X-RAY CRYSTAL STRUCTURE OF A CONTINUOUSLY HYDROGEN BONDED 14 LATTICE. DNA (5'-D(GGAAACGTTGGAGA) DNA SELF-ASSEMBLY, DNA CRYSTAL STRUCTURE, NON-CANONICAL BASE PAI
5bzy nuc 2.40 MAGNESIUM ION 2(MG 2+) X-RAY CRYSTAL STRUCTURE OF A CONTINUOUSLY HYDROGEN BONDED 14 LATTICE. DNA (5'-D(*GP*GP*AP*AP*AP*TP*AP*TP*TP*GP*GP*AP*GP CHAIN: A DNA DNA CRYSTAL STRUCTURE, SELF-ASSEMBLY, NON-CANONICAL BASE PAI
5c45 nuc 2.93 MAGNESIUM ION 2(MG 2+) SELECTIVE SMALL MOLECULE INHIBITION OF THE FMN RIBOSWITCH FMN RIBOSWITCH, FMN RIBOSWITCH RNA/INHIBITOR RNA, TRANSLATION, RNA-INHIBITOR COMPLEX
5cjy nuc 1.55 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A B-FORM DNA DUPLEX CONTAINING 5- HYDROXYLMETHYLCYTIDINE DNA (5'-D(*CP*GP*(5HC)P*GP*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DNA DUPLEX, B-FORM, 5-HYDROXYLMETHYLCYTIDINE, DNA
5cki nuc 2.99 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF 9DB1* DEOXYRIBOZYME (COBALT HEXAMMINE S CRYSTALS) DNA (44-MER), RNA (5'-R(P*GP*CP*AP*CP*UP*AP*GP*AP*UP*CP*GP*GP*A 3') DNA DEOXYRIBOZYME, RNA-LIGASE, CATALYTIC DNA, DNA
5ckk nuc 2.80 MAGNESIUM ION 3(MG 2+) CRYSTAL STRUCTURE OF 9DB1* DEOXYRIBOZYME RNA (5'-R(P*GP*CP*AP*CP*UP*AP*GP*AP*UP*CP*GP*GP*A 3'), DNA (44-MER) LIGASE DEOXYRIBOZYME, RNA-LIGASE, CATALYTIC DNA, LIGASE
5d5l nuc 2.50 MAGNESIUM ION 15(MG 2+) PREQ1-II RIBOSWITCH WITH AN ENGINEERED G-U WOBBLE PAIR BOUND PREQ1-II RIBOSWITCH RNA GU WOBBLE, PSEUDOKNOT, SHINE-DALGARNO SEQUENCE, RNA
5dam nuc 1.95 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF P-IODOHOECHST BOUND TO D(CGCAAATTTGCG) DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)-3' CHAIN: A, B DNA MINOR GROOVE BINDER DNA, DNA
5dh6 nuc 2.78 MAGNESIUM ION 5(MG 2+) TWO DIVALENT METAL IONS AND CONFORMATIONAL CHANGES PLAY ROLE HAMMERHEAD RIBOZYME CLEAVAGE REACTION-G12A MUTANT IN MG2+ HAMMERHEAD RIBOZYME, 5'-R(*GP*GP*GP*CP*GP*U)-D(P*C)- R(P*UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3' RNA RIBOZYME, HAMMERHEAD, RNA
5dhc nuc 1.55 MAGNESIUM ION 15(MG 2+) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA, MONOMER, COOPERATIVITY
5dnb nuc 1.40 MAGNESIUM ION 4(MG 2+) STRUCTURE OF THE B-DNA DECAMER C-C-A-A-C-G-T-T-G-G AND COMPA ISOMORPHOUS DECAMERS C-C-A-A-G-A-T-T-G-G AND C-C-A-G-G-C-C- DNA (5'-D(*CP*CP*AP*AP*CP*GP*TP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX, DNA
5dqk nuc 2.71 MAGNESIUM ION MG 2+ TWO DIVALENT METAL IONS AND CONFORMATIONAL CHANGES PLAY ROLE HAMMERHEAD RIBOZYME CLEAVAGE REACTION-WT RIBOZYME IN MG2+ RNA (5'-R(*GP*GP*GP*CP*GP*U)-D(P*C)- R(P*UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3'), RNA (48-MER) RNA RIBOZYME, HAMMERHEAD, RNA
5dun nuc 2.64 MAGNESIUM ION 8(MG 2+) THE CRYSTAL STRUCTURE OF OME SUBSTITUTED TWISTER RIBOZYME RNA (54-MER) RNA OME, TWISTER, RNA, RIBOZYME
5e36 nuc 1.60 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF 2'-PROPARGYL-MODIFIED DNA 8MER-DUPLEX DNA (5'-D(*GP*(OMU)P*GP*TP*(5JO)P*CP*AP*C)-3') DNA MODIFIED DNA, 2'-PROPARGYL, DNA
5e54 nuc 2.30 MAGNESIUM ION 4(MG 2+) TWO APO STRUCTURES OF THE ADENINE RIBOSWITCH APTAMER DOMAIN USING AN X-RAY FREE ELECTRON LASER VIBRIO VULNIFICUS STRAIN 93U204 CHROMOSOME II, AD RIBOSWITCH APTAMER DOMAIN RNA ADENINE RIBOSWITCH, PURINE RIBOSWITCH, APO, LIGAND-FREE, RNA REGULATION, X-RAY FREE ELECTRON LASER
5eao nuc 2.99 MAGNESIUM ION 8(MG 2+) TWO ACTIVE SITE DIVALENT ION IN THE CRYSTAL STRUCTURE OF THE HAMMERHEAD RIBOZYME BOUND TO A TRANSITION STATE ANALOG-MG2+ RNA (5'-R(*GP*GP*GP*CP*GP*U*(CVC) *UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3'), RNA (48-MER) RNA RIBOZYME, HAMMERHEAD, RNA
5ew4 nuc 1.47 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF C9ORF72 ANTISENSE CCCCGG REPEAT RNA ASS WITH LOU GEHRIG'S DISEASE AND FRONTOTEMPORAL DEMENTIA, CRYS WITH SR2+ RNA (5'- R(*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP 3') RNA REPEAT EXPANSION DISORDER, GENETIC DISEASE, RNA
5ew7 nuc 1.75 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF C9ORF72 ANTISENSE CCCCGG REPEAT RNA ASS WITH LOU GEHRIG'S DISEASE AND FRONTOTEMPORAL DEMENTIA, CRYS WITH BA2+ RNA (5'- R(*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP 3') RNA REPEAT EXPANSION DISORDER, GENETIC DISEASE, RNA
5fj0 nuc 2.20 MAGNESIUM ION 3(MG 2+) STRUCTURE OF THE STANDARD KINK TURN HMKT-7 AS SIMPLE DUPLEX IN P4222 SPACE GROUP HMKT-7: KINK TURN MOTIF, RESIDUES 1-19 RNA RNA, KINK TURN, RNA MOTIF
5fj1 nuc 2.75 MAGNESIUM ION 21(MG 2+) STRUCTURE OF THE STANDARD KINK TURN HMKT-7 AS STEM LOOP IN P212121 SPACE GROUP HMKT-7: KINK TURN MOTIF, RESIDUES 1-24 RNA RNA, KINK TURN, RNA MOTIF
5fjc nuc 1.71 MAGNESIUM ION 2(MG 2+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT C- SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
5hby nuc 1.18 MAGNESIUM ION MG 2+ RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA
5j01 nuc 3.39 MAGNESIUM ION 42(MG 2+) STRUCTURE OF THE LARIAT FORM OF A CHIMERIC DERIVATIVE OF THE OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE PRESENCE OF MG2+. GROUP II INTRON LARIAT RNA GROUP II INTRON, LARIAT, 2'-5' PHOSPHODIESTER BOND, RIBOZYME CATALYSIS, SELF-SPLICING, RNA
5j02 nuc 3.49 MAGNESIUM ION 50(MG 2+) STRUCTURE OF THE LARIAT FORM OF A CHIMERIC DERIVATIVE OF THE OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE PRESENCE OF MG2+ AND AN INACTIVE 5' EXON. GROUP II INTRON LARIAT, 5' EXON ANALOG (5'-R(*CP*UP*GP*UP*UP*AP*(5MU))-3' CHAIN: B RNA GROUP II INTRON, LARIAT, 2'-5' PHOSPHODIESTER BOND, RIBOZYME CATALYSIS, SELF-SPLICING, RNA
5ju4 nuc 2.00 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF A DNA SEQUENCE D(CGTGAATTCACG) AT 130K DNA (5'-D(*CP*GP*TP*GP*AP*AP*TP*TP*CP*AP*CP*G)-3' CHAIN: A, B DNA DNA
5jzq nuc 0.78 MAGNESIUM ION 3(MG 2+) ULTRAHIGH-RESOLUTION CENTROSYMMETRIC CRYSTAL STRUCTURE OF Z- REVEALS MASSIVE PRESENCE OF MULTIPLE CONFORMATIONS DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA DUPLEX, SELF-COMPLEMENTARY DUPLEX, CENTROSYMMETRIC SPA DNA ENANTIOMER; RACEMATE, L-RIBOSE NUCLEIC ACID; DISORDER; MACROMOLECULAR PHASE PROBLEM, AB INITIO METHODS, DUAL-SPACE DNA
5k7c nuc 2.73 MAGNESIUM ION 3(MG 2+) THE NATIVE STRUCTURE OF NATIVE PISTOL RIBOZYME RNA 47-MER, DNA/RNA 11-MER RNA/DNA RIBOZYME, RNA STRUCTURE, PISTOL, RNA-DNA COMPLEX
5k7d nuc 2.68 MAGNESIUM ION 5(MG 2+) THE STRUCTURE OF NATIVE PISTOL RIBOZYME, BOUND TO IRIDIUM RNA 47-MER, DNA/RNA 11-MER RNA/DNA RIBOZYME, RNA STRUCTURE, PISTOL, RNA-DNA COMPLEX
5kpy nuc 2.00 MAGNESIUM ION 6(MG 2+) STRUCTURE OF A 5-HYDROXYTRYPTOPHAN APTAMER 5-HYDROXYTRYPTOPHAN RNA APTAMER RNA RNA, APTAMER, RIBOSWITCH, 5-HYDROXYTRYPTOPHAN
5ktj nuc 2.97 MAGNESIUM ION 19(MG 2+) CRYSTAL STRUCTURE OF PISTOL, A CLASS OF SELF-CLEAVING RIBOZY RNA (5'-R(*UP*CP*UP*GP*CP*UP*CP*UP*CP*GP*UP*CP*CP 3'), PISTOL (50-MER) RNA RIBOZYME, SELF-CLEAVAGE, INTERNAL TRANSESTERIFICATION, RNA
5kx9 nuc 2.90 MAGNESIUM ION 4(MG 2+) SELECTIVE SMALL MOLECULE INHIBITION OF THE FMN RIBOSWITCH FMN RIBOSWITCH, FMN RIBOSWITCH RNA/INHIBITOR RNA, TRANSLATION, RNA-INHIBITOR COMPLEX
5l00 nuc 1.25 MAGNESIUM ION 4(MG 2+) SELF-COMPLIMENTARY RNA 15MER BINDING WITH GMP MONOMERS RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA
5lys nuc 2.32 MAGNESIUM ION MG 2+ THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - GOLD DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
5lyu nuc 2.20 MAGNESIUM ION MG 2+ THE NATIVE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN RNA (58-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
5lyv nuc 2.35 MAGNESIUM ION MG 2+ THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - OSMIUM DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
5mvl nuc 1.41 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF AN A-DNA DODECAMER CONTAINING 5-BROMOUR BROMINATED DNA DODECAMER DNA A-DNA, 5-BROMOURACIL, CPG, DNA
5mvq nuc 1.60 MAGNESIUM ION 2(MG 2+) CRYSTAL STRUCTURE OF AN UNMODIFIED, SELF-COMPLEMENTARY DODEC DNA DNA A-DNA, UNMODIFIED, SELF-COMPLEMENTARY, DNA
5ndh nuc 1.81 MAGNESIUM ION MG 2+ THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P2 RNA (5'-R(*GP*(CBV) P*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*GP*C)-3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA
5swd nuc 2.50 MAGNESIUM ION 3(MG 2+) STRUCTURE OF THE ADENINE RIBOSWITCH APTAMER DOMAIN IN AN INT BOUND STATE VIBRIO VULNIFICUS STRAIN 93U204 CHROMOSOME II, AD RIBOSWITCH APTAMER DOMAIN RNA ADENINE RIBOSWITCH, PURINE RIBOSWITCH, LIGAND MIXING, INTERM STATE, RNA, GENE REGULATION, X-RAY FREE ELECTRON LASER
5t5a nuc 2.00 MAGNESIUM ION 9(MG 2+) CRYSTAL STRUCTURE OF THE TWISTER SISTER (TS) RIBOZYME AT 2.0 DNA/RNA (71-MER) RNA RNA JUNCTION CATALYSIS, RNA
5t83 nuc 2.71 MAGNESIUM ION 2(MG 2+) STRUCTURE OF A GUANIDINE-I RIBOSWITCH FROM S. ACIDOPHILUS RNA (95-MER) RNA RIBOSWITCH, GUANIDINE, S-TURN, A-MINOR, RNA
5tpy nuc 2.81 MAGNESIUM ION MG 2+ CRYSTAL STRUCTURE OF AN EXONUCLEASE RESISTANT RNA FROM ZIKA RNA (71-MER) RNA ZIKA RNA EXONUCLEASE RESISTANCE, RNA
5u3g nuc 2.30 MAGNESIUM ION 24(MG 2+) STRUCTURE OF THE DICKEYA DADANTII YKKC RIBOSWITCH BOUND TO G YKKC RIBOSWITCH RNA RIBOSWITCH, YKKC, GUANIDINE, GUANIDINIUM, RNA
5une nuc 2.90 MAGNESIUM ION 2(MG 2+) DIMERIZED STRUCTURE GIVES FURTHER INSIGHT INTO THE FUNCTION NOVEL RNA GENE: HAR1 RNA (47-MER) RNA HAR1 RNA, RNA GENE, RNA
5v0h nuc 1.90 MAGNESIUM ION 2(MG 2+) RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-ONE BINDING SITE RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA, ANALOGUE
5v0j nuc 1.50 MAGNESIUM ION MG 2+ RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA
5v0k nuc 1.60 MAGNESIUM ION MG 2+ RNA DUPLEX WITH 2-MEIMPG ANALOGUE BOUND-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA
6tna nuc 2.70 MAGNESIUM ION 4(MG 2+) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
8bna nuc 2.20 MAGNESIUM ION MG 2+ BINDING OF HOECHST 33258 TO THE MINOR GROOVE OF B-DNA DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA
Code Class Resolution Description 229d nuc NMR 2'-DEOXY-1-METHYLGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P DNA ANALOG OF YEAST TRANSFER RNA PHE ANTICODON DOMAIN WITH MODIFIED BASES 5-METHYL CYTOSINE AND 1-METHYL GUANINE DNA (5'-D(*CP*CP*AP*GP*AP*CP*(UMP) P*GP*AP*AP*(MG1)P*AP*(UMP)P*(5CM)P*(UMP)P*GP*G)-3') DNA DNA, TRANSFER RNA, ANTICODON, HAIRPIN LOOP
Code Class Resolution Description 1q8n nuc NMR MALACHITE GREEN C23 H25 N2 1+ SOLUTION STRUCTURE OF THE MALACHITE GREEN RNA BINDING APTAMER RNA APTAMER RNA RNA APTAMER, MALACHITE GREEN, BASE TRIPLE, BASE QUADRUPLE, RNA LIGAND INTERACTIONS
Code Class Resolution Description 5nep nuc 1.60 1-METHYLGUANIDINE C2 H7 N3 THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH METHYLGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, METHYLGUANIDINE, RNA
Code Class Resolution Description 3bbv nuc 10.00 2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE C16 H26 N5 O7 P S THE TRNA(PHE) FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF 50S.NC-TRNA.HSP15 COMPLEX TRNA(PHE) RIBOSOME PHE, TRNA, RESCUE STALLED RIBOSOME, RIBOSOME
Code Class Resolution Description
2kgp nuc NMR 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL) AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE C22 H28 N4 O6 STRUCTURAL BASIS FOR STABILIZATION OF THE TAU PRE-MRNA SPLIC REGULATORY ELEMENT BY NOVANTRONE (MITOXANTRONE) RNA (25-MER) RNA TAU PRE-MRNA, SPLICING REGULATORY ELEMENT, MITOXANTRONE, NOV RNA-SMALL MOLECULE, TAUOPATHIES, RNA
Code Class Resolution Description 2jwq nuc NMR N,N'-(DIBENZO[B,J][1,7]PHENANTHROLINE-2,10- DIYLDIMETHANEDIYL)DIPROPAN-1-AMINE 2(C28 H30 N4) G-QUADRUPLEX RECOGNITION BY QUINACRIDINES: A SAR, NMR AND BIOLOGICAL STUDY DNA (5'-D(*DTP*DTP*DAP*DGP*DGP*DGP*DT)-3') DNA G-QUADRUPLEX, QUINACRIDINE, TELOMERASE INHIBITORS, DNA
Code Class Resolution Description 2lho nuc NMR (1R)-1,4-ANHYDRO-2-DEOXY-1-(2-METHOXY-4-METHYLPHENYL)- 5-O-PHOSPHONO-D-ERYTHRO-PENTITOL C13 H19 O7 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING AN UNNATURAL, HYDROPHOBIC BASE PAIR DNA (5'-D(*CP*GP*TP*TP*TP*CP*(LHO)P*TP*TP*CP*TP*C CHAIN: A, DNA (5'-D(*GP*AP*GP*AP*AP*(MM7)P*GP*AP*AP*AP*CP*G CHAIN: B DNA DNA, UNNATURAL BASE PAIR
Code Class Resolution Description 4fxm nuc 1.65 N-METHYLMESOPORPHYRIN C35 H40 N4 O4 CRYSTAL STRUCTURE OF THE COMPLEX OF A HUMAN TELOMERIC REPEAT QUADRUPLEX AND N-METHYL MESOPORPHYRIN IX (P21212) DNA (5'- D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP 3') DNA PARALLEL QUADRUPLEX, N-METHYL MESOPORPHYRIN IX, DNA 4g0f nuc 2.15 N-METHYLMESOPORPHYRIN C35 H40 N4 O4 CRYSTAL STRUCTURE OF THE COMPLEX OF A HUMAN TELOMERIC REPEAT QUADRUPLEX AND N-METHYL MESOPORPHYRIN IX (P6) DNA (5'- D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP 3') DNA QUADRUPLEX, N-METHYL MESOPORPHYRIN IX, DNA
Code Class Resolution Description 1cx5 nuc NMR 5'-O-(DIMETHYLAMINO)-THYMIDINE C12 H19 N3 O5 ANTISENSE DNA/RNA HYBRID CONTAINING MODIFIED BACKBONE 5'-R(*GP*CP*GP*CP*AP*AP*AP*AP*CP*GP*CP*G), 5'-D(*CP*GP*CP*GP*TP*T*(MMT)P*TP*GP*CP*GP*C) DNA-RNA HYBRID ANTISENSE, DNA/RNA HYBRID, NMR, MODIFIED BACKBONE LINKER, DNA-RNA HYBRID
Code Class Resolution Description 1ehz nuc 1.93 MANGANESE (II) ION 3(MN 2+) THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1qdg nuc model MANGANESE (II) ION 2(MN 2+) DNA QUADRUPLEX STRUCTURE, APTAMER (15MER) DNA, THEORETICAL MODEL DNA APTAMER (15MER, D(GGTTGGTGTGGTTGG)) TELOMERE DNA QUDRAPLEX DNA, THROMBIN INHIBITOR, MN BINDING DNA, TELOMERE DNA 1qdh nuc NMR MANGANESE (II) ION 2(MN 2+) THE NMR STUDY OF DNA QUADRUPLEX STRUCTURE, APTAMER (15MER) DNA DNA (5'- D(*GP*GP*TP*TP*GP*GP*TP*GP*TP*GP*GP*TP*TP*GP*G)-3') DNA QUDRAPLEX DNA, THROMBIN INHIBITOR, MN BINDING DNA, TELOMERE DNA 1qdj nuc model MANGANESE (II) ION 2(MN 2+) DNA QUADRUPLEX STRUCTURE, (12MER) DNA, THEORETICAL MODEL DNA (12MER, D(GGGGTTTTGGG)) TELOMERE DNA DUPLEX QUDRAPLEX DNA, MN BINDING DNA, NON-THROMBIN INHIBITOR, TELOMERE DNA DUPLEX 1qdk nuc NMR MANGANESE (II) ION 2(MN 2+) THE NMR STUDY OF DNA QUADRUPLEX STRUCTURE, (12MER) DNA DNA (5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)- 3') DNA QUDRAPLEX DNA, MN BINDING DNA, NON-THROMBIN INHIBITOR, TELOMERE DNA DUPLEX 1y3o nuc 2.70 MANGANESE (II) ION 4(MN 2+) HIV-1 DIS RNA SUBTYPE F- MN SOAKED 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1y90 nuc 3.08 MANGANESE (II) ION 12(MN 2+) HIV-1 DIS(MAL) DUPLEX MN-SOAKED 5'-R(*CP*(5BU) P*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP* AP*G)-3' RNA HIV-1, RNA, METAL IONS, BULGE 1yn2 nuc NMR MANGANESE (II) ION 4(MN 2+) SOLUTION STRUCTURE OF THE NEUROSPORA VS RIBOZYME STEM-LOOP V IN THE PRESENCE OF MGCL2 WITH MODELING OF BOUND MANGANESE IONS VS RIBOZYME STEM-LOOP V: SL5 RNA U-TURN; HAIRPIN; MAGNESIUM IONS; MANGANESE IONS; PARAMAGNETIC, RNA 283d nuc 2.30 MANGANESE (II) ION MN 2+ A CURVED RNA HELIX INCORPORATING AN INTERNAL LOOP WITH G-A AND A-A NON-WATSON-CRICK BASE PAIRING RNA (5'-R(*GP*GP*CP*CP*GP*AP*AP*AP*GP*GP*CP*C)- 3') RNA UNUSUAL RNA, DOUBLE HELIX, CURVED, INTERNAL LOOP, MISMATCHED 2a2t nuc 3.10 MANGANESE (II) ION 6(MN 2+) CRYSTAL STRUCTURE OF D(AAATATTT) 5'-D(*AP*AP*AP*TP*AP*TP*TP*T)-3' DNA AT, MN, CACODYLATE, HASO, DNA 2hoj nuc 2.50 MANGANESE (II) ION 12(MN 2+) CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, MANGANESE IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 2i7z nuc NMR MANGANESE (II) ION 10(MN 2+) GAAA TETRALOOP RECEPTOR COMPLEX WITH ASSOCIATED MANGANESE IO 43-MER RIBONUCLEIC ACID GAAA TETRALOOP, 11-NUCLEOTIDE RECEPTOR, RNA TERTIARY STRUCTU RIBONUCLEIC ACID 2nok nuc 3.00 MANGANESE (II) ION 5(MN 2+) CRYSTAL STRUCTURE OF AN RNA DOMAIN FROM HEPATITIS C VIRUS. 5'- R(*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*UP*CP*UP*UP*CP *AP*CP*GP*CP*C)-3', 5'- R(*GP*CP*GP*UP*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*UP*CP*CP*GP *G)-3' RNA MG BINDING SITE, BENT RNA 2oeu nuc 2.00 MANGANESE (II) ION 5(MN 2+) FULL-LENGTH HAMMERHEAD RIBOZYME WITH MN(II) BOUND HAMMERHEAD RIBOZYME, 5'-R(*GP*GP*CP*GP*UP*(OMC)P*CP*UP*GP*GP*(5BU) P*AP*UP*CP*CP*AP*AP*UP*CP*(DC))-3' RNA RIBOZYME, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, MANGANESE, MN 2oj0 nuc 2.60 MANGANESE (II) ION 3(MN 2+) CRYSTAL STRUCTURE OF THE DUPLEX FORM OF THE HIV-1(LAI) RNA DIMERIZATION INITIATION SITE MN SOAKED 5'-R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*C *GP*CP*AP*AP*G)-3' RNA HIV-1, DIS, RNA, DIMERIZATION, METAL IONS 2r21 nuc 1.59 MANGANESE (II) ION MN 2+ STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.6 A (BRMN) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA MANGANESE, ASYMMETRY, ELECROSTATIC, MNOVALENT, RNA 2r22 nuc 1.40 MANGANESE (II) ION MN 2+ STRUCTURE OF THE NATIVE RNA TRIDECAMER R(GCGUUUGAAACGC) AT 1.5 A (NATMN) RNA (5'- R(*GP*CP*GP*UP*UP*UP*GP*AP*AP*AP*CP*GP*C)-3') RNA MONOVALENT, ELECTROSTATIC, ASYMMETRY, MANGANESE, RNA 300d nuc 3.00 MANGANESE (II) ION 6(MN 2+) CAPTURING THE STRUCTURE OF A CATALYTIC RNA INTERMEDIATE: RNA HAMMERHEAD RIBOZYME, MN(II)-SOAKED RNA HAMMERHEAD RIBOZYME, RNA HAMMERHEAD RIBOZYME RIBOZYME RNA HAMMERHEAD RIBOZYME, CATALYTIC RNA, LOOP 3diy nuc 2.71 MANGANESE (II) ION 2(MN 2+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, MN2+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3eil nuc 2.60 MANGANESE (II) ION 7(MN 2+) STRUCTURE OF B-DNA D(CGTTAATTAACG)2 IN THE PRESENCE OF MANGANESE 5'- D(*DCP*DGP*DTP*DTP*DAP*DAP*DTP*DTP*DAP*DAP*DCP*DG)-3' DNA B-DNA, MANGANESE 3f2y nuc 3.20 MANGANESE (II) ION 4(MN 2+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, MN2+ S FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, MANGANESE, RNA 3fq5 nuc 2.80 MANGANESE (II) ION 2(MN 2+) CRYSTAL STRUCTURE OF D(CACGCG).D(CGCGTG) WITH 10MM MNCL2 5'-D(*CP*GP*CP*GP*TP*G)-3', 5'-D(*CP*AP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DNA 3g2r nuc 2.15 MANGANESE (II) ION MN 2+ CRYSTAL STRUCTURE OF D(CACGCG).D(CGCGTG) COCRYSTALLIZED WITH MNCL2 5'-D(*CP*GP*TP*GP*CP*G)-3' DNA DUPLEX Z-FORM DNA WITH WATSON-CRICK BASE PAIRING 3gx6 nuc 2.80 MANGANESE (II) ION 5(MN 2+) CRYSTAL STRUCTURE OF THE T. TENGCONGENSIS SAM-I RIBOSWITCH VARIANT U34C/A94G BOUND WITH SAM IN MANGANESE CHLORIDE RNA (94-MER) RNA KINK-TURN, FOUR-WAY JUNCTION, PSEUDOKNOT, RIBOSWITCH, RNA 3oxe nuc 2.90 MANGANESE (II) ION 32(MN 2+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, MN2+ SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 3pdr nuc 1.85 MANGANESE (II) ION 25(MN 2+) CRYSTAL STRUCTURE OF MANGANESE BOUND M-BOX RNA M-BOX RIBOSWITCH RNA RNA MANGANESE-RNA COMPLEX, RNA 3skt nuc 3.10 MANGANESE (II) ION 10(MN 2+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, MANGANESE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY-GUANOSINE, RNA 3v9d nuc 2.50 MANGANESE (II) ION MN 2+ CRYSTAL STRUCTURE OF THE TETRA-DECANUCLEOTIDE D(CCCCGGTACCGG A-DNA DUPLEX DNA (5'-D(*CP*CP*CP*CP*GP*GP*TP*AP*CP*CP*GP*GP*GP CHAIN: A, B DNA TETRA-DECANUCLEOTIDE, A-DNA DUPLEX, CRYSTAL PACKING, A-TYPE HELIX, DNA 3vrs nuc 2.60 MANGANESE (II) ION 9(MN 2+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, SOAKED IN MN2+ FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA 4dwy nuc 1.61 MANGANESE (II) ION 2(MN 2+) INTERACTIONS OF MN2+ WITH A NON-SELF-COMPLEMENTARY Z-TYPE DN DNA (5'-D(*CP*GP*CP*GP*TP*G)-3'), DNA (5'-D(*CP*AP*CP*GP*CP*G)-3') DNA Z-TYPE DNA DOUBLE HELICES, DNA 4dy8 nuc 1.76 MANGANESE (II) ION MN 2+ INTERACTIONS OF MN2+ WITH A NON-SELF-COMPLEMENTARY Z-TYPE DN DNA (5'-D(*CP*AP*CP*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*GP*TP*G)-3'), DNA (5'-D(P*TP*G)-3') DNA Z-TYPE DNA DOUBLE HELICES, MANGANESE IONS, DNA 4hig nuc 0.75 MANGANESE (II) ION MN 2+ ULTRAHIGH-RESOLUTION CRYSTAL STRUCTURE OF Z-DNA IN COMPLEX W ION. DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA SELF-COMPLEMENTARY DNA, Z-DNA, DNA 4kz2 nuc 3.05 MANGANESE (II) ION 3(MN 2+) CRYSTAL STRUCTURE OF PHI29 PRNA 3WJ CORE PHI29 PRNA 3WJ CORE RNA 20 MER, PHI29 PRNA 3WJ CORE RNA 16 MER, PHI29 PRNA 3WJ CORE RNA 18 MER RNA PHI29 DNA PACKAGING MOTOR PRNA CORE ELEMENT, RNA 4nyb nuc 3.10 MANGANESE (II) ION 4(MN 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX (1,2,3-THIADIAZOL-4-YL)PHENYL)METHANAMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4nyc nuc 3.15 MANGANESE (II) ION 5(MN 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX THIENO[2,3-B]PYRAZIN-7-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4nyd nuc 2.90 MANGANESE (II) ION 4(MN 2+) CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX HYPOXANTHINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA 4rgf nuc 3.20 MANGANESE (II) ION 11(MN 2+) CRYSTAL STRUCTURE OF THE IN-LINE ALIGNED ENV22 TWISTER RIBOZ WITH MN2+ ENV22 TWISTER RIBOZYME RNA PSEUDOKNOT, STEMS, CLEAVAGE, RNA 4u3o nuc 1.80 MANGANESE (II) ION 4(MN 2+) OCTAMERIC RNA DUPLEX SOAKED IN MANGANESE(II)CHLORIDE RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3') RNA RNA, DUPLEX, DI- AND TRIVALENT METAL IONS 4y1i nuc 2.85 MANGANESE (II) ION 3(MN 2+) LACTOCOCCUS LACTIS YYBP-YKOY MN RIBOSWITCH BOUND TO MN2+ LACTOCOCCUS LACTIS YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE-BINDING, RNA 5dh7 nuc 3.06 MANGANESE (II) ION 11(MN 2+) TWO DIVALENT METAL IONS AND CONFORMATIONAL CHANGES PLAY ROLE HAMMERHEAD RIBOZYME CLEAVAGE REACTION-G12A MUTANT IN MN2+ 5'-R(*GP*GP*GP*CP*GP*UP*DC*UP*GP*GP*GP*CP*AP*GP*U *CP*A)-3', RNA (48-MER) RNA RIBOZYME, HAMMERHEAD, RNA 5di2 nuc 2.99 MANGANESE (II) ION 7(MN 2+) TWO DIVALENT METAL IONS AND CONFORMATIONAL CHANGES PLAY ROLE HAMMERHEAD RIBOZYME CLEAVAGE REACTION-WT RIBOZYME IN MN2+ A 5'-R(*GP*GP*GP*CP*GP*U)-D(P*C)- R(P*UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3', RNA (48-MER) RNA RIBOZYME, HAMMERHEAD, RNA 5di4 nuc 2.95 MANGANESE (II) ION 11(MN 2+) TWO DIVALENT METAL IONS AND CONFORMATIONAL CHANGES PLAY ROLE HAMMERHEAD RIBOZYME CLEAVAGE REACTION-WT RIBOZYME IN MN2+ A 5'-R(*GP*GP*GP*CP*GP*U)-D(P*C)- R(P*UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3', RNA (48-MER) RNA RIBOZYME, HAMMERHEAD, RNA 5eaq nuc 3.20 MANGANESE (II) ION 6(MN 2+) TWO ACTIVE SITE DIVALENT ION IN THE CRYSTAL STRUCTURE OF THE HAMMERHEAD RIBOZYME BOUND TO A TRANSITION STATE ANALOG-MN2+ RNA (48-MER), RNA (5'-R(*GP*GP*GP*CP*GP*U*(CVC) *UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3') RNA RIBOZYME, HAMMERHEAD, RNA 5k7e nuc 3.27 MANGANESE (II) ION 2(MN 2+) THE STRUCTURE OF PISTOL RIBOZYME, SOAKED WITH MN2+ RNA 47-MER, DNA/RNA 11-MER RNA/DNA RIBOZYME, RNA STRUCTURE, PISTOL, RNA-DNA COMPLEX
Code Class Resolution Description 202d nuc NMR MENOGARIL 2(C28 H31 N O10) SOLUTION STRUCTURE OF THE MENOGARIL-DNA COMPLEX DNA (5'-D(*GP*AP*CP*AP*TP*GP*TP*C)-3') DNA DNA, NMR, MENOGARIL
Code Class Resolution Description 199d nuc NMR CARBAMIC ACID 2,6-DIAMINO-5-METHYL-4,7-DIOXO-2,3,4,7- TETRAHYDRO-1H-3A-AZA-CYCLOPENTA[A]INDEN-8-YLMETHYL ESTER C14 H16 N4 O4 SOLUTION STRUCTURE OF THE MONOALKYLATED MITOMYCIN C-DNA COMPLEX DNA (5'-D(*(DI)P*CP*AP*CP*GP*TP*CP*(DI)P*T)-3'), DNA (5'-D(*AP*CP*GP*AP*CP*GP*TP*GP*C)-3') DNA DNA, NMR, MITOMYCIN, DOUBLE HELIX
Code Class Resolution Description 1kgk nuc 1.00 METHOXY-ETHOXYL 2(C3 H7 O2 1-) DIRECT OBSERVATION OF A CYTOSINE ANALOG THAT FORMS FIVE HYDROGEN BONDS TO GUANOSINE; GUANYL G-CLAMP 5'-D(*GP*(GCK)P*GP*TP*AP*TP*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, CYTOSINE ANALOGUE, DNA
Code Class Resolution Description 4xqz nuc 2.15 METHANOL C H4 O CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY CHLORIDE AND MES DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA
Code Class Resolution Description 1g4q nuc 1.15 (4S)-2-METHYL-2,4-PENTANEDIOL C6 H14 O2 RNA/DNA HYBRID DECAMER OF CAAAGAAAAG/CTTTTCTTTG 5'-R(*CP*AP*AP*AP*GP*AP*AP*AP*AP*G)-3': POLYPURINE TRACT OF HIV-1, 5'-D(*CP*TP*TP*TP*TP*CP*TP*TP*TP*G)-3' DNA-RNA HYBRID RNA/DNA HYBRID, POLYPURINE TRACT OF HIV-1, DIRECT METHODS, DNA/RNA COMPLEX, DNA-RNA HYBRID 1i7j nuc 1.19 (4S)-2-METHYL-2,4-PENTANEDIOL 2(C6 H14 O2) CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RNA DUPLEX AT 1.19 A RESOLUTION. 2-METHYL-2,4-PENTANEDIOL AND MAGNESIUM BINDING. 5'-R(*(OMC)P*(OMG)P*(OMC)P*(OMG)P*(OMC)P*(OMG))- 3' RNA X-RAY, 2'-O-MERNA DUPLEX, 2-METHYL-2, 4-PENTANEDIOL, MAGNESIUM, GROOVE HYDRATION AND BINDING 3ey3 nuc 1.25 (4S)-2-METHYL-2,4-PENTANEDIOL 2(C6 H14 O2) A CONFORMATIONAL TRANSITION IN THE STRUCTURE OF A 2'- THIOMETHYL-MODIFIED DNA VISUALIZED AT HIGH RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*(USM)P*(USM) P*CP*GP*CP*G)-3' DNA MODIFIED DNA DUPLEX, CRYSTAL STRUCTURE, 2'-THIOMETHYL URIDINE, MODIFIED SUGAR 3oz3 nuc 1.57 (4S)-2-METHYL-2,4-PENTANEDIOL C6 H14 O2 VINYL CARBOCYCLIC LNA DNA (5'-D(*GP*CP*GP*TP*AP*(UVX)P*AP*CP*GP*C)-3') DNA A-FORM DNA, VINYL CARBOCYCLIC LNA, ANTISENSE OLIGONUCLEOTIDE 452d nuc 1.60 (4S)-2-METHYL-2,4-PENTANEDIOL C6 H14 O2 ACRIDINE BINDING TO DNA DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA INTERCALATION, GROOVE BINDING, DNA
Code Class Resolution Description 2pik nuc NMR 3-O-METHYL-ALPHA-L-RHAMNOPYRANOSIDE C7 H14 O5 CALICHEAMICIN GAMMA1I-DNA COMPLEX, NMR, 6 STRUCTURES DNA(5'-D(C*AP*CP*TP*CP*CP*TP*GP*GP*TP*TP*TP*TP* TP*GP*TP*GP*AP*GP*GP*AP*CP*CP)-3') DNA DEOXYRIBONUCLEIC ACID, CALICHEAMICIN GAMMA1I - DNA COMPLEX, ENEDIYNE ALIGNMENT IN MINOR GROOVE, SACCHARIDE DNA MINOR GROOVE INTERACTIONS, INTERMOLECULAR DRUG IODINE-GUANINE AMINO PROTON INTERACTIONS, SPECIFICITY AND CLEAVAGE PROCESS
Code Class Resolution Description 3fwo nuc 3.71 (3R,4S,5S,7R,9E,11S,12R)-12-ETHYL-11-HYDROXY-3,5,7,11- TETRAMETHYL-2,8-DIOXOOXACYCLODODEC-9-EN-4-YL 3,4,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-XYLO-HEXOPYRANOSIDE C25 H43 N O7 THE LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COM WITH METHYMYCIN 23S RIBOSOMAL RNA, 5S RIBOSOMAL RNA RIBOSOME RIBOSOME; LARGE SUBUNIT; 50S; DEINOCOCCUS RADIODURANS; X-RAY STRUCTURE; PEPTIDYL-TRANSFERASE, PEPTIDE BOND FORMATION,ANT MACROLIDES, RIBOSOME
Code Class Resolution Description 1pik nuc NMR [1,8-DIHYDROXY-11-OXO-13-(2-METHYLTRITHIO-ETHYLIDENE)- BICYCLO[7.3.1]TRIDECA-4,9-DIENE-2,6-DIYN-10-YL]- CARBAMIC ACID METHYL ESTER C18 H17 N O4 S3 ESPERAMICIN A1-DNA COMPLEX, NMR, 4 STRUCTURES DNA (5'-D(C*GP*GP*AP*TP*CP*CP*GP)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, DNA 2pik nuc NMR [1,8-DIHYDROXY-11-OXO-13-(2-METHYLTRITHIO-ETHYLIDENE)- BICYCLO[7.3.1]TRIDECA-4,9-DIENE-2,6-DIYN-10-YL]- CARBAMIC ACID METHYL ESTER C18 H17 N O4 S3 CALICHEAMICIN GAMMA1I-DNA COMPLEX, NMR, 6 STRUCTURES DNA(5'-D(C*AP*CP*TP*CP*CP*TP*GP*GP*TP*TP*TP*TP* TP*GP*TP*GP*AP*GP*GP*AP*CP*CP)-3') DNA DEOXYRIBONUCLEIC ACID, CALICHEAMICIN GAMMA1I - DNA COMPLEX, ENEDIYNE ALIGNMENT IN MINOR GROOVE, SACCHARIDE DNA MINOR GROOVE INTERACTIONS, INTERMOLECULAR DRUG IODINE-GUANINE AMINO PROTON INTERACTIONS, SPECIFICITY AND CLEAVAGE PROCESS
Code Class Resolution Description 1ngt nuc 2.04 (5-METHYL-6-OXO-1,6-DIHYDRO-PYRIDIN-3-YL)-1,2-DIDEOXY- RIBOFURANOSE-5-MONOPHOSPHATE 2(C11 H16 N O7 P) THE ROLE OF MINOR GROOVE FUNCTIONAL GROUPS IN DNA HYDRATION 5'-D(*CP*GP*CP*GP*AP*AP*(MTR)P*TP*CP*GP*CP*G)-3' DNA SPINE OF HYDRATION, DNA CONFORMATION, MODIFIED BASE
Code Class Resolution Description 1t0d nuc 2.20 9-BETA-D-RIBOFURANOSYL-9H-PURIN-2-AMINE 2(C10 H14 N5 O7 P) CRYSTAL STRUCTURE OF 2-AMINOPURINE LABELLED BACTERIAL DECODING SITE RNA 5'- R(*CP*AP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*AP*CP*CP*C)-3', 5'-R(*GP*GP*UP*GP*GP*UP*GP*(MTU) P*AP*GP*UP*CP*GP*CP*UP*GP*G)-3' RNA CRYSTAL STRUCTURE, 2-AMINOPURINE, BACTERIAL DECODING SITE RNA, FLUORESCENCE EMISSION SPECTRA, 9-BETA-D-RIBOFURANOSYL- 9H-PURIN-2-AMINE 2bcy nuc 2.70 9-BETA-D-RIBOFURANOSYL-9H-PURIN-2-AMINE C10 H14 N5 O7 P CRYSTAL STRUCTURE OF A MINIMAL, MUTANT ALL-RNA HAIRPIN RIBOZYME (U39C, G8MTU) 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*(MTU)P*AP*AP*GP*GP*G)-3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3' RNA RIBOZYME, G8, MTU, RNA 3b91 nuc 2.75 9-BETA-D-RIBOFURANOSYL-9H-PURIN-2-AMINE C10 H14 N5 O7 P MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES ADE38(2AP) AND 2',5'-PHOSPHODIESTER LINKAGE MUTATIONS AT THE ACTIVE SITE 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME; 2'5' PHOSPHODIESTER; RNA; 2-AMINOPURINE 3bbi nuc 2.35 9-BETA-D-RIBOFURANOSYL-9H-PURIN-2-AMINE C10 H14 N5 O7 P MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATING A38(2AP) 2'-O-ME MODIFICATIONS NEAR ACTIVE SITE LOOP A SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2-AMINOPURINE, 2'O-METHYL, PHOSPHORYL TRAN RNA, LINKER
Code Class Resolution Description 4ocd nuc 2.10 N1-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-N4-(4-((4,5-DIHYDRO- 1H-IMIDAZOL-2-YL)AMINO)PHENYL)BENZENE-1,4-DIAMINE 3(C18 H21 N7) IN AND OUT THE MINOR GROOVE: INTERACTION OF AN AT RICH-DNA W CD27 DRUG D(AAAATTTT) DNA DNA MINOR GROOVE BINDING DRUGS, ALL-AT DNA, DICATIONIC DRUG, IMIDAZOLINE DRUG, DNA
Code Class Resolution Description 2o3x nuc 2.90 (1R,2R,3S,4R,6S)-4,6-DIAMINO-2-[(5-AMINO-5-DEOXY-BETA- D-RIBOFURANOSYL)OXY]-3-HYDROXYCYCLOHEXYL 2-AMINO-2- DEOXY-ALPHA-D-GLUCOPYRANOSIDE C17 H34 N4 O10 CRYSTAL STRUCTURE OF THE PROKARYOTIC RIBOSOMAL DECODING SITE COMPLEXED WITH PAROMAMINE DERIVATIVE NB30 RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP *UP*CP*GP*C)-3') RNA AMINOGLYCOSIDE, ANTIBIOTICS, RIBOSOME, DECODING SITE, PROKARYOTE, TRANSLATION INHIBITION, STOP CODON READTHROUGH, RNA
Code Class Resolution Description
2o3v nuc 2.80 (2S,3R,4R,5S,6R)-3-AMINO-4-({[(2S,3R,4R,5S,6R)-3- AMINO-2-{[(1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3- DIHYDROXYCYCLOHEXYL]OXY}-5-HYDROXY-6-(HYDROXYMETHYL) TETRAHYDRO-2H-PYRAN-4-YL]OXY}METHOXY)-6- (HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2,5-DIOL C19 H38 N4 O12 CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING SITE COMPLEXED WITH PAROMAMINE DERIVATIVE NB33 RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3') RNA AMINOGLYCOSIDE, ANTIBIOTICS, RIBOSOME, DECODING SITE, HOMO SAPIENS, EUKARYOTE, CYTOPLASMIC, TRANSLATION INHIBITION, STOP CODON READTHROUGH, RNA
Code Class Resolution Description 3ey2 nuc 1.04 N-METHYLPROPANE-1,3-DIAMINE C4 H12 N2 A CONFORMATIONAL TRANSITION IN THE STRUCTURE OF A 2'- THIOMETHYL-MODIFIED DNA VISUALIZED AT HIGH RESOLUTION 5'-D(*GP*CP*GP*TP*AP*(USM)P*AP*CP*GP*C)-3' DNA 2'-THIOMETHYL MODIFIED DNA, MODIFIED SUGAR, NUCLEIC ACID STRUCTURE.
Code Class Resolution Description
2mcj nuc NMR N-[3-({4-[(3-AMINOPROPYL)AMINO]BUTYL}AMINO)PROPYL]-2'- DEOXYCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C19 H37 N6 O7 P NMR STRUCTURE OF SPERMINE MODIFIED DNA DUPLEX DNA_(5'-D(*CP*AP*GP*(N4S)P*CP*GP*AP*C)-3'), DNA_(5'-D(*GP*TP*CP*GP*GP*CP*TP*G)-3') DNA DNA, NUCELIC ACID, POLIAMINE, SPERMINE, POLIAMINOOLIGONUCLEO DUPLEX
Code Class Resolution Description 2fgp nuc 2.40 ((2R,3S,4R,5S)-5-(2,6-DIAMINO-9H-PURIN-9-YL)-3,4- DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL DIHYDROGEN PHOSPHATE C10 H15 N6 O7 P CRYSTAL STRUCTURE OF A MINIMAL, ALL RNA HAIRPIN RIBOZYME WITH MODIFICATIONS (G8DAP, U39C) AT PH 8.6 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*(N6G)P*AP*AP*GP*GP*G)-3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3' RNA RIBOZYME, G8, DIAMINOPURINE, IN-LINE GEOMETRY, MUTANT, RNA 3b5f nuc 2.70 ((2R,3S,4R,5S)-5-(2,6-DIAMINO-9H-PURIN-9-YL)-3,4- DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL DIHYDROGEN PHOSPHATE C10 H15 N6 O7 P CRYSTAL STRUCTURE OF A MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATING THE ADE38DAP MUTATION AND A 2',5' PHOSPHODIESTER LINKAGE AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; 2, 6 DIAMINOPURINE; RNA; 2', 5' PHOSPHODIESTER LINKAGE 3b5s nuc 2.25 ((2R,3S,4R,5S)-5-(2,6-DIAMINO-9H-PURIN-9-YL)-3,4- DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL DIHYDROGEN PHOSPHATE C10 H15 N6 O7 P MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES A38DAP MUTATI O-METHYL MODIFICATION AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; RNA; 2, 6 DIAMINOPURINE; 2'-O-METHYL, RNA
Code Class Resolution Description 2xo1 nuc 1.60 N-METHYL-9H-PURIN-6-AMINE C6 H7 N5 XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO N6-METHYL GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA
Code Class Resolution Description 131d nuc 1.00 SODIUM ION 2(NA 1+) THE LOW-TEMPERATURE CRYSTAL STRUCTURE OF THE PURE-SPERMINE FORM OF Z-DNA REVEALS BINDING OF A SPERMINE MOLECULE IN THE MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX 191d nuc 1.40 SODIUM ION 3(NA 1+) CRYSTAL STRUCTURE OF INTERCALATED FOUR-STRANDED D(C3T) DNA (5'-D(*CP*CP*CP*T)-3') DNA U-DNA, QUADRUPLE HELIX, PARALLEL-STRANDED TETRAPLEX, BASE INTERCALATED, MISMATCHED, DNA 192d nuc 1.92 SODIUM ION NA 1+ RECOMBINATION-LIKE STRUCTURE OF D(CCGCGG) DNA (5'-D(*CP*CP*GP*CP*GP*G)-3') DNA Z-DNA, DOUBLE HELIX, FLIPPED-OUT BASES 1d10 nuc 1.50 SODIUM ION NA 1+ STRUCTURAL COMPARISON OF ANTICANCER DRUG-DNA COMPLEXES. ADRIAMYCIN AND DAUNOMYCIN DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d11 nuc 1.18 SODIUM ION NA 1+ INTERACTIONS BETWEEN AN ANTHRACYCLINE ANTIBIOTIC AND DNA MOL STRUCTURE OF DAUNOMYCIN COMPLEXED TO D(CPGPTPAPCPG) AT 1.2- RESOLUTION DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1d12 nuc 1.70 SODIUM ION NA 1+ STRUCTURAL COMPARISON OF ANTICANCER DRUG-DNA COMPLEXES. ADRIAMYCIN AND DAUNOMYCIN DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d39 nuc 1.20 SODIUM ION NA 1+ COVALENT MODIFICATION OF GUANINE BASES IN DOUBLE STRANDED DNA: THE 1.2 ANGSTROMS Z-DNA STRUCTURE OF D(CGCGCG) IN THE PRESENCE OF CUCL2 DNA (5'-D(*CP*(CU)GP*CP*(CU)GP*CP*(CU)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 1dcr nuc 1.60 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G-A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*(BRU)P*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DEOXYRIBONUCLEIC ACID, DNA 1dcw nuc 2.10 SODIUM ION NA 1+ STRUCTURE OF A FOUR-WAY JUNCTION IN AN INVERTED REPEAT SEQUENCE. DNA (5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3') DNA HOLLIDAY JUNCTION, INVERTED REPEAT, FOUR-WAY JUNCTION, DEOXYRIBONUCLEIC ACID, DNA 1duq nuc 2.10 SODIUM ION 10(NA 1+) CRYSTAL STRUCTURE OF THE REV BINDING ELEMENT OF HIV-1 THE REV BINDING ELEMENT: LONG CHAIN, THE REV BINDING ELEMENT: SHORT CHAIN RNA RRE, HIV-1, REV BINDING DOMAIN, RNA 1ez5 nuc model SODIUM ION NA 1+ COMPUTER MODEL OF A COVALENT COMPLEX BETWEEN D(TAAAGCTTA) AND ANTITUMOR DRUG ECTEINASCIDIN 743 DNA (5'-D(*TP*AP*AP*GP*CP*TP*TP*TP*A)-3'), DNA (5'-D(*TP*AP*AP*AP*GP*CP*TP*TP*A)-3') DEOXYRIBONUCLEIC ACID ANTICANCER, DNA, ECTEINASCIDIN, DEOXYRIBONUCLEIC ACID 1fir nuc 3.30 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA 1fn2 nuc 1.60 SODIUM ION NA 1+ 9-AMINO-(N-(2-DIMETHYLAMINO)BUTYL)ACRIDINE-4-CARBOXAMIDE BOUND TO D(CGTACG)2 DNA (5'-D(*CP*GP*TP*AP*CP*G)-3'), DNA (5'-D(P*GP*TP*AP*CP*G)-3') DNA DNA, ACRIDINE-4-CARBOXAMIDE, INTERCALATION, QUADRUPLEX 1i0g nuc 1.45 SODIUM ION NA 1+ 1.45 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-FLUOROETHYL THYMINE IN PLACE OF T6, MEDIUM NA-SALT 5'-D(*GP*CP*GP*TP*AP*(125)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0q nuc 1.30 SODIUM ION 2(NA 1+) 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM NA-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1j6s nuc 1.40 SODIUM ION 8(NA 1+) CRYSTAL STRUCTURE OF AN RNA TETRAPLEX (UGAGGU)4 WITH A- TETRADS, G-TETRADS, U-TETRADS AND G-U OCTADS 5'-R(*(BRUP*GP*AP*GP*GP*U)-3' RNA RNA, TETRAPLEX, G-U OCTADS, A-TETRADS, U-TETRADS, G-TETRADS 1j8g nuc 0.61 SODIUM ION 2(NA 1+) X-RAY ANALYSIS OF A RNA TETRAPLEX R(UGGGGU)4 AT ULTRA-HIGH R 5'-R(*UP*GP*GP*GP*GP*U)-3' RNA RNA TETRAPLEX, SR IONS, U TETRAD, OCTAPLEX, RNA 1jtw nuc NMR SODIUM ION 15(NA 1+) STRUCTURE OF SL4 RNA FROM THE HIV-1 PACKAGING SIGNAL 5'- R(*GP*GP*GP*UP*GP*CP*GP*AP*GP*AP*GP*CP*GP*UP*CP*A)-3' RNA HAIRPIN, TANDEM G-U PAIRS, GAGA TETRALOOPS, RNA 1k8p nuc 2.40 SODIUM ION NA 1+ STRUCTURE OF THE HUMAN G-QUADRUPLEX REVEALS A NOVEL TOPOLOGY 5'-D(*(BRU)P*AP*GP*GP*GP*(BRU) P*TP*AP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, DOUBLE CHAIN REVERSAL LOOP, DIMERIC QUADRUPLEX, HUMAN TELOMERE SEQUENCE, G(ANTI).G(ANTI) .G(ANTI).G(ANTI), PARALLEL STRANDED 1l0r nuc NMR SODIUM ION 12(NA 1+) NMR SOLUTION STRUCTURE OF NOGALAMYCIN INTERCALATION BETWEEN CO-AXIALLY STACKED HAIRPINS 5'-D(*AP*CP*GP*AP*AP*GP*TP*GP*CP*GP*AP*AP*GP*C)- 3' DNA GAA LOOP, SINGLE STRAND BREAK, DRUG-DNA RECOGNITION, NOGALAMYCIN INTERCALATION 1l2x nuc 1.25 SODIUM ION 3(NA 1+) ATOMIC RESOLUTION CRYSTAL STRUCTURE OF A VIRAL RNA PSEUDOKNOT RNA PSEUDOKNOT RNA PSEUDOKNOT, FRAMESHIFTING, ATOMIC RESOLUTION, VIRAL RNA, METAL IONS, FLEXIBILITY 1l3z nuc 2.01 SODIUM ION NA 1+ CRYSTAL STRUCTURE ANALYSIS OF AN RNA HEPTAMER 5'-R(*GP*UP*AP*UP*AP*CP*A)-3' RNA RNA 1l4j nuc 1.85 SODIUM ION 2(NA 1+) HOLLIDAY JUNCTION TCGGTACCGA WITH NA AND CA BINDING SITES. 5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3' DNA HOLLIDAY JUNCTION, DNA 1mdg nuc 1.50 SODIUM ION 5(NA 1+) AN ALTERNATING ANTIPARALLEL OCTAPLEX IN AN RNA CRYSTAL STRUC 5'-R(*UP*(BGM)GP*AP*GP*GP*U)-3' RNA TETRAPLEX, BASE TETRADS, BASE OCTADS, RNA 1n5c nuc 1.79 SODIUM ION NA 1+ CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAATT(E 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(EDC)P*GP*CP*G)-3' DNA B FORM DOUBLE HELIX, 3, N4-ETHENO-2'-CYTIDINE MODIFICATION O G, DNA 1nta nuc 2.90 SODIUM ION 2(NA 1+) 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RNA-APTAMER 5'-R(*CP*GP*GP*CP*AP*CP*CP*AP*CP*GP*GP*UP*CP*GP*G -3', 5'-R(*GP*GP*AP*UP*CP*GP*CP*AP*UP*UP*UP*GP*GP*AP*C *UP*GP*CP*C)-3' RNA STREPTOMYCIN RNA-APTAMER, BARIUM FORM, RNA 1ntb nuc 2.90 SODIUM ION 2(NA 1+) 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RNA-APTAMER COMPLEX 5'- R(*CP*GP*GP*CP*AP*CP*CP*AP*CP*GP*GP*UP*CP*GP*GP*AP*UP*C)- 3', 5'- R(*GP*GP*AP*UP*CP*GP*CP*AP*UP*UP*UP*GP*GP*AP*CP*UP*UP*CP*UP *GP*CP*C)-3' RNA STREPTOMYCIN RNA-APTAMER, MAGNESIUM FORM 1o0k nuc 1.17 SODIUM ION 3(NA 1+) STRUCTURE OF THE FIRST PARALLEL DNA QUADRUPLEX-DRUG COMPLEX 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA G-4 QUADRUPLEX DRUG COMPLEX, PARALLEL QUADRUPLEX, DNA 1p4y nuc 1.70 SODIUM ION 4(NA 1+) EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DNA HOLLIDAY JUNCTIONS 5'-D(*CP*CP*GP*GP*CP*GP*CP*CP*GP*G)-3' DNA HOLLIDAY JUNCTION, DNA FOUR-WAY JUNCTION 1p4z nuc 2.00 SODIUM ION 3(NA 1+) EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DNA HOL JUNCTIONS 5'-D(*CP*CP*AP*GP*TP*AP*CP*TP*GP*G)-3' DNA B-DNA, DOUBLE HELIX, DNA 1p54 nuc 1.90 SODIUM ION NA 1+ EFFECT OF SEQUENCE ON THE CONFORMATIONAL GEOMETRY OF DNA HOL JUNCTIONS 5'-D(*CP*CP*AP*GP*TP*AP*CP*(BRU)P*GP*G)-3' DNA DNA HOLLIDAY JUNCTION, FOUR-WAY JUNCTION, STACKED-X JUNCTION BROMINATED URACIL, DNA 1ply nuc 3.20 SODIUM ION 10(NA 1+) SODIUM IONS AND WATER MOLECULES IN THE STRUCTURE OF POLY D(A)(DOT)POLY D(T) DNA (5'-D(P*TP*TP*TP*TP*T)-3'), DNA (5'-D(P*AP*AP*AP*AP*A)-3') DNA DNA 1q93 nuc 2.25 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF A MUTANT OF THE SARCIN/RICIN DOMAIN FROM RAT 28S RRNA SARCIN/RICIN 28S RRNA: SARCIN/RICIN DOMAIN RNA SARCIN/RICIN DOMAIN, RIBONUCLEIC ACID, RNA RECOGNITION, RIBOSOMES, ELONGATION FACTORS, MUTANT, STEM-LOOP 1qch nuc NMR SODIUM ION 9(NA 1+) STRUCTURE, DYNAMICS AND HYDRATION OF THE NOGALAMYCIN- D(ATGCAT)2 COMPLEX DETERMINED BY NMR AND MOLECULAR DYNAMICS SIMULATIONS IN SOLUTION 5'-D(*AP*TP*GP*CP*AP*T)-3' DNA NOGALAMYCIN, NOGALAMYCIN-DNA COMPLEX, NMR SPECTROSCOPY, ANTHRACYCLINE ANTIBIOTIC, HYDRATION 1qsx nuc NMR SODIUM ION 19(NA 1+) SOLUTION NMR STRUCTURE OF THE 2:1 HOECHST 33258- D(CTTTTGCAAAAG)2 COMPLEX 5'-D(CP*TP*TP*TP*TP*GP*CP*AP*AP*AP*AP*G)-3' DNA DRUG-DNA COMPLEX, HOECHST 33258, DEOXYRIBONUCLEIC ACID, MINOR GROOVE RECOGNITION, DOUBLE HELIX, NMR SPECTROSCOPY 1s1k nuc 1.90 SODIUM ION NA 1+ INFLUENCE OF GROOVE INTERACTIONS ON DNA HOLLIDAY JUNCTION FORMATION 5'-D(*CP*CP*(1AP)P*GP*TP*AP*CP*TP*GP*G)-3' DNA B-DNA, DOUBLE HELIX, 2, 6-DIAMINOPURINE, MINOR GROOVE INTERACTIONS 1s45 nuc 2.20 SODIUM ION NA 1+ CRYSTAL STRUCTURE ANALYSIS OF THE DNA QUADRUPLEX D(TGGGGT) S1 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, THYMINE TRIADS, THALLIUM 1s47 nuc 2.50 SODIUM ION 7(NA 1+) CRYSTAL STRUCTURE ANALYSIS OF THE DNA QUADRUPLEX D(TGGGGT)S2 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, THYMINE TRIADS AND TETRADS, THALLIUM 1uhx nuc 2.00 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF D(GCGAGAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID 1uhy nuc 1.70 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF D(GCGATAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*TP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID 1ve8 nuc 1.65 SODIUM ION NA 1+ X-RAY ANALYSES OF OLIGONUCLEOTIDES CONTAINING 5- FORMYLCYTOSINE, SUGGESTING A STRUCTURAL REASON FOR CODON- ANTICODON RECOGNITION OF MITOCHONDRIAL TRNA-MET; PART 1, D(CGCGAATT(F5C)GCG) 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5FC)P*GP*CP*G)-3' DNA 5-FORMYLCYTOSINE, ANTICODON OF TRNA-MET, DNA DODECAMER 1xcu nuc 2.00 SODIUM ION NA 1+ OLIGONUCLEOTID/DRUG COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, ANTHRAQUINONE, CO2+ 1xp7 nuc 2.50 SODIUM ION NA 1+ HIV-1 SUBTYPE F GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1xpe nuc 1.94 SODIUM ION 4(NA 1+) HIV-1 SUBTYPE B GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1xpf nuc 2.30 SODIUM ION NA 1+ HIV-1 SUBTYPE A GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1y3o nuc 2.70 SODIUM ION 3(NA 1+) HIV-1 DIS RNA SUBTYPE F- MN SOAKED 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1y6t nuc 2.60 SODIUM ION 2(NA 1+) HIV-1 DIS(MAL) DUPLEX CO HEXAMINE-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, METAL IONS 1zew nuc 2.25 SODIUM ION NA 1+ B-DNA 5'-D(*CP*CP*TP*CP*TP*AP*GP*AP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zey nuc 1.70 SODIUM ION 2(NA 1+) CGG A-DNA 5'-D(*CP*CP*CP*CP*GP*CP*GP*GP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zf4 nuc 1.65 SODIUM ION NA 1+ ATC FOUR-STRANDED DNA HOLLIDAY JUNCTION 5'-D(*CP*CP*GP*AP*TP*AP*TP*CP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, M STRUCTURE, DNA 1zf6 nuc 1.50 SODIUM ION NA 1+ TGG DUPLEX A-DNA 5'-D(*CP*CP*CP*CP*AP*TP*GP*GP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zf7 nuc 1.05 SODIUM ION NA 1+ GAC DUPLEX B-DNA 5'-D(*CP*CP*GP*TP*CP*GP*AP*CP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zf9 nuc 1.38 SODIUM ION 2(NA 1+) GGG DUPLEX A-DNA 5'-D(*CP*CP*CP*CP*CP*GP*GP*GP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 1zfa nuc 1.56 SODIUM ION 3(NA 1+) GGA DUPLEX A-DNA 5'-D(*CP*CP*TP*CP*CP*GP*GP*AP*GP*G)-3' DNA CRYSTALLOGRAPHIC SCREEN, DNA STRUCTURE, HOLLIDAY JUNCTION, MOLECULAR STRUCTURE 231d nuc 2.40 SODIUM ION NA 1+ STRUCTURE OF A DNA-PORPHYRIN COMPLEX DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, FLIPPED-OUT BASES, COMPLEXED WITH DRUG 244d nuc 1.20 SODIUM ION 14(NA 1+) THE HIGH-RESOLUTION CRYSTAL STRUCTURE OF A PARALLEL- STRANDED GUANINE TETRAPLEX DNA (5'-D(*TP*GP*GP*GP*GP*T)-3') DNA UNUSUAL DNA, QUADRUPLE HELIX, PARALLEL-STRANDED TETRAPLEX 246d nuc 2.20 SODIUM ION 2(NA 1+) STRUCTURE OF THE PURINE-PYRIMIDINE ALTERNATING RNA DOUBLE HELIX, R(GUAUAUA)D(C) , WITH A 3'-TERMINAL DEOXY RESIDUE DNA/RNA (5'-R(*GP*UP*AP*UP*AP*UP*AP*)-D(*C)-3') DNA/RNA A-DNA/RNA, DOUBLE HELIX 258d nuc 1.58 SODIUM ION NA 1+ FACTORS AFFECTING SEQUENCE SELECTIVITY ON NOGALAMYCIN INTERCALATION: THE CRYSTAL STRUCTURE OF D(TGTACA)- NOGALAMYCIN DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 284d nuc 1.10 SODIUM ION NA 1+ THE BI-LOOP, A NEW GENERAL FOUR-STRANDED DNA MOTIF DNA (5'-CD(*P*AP*TP*TP*CP*AP*TP*TP*C)-3') DNA CYCLIC B-DNA, QUADRUPLE HELIX, BI-LOOP 292d nuc 1.00 SODIUM ION NA 1+ INTERACTION BETWEEN THE LEFT-HANDED Z-DNA AND POLYAMINE:THE CRYSTAL STRUCTURE OF THE D(CG)3 AND N-(2-AMINOETHYL)-1,4- DIAMINOBUTANE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, COMPLEXED WITH N-(2-AMINOETHYL)-1,4- DIAMINOBUTANE 293d nuc 1.00 SODIUM ION NA 1+ INTERACTION BETWEEN THE LEFT-HANDED Z-DNA AND POLYAMINE-2: THE CRYSTAL STRUCTURE OF THE D(CG)3 AND SPERMIDINE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, COMPLEXED WITH SPERMIDINE 2b2b nuc 1.50 SODIUM ION 3(NA 1+) STRUCTURAL DISTORTIONS IN PSORALEN CROSS-LINKED DNA 5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3' DNA RECOMBINATION, PSORALEN, NUCLEIC ACID STRUCTURE, DNA 2b8r nuc 2.60 SODIUM ION NA 1+ STRUCTURE OF HIV-1(LAI) GENOMIC RNA DIS 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, HAIRPIN 2b8s nuc 2.76 SODIUM ION 2(NA 1+) STRUCTURE OF HIV-1(MAL) GENOMIC RNA DIS 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, HAIRPIN 2des nuc 1.50 SODIUM ION 2(NA 1+) INTERACTIONS BETWEEN MORPHOLINYL ANTHRACYCLINES AND DNA: THE CRYSTAL STRUCTURE OF A MORPHOLINO DOXORUBICIN BOUND TO D(CGTACG) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 2dqo nuc 2.30 SODIUM ION 3(NA 1+) CRYSTAL STRUCTURE OF D(CXCTXCTTC):R(GAAGAAGAG) WHERE X IS 5- (N-AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID 2dyw nuc 1.13 SODIUM ION NA 1+ A BACKBONE BINDING DNA COMPLEX 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA PLATINUM, PHOSPHATE CLAMP, ANTICANCER DRUG, DNA 2elg nuc 1.00 SODIUM ION NA 1+ THE RARE CRYSTALLOGRAPHIC STRUCTURE OF D(CGCGCG)2: THE NATURAL SPERMIDINE MOLECULE BOUND TO THE MINOR GROOVE OF LEFT-HANDED Z-DNA D(CGCGCG)2 AT 10 DEGREE CELSIUS DNA (5'-D(*DCP*DGP*DCP*DGP*DCP*DG)-3') DNA D(CGCGCG)2, LEFT-HANDED Z-DNA, SPERMIDINE, X-RAY CRYSTALLOGRAPHY, POLYAMINE 2fza nuc 3.60 SODIUM ION 5(NA 1+) CRYSTAL STRUCTURE OF D(GCGGGAGC): THE BASE-INTERCALATED DUPLEX 5'-D(*GP*(CBR)P*GP*GP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G:A PAIR, DNA, DNA HEXAPLEX, DEOXYRIBONUCLEIC ACID 2gdi nuc 2.05 SODIUM ION 2(NA 1+) CRYSTAL STRUCTURE OF THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWI COMPLEX WITH THIAMINE PYROPHOSPHATE TPP RIBOSWITCH: SENSING DOMAIN RNA RIBOSWITCH, THIAMINE PYROPHOSPHATE, RNA 2gw0 nuc 1.55 SODIUM ION 4(NA 1+) A D(TGGGGT)- SODIUM AND CALCIUM COMPLEX. 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA DNA, QUADRUPLEX, G-QUADRUPLEX, TETRAPLEX, G-TETRAPLEX, QUADRUPLE HELIX, PARALLEL-STRANDED, D(TGGGGT), HYDRATED CALCIUM ION, CALCIUM, CALCIUM ION, SODIUM, SODIUM ION. 2jja nuc 1.30 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA 2mco nuc NMR SODIUM ION 2(NA 1+) STRUCTURAL STUDIES ON DINUCLEAR RUTHENIUM(II) COMPLEXES THAT DIASTEREOSELECTIVELY TO AN ANTI-PARALLEL FOLDED HUMAN TELOM SEQUENCE HUMAN TELOMERE QUADRUPLEX DNA DNA, QUADRUPLEX, COMPLEX, RUTHENIUM 2o4f nuc 1.50 SODIUM ION 7(NA 1+) STRUCTURE OF A PARALLEL-STRANDED GUANINE TETRAPLEX CRYSTALLISED WITH MONOVALENT IONS 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA DNA, QUADRUPLE HELIX, PARALLEL-STRANDED 2oj0 nuc 2.60 SODIUM ION 3(NA 1+) CRYSTAL STRUCTURE OF THE DUPLEX FORM OF THE HIV-1(LAI) RNA DIMERIZATION INITIATION SITE MN SOAKED 5'-R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*C *GP*CP*AP*AP*G)-3' RNA HIV-1, DIS, RNA, DIMERIZATION, METAL IONS 2orf nuc 1.85 SODIUM ION NA 1+ DIRECTING MACROMOLECULAR CONFORMATION THROUGH HALOGEN BONDS DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*TP*AP*(BRU)P*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND 2orh nuc 1.90 SODIUM ION 2(NA 1+) DIRECTING MACROMOLECULAR CONFORMATION THROUGH HALOGEN BONDS DNA (5'-D(*CP*CP*GP*GP*TP*AP*(DU)P*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND 2p7d nuc 2.25 SODIUM ION NA 1+ A MINIMAL, 'HINGED' HAIRPIN RIBOZYME CONSTRUCT SOLVED WITH MIMICS OF THE PRODUCT STRANDS AT 2.25 ANGSTROMS RESOLUTION RIBOZYME STRAND II, RIBOZYME STRAND I, 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; PRODUCT MIMIC; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 2plo nuc 1.40 SODIUM ION NA 1+ D-(GTATACC) LOW TEMPERATURE (100K) 5'-D(*DGP*DGP*DTP*DAP*DTP*DAP*DCP*DC)-3' DNA DNA, HIGH PRESSURE, LOW TEMPERATURE, COMPRESSIBILITY, CRYSTALS 2r1s nuc 1.40 SODIUM ION 5(NA 1+) STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.4 A (BR1) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA ASYMMETRY, ELECTROSTATIC, MONOVALENT CATIONS, STRUCTURAL PLASTICITY, RNA 2r20 nuc 1.30 SODIUM ION 5(NA 1+) STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.3 A (BR2) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA ASYMMETRY, METAL ION BINDING, UNSTACKING, ELECTROSTATIC, RNA 2r21 nuc 1.59 SODIUM ION 4(NA 1+) STRUCTURE OF THE RNA BROMINATED TRIDECAMER R(GCGUU- 5BUGAAACGC) AT 1.6 A (BRMN) RNA (5'-R(*GP*CP*GP*UP*UP*(5BU) P*GP*AP*AP*AP*CP*GP*C)-3') RNA MANGANESE, ASYMMETRY, ELECROSTATIC, MNOVALENT, RNA 2r22 nuc 1.40 SODIUM ION 4(NA 1+) STRUCTURE OF THE NATIVE RNA TRIDECAMER R(GCGUUUGAAACGC) AT 1.5 A (NATMN) RNA (5'- R(*GP*CP*GP*UP*UP*UP*GP*AP*AP*AP*CP*GP*C)-3') RNA MONOVALENT, ELECTROSTATIC, ASYMMETRY, MANGANESE, RNA 2xc6 nuc 1.83 SODIUM ION 2(NA 1+) CRYSTAL STRUCTURE OF THE GNA 3'-CTC(BR)UAGAG-2' GNA RNA RNA, WATSON-CRICK BASE PAIR, GLYCOL NUCLEIC ACID 2ygh nuc 2.60 SODIUM ION 4(NA 1+) SAM-I RIBOSWITCH WITH A G2NA MUTATION IN THE KINK TURN IN CO WITH S-ADENOSYLMETHIONINE SAM-I RIBOSWITCH RNA RNA 352d nuc 0.95 SODIUM ION 14(NA 1+) THE CRYSTAL STRUCTURE OF A PARALLEL-STRANDED PARALLEL- STRANDED GUANINE TETRAPLEX AT 0.95 ANGSTROM RESOLUTION DNA (5'-D(*TP*GP*GP*GP*GP*T)-3') DNA U-DNA, QUADRUPLE HELIX, PARALLEL-STRANDED 378d nuc 2.40 SODIUM ION NA 1+ STRUCTURE OF THE SIDE-BY-SIDE BINDING OF DISTAMYCIN TO DNA DNA (5'-D(*GP*TP*AP*TP*AP*TP*AP*C)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, DOUBLE DRUG IN MINOR GROOVE 3bnt nuc 2.30 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF [CO(NH3)6]CL3 (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME RNA RIBOSOME, DECODING SITE, RNA 3cco nuc 2.20 SODIUM ION NA 1+ STRUCTURAL ADAPTATION AND CONSERVATION IN QUADRUPLEX-DRUG RECOGNITION DNA (5'- D(*DTP*DAP*DGP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DGP*DT)-3') DNA QUADRUPLEX, DNA, PROPELLER, DIMERIC, HUMAN TELOMERE PARALLEL STRANDED, LIGAND, COMPLEX, NAPHTHALENE DIIMIDINE 3dig nuc 2.80 SODIUM ION 14(NA 1+) CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO S-(2-AMINOETHYL)-L-CYSTEINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dil nuc 1.90 SODIUM ION 29(NA 1+) CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dim nuc 2.90 SODIUM ION 15(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, CS+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dio nuc 2.40 SODIUM ION 14(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO LYSINE, IRIDIUM HEXAMINE SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diq nuc 2.70 SODIUM ION 9(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH BOUND TO HOMOARGININE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dir nuc 2.90 SODIUM ION 11(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH N6-1-IMINOETHYL-L-LYSINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dis nuc 3.10 SODIUM ION 11(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH FORM RNA (174-MER) RNA FREE FORM, RIBOSWITCH, RNA 3dix nuc 2.90 SODIUM ION 5(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, K+ ANOMALOUS DATA RNA (174-MER) RNA RIBOSWITCH, LYSINE, POTASSIUM CATION, RNA 3diy nuc 2.71 SODIUM ION 8(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, MN2+ SOAK RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3diz nuc 2.85 SODIUM ION 12(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE IN THE ABSENCE OF MG2+ RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA 3dj0 nuc 2.50 SODIUM ION 17(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH L-4-OXALYSINE RNA (174-MER) RNA LYSINE RIBSOWITCH, OXALYSINE, RNA 3dj2 nuc 2.50 SODIUM ION 8(NA 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, TL+ SOAK RNA (174-MER) RNA LYSINE, RIBOSWITCH, RNA 3gjl nuc 1.92 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF A DNA DUPLEX CONTAINING 7,8- DIHYDROPYRIDOL[2,3-D]PYRIMIDIN-2-ONE 5'-D(*CP*GP*CP*GP*AP*A)-3', 5'-D(P*TP*TP*(B7C)P*GP*CP*G)-3' DNA DNA, DUPLEX, BICYCLIC CYTOSINE, 7, 8-DIHYDROPYRIDOL[2, 3- D]PYRIMIDIN-2-ONE 3gnk nuc 2.10 SODIUM ION 2(NA 1+) CALCIUM BOUND TO THE HOLLIDAY JUNCTION SEQUENCE D(TCGGCGCCGA)4 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA HOLLIDAY JUNCTION CALCIUM ION CA2+, DNA 3gsj nuc 1.80 SODIUM ION NA 1+ A BULKY RHODIUM COMPLEX BOUND TO AN ADENOSINE-ADENOSINE DNA MISMATCH 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*AP*CP*CP*G)-3' DNA DNA MISMATCH, METALLOINTERCALATOR, DNA RECOGNITION 3nd3 nuc 1.37 SODIUM ION NA 1+ UHELIX 16-MER DSRNA 5'-R(*AP*GP*AP*GP*AP*AP*GP*AP*UP*UP*UP*UP*UP*UP*U CHAIN: A RNA DOUBLE-STRANDED RNA, RNA, U-HELIX, OLIGO-U TAIL, POLYU RNA 3nd4 nuc 1.52 SODIUM ION NA 1+ WATSON-CRICK 16-MER DSRNA 5'-R(*AP*GP*AP*GP*AP*AP*GP*AP*UP*CP*UP*UP*CP*UP*C CHAIN: A RNA DOUBLE-STRANDED RNA, RNA, 16 BASE PAIR RNA 3opi nuc 1.10 SODIUM ION 4(NA 1+) 7-DEAZA-2'-DEOXYADENOSINE MODIFICATION IN B-FORM DNA DNA (5'-D(*CP*GP*CP*GP*AP*(7DA)P*TP*TP*CP*GP*CP*G CHAIN: A, B DNA B-DNA, DODECAMER, 7-DEAZA-DEOXYADENOSINE, 7-DEAZA-DA, DNA 3pbx nuc 1.88 SODIUM ION NA 1+ STRONTIUM BOUND TO THE SEQUENCE D(CCGGCGCCGG) DNA DNA HOLLIDAY JUNCTION (HIGHER ORDER DNA STRUCTURE), INTERMEDIATE IN HOMOLOGOUS RECOMBINATION, DNA 3suh nuc 2.65 SODIUM ION 2(NA 1+) CRYSTAL STRUCTURE OF THF RIBOSWITCH, BOUND WITH 5-FORMYL-THF RIBOSWITCH RNA THREE-WAY JUNCTION, PSEUDOKNOT, GENE REGULATOR, THF, RNA 3sux nuc 2.90 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF THF RIBOSWITCH, BOUND WITH THF RIBOSWITCH RNA THREE-WAY JUNCTION, PSEUDOKNOT, GENE REGULATOR, THF, RNA 3tok nuc 1.74 SODIUM ION NA 1+ ASSAYING THE ENERGIES OF BIOLOGICAL HALOGEN BONDS. DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*TP*AP*TP*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, DNA 3tvb nuc 1.08 SODIUM ION 8(NA 1+) A HIGHLY SYMMETRIC DNA G-4 QUADRUPLEX/DRUG COMPLEX DNA (5'-D(*GP*GP*GP*G)-3') DNA/ANTIBIOTIC G-4 QUADRUPLEX, DAUNOMYCIN, DNA-DRUG COMPLEX, DNA-ANTIBIOTIC 3zp8 nuc 1.55 SODIUM ION 16(NA 1+) HIGH-RESOLUTION FULL-LENGTH HAMMERHEAD RIBOZYME HAMMERHEAD RIBOZYME, SUBSTRATE STRAND, HAMMERHEAD RIBOZYME, ENZYME STRAND RNA RNA, CATALYTIC RNA 420d nuc 1.90 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF A 16-MER RNA DUPLEX WITH NON-ADJACENT A(ANTI).G(SYN) MISMATCHES RNA (5'- R(*GP*CP*AP*GP*AP*GP*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3') RNA A-RNA STRUCTURE, MISMATCH A RNA 434d nuc 1.16 SODIUM ION NA 1+ 5'-R(*UP*AP*GP*CP*UP*CP*C)-3', 5'-R(*GP*GP*GP*GP*CP*UP*A)-3' RNA (5'-R(*UP*AP*GP*CP*UP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*GP*CP*UP*A)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM, DOUBLE HELIX 435d nuc 1.40 SODIUM ION 2(NA 1+) 5'-R(*UP*AP*GP*CP*CP*CP*C)-3', 5'-R(*GP*GP*GP*GP*CP*UP*A)-3' RNA (5'-R(*GP*GP*GP*GP*CP*UP*A)-3'), RNA (5'-R(*UP*AP*GP*CP*CP*CP*C)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM C70 MUTANT, DOUBLE HELIX 437d nuc 1.60 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF AN RNA PSEUDOKNOT FROM BEET WESTERN YEL INVOLVED IN RIBOSOMAL FRAMESHIFTING RNA PSEUDOKNOT RNA PSEUDOKNOT, RNA, TRIPLEX, VIRAL FRAMESHIFTING 464d nuc 1.23 SODIUM ION NA 1+ DISORDER AND TWIN REFINEMENT OF RNA HEPTAMER DOUBLE HELIX RNA (5'-R(*UP*AP*GP*CP*UP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*GP*CP*(IU)P*A)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM, DOUBLE HELIX, RIBONUCLEIC ACID, DISORDERED MODEL 466d nuc 1.16 SODIUM ION NA 1+ DISORDER AND TWIN REFINEMENT OF RNA HEPTAMER DOUBLE HELIX RNA (5'-R(*UP*AP*GP*CP*UP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*GP*CP*UP*A)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM, DOUBLE HELIX, RIBONUCLEIC ACID, DISORDERED MODEL 4aob nuc 2.95 SODIUM ION 4(NA 1+) SAM-I RIBOSWITCH CONTAINING THE T. SOLENOPSAE KT-23 IN COMPL S-ADENOSYL METHIONINE SAM-I RIBOSWITCH TRANSLATION TRANSLATION, K-TURN, RNA 4ez2 nuc 1.60 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF D(CCGGGACCGG)4 AS A FOUR-WAY JUNCTION A ANGSTROM RESOLUTION 5'-D(*CP*CP*GP*GP*GP*AP*CP*CP*GP*G)-3' DNA DNA FOUR-WAY JUNCTION, SODIUM ION, DNA 4fax nuc 3.10 SODIUM ION 8(NA 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF NA+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4gqd nuc 1.94 SODIUM ION 3(NA 1+) DNA HOLLIDAY JUNCTION STABILIZED BY CHLORINE HALOGEN BOND. DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*TP*AP*(UCL)P*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND, DNA 4mnb nuc 1.40 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE MARINE ANTICANCER VARIOLIN B AND DNA 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA DUPLEX, INTERCALATION, DRUG BINDING, NUCLEUS, DNA 4o5z nuc 1.75 SODIUM ION NA 1+ O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 4p43 nuc 2.00 SODIUM ION 2(NA 1+) CRYSTAL STRUCTURE OF THE BACTERIAL A1408U-MUTANT RIBOSOMAL D SITE (C2 FORM 2) 5'-R(*UP*UP*GP*CP*GP*UP*CP*UP*CP*GP*UP*CP*GP*AP*C *GP*UP*CP*GP*C)-3' RNA RIBOSOME, ANTIBIOTIC-RESISTANCE, AMINOGLYCOSIDE, DECODING, R 4p95 nuc 2.50 SODIUM ION NA 1+ SPECIATION OF A GROUP I INTRON INTO A LARIAT CAPPING RIBOZYM (CIRCULARLY PERMUTATED RIBOZYME) RNA (192-MER) RNA CATALYTIC RNA, LARIAT-CAPPING RIBOZYME, BRANCHING REACTION, FOLD, RNA 4r0d nuc 3.68 SODIUM ION 16(NA 1+) CRYSTAL STRUCTURE OF A EUKARYOTIC GROUP II INTRON LARIAT LIGATED EXONS, GROUP IIB INTRON LARIAT RNA LARIAT, RIBOZYME, 2'-5' PHOSPHODIESTER, RNA 4r44 nuc 2.69 SODIUM ION 4(NA 1+) RACEMIC CRYSTAL STRUCTURE OF A TETRAMOLECULAR DNA G-QUADRUPL 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA RACEMIC DNA, RACEMATES, DNA 4r48 nuc 2.33 SODIUM ION NA 1+ RACEMIC CRYSTAL STRUCTURE OF A CALCIUM-BOUND DNA FOUR-WAY JU 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4r49 nuc 1.28 SODIUM ION 2(NA 1+) RACEMIC CRYSTAL STRUCTURE OF A CALCIUM-BOUND B-DNA DUPLEX 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4r4d nuc 1.29 SODIUM ION NA 1+ RACEMIC CRYSTAL STRUCTURE OF A MAGNESIUM-BOUND B-DNA DUPLEX 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA 4rj1 nuc 0.92 SODIUM ION 2(NA 1+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4rkv nuc 0.88 SODIUM ION 2(NA 1+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4rne nuc 1.01 SODIUM ION 4(NA 1+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 5ay4 nuc 1.70 SODIUM ION NA 1+ CRYSTAL STRUCTURE OF RNA DUPLEX CONTAINING C-C BASE PAIRS OB THE PRESENCE OF HG(II) RNA (5'-R(*GP*GP*AP*CP*UP*(CBR)P*GP*AP*CP*UP*CP*C CHAIN: A, B RNA RNA, X-RAY ANALYSIS, METALLO BASE PAIR, AG(I), HG(II) 5btm nuc 2.78 SODIUM ION 2(NA 1+) CRYSTAL STRUCTURE OF AUUCU REPEATING RNA THAT CAUSES SPINOCE ATAXIA TYPE 10 (SCA10) RNA (55-MER) RNA NUCLEIC ACIDS, RNA STRUCTURE, REPEAT EXPANSION DISORDER, GEN DISEASE, RNA 5eyq nuc 2.30 SODIUM ION NA 1+ RACEMIC CRYSTAL STRUCTURES OF PRIBNOW BOX CONSENSUS PROMOTER (PNNA) COMPLEMENTARY STRAND, PRIBNOW BOX TEMPLATE STRAND DNA PRIBNOW BOX CONSENSUS SEQUENCE, -10 ELEMENT, TRANSCRIPTION INITIATION, B-DNA DOUBLE HELIX, DNA 5fj1 nuc 2.75 SODIUM ION 3(NA 1+) STRUCTURE OF THE STANDARD KINK TURN HMKT-7 AS STEM LOOP IN P212121 SPACE GROUP HMKT-7: KINK TURN MOTIF, RESIDUES 1-24 RNA RNA, KINK TURN, RNA MOTIF 5fjc nuc 1.71 SODIUM ION NA 1+ SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT C- SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk1 nuc 2.50 SODIUM ION 3(NA 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fke nuc 2.80 SODIUM ION 2(NA 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS GU SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkf nuc 2.80 SODIUM ION 2(NA 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS UC SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkg nuc 2.95 SODIUM ION 4(NA 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN (1-94) RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkh nuc 2.65 SODIUM ION 2(NA 1+) SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5gwl nuc NMR SODIUM ION 7(NA 1+) STRUCTURE OF TWO CCTG REPEATS DNA (5'-D(*CP*CP*TP*GP*CP*CP*TP*G)-3') DNA MINIDUMBBELL, TYPE II LOOP, DNA 5gwq nuc NMR SODIUM ION 7(NA 1+) STRUCTURE OF TWO TTTA REPEATS DNA (5'-D(*TP*TP*TP*AP*TP*TP*TP*A)-3') DNA MINIDUMBBELL, TYPE II LOOP, DNA 5hn2 nuc 1.50 SODIUM ION NA 1+ BASE PAIRING AND STRUCTURE INSIGHTS INTO THE 5-FORMYLCYTOSIN DUPLEX RNA (5'-R(*GP*UP*AP*(OFC)P*GP*UP*AP*C)-3') RNA RNA, 5-FORMYLCYTOSINE 5hnj nuc 1.24 SODIUM ION 2(NA 1+) BASE PAIRING AND STRUCTURE INSIGHTS INTO THE 5-FORMYLCYTOSIN DUPLEX RNA (5'-R(*GP*UP*AP*(OFC)P*GP*UP*AP*C)-3') RNA RNA, 5-FORMYLCYTOSINE 5jvw nuc 2.00 SODIUM ION 7(NA 1+) CRYSTAL STRUCTURE OF MITHRAMYCIN ANALOGUE MTM SA-TRP IN COMP 10-MER DNA AGAGGCCTCT. DNA (5'-D(*AP*GP*AP*GP*GP*CP*CP*TP*CP*T)-3') DNA/ANTIBIOTIC ANTI-CANCER AGENT, EWING SARCOMA, TRANSCRIPTION FACTOR, MINO DNA BINDING, DNA-ANTIBIOTIC COMPLEX 5l4o nuc 2.80 SODIUM ION NA 1+ STRUCTURE OF AN E.COLI INITIATOR TRNAFMET A1-U72 VARIANT TRNA (76-MER) TRANSLATION TRNA-TRANSLATION INITIATION, TRANSLATION 5lys nuc 2.32 SODIUM ION NA 1+ THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - GOLD DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA 5lyu nuc 2.20 SODIUM ION NA 1+ THE NATIVE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN RNA (58-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA 5ndh nuc 1.81 SODIUM ION 4(NA 1+) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P2 RNA (5'-R(*GP*(CBV) P*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*GP*C)-3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA 5ndi nuc 2.57 SODIUM ION NA 1+ THE STRUCTURE OF THE E.COLI GUANIDINE II RIBOSWITCH P1 STEM- RNA (5'- R(*UP*UP*UP*GP*CP*AP*GP*GP*AP*CP*GP*AP*CP*CP*UP*GP*(CBV)P*A 3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA 5nef nuc 1.91 SODIUM ION 6(NA 1+) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5neo nuc 1.69 SODIUM ION 2(NA 1+) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5nep nuc 1.60 SODIUM ION 4(NA 1+) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH METHYLGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, METHYLGUANIDINE, RNA 5neq nuc 1.69 SODIUM ION 7(NA 1+) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH AMINOGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, AMINOGUANIDINE, RNA 5nex nuc 1.72 SODIUM ION 8(NA 1+) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH AGMATINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA, 5nom nuc 1.93 SODIUM ION 2(NA 1+) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA
Code Class Resolution Description
1x26 nuc NMR N~3~-{3-[(7-METHYL-1,8-NAPHTHYRIDIN-2-YL)AMINO]-3- OXOPROPYL}-N~1~-[(7-OXO-7,8-DIHYDRO-1,8-NAPHTHYRIDIN- 2-YL)METHYL]-BETA-ALANINAMIDE 2(C24 H25 N7 O3) SOLUTION STRUCTURE OF THE AA-MISMATCH DNA COMPLEXED WITH NAPHTHYRIDINE-AZAQUINOLONE 5'-D(*CP*AP*TP*TP*CP*AP*GP*TP*TP*AP*G)-3', 5'-D(*CP*TP*AP*AP*CP*AP*GP*AP*AP*TP*G)-3' DNA DNA, AA MISMATCH, DRUG
Code Class Resolution Description 1qms nuc NMR N-BUTANE C4 H10 HEAD-TO-TAIL DIMER OF CALICHEAMICIN GAMMA-1-I OLIGOSACCHARIDE BOUND TO DNA DUPLEX, NMR, 9 STRUCTURES DNA (5'-D(*GP*CP*AP*CP*CP*TP*TP*CP*CP*TP*GP*C)-3'), DNA (5'-D(*GP*CP*AP*GP*GP*AP*AP*GP*GP*TP*GP*C)-3') DNA DEOXYRIBONUCLEIC ACID/CALICHEAMICIN, CALICHEAMICIN, HEAD-TO-TAIL DIMER, DNA, MINOR GROOVE BINDING, ANTITUMOR AGENT, LIGAND-DNA COMPLEX, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description
3eui nuc 2.20 3-[(2R)-2-ETHYLPIPERIDIN-1-YL]-N-[6-({3-[(2S)-2- ETHYLPIPERIDIN-1-YL]PROPANOYL}AMINO)ACRIDIN-3- YL]PROPANAMIDE C33 H45 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6042 IN A LARGE UNIT CELL 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6042, BSU6042, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX
Code Class Resolution Description 3em2 nuc 2.30 3,6-BIS[(3-MORPHOLINOPROPIONAMIDO)] ACRIDINE C27 H33 N5 O4 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6038 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6038, BSU6038, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, G-QUADRUPLEX, DNA
Code Class Resolution Description 1mp7 nuc NMR [(R)-4-((1,3-DIOXOLANE-2-OXY)-4-(S)-YL)-4-HYDROXY]- (R)-10-(2-METHYLAMINO-5-METHYL-2,6- DIDEOXYGALACTOPYRANOSYL-OXY)-(R)-11-(2-HYDROXY-5- METHYL-7-METHOXY-1-NAPHTHOYL-OXY)-(R)-12-S- GLUTATHIONYL-4,10,11,12-TETRAHYDROINDACENE C45 H52 N4 O18 S A THIRD COMPLEX OF POST-ACTIVATED NEOCARZINOSTATIN CHROMOPHORE WITH DNA. BULGE DNA BINDING FROM THE MINOR GROOVE 5'-D(*GP*CP*CP*AP*GP*AP*GP*AP*GP*C)-3' DNA DNA-DRUG COMPLEX, BULGE DNA, RECOGNITION OF ANTICANCER
Code Class Resolution Description
3eqw nuc 2.20 3,6-BIS{3-[(2R)-(2-ETHYLPIPERIDINO) ]PROPIONAMIDO}ACRIDINE C33 H45 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6042 IN SMALL UNIT CELL 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6042, BSU6042, ANTI- PARALLEL, BIMOLECULAR, MACROMLECULE, DNA, G-QUADRUPLEX, TELOMERE
3eui nuc 2.20 3,6-BIS{3-[(2R)-(2-ETHYLPIPERIDINO) ]PROPIONAMIDO}ACRIDINE C33 H45 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6042 IN A LARGE UNIT CELL 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6042, BSU6042, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX
Code Class Resolution Description
3eru nuc 2.00 3,6-BIS{3-[(2R)-2-METHYLPIPERIDINO) ]PROPIONAMIDO}ACRIDINE C31 H41 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6045 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6045, BSU6045, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, G-QUADRUPLEX, TELOMERE, DNA
Code Class Resolution Description 3es0 nuc 2.20 3,6-BIS[3-(4-METHYLPIPERIDINO)PROPIONAMIDO]ACRIDINE C31 H41 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6048 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6048, BSU6048, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX
Code Class Resolution Description
3et8 nuc 2.45 3,6-BIS{3-(3-[(3R)-METHYLPIPERIDINO) ]PROPIONAMIDO}ACRIDINE C31 H41 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6054 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6054, BSU6054, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX
Code Class Resolution Description 1ajf nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF THE P5B STEM LOOP FROM A GROUP I INTRON COMPLEXED WITH COBALT (III) HEXAMMINE, NMR, MINIMIZED AVERAGE STRUCTURE RNA (5'- R(*GP*AP*CP*AP*GP*GP*GP*GP*AP*AP*AP*CP*UP*UP*UP*GP*UP*C)- 3'): TETRALOOP OF TETRALOOP-TETRALOOP RECEPTOR TERTIARY INTERACTION RNA RIBONUCLEIC ACID, COBALT (III) HEXAMMINE, METAL BINDING, NMR, RNA STRUCTURE 1c0o nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF THE P5 HAIRPIN FROM A GROUP I INTRON COMPLEXED WITH COBALT (III) HEXAMMINE, NMR, 19 CONVERGED STRUCTURES RNA (5'- R(*GP*GP*GP*UP*CP*UP*UP*CP*GP*GP*GP*UP*CP*C)-3') RNA RIBONUCLEIC ACID, COBALT (III) HEXAMMINE, METAL BINDING, NMR, RNA STRUCTURE 1d8x nuc 1.20 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*TP*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DNA 1d9r nuc 1.50 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G-A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*(BRU)P*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DEOXYRIBONUCLEIC ACID, DNA 1dn8 nuc 1.50 COBALT HEXAMMINE(III) CO H18 N6 3+ STRUCTURE OF A Z-DNA WITH TWO DIFFERENT BACKBONE CHAIN CONFORMATIONS. STABILIZATION OF THE DECADEOXYOLIGONUCLEOTIDE D(CGTACGTACG) BY (CO(NH3)6)3+ BINDING TO THE GUANINE DNA (5'-D(*P*CP*GP*TP*AP*CP*GP*TP*AP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX 1f69 nuc 2.60 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF THE B-DNA HEXAMER GGCGCC WITH COBALT HEXAMINE DNA (5'-D(*GP*GP*CP*GP*CP*C)-3') DNA B-DNA, E-DNA, DOUBLE HELIX 1f78 nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF RNASE P RNA (M1 RNA) P4 STEM OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT (III) HEXAMINE, NMR, MINIMIZED AVERAGE STRUCTURE RNASE P RNA RIBOZYME, P4 DOMAIN: P4 STEM RNA RIBONUCLEASE P, RIBOZYME, TRANSFER RNA PROCESSING, P4 STEM, METAL BINDING SITE, METAL COMPLEX, COBALT (III) HEXAMMINE COMPLEX 1f79 nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF RNASE P RNA (M1 RNA) P4 STEM C70U MUTANT OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT(III) HEXAMMINE, NMR, MINIMIZED AVERAGE STRUCTURE RNASE P RNA RIBOZYME, P4 DOMAIN MUTANT: P4 STEM RNA RIBONUCLEASE P, RIBOZYME, TRANSFER RNA PROCESSING, P4 STEM, C70U MUTANT, METAL BINDING SITE, METAL COMPLEX, COBALT (III) HEXAMMINE COMPLEX 1f7h nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF THE RNASE P RNA (M1 RNA) P4 STEM OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT (III) HEXAMINE, NMR, ENSEMBLE OF 11 STRUCTURES RNASE P RNA RIBOZYME, P4 DOMAIN: P4 STEM RNA RIBONUCLEASE P, RIBOZYME, TRANSFER RNA PROCESSING, P4 STEM, METAL BINDING SITE, METAL COMPLEX, COBALT (III) HEXAMMINE COMPLEX 1f7i nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF THE RNASE P RNA (M1 RNA) P4 STEM C70U MUTANT OLIGORIBONUCLEOTIDE COMPLEXED WITH COBALT (III) HEXAMINE ,NMR, ENSEMBLE OF 12 STRUCTURES RNASE P RNA RIBOZYME, P4 DOMAIN: P4 STEM RNA RIBONUCLEASE P, RIBOZYME, TRANSFER RNA PROCESSING, P4 STEM, C70U MUTANT, METAL BINDING SITE, METAL COMPLEX, COBALT (III) HEXAMMINE COMPLEX 1gid nuc 2.50 COBALT HEXAMMINE(III) 4(CO H18 N6 3+) CRYSTAL STRUCTURE OF A GROUP I RIBOZYME DOMAIN: PRINCIPLES OF RNA PACKING P4-P6 RNA RIBOZYME DOMAIN RIBOZYME RNA, P4-P6 RIBOZYME DOMAIN OF THE TETRAHYMENA GROUP I INTRON 1ih1 nuc 2.00 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF THE B-DNA HEXAMER GGCGCC WITH COBALT HE RESOLVED TO 2.0 ANGSTROMS 5'-D(*GP*GP*CP*GP*CP*C)-3' DNA B TO A DNA TRANSITION, DNA TRANSITION, STRUCTURAL TRANSITION 1ixj nuc 2.50 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF D(GCGAAAGCT) CONTAINING PARALLEL- STRANDED DUPLEX WITH HOMO BASE PAIRS AND ANTI-PARALLEL DUPLEX WITH WATSON-CRICK BASE PAIRS 5'-D(*GP*CP*GP*AP*AP*AP*GP*CP*T)-3' DNA PARALLEL DNA, HOMO BASE PAIRS, PARALLEL-STRANDED HELIX, PARALLEL DUPLEX 1m77 nuc 1.25 COBALT HEXAMMINE(III) CO H18 N6 3+ NEAR ATOMIC RESOLUTION CRYSTAL STRUCTURE OF AN A-DNA DECAMER D(CCCGATCGGG): COBALT HEXAMMINE INTERACTIONS WITH A-DNA 5'-D(*CP*CP*CP*GP*AP*TP*CP*GP*GP*G)-3' DNA A-DNA, COBALT HEXAMMINE 1mdg nuc 1.50 COBALT HEXAMMINE(III) CO H18 N6 3+ AN ALTERNATING ANTIPARALLEL OCTAPLEX IN AN RNA CRYSTAL STRUC 5'-R(*UP*(BGM)GP*AP*GP*GP*U)-3' RNA TETRAPLEX, BASE TETRADS, BASE OCTADS, RNA 1mf5 nuc 1.10 COBALT HEXAMMINE(III) CO H18 N6 3+ GCATGCT QUADRUPLEX 5'-D(*GP*CP*AP*TP*GP*CP*T)-3' DNA QUADRUPLEX, ATOMIC RESOLUTION, DNA 1omk nuc 1.30 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THE CRYSTAL STRUCTURE OF D(CACG(5IU)G) 5'-D(*CP*AP*CP*GP*(5IU)P*G)-3' DNA Z-DNA, 5-IODO-2'-DEOXYURIDINE 1ub8 nuc 1.60 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) CRYSTAL STRUCTURE OF D(GCGAAGC), BENDING DUPLEX WITH A BULGE-IN RESIDUE 5'-D(*GP*CP*GP*AP*AP*GP*C)-3' DNA DNA, SHEARED G:A PAIR, BULGE-IN DUPLEX, G:AXA:G CROSSING 1ue2 nuc 1.40 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF D(GC38GAAAGCT) 5'-D(*GP*(C38)P*GP*AP*AP*AP*GP*CP*T)-3' DNA DNA, BASE-INTERCALATED DUPLEX, MINI-HAIRPIN STRUCTURE, SHEAR PAIR, ZIPPER-LIKE DUPLEX 1ue3 nuc 2.15 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF D(GCGAAAGC) CONTAINING HEXAAMMINECOBALT 5'-D(*GP*CP*GP*AP*AP*AP*GP*C)-3' DNA DNA, BASE-INTERCALATED DUPLEX, MINI-HAIRPIN STRUCTURE, SHEARED G:A PAIR, ZIPPER-LIKE DUPLEX 1uhx nuc 2.00 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF D(GCGAGAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*GP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID 1uhy nuc 1.70 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF D(GCGATAGC): THE BASE-INTERCALATED DUPL 5'-D(*GP*(CBR)P*GP*AP*TP*AP*GP*C)-3' DNA BASE-INTERCALATED DUPLEX, BASE-INTERCALATED MOTIF, SHEARED G DNA, DEOXYRIBONUCLEIC ACID 1x9c nuc 2.19 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) AN ALL-RNA HAIRPIN RIBOZYME WITH MUTATION U39C 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, JUNCT LOW SALT, S-TURN, E-LOOP, CATALYTIC RNA, 2'-OME, RNA 1xa2 nuc 1.71 COBALT HEXAMMINE(III) CO H18 N6 3+ COBALT HEXAMMINE INDUCED TAUTOMERIC SHIFT IN Z-DNA: THE STRUCTURE OF D(CGCGCA).D(TGCGCG) IN TWO CRYSTAL FORMS 5'-D(*TP*GP*CP*GP*CP*G)-3', 5'-D(*CP*GP*CP*GP*CP*A)-3' DNA DOUBLE HELIX, Z-DNA 1xam nuc 1.86 COBALT HEXAMMINE(III) CO H18 N6 3+ COBALT HEXAMMINE INDUCED TAUTAMERIC SHIFT IN Z-DNA: STRUCTURE OF D(CGCGCA).D(TGCGCG) IN TWO CRYSTAL FORMS. CGCGCA, TG, TGCGCG DNA DOUBLE HELIX, Z-DNA 1xst nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF E.COLI RNASE P RNA P4 STEM, U69A MUTATION, COMPLEXED WITH COBALT (III) HEXAMMINE. RNA (27-MER) RNA RIBONUCLEASE P RNA, RIBOZYME, TRANSFER RNA PROCESSING, P4 STEM, U69A MUTANT, METAL BINDING SITE, METAL COMPLEX, COBALT (III) HEXAMMINE COMPLEX 1xsu nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF E.COLI RNASE P RNA P4 STEM, U69C/C70U MUTATION, COMPLEXED WITH COBALT (III) HEXAMMINE. RNA (27-MER) RNA RIBONUCLEASE P RNA, RIBOZYME, TRANSFER RNA PROCESSING, P4 STEM, U69C/C70U MUTANT, METAL BINDING SITE, METAL COMPLEX, COBALT (III) HEXAMMINE COMPLEX 1zft nuc 2.33 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THE CRYSTAL STRUCTURE OF AN ALL-RNA MINIMAL HAIRPIN RIBOZYME MUTANT G8I AT THE CLEAVAGE SITE 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*CP*GP*GP*UP*GP*AP*IP*AP*AP*GP*GP*G)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3' RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, INOSI JUNCTIONLESS, LOW SALT, S-TURN, E-LOOP, RIBOSE ZIPPER, CATA RNA, 2'-OME, RNA 1zfv nuc 2.40 COBALT HEXAMMINE(III) CO H18 N6 3+ THE STRUCTURE OF AN ALL-RNA MINIMAL HAIRPIN RIBOZYME WITH MUTATION G8A AT THE CLEAVAGE SITE 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*AP*AP*AP*GP*GP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3' RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, JUNCTIONLESS, LOW SALT, S-TURN, E-LOOP, RIBOSE ZIPPER, CATALYTIC RNA 1zfx nuc 2.38 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THE STRUCTURE OF A MINIMAL ALL-RNA HAIRPIN RIBOZYME WITH THE MUTANT G8U AT THE CLEAVAGE SITE 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*UP*AP*AP*GP*GP*G)-3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3' RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, LOW SALT, S-TURN, E-LOOP, RIBOSE ZIPPER, CATALYTIC RNA 1zjg nuc 3.00 COBALT HEXAMMINE(III) CO H18 N6 3+ 13MER-CO 5'-D(*AP*TP*GP*GP*GP*GP*CP*GP*GP*GP*GP*CP*T)-3', 5'-D(*TP*AP*GP*CP*CP*CP*CP*GP*CP*CP*CP*CP*A)-3' DNA A-DNA, FLIPPED-OUT BASE, COBALT HEXAMMINE, PEG 400 212d nuc 1.90 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) INFLUENCE OF COUNTER-IONS ON THE CRYSTAL STRUCTURES OF DNA DECAMERS: BINDING OF [CO(NH3)6]3+ AND BA2+ TO A-DNA DNA (5'-D(*AP*CP*CP*GP*GP*CP*CP*GP*GP*T)-3') DNA A-DNA, DOUBLE HELIX 222d nuc 1.90 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) INFLUENCE OF COUNTER-IONS ON THE CRYSTAL STRUCTURES OF DNA DECAMERS: BINDING OF [CO(NH3)6]3+ AND BA2+ TO A-DNA DNA/RNA (5'-R(*GP*CP*)- D(*GP*TP*AP*TP*AP*CP*GP*C)-3') DNA/RNA A-DNA/RNA, DOUBLE HELIX 232d nuc 1.30 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE DNA DECAMER D(AGGCATGCCT) DNA (5'-D(*AP*GP*GP*CP*AP*TP*GP*CP*CP*T)-3') DNA A-DNA, DOUBLE HELIX, FLIPPED-OUT BASES 2b1d nuc 2.50 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) 5'-D(*GP*CP*AP*GP*AP*CP*GP*TP*CP*TP*GP*C)-3' METHIONINE REPR BINDING SITE 5'-D(*GP*CP*AP*GP*AP*CP*GP*TP*CP*TP*GP*C)-3' DNA SEQUENCE DEPENDENT DNA DEFORMABILITY, PROTEIN-DNA RECOGNITIO 2b57 nuc 2.15 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) GUANINE RIBOSWITCH C74U MUTANT BOUND TO 2,6-DIAMINOPURINE 65-MER: G-BOX RNA RNA RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLES, BASE QUADRUPLES, MRNA, PURINE 2bcy nuc 2.70 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF A MINIMAL, MUTANT ALL-RNA HAIRPIN RIBOZYME (U39C, G8MTU) 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*(MTU)P*AP*AP*GP*GP*G)-3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3' RNA RIBOZYME, G8, MTU, RNA 2bcz nuc 2.40 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF A MINIMAL, MUTANT ALL-RNA HAIRPIN RIBOZYME (U39C, G8I, 2'DEOXY A-1) 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', 5'-R(*UP*CP*CP*CP*(DA)P*GP*UP*CP*CP*AP*CP*CP*G)- 3'), 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*IP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, G8, INOSINE,, RNA 2cd5 nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ REFINEMENT OF RNASE P P4 STEMLOOP STRUCTURE USING RESIDUAL DIPOLAR COUPLINGS - COBALT(III) HEXAMMINE COMPLEX STRUCTURE 5'-R(*GP*GP*AP*AP*GP*UP*CP*CP*GP*GP*UP*CP*UP *UP*CP*GP*GP*AP*CP*CP*GP*GP*CP*UP*UP*CP*C)-3': P4 STEM, RESIDUES 1-27 NUCLEIC ACID COBALT (III) HEXAMMINE COMPLEX, METAL BINDING SITE, METAL COMPLEX, P4 STEM, RIBONUCLEASE P, RIBONUCLEIC ACID, RIBOZYME, TRANSFER RNA PROCESSING, NUCLEIC ACID 2cd6 nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ REFINEMENT OF RNASE P P4 STEMLOOP STRUCTURE USING RESIDUAL DIPOLAR COUPLING DATA, C70U MUTANT COBALT(III) HEXAMMINE COMPLEX 5'-R(*GP*GP*AP*AP*GP*UP*UP*CP*CP*GP *UP*CP*UP*UP*CP*GP*GP*AP*CP*CP*GP*GP*CP*UP*UP*CP*C)-3' NUCLEIC ACID C70U MUTANT, COBALT (III HEXAMMINE COMPLEX, METAL BINDING SITE, METAL COMPLEX, P4 STEM, RIBONUCLEASE P, RIBONUCLEIC ACID, RIBOZYME, TRANSFER RNA PROCESSING, NUCLEIC ACID 2d2k nuc 2.65 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF A MINIMAL, NATIVE (U39) ALL-RNA HAIRPIN 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*UP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, S-TURN, DUAL CONFORMATION, RNA 2d2l nuc 2.50 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) CRYSTAL STRUCTURE OF A MINIMAL, ALL-RNA HAIRPIN RIBOZYME WIT LINKER (C3) AT POSITION U39 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*(P1P) P*AP*UP*UP*AP*CP*CP*UP*GP*CP*C)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, PROPYL LINKER, RNA 2ees nuc 1.75 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) GUANINE RIBOSWITCH A21U, U75A MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, GUANINE, HYPOXANTHINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 2eet nuc 1.95 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) GUANINE RIBOSWITCH A21G, U75C MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, HYPOXANTHINE, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 2eeu nuc 1.95 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) GUANINE RIBOSWITCH U22A, A52U MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, GUANINE, HYPOXANTHINE, RNA-LIGAND COMPLEX, THREE-WAY JUNCTION, DOUBLE HELIX 2eev nuc 1.95 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) GUANINE RIBOSWITCH U22C, A52G MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, HYPOXANTHINE, GUANINE, THREE-WAY JUNCTION, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLE 2eew nuc 2.25 COBALT HEXAMMINE(III) 8(CO H18 N6 3+) GUANINE RIBOSWITCH U47C MUTANT BOUND TO HYPOXANTHINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, RNA-LIGAND COMPLEX, THREE-WAY JUNCTION, HYPOXANTHINE, GUANINE, BASE TRIPLE 2f1q nuc NMR COBALT HEXAMMINE(III) CO H18 N6 3+ SOLUTION STRUCTURE OF A DNA HOLLIDAY JUNCTION 42-MER DNA DNA, HOLLIDAY JUNCTION, BRANCHED NUCLEIC ACIDS,GENETIC RECOMBINATION, FOUR-WAY JUNCTION 2fgp nuc 2.40 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF A MINIMAL, ALL RNA HAIRPIN RIBOZYME WITH MODIFICATIONS (G8DAP, U39C) AT PH 8.6 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*(N6G)P*AP*AP*GP*GP*G)-3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3' RNA RIBOZYME, G8, DIAMINOPURINE, IN-LINE GEOMETRY, MUTANT, RNA 2fij nuc 1.19 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) CRYSTAL STRUCTURE ANALYSIS OF THE A-DNA DECAMER GCGT-2'OMEA- WITH INCORPORATED 2'-O-METHYLATED-ADENOSINE (2'OMEA) AND AR URIDINE (AU) 5'-D(*GP*CP*GP*TP*(A2M)P*(UAR)P*AP*CP*GP*C)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, A-FORM DNA, DNA 2fil nuc 1.69 COBALT HEXAMMINE(III) 7(CO H18 N6 3+) CRYSTAL STRUCTURE ANALYSIS OF THE A-DNA DECAMER GCGT-2'OMEA- WITH INCORPORATED 2'-O-METHYLATED-ADENOSINE (2'OMEA) AND 2' FLUOROARABINO-THYMIDINE (FAT) 5'-D(*GP*CP*GP*TP*(A2M)P*(TAF)P*AP*CP*GP*C)-3' DNA 2'-FLUOROARABINO ACID, SUGAR MODIFICATIONS, A-FORM DNA, DNA 2fqn nuc 2.30 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING A SITE 5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3' RNA RNA DUPLEX, RRNA, DECODING SITE, A SITE, HOMO SAPIENS CYTOPLASM 2g5k nuc 2.80 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING SITE COMPLEXED WITH APRAMYCIN 5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3' RNA AMINOGLYCOSIDE, ANTIBIOTICS, APRAMYCIN, RIBOSOME, DECODING SITE, HOMO SAPIENS, CYTOPLASM, RNA 2g9c nuc 1.70 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) MODIFIED PYRIMIDINES SPECIFICALLY BIND THE PURINE RIBOSWITCH GUANINE RIBOSWITCH RNA MRNA, RIBOSWITCH, TRIAMINOPYRIMIDINE, RNA-LIGAND COMPLEX 2i7e nuc NMR COBALT HEXAMMINE(III) 4(CO H18 N6 3+) GAAA TETRALOOOP RECEPTOR COMPLEX WITH ASSOCIATED COBALT HEXAMMINE. 43-MER RIBONUCLEIC ACID GAAA TETRALOOP, 11-NUCLEOTIDE RECEPTOR, RNA TERTIARY STRUCTURE, RIBONUCLEIC ACID 2jja nuc 1.30 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA 2npy nuc 2.65 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF A JUNCTIONED HAIRPIN RIBOZYME INCORPORA LINKER AND 2'-DEOXY 2'-AMINO U AT A-1 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(U2N)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3': S-TURN STRAND, 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA HAIRPIN RIBOZYME, MUTATION, S-TURN, E-LOOP, RIBOSE ZIPPER, C RNA, 2'-DEOXY 2'-AMINO, 9S LINKER, RNA 2npz nuc 3.35 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF JUNCTIONED HAIRPIN RIBOZYME INCORPORATING SYNTHETIC PROPYL LINKER 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3', 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3': S-TURN STRAND RNA RNA, RIBOZYME, HAIRPIN, E LOOP, S TURN, PROPYL 2oue nuc 2.05 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF A JUNCTIONLESS ALL-RNA HAIRPIN RIBOZYME ANGSTROMS RESOLUTION SUBSTRATE STRAND - MINIMAL JUNCTIONLESS HAIRPIN R CHAIN: A, LOOP B S-TURN STRAND, LOOP B RIBOZYME STRAND, LOOP A RIBOZYME STRAND RNA RNA, HAIRPIN RIBOZYME, ALL-RNA, MUTATION, LOW SALT, S-TURN, RIBOSE ZIPPER, CATALYTIC RNA 2p7d nuc 2.25 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) A MINIMAL, 'HINGED' HAIRPIN RIBOZYME CONSTRUCT SOLVED WITH MIMICS OF THE PRODUCT STRANDS AT 2.25 ANGSTROMS RESOLUTION RIBOZYME STRAND II, RIBOZYME STRAND I, 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; PRODUCT MIMIC; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 2p7e nuc 2.05 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) VANADATE AT THE ACTIVE SITE OF A SMALL RIBOZYME SUGGESTS A ROLE FOR WATER IN TRANSITION-STATE STABILIZATION 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, RIBOZYME STRAND I, RIBOZYME STRAND II, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; VANADATE; REACTION INTERMEDIATE; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 2p7f nuc 2.35 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THE NOVEL USE OF A 2',5'-PHOSPHODIESTER LINKAGE AS A REACTION INTERMEDIATE AT THE ACTIVE SITE OF A SMALL RIBOZYME SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP B RIBOZYME STRAND, LOOP A RIBOZYME STRAND RNA HAIRPIN RIBOZYME; 2',5' PHOSPHODIESTER; VANADATE; REACTION INTERMEDIATE; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 2p8d nuc 1.90 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) THE STRUCTURE OF THE DICKERSON SEQUENCE WITH AN INCORPORATED CENA RESIDUE 5'-D(*DCP*DGP*DCP*DGP*DAP*(XAR) P*DTP*DTP*DCP*DGP*DCP*DG)-3' DNA CENA, SUGAR MODIFICATION, DNA 2wna nuc 0.97 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE GNA 3'-G(BR)CGCGC-2' GNA RNA RNA, GNA, NUCLEIC ACID, GLYCOL NUCLEIC ACID, WATSON-CRICK BASE PAIR 2x2q nuc 1.90 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF AN 'ALL LOCKED' LNA DUPLEX AT 1.9 ANGST RESOLUTION LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX, LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX DNA DNA, MODIFIED NUCLEIC ACID, LOCKED NUCLEIC ACID, THERMOSTABI 2xnw nuc 1.50 COBALT HEXAMMINE(III) 7(CO H18 N6 3+) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO A TRIAZOLO-TRIAZOLE-DIAMINE LIGAND IDENTIFIED BY VIRTUAL SCRE GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 2xnz nuc 1.59 COBALT HEXAMMINE(III) 6(CO H18 N6 3+) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO ACETOGUAN IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA, APTAMER, RNA-LIGAND COMPLEX, MRNA 2xo0 nuc 1.70 COBALT HEXAMMINE(III) 6(CO H18 N6 3+) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO 24-DIAMINO-1,3,5-TRIAZINE IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 2xo1 nuc 1.60 COBALT HEXAMMINE(III) 7(CO H18 N6 3+) XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO N6-METHYL GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA 312d nuc 1.80 COBALT HEXAMMINE(III) CO H18 N6 3+ Z-DNA HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE WATSON- CRICK BASE PAIR DNA (5'-D(*CP*CP*GP*CP*GP*CP*G)-3'), DNA (5'-D(*GP*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, OVERHANGING BASE, FLIPPED-OUT BASE 313d nuc 1.68 COBALT HEXAMMINE(III) CO H18 N6 3+ Z-DNA HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE HOOGSTEEN BASE PAIR DNA (5'-D(*GP*(5CM)P*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, OVERHANGING BASE, FLIPPED- OUT BASE 314d nuc 1.90 COBALT HEXAMMINE(III) CO H18 N6 3+ Z-DNA HEXAMER WITH 5' OVERHANGS THAT FORM A REVERSE WOBBLE BASE PAIR DNA (5'-D(*GP*CP*GP*CP*GP*CP*G)-3'), DNA (5'-D(*TP*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, OVERHANGING BASE, FLIPPED-OUT BASE 331d nuc 1.65 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF D(GCGCGCG) WITH 5'-OVERHANG G'S DNA (5'-D(*GP*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, OVERHANGING BASE, FLIPPED-OUT BASE 362d nuc 1.30 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THE STRUCTURE OF D(TGCGCA)2 AND A COMPARISON TO OTHER Z-DNA HEXAMERS DNA (5'-D(*TP*GP*CP*GP*CP*A)-3') DNA Z-DNA, DOUBLE HELIX 376d nuc 2.10 COBALT HEXAMMINE(III) CO H18 N6 3+ A ZIPPER-LIKE DNA DUPLEX D(GCGAAAGCT) DNA (5'-D(*GP*(CBR)P*GP*AP*AP*AP*GP*CP*T)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, OVERHANGING BASE, MODIFIED, MISMATCHED 3b58 nuc 2.65 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38G MUTATION AND A 2',5'-PHOSPHODIESTER LINKAGE AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; 2', 5' PHOSPHODIESTER, RNA 3b5a nuc 2.35 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF A MINIMALLY HINGED HAIRPIN RIBOZYME INC A38G MUTATION WITH A 2'OME MODIFICATION AT THE ACTIVE SITE LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND29-MER LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2'O-METHYL, RIBOZYME, RNA 3b5f nuc 2.70 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF A MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATING THE ADE38DAP MUTATION AND A 2',5' PHOSPHODIESTER LINKAGE AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; 2, 6 DIAMINOPURINE; RNA; 2', 5' PHOSPHODIESTER LINKAGE 3b5s nuc 2.25 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES A38DAP MUTATI O-METHYL MODIFICATION AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; RNA; 2, 6 DIAMINOPURINE; 2'-O-METHYL, RNA 3b91 nuc 2.75 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES ADE38(2AP) AND 2',5'-PHOSPHODIESTER LINKAGE MUTATIONS AT THE ACTIVE SITE 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME; 2'5' PHOSPHODIESTER; RNA; 2-AMINOPURINE 3bbi nuc 2.35 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATING A38(2AP) 2'-O-ME MODIFICATIONS NEAR ACTIVE SITE LOOP A SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2-AMINOPURINE, 2'O-METHYL, PHOSPHORYL TRAN RNA, LINKER 3bbk nuc 2.75 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) MIMINALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38C AND 2'5'-PHOSPHODIESTER LINKAGE WITHIN ACTIVE SITE LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME, RNA, PHOSPHORYL TRANSFER, A38C, 2'5'- PHOSPHODIESTER, REVERSE LINKAGE 3bbm nuc 2.65 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38C AND MODIFICATION AT ACTIVE SITE LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME, PHOSPHORYL TRANSFER, 2'O-METHYL, RNA, SMAL RIBOZYME 3bnl nuc 2.60 COBALT HEXAMMINE(III) 8(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING A SITE IN THE PRESENCE OF [CO(NH3)6]CL3 A SITE OF BACTERIAL RIBOSOME RNA RIBOSOME, DECODING SITE, RNA 3bnt nuc 2.30 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF [CO(NH3)6]CL3 (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME RNA RIBOSOME, DECODING SITE, RNA 3cqs nuc 2.80 COBALT HEXAMMINE(III) CO H18 N6 3+ A 3'-OH, 2',5'-PHOSPHODIESTER SUBSTITUTION IN THE HAIRPIN RIBOZYME ACTIVE SITE REVEALS SIMILARITIES WITH PROTEIN RIBONUCLEASES 19-MER RIBOZYME STRAND, 29-MER RIBOZYME STRAND WITH S9L SYNTHETIC LINKER AT 13TH POSITION, 13-MER SUBSTRATE STRAND WITH 3'-OH, 2',5'- PHOSPHODIESTER COVALENTLY LINKING 5TH AND 6TH NUCLEOTIDES RNA 2',5' PHOSPHODIESTER; HAIRPIN RIBOZYME; REACTION- INTERMEDIATE; TRANSITION-STATE STABILIZATION; RIBONUCLEASE; PHOSPHORYL-TRANSFER, RNA 3ds7 nuc 1.85 COBALT HEXAMMINE(III) 11(CO H18 N6 3+) STRUCTURE OF AN RNA-2'-DEOXYGUANOSINE COMPLEX 67-MER RNA RNA, RNA-LIGAND COMPLEX, RIBOSWITCH 3f30 nuc 3.15 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO FMN, COBALT SOAK. FMN RIBOSWITCH RNA FMN, RIBOSWITCH, TRANSCRIPTION, COBALT HEXAMINE, RNA 3fl6 nuc 1.17 COBALT HEXAMMINE(III) 7(CO H18 N6 3+) INFLUENCE OF THE INCORPORATION OF A CYCLOHEXENYL NUCLEIC ACI RESIDUE ONTO THE SEQUENCE D(GCGTGCG)/D(CGCACGC) 5'-D(*CP*GP*CP*AP*CP*GP*C)-3', 5'-D(*GP*CP*GP*(XTR)P*GP*CP*G)-3' DNA DOUBLE HELIX, CENA, SUGAR MODIFICATION, RIGHT-HANDED, DNA 3fo4 nuc 1.90 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH C74U MUTANT BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH C74U MUTANT RNA MRNA, RIBOSWITCH, 6-CHLOROGUANINE, ADENINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 3fo6 nuc 1.90 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH BOUND TO 6-O- METHYLGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, 6-O-METHYLGUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION 3ft6 nuc 1.12 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) CRYSTAL STRUCTURE OF PROFLAVINE IN COMPLEX WITH A DNA HEXAMER DUPLEX 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA DNA, DNA BINDING, PROFLAVINE, INTERCALATOR 3g4m nuc 2.40 COBALT HEXAMMINE(III) 11(CO H18 N6 3+) CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH BOUND TO 2- AMINOPURINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, 2-AMINOPURINE, GUANINE, THREE-WAY JUNCTION, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE-TRIPLE. 3gao nuc 1.90 COBALT HEXAMMINE(III) 13(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE GUANINE RIBOSWITCH BOUND TO XANTHINE. GUANINE RIBOSWITCH RNA RIBOSWITCH, GUANINE, XANTHINE, MRNA, RNA_LIGAND COMPLEX, THREE-WAY JUNCTION 3ger nuc 1.70 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) GUANINE RIBOSWITCH BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 3ges nuc 2.15 COBALT HEXAMMINE(III) 8(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE GUANINE RIBOSWITCH C74U MUTANT BOUND TO 6-O-METHYLGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 3gog nuc 2.10 COBALT HEXAMMINE(III) 8(CO H18 N6 3+) GUANINE RIBOSWITCH A21G,U75C MUTANT BOUND TO 6-CHLOROGUANINE GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, THREE-WAY JUNCTION, BASE TRIPLE 3got nuc 1.95 COBALT HEXAMMINE(III) 11(CO H18 N6 3+) GUANINE RIBOSWITCH C74U MUTANT BOUND TO 2-FLUOROADENINE. GUANINE RIBOSWITCH RNA RIBOSWITCH, MRNA, GUANINE, RNA-LIGAND COMPLEX, DOUBLE HELIX, BASE TRIPLE, THREE-WAY JUNCTION 3gs1 nuc 2.85 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) AN ALL-RNA HAIRPIN RIBOZYME WITH MUTATION A38N1DA RNA (5'- R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)-3'), RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3'), RNA (5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)- 3'), RNA (5'- R(P*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3') RNA RNA, RIBOZYME, HAIRPIN RIBOZYME, N1-DEAZAADENOSINE 3gs5 nuc 2.75 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) AN ALL-RNA HAIRPIN RIBOZYME A38N1DA VARIANT WITH A PRODUCT MIMIC SUBSTRATE STRAND RNA (36-MER), RNA (25-MER) RNA HAIRPIN RIBOZYME, RNA RIBOZYME, N1-DEAZAADENOSINE 3gs8 nuc 2.85 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) AN ALL-RNA HAIRPIN RIBOZYME A38N1DA38 VARIANT WITH A TRANSITION-STATE MIMIC SUBSTRATE STRAND RNA (5'- R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)-3'), RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3'), RNA (5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)- 3'), RNA (5'- R(P*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3') RNA HAIRPIN RIBOZYME, RNA RIBOZYME, N1-DEAZAADENOSINE 3i2q nuc 2.90 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH 2'OME SUBSTRA AND N1-DEAZAADENOSINE AT POSITION A9 DNA/RNA (30-MER), 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2r nuc 2.80 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE WITH N1-DEAZAADENOSINE AT POSITION A9 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2s nuc 2.75 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2'OME SUBST N1-DEAZAADENOSINE AT POSITION A10 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', DNA/RNA (30-MER) RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2u nuc 2.80 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE HAIPRIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE AND N1-DEAZAADENOSINE AT POSITION A10 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3lln nuc 3.00 COBALT HEXAMMINE(III) CO H18 N6 3+ COMPARISON BETWEEN THE ORTHORHOMBIC AN TETRAGONAL FORM OF TH SEQUENCE D(GCG(XT)GCG)/D(CGCACGC). DNA (5'-D(*GP*CP*GP*(XTR)P*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*AP*CP*GP*C)-3') DNA DOUBLE HELIX, CENA, SUGAR MODIFICATION, RIGHT-HANDED, DNA 3npq nuc 2.18 COBALT HEXAMMINE(III) 15(CO H18 N6 3+) STRUCTURE OF THE S-ADENOSYLHOMOCYSTEINE RIBOSWITCH AT 2.18 A S-ADENOSYLHOMOCYSTEINE RIBOSWITCH RNA RNA, RIBOSWITCH, S-ADENOSYL-HOMOCYSTEINE 3p59 nuc 2.18 COBALT HEXAMMINE(III) 10(CO H18 N6 3+) FIRST CRYSTAL STRUCTURE OF A RNA NANOSQUARE RNA (5'-R(*CP*CP*GP*GP*CP*AP*GP*CP*CP*U)-3'), RNA (5'-R(*CP*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP P*G)-3') RNA RNA SQUARE, RNA 3rkf nuc 2.50 COBALT HEXAMMINE(III) 26(CO H18 N6 3+) CRYSTAL STRUCTURE OF GUANINE RIBOSWITCH C61U/G37A DOUBLE MUT TO THIO-GUANINE GUANINE RIBOSWITCH RNA THREE-WAY JUNCTION, RIBOSWITCH, M-RNA, THIOGUANINE, RNA 3skr nuc 3.10 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE, COBALT HEXAMMINE SOAK RNA (66-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 4f2x nuc 1.57 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) STRUCTURE OF 3'-FLUORO CYCLOHEXENYL NUCLEIC ACID HEPTAMER 5'-D(*CP*GP*CP*AP*CP*GP*C)-3', 5'-D(*GP*CP*GP*(XTF)P*GP*CP*G)-3' DNA FLUORO CYCLOHEXENYL NUCLEIC ACID, F-CENA, MODIFIED DNA, B-FO DNA 4f8g nuc 1.93 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THREE-DIMENSIONAL DNA LATTICES WITH NON-CANONICAL BASE PAIRS DNA (5'- D(*G*CP*GP*AP*AP*AP*GP*GP*GP*CP*AP*CP*GP*TP*GP*CP*CP*CP*T)- CHAIN: A DNA NON-CANONICAL DNA, DNA NANOTECHNOLOGY, CRYSTAL DESIGN, PARAL DNA 4f8i nuc 2.00 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) THREE-DIMENSIONAL DNA LATTICES WITH NON-CANONICAL BASE PAIRS DNA (5'- D(*G*CP*GP*AP*AP*AP*GP*GP*GP*CP*AP*CP*GP*TP*GP*CP*CP*CP*T)- CHAIN: A DNA NON-CANONICAL DNA, DNA NANOTECHNOLOGY, CRYSTAL DESIGN, PARAL DNA 4fe5 nuc 1.32 COBALT HEXAMMINE(III) 6(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE XPT-PBUX GUANINE RIBOSWITCH APTAMER COMPLEX WITH HYPOXANTHINE XPT-PBUX GUANINE RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENE RE ELEMENT, HYPOXANTHINE, RNA 4fej nuc 1.50 COBALT HEXAMMINE(III) 7(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE A24U MUTANT XPT-PBUX GUANINE RIBOSW APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE A24U MUTANT OF THE B. SUBTILIS XPT-PBUX GUANINE R APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, HYPOXANTHINE, RNA 4fel nuc 1.60 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE U25A/A46G MUTANT OF THE XPT-PBUX GU RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE U25A/A46G MUTANT OF THE B. SUBTILIS XPT-PBUX GUAN RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, HYPOXANTHINE, RNA 4fen nuc 1.35 COBALT HEXAMMINE(III) 7(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE A24U/U25A/A46G MUTANT XPT-PBUX GUAN RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH HYPOXANTHINE A24U/U25A/A46G MUTANT OF THE B. SUBTILIS XPT-PBUX RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, RNA 4feo nuc 1.60 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE AU25A/A46G/C74U MUTANT XPT-PBUX GUA RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH 2,6-DIAMINOPURINE U25A/A46G/C74U MUTANT OF THE B. SUBTILIS XPT-PBUX RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, 2,6-DIAMINOPURINE, RNA 4fep nuc 1.65 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) CRYSTAL STRUCTURE OF THE A24U/U25A/A46G/C74U MUTANT XPT-PBUX RIBOSWITCH APTAMER DOMAIN IN COMPLEX WITH 2,6-DIAMINOPURINE A24U/U25A/A46G/C74U MUTANT OF THE B. SUBTILIS XPT GUANINE RIBOSWITCH APTAMER DOMAIN RNA THREE-WAY JUNCTION WITH DISTAL TERTIARY INTERACTION, GENETIC REGULATORY ELEMENT, 2,6-DIAMINOPURINE, RNA 4g6p nuc 2.64 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) MINIMAL HAIRPIN RIBOZYME IN THE PRECATALYTIC STATE WITH A38P LOOP A SUBSTRATE STRAND, LOOP B OF THE RIBOZYME STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4g6s nuc 2.84 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH A38P V LOOP A SUBSTRATE STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP B OF THE RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4l81 nuc 2.95 COBALT HEXAMMINE(III) 9(CO H18 N6 3+) STRUCTURE OF THE SAM-I/IV RIBOSWITCH (ENV87(DELTAU92, DELTAG SAM-I/IV VARIANT RIBOSWITCH APTAMER DOMAIN: APTAMER DOMAIN RNA RIBOSWITCH, GENE REGULATION, SAM BINDING, RNA 4mnb nuc 1.40 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE MARINE ANTICANCER VARIOLIN B AND DNA 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA DUPLEX, INTERCALATION, DRUG BINDING, NUCLEUS, DNA 4pco nuc 1.32 COBALT HEXAMMINE(III) 12(CO H18 N6 3+) CRYSTAL STRUCTURE OF DOUBLE-STRANDED RNA WITH FOUR TERMINAL BASE PAIRS RNA (5'-D(*GP*GP*UP*GP*GP*CP*UP*GP*UP*U)-3') RNA GU WOBBLE BASE PAIR MOTIF, RNA 4u6k nuc 1.50 COBALT HEXAMMINE(III) 3(CO H18 N6 3+) CRYSTAL STRUCTURE OF DNA/RNA DUPLEX CONTAINING 2'-4'-BNA-NC RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*(NCU)P*(NTT)P*CP*TP*TP*CP*TP*(NTT)P*(N CHAIN: B, D DNA/RNA DNA/RNA DUPLEX, ANTISENSE, BRIDGED NUCLEIC ACID, DNA-RNA COM 4u6l nuc 1.90 COBALT HEXAMMINE(III) CO H18 N6 3+ CRYSTAL STRUCTURE OF DNA/RNA DUPLEX OBTAINED IN THE PRESENCE [CO(NH3)6]CL3 AND SRCL2 DNA (5'-D(*(5CM)P*TP*CP*TP*TP*CP*TP*TP*(5CM))-3') CHAIN: B, RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3') DNA/RNA DNA/RNA HYBRID DUPLEX, ANTISENSE, DNA-RNA COMPLEX 4wfl nuc 2.49 COBALT HEXAMMINE(III) 15(CO H18 N6 3+) STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN RNA: RESIDUES 3-81,RESIDUES 3-81 RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST 4wfm nuc 3.10 COBALT HEXAMMINE(III) 23(CO H18 N6 3+) STRUCTURE OF THE COMPLETE BACTERIAL SRP ALU DOMAIN BACILLUS SUBTILIS SMALL CYTOPLASMIC RNA (SCRNA),R CHAIN: A, B RNA NON-CODING, RNA, SRP RNA, ELONGATION ARREST 5c7u nuc 3.05 COBALT HEXAMMINE(III) 7(CO H18 N6 3+) 5'-MONOPHOSPHATE WT GUANINE RIBOSWITCH BOUND TO HYPOXANTHINE 5'-MONOPHOSPHATE WT GUANINE RIBOSWITCH RNA EXPANDED RNA; RIBOSWITCH; UNNATURAL BASE PAIR, RNA 5c7w nuc 3.22 COBALT HEXAMMINE(III) 8(CO H18 N6 3+) 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH BOUND TO HYPOXANTHIN 5'-MONOPHOSPHATE Z:P GUANINE RIBOSWITCH RNA EXPANDED RNA; RIBOSWITCH; UNNATURAL BASE PAIR, RNA 5d8t nuc 1.20 COBALT HEXAMMINE(III) 4(CO H18 N6 3+) RNA OCTAMER CONTAINING (S)-5' METHYL, 2'-F U. RNA OLIGONUCLEOTIDE CONTAINING (S)-C5'-ME-2'-FU RNA RNA, MODIFIED BASE 5dek nuc 1.99 COBALT HEXAMMINE(III) 2(CO H18 N6 3+) RNA OCTAMER CONTAINING DT RNA OLIGONUCLEOTIDE CONTAINING DT RNA RNA, OLIGONUCLEOTIDE 5jev nuc 0.99 COBALT HEXAMMINE(III) CO H18 N6 3+ DEL-[RU(PHEN)2(DPPZ]2+ BOUND TO D(TCGGCGCCGA) WITH COBALT HE DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA, RUTHENIUM, CROSS-LINKING, DNA PROBE 5ktj nuc 2.97 COBALT HEXAMMINE(III) 10(CO H18 N6 3+) CRYSTAL STRUCTURE OF PISTOL, A CLASS OF SELF-CLEAVING RIBOZY RNA (5'-R(*UP*CP*UP*GP*CP*UP*CP*UP*CP*GP*UP*CP*CP 3'), PISTOL (50-MER) RNA RIBOZYME, SELF-CLEAVAGE, INTERNAL TRANSESTERIFICATION, RNA
Code Class Resolution Description 3eum nuc 1.78 3,6-BIS[3-(AZEPAN-1-YL)PROPIONAMIDO]ACRIDINE C31 H41 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6066 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXTYRICHA NOVA, BSU-6066, BSU6066, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX
Code Class Resolution Description 1kvh nuc NMR SPIRO[[7-METHOXY-5-METHYL-1,2-DIHYDRO-NAPHTHALENE]-3, 1'-[5-HYDROXY-9-[2-METHYLAMINO-2,6- DIDEOXYGALACTOPYRANOSYL-OXY]-5-(2-OXO-[1,3]DIOXOLAN-4- YL)-3A,5,9,9A-TETRAHYDRO-3H-1-OXA-CYCLOPENTA[A]-S- INDACEN-2-ONE]] C35 H36 N O12 1+ NCSI-GB-BULGE-DNA COMPLEX INDUCED FORMATION OF A DNA BULGE STRUCTURE BY A MOLECULAR WEDGE LIGAND-POST-ACTIVATED NEOCARZINOSTATIN CHROMOPHORE 5'-D(*GP*CP*AP*AP*TP*TP*CP*GP*GP*G)-3', 5'-D(*CP*CP*CP*GP*AP*TP*GP*C)-3' DNA DNA 2neo nuc NMR SPIRO[[7-METHOXY-5-METHYL-1,2-DIHYDRO-NAPHTHALENE]-3, 1'-[5-HYDROXY-9-[2-METHYLAMINO-2,6- DIDEOXYGALACTOPYRANOSYL-OXY]-5-(2-OXO-[1,3]DIOXOLAN-4- YL)-3A,5,9,9A-TETRAHYDRO-3H-1-OXA-CYCLOPENTA[A]-S- INDACEN-2-ONE]] C35 H36 N O12 1+ SOLUTION NMR STRUCTURE OF A TWO-BASE DNA BULGE COMPLEXED WITH AN ENEDIYNE CLEAVING ANALOG, 11 STRUCTURES DNA (5'- D(*CP*CP*CP*GP*AP*TP*GP*CP*PGE*GP*CP*AP*AP*TP*TP*CP*GP*GP*G )-3') DNA DNA, BULGE DNA, ENEDIYNE ANTIBIOTICS ANTITUMOR AGENTS, CARBOHYDRATES, BULGE BINDING LIGANDS, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 4u6k nuc 1.50 [(1R,5R,7R,8S)-7-(4-AMINO-5-METHYL-2-OXOPYRIMIDIN- 1(2H)-YL)-8-HYDROXY-3-METHYL-2,6-DIOXA-3- AZABICYCLO[3.2.1]OCT-5-YL]METHYL DIHYDROGEN PHOSPHATE 4(C12 H19 N4 O8 P) CRYSTAL STRUCTURE OF DNA/RNA DUPLEX CONTAINING 2'-4'-BNA-NC RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*(NCU)P*(NTT)P*CP*TP*TP*CP*TP*(NTT)P*(N CHAIN: B, D DNA/RNA DNA/RNA DUPLEX, ANTISENSE, BRIDGED NUCLEIC ACID, DNA-RNA COM
Code Class Resolution Description 2o4y nuc NMR 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-5-NITRO-1H-INDOLE-3-CARBOXAMIDE C14 H16 N3 O9 P SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING THE UNIVERSAL BASE 5-NITROINDOLE-3-CARBOXAMIDE DNA (5'-D(*GP*TP*AP*CP*(NCX)P*AP*CP*G)-3'), DNA (5'-D(*CP*GP*TP*TP*GP*TP*AP*C)-3') DNA DNA UNIVERSAL BASE NITROINDOLE INTERCALATION DYNAMICS
Code Class Resolution Description 1nem nuc NMR 2-DEOXY-D-STREPTAMINE C6 H15 N2 O3 1+ SACCHARIDE-RNA RECOGNITION IN THE NEOMYCIN B / RNA APTAMER COMPLEX 5'- R(*GP*GP*AP*CP*UP*GP*GP*GP*CP*GP*AP*GP*AP*AP*GP*UP*UP*UP*AP *GP*UP*CP*C)-3' RNA RNA APTAMER, AMINOGLYCOSIDE, ANTIBIOTIC
Code Class Resolution Description 1cx3 nuc NMR N,N'-(3,7-DIAZANONYLENE)-BIS-NAPHTHALIMIDE C31 H30 N4 O4 2+ SOLUTION STRUCTURE OF A COMPLEX BETWEEN D(ATGCAT)2 AND THE ANTITUMOR BISNAPHTHALIMIDE LU-79553 DNA (5'-D(*AP*TP*GP*CP*AP*T)-3') DNA TOPOISOMERASE, ANTICANCER, DNA, NAPHTHALIMIDE, INTERCALATION, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 2g92 nuc 1.61 (1S)-1,4-ANHYDRO-1-(2,4-DIFLUORO-5-METHYLPHENYL)-5-O- PHOSPHONO-D-RIBITOL 2(C12 H15 F2 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE RNA DODECAMER CGC-(NF2)- AAUUAGCG, WITH AN INCORPORATED 2,4-DIFLUOROTOLUYL RESIDUE (NF2) 5'-R(*CP*GP*CP*(NF2)P*AP*AP*UP*UP*AP*GP*CP*G)-3' RNA 2, 4-DIFLUOROTOLUYL NUCLEOSIDE, CHEMICAL MODIFICATION, RNA, RNA INTERFERENCE, HYDROGEN BONDING 2q1o nuc 1.10 (1S)-1,4-ANHYDRO-1-(2,4-DIFLUORO-5-METHYLPHENYL)-5-O- PHOSPHONO-D-RIBITOL 4(C12 H15 F2 O7 P) CRYSTAL STRUCTURE ANALYSIS OF THE RNA DODECAMER CGC-NF2- AAUUGGCG, WITH AN INCORPORATED 2,4-DIFLUOROTOLUYL RESIDUE (NF2) RNA (5'-R(*CP*GP*CP*(NF2) P*AP*AP*UP*UP*GP*GP*CP*G)-3') RNA 2,4-DIFLUOROTOLUYL NUCLEOSIDE, CHEMICAL MODIFICATION, RNA, RNAI, HYDROGEN BOND
Code Class Resolution Description 182d nuc 1.80 NOGALAMYCIN 2(C39 H49 N O16) DNA-NOGALAMYCIN INTERACTIONS: THE CRYSTAL STRUCTURE OF D(TGATCA) COMPLEXED WITH NOGALAMYCIN DNA (5'-D(*TP*GP*AP*TP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d17 nuc 2.00 NOGALAMYCIN C39 H49 N O16 DNA-NOGALAMYCIN INTERACTIONS DNA (5'-D(*(5CM)P*GP*TP*AP*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE 1d21 nuc 1.70 NOGALAMYCIN 2(C39 H49 N O16) BINDING OF THE ANTITUMOR DRUG NOGALAMYCIN AND ITS DERIVATIVE STRUCTURAL COMPARISON DNA (5'-D(*(5CM)P*GP*TP*(AS)P*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE 1qch nuc NMR NOGALAMYCIN C39 H49 N O16 STRUCTURE, DYNAMICS AND HYDRATION OF THE NOGALAMYCIN- D(ATGCAT)2 COMPLEX DETERMINED BY NMR AND MOLECULAR DYNAMICS SIMULATIONS IN SOLUTION 5'-D(*AP*TP*GP*CP*AP*T)-3' DNA NOGALAMYCIN, NOGALAMYCIN-DNA COMPLEX, NMR SPECTROSCOPY, ANTHRACYCLINE ANTIBIOTIC, HYDRATION 224d nuc 1.40 NOGALAMYCIN 2(C39 H49 N O16) DNA-DRUG REFINEMENT: A COMPARISON OF THE PROGRAMS NUCLSQ, PROLSQ, SHELXL93 AND X-PLOR, USING THE LOW TEMPERATURE D(TGATCA)-NOGALAMYCIN STRUCTURE DNA (5'-D(*TP*GP*AP*TP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 245d nuc 1.40 NOGALAMYCIN 2(C39 H49 N O16) DNA-DRUG REFINEMENT: A COMPARISON OF THE PROGRAMS NUCLSQ, PROLSQ, SHELXL93 AND X-PLOR, USING THE LOW TEMPERATURE D(TGATCA)-NOGALAMYCIN STRUCTURE DNA (5'-D(*TP*GP*AP*TP*CP*A)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 258d nuc 1.58 NOGALAMYCIN 4(C39 H49 N O16) FACTORS AFFECTING SEQUENCE SELECTIVITY ON NOGALAMYCIN INTERCALATION: THE CRYSTAL STRUCTURE OF D(TGTACA)- NOGALAMYCIN DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 282d nuc 2.40 NOGALAMYCIN C39 H49 N O16 A CONTINOUS TRANSITION FROM A-DNA TO B-DNA IN THE 1:1 COMPLEX BETWEEN NOGALAMYCIN AND THE HEXAMER DCCCGGG DNA (5'-D(*CP*CP*CP*GP*GP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1l0r nuc NMR NOGALAMYCIN (PROTONATED FORM) C39 H52 N O16 1+ NMR SOLUTION STRUCTURE OF NOGALAMYCIN INTERCALATION BETWEEN CO-AXIALLY STACKED HAIRPINS 5'-D(*AP*CP*GP*AP*AP*GP*TP*GP*CP*GP*AP*AP*GP*C)- 3' DNA GAA LOOP, SINGLE STRAND BREAK, DRUG-DNA RECOGNITION, NOGALAMYCIN INTERCALATION
Code Class Resolution Description 1d22 nuc 1.80 U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN 2(C39 H49 N O17) BINDING OF THE ANTITUMOR DRUG NOGALAMYCIN AND ITS DERIVATIVES TO DNA: STRUCTURAL COMPARISON DNA (5'-D(*(5CM)P*GP*TP*(AS)P*(5CM)P*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 1nr8 nuc 1.66 AMINO GROUP H2 N THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX 1pdt nuc NMR AMINO GROUP H2 N PD235, PNA-DNA DUPLEX, NMR, 8 STRUCTURES DNA (5'-D(*GP*AP*CP*AP*TP*AP*GP*C)-3', PEPTIDE NUCLEIC ACID (COOH-P(*G*C*T*A*T*G*T*C)-NH CHAIN: B PEPTIDE NUCLEIC ACID/DNA COMPLEX (PEPTIDE NUCLEIC ACID-DNA), NUCLEIC ACID COMPLEX, DU HYBRID, PEPTIDE NUCLEIC ACID-DNA COMPLEX 1vty nuc 1.30 AMINO GROUP 2(H2 N) CRYSTAL STRUCTURE OF A Z-DNA FRAGMENT CONTAINING THYMINE/2- AMINOADENINE BASE PAIRS DNA (5'-D(*CP*(NH2)AP*CP*GP*TP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, DNA 2kmj nuc NMR AMINO GROUP 2(H2 N) HIGH RESOLUTION NMR SOLUTION STRUCTURE OF A COMPLEX OF HIV-2 TAR RNA AND A SYNTHETIC TRIPEPTIDE IN A 1:2 STOICHIOMETRY PYRIMIDINYLPEPTIDE, RNA (28-MER) RNA/PEPTIDE RNA-LIGAND COMPLEX, BINDING STOICHIOMETRY, HIV-2 TAR, RNA/PEPTIDE COMPLEX
Code Class Resolution Description 1qc0 nuc 1.55 AMMONIUM ION 7(H4 N 1+) CRYSTAL STRUCTURE OF A 19 BASE PAIR COPY CONTROL RELATED RNA DUPLEX 5'-R(*UP*AP*GP*CP*GP*GP*UP*GP*C)-3', 5'- R(*GP*CP*AP*CP*CP*GP*CP*UP*AP*CP*CP*AP*AP*CP*GP*GP*UP*GP*C) -3', 5'-R(GP*CP*AP*CP*CP*GP*CP*UP*AP*C)-3', 5'- R(*GP*CP*AP*CP*CP*GP*UP*UP*GP*GP*UP*AP*GP*CP*GP*GP*UP*GP*C) -3' RNA A-RNA STRUCTURE, RIBONUCLEIC ACID 1qcu nuc 1.20 AMMONIUM ION 4(H4 N 1+) CRYSTAL STRUCTURE OF AN 18 BASE PAIR COPY CONTROL RELATED RNA DUPLEX 5'-R(P*GP*GP*GP*GP*GP*GP*GP*GP*GP*GP*G)-3', 5'-R(P*CP*CP*CP*CP*CP*CP*CP*CP*CP*CP*C)-3' RNA A-RNA STRUCTURE, RIBONUCLEIC ACID 363d nuc 2.00 AMMONIUM ION 24(H4 N 1+) HIGH-RESOLUTION CRYSTAL STRUCTURE OF A FULLY MODIFIED N3'-> PHOSPHORAMIDATE DNA DODECAMER DUPLEX 5'-D(*(C42)P*(G38)P*(C42)P*(G38)P*(A43)P*(A43)P*( P*(NYM)P*(C42)P*(G38)P*(C42)P*DG)-3' DNA A-DNA, MODIFIED, DNA 4e8n nuc 2.96 AMMONIUM ION 14(H4 N 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF NH4+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4jrd nuc 1.00 AMMONIUM ION 18(H4 N 1+) CRYSTAL STRUCTURE OF THE PARALLEL DOUBLE-STRANDED HELIX OF P RNA (5'-R(*AP*AP*AP*AP*AP*AP*AP*AP*AP*AP*A)-3') RNA PARALLEL DOUBLE HELIX, POLY(A), MRNA, PABP, POLY(A) MOTIF, R 5j01 nuc 3.39 AMMONIUM ION 3(H4 N 1+) STRUCTURE OF THE LARIAT FORM OF A CHIMERIC DERIVATIVE OF THE OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE PRESENCE OF MG2+. GROUP II INTRON LARIAT RNA GROUP II INTRON, LARIAT, 2'-5' PHOSPHODIESTER BOND, RIBOZYME CATALYSIS, SELF-SPLICING, RNA 5j02 nuc 3.49 AMMONIUM ION 10(H4 N 1+) STRUCTURE OF THE LARIAT FORM OF A CHIMERIC DERIVATIVE OF THE OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE PRESENCE OF MG2+ AND AN INACTIVE 5' EXON. GROUP II INTRON LARIAT, 5' EXON ANALOG (5'-R(*CP*UP*GP*UP*UP*AP*(5MU))-3' CHAIN: B RNA GROUP II INTRON, LARIAT, 2'-5' PHOSPHODIESTER BOND, RIBOZYME CATALYSIS, SELF-SPLICING, RNA 5k8h nuc 1.07 AMMONIUM ION H4 N 1+ THE X-RAY CRYSTAL STRUCTURE OF A PARALLEL POLY(RA) DOUBLE HE GENERATED BY RA7 AT ACIDIC PH RNA 7-MER RNA PARALLEL DOUBLE-HELIX POLY(RA) ACIDIC PH ADENINE N1 PROTONAT 5neo nuc 1.69 AMMONIUM ION H4 N 1+ THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA
Code Class Resolution Description 1g3v nuc 3.10 NICKEL (II) ION 8(NI 2+) CRYSTAL STRUCTURE OF NICKEL-D[CGTGTACACG]2 5'-D(*CP*GP*TP*GP*TP*AP*CP*AP*CP*G)-3' DNA NICKEL BINDING, B-DNA 1p25 nuc 2.90 NICKEL (II) ION 5(NI 2+) CRYSTAL STRUCTURE OF NICKEL(II)-D(GGCGCC)2 5'-D(*GP*GP*CP*GP*CP*C)-3' DNA B-DNA, NICKEL BINDING 1r2o nuc 2.38 NICKEL (II) ION NI 2+ D(GCATGCT) + NI2+ 5'-D(*GP*CP*AP*TP*GP*CP*T)-3' DNA METAL ION, DNA QUADRUPLEX 1s9b nuc 2.81 NICKEL (II) ION 4(NI 2+) CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA GAATTCG 5'-D(*GP*AP*AP*TP*TP*CP*G)-3' DNA DOUBLE HELIX, CUBIC DNA, NICKEL 3t4b nuc 3.55 NICKEL (II) ION 17(NI 2+) CRYSTAL STRUCTURE OF THE HCV IRES PSEUDOKNOT DOMAIN HCV IRES PSEUDOKNOT DOMAIN PLUS CRYSTALLIZATION M CHAIN: A: PSEUDOKNOT DOMAIN, RESIDUES 220-270 RNA PSEUDOKNOT, FOUR-WAY JUNCTION, HCV IRES CENTRAL DOMAIN, RNA 446d nuc 3.00 NICKEL (II) ION 9(NI 2+) STRUCTURE OF THE OLIGONUCLEOTIDE D(CGTATATACG) AS A SITE SPECIFIC COMPLEX WITH NICKEL IONS DNA (5'-D(*CP*GP*TP*AP*TP*AP*TP*AP*CP*G)-3') DNA TRIPLE HELIX, NICKEL BINDING, DNA 473d nuc 1.58 NICKEL (II) ION 4(NI 2+) NI2+/GUANINE INTERACTIONS AND NETROPSIN/GUANINE STACKING IN D(CGTATATACG)2 DNA (5'-D(*CP*GP*TP*AP*TP*AP*TP*AP*CP*G)-3') DNA NETROPSIN/GUANINE STACKING, NI2+/GUANINE INTERACTIONS, MINOR GROOVE BINDING, DNA 5erz nuc 1.75 NICKEL (II) ION 3(NI 2+) CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-D(TTCCGCCG COMPLEX DNA (5'-D(*TP*TP*CP*CP*GP*CP*CP*GP*CP*CP*GP*AP*A) CHAIN: A, B DNA/ANTIBIOTIC NUCLEOTIDE FLIPPING-OUT, CCG TRINUCLEOTIDE REPEATS, CHROMOMY METALLOANTIBIOTICS, MINOR GROOVE BINDING DRUG, DNA-ANTIBIOT COMPLEX
Code Class Resolution Description 3cco nuc 2.20 2,7-BIS[3-(DIMETHYLAMINO)PROPYL]-4,9-BIS[(3- HYDROXYPROPYL)AMINO]BENZO[LMN][3,8]PHENANTHROLINE-1,3, 6,8(2H,7H)-TETRONE 3(C30 H42 N6 O6) STRUCTURAL ADAPTATION AND CONSERVATION IN QUADRUPLEX-DRUG RECOGNITION DNA (5'- D(*DTP*DAP*DGP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DGP*DT)-3') DNA QUADRUPLEX, DNA, PROPELLER, DIMERIC, HUMAN TELOMERE PARALLEL STRANDED, LIGAND, COMPLEX, NAPHTHALENE DIIMIDINE 3cdm nuc 2.10 2,7-BIS[3-(DIMETHYLAMINO)PROPYL]-4,9-BIS[(3- HYDROXYPROPYL)AMINO]BENZO[LMN][3,8]PHENANTHROLINE-1,3, 6,8(2H,7H)-TETRONE 6(C30 H42 N6 O6) STRUCTURAL ADAPTATION AND CONSERVATION IN QUADRUPLEX-DRUG RECOGNITION DNA (5'- D(*DT*DAP*DGP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DGP*DTP*DTP*DAP*D GP*DGP*DGP*DTP*DTP*DAP*DGP*DGP*DG)-3') DNA QUADRUPLEX, DNA, PROPELLER, INTRAMOLECULAR, HUMAN TELOMERE PARALLEL STRANDED, LIGAND, COMPLEX
Code Class Resolution Description 2bq2 nuc NMR NALIDIXIC ACID 2(C12 H12 N2 O3) SOLUTION STRUCTURE OF THE DNA DUPLEX ACGCGU-NA WITH A 2' AMIDO-LINKED NALIDIXIC ACID RESIDUE AT THE 3' TERMINAL NUCLEOTIDE 5'-D(*AP*CP*GP*CP*GP*2AU)-3' DNA NUCLEIC ACID, DEOXYRIBONUCLEIC ACID, DISRUPTED TERMINAL BASEPAIRS, DNA, QUINOLONE, SYNTHETIC HYBRID, DNA COMPLEX
Code Class Resolution Description 1ddy nuc 3.00 METHYLAMINE 4(C H5 N) MOLECULAR RECOGNITION BY THE VITAMIN B12 RNA APTAMER VITAMIN B12 BINDING RNA RNA RNA, TRIPLEX, VITAMIN B12, APTAMER
Code Class Resolution Description 1xux nuc 1.30 1-(O2-(2-METHYLAMINO-2-OXO-ETHYL)-O5- HYDROXYPHOSPHINYL-BETA-D-RIBOFURANOSYL)THYMINE 4(C13 H20 N3 O10 P) STRUCTURAL RATIONALIZATION OF A LARGE DIFFERENCE IN RNA AFFINITY DESPITE A SMALL DIFFERENCE IN CHEMISTRY BETWEEN TWO 2'-O-MODIFIED NUCLEIC ACID ANALOGS DNA (5'-D(*GP*CP*GP*TP*AP*(NMS)P*AP*CP*GP*C)-3') DNA RNA MIMETIC METHYLAMINO AMIDE ANALOG, DNA
Code Class Resolution Description 1xuw nuc 1.25 1-(O2-(METHYLCARBAMOYL)-O5-HYDROXYPHOSPHINYL-BETA-D- RIBOFURANOSYL)THYMINE 2(C12 H20 N3 O10 P) STRUCTURAL RATIONALIZATION OF A LARGE DIFFERENCE IN RNA AFFINITY DESPITE A SMALL DIFFERENCE IN CHEMISTRY BETWEEN TWO 2'-O-MODIFIED NUCLEIC ACID ANALOGS DNA (5'-D(*GP*CP*GP*TP*AP*(NMT)P*AP*CP*GP*C)-3') DNA RNA MIMETIC METHYLCARBAMATE AMIDE ANALOG, DNA
Code Class Resolution Description 1ei2 nuc NMR NEOMYCIN C23 H46 N6 O13 STRUCTURAL BASIS FOR RECOGNITION OF THE RNA MAJOR GROOVE IN EXON 10 SPLICING REGULATORY ELEMENT BY AMINOGLYCOSIDE ANTIB TAU EXON 10 SRE RNA: TAU EXON 10 SPLICING REGULATORY ELEMENT RNA RNA, TAU, FRONTOTEMPORAL DEMENTIA FTDP-17, INTRONIC MUTATION AMINOGLYCOSIDE, RNA MAJOR GROOVE RECOGNITION 1i9v nuc 2.60 NEOMYCIN C23 H46 N6 O13 CRYSTAL STRUCTURE ANALYSIS OF A TRNA-NEOMYCIN COMPLEX PHENYLALANINE TRANSFER RNA RNA AMINO-ACID TRANSPORT, YEAST, PHE-TRNA,PHENYLALANINE, TRANSFER RNA, AMINOGLYCOSIDE, NEOMYCIN B 2a04 nuc 2.95 NEOMYCIN 4(C23 H46 N6 O13) MOLECULAR RECOGNITION OF RNA BY NEOMYCIN AND A RESTRICTED NEOMYCIN DERIVATIVE 5'- R(*GP*UP*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*CP*GP*G)-3': RIBOSOMAL RNA A-SITE, 5'-R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*AP*CP*C)- 3': RIBOSOMAL RNA A-SITE RNA RIBOSOME, RNA, A-SITE. DOUBLE HELIX, NEOMYCIN 2et4 nuc 2.40 NEOMYCIN 2(C23 H46 N6 O13) COMPLEX BETWEEN NEOMYCIN B AND THE 16S-RRNA A-SITE 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES 2fcy nuc 2.20 NEOMYCIN 2(C23 H46 N6 O13) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 3c7r nuc 1.70 NEOMYCIN 2(C23 H46 N6 O13) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO NEOMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, NEOMYCIN, EXTENDED DUPLEX
Code Class Resolution Description
4pdq nuc 3.00 (2S)-4-AMINO-N-{(1R,2S,3R,4R,5S)-5-AMINO-3-{[3-O-(2,6- DIAMINO-2,6-DIDEOXY-BETA-L-IDOPYRANOSYL)-BETA-D- RIBOFURANOSYL]OXY}-4-[(2,6-DIAMINO-2,4,6-TRIDEOXY-4- FLUORO-ALPHA-D-GALACTOPYRANOSYL)OXY]-2- HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE C27 H52 F N7 O14 CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH 4'-DEOXY-4'-FLUORO NEOMYCIN ANALOG RNA (5'- *UP*UP*GP*CP*GP*UP*CP*AP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP*U 3') RNA/ANTIBIOTIC RIBOSOME, AMINOGLYCOSIDE, RNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 385d nuc 1.60 N-ETHYLHYDROXY-DOXORUBICIN C29 H33 N O12 FORMATION OF A NEW COMPOUND IN THE CRYSTAL STRUCTURE OF CYANOMORPHOLINODOXORUBICIN COMPLEXED WITH D(CGATCG) DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1dk6 nuc NMR 1-[2-DEOXY-RIBOFURANOSYL]-1H-[3-NITRO-PYRROL]-5'- PHOSPHATE C9 H13 N2 O8 P NMR STRUCTURE ANALYSIS OF THE DNA NINE BASE PAIR DUPLEX D(CATGAGTAC) D(GTAC(NP3)CATG) 5'-D(CP*AP*TP*GP*AP*GP*TP*AP*CP*)-3', 5'-D(GP*TP*AP*CP*(NP3)P*CP*AP*TP*GP*)-3' DNA DNA DOUBLE HELIX, 3-NITROPYRROLE, NMR
Code Class Resolution Description
2et0 nuc 1.70 N-[(1E)-PYRIDIN-2-YLMETHYLENE]-N-[4-(4-{[(1E)-PYRIDIN- 2-YLMETHYLENE]AMINO}BENZYL)PHENYL]AMINE 5(C25 H20 N4) THE STRUCTURE OF A THREE-WAY DNA JUNCTION IN COMPLEX WITH A SUPRAMOLECULAR HELICATE REVEALS A NEW TARGET FOR DRUGS 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, 3-WAY JUNCTION, DNA STRUCTURE RECOGNITION,
3i1d nuc 2.50 N-[(1E)-PYRIDIN-2-YLMETHYLENE]-N-[4-(4-{[(1E)-PYRIDIN- 2-YLMETHYLENE]AMINO}BENZYL)PHENYL]AMINE 9(C25 H20 N4) DISTINCT RECOGNITION OF THREE-WAY DNA JUNCTIONS BY THE TWO E OF A METALLO-SUPRAMOLECULAR CYLINDER ('HELICATE') 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, 3-WAY JUNCTION, DNA STRUCTURE RECOGNITION,
4jiy nuc 1.91 N-[(1E)-PYRIDIN-2-YLMETHYLENE]-N-[4-(4-{[(1E)-PYRIDIN- 2-YLMETHYLENE]AMINO}BENZYL)PHENYL]AMINE 2(C25 H20 N4) RNA THREE-WAY JUNCTION STABILIZED BY A SUPRAMOLECULAR DI-IRO CYLINDER DRUG 5'-(CGUACG)-3' RNA RNA, THREE-WAY JUNCTION, DRUG-RNA COMPLEX, RNA STRUCTURE REC CYLINDER, SUPRAMOLECULE
Code Class Resolution Description 2hto nuc 1.54 RUTHENIUM (III) HEXAAMINE ION H18 N6 RU 3+ RUTHENIUM HEXAMMINE ION INTERACTIONS WITH Z-DNA DNA (5'-D(*DCP*DGP*DCP*DGP*DCP*DA)-3'), DNA (5'-D(*DTP*DGP*DCP*DGP*DCP*DG)-3') DNA Z-DNA, DOUBLE HELIX 2htt nuc 2.60 RUTHENIUM (III) HEXAAMINE ION H18 N6 RU 3+ RUTHENIUM HEXAMMINE ION INTERACTIONS WITH Z-DNA DNA (5'-D(P*DTP*DG)-3'), DNA (5'-D(*DCP*DGP*DCP*DGP*DCP*DA)-3'), DNA (5'-D(*DTP*DGP*DCP*DGP*DCP*DG)-3') DNA Z-DNA, DOUBLE HELIX
Code Class Resolution Description 101d nuc 2.25 NETROPSIN C18 H26 N10 O3 REFINEMENT OF NETROPSIN BOUND TO DNA: BIAS AND FEEDBACK IN ELECTRON DENSITY MAP INTERPRETATION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 121d nuc 2.20 NETROPSIN C18 H26 N10 O3 MOLECULAR STRUCTURE OF THE A-TRACT DNA DODECAMER D(CGCAAATTTGCG) COMPLEXED WITH THE MINOR GROOVE BINDING DRUG NETROPSIN DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 195d nuc 2.30 NETROPSIN C18 H26 N10 O3 X-RAY STRUCTURES OF THE B-DNA DODECAMER D(CGCGTTAACGCG) WITH AN INVERTED CENTRAL TETRANUCLEOTIDE AND ITS NETROPSIN COMPLEX DNA (5'-D(*CP*GP*CP*GP*TP*TP*AP*AP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d85 nuc 2.50 NETROPSIN C18 H26 N10 O3 STRUCTURAL CONSEQUENCES OF A CARCINOGENIC ALKYLATION LESION ON DNA: EFFECT OF O6-ETHYL-GUANINE ON THE MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG)-NETROPSIN COMPLEX DNA (5'-D(*CP*GP*CP*(G36) P*AP*AP*TP*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 1d86 nuc 2.20 NETROPSIN C18 H26 N10 O3 STRUCTURAL CONSEQUENCES OF A CARCINOGENIC ALKYLATION LESION ON DNA: EFFECT OF O6-ETHYL-GUANINE ON THE MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG)-NETROPSIN COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1dne nuc 2.40 NETROPSIN C18 H26 N10 O3 MOLECULAR STRUCTURE OF THE NETROPSIN-D(CGCGATATCGCG) COMPLEX: DNA CONFORMATION IN AN ALTERNATING AT SEGMENT; CONFORMATION 2 DNA (5'-D(*CP*GP*CP*GP*AP*TP*AP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1dvl nuc 2.40 NETROPSIN C18 H26 N10 O3 CRYSTAL STRUCTURE OF THE 1:1 NETROPSIN-DECAMER D(CCIICICCII)2 COMPLEX WITH ONLY ONE DRUG BOUND AT ONE END 5'-D(*CP*CP*IP*IP*CP*IP*CP*CP*IP*I)-3' DNA DRUG BINDING, DNA 1vtj nuc 2.40 NETROPSIN C18 H26 N10 O3 MOLECULAR STRUCTURE OF THE NETROPSIN-D(CGCGATATCGCG) COMPLEX CONFORMATION IN AN ALTERNATING AT SEGMENT; CONFORMATION 1 DNA (5'-D(*CP*GP*CP*GP*AP*TP*AP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, DNA 1z8v nuc 1.75 NETROPSIN C18 H26 N10 O3 THE STRUCTURE OF D(GGCCAATTGG) COMPLEXED WITH NETROPSIN (5'-D(*GP*GP*CP*CP*AP*AP*TP*TP*GP*G)-3') DNA B-DNA DOUBLE HELIX, BASE TRIPLETS, MINOR GROOVE BINDER, DRUG, NETROPSIN 261d nuc 2.40 NETROPSIN C18 H26 N10 O3 CRYSTAL STRUCTURE OF THE DNA DECAMER D(CGCAATTGCG) COMPLEXED WITH THE MINOR GROOVE BINDING DRUG NETROPSIN DNA (5'-D(*CP*GP*CP*AP*AP*TP*TP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, FLIPPED-OUT BASES, INTERMOLECULAR BASE TRIPLET, CONTINUOUS HELIX, COMPLEXED WITH DRUG 2lwh nuc NMR NETROPSIN C18 H26 N10 O3 NMR STRUCTURE OF THE SELF-COMPLEMENTARY 10 MER DNA DUPLEX 5' GGATATATCC-3' IN COMPLEX WITH NETROPSIN DNA (5'-D(*GP*GP*AP*TP*AP*TP*AP*TP*CP*C)-3') DNA MICROSTRUCTURE, INDUCED DNA BINDING, DNA MINOR GROOVE VARIAT 358d nuc 2.50 NETROPSIN 2(C18 H26 N10 O3) CRYSTAL STRUCTURE OF THE 2:1 NETROPSIN-DNA DECAMER D(CBRCCCCIIIII) COMPLEX WITH END-TO-END BINDING DNA (5'-D(*CP*(CBR)P*CP*CP*CP*IP*IP*IP*IP*I)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED 375d nuc 2.40 NETROPSIN 4(C18 H26 N10 O3) A NOVEL END-TO-END BINDING OF TWO NETROPSINS TO THE DNA DECAMER D(CCCCCIIIII)2 DNA (5'-D(*CP*CP*CP*CP*CP*IP*IP*IP*IP*I)-3') DNA UNUSUAL DNA/RNA, DOUBLE HELIX, DOUBLE DRUG IN MINOR GROOVE, COMPLEXED WITH DRUG, MISMATCHED 473d nuc 1.58 NETROPSIN C18 H26 N10 O3 NI2+/GUANINE INTERACTIONS AND NETROPSIN/GUANINE STACKING IN D(CGTATATACG)2 DNA (5'-D(*CP*GP*TP*AP*TP*AP*TP*AP*CP*G)-3') DNA NETROPSIN/GUANINE STACKING, NI2+/GUANINE INTERACTIONS, MINOR GROOVE BINDING, DNA 474d nuc 2.40 NETROPSIN 4(C18 H26 N10 O3) A NOVEL END-TO-END BINDING OF TWO NETROPSINS TO THE DNA DECAMER D(CCCCCIIIII)2 DNA (5'-D(*CP*CP*CP*(CBR)P*CP*IP*IP*IP*IP*I)-3') DNA B-DNA/RNA, DOUBLE HELIX, DOUBLE DRUG IN MINOR GROOVE, COMPLEXED WITH DRUG, MODIFIED, MISMATCHED 6bna nuc 2.21 NETROPSIN C18 H26 N10 O3 BINDING OF AN ANTITUMOR DRUG TO DNA. NETROPSIN AND C-G-C-G- A-A-T-T-BRC-G-C-G DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 4u6k nuc 1.50 [(1R,5R,7R,8S)-8-HYDROXY-3-METHYL-7-(5-METHYL-2,4- DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-2,6-DIOXA-3- AZABICYCLO[3.2.1]OCT-5-YL]METHYL DIHYDROGEN PHOSPHATE 4(C12 H18 N3 O9 P) CRYSTAL STRUCTURE OF DNA/RNA DUPLEX CONTAINING 2'-4'-BNA-NC RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*(NCU)P*(NTT)P*CP*TP*TP*CP*TP*(NTT)P*(N CHAIN: B, D DNA/RNA DNA/RNA DUPLEX, ANTISENSE, BRIDGED NUCLEIC ACID, DNA-RNA COM
Code Class Resolution Description
3qsf nuc 2.40 [2,2'-{(4,5-DIFLUOROBENZENE-1,2-DIYL)BIS[(NITRILO- KAPPAN)METHYLYLIDENE]}BIS{5-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOLATO-KAPPAO}(2-)]NICKEL (II) C34 H38 F2 N4 NI O4 THE FIRST CRYSTAL STRUCTURE OF A HUMAN TELOMERIC G-QUADRUPLE BOUND TO A METAL-CONTAINING LIGAND (A NICKEL COMPLEX) 5'-D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*T)-3' DNA PARALLEL, TELOMERE, NICKEL, DRUG, DNA, METAL COMPLEX
Code Class Resolution Description 363d nuc 2.00 3'-DEOXY-3'-AMINOTHYMIDINE MONOPHOSPHATE 12(C10 H16 N3 O7 P) HIGH-RESOLUTION CRYSTAL STRUCTURE OF A FULLY MODIFIED N3'-> PHOSPHORAMIDATE DNA DODECAMER DUPLEX 5'-D(*(C42)P*(G38)P*(C42)P*(G38)P*(A43)P*(A43)P*( P*(NYM)P*(C42)P*(G38)P*(C42)P*DG)-3' DNA A-DNA, MODIFIED, DNA
Code Class Resolution Description 1enn nuc 0.89 OXYGEN ATOM 3(O) SOLVENT ORGANIZATION IN AN OLIGONUCLEOTIDE CRYSTAL: THE STRUCTURE OF D(GCGAATTCG)2 AT ATOMIC RESOLUTION DNA (5'-D(*GP*CP*GP*AP*AP*TP*TP*CP*G)-3') DNA B-DNA, ATOMIC RESOLUTION, IONS, HYDRATION, BASE TRIPLET 1g5l nuc NMR OXYGEN ATOM O CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1gj2 nuc NMR OXYGEN ATOM O CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION
Code Class Resolution Description 1iek nuc NMR N-OCTANE C8 H18 SOLUTION STRUCTURE OF THE DNA DUPLEX D(CCACCGGAAC) .(GTTCCGGTGG) WITH A CHIRAL ALKYL-PHOSPHONATE MOIETY (DIAESTEREOISOMER S) 5'-D(*CP*CP*AP*CP*CP*(OCT)GP*GP*AP*AP*C)-3', 5'-D(*GP*TP*TP*CP*CP*GP*GP*TP*GP*G)-3' DNA DOUBLE HELIX, DNA BENDING, MODIFIED OLIGONUCLEOTIDE, CHARGE NEUTRALIZATION. 1iey nuc NMR N-OCTANE C8 H18 SOLUTION STRUCTURE OF THE DNA DUPLEX D(CCACCGGAAC) .(GTTCCGGTGG) WITH A CHIRAL ALKYL-PHOSPHONATE MOIETY (DIAESTEREOISOMER R) 5'-D(P*CP*CP*AP*CP*CP*(OCT)GP*GP*AP*AP*C)-3', 5'-D(*GP*TP*TP*CP*CP*GP*GP*TP*GP*G)-3' DNA DOUBLE HELIX, DNA BENDING, MODIFIED OLIGONUCLEOTIDE, CHARGE NEUTRALIZATION
Code Class Resolution Description 5lyv nuc 2.35 OSMIUM (III) HEXAMMINE H12 N6 OS THE CRYSTAL STRUCTURE OF 7SK 5'-HAIRPIN - OSMIUM DERIVATIVE RNA (57-MER) RNA NON-CODING RNA MAJOR GROOVE BASE TRIPLE TRANSCRIPTION, RNA
Code Class Resolution Description 3dj0 nuc 2.50 O-(2-AMINOETHYL)-L-SERINE C5 H12 N2 O3 CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH L-4-OXALYSINE RNA (174-MER) RNA LYSINE RIBSOWITCH, OXALYSINE, RNA
Code Class Resolution Description 1ehz nuc 1.93 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 5(C10 H16 N3 O8 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1i7j nuc 1.19 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RNA DUPLEX AT 1.19 A RESOLUTION. 2-METHYL-2,4-PENTANEDIOL AND MAGNESIUM BINDING. 5'-R(*(OMC)P*(OMG)P*(OMC)P*(OMG)P*(OMC)P*(OMG))- 3' RNA X-RAY, 2'-O-MERNA DUPLEX, 2-METHYL-2, 4-PENTANEDIOL, MAGNESIUM, GROOVE HYDRATION AND BINDING 1ipl nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 3(C10 H16 N3 O8 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1ipv nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO R SITE, 5'-R(P*UP*UP*UP*UP*UP*UP*UP*UP*U)-3' RIBONUCLEIC ACID COGNATE CODON-ANTICODON INTERACTION, MRNA, TRNA 1ipy nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 5'-R(P*UP*UP*UP*UP*AP*UP*UP*UP*U)-3', TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE CODON-ANTICODON INTERACTION 1k7n nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1luu nuc NMR O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 4 MODIFICATIONS (OMC32 OMG34 1MG37 5MC40) 5'-R(*CP*CP*AP*GP*AP*(OMC)P*UP*(OMG) P*AP*AP*(1MG)P*AP*UP*(5MC)P*UP*GP*G)-3' RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, 1MG, 2'-O-METHYL, 5MC 1lux nuc NMR O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 3 MODIFICATIONS (OMC32 OMG34 M5C40) 5'-R(*CP*CP*AP*GP*AP*(OMC)P*UP*(OMG) P*AP*AP*GP*AP*UP*(5MC)P*UP*GP*G)-3' RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, 2'-O- METHYL, M5C 1nao nuc NMR O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 3(C10 H16 N3 O8 P) SOLUTION STRUCTURE OF AN RNA 2'-O-METHYLATED RNA DUPLEX CONTAINING AN RNA/DNA HYBRID SEGMENT AT THE CENTER, NMR, MINIMIZED AVERAGE STRUCTURE RNA (5'-R(*GP*GP*AP*GP*AP*UP*GP*AP*C)-3'), DNA/RNA (5'-R(*OMGP*OMUP*OMC)-D(P*AP*TP*CP*T)- R(P*OMCP*OMC)-3') DNA-RNA HYBRID DNA/RNA DUPLEX, DNA-RNA HYBRID 1nrt nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 3(C10 H16 N3 O8 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1pbl nuc NMR O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O8 P) STRUCTURE OF RIBONUCLEIC ACID, NMR, 1 STRUCTURE RNA (5'-R(*OMCP*OMGP*OMCP*OMGP*OMCP*OMG)-3') RNA RIBONUCLEIC ACID, RNA DUPLEX 1q49 nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 2(C10 H16 N3 O8 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 2kwg nuc NMR O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 4(C10 H16 N3 O8 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 2oeu nuc 2.00 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P FULL-LENGTH HAMMERHEAD RIBOZYME WITH MN(II) BOUND HAMMERHEAD RIBOZYME, 5'-R(*GP*GP*CP*GP*UP*(OMC)P*CP*UP*GP*GP*(5BU) P*AP*UP*CP*CP*AP*AP*UP*CP*(DC))-3' RNA RIBOZYME, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, MANGANESE, MN 2z9q nuc 11.70 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 310d nuc 1.30 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE 6(C10 H16 N3 O8 P) CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RNA DUPLEX AT 1.3 A RESOLUTION. HYDRATION PATTERN OF 2'-O-METHYLATED RNA RNA (5'-R(*(OMC)P*(OMG)P*(OMC)P*(OMG)P*(OMC) P*(OMG))-3') RNA A-RNA, DOUBLE HELIX, MODIFIED 3cw5 nuc 3.10 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 3cw6 nuc 3.30 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA 3zd4 nuc 2.20 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P FULL-LENGTH HAMMERHEAD RIBOZYME WITH G12A SUBSTITUTION AT THE GENERAL BASE POSITION HAMMERHEAD RIBOZYME, ENZYME STRAND, HAMMERHEAD RIBOZYME, SUBSTRATE STRAND RNA RNA, GENERAL BASE CATALYSIS 3zd5 nuc 2.20 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P THE 2.2 A STRUCTURE OF A FULL-LENGTH CATALYTICALLY ACTIVE HAMMERHEAD RIBOZYME HAMMERHEAD RIBOZYME, ENZYME STRAND, HAMMERHEAD RIBOZYME, SUBSTRATE STRAND RNA CATALYTIC RNA, IN-LINE ATTACK, HAMMERHEAD RNA, STEM-LOOP INTERACTION, URIDINE TURN, A-FORM HELIX, RNA 3zp8 nuc 1.55 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P HIGH-RESOLUTION FULL-LENGTH HAMMERHEAD RIBOZYME HAMMERHEAD RIBOZYME, SUBSTRATE STRAND, HAMMERHEAD RIBOZYME, ENZYME STRAND RNA RNA, CATALYTIC RNA 486d nuc 7.50 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME 4tna nuc 2.50 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 5l4o nuc 2.80 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P STRUCTURE OF AN E.COLI INITIATOR TRNAFMET A1-U72 VARIANT TRNA (76-MER) TRANSLATION TRNA-TRANSLATION INITIATION, TRANSLATION 6tna nuc 2.70 O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE C10 H16 N3 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1ehz nuc 1.93 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 1evv nuc 2.00 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 5(C11 H16 N5 O8 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1i7j nuc 1.19 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 6(C11 H16 N5 O8 P) CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RNA DUPLEX AT 1.19 A RESOLUTION. 2-METHYL-2,4-PENTANEDIOL AND MAGNESIUM BINDING. 5'-R(*(OMC)P*(OMG)P*(OMC)P*(OMG)P*(OMC)P*(OMG))- 3' RNA X-RAY, 2'-O-MERNA DUPLEX, 2-METHYL-2, 4-PENTANEDIOL, MAGNESIUM, GROOVE HYDRATION AND BINDING 1ipl nuc model O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 3(C11 H16 N5 O8 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1ipv nuc model O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO R SITE, 5'-R(P*UP*UP*UP*UP*UP*UP*UP*UP*U)-3' RIBONUCLEIC ACID COGNATE CODON-ANTICODON INTERACTION, MRNA, TRNA 1ipy nuc model O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 5'-R(P*UP*UP*UP*UP*AP*UP*UP*UP*U)-3', TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE CODON-ANTICODON INTERACTION 1ks1 nuc model O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1luu nuc NMR O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 4 MODIFICATIONS (OMC32 OMG34 1MG37 5MC40) 5'-R(*CP*CP*AP*GP*AP*(OMC)P*UP*(OMG) P*AP*AP*(1MG)P*AP*UP*(5MC)P*UP*GP*G)-3' RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, 1MG, 2'-O-METHYL, 5MC 1lux nuc NMR O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF YEAST TRNA-PHE WITH 3 MODIFICATIONS (OMC32 OMG34 M5C40) 5'-R(*CP*CP*AP*GP*AP*(OMC)P*UP*(OMG) P*AP*AP*GP*AP*UP*(5MC)P*UP*GP*G)-3' RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, 2'-O- METHYL, M5C 1nao nuc NMR O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P SOLUTION STRUCTURE OF AN RNA 2'-O-METHYLATED RNA DUPLEX CONTAINING AN RNA/DNA HYBRID SEGMENT AT THE CENTER, NMR, MINIMIZED AVERAGE STRUCTURE RNA (5'-R(*GP*GP*AP*GP*AP*UP*GP*AP*C)-3'), DNA/RNA (5'-R(*OMGP*OMUP*OMC)-D(P*AP*TP*CP*T)- R(P*OMCP*OMC)-3') DNA-RNA HYBRID DNA/RNA DUPLEX, DNA-RNA HYBRID 1nrt nuc model O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 3(C11 H16 N5 O8 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1pbl nuc NMR O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 6(C11 H16 N5 O8 P) STRUCTURE OF RIBONUCLEIC ACID, NMR, 1 STRUCTURE RNA (5'-R(*OMCP*OMGP*OMCP*OMGP*OMCP*OMG)-3') RNA RIBONUCLEIC ACID, RNA DUPLEX 1tn1 nuc 3.00 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 2kwg nuc NMR O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 2(C11 H16 N5 O8 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 2o32 nuc NMR O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 4(C11 H16 N5 O8 P) SOLUTION STRUCTURE OF U2 SNRNA STEM I FROM HUMAN, CONTAINING MODIFIED NUCLEOTIDES 5'-R(*(PSU)P*CP*UP*CP*(OMG)P*(OMG)P*CP*CP*(PSU) P*UP*UP*UP*(OMG)P*GP*CP*UP*AP*AP*(OMG)P*A)-3' RNA RNA, WOBBLE BASE-PAIRS, TETRALOOP 2z9q nuc 11.70 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 310d nuc 1.30 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE 6(C11 H16 N5 O8 P) CRYSTAL STRUCTURE OF 2'-O-ME(CGCGCG)2: AN RNA DUPLEX AT 1.3 A RESOLUTION. HYDRATION PATTERN OF 2'-O-METHYLATED RNA RNA (5'-R(*(OMC)P*(OMG)P*(OMC)P*(OMG)P*(OMC) P*(OMG))-3') RNA A-RNA, DOUBLE HELIX, MODIFIED 4tna nuc 2.50 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4y27 nuc 1.00 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P E.COLI 23S SARCIN-RICIL LOOP, MODIFIED WITH A 2-ME ON G2661 METHYLPHOSPHONATE ON A2662 27-MER SRL RNA RNA RNA, MODIFICATION, RIBOSOME 5tra nuc model O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA 6tna nuc 2.70 O2'-METHYLGUANOSINE-5'-MONOPHOSPHATE C11 H16 N5 O8 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1i3y nuc NMR O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P SOLUTION STRUCTURE OF THE A LOOP OF 23S RIBOSOMAL RNA. 5'-R(*GP*GP*CP*UP*GP*GP*CP*(OMU) P*GP*UP*UP*CP*GP*CP*CP*AP*GP*CP*C)-3' RNA A LOOP, A SITE, 23S RRNA 1ipl nuc model O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1nao nuc NMR O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P SOLUTION STRUCTURE OF AN RNA 2'-O-METHYLATED RNA DUPLEX CONTAINING AN RNA/DNA HYBRID SEGMENT AT THE CENTER, NMR, MINIMIZED AVERAGE STRUCTURE RNA (5'-R(*GP*GP*AP*GP*AP*UP*GP*AP*C)-3'), DNA/RNA (5'-R(*OMGP*OMUP*OMC)-D(P*AP*TP*CP*T)- R(P*OMCP*OMC)-3') DNA-RNA HYBRID DNA/RNA DUPLEX, DNA-RNA HYBRID 2dpc nuc 1.55 O2'-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF D(CGCGAATXCGCG) WHERE X IS 5-(N- AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE DNA (5'-D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*(OMU) P*DCP*DGP*DCP*DG)-3') DNA MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, B-DNA 2dqo nuc 2.30 O2'-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF D(CXCTXCTTC):R(GAAGAAGAG) WHERE X IS 5- (N-AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID 2dqp nuc 2.10 O2'-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) STRUCTURAL ANALYSES OF DNA:DNA AND RNA:DNA DUPLEXES CONTAINING 5-(N-AMINOHEXYL)CARBAMOYL MODIFIED URIDINES RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3'), DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID 2dqq nuc 2.00 O2'-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF D(CXCTXCTTC):R(GAAGAAGAG) WHERE X IS 5- (N-AMINOHEXYL)CARBAMOYL-2'-O-METHYLURIDINE DNA (5'-D(*DCP*(OMU)P*DCP*DTP*(OMU) P*DCP*DTP*DTP*DC)-3'), RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3') DNA-RNA HYBRID MODIFIED NUCLEOTIDE, 5-(N-AMINOHEXYL)CARBAMOYL-2'-O- METHYLURIDINE, A-FORM RNA:DNA HYBRID DUPLEX, DNA-RNA HYBRID 2kwg nuc NMR O2'-METHYLURIDINE 5'-MONOPHOSPHATE 10(C10 H15 N2 O9 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 3dvv nuc 2.00 O2'-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO RIBOSTAMYCIN (U267OME) HIV-1 GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC, AMINOGLYCOSIDE 3dw4 nuc 0.97 O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 U2650-OCH3 MODIFIED SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA RNA RNA, SARCIN RICIN LOOP 3dw5 nuc 0.96 O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 U2656-OCH3 MODIFIED SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA RNA RNA, SARCIN RICIN LOOP 3hr3 nuc 1.75 O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P INTERPLAY OF STRUCTURE, HYDRATION AND THERMAL STABILITY IN F MODIFIED OLIGONUCLEOTIDES: RNA MAY TOLERATE HYDROPHOBIC MOD BETTER THAN DNA 5'-D(*GP*CP*GP*(US4)P*(OMU))P*AP*CP*GP*C)-3' DNA DNA, RNA, FORMACETAL-DNA, RNA HYDRATION 3ot0 nuc 1.70 O2'-METHYLURIDINE 5'-MONOPHOSPHATE 2(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF A DNA CONTAINING THE RIGID NITROXIDE SP NUCLEOTIDE C-SPIN SPIN-LABELED DNA DNA NITROXIDE, SPIN-LABEL, EPR SPECTROSCOPY, FLUORESCENCE SPECTR MODIFIED NUCLEIC ACID, C-SPIN, DEOXYCYTOSINE ANALOG, PHENOX SPECTROSCOPIC PROBE, PELDOR, 2'-O-METHYL U, DNA 5d99 nuc 0.97 O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P 3DW4 REDETERMINED BY DIRECT METHODS STARTING FROM RANDOM PHA RNA (27-MER) HAIRPIN FROM SARCIN-RICIN DOMAIN OF 23S RRNA RNA AB INITIO DIRECT METHODS STRUCTURE DETERMINATION, HAIRPIN RN 5dun nuc 2.64 O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P THE CRYSTAL STRUCTURE OF OME SUBSTITUTED TWISTER RIBOZYME RNA (54-MER) RNA OME, TWISTER, RNA, RIBOZYME 5e36 nuc 1.60 O2'-METHYLURIDINE 5'-MONOPHOSPHATE 3(C10 H15 N2 O9 P) CRYSTAL STRUCTURE OF 2'-PROPARGYL-MODIFIED DNA 8MER-DUPLEX DNA (5'-D(*GP*(OMU)P*GP*TP*(5JO)P*CP*AP*C)-3') DNA MODIFIED DNA, 2'-PROPARGYL, DNA 5tra nuc model O2'-METHYLURIDINE 5'-MONOPHOSPHATE C10 H15 N2 O9 P SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA
Code Class Resolution Description 1g5d nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: ALPHA ANOMER 5'-D(*CP*CP*AP*AP*AP*GP*(D1P)P*AP*CP*TP*GP*GP*G)- 3', 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3' DNA DAMAGED DNA, APYRIMIDINIC SITE 1giz nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: ALPHA ANOMER 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(D1P)P*AP*CP*TP*GP*GP*G)- 3' DNA DAMAGED DNA, APYRIMIDINIC SITE 1sjk nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P A DUPLEX DNA WITH AN ABASIC SITE IN A DA TRACT, ALPHA FORM, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*GP*CP*AP*AP*AP*AP*AP*TP*GP*CP*G)- 3'), DNA (5'-D(*CP*GP*CP*AP*TP*TP*ORPP*TP*TP*GP*CP*G)- 3') DNA DUPLEX DNA WITH AN ABASIC SITE IN A DA TRACT, DAMAGED DNA, AT TRACT DNA, DEOXYRIBONUCLEIC ACID 2hsk nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P NMR STRUCTURE OF 13MER DUPLEX DNA CONTAINING AN ABASIC SITE (Y) IN 5'-CCAAAGYACCGGG-3' (10 STRUCTURES, ALPHA ANOMER) 5'-D(*CP*CP*CP*GP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(D1P)P*AP*CP*CP*GP*GP*G)- 3' DNA ABASIC SITE, DNA LESION, BASE EXCISION REPAIR, APE1 2hsl nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P NMR STRUCTURE OF 13MER DUPLEX DNA CONTAINING AN ABASIC SITE, AVERAGED STRUCTURE (ALPHA ANOMER) 5'-D(*CP*CP*AP*AP*AP*GP*(D1P)P*AP*CP*CP*GP*GP*G)- 3', 5'-D(*CP*CP*CP*GP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3' DNA ABASIC SITE, DNA LESION, BASE EXCISION REPAIR, APE1 2m3p nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ALPHA ANOMER DNA (5'-D(*GP*CP*GP*TP*GP*GP*GP*AP*(8OG)P*CP*G)-3 CHAIN: B, DNA (5'-D(*CP*GP*CP*TP*CP*(ORP)P*CP*AP*CP*GP*C)-3 CHAIN: A DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2m43 nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P DNA CONTAINING A CLUSTER OF 8-OXO-GUANINE AND ABASIC SITE LE ALPHA ANOMER (AP6, 8OG 14) DNA (5'-D(*CP*GP*CP*TP*CP*(ORP)P*CP*AP*CP*GP*C)-3 CHAIN: A, DNA (5'-D(*GP*CP*(8OG)P*TP*GP*GP*GP*AP*GP*CP*G)-3 CHAIN: B DNA DNA LESION CLUSTER, 8-OXO-GUANINE, ABASIC SITE, DNA 2o7w nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P DUPLEX DNA CONTAINING AN ABASIC SITE WITH AN OPPOSITE G (ALPHA ANOMER) IN 5'-G_AC-3' (10 STRUCTURE ENSEMBLE AND AVERAGED STRUCTURE) 5'-D(*CP*CP*AP*AP*AP*GP*(ORP)P*AP*CP*CP*GP*GP*G)- 3', 5'-D(*CP*CP*CP*GP*GP*TP*GP*CP*TP*TP*TP*GP*G)-3' DNA DNA DAMAGE, APE1, ABASIC, NMR, AMBER, MOLECULAR DYNAMICS 2o7y nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P DUPLEX DNA CONTAINING AN ABASIC SITE WITH AN OPPOSITE T (ALPHA ANOMER) IN 5'-G_AC-3' (10 STRUCTURE ENSEMBLE AND AVERAGED STRUCTURE) 5'-D(*CP*CP*AP*AP*AP*GP*(ORP)P*AP*CP*CP*GP*GP*G)- 3', 5'-D(*CP*CP*CP*GP*GP*TP*TP*CP*TP*TP*TP*GP*G)-3' DNA DNA DAMAGE, APE1, ABASIC, NMR, AMBER, MOLECULAR DYNAMICS 2o80 nuc NMR 2-DEOXY-5-PHOSPHONO-RIBOSE C5 H11 O7 P DUPLEX DNA CONTAINING AN ABASIC SITE WITH AN OPPOSITE DC (ALPHA ANOMER) IN 5'-G_AC-3' (10 STRUCTURE ENSEMBLE AND AVERAGED STRUCTURE) 5'-D(*CP*CP*CP*GP*GP*TP*CP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(ORP)P*AP*CP*CP*GP*GP*G)- 3' DNA DNA DAMAGE, APE1, ABASIC, NMR, AMBER, MOLECULAR DYNAMICS
Code Class Resolution Description 2a2e nuc 3.85 OSMIUM ION 17(OS 3+) CRYSTAL STRUCTURE OF THE RNA SUBUNIT OF RIBONUCLEASE P. BACT TYPE. RNA SUBUNIT OF RNASE P RNA RNASE P, RIBONUCLEASE P RNA, P RNA, RIBOZYME, TRNA, PRE-TRNA THERMOTOGA MARITIMA, TETRALOOP-RECEPTOR, T-LOOP, COAXIAL HE RIBOSE ZIPPERS, RNA 2cky nuc 2.90 OSMIUM ION 12(OS 3+) STRUCTURE OF THE ARABIDOPSIS THALIANA THIAMINE PYROPHOSPHATE RIBOSWITCH WITH ITS REGULATORY LIGAND NUCLEIC ACID NUCLEIC ACID NUCLEIC ACID 3dhs nuc 3.60 OSMIUM ION 15(OS 3+) MAPPING METAL-BINDING SITES IN THE CATALYTIC DOMAIN OF BACTERIAL RNASE P RNA RNASE P RNA: CATALYTIC DOMAIN HYDROLASE, RNA CATALYTIC RNA, RNA PROCESSING, HYDROLASE, RNA
Code Class Resolution Description 1kse nuc NMR OXOLINIC ACID 2(C13 H11 N O5) SOLUTION STRUCTURE OF A QUINOLONE-CAPPED DNA DUPLEX 5'-D(*(5AT)P*GP*CP*GP*CP*A)-3' DNA DNA, QUINOLONE, SYNTHETIC HYBRID, DISRUPTED TERMINAL BASEPAIRS
Code Class Resolution Description 1ag3 nuc NMR 2'-DEOXY-N1,N2-PROPANO GUANOSINE MONOPHOSPHATE C13 H18 N5 O7 P DUPLEX OLIGODEOXYNUCLEOTIDE CONTAINING PROPANODEOXYGUANOSINE OPPOSITE A TWO-BASE DELETION, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*AP*TP*GP*CP*CP*GP*CP*GP*AP*T)-3'), DNA (5'- D(*AP*TP*CP*GP*CP*PP*CP*GP*GP*CP*AP*TP*G)-3') DNA DNA ADDUCTS, DNA CONFORMATION, NMR SPECTROSCOPY, STRUCTURAL REFINEMENT, PROPANODEOXYGUANOSINE, SALMONELLA TYPHIMURIUM HISD3052, DEOXYRIBONUCLEIC ACID 1lae nuc NMR 2'-DEOXY-N1,N2-PROPANO GUANOSINE MONOPHOSPHATE C13 H18 N5 O7 P SOLUTION STRUCTURE OF THE DNA 13-MER HAIRPIN CGCGGTXTCCGCG (X=PDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT AT THE SEVENTH POSITION 5'-D(*CP*GP*CP*GP*GP*TP*(P)P*TP*CP*CP*GP*CP*G)- 3' DNA DNA, HAIRPIN, NMR, PROPANPODEOXYGUANOSINE 1laq nuc NMR 2'-DEOXY-N1,N2-PROPANO GUANOSINE MONOPHOSPHATE C13 H18 N5 O7 P SOLUTION STRUCTURE OF THE B-DNA DUPLEX CGCGGTXTCCGCG (X=PDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT WITH THE DEOXYRIBOSE AT C20 OPPOSITE PDG IN THE C2' ENDO CONFORMATION. 5'-D(*CP*GP*CP*GP*GP*AP*(DNR)P*AP*CP*CP*GP*CP*G)- 3', 5'-D(*CP*GP*CP*GP*GP*TP*(P)P*TP*CP*CP*GP*CP*G)- 3' DNA DNA, B-TYPE, NMR, PROPANODEOXYGUANOSINE 1las nuc NMR 2'-DEOXY-N1,N2-PROPANO GUANOSINE MONOPHOSPHATE C13 H18 N5 O7 P SOLUTION STRUCTURE OF THE B-DNA DUPLEX CGCGGTXTCCGCG (X=PDG) CONTAINING THE 1,N2-PROPANODEOXYGUANOSINE ADDUCT WITH THE DEOXYRIBOSE AT C20 OPPOSITE PDG IN THE C3' ENDO CONFORMATION. 5'-D(*CP*GP*CP*GP*GP*AP*(DNR)P*AP*CP*CP*GP*CP*G)- 3', 5'-D(*CP*GP*CP*GP*GP*TP*(P)P*TP*CP*CP*GP*CP*G)- 3' DNA DNA, B-TYPE, NMR, PROPANODEOXYGUANOSINE
Code Class Resolution Description 1lej nuc NMR IMIDAZOLE-PYRROLE-BETA ALANINE-IMIDAZOLE-BETA ALANINE- IMIDAZOLE-PYRROLE-BETA ALANINE-DIMETHYLAMINO PROPYLAMIDE C41 H56 N17 O8 1+ NMR STRUCTURE OF A 1:1 COMPLEX OF POLYAMIDE (IM-PY-BETA-IM- BETA-IM-PY-BETA-DP) WITH THE TRIDECAMER DNA DUPLEX 5'- CCAAAGAGAAGCG-3' 5'-D(*CP*GP*CP*TP*TP*CP*TP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*AP*GP*AP*AP*GP*CP*G)-3' DNA POLYAMIDE, PURINE TRACT, BETA ALANINE, MINOR GROOVE, DNA
Code Class Resolution Description 1uui nuc NMR 4-[AMINO(IMINO)METHYL]-1-[2-(3- AMMONIOPROPOXY)-5-METHOXYBENZYL]PIPERAZIN-1- IUM C16 H29 N5 O2 NMR STRUCTURE OF A SYNTHETIC SMALL MOLECULE, RBT158, BOUND TO HIV-1 TAR RNA 5'-R(*GP*GP*CP*AP*GP*AP*UP*CP*UP*GP*AP*GP*CP* CP*UP*GP*GP*GP*AP*GP*CP*UP*CP*UP*CP*UP*GP*CP*C)-3': HIV_1 TAR BULGED STEM LOOP HIV-1 HIV-1, TAR RNA, DRUG DESIGN, LIGAND-RNA INTERACTION, RNA BULGE, INHIBITOR
Code Class Resolution Description 1uts nuc NMR N-[2-(3-AMINOPROPOXY)-5-(1H-INDOL-5-YL) BENZYL]-N-(2-PIPERAZIN-1-YLETHYL)AMINE C24 H33 N5 O DESIGNED HIV-1 TAR BINDING LIGAND RNA (5'-(*GP*GP*CP*AP*GP*AP*UP*CP*UP*GP*AP*GP *CP*CP*UP*GP*GP*GP*AP*GP*CP*UP*CP*UP*CP*UP*GP*CP*C) -3') HIV-1 HIV-1, TAR RNA, DRUG DESIGN, ANTIVIRAL, LIGAND BINDING, CONFORMATIONAL CHANGE
Code Class Resolution Description
1uud nuc NMR N-[2-(2-{[(4-{[AMINO(IMINO)METHYL]AMINO} BUTYL)AMINO]METHYL}-4-METHOXYPHENOXY)ETHYL] GUANIDINE C16 H31 N7 O2 NMR STRUCTURE OF A SYNTHETIC SMALL MOLECULE, RBT203, BOUND TO HIV-1 TAR RNA RNA (5'-(*GP*GP*CP*AP*GP*AP*UP*CP*UP*GP*AP*GP *CP*CP*UP*GP*GP*GP*AP*GP*CP*UP*CP*UP*CP*UP*GP*CP*C) -3') HIV-1 HIV-1, TAR RNA, DRUG DESIGN, LIGAND-RNA INTERACTION, RNA BULGE
Code Class Resolution Description
2d2l nuc 2.50 3-{[OXIDO(OXO)PHOSPHINO]OXY}PROPAN-1-OLATE C3 H6 O4 P 1- CRYSTAL STRUCTURE OF A MINIMAL, ALL-RNA HAIRPIN RIBOZYME WIT LINKER (C3) AT POSITION U39 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*(P1P) P*AP*UP*UP*AP*CP*CP*UP*GP*CP*C)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, PROPYL LINKER, RNA
Code Class Resolution Description 1o9m nuc 2.40 1-(AMINOETHYL)AMINO-4-AMINOBUTANE C6 H17 N3 THE COMPLEX OF A NOVEL ANTIBIOTIC WITH THE AMINOACYL SITE OF THE BACTERIAL RIBOSOME REVEALED BY X-RAY CRYSTALLOGRAPHY. EUBACTERIAL A-SITE ANTIBIOTIC/RNA ANTIBIOTIC/RNA, RNA-ANTIBIOTIC INTERACTIONS, A-SITE 292d nuc 1.00 1-(AMINOETHYL)AMINO-4-AMINOBUTANE C6 H17 N3 INTERACTION BETWEEN THE LEFT-HANDED Z-DNA AND POLYAMINE:THE CRYSTAL STRUCTURE OF THE D(CG)3 AND N-(2-AMINOETHYL)-1,4- DIAMINOBUTANE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, COMPLEXED WITH N-(2-AMINOETHYL)-1,4- DIAMINOBUTANE
Code Class Resolution Description 1y8v nuc 1.50 2'-O-PROPYL THYMIDINE-5-MONOPHOSPHATE 2(C13 H21 N2 O9 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O- PROPYL THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(P2T)P*AP*CP*GP*C)-3' DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER
Code Class Resolution Description 1mv1 nuc NMR PURINE RIBOSIDE-5'-MONOPHOSPHATE 2(C10 H13 N4 O7 P) THE TANDEM, SHEARED PA PAIRS IN 5'(RGGCPAGCCU)2 5'-R(*GP*GP*CP*(P5P)P*AP*GP*CP*CP*U)-3' RNA RIBONUCLEIC ACID, DUPLEX, TANDEM MISMATCH, PURINE, RNA 1mv2 nuc NMR PURINE RIBOSIDE-5'-MONOPHOSPHATE 2(C10 H13 N4 O7 P) THE TANDEM, FACE-TO-FACE AP PAIRS IN 5'(RGGCAPGCCU)2 5'-R(*GP*GP*CP*AP*(P5P)P*GP*CP*CP*U)-3' RNA RIBONUCLEIC ACID, DUPLEX, TANDEM MISMATCH, PURINE, RNA 1mv6 nuc NMR PURINE RIBOSIDE-5'-MONOPHOSPHATE 4(C10 H13 N4 O7 P) THE TANDEM, SHEARED PP PAIRS IN 5'(RGGCPPGCCU)2 5'-R(*GP*GP*CP*(P5P)P*(P5P)P*GP*CP*CP*U)-3' RNA RIBONUCLEIC ACID, DUPLEX, TANDEM MISMATCH, PURINE, RNA 1xv0 nuc NMR PURINE RIBOSIDE-5'-MONOPHOSPHATE C10 H13 N4 O7 P SOLUTION NMR STRUCTURE OF RNA INTERNAL LOOP WITH THREE CONSECUTIVE SHEARED GA PAIRS IN 5'GGUGGAGGCU/3'PCCGAAGCCG 5'-R(*GP*CP*CP*GP*AP*AP*GP*CP*CP*(P5P)-3', 5'-R(*GP*GP*UP*GP*GP*AP*GP*GP*CP*U)-3' RNA THERMODYNAMICS AND STRUCTURE, BASE STACKING AND HYDROGEN BONDING, 3-GA MOTIF, RNA 2dd1 nuc NMR PURINE RIBOSIDE-5'-MONOPHOSPHATE C10 H13 N4 O7 P THREE CONSECUTIVE SHEARED GA PAIRS IN 5'GGUGGAGGCU/3'PCCAAAGCCG 5'-R(*GP*GP*UP*GP*GP*AP*GP*GP*CP*U)-3', 5'-R(*GP*CP*CP*GP*AP*AP*AP*CP*CP*(P5P))-3' RNA THREE CONSECUTIVE SHEARED GA PAIRS, THERMODYNAMICS OF MOLECULAR RECOGNITION, K-TURN MOTIF, A-MINOR MOTIF, SECONDARY STRUCTURE OF RNA 2dd2 nuc NMR PURINE RIBOSIDE-5'-MONOPHOSPHATE C10 H13 N4 O7 P AN ALTERNATING SHEARED AA PAIR IN 5'GGUGAAGGCU/3'PCCGAAGCCG: I. THE MAJOR CONFORMATION WITH A6/A15/A16 STACK 5'-R(*GP*CP*CP*GP*AP*AP*GP*CP*CP*(P5P))-3', 5'-R(*GP*GP*UP*GP*AP*AP*GP*GP*CP*U)-3' RNA ALTERNATING, CONFORMATION EXCHANGE, DYNAMICS, SHEARED AA PAIR, SHEARED GA PAIR, THERMODYNAMICS, RNA SECONDARY STRUCTURE, A-MINOR MOTIF, KINK-TURN 2dd3 nuc NMR PURINE RIBOSIDE-5'-MONOPHOSPHATE C10 H13 N4 O7 P AN ALTERNATING SHEARED AA PAIR IN 5'GGUGAAGGCU/3'PCCGAAGCCG: II. THE MINOR CONFORMATION WITH A6/A5/A16 STACK 5'-R(*GP*GP*UP*GP*AP*AP*GP*GP*CP*U)-3', 5'-R(*GP*CP*CP*GP*AP*AP*GP*CP*CP*(P5P))-3' RNA RAPID CONFORMATION EXCHANGE, ALTERNATING SHEARED AA PAIR, SEQUENCE SPECIFIC A-MINOR MOTIF, KINK-TURN MOTIF, THERMODYNAMICS, RNA SECONDARY STRUCTURE PREDICTION 4g6p nuc 2.64 PURINE RIBOSIDE-5'-MONOPHOSPHATE C10 H13 N4 O7 P MINIMAL HAIRPIN RIBOZYME IN THE PRECATALYTIC STATE WITH A38P LOOP A SUBSTRATE STRAND, LOOP B OF THE RIBOZYME STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4g6s nuc 2.84 PURINE RIBOSIDE-5'-MONOPHOSPHATE C10 H13 N4 O7 P MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH A38P V LOOP A SUBSTRATE STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP B OF THE RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT
Code Class Resolution Description 1pbr nuc NMR 2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE C6 H13 N O5 STRUCTURE OF 16S RIBOSOMAL RNA, NMR, MINIMIZED AVERAGE STRUC 16S RIBOSOMAL RNA RNA AMINOGLYCOSIDE, RIBOSOMAL RNA, RNA TRANSCRIPT, ANTIBIOTIC, RIBONUCLEIC ACID, RNA
Code Class Resolution Description 1o9m nuc 2.40 PAROMOMYCIN (RING 2) C6 H14 N2 O2 THE COMPLEX OF A NOVEL ANTIBIOTIC WITH THE AMINOACYL SITE OF THE BACTERIAL RIBOSOME REVEALED BY X-RAY CRYSTALLOGRAPHY. EUBACTERIAL A-SITE ANTIBIOTIC/RNA ANTIBIOTIC/RNA, RNA-ANTIBIOTIC INTERACTIONS, A-SITE
Code Class Resolution Description 1fyp nuc NMR PAROMOMYCIN C23 H45 N5 O14 EUKARYOTIC DECODING REGION A-SITE RNA-PAROMOMYCIN COMPLEX FRAGMENT OF 18S RIBOSOMAL RNA: 18S RNA - NUCLEOTIDES 1404-1412, 1488-1497 (E. COLI NUMBERING) RNA RNA-PAROMOMYCIN COMPLEX, AMINOGLYCOSIDE, STEM-INTERNAL LOOP- STEM-TETRALOOP, RNA-DRUG, G-A BASE PAIR 1j7t nuc 2.50 PAROMOMYCIN 2(C23 H45 N5 O14) COMPLEX BETWEEN PAROMOMYCIN AND THE 16S-RRNA A-SITE AT 2.5 A RESOLUTION 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES 2mxs nuc NMR PAROMOMYCIN C23 H45 N5 O14 SOLUTION NMR-STRUCTURE OF THE NEOMYCIN SENSING RIBOSWITCH RN PAROMOMYCIN RNA (27-MER) RNA RNA, RIBOSWITCH, AMINOGLYCOSIDE 2o3w nuc 2.80 PAROMOMYCIN C23 H45 N5 O14 CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING SITE IN PRESENCE OF PAROMOMYCIN RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3') RNA AMINOGLYCOSIDE, ANTIBIOTICS, RIBOSOME, DECODING SITE, HOMO SAPIENS, EUKARYOTE, CYTOPLASMIC, TRANSLATION INHIBITION, STOP CODON READTHROUGH, UNSPECIFIC BINDING, RNA 3bnq nuc 2.00 PAROMOMYCIN C23 H45 N5 O14 CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF SRCL2 (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, B CHAIN, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, A CHAIN RNA RIBOSOME, DECODING SITE, RNA 3bnr nuc 2.10 PAROMOMYCIN C23 H45 N5 O14 CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF NONSPECIFICALLY BOUND PAROMOMYCIN (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN THREE, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN TWO, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, CHAIN ONE RNA RIBOSOME, DECODING SITE, RNA 3c44 nuc 2.00 PAROMOMYCIN 2(C23 H45 N5 O14) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO PAROMOMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC, PAROMOMYCIN, EXTENDED DUPLEX 4wcr nuc 3.50 PAROMOMYCIN C23 H45 N5 O14 CRYSTAL STRUCTURE OF THE BACTERIAL A1408ME1A-MUTANT RIBOSOMA SITE IN COMPLEX WITH PAROMOMYCIN RNA (5'-R(*UP*UP*GP*CP*GP*UP*CP*(1MA) P*CP*GP*UP*CP*GP*AP*CP*GP*AP*AP*GP*UP*CP*GP*C)-3') RNA RIBOSOME, RNA, AMINOGLYCOSIDE, ANTIBIOTIC-RESISTANCE 4zc7 nuc 3.04 PAROMOMYCIN 2(C23 H45 N5 O14) PAROMOMYCIN BOUND TO A LEISHMANIAL RIBOSOMAL A-SITE RNA DUPLEX RNA A-SITE, RIBOSOME, PAROMOMYCIN, LEISHMANIA, RNA
Code Class Resolution Description
2ie1 nuc 1.60 N-(2-AMINOETHYL)-N'-{2-[(2-AMINOETHYL) AMINO]ETHYL}ETHANE-1,2-DIAMINE 2(C8 H23 N5) POLYAMINES STABILIZE LEFT-HANDED Z-DNA. WE FOUND NEW TYPE OF POLYAMINE WHICH STABILIZE LEFT-HANDED Z-DNA BY X-RAY CRYSTALLOGRAPHY DNA (5'-D(*DCP*DGP*DCP*DGP*DCP*DG)-3') DNA DEOXY NUCLEIC ACID, D(CGCGCG)2, Z-DNA, N1-{2-[2-(2-AMINO- ETHYLAMINO)-ETHYLAMINO]-ETHYL}-ETHANE-1,2-DIAMINE, PA(2222) POLYAMINE, METAL FREE CRYSTAL STRUCTURE
Code Class Resolution Description 1nbs nuc 3.15 LEAD (II) ION 23(PB 2+) CRYSTAL STRUCTURE OF THE SPECIFICITY DOMAIN OF RIBONUCLEASE P RNA RIBONUCLEASE P RNA: SPECIFICITY-DOMAIN, S-DOMAIN RNA RIBONUCLEASE P RNA, P RNA, S-DOMAIN 1tn1 nuc 3.00 LEAD (II) ION 3(PB 2+) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 LEAD (II) ION 3(PB 2+) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1y95 nuc 2.80 LEAD (II) ION 3(PB 2+) HIV-1 DIS(MAL) DUPLEX PB-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, HIV-1, METAL IONS, BULGE
Code Class Resolution Description
2ktt nuc NMR (11AS)-7-METHOXY-8-(3-{4-[6-(4-METHYLPIPERAZIN-1-YL)- 1H-BENZIMIDAZOL-2-YL]PHENOXY}PROPOXY)-1,2,3,10,11,11A- HEXAHYDRO-5H-PYRROLO[2,1-C][1,4]BENZODIAZEPIN-5-ONE C34 H40 N6 O4 SOLUTION STRUCTURE OF A COVALENTLY BOUND PYRROLO[2,1-C][1, 4]BENZODIAZEPINE-BENZIMIDAZOLE HYBRID TO A 10MER DNA DUPLEX 5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3' DNA DNA DUPLEX, PYRROLOBENZODIAZEPINE, PBD-BENZIMIDAZOLE HYBRID, DNA-DRUG COMPLEX, DNA
Code Class Resolution Description 1ql5 nuc NMR [3-HYDROXY-5-(5-METHYL-2,4-DIOXOTETRAHYDRO-1(2H)- PYRIMIDINYL)TETRAHYDRO-2-FURANYL]METHYL DIHYDROGEN PHOSPHATE 2(C10 H17 N2 O8 P) DNA DECAMER DUPLEX CONTAINING T5-T6 PHOTOADDUCT DNA (5'-D(*CP*GP*CP*AP*TP*+TP*AP*CP*GP*C)- 3'), DNA (5'-D(*GP*CP*GP*TP*TP*AP*TP*GP*CP*G)-3') DNA DNA, DEOXYRIBONUCLEIC ACID, DNA PHOTOPRODUCT, (6-4) ADDUCT, MUTAGENESIS
Code Class Resolution Description 231d nuc 2.40 CU(II)MESO(4-N-TETRAMETHYLPYRIDYL)PORPHYRIN C44 H36 CU N8 STRUCTURE OF A DNA-PORPHYRIN COMPLEX DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, FLIPPED-OUT BASES, COMPLEXED WITH DRUG
Code Class Resolution Description 1ejz nuc NMR PHOSPHORIC ACID MONO-(3-HYDROXY-PROPYL) ESTER C3 H9 O5 P SOLUTION STRUCTURE OF A HNA-RNA HYBRID DNA (5'-H(*(6HG)P*(6HC)P*(6HG)P*(6HT)P*(6HA) P*(6HG)P*(6HC)P*(6HG))-3'), RNA (5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3') RNA HNA-RNA COMPLEX, DOUBLE HELIX, A-TYPE CONFORMATION 2npz nuc 3.35 PHOSPHORIC ACID MONO-(3-HYDROXY-PROPYL) ESTER C3 H9 O5 P CRYSTAL STRUCTURE OF JUNCTIONED HAIRPIN RIBOZYME INCORPORATING SYNTHETIC PROPYL LINKER 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3', 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3': S-TURN STRAND RNA RNA, RIBOZYME, HAIRPIN, E LOOP, S TURN, PROPYL
Code Class Resolution Description 5wsq nuc 1.05 1,3-PROPANDIOL C3 H8 O2 CRYSTAL STRUCTURE OF C-HG-T PAIR CONTAINING DNA DUPLEX DNA (5'-D(*GP*CP*CP*CP*GP*TP*GP*C)-3') DNA DNA DUPLEX, C-HG-T PAIR, DNA
Code Class Resolution Description 1nts nuc NMR 5(1-PROPYNYL)-2'-DEOXYURIDINE-5-MONOPHOSPHATE 3(C12 H19 N2 O8 P) 5'(DCCPUPCPCPUPUP)3':3'(RAGGAGGAAA)5', WHERE P=PROPYNYL 5'-D(*(5PC)P*(5PC)P*(PDU)P*(5PC)P*(5PC)P*(PDU) P*(PDU))-3', 5'-R(*AP*AP*AP*GP*GP*AP*GP*GP*A)-3' RNA/DNA DNA, RNA, HYBRID, PROPYNYL, RNA/DNA COMPLEX 1ntt nuc NMR 5(1-PROPYNYL)-2'-DEOXYURIDINE-5-MONOPHOSPHATE 3(C12 H19 N2 O8 P) 5'(DCPCPUPCPCPUPUP)3':(RAGGAGGAAA)5', WHERE P=PROPYNYL 5'-D(*CP*(5PC)P*(PDU)P*(5PC)P*(5PC)P*(PDU) P*(PDU))-3', 5'-R(*AP*AP*AP*GP*GP*AP*GP*GP*A)-3' RNA/DNA DNA, RNA, HYBRID, PROPYNYL, RNA/DNA COMPLEX 1oo7 nuc NMR 5(1-PROPYNYL)-2'-DEOXYURIDINE-5-MONOPHOSPHATE 5(C12 H19 N2 O8 P) DNA.RNA HYBRID DUPLEX CONTAINING A 5-PROPYNE DNA STRAND AND PURINE-RICH RNA STRAND, NMR, 4 STRUCTURES 5'-D(*GP*(5PC)P*(PDU)P*(PDU)P*(5PC)P*(PDU) P*(5PC)P*(PDU)P*(PDU)P*C)-3', 5'-R(*GP*AP*AP*GP*AP*GP*AP*AP*GP*C)-3' DNA-RNA HYBRID DNA.RNA HYBRID, PURINE/PYRIMIDINE-RICH STRANDS, ANTISENSE, DNA/RNA COMPLEX, DNA-RNA HYBRID 1p3x nuc NMR 5(1-PROPYNYL)-2'-DEOXYURIDINE-5-MONOPHOSPHATE 5(C12 H19 N2 O8 P) INTRAMOLECULAR DNA TRIPLEX WITH 1-PROPYNYL DEOXYURIDINE IN THE THIRD STRAND, NMR, 10 STRUCTURES DNA (5'-D(*AP*GP*AP*GP*AP*GP*AP*A)-3'), DNA (5'-D(*TP*TP*CP*TP*CP*TP*CP*T)-3') DNA OLIGONUCLEOTIDE, TRIPLEX, PROPYNE, DNA
Code Class Resolution Description 1g1n nuc NMR PHOSPHORYL-HEXAETHYLENE GLYCOL 2(C12 H27 O10 P) NICKED DECAMER DNA WITH PEG6 TETHER, NMR, 30 STRUCTURES 5'-D(P*GP*CP*GP*TP*T)-3', 5'-D(P*GP*CP*GP*AP*CP*AP*AP*CP*GP*C)-3', 5'-D(*GP*TP*CP*GP*C)-3' DNA NICKED DUPLEX DNA, PEG6 TETHER
Code Class Resolution Description 1g5l nuc NMR HYDROGEN PEROXIDE H2 O2 CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1gj2 nuc NMR HYDROGEN PEROXIDE H2 O2 CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1mtg nuc NMR HYDROGEN PEROXIDE H2 O2 NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GAGCTC 5'-D(*GP*AP*GP*CP*TP*C)-3' DNA DRUG-DNA COMPLEX, COBALT(III), DNA 1mxk nuc NMR HYDROGEN PEROXIDE H2 O2 NMR STRUCTURE OF HO2-CO(III)BLEOMYCIN A(2) BOUND TO D(GGAAGCTTCC)(2) 5'-D(*GP*GP*AP*AP*GP*CP*TP*TP*CP*C)-3' DNA DRUG-DNA COMPLEX, COBALT(III)
Code Class Resolution Description 166d nuc 2.20 1,5-DI(4-AMIDINOPHENOXY)-3-OXA-PENTANE C18 H22 N4 O3 DRUG-DNA MINOR GROOVE RECOGNITION: CRYSTAL STRUCTURE OF GAMMA-OXAPENTAMIDINE COMPLEXED WITH D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1zjg nuc 3.00 TETRAETHYLENE GLYCOL 3(C8 H18 O5) 13MER-CO 5'-D(*AP*TP*GP*GP*GP*GP*CP*GP*GP*GP*GP*CP*T)-3', 5'-D(*TP*AP*GP*CP*CP*CP*CP*GP*CP*CP*CP*CP*A)-3' DNA A-DNA, FLIPPED-OUT BASE, COBALT HEXAMMINE, PEG 400
Code Class Resolution Description 1g5k nuc NMR 2-PHOSPHOGLYCOLIC ACID C2 H5 O6 P NMR STRUCTRURE OF D(CCAAAGXACTGGG), X IS A 3'- PHOSPHOGLYCOLATE, 5'-PHOSPHATE GAPPED LESION, 10 STRUCTURES 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DNA, NMR, BLEOMYCIN, PHOSPHOGLYCOLATE 1g5l nuc NMR 2-PHOSPHOGLYCOLIC ACID C2 H5 O6 P CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1gj1 nuc NMR 2-PHOSPHOGLYCOLIC ACID C2 H5 O6 P NMR STRUCTURE OF D(CCAAAGXACTGGG), X IS A 3'PHOSPHOGLYCOLATE, 5'PHOSPHATE GAPPED LESION 5'-D(*CP*CP*AP*AP*AP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3' DNA DNA, NMR, BLEOMYCIN, PHOSPHOGLYCOLATE 1gj2 nuc NMR 2-PHOSPHOGLYCOLIC ACID C2 H5 O6 P CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(P*AP*CP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*G)-3' DNA DAMAGED DNA, DNA-DRUG COMPLEX, INTERCALATION 1n0k nuc NMR 2-PHOSPHOGLYCOLIC ACID C2 H5 O6 P NMR STRUCTURE OF DUPLEX DNA D(CCAAGGXCTTGGG), X IS A 3' PHOSPHOGLYCOLATE, 5'PHOSPHATE GAPPED LESION 5'-D(*CP*CP*AP*AP*GP*G)-3', 5'-D(*CP*CP*CP*AP*AP*GP*GP*CP*CP*TP*TP*GP*G)-3', 5'-D(P*CP*TP*TP*GP*GP*G)-3' DNA DNA, NMR, BLEOMYCIN, PHOSPHOGLYCOLATE, 1n0o nuc NMR 2-PHOSPHOGLYCOLIC ACID C2 H5 O6 P NMR STRUCTURE OF D(CCAAGGXCTTGGG), X IS A 3'- PHOSPHOGLYCOLATE, 5'-PHOSPHATE GAPPED LESION, 10 STRUCTURES 5'-D(*CP*CP*CP*AP*AP*GP*GP*CP*CP*TP*TP*GP*G)-3', 5'-D(P*CP*TP*TP*GP*GP*G)-3', 5'-D(*CP*CP*AP*AP*GP*G)-3' DNA DNA, NMR, BLEOMYCIN, PHOSPHOGLYCOLATE
Code Class Resolution Description 1duh nuc 2.70 GUANOSINE-3',5'-DIPHOSPHATE C10 H15 N5 O11 P2 CRYSTAL STRUCTURE OF THE CONSERVED DOMAIN IV OF E. COLI 4.5S RNA 4.5S RNA DOMAIN IV: DOMAIN IV RNA 4.5S RNA, DOMAIN IV, HELIX 8, SIGNAL RECOGNITION PARTICLE, SRP, FFH, SRP54, ELONGATION FACTOR G, EF-G, 23S RNA, NON- CANONICAL BASE PAIRS, MISMATCH
Code Class Resolution Description 1hz0 nuc NMR 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE C13 H12 N4 NMR STRUCTURE OF THE 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5- B]PYRIDINE (PHIP) C8-DEOXYGUANOSINE ADDUCT IN DUPLEX DNA DNA (5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3'), DNA (5'-D(*CP*CP*AP*TP*CP*GP*CP*TP*AP*CP*C)-3') DNA DNA ADDUCT DUPLEX
Code Class Resolution Description 1ao1 nuc NMR COBALT (III)-DEGLYCOPEPLEOMYCIN C48 H68 CO N17 O12 S2 1+ INTERACTIONS OF DEGLYCOSYLATED COBALT(III)-PEPLEOMYCIN WITH DNA, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA ANTICANCER DRUGS, DEGLYCOSYLATED PEPLEOMYCIN, BLEOMYCINS, DNA, DNA CLEAVAGE, TWO-DIMENSIONAL NMR, SOLUTION STRUCTURES DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1lvj nuc NMR 1-[10-(3-DIMETHYLAMINO-PROPYL)-10H-PHENOTHIAZIN-2-YL]- ETHANONE C19 H22 N2 O S STRUCTURE OF TAR RNA COMPLEXED WITH A TAT-TAR INTERACTION NANOMOLAR INHIBITOR THAT WAS IDENTIFIED BY COMPUTATIONAL SCREENING HIV-1 TRANS ACTIVATING REGION RNA RNA TRANSCRIPTIONAL ACTIVATION, NMR, COMPLEX (RNA/DRUG)
Code Class Resolution Description 1em0 nuc 0.90 TETRA[N-METHYL-PYRIDYL] PORPHYRIN-NICKEL 2(C44 H36 N8 NI) COMPLEX OF D(CCTAGG) WITH TETRA-[N-METHYL-PYRIDYL] PORPHYRIN DNA (5'-D(*(CBR)P*CP*TP*AP*GP*G)-3') DNA PORPHYRIN, RUFFLING, DNA DISTORTION, GROOVE BINDING
Code Class Resolution Description 1d64 nuc 2.10 1,5-BIS(4-AMIDINOPHENOXY)PENTANE C19 H24 N4 O2 CRYSTAL STRUCTURE OF A PENTAMIDINE-OLIGONUCLEOTIDE COMPLEX: IMPLICATIONS FOR DNA-BINDING PROPERTIES DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 3ey0 nuc 2.52 1,5-BIS(4-AMIDINOPHENOXY)PENTANE C19 H24 N4 O2 A NEW FORM OF DNA-DRUG INTERACTION IN THE MINOR GROOVE OF A COIL 5'-D(*DAP*DTP*DAP*DTP*DAP*DTP*DAP*DTP*DAP*DT)-3' DNA DNA DRUG PENTAMIDINE COILED-COIL ALL-AT, DNA
Code Class Resolution Description 1y27 nuc 2.40 HYPOPHOSPHITE O2 P 1- G-RIBOSWITCH-GUANINE COMPLEX BACILLUS SUBTILIS XPT: SEQUENCE DATABASE RESIDUES 185-252 RNA G-RIBOSWITCH GUANINE RECOGNITION, RNA
Code Class Resolution Description 2qwy nuc 2.80 PHOSPHATE ION 6(O4 P 3-) SAM-II RIBOSWITCH BOUND TO S-ADENOSYLMETHIONINE SAM-II RIBOSWITCH RNA MRNA, RIBOSWITCH, SAM, S-ADENOSYLMETHIONINE, ADOMET, RNA- LIGAND COMPLEX, DOUBLE HELIX, PSEUDOKNOT, BASE TRIPLE 3b31 nuc 2.40 PHOSPHATE ION O4 P 3- CRYSTAL STRUCTURE OF DOMAIN III OF THE CRICKET PARALYSIS VIRUS IRES RNA RNA (5'- R(P*UP*AP*AP*GP*AP*AP*AP*UP*UP*UP*AP*CP*CP*U)-3'): RESIDUES 6203-6216, RNA (29-MER): RESIDUES 6174-6202 RNA IRES, RNA STRUCTURE, TRANSLATION INITIATION, TRNA ANTICODON, HYBRID STATE, TRNA MIMICRY 3ok2 nuc 1.96 PHOSPHATE ION 3(O4 P 3-) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER WITHOUT LATTICE TRA DEFECTS (A6C)(A6C)(A6G)(A6U)(A6A)(A6A)(A6U)(A6G)(A6C)(A6C CHAIN: A, C, E, GGCAUUACGG RNA RNA, HYBRID, ANA, SUGAR MODIFICATION, ALTRITOL SUGAR RINGS 3ok4 nuc 1.15 PHOSPHATE ION 15(O4 P 3-) CRYSTAL STRUCTURE OF THE ANA:RNA DECAMER SUFFERING FROM LATT TRANSLOCATION DEFECTS ANA, RNA RNA ALTRITOL, SUGAR MODIFICATION, RNA, LATTICE TRANSLOCATION DEF 3syw nuc 1.57 PHOSPHATE ION 2(O4 P 3-) CRYSTAL STRUCTURE OF THE TRIPLET REPEAT IN MYOTONIC DYSTROPH HETEROGENEOUS 1X1 NUCLEOTIDE UU INTERNAL LOOP CONFORMATIONS RNA (5'- R(*UP*UP*GP*GP*GP*CP*CP*UP*GP*CP*UP*GP*CP*UP*GP*GP*UP*CP*C) CHAIN: A, B: RNA RNA CUG REPEAT RNA, A-FORM RNA, MYOTONIC DYSTROPHY, INTERNAL LOO 4j50 nuc 1.65 PHOSPHATE ION 2(O4 P 3-) CRYSTAL STRUCTURE OF AN EXPANDED RNA CAG REPEAT RNA (5'- R(*UP*UP*GP*GP*GP*CP*CP*AP*GP*CP*AP*GP*CP*AP*GP*GP*UP*CP*C) CHAIN: A, B RNA A FORM RNA, CAG REPEAT EXPANSION, POLYQ, GAIN OF RNA FUNCTIO HUNTINGTIN DISEASE, SPINAL-BULBAR MUSCULAR ATROPHY, DENTATO PALLIDOLUYSIAN ATROPHY, SPINOCEREBELLAR ATAXIA, RNA 4yn6 nuc 2.30 PHOSPHATE ION 2(O4 P 3-) STRUCTURAL INSIGHT REVEALS DYNAMICS IN REPEATING R(CAG) TRAN FOUND IN HUNTINGTON'S DISEASE (HD) AND SPINOCEREBELLAR ATAX RNA (5'- R(P*UP*UP*GP*GP*GP*CP*CP*AP*GP*CP*AP*GP*CP*AP*GP*GP*UP*CP*C CHAIN: A, B RNA RNA, TRINUCLEOTIDE REPEAT, HUNTINGTON'S DISEASE (HD), SPINOC ATAXIAS (SCAS) 5v3f nuc 1.70 PHOSPHATE ION 2(O4 P 3-) CO-CRYSTAL STRUCTURE OF THE FLUOROGENIC RNA MANGO RNA (31-MER) RNA QUADRUPLEX FLUORESCENT RNA, RNA
Code Class Resolution Description 2a5r nuc NMR (1Z,4Z,9Z,15Z)-5,10,15,20-TETRAKIS(1-METHYLPYRIDIN-1- IUM-4-YL)-21,23-DIHYDROPORPHYRIN C44 H38 N8 4+ COMPLEX OF TETRA-(4-N-METHYLPYRIDYL) PORPHIN WITH MONOMERIC STRANDED DNA TETRAPLEX, SNAP-BACK 3+1 3' G-TETRAD, SINGLE-R CHAIN REVERSAL LOOPS, GAG TRIAD IN THE CONTEXT OF GAAG DIAG C-MYC PROMOTER, NMR, 6 STRUCT. 5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*IP*GP*AP*GP*GP*G *GP*GP*AP*AP*GP*G)-3' DNA MONOMERIC PARALLEL-STRANDED QUADRUPLEX; C-MYC PROMOTER 3+1 G SINGLE NUCLEOTIDE CHAIN REVERSAL LOOP; GAG TRIAD; GAAG LOOP 2hri nuc 2.09 (1Z,4Z,9Z,15Z)-5,10,15,20-TETRAKIS(1-METHYLPYRIDIN-1- IUM-4-YL)-21,23-DIHYDROPORPHYRIN 2(C44 H38 N8 4+) A PARALLEL STRANDED HUMAN TELOMERIC QUADRUPLEX IN COMPLEX WI PORPHYRIN TMPYP4 5'-D(*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3': TELOMERE DNA QUADRUPLEX, DNA, PROPELLER, DIMERIC, HUMAN TELOMERE PARALLEL STRANDED, LIGAND, COMPLEX
Code Class Resolution Description 1fg0 nuc 3.00 PUROMYCIN-5'-MONOPHOSPHATE C22 H30 N7 O8 P LARGE RIBOSOMAL SUBUNIT COMPLEXED WITH A 13 BP MINIHELIX- PUROMYCIN COMPOUND 5'-R(CCGGCGGGCUGGUUCAAACCGGCCCGCCGGACC)-3'-5'- R(P-PUROMYCIN)-3', 23S RIBOSOMAL RNA: DOMAIN V OF 23S RIBOSOMAL RNA RIBOSOME RIBOSOME ASSEMBLY, RNA-RNA, RIBOZYME, A-SITE 1njo nuc 3.70 PUROMYCIN-5'-MONOPHOSPHATE C22 H30 N7 O8 P THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH A SHORT SUBSTRATE ANALOG ACCPUROMYCIN (ACCP) RNA ACC(PUROMYCIN), 23S RIBOSOMAL RNA RIBOSOME RIBOSOMES, TRNA, PUROMYCIN, SPARSOMYCIN, PEPTIDYL- TRANSFERASE, PEPTIDE BOND FORMATION
Code Class Resolution Description 1i5v nuc NMR 2-(PYRIDO[1,2-E]PURIN-4-YL)AMINO-ETHANOL 2(C11 H11 N5 O) SOLUTION STRUCTURE OF 2-(PYRIDO[1,2-E]PURIN-4-YL)AMINO- ETHANOL INTERCALATED IN THE DNA DUPLEX D(CGATCG)2 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX
Code Class Resolution Description 3gca nuc 2.75 2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDINE- 5-CARBONITRILE C7 H5 N5 O THE STRUCTURAL BASIS FOR RECOGNITION OF THE PREQ0 METABOLITE BY AN UNUSUALLY SMALL RIBOSWITCH APTAMER DOMAIN PREQ1 RIBOSWITCH RNA PREQ1, PREQ0, RIBOSWITCH, RNA, RIBOSOMAL BINDING SITE, AMPTAMER, METABOLITE
Code Class Resolution Description 2mgn nuc NMR N2,N9-BIS(1-METHYLQUINOLIN-3-YL)-1,10-PHENANTHROLINE-2, 9-DICARBOXAMIDE C34 H26 N6 O2 SOLUTION STRUCTURE OF A G-QUADRUPLEX BOUND TO THE BISQUINOLI COMPOUND PHEN-DC3 5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*TP*GP*AP*GP*GP*G *GP*GP*AP*AP*GP*G)-3' DNA LIGAND, C-MYC PROMOTER, DNA
Code Class Resolution Description 2l1v nuc NMR 7-DEAZA-7-AMINOMETHYL-GUANINE C7 H9 N5 O SOLUTION STRUCTURE OF A PREQ1 RIBOSWITCH (CLASS I) APTAMER B PREQ1 36-MER RNA PREQ1, RIBOSWITCH, RNA, APTAMER, PSEUDOKNOT 2miy nuc NMR 7-DEAZA-7-AMINOMETHYL-GUANINE C7 H9 N5 O SOLUTION NMR STRUCTURE OF A PREQ1 CLASS II RIBOSWITCH FROM STREPTOCOCCUS PNEUMONIAE RNA_(59-MER) RNA PREQ1, RIBOSWITCH, CLASSII, PSEUDOKNOT, STREPTOCOCCUS PNEUMO 3fu2 nuc 2.85 7-DEAZA-7-AMINOMETHYL-GUANINE 3(C7 H9 N5 O) COCRYSTAL STRUCTURE OF A CLASS-I PREQ1 RIBOSWITCH PREQ1 RIBOSWITCH RNA RNA; APTAMER; RIBOSWITCH; QUEUOSINE; PREQ1 3k1v nuc 2.20 7-DEAZA-7-AMINOMETHYL-GUANINE C7 H9 N5 O COCRYSTAL STRUCTURE OF A MUTANT CLASS-I PREQ1 RIBOSWITCH PREQ1 RIBOSWITCH RNA RNA; APTAMER; RIBOSWITCH; QUEUOSINE; PREQ1 3q50 nuc 2.75 7-DEAZA-7-AMINOMETHYL-GUANINE C7 H9 N5 O STRUCTURAL ANALYSIS OF A CLASS I PREQ1 RIBOSWITCH APTAMER IN METABOLITE-BOUND STATE PREQ1 RIBOSWITCH RNA PREQ1, PREQ0, RNA, RIBOSOMAL BINDING SITE, APTAMER, METABOLI PSEUDOKNOT, H-TYPE, RIBOSWITCH 4jf2 nuc 2.28 7-DEAZA-7-AMINOMETHYL-GUANINE C7 H9 N5 O STRUCTURE OF A CLASS II PREQ1 RIBOSWITCH REVEALS LIGAND RECO A NEW FOLD PREQ1-II RIBOSWITCH RNA RIBOSWITCH, H-TYPE PSEUDOKNOT, RNA 4rzd nuc 2.75 7-DEAZA-7-AMINOMETHYL-GUANINE C7 H9 N5 O CRYSTAL STRUCTURE OF A PREQ1 RIBOSWITCH PREQ1-III RIBOSWITCH (CLASS 3) RNA THREE-WAY HELICAL JUNCTION, HL(OUT)-TYPE PSEUDOKNOT, TRANSLA REGULATION, RNA 5d5l nuc 2.50 7-DEAZA-7-AMINOMETHYL-GUANINE 4(C7 H9 N5 O) PREQ1-II RIBOSWITCH WITH AN ENGINEERED G-U WOBBLE PAIR BOUND PREQ1-II RIBOSWITCH RNA GU WOBBLE, PSEUDOKNOT, SHINE-DALGARNO SEQUENCE, RNA
Code Class Resolution Description 1vtf nuc 2.00 PROFLAVIN 6(C13 H11 N3) STRUCTURE OF 5'-D(*(BRO)CP*GP*(BRO)CP*G)-3' IN COMPLEX WITH DNA (5'-D(*(BRO)CP*GP*(BRO)CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIE DEOXYRIBONUCLEIC ACID, DNA 2kd4 nuc NMR PROFLAVIN 2(C13 H11 N3) SOLUTION STRUCTURE AND THERMODYNAMICS OF 2',5' RNA INTERCALATION 5'-R(*GP*CP*CP*GP*CP*GP*GP*C)-2' RNA PROFLAVINE, NMR, INTERCALATION, 2',5' RNA, RNA, NEAREST- NEIGHBOR EXCLUSION 3ft6 nuc 1.12 PROFLAVIN 2(C13 H11 N3) CRYSTAL STRUCTURE OF PROFLAVINE IN COMPLEX WITH A DNA HEXAMER DUPLEX 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA DNA, DNA BINDING, PROFLAVINE, INTERCALATOR
Code Class Resolution Description 1fhy nuc 2.20 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN C15 H14 O4 PSORALEN CROSS-LINKED D(CCGCTAGCGG) FORMS HOLLIDAY JUNCTION DNA (5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3') DNA PSORALEN, CROSS-LINKED DNA, HOLLIDAY JUNCTION, 4-WAY JUNCTION, DNA-DRUG COMPLEX 1fhz nuc 2.20 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN C15 H14 O4 PSORALEN CROSS-LINKED D(CCGGTACCGG) FORMS HOLLIDAY JUNCTION DNA (5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3') DNA PSORALEN, CROSS-LINKED DNA, HOLLIDAY JUNCTION, DNA-DRUG COMPLEX 203d nuc NMR 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN C15 H14 O4 THE SOLUTION STRUCTURES OF PSORALEN MONOADDUCTED AND CROSSLINKED DNA OLIGOMERS BY NMR SPECTROSCOPY AND RESTRAINED MOLECULAR DYNAMICS DNA (5'-D(*GP*CP*GP*TP*AP*CP*GP*C)-3') DNA DNA 204d nuc NMR 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN C15 H14 O4 THE SOLUTION STRUCTURES OF PSORALEN MONOADDUCTED AND CROSSLINKED DNA OLIGOMERS BY NMR SPECTROSCOPY AND RESTRAINED MOLECULAR DYNAMICS DNA (5'-D(*GP*CP*GP*TP*AP*CP*GP*C)-3') DNA DNA 2b2b nuc 1.50 4'-HYDROXYMETHYL-4,5',8-TRIMETHYLPSORALEN C15 H14 O4 STRUCTURAL DISTORTIONS IN PSORALEN CROSS-LINKED DNA 5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3' DNA RECOMBINATION, PSORALEN, NUCLEIC ACID STRUCTURE, DNA
Code Class Resolution Description 219d nuc NMR THYMIDINE-5'-THIOPHOSPHATE C10 H15 N2 O7 P S DNA/RNA HYBRID DUPLEX (5'-D(*GP*CP*TP*AP*TP*AP*APS*TP*GP*G)- 3')(DOT) (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3') WITH A PHOSPHOROTHIOATE MOIETY RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3'), DNA (5'-D(*GP*CP*TP*AP*TP*AP*AP*TP*GP*G)-3') DNA-RNA HYBRID DNA, RNA, NMR, HYBRID, PHOSPHOROTHIOATE, DNA/RNA COMPLEX, DNA-RNA HYBRID 8psh nuc NMR THYMIDINE-5'-THIOPHOSPHATE C10 H15 N2 O7 P S HIGH RESOLUTION NMR STRUCTURE OF THE STEREOREGULAR (ALL-RP)- PHOSPHOROTHIOATE-DNA/RNA HYBRID D (G*PS*C*PS*G*PS*T*PS*C*PS*A*PS*G*PS*G)R(CCUGACGC), MINIMIZED AVERAGE STRUCTURE RNA (5'-R(*CP*CP*UP*GP*AP*CP*GP*C)-3'), DNA (5'-D(*DGP*(SC)P*(GS)P*(PST)P*(SC)P*(AS) P*(GS)P*(GS))-3') DNA-RNA HYBRID OLIGONUCLEOTIDE, DNA-RNA HYBRID, PHOSPHOROTHIOATE, THIONUCLEOTIDE, ANTISENSE
Code Class Resolution Description
1bzt nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P STABILIZATION OF THE ANTICODON STEM-LOOP OF TRNALYS,3 BY AN A+C BASE PAIR AND BY PSEUDOURIDINE, NMR, 1 STRUCTURE TRNA: ANTICODON (RESIDUES 27-43) RNA TRNA, PSEUDOURIDINE, ANTICODON
1bzu nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P STABILIZATION OF THE ANTICODON STEM-LOOP OF TRNALYS, 3 BY AN A+C BASE PAIR AND BY PSEUDOURIDINE, NMR, 1 STRUCTURE TRNA: ANTICODON (RESIDUES 27-43) RNA TRNA, PSEUDOURIDINE, ANTICODON
1c2w nuc 7.50 PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) 23S RRNA STRUCTURE FITTED TO A CRYO-ELECTRON MICROSCOPIC MAP ANGSTROMS RESOLUTION 23S RIBOSOMAL RNA RIBOSOME 23S RRNA, RIBOSOME, LARGE RIBOSOMAL SUBUNIT, ATOMIC PROTEIN BIOSYNTHESIS, RIBONUCLEIC ACID, EM-RECONSTRUCTION, 3D ARRAN FITTING
1ehz nuc 1.93 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA
1evv nuc 2.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA
1fcw nuc 17.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 10(C9 H13 N2 O9 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION
1fir nuc 3.30 PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA HIV-1 REVERSE TRANSCRIPTION PRIMER TRNA(LYS3) RNA MAMMALIAN TRANSFERT RIBONUCLEIC ACID, HIV-1 PRIMER TRNA, AMI TRANSPORT, CANONICAL TRNA STRUCTURE, CANONICAL ANTICODON, FRAMESHIFTING, CODON/ANTICODON MIMICRY, MODIFIED BASES, RNA
1fl8 nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P HYPERMODIFIED NUCLEOSIDES IN THE ANTICODON OF TRNALYS STABILIZE A CANONICAL U-TURN STRUCTURE ANTICODON DOMAIN OF TRNA(LYS): 17-MER TRNA(LYS) ANTICODON DOMAIN RNA TRNA, ANTICODON, PSEUDOURIDINE, MNM5S2U, T6A
1ipl nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA
1ipv nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO R SITE, 5'-R(P*UP*UP*UP*UP*UP*UP*UP*UP*U)-3' RIBONUCLEIC ACID COGNATE CODON-ANTICODON INTERACTION, MRNA, TRNA
1ipx nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID TRNA-TRNA INTERACTION
1ipy nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 5'-R(P*UP*UP*UP*UP*AP*UP*UP*UP*U)-3', TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE CODON-ANTICODON INTERACTION
1ipz nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO P SITE, TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE TRNA-TRNA INTERACTION
1k7n nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1k7o nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1k7p nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1k7r nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1ks1 nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA
1lpw nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P SOLUTION STRUCTURE OF THE YEAST SPLICEOSOMAL U2 SNRNA- INTRON BRANCH SITE HELIX FEATURING A CONSERVED PSEUDOURIDINE 5'-R(*UP*AP*CP*UP*AP*AP*CP*AP*CP*C)-3', 5'-R(*GP*GP*UP*GP*(PSU)P*AP*GP*UP*A)-3' RNA U2 SNRNA, BRANCH SITE, NMR, PSEUDOURIDINE
1lu3 nuc 16.80 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P SEPARATE FITTING OF THE ANTICODON LOOP REGION OF TRNA (NUCLEOTIDE 26-42) IN THE LOW RESOLUTION CRYO-EM MAP OF AN EF-TU TERNARY COMPLEX (GDP AND KIRROMYCIN) BOUND TO E. COLI 70S RIBOSOME PHENYLALANINE TRANSFER RNA: ANTICODON LOOP REGION RNA TRNA, TERNARY COMPLEX, CRYO-EM, 70S E.COLI RIBOSOME, CONFORMATIONAL CHANGE
1nrt nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 6(C9 H13 N2 O9 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL
1q49 nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1q5s nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1qxu nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1qxv nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1rcz nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1rd0 nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1rd1 nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1rd2 nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA
1tn1 nuc 3.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA
1tn2 nuc 3.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
1tra nuc 3.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
1vtq nuc 3.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) THREE-DIMENSIONAL STRUCTURE OF YEAST T-RNA-ASP. I. STRUCTURE DETERMINATION TRNAASP RNA T-RNA, SINGLE STRAND, LOOPS, RNA
2awq nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P SOLUTION STRUCTURE OF PSEUDOURIDINE-32 MODIFIED ANTICODON STEM-LOOP OF E. COLI TRNAPHE 5'-R(*GP*GP*GP*GP*AP*(PSU) P*UP*GP*AP*AP*AP*AP*UP*CP*CP*CP*C)-3': ANTICODON ARM RNA TRI-LOOP,WATSON-CRICK TYPE PSI32-A38 BASE PAIR, RNA
2k7e nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P NMR STRUCTURE OF THE HUMAN TRNALYS3 BOUND TO THE HIV GENOME LOOP I RNA (5'-R(*GP*CP*GP*GP*UP*GP*UP*AP*AP*AP*AP*G)- 3'), RNA (5'-R(*CP*UP*(SUR)P*UP*UP*AP*AP*(PSU) P*CP*UP*GP*C)-3') RNA RNA, TRNALYS3, PSEUDOURIDINE, HIV, 2-THIOURIDINE, S2U, PSU, MODIFICATIONS
2kry nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P SOLUTION STRUCTURE OF THE HUMAN MITOCHONDRIAL TRNAMET ASL CO THE 5-FORMYLCYTIDINE MODIFICATION IN POSITION 34 RNA (5'-R(*(PSU)P*CP*GP*GP*GP*CP*CP*(RSQ) P*AP*UP*AP*CP*CP*CP*CP*GP*A)-3') RNA RNA, TRNA, 5-FORMYLCYTIDINE, ASL, MODIFICATION
2krz nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P SOLUTION STRUCTURE OF THE HUMAN MITOCHONDRIAL TRNAMET RNA (5'-R(*(PSU) P*CP*GP*GP*GP*CP*CP*CP*AP*UP*AP*CP*CP*CP*CP*GP*A)-3') RNA RNA, TRNA, METHIONINE, ASL, MODIFICATION
2kye nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE 4(C9 H13 N2 O9 P) SOLUTION STRUCTURE OF THE PSEUDOURIDINE MODIFIED P6.1 HAIRPI TELOMERASE RNA RNA (5'-R(*GP*AP*GP*AP*GP*(PSU)P*(PSU)P*GP*GP*GP* P*CP*(PSU)P*C)-3') RNA TELOMERASE, RNA, PSEUDOURIDINE, P6.1, HAIRPIN
2la9 nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P NMR STRUCTURE OF PSEUDOURIDINE_ASL_TYR RNA (5'-R(*GP*GP*GP*GP*AP*CP*UP*GP*UP*AP*AP*AP*(P P*CP*CP*CP*C)-3') RNA TYROSYL-TRNA, RNA
2lbr nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P CONFORMATION EFFECTS OF BASE MODIFICATION ON THE ANTICODON S OF BACILLUS SUBTILIS TRNATYR RNA (5'-R(*GP*GP*GP*GP*AP*CP*UP*GP*UP*AP*(6IA)P*A P*CP*CP*CP*C)-3') RNA TYROSYL-TRNA, RNA
2mer nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) STRUCTURE OF HELIX 69 FROM ESCHERICHIA COLI 23S RIBOSOMAL RN RNA_(5'-R(P*GP*GP*CP*CP*GP*(PSU)P*AP*AP*CP*(PSU)P P*AP*AP*CP*GP*GP*UP*C)-3') RNA PSEUDOURIDINE, HELIX 69, RIBOSOMAL, RNA
2o32 nuc NMR PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) SOLUTION STRUCTURE OF U2 SNRNA STEM I FROM HUMAN, CONTAINING MODIFIED NUCLEOTIDES 5'-R(*(PSU)P*CP*UP*CP*(OMG)P*(OMG)P*CP*CP*(PSU) P*UP*UP*UP*(OMG)P*GP*CP*UP*AP*AP*(OMG)P*A)-3' RNA RNA, WOBBLE BASE-PAIRS, TETRALOOP
2tra nuc 3.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS
2z9q nuc 11.70 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA
3bbv nuc 10.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) THE TRNA(PHE) FITTED INTO THE LOW RESOLUTION CRYO-EM MAP OF 50S.NC-TRNA.HSP15 COMPLEX TRNA(PHE) RIBOSOME PHE, TRNA, RESCUE STALLED RIBOSOME, RIBOSOME
3cgp nuc 1.57 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P X-RAY STRUCTURE OF A PSEUDOURIDINE-CONTAINING YEAST SPLICEOSOMAL U2 SNRNA-INTRON BRANCH SITE DUPLEX BOUND TO IODIDE IONS RNA (5'-R(*GP*CP*GP*CP*GP*(PSU) P*AP*GP*UP*AP*GP*C)-3'), RNA (5'- R(*CP*GP*CP*UP*AP*CP*UP*AP*AP*CP*GP*CP*G)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING
3cgq nuc 2.55 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P X-RAY STRUCTURE OF A PSEUDOURIDINE-CONTAINING YEAST SPLICEOSOMAL U2 SNRNA-INTRON BRANCH SITE DUPLEX RNA (5'-R(*GP*CP*GP*CP*GP*(PSU) P*AP*GP*UP*AP*GP*C)-3'), RNA (5'- R(*CP*GP*CP*UP*AP*CP*UP*AP*AP*CP*GP*CP*G)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING
3cgr nuc 2.10 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P X-RAY STRUCTURE CONTAINING THE PSEUDOURIDYLATED U2 SNRNA AND INTRON BRANCH SITE CONSENSUS SEQUENCES RNA (5'- R(*CP*GP*CP*AP*CP*UP*AP*AP*CP*CP*GP*CP*G)-3'), RNA (5'-R(*GP*CP*GP*CP*GP*GP*(PSU) P*AP*GP*UP*GP*C)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING
3cgs nuc 1.65 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P X-RAY STRUCTURE CONTAINING THE PSEUDOURIDYLATED U2 SNRNA AND MAMMALIAN INTRON BRANCH SITE CONSENSUS SEQUENCES RNA (5'-R(*GP*CP*GP*CP*GP*(PSU) P*AP*GP*UP*AP*GP*C)-3'), RNA (5'- R(*CP*GP*CP*UP*AP*CP*UP*GP*AP*CP*GP*CP*G)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING
3cw5 nuc 3.10 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA
3cw6 nuc 3.30 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P E. COLI INITIATOR TRNA INITIATOR TRNA RNA TRNA, INITIATOR, RNA
3tra nuc 3.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPARTIC ACID AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS
486d nuc 7.50 PSEUDOURIDINE-5'-MONOPHOSPHATE 7(C9 H13 N2 O9 P) X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME
4pcj nuc 1.90 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P MODIFICATIONS TO TOXIC CUG RNAS INDUCE STRUCTURAL STABILITY MIS-SPLICING IN MYOTONIC DYSTROPHY TRCUG-3('5) RNA PSEUDOU, CUG REPEATS, TETRALOOP RECEPTOR
4tna nuc 2.50 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
4tra nuc 3.00 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
5l4o nuc 2.80 PSEUDOURIDINE-5'-MONOPHOSPHATE C9 H13 N2 O9 P STRUCTURE OF AN E.COLI INITIATOR TRNAFMET A1-U72 VARIANT TRNA (76-MER) TRANSLATION TRNA-TRANSLATION INITIATION, TRANSLATION
5tra nuc model PSEUDOURIDINE-5'-MONOPHOSPHATE 3(C9 H13 N2 O9 P) SOLUTION STRUCTURE OF A TRNA WITH A LARGE VARIABLE REGION: YEAST TRNA-SER T-RNA (85-MER) AMINO-ACID TRANSPORT T-RNA
6tna nuc 2.70 PSEUDOURIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1ihh nuc 2.40 PLATINUM (II) ION PT 2+ 2.4 ANGSTROM CRYSTAL STRUCTURE OF AN OXALIPLATIN 1,2-D(GPG) INTRASTRAND CROSS-LINK IN A DNA DODECAMER DUPLEX 5'-D(*GP*GP*AP*GP*AP*CP*CP*AP*GP*AP*GP*G)-3', 5'-D(*CP*CP*TP*CP*TP*GP*GP*TP*CP*TP*CP*C)-3' DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, OXALIPLATIN, MODIFIED, DEOXYNUCLEIC ACID 4h5a nuc 1.42 PLATINUM (II) ION PT 2+ DNA OCTAMER D (GTSEGTACAC) PARTIALLY CROSSLINKED WITH PLATIN DNA (5'-D(*GP*(2ST)P*GP*GP*CP*CP*AP*C)-3') DNA SELENIUM MODIFICATION TO FACILITATE CRYSTALLIZATION, DNA 4i1g nuc 1.25 PLATINUM (II) ION 2(PT 2+) DNA OCTAMER D(GTSEGTACAC) PARTIALLY CROSSLINKED WITH TWO PLA DNA (5'-D(*GP*(2ST)P*GP*GP*CP*CP*AP*C)-3') DNA PLATINUM CROSSLINK, SELENIUM, DNA
Code Class Resolution Description 1y73 nuc 2.90 PLATINUM (IV) ION 2(PT 4+) HIV-1 DIS(MAL) DUPLEX PT-SOAKED 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, METAL IONS
Code Class Resolution Description 211d nuc 1.60 PLATINUM TRIAMINE ION H9 N3 PT 2+ THE CRYSTAL AND MOLECULAR STRUCTURE OF A NEW Z-DNA CRYSTAL FORM: D[CGT(2-NH2-A) CG] AND ITS PLATINATED DERIVATIVE DNA (5'-D(*CP*GP*TP*(1AP)P*CP*(PT(NH3)3)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 5bna nuc 2.60 PLATINUM TRIAMINE ION 3(H9 N3 PT 2+) THE PRIMARY MODE OF BINDING OF CISPLATIN TO A B-DNA DODECAMER: C-G-C-G-A-A-T-T-C-G-C-G DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 1ffz nuc 3.20 PUROMYCIN-N-AMINOPHOSPHONIC ACID C22 H30 N7 O8 P LARGE RIBOSOMAL SUBUNIT COMPLEXED WITH R(CC)-DA-PUROMYCIN 23S RIBOSOMAL RNA: DOMAIN V OF 23S RIBOSOMAL RNA, R(P*CP*C*)-D(P*A)-R(P*(PU)) RIBOSOME RIBOSOME ASSEMBLY, RNA-RNA COMPLEX, RIBOZYME, RIBOSOMAL RNA
Code Class Resolution Description
3d2v nuc 2.00 1-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-3-(2- {[HYDROXY(PHOSPHONOOXY)PHOSPHORYL]OXY}ETHYL)-2- METHYLPYRIDINIUM 2(C14 H21 N4 O7 P2 1+) STRUCTURE OF THE EUKARYOTIC TPP-SPECIFIC RIBOSWITCH BOUND TO ANTIBACTERIAL COMPOUND PYRITHIAMINE PYROPHOSPHATE TPP-SPECIFIC RIBOSWITCH RNA RNA, RIBOSWITCH, ANTIBIOTIC, THIAMINE PYROPHOSPHATE, PYRITHI PYROPHOSPHATE, COMPLEX
Code Class Resolution Description 1l1h nuc 1.75 3-PYRROLIDIN-1-YL-N-[6-(3-PYRROLIDIN-1-YL- PROPIONYLAMINO)-ACRIDIN-3-YL]-PROPIONAMIDE C27 H33 N5 O2 CRYSTAL STRUCTURE OF THE QUADRUPLEX DNA-DRUG COMPLEX 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA G-QUADRUPLEX, OXYTRICHA, FOUR-STRANDED DNA
Code Class Resolution Description 1fzl nuc NMR 2'-DEOXYRIBOFURANOSYLPYRENE-5'-MONOPHOSPHATE C21 H19 O6 P DNA WITH PYRENE PAIRED AT ABASIC SITES 5'-D(*GP*TP*GP*CP*(3DR)P*TP*GP*TP*TP*TP*GP*TP*G)- 3', 5'-D(*CP*AP*CP*AP*AP*AP*CP*AP*(PYP)P*GP*CP*AP*C)- 3' DNA PYRENE, TETRAHYDROFURAN, NON-HYDROGEN BONDED DNA BASE PAIR 1fzs nuc NMR 2'-DEOXYRIBOFURANOSYLPYRENE-5'-MONOPHOSPHATE C21 H19 O6 P DNA WITH PYRENE PAIRED AT ABASIC SITE 5'-D(*GP*TP*GP*CP*(3DR)P*TP*GP*TP*TP*TP*GP*TP*G)- 3', 5'-D(*CP*AP*CP*AP*AP*AP*CP*AP*(PYP))-3' DNA PYRENE, FURAN, NON-POLAR DNA PAIR
Code Class Resolution Description 1g2j nuc 1.97 D-RIBOFURANOSYL-BENZENE-5'-MONOPHOSPHATE C11 H15 O7 P RNA OCTAMER R(CCCP*GGGG) CONTAINING PHENYL RIBONUCLEOTIDE 5'-R(*CP*CP*CP*(PYY)P*GP*GP*GP*G)-3' RNA RNA DUPLEX, PHENYL-RIBONUCLEOTIDE
Code Class Resolution Description 2k4l nuc NMR (11AS)-7,8-DIMETHOXY-2-NAPHTHALEN-2-YL-1,10,11,11A- TETRAHYDRO-5H-PYRROLO[2,1-C][1,4]BENZODIAZEPIN-5-ONE 2(C24 H22 N2 O3) SOLUTION STRUCTURE OF A 2:1C2-(2-NAPHTHYL)PYRROLO[2,1-C][1, 4]BENZODIAZEPINE (PBD) DNA ADDUCT: MOLECULAR BASIS FOR UNEX HIGH DNA HELIX STABILIZATION. 5'-D(*DAP*DAP*DTP*DCP*DTP*DTP*DTP*DAP*DAP*DAP*DGP T)-3' DNA PYRROLO[2, 1-C][1, 4]BENZODIAZEPINE, PBD, DNA ADDUCT, DNA
Code Class Resolution Description
5hbw nuc 1.90 [(2~{R},3~{S},4~{R},5~{R})-5-(2-AZANYL-6-OXIDANYLIDENE- 1~{H}-PURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN-2- YL]METHOXY-(3-METHYL-1~{H}-PYRAZOL-4-YL)PHOSPHINIC ACID 2(C14 H18 N7 O7 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA
5hbx nuc 1.70 [(2~{R},3~{S},4~{R},5~{R})-5-(2-AZANYL-6-OXIDANYLIDENE- 1~{H}-PURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN-2- YL]METHOXY-(3-METHYL-1~{H}-PYRAZOL-4-YL)PHOSPHINIC ACID 8(C14 H18 N7 O7 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-2 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3') RNA RNA
5hby nuc 1.18 [(2~{R},3~{S},4~{R},5~{R})-5-(2-AZANYL-6-OXIDANYLIDENE- 1~{H}-PURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN-2- YL]METHOXY-(3-METHYL-1~{H}-PYRAZOL-4-YL)PHOSPHINIC ACID 2(C14 H18 N7 O7 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE-3 BINDING SITES RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3') RNA RNA
5krg nuc 1.60 [(2~{R},3~{S},4~{R},5~{R})-5-(2-AZANYL-6-OXIDANYLIDENE- 1~{H}-PURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN-2- YL]METHOXY-(3-METHYL-1~{H}-PYRAZOL-4-YL)PHOSPHINIC ACID 4(C14 H18 N7 O7 P) RNA 15MER DUPLEX BINDING WITH PZG MONOMER RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG) P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3') RNA RNA
Code Class Resolution Description 2ms6 nuc NMR 3,5,7,3',4'-PENTAHYDROXYFLAVONE 2(C15 H10 O7) HUMAN TELOMERIC G-QUADRUPLEX DNA SEQUENCE (TTAGGGT)4 COMPLEX FLAVONOID QUERCETIN DNA_(5'-D(*TP*TP*AP*GP*GP*GP*T)-3') DNA DNA G-QUADRUPLEX, QUERCETIN, TELOMERIC SEQUENCE, DNA 2n6c nuc NMR 3,5,7,3',4'-PENTAHYDROXYFLAVONE 2(C15 H10 O7) SOLUTION STRUCTURE FOR QUERCETIN COMPLEXED WITH C-MYC G-QUAD DNA (5'- D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP GP*G)-3') DNA C-MYC, QUERCETIN, FLAVONOIDS, G-QUADRUPLEX, DNA
Code Class Resolution Description 2l7v nuc NMR N,N-DIETHYL-N'-(10H-INDOLO[3,2-B]QUINOLIN-11-YL)ETHANE- 1,2-DIAMINE 2(C21 H24 N4) QUINDOLINE/G-QUADRUPLEX COMPLEX DNA (5'- D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP 3') DNA/INHIBITOR C-MYC PROMOTER, DNA-INHIBITOR COMPLEX, C-MYC PROMOTER G-QUAD
Code Class Resolution Description 1agk nuc NMR 2'-DEOXY-N6-(R)STYRENE OXIDE ADENOSINE MONOPHOSPHATE C18 H22 N5 O7 P THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE SECOND POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*GP*GP*AP*CP*RP*AP*GP*AP*AP*G)-3'), DNA (5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3') DNA DNA DUPLEX, B-DNA, NMR, HUMAN N-RAS GENE, CODON 61 SEQUENCE, R-STYRENE OXIDE ADDUCT, N6-ADENINE, MAJOR GROOVE, DEOXYRIBONUCLEIC ACID 1agz nuc NMR 2'-DEOXY-N6-(R)STYRENE OXIDE ADENOSINE MONOPHOSPHATE C18 H22 N5 O7 P THE SOLUTION NMR STRUCTURE OF AN (R)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3'), DNA (5'-D(*CP*GP*GP*AP*CP*AP*RP*GP*AP*AP*G)-3') DNA DNA DUPLEX, B-DNA, NMR, HUMAN N-RAS GENE, CODON 61 SEQUENCE, R-STYRENE OXIDE ADDUCT, N6-ADENINE, MAJOR GROOVE, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 3mij nuc 2.60 N,N'-[ACRIDINE-3,6-DIYLBIS(1H-1,2,3-TRIAZOLE-1,4- DIYLBENZENE-3,1-DIYL)]BIS[3-(DIETHYLAMINO)PROPANAMIDE] C43 H47 N11 O2 CRYSTAL STRUCTURE OF A TELOMERIC RNA G-QUADRUPLEX COMPLEXED ACRIDINE-BASED LIGAND. RNA (5'-R(*UP*AP*GP*GP*GP*UP*UP*AP*GP*GP*GP*U)-3' CHAIN: A RNA QUADRUPLEX, RNA-LIGAND COMPLEX, RNA, TELOMERIC 3qcr nuc 3.20 N,N'-[ACRIDINE-3,6-DIYLBIS(1H-1,2,3-TRIAZOLE-1,4- DIYLBENZENE-3,1-DIYL)]BIS[3-(DIETHYLAMINO)PROPANAMIDE] C43 H47 N11 O2 INCOMPLETE STRUCTURAL MODEL OF A HUMAN TELOMERIC DNA QUADRUP ACRIDINE COMPLEX. HUMAN TELOMERIC REPEAT DEOXYRIBONUCLEIC ACID DNA QUADRUPLEX, ACRIDINE LIGAND-COMPLEX, TELOMERE, DNA
Code Class Resolution Description 2o1i nuc 1.10 BIS(2,2'-BIPYRIDINE-KAPPA~2~N~1~,N~1'~)[CHRYSENE-5,6- DIIMINATO(2-)-KAPPA~2~N,N']RHODIUM(4+) 3(C38 H26 N6 RH 4+) RH(BPY)2CHRYSI COMPLEXED TO MISMATCHED DNA 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*CP*CP*CP*G)-3' DNA DNA MISMATCH, METALLOINTERCALATOR, DNA RECOGNITION 3gsj nuc 1.80 BIS(2,2'-BIPYRIDINE-KAPPA~2~N~1~,N~1'~)[CHRYSENE-5,6- DIIMINATO(2-)-KAPPA~2~N,N']RHODIUM(4+) 2(C38 H26 N6 RH 4+) A BULKY RHODIUM COMPLEX BOUND TO AN ADENOSINE-ADENOSINE DNA MISMATCH 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*AP*CP*CP*G)-3' DNA DNA MISMATCH, METALLOINTERCALATOR, DNA RECOGNITION 3gsk nuc 1.60 BIS(2,2'-BIPYRIDINE-KAPPA~2~N~1~,N~1'~)[CHRYSENE-5,6- DIIMINATO(2-)-KAPPA~2~N,N']RHODIUM(4+) 2(C38 H26 N6 RH 4+) A BULKY RHODIUM COMPLEX BOUND TO AN ADENOSINE-ADENOSINE DNA 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*AP*CP*CP*G)-3' DNA DNA MISMATCH, METALLOINTERCALATOR, DNA RECOGNITION, DNA
Code Class Resolution Description 4e1u nuc 0.92 DELTA-[RU(BPY)2DPPZ]2+ 5(C38 H26 N8 RU) [RU(BPY)2 DPPZ]2+ BOUND TO DNA 5'-D(*CP*GP*GP*AP*AP*AP*TP*TP*AP*CP*CP*G)-3' DNA MISMATCH, SMALL MOLECULE, DNA 5lfs nuc 1.85 DELTA-[RU(BPY)2DPPZ]2+ C38 H26 N8 RU LAMBDA-[RU(BPY)2(DPPZ)]2+ BOUND TO BROMINATED DNA DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, INTERCALATION, LIGHT-SWITCH
Code Class Resolution Description 2v3l nuc NMR RHODAMINE 6G C33 H41 N3 O5 ORIENTATIONAL AND DYNAMICAL HETEROGENEITY OF RHODAMINE 6G TE ATTACHED TO A DNA HELIX 5'-D(*CP*AP*AP*AP*GP*CP*GP*CP*CP*AP *TP*TP*CP*GP*CP*CP*AP*TP*TP*C)-3', 5'-D(*GP*AP*AP*TP*GP*GP*CP*GP*AP*AP *TP*GP*GP*CP*GP*CP*TP*TP*TP*G)-3' DNA DNA, NUCLEIC ACID
Code Class Resolution Description
3sc8 nuc 2.30 2,7-BIS[3-(4-METHYLPIPERAZIN-1-YL)PROPYL]-4,9-BIS{[3- (4-METHYLPIPERAZIN-1-YL)PROPYL]AMINO}BENZO[LMN][3, 8]PHENANTHROLINE-1,3,6,8(2H,7H)-TETRONE C46 H72 N12 O4 CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX BOUND BY THE NAPHTHALENE DIIMIDE BMSG-SH-3 HUMAN TELOMERIC REPEAT SEQUENCE DNA G-QUADRUPLEX, INTRAMOLECULAR, LIGAND-COMPLEX, TELOMERIC, DNA
4daq nuc 2.75 2,7-BIS[3-(4-METHYLPIPERAZIN-1-YL)PROPYL]-4,9-BIS{[3- (4-METHYLPIPERAZIN-1-YL)PROPYL]AMINO}BENZO[LMN][3, 8]PHENANTHROLINE-1,3,6,8(2H,7H)-TETRONE C46 H72 N12 O4 CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX 21-MER BOUND BY THE NAPHTHALENE DIIMIDE COMPOUND DNA (5'- D(*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP 3') DNA INTRAMOLECULAR, LIGAND-COMPLEX, G-QUADRUPLEX, DNA
Code Class Resolution Description 1z58 nuc 3.80 RAPAMYCIN IMMUNOSUPPRESSANT DRUG C51 H79 N O13 CRYSTAL STRUCTURE OF A COMPLEX OF THE RIBOSOME LARGE SUBUNIT WITH RAPAMYCIN 23S RIBOSOMAL RNA RIBOSOME RIBOSOME, TUNNEL, POLYKETYDE
Code Class Resolution Description 1i0m nuc 1.05 RUBIDIUM ION 3(RB 1+) 1.05 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-FLUOROETHYL THYMINE IN PLACE OF T6, HIGH RB-SALT 5'-D(*GP*CP*GP*TP*AP*(125)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0n nuc 1.30 RUBIDIUM ION 3(RB 1+) 1.3 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-[TRI(OXYETHYL)] THYMINE IN PLACE OF T6, MEDIUM RB-SALT 5'-D(*GP*CP*GP*TP*AP*(126)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 3ggk nuc 0.87 RUBIDIUM ION 2(RB 1+) LOCATING MONOVALENT CATIONS IN ONE TURN OF G/C RICH B-DNA 5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G) -3' DNA DNA, CATIONS, DIVALENT CATIONS, MONOVALENT CATIONS, RUBIDIUM ION 460d nuc 1.20 RUBIDIUM ION RB 1+ A "HYDRAT-ION SPINE" IN A B-DNA MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DODECAMER DUPLEX, TYPE 1 RB+ FORM CRYSTAL 461d nuc 1.50 RUBIDIUM ION RB 1+ A "HYDRAT-ION SPINE" IN A B-DNA MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DODECAMER DUPLEX, TYPE 2 RB+ FORM CRYSTAL 4e8p nuc 3.28 RUBIDIUM ION 18(RB 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF RB+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYMES, SELF-SPLICING, RETROTRANSPOSITION,
Code Class Resolution Description 2mhx nuc NMR (R,R)-N6,N6-(2,3-DIHYDROXY-1,4-BUTADIYL)-2'- DEOXYADENOSINE-5'-MONOPHOSPHATE C14 H22 N5 O8 P STRUCTURE OF EXOCYCLIC R,R N6,N6-(2,3-DIHYDROXY-1,4-BUTADIYL DEOXYADENOSINE ADDUCT INDUCED BY 1,2,3,4-DIEPOXYBUTANE IN D 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3'), 5'-D(*CP*GP*GP*AP*CP*(RBD)P*AP*GP*AP*AP*G)-3') DNA B-FORM DNA, 11-MER, DEB INDUCED ADDUCT, DHB-DA ADDUCT, N-RAS SEQUENCE, DNA
Code Class Resolution Description 3f4g nuc 3.01 RIBOFLAVIN C17 H20 N4 O6 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO RIBOFLAVIN. FMN RIBOSWITCH, FMN RIBOSWITCH RNA RIBOFLAVIN, FMN, RIBOSWITCH, TRANSCRIPTION, RNA
Code Class Resolution Description
3ukb nuc 1.42 1-{2,5-ANHYDRO-6-DEOXY-4-[(PHOSPHONOOXY)METHYL]-BETA-D- GULOFURANOSYL}PYRIMIDINE-2,4(1H,3H)-DIONE 2(C11 H15 N2 O9 P) (R)-CET-BNA DECAMER STRUCTURE DNA (5'-D(*GP*CP*GP*TP*AP*(RCE)P*AP*CP*GP*C)-3') DNA A-FORM DNA, BICYCLIC NUCLEIC ACID, BNA, DNA, CET-BNA, ANTISE OLIGONUCLEOTIDES
Code Class Resolution Description 4iii nuc 1.02 RU(TAP)2(CL-DPPZ) COMPLEX C38 H21 CL N12 RU 2+ LAMBDA-[RU(TAP)2(11-CL-DPPZ)] WITH A DNA DECAMER AT ATOMIC R 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA DUPLEX, RUTHENIUM, DNA
Code Class Resolution Description 165d nuc 1.55 RHODIUM HEXAMINE ION 4(H18 N6 RH 3+) THE STRUCTURE OF A MISPAIRED RNA DOUBLE HELIX AT 1.6 ANGSTROMS RESOLUTION AND IMPLICATIONS FOR THE PREDICTION OF RNA SECONDARY STRUCTURE DNA/RNA (5'-R(*GP*CP*UP*UP*CP*GP*GP*CP*)- D(*(BRU))-3') DNA-RNA HYBRID A-DNA/RNA, DOUBLE HELIX, OVERHANGING BASES, MODIFIED, MISMATCHED, DNA-RNA HYBRID 1id9 nuc 1.60 RHODIUM HEXAMINE ION 2(H18 N6 RH 3+) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[F]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UFP))-3' DNA/RNA RNA/DNA HYBRID, FLUORO URACIL, RHODIUM(III) HEXAMMINE, C-U MISMATCH, G-U MISMATCH, DNA/RNA COMPLEX 1idw nuc 1.80 RHODIUM HEXAMINE ION 2(H18 N6 RH 3+) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[CL]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UCL))-3' DNA/RNA RNA/DNA HYBRID, RHODIUM HEXAMMINE, C-U MISMATCH, G-U MISMATCH, DNA/RNA COMPLEX 1iha nuc 1.60 RHODIUM HEXAMINE ION 2(H18 N6 RH 3+) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[BR]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(BRU))-3' DNA/RNA RNA/DNA HYBRID, BROMO URACIL, RHODIUM(III) HEXAMMINE, C-U G- U MISMATCH, DNA/RNA COMPLEX
Code Class Resolution Description 454d nuc 1.20 DELTA-ALPHA-RH[2R,9R-DIAMINO-4,7-DIAZADECANE]9,10- PHENANTHRENEQUINONE DIIMINE 5(C22 H27 N6 RH 2+) INTERCALATION AND MAJOR GROOVE RECOGNITION IN THE 1.2 A RESOLUTION CRYSTAL STRUCTURE OF RH[ME2TRIEN]PHI BOUND TO 5'-G(5IU)TGCAAC-3' 5'-D(*GP*(5IU)P*TP*GP*CP*AP*AP*C)-3' DNA METALLOINTERCALATOR, INTERCALATION, MAJOR GROOVE RECOGNITION, PHOTOEXCITABLE, DNA
Code Class Resolution Description 1yfg nuc 3.00 2'-O-[(5'-PHOSPHO)RIBOSYL]ADENOSINE-5'-MONOPHOSPHATE C15 H23 N5 O14 P2 YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA
Code Class Resolution Description 1qd3 nuc NMR RIBOSE C5 H10 O5 HIV-1 TAR RNA/NEOMYCIN B COMPLEX HIV-1 TAR RNA: RESIDUES 17-45 RNA NMR, HIV-1, AMINOGLYCOSIDE-RNA-COMPLEX, MINOR GROOVE BINDING
Code Class Resolution Description 2et5 nuc 2.20 RIBOSTAMYCIN 4(C17 H34 N4 O10) COMPLEX BETWEEN RIBOSTAMYCIN AND THE 16S-RRNA A-SITE 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES 2fcz nuc 2.01 RIBOSTAMYCIN 4(C17 H34 N4 O10) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH RIBOSTAMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2kxm nuc NMR RIBOSTAMYCIN C17 H34 N4 O10 SOLUTION NMR STRUCTURE OF THE 27 NUCLEOTIDE ENGINEERED NEOMY SENSING RIBOSWITCH RNA-RIBOSTMYCIN COMPLEX RNA (27-MER) RNA/ANTIBIOTIC RIBOSWITCHES, RNA-LIGAND INTERACTION, AMINOGLYCOSIDES, RNA RECOGNITION, ANTIBIOTIC, RNA-ANTIBIOTIC COMPLEX 2n0j nuc NMR RIBOSTAMYCIN C17 H34 N4 O10 SOLUTION NMR STRUCTURE OF THE 27 NUCLEOTIDE ENGINEERED NEOMY SENSING RIBOSWITCH RNA-RIBOSTAMYCIN COMPLEX RNA_(27-MER) RNA RIBOSWITCHES, RNA-LIGAND INTERACTION, AMINOGLYCOSIDES, RNA RECOGNITION, RNA STRUCTURE, RNA 3c3z nuc 1.50 RIBOSTAMYCIN 2(C17 H34 N4 O10) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO RIBOSTAMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC 3dvv nuc 2.00 RIBOSTAMYCIN 2(C17 H34 N4 O10) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO RIBOSTAMYCIN (U267OME) HIV-1 GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC, AMINOGLYCOSIDE
Code Class Resolution Description 2gyx nuc 1.86 N,N'-(1H-PYRROLE-2,5-DIYLDI-4,1-PHENYLENE) DIBENZENECARBOXIMIDAMIDE C30 H25 N5 CRYSTAL STRUCTURE OF DB884- D(CGCGAATTCGCG)2 COMPLEX AT 1.86 A RESOLUTION. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-TYPE DUPLEX DNA, DOUBLE HELIX, DODECAMER, COMPOUND DB 884.
Code Class Resolution Description 4ms5 nuc 2.23 (11,12-DIFLUORODIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM(2+) C38 H20 F2 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ-11,12-(F)2)]2+ BOUND TO CCGGATCCGG DNA DNA INTERCALATION, SEMI-INTERCALATION, DNA, RUTHENIUM
Code Class Resolution Description 3qf8 nuc 1.73 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D BOUND TO D(TCGGCGCCGA) AT MEDIUM RESOLUTION 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA B-DNA, INTERCALATION, KINK, FLIPPED OUT BASE, DNA 3qrn nuc 1.10 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D BOUND TO D(TCGGCGCCGA)AT HIGH RESOLUTION 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA INTERCALATION, SEMI-INTERCALATION, B-DNA, DNA 3uyb nuc 1.50 RU(TAP)2(DPPZ) COMPLEX 2(C38 H22 N12 RU 2+) X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D BOUND TO D(TCGGTACCGA) 5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3' DNA DNA-RUTHENIUM COMPLEX, SEMIINTERCALATION, INTERCALATION, MIN INTERACTION, DNA 4ltf nuc 1.50 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY(1/7) DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA 4ltg nuc 1.18 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (2/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA 4lth nuc 1.60 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY (3/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA 4lti nuc 1.41 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (4/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA 4ltj nuc 1.80 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY (5/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA 4ltk nuc 1.45 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 74% RELATIVE HUMIDITY (6/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA 4ltl nuc 2.07 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ DEHYDRATION/REHYDRATION OF A NUCLEIC ACID SYSTEM CONTAINING POLYPYRIDYL RUTHENIUM COMPLEX AT 97% RELATIVE HUMIDITY (7/7 DNA DNA DEHYDRATION, HC1B, KINKING, RUTHENIUM, DNA 4qio nuc 0.95 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(TCGGCGCCIA) AT HIGH RES 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*IP*A)-3' DNA INTERCALATION, RUTHENIUM COMPLEX, INOSINE, DNA 4r8j nuc 1.21 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ D(TCGGCGCCGA) WITH LAMBDA-[RU(TAP)2(DPPZ)]2+ SOAKED IN D2O DNA (5'-D(*(THM)P*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA KINKING, INFRA-RED, RUTHENIUM, DNA 4re7 nuc 2.18 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(TCIGCGCCGA) 5'-D(*TP*CP*IP*GP*CP*GP*CP*CP*GP*A)-3' DNA INOSINE, KINKING, RUTHENIUM, DNA 4ymc nuc 1.88 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(CCGGATCCGG)2 DNA (5'-D(*CP*CP*GP*GP*AP*TP*CP*CP*GP*G)-3') DNA RUTHENIUM, COMPLEX, DNA, INTERCALATION 5et2 nuc 1.39 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ LAMBDA-RU(TAP)2(DPPZ)]2+ BOUND TO D(TTGGCGCCAA) DNA (5'-D(*(THM)P*TP*GP*GP*CP*GP*CP*CP*AP*A)-3') DNA RUTHENIUM INTERCALATION DNA PHOTOACTIVE, DNA 5ip8 nuc 1.76 RU(TAP)2(DPPZ) COMPLEX 2(C38 H22 N12 RU 2+) LAMBDA-RU(TAP)2DPPZ BOUND TO D(CCGGCTCCGG) DNA (5'-D(*CP*CP*GP*GP*AP*GP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*CP*TP*CP*CP*GP*G)-3') DNA SEQUENCE SPECIFIC, DNA, RUTHENIUM, PHOTOOXIDISING 5iwj nuc 1.88 RU(TAP)2(DPPZ) COMPLEX C38 H22 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ)]2+ BOUND TO D(CCGGGCCCGG DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*CP*GP*G)-3') DNA RUTHENIUM, PHOTOOXIDISING, DNA, INTERCALATION
Code Class Resolution Description 4x18 nuc 1.05 (11-METHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM C39 H24 N12 RU [RU(TAP)2(DPPZ-11-ME)]2+ BOUND TO D(TCGGCGCCGA) DNA (5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA RUTHENIUM, DNA, SUBSTITUTION, DUPLEX
Code Class Resolution Description 3u38 nuc 2.13 LAMBDA-RU(PHEN)2(DPPZ) COMPLEX 2(C42 H26 N8 RU) INTERCALATION OF LAMBDA-[RU(PHEN)2(DPPZ)]2+ INTO D(CCGGTACCG 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA B-DNA, RUTHENIUM, DNA 4e7y nuc 1.70 LAMBDA-RU(PHEN)2(DPPZ) COMPLEX C42 H26 N8 RU LAMBDA-[RU(PHEN)2(DPPZ)]2+ BOUND TO CCGGATCCGG 5'-D(*CP*CP*GP*GP*AP*TP*CP*CP*GP*G)-3' DNA INTERCALATION, DNA, LAMBDA-[RU(PHEN)2(DPPZ)]2+ 4jd8 nuc 1.16 LAMBDA-RU(PHEN)2(DPPZ) COMPLEX C42 H26 N8 RU RACEMIC-[RU(PHEN)2(DPPZ)]2+] BOUND TO SYNTHETIC DNA AT HIGH DNA (5'-D(*AP*TP*GP*CP*AP*T)-3') DNA INTERCALATION, RACEMIC LIGAND-DNA, DNA 4ly2 nuc 2.10 LAMBDA-RU(PHEN)2(DPPZ) COMPLEX 2(C42 H26 N8 RU) X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(PHEN)2( BOUND TO D(TCGGTACCGA) DNA DNA INTERCALATION, SEMI-INTERCALATION, SYMMETRICAL INTERCALATION BINDING, LIGHT-SWITCH COMPOUNDS, DNA DAMAGE AGENT, GUANINE OXIDATION, DNA 5lfw nuc 1.28 LAMBDA-RU(PHEN)2(DPPZ) COMPLEX C42 H26 N8 RU LAMBDA-[RU(PHEN)2(DPPZ)]2+ BOUND TO A SHORT SUBSTITUTED DNA DNA (5'-D(*(CBR)P*GP*GP*C)-3'), DNA (5'-D(*GP*CP*CP*G)-3') DNA DNA, RUTHENIUM, INTERCALATION, LIGHT-SWITCH
Code Class Resolution Description
4e8s nuc 1.24 (11,12-DIMETHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM(2+) C40 H26 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ{ME2}2)]2+ BOUND TO TCGGCGCCGA AT HIGH 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA INTERCALATION, PHOTOREACTIVE, DNA, RUTHENIUM COMPLEX
4e8x nuc 2.18 (11,12-DIMETHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM(2+) C40 H26 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ-(ME)2)]2+ BOUND TO D(CCGGCGCCGG)2 5'-D(*CP*CP*GP*GP*CP*GP*CP*CP*GP*G)-3' DNA INTERCALATION, PHOTOREACTIVE, LAMBDA-[RU(TAP)2(DPPZ-(ME)2)]2
4e95 nuc 1.94 (11,12-DIMETHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM(2+) C40 H26 N12 RU 2+ LAMBDA-[RU(TAP)2(DPPZ-(ME)2)]2+ BOUND TO CCGGATCCGG 5'-D(*CP*CP*GP*GP*AP*TP*CP*CP*GP*G)-3' DNA INTERCALATION, PHOTOREACTIVE, LAMBDA-[RU(TAP)2(DPPZ-(ME)2]2+
4m3i nuc 2.10 (11,12-DIMETHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM(2+) 2(C40 H26 N12 RU 2+) X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D {ME2})]2+ BOUND TO D(CCGGTACCGG) SYNTHETIC DNA CCGGTACCGG DNA INTERCALATION, SEMI-INTERCALATION, MINOR-GROOVE BINDER, LIGH BENDING, KINKING, DNA
4m3v nuc 2.05 (11,12-DIMETHYLDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- KAPPA~2~N~4~,N~5~)[BIS(PYRAZINO[2,3-F]QUINOXALINE- KAPPA~2~N~1~,N~10~)]RUTHENIUM(2+) 2(C40 H26 N12 RU 2+) X-RAY CRYSTAL STRUCTURE OF THE RUTHENIUM COMPLEX [RU(TAP)2(D {ME2})]2+ BOUND TO D(TCGGTACCGA) DNA DECAMER SEQUENCE DNA MINOR-GROOVE, SEMI-INTERCALATION, INTERCALATION, BENDING, KI SYMMETRICAL INTERCALATION, DNA LIGHT-SWITCH COMPOUND, DNA
Code Class Resolution Description 1k1h nuc NMR 2'-DEOXY-ADENOSINE-5'-RP-MONOMETHYLPHOSPHONATE 3(C11 H16 N5 O5 P) HETERODUPLEX OF CHIRALLY PURE METHYLPHOSPHONATE/DNA DUPLEX 5'-D(*TP*GP*TP*TP*TP*GP*GP*C)-3', 5'-D(*CP*(CMR)P*(RMP)P*(RMP)P*(SMP)P*(CMR) P*(RMP))-3' DNA METHYL PHOSPHONATE, ANTI SENSE, DNA 1k1r nuc NMR 2'-DEOXY-ADENOSINE-5'-RP-MONOMETHYLPHOSPHONATE 4(C11 H16 N5 O5 P) HETERODUPLEX OF CHIRALLY PURE R-METHYLPHOSPHONATE/DNA DUPLEX 5'-D(*TP*GP*TP*TP*TP*GP*GP*C)-3', 5'-D(*CP*(CMR)P*(RMP)P*(RMP)P*(RMP)P*(CMR) P*(RMP))-3' DNA METHYL PHOSPHONATE, MODIFIED DNA, ANTI SENSE, APTAMERS
Code Class Resolution Description 3nyp nuc 1.18 3,6-BIS(3-(3'-(R)-FLUOROPYRROLINDINO)PROPIONAMIDO) ACRIDINE C27 H31 F2 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERI QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE LIG CONTAINING BIS-3-FLUOROPYRROLIDINE END SIDE CHAINS 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, OXTYRICHA NOVA, BSU-6039, BSU6039, ANTI-PARALLEL BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX, TELOMERE, AC
Code Class Resolution Description
302d nuc 2.20 3-[5-[5-(4-METHYL-PIPERAZIN-1-YL)-1H-IMIDAZO[4,5- B]PYRIDIN-2-YL]-BENZIMIDAZOL-2-YL]-PHENOL C24 H23 N7 O META-HYDROXY ANALOGUE OF HOECHST 33258 ('HYDROXYL IN' CONFORMATION) BOUND TO D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
303d nuc 2.20 3-[5-[5-(4-METHYL-PIPERAZIN-1-YL)-1H-IMIDAZO[4,5- B]PYRIDIN-2-YL]-BENZIMIDAZOL-2-YL]-PHENOL C24 H23 N7 O META-HYDROXY ANALOGUE OF HOECHST 33258 ('HYDROXYL OUT' CONFORMATION) BOUND TO D(CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1f1t nuc 2.80 N,N'-TETRAMETHYL-ROSAMINE C23 H23 N2 O 1+ CRYSTAL STRUCTURE OF THE MALACHITE GREEN APTAMER COMPLEXED WITH TETRAMETHYL-ROSAMINE MALACHITE GREEN APTAMER RNA RNA U-TURN, BASE QUADRUPLE, BASE TRIPLE, GNRA TETRALOOP, 5- BROMO-URIDINE, RNA
Code Class Resolution Description 4gqj nuc 2.95 (MU-11,11'-BIDIPYRIDO[3,2-A:2',3'-C]PHENAZINE- 1KAPPA~2~N~4~,N~5~:2KAPPA~2~N~4'~,N~5'~)[TETRAKIS(1, 10-PHENANTHROLINE-KAPPA~2~N~1~,N~10~)]DIRUTHENIUM C84 H50 N16 RU2 COMPLEX OF A BINUCLEAR RUTHENIUM COMPOUND D,D-([MU-(11,11')- (1,10-PHENANTHROLINE)4-RU2]4+) BOUND TO D(CGTACG) DNA (5'-D(*CP*GP*TP*AP*CP*G)-3') DNA DNA RECOGNITION, DNA BINSINF, DNA
Code Class Resolution Description 3f4h nuc 3.00 1-DEOXY-1-[8-(DIMETHYLAMINO)-7-METHYL-2,4-DIOXO-3,4- DIHYDROBENZO[G]PTERIDIN-10(2H)-YL]-D-RIBITOL C18 H23 N5 O6 CRYSTAL STRUCTURE OF THE FMN RIBOSWITCH BOUND TO ROSEOFLAVIN FMN RIBOSWITCH, FMN RIBOSWITCH RNA ROSEOFLAVIN, FMN, RIBOSWITCH, TRANSCRIPTION, RNA
Code Class Resolution Description 1n37 nuc NMR RESPINOMYCIN D C51 H75 N2 O22 1+ NMR SOLUTION STRUCTURE OF THE ANTHRACYCLINE RESPINOMYCIN D INTERCALATION COMPLEX WITH A DOUBLE STRANDED DNA MOLECULE (AGACGTCT)2 5'-D(*AP*GP*AP*CP*GP*TP*CP*T)-3' DNA DRUG-DNA RECOGNITION, ANTHRACYCLINE ANTIBIOTCS, RESPINOMYCIN D, MOLECULAR DYNAMICS SIMULATIONS, NMR SPECTROSCOPY
Code Class Resolution Description 2krv nuc NMR 4-AMINO-1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL) PYRIMIDINE-2(1H)-THIONE C9 H14 N3 O7 P S SOLUTION STRUCTURE OF THE E. COLI TRNA-ARG1 (ICG) ASL CONTAI 2-THIOCYTIDINE MODIFICATION RNA (5'-R(*CP*UP*CP*GP*GP*(RSP) P*UP*IP*CP*GP*AP*AP*CP*CP*GP*AP*G)-3') RNA RNA, TRNA, 2-THIOCYTIDINE, MODIFICATION, ASL 2krw nuc NMR 4-AMINO-1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL) PYRIMIDINE-2(1H)-THIONE C9 H14 N3 O7 P S SOLUTION STRUCTURE OF THE E COLI TRNA-ARG1 (ACG) CONTAINING THIOCYTIDINE MODIFICATION IN POSITION 32 RNA (5'-R(*CP*UP*CP*GP*GP*(N) P*UP*AP*CP*GP*AP*AP*CP*CP*GP*AP*G)-3') RNA RNA, TRNA, 2-THIOCYTIDINE, ASL, MODIFICATION
Code Class Resolution Description 2kry nuc NMR 5-FORMYLCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H14 N3 O9 P SOLUTION STRUCTURE OF THE HUMAN MITOCHONDRIAL TRNAMET ASL CO THE 5-FORMYLCYTIDINE MODIFICATION IN POSITION 34 RNA (5'-R(*(PSU)P*CP*GP*GP*GP*CP*CP*(RSQ) P*AP*UP*AP*CP*CP*CP*CP*GP*A)-3') RNA RNA, TRNA, 5-FORMYLCYTIDINE, ASL, MODIFICATION 5hn2 nuc 1.50 5-FORMYLCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 6(C10 H14 N3 O9 P) BASE PAIRING AND STRUCTURE INSIGHTS INTO THE 5-FORMYLCYTOSIN DUPLEX RNA (5'-R(*GP*UP*AP*(OFC)P*GP*UP*AP*C)-3') RNA RNA, 5-FORMYLCYTOSINE 5hnj nuc 1.24 5-FORMYLCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 6(C10 H14 N3 O9 P) BASE PAIRING AND STRUCTURE INSIGHTS INTO THE 5-FORMYLCYTOSIN DUPLEX RNA (5'-R(*GP*UP*AP*(OFC)P*GP*UP*AP*C)-3') RNA RNA, 5-FORMYLCYTOSINE 5hnq nuc 2.40 5-FORMYLCYTIDINE 5'-(DIHYDROGEN PHOSPHATE) 13(C10 H14 N3 O9 P) BASE PAIRING AND STRUCTURE INSIGHTS INTO THE 5-FORMYLCYTOSIN DUPLEX 5FC MODIFIED RNA RNA RNA, 5-FORMYLCYTOSINE
Code Class Resolution Description 1nrt nuc model RIBOSYLTHYMINE-5'-MONOPHOSPHATE 3(C10 H15 N2 O9 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL
Code Class Resolution Description 1o3z nuc 2.65 RUTHENIUM ION 3(RU 3+) HIV-1 DIS(MAL) DUPLEX RU HEXAMINE-SOAKED HIV-1 DIS(MAL) GENOMIC RNA RNA HIV-1, RNA, METAL IONS, DIS
Code Class Resolution Description
2o45 nuc 3.60 (3AS,4R,7R,8S,9S,10R,11R,13R,15R,15AR)-4-ETHYL-11- METHOXY-3A,7,9,11,13,15-HEXAMETHYL-2,6,14-TRIOXO-1-[4- (4-PYRIDIN-3-YL-1H-IMIDAZOL-1-YL)BUTYL]-10-{[3,4,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-XYLO- HEXOPYRANOSYL]OXY}TETRADECAHYDRO-2H- OXACYCLOTETRADECINO[ C51 H81 N5 O13 STRUCTURE OF THE 23S RRNA OF THE LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS IN COMPLEX WITH THE MACROLIDE RU-69874 23S RRNA RNA RIBOSOME, MACROLIDES,TUNNEL, RNA
Code Class Resolution Description 2mcc nuc NMR TETRAKIS(2,2'-BIPYRIDINE-KAPPA~2~N~1~,N~1'~)(MU- TETRAPYRIDO[3,2-A:2',3'-C:3'',2''-H:2''',3'''- J]PHENAZINE-1KAPPA~2~N~4~,N~5~:2KAPPA~2~N~13~,N~14~) DIRUTHENIUM(4+) C64 H44 N14 RU2 4+ STRUCTURAL STUDIES ON DINUCLEAR RUTHENIUM(II) COMPLEXES THAT DIASTEREOSELECTIVELY TO AN ANTI-PARALLEL FOLDED HUMAN TELOM SEQUENCE HUMAN_TELOMERE_QUADRUPLEX DNA DNA, QUADRUPLEX, COMPLEX, RUTHENIUM
Code Class Resolution Description 3s49 nuc 2.30 1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL)-2- SELANYLPYRIMIDIN-4(1H)-ONE 7(C9 H13 N2 O8 P SE) RNA CRYSTAL STRUCTURE WITH 2-SE-URIDINE MODIFICATION RNA (5'-R(*GP*UP*AP*UP*AP*(RUS)P*AP*C)-3') RNA RNA, 2-SE-URIDINE 4jah nuc 1.50 1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL)-2- SELANYLPYRIMIDIN-4(1H)-ONE 6(C9 H13 N2 O8 P SE) CRYSTAL STRUCTURE OF 2-SELENOURIDINE CONTAINING RNA RNA (5'-R(*GP*UP*GP*UP*AP*(RUS)P*AP*C)-3') RNA 2-SELENOURIDINE, HIGH FIDELITY BASE PAIRING, RNA
Code Class Resolution Description
1cs7 nuc 3.20 PHOSPHORIC ACID MONO-[2-(4-{2-[4-(2-HYDROXY-ETHOXY)- CYCLOHEXYLIDENE]-ETHYLIDENE}-CYCLOHEXYLOXY) -ETHYL] ESTER 4(C18 H31 O7 P) SYNTHETIC DNA HAIRPIN WITH STILBENEDIETHER LINKER 5'-D(GP*(BRU)P*TP*TP*TP*GP*(S02) *CP*AP*AP*AP*AP*C)-3' DNA DNA HAIRPIN
1puy nuc 1.50 PHOSPHORIC ACID MONO-[2-(4-{2-[4-(2-HYDROXY-ETHOXY)- CYCLOHEXYLIDENE]-ETHYLIDENE}-CYCLOHEXYLOXY) -ETHYL] ESTER 2(C18 H31 O7 P) 1.5 A RESOLUTION STRUCTURE OF A SYNTHETIC DNA HAIRPIN WITH A STILBENEDIETHER LINKER 5'-D(*GP*TP*TP*TP*TP*GP*(S02)P*CP*AP*AP*AP*AP*C)- 3' DNA DNA
Code Class Resolution Description 2oey nuc NMR (1R,3A'S,10'S,10A'R)-7-METHOXY-2-OXO-10',10A'-DIHYDRO- 2H,3A'H-SPIRO[NAPHTHALENE-1,3'-PENTALENO[1,2- B]NAPHTHALEN]-10'-YL 2,6-DIDEOXY-2-(METHYLAMINO)- ALPHA-D-GALACTOPYRANOSIDE C33 H33 N O6 SOLUTION STRUCTURE OF A DESIGNED SPIROCYCLIC HELICAL LIGAND BINDING AT A TWO-BASE BULGE SITE IN DNA DNA (25-MER) DNA DESIGNED SPIROCYCLIC HELICAL LIGAND-BULGED DNA COMPLEX
Code Class Resolution Description 2axb nuc 1.61 2'-O-[2-(METHOXY)ETHYL]-2-THIOTHYMIDINE-5'- MONOPHOSPHATE 2(C13 H21 N2 O9 P S) CRYSTAL STRUCTURE ANALYSIS OF A 2-O-[2-(METHOXY)ETHYL]-2- THIOTHYMIDINE MODIFIED OLIGODEOXYNUCLEOTIDE DUPLEX 5'-D(*GP*CP*GP*TP*AP*(S2M)P*AP*CP*GP*C)-3') DNA DNA
Code Class Resolution Description 2rmq nuc NMR 2'-DEOXY-4'-THIOADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 4(C10 H14 N5 O5 P S) SOLUTION STRUCTURE OF FULLY MODIFIED 4'-THIODNA WITH THE SEQUENCE OF D(CGCGAATTCGCG) DNA (5'-D(*(C4S)P*(S4G)P*(C4S)P*(S4G)P*(S4A) P*(S4A)P*(T49)P*(T49)P*(C4S)P*(S4G)P*(C4S)P*(S4G))-3') DNA 4'-THIODNA, A-FORM
Code Class Resolution Description 2a0p nuc 1.95 4'-THIO-4'-DEOXY-CYTOSINE-5'-MONOPHOSPHATE 2(C9 H14 N3 O7 P S) CRYSTAL STRUCTURE OF RNA OLIGOMER CONTAINING 4'-THIORIBOSE 5'-R(*CP*CP*(S4C)P*CP*GP*GP*GP*G)-3' RNA A-RNA; DOUBLE HELIX; RIBONUCLEIC ACID; 4'-THIO RNA
Code Class Resolution Description 2rmq nuc NMR 2'-DEOXY-4'-THIOGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 8(C10 H14 N5 O6 P S) SOLUTION STRUCTURE OF FULLY MODIFIED 4'-THIODNA WITH THE SEQUENCE OF D(CGCGAATTCGCG) DNA (5'-D(*(C4S)P*(S4G)P*(C4S)P*(S4G)P*(S4A) P*(S4A)P*(T49)P*(T49)P*(C4S)P*(S4G)P*(C4S)P*(S4G))-3') DNA 4'-THIODNA, A-FORM
Code Class Resolution Description 2gxm nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-IMIDAZOLINYL)-2-(4-HYDROXYPHENYL)BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 1kb1 nuc NMR 6-THIO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O6 P S SOLUTION STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING 6- THIOGUANINE OPPOSITE CYTOSINE 5'-D(*GP*CP*AP*TP*GP*CP*GP*TP*AP*CP*G)-3', 5'-D(*CP*GP*TP*AP*CP*(S6G)P*CP*AP*TP*GP*C)-3' DNA THIOGUANINE, 6-THIOGUANINE, TG, 6TG, S6G, THIOPURINE, DOUBLE HELIX, B-FORM DNA 1kbm nuc NMR 6-THIO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O6 P S SOLUTION STRUCTURE OF AN 11-MER DNA DUPLEX CONTAINING 6- THIOGUANINE OPPOSITE THYMINE 5'-D(*GP*CP*AP*TP*GP*TP*GP*TP*AP*CP*G)-3', 5'-D(*CP*GP*TP*AP*CP*(S6G)P*CP*AP*TP*GP*C)-3' DNA THIOGUANINE, 6-THIOGUANINE, TG, 6TG, S6G, THIOPURINE, DOUBLE HELIX, B-FORM DNA 1n17 nuc NMR 6-THIO-2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE C10 H14 N5 O6 P S STRUCTURE AND DYNAMICS OF THIOGUANINE-MODIFIED DUPLEX DNA 5'-D(*GP*CP*TP*AP*AP*GP*(S6G)P*AP*AP*AP*GP*CP*C)- 3', 5'-D(*GP*GP*CP*TP*TP*TP*CP*CP*TP*TP*AP*GP*C)-3' DNA THIOGUANINE, 6-MERCAPTO PURINE, ANTI-CANCER THERAPY, DNA
Code Class Resolution Description 5bxk nuc 3.10 (1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYL 2, 6-DIAMINO-2,4,6-TRIDEOXY-4-FLUORO-ALPHA-D- GLUCOPYRANOSIDE C12 H25 F N4 O5 CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH 4'-DEOXY-4'-FLUORO NEAMINE ANALOG (EQUATORIAL 4'-F) RNA (5'- D(P*UP*UP*GP*CP*GP*UP*CP*AP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*G *C)-3') RNA/ANTIBIOTIC RNA, ANTIBIOTIC, RNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 2npy nuc 2.65 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF A JUNCTIONED HAIRPIN RIBOZYME INCORPORA LINKER AND 2'-DEOXY 2'-AMINO U AT A-1 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(U2N)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3': S-TURN STRAND, 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA HAIRPIN RIBOZYME, MUTATION, S-TURN, E-LOOP, RIBOSE ZIPPER, C RNA, 2'-DEOXY 2'-AMINO, 9S LINKER, RNA 2p7d nuc 2.25 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P A MINIMAL, 'HINGED' HAIRPIN RIBOZYME CONSTRUCT SOLVED WITH MIMICS OF THE PRODUCT STRANDS AT 2.25 ANGSTROMS RESOLUTION RIBOZYME STRAND II, RIBOZYME STRAND I, 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; PRODUCT MIMIC; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 2p7e nuc 2.05 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P VANADATE AT THE ACTIVE SITE OF A SMALL RIBOZYME SUGGESTS A ROLE FOR WATER IN TRANSITION-STATE STABILIZATION 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, RIBOZYME STRAND I, RIBOZYME STRAND II, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; VANADATE; REACTION INTERMEDIATE; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 3b58 nuc 2.65 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38G MUTATION AND A 2',5'-PHOSPHODIESTER LINKAGE AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; 2', 5' PHOSPHODIESTER, RNA 3b5a nuc 2.35 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF A MINIMALLY HINGED HAIRPIN RIBOZYME INC A38G MUTATION WITH A 2'OME MODIFICATION AT THE ACTIVE SITE LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND29-MER LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2'O-METHYL, RIBOZYME, RNA 3b5f nuc 2.70 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF A MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATING THE ADE38DAP MUTATION AND A 2',5' PHOSPHODIESTER LINKAGE AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; 2, 6 DIAMINOPURINE; RNA; 2', 5' PHOSPHODIESTER LINKAGE 3b5s nuc 2.25 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES A38DAP MUTATI O-METHYL MODIFICATION AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; RNA; 2, 6 DIAMINOPURINE; 2'-O-METHYL, RNA 3b91 nuc 2.75 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES ADE38(2AP) AND 2',5'-PHOSPHODIESTER LINKAGE MUTATIONS AT THE ACTIVE SITE 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME; 2'5' PHOSPHODIESTER; RNA; 2-AMINOPURINE 3bbi nuc 2.35 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATING A38(2AP) 2'-O-ME MODIFICATIONS NEAR ACTIVE SITE LOOP A SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2-AMINOPURINE, 2'O-METHYL, PHOSPHORYL TRAN RNA, LINKER 3bbk nuc 2.75 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MIMINALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38C AND 2'5'-PHOSPHODIESTER LINKAGE WITHIN ACTIVE SITE LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME, RNA, PHOSPHORYL TRANSFER, A38C, 2'5'- PHOSPHODIESTER, REVERSE LINKAGE 3bbm nuc 2.65 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38C AND MODIFICATION AT ACTIVE SITE LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME, PHOSPHORYL TRANSFER, 2'O-METHYL, RNA, SMAL RIBOZYME 3cqs nuc 2.80 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P A 3'-OH, 2',5'-PHOSPHODIESTER SUBSTITUTION IN THE HAIRPIN RIBOZYME ACTIVE SITE REVEALS SIMILARITIES WITH PROTEIN RIBONUCLEASES 19-MER RIBOZYME STRAND, 29-MER RIBOZYME STRAND WITH S9L SYNTHETIC LINKER AT 13TH POSITION, 13-MER SUBSTRATE STRAND WITH 3'-OH, 2',5'- PHOSPHODIESTER COVALENTLY LINKING 5TH AND 6TH NUCLEOTIDES RNA 2',5' PHOSPHODIESTER; HAIRPIN RIBOZYME; REACTION- INTERMEDIATE; TRANSITION-STATE STABILIZATION; RIBONUCLEASE; PHOSPHORYL-TRANSFER, RNA 3cr1 nuc 2.25 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF A MINIMAL, MUTANT, ALL-RNA HAIRPIN RIBO (A38C, A-1OMA) GROWN FROM MGCL2 RNA (5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*C CHAIN: A, LOOP A AND B RIBOZYME STRAND, RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*CP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) CHAIN: C RNA RIBOZYME, A38, RNA 3gs1 nuc 2.85 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P AN ALL-RNA HAIRPIN RIBOZYME WITH MUTATION A38N1DA RNA (5'- R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)-3'), RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3'), RNA (5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)- 3'), RNA (5'- R(P*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3') RNA RNA, RIBOZYME, HAIRPIN RIBOZYME, N1-DEAZAADENOSINE 3gs5 nuc 2.75 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P AN ALL-RNA HAIRPIN RIBOZYME A38N1DA VARIANT WITH A PRODUCT MIMIC SUBSTRATE STRAND RNA (36-MER), RNA (25-MER) RNA HAIRPIN RIBOZYME, RNA RIBOZYME, N1-DEAZAADENOSINE 3gs8 nuc 2.85 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P AN ALL-RNA HAIRPIN RIBOZYME A38N1DA38 VARIANT WITH A TRANSITION-STATE MIMIC SUBSTRATE STRAND RNA (5'- R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)-3'), RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3'), RNA (5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)- 3'), RNA (5'- R(P*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3') RNA HAIRPIN RIBOZYME, RNA RIBOZYME, N1-DEAZAADENOSINE 3i2q nuc 2.90 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH 2'OME SUBSTRA AND N1-DEAZAADENOSINE AT POSITION A9 DNA/RNA (30-MER), 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2r nuc 2.80 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE WITH N1-DEAZAADENOSINE AT POSITION A9 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2s nuc 2.75 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2'OME SUBST N1-DEAZAADENOSINE AT POSITION A10 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', DNA/RNA (30-MER) RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2u nuc 2.80 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P CRYSTAL STRUCTURE OF THE HAIPRIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE AND N1-DEAZAADENOSINE AT POSITION A10 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 4g6p nuc 2.64 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MINIMAL HAIRPIN RIBOZYME IN THE PRECATALYTIC STATE WITH A38P LOOP A SUBSTRATE STRAND, LOOP B OF THE RIBOZYME STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4g6s nuc 2.84 2-[2-(2-HYDROXYETHOXY)ETHOXY]ETHYL DIHYDROGEN PHOSPHATE C6 H15 O7 P MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH A38P V LOOP A SUBSTRATE STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP B OF THE RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT
Code Class Resolution Description 3e5e nuc 2.90 S-ADENOSYL-L-HOMOCYSTEINE C14 H20 N6 O5 S CRYSTAL STRUCTURES OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SAH SMK BOX (SAM-III) RIBOSWITCH FOR RNA RNA SMK SAM RIBOSWITCH SHINE-DELGARNO TRANSLATION REGULATION, RNA 3gx3 nuc 2.70 S-ADENOSYL-L-HOMOCYSTEINE C14 H20 N6 O5 S CRYSTAL STRUCTURE OF THE T. TENGCONGENSIS SAM-I RIBOSWITCH VARIANT U34C/A94G BOUND WITH SAH RNA (94-MER) RNA KINK-TURN, FOUR-WAY JUNCTION, PSEUDOKNOT, RIBOSWITCH, RNA 3npn nuc 2.79 S-ADENOSYL-L-HOMOCYSTEINE C14 H20 N6 O5 S STRUCTURE OF THE S-ADENOSYLHOMOCYSTEINE RIBOSWITCH AT 3.0A S-ADENOSYLHOMOCYSTEINE RIBOSWITCH: RNA RNA RNA, RIBOSWITCH, S-ADENOSYL-HOMOCYSTEINE 3npq nuc 2.18 S-ADENOSYL-L-HOMOCYSTEINE 3(C14 H20 N6 O5 S) STRUCTURE OF THE S-ADENOSYLHOMOCYSTEINE RIBOSWITCH AT 2.18 A S-ADENOSYLHOMOCYSTEINE RIBOSWITCH RNA RNA, RIBOSWITCH, S-ADENOSYL-HOMOCYSTEINE
Code Class Resolution Description 2gis nuc 2.90 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S STRUCTURE OF THE S-ADENOSYLMETHIONINE RIBOSWITCH MRNA REGULATORY ELEMENT SAM-I RIBOSWITCH RNA MRNA, RIBOSWITCH, S-ADENOSYLMETHIONINE, SAM, RNA-LIGAND COMPLEX 2qwy nuc 2.80 S-ADENOSYLMETHIONINE 3(C15 H22 N6 O5 S) SAM-II RIBOSWITCH BOUND TO S-ADENOSYLMETHIONINE SAM-II RIBOSWITCH RNA MRNA, RIBOSWITCH, SAM, S-ADENOSYLMETHIONINE, ADOMET, RNA- LIGAND COMPLEX, DOUBLE HELIX, PSEUDOKNOT, BASE TRIPLE 2ydh nuc 2.90 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S CRYSTAL STRUCTURE OF THE SAM-I RIBOSWITCH A94G U34 G18U G19U VARIANT IN COMPLEX WITH SAM SAM-I RIBOSWITCH RNA RNA, K-TURN 2ygh nuc 2.60 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH WITH A G2NA MUTATION IN THE KINK TURN IN CO WITH S-ADENOSYLMETHIONINE SAM-I RIBOSWITCH RNA RNA 3e5c nuc 2.25 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S CRYSTAL STRUCTURE OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SAM SMK BOX (SAM-III) RIBOSWITCH RNA SAM RIBOSWITCH SMK SAM-III TRANSLATION REGULATION SD, RNA 3gx5 nuc 2.40 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S CRYSTAL STRUCTURE OF T. TENCONGENSIS SAM-I RIBOSWITCH VARIANT A94G/U34 BOUND WITH SAM RNA (94-MER) RNA KINK-TURN, PSEUDOKNOT, FOUR-WAY JUNCTION, RIBOSWITCH, RNA 3gx6 nuc 2.80 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S CRYSTAL STRUCTURE OF THE T. TENGCONGENSIS SAM-I RIBOSWITCH VARIANT U34C/A94G BOUND WITH SAM IN MANGANESE CHLORIDE RNA (94-MER) RNA KINK-TURN, FOUR-WAY JUNCTION, PSEUDOKNOT, RIBOSWITCH, RNA 3gx7 nuc 2.95 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S CRYSTAL STRUCTURE OF THE T. TENGCONGENSIS SAM-I RIBOSWITCH VARIANT U34C/A94G MUTANT A6C/U7G/A87C/U88G BOUND WITH SAM RNA (94-MER) RNA KINK-TURN, FOUR-WAY JUNCTION, PSEUDOKNOT, RIBOSWITCH, RNA 3iqn nuc 2.70 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S FREE-STATE STRUCTURAL TRANSITIONS OF THE SAM-I RIBOSWITCH SAM-I RIBOSWITCH RNA RIBOSWITCH, SAM, KINK-TURN, PSUEDOKNOT, RNA 3iqr nuc 2.55 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH FROM T. TENCONGENSIS VARIANT A94G BOUND WIT SAM-I RIBOSWITCH RNA RIBOSWITCH, SAM, KINK-TURN, PSUEDOKNOT, RNA 4aob nuc 2.95 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH CONTAINING THE T. SOLENOPSAE KT-23 IN COMPL S-ADENOSYL METHIONINE SAM-I RIBOSWITCH TRANSLATION TRANSLATION, K-TURN, RNA 4b5r nuc 2.95 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI K-T-7 SAM-I RIBOSWITCH: APTAMER DOMAIN, RESIDUES 1-94 RNA RNA, RIBOSWITCH, K-TURN 4kqy nuc 3.02 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S BACILLUS SUBTILIS YITJ S BOX/SAM-I RIBOSWITCH YITJ S BOX/SAM-I RIBOSWITCH RNA GENE REGULATION, RNA 4l81 nuc 2.95 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S STRUCTURE OF THE SAM-I/IV RIBOSWITCH (ENV87(DELTAU92, DELTAG SAM-I/IV VARIANT RIBOSWITCH APTAMER DOMAIN: APTAMER DOMAIN RNA RIBOSWITCH, GENE REGULATION, SAM BINDING, RNA 4oqu nuc 3.20 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S STRUCTURE OF THE SAM-I/IV RIBOSWITCH (ENV87(DELTAU92)) SAM-I/IV RIBOSWITCH RNA RIBOSWITCH, APTAMER, PSEUDOKNOT, REGULATION, S-ADENOSYLMETHI RNA 5fjc nuc 1.71 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT C- SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk1 nuc 2.50 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk2 nuc 2.60 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk3 nuc 2.50 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk4 nuc 2.43 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-93 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk5 nuc 3.32 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-93 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fk6 nuc 2.50 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS CA SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkd nuc 3.00 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS UA SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fke nuc 2.80 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS GU SAM-I RIBOSWITCH: SAM BINDING DOMAIN, RESIDUES 1-94 RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkf nuc 2.80 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN IS UC SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkg nuc 2.95 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN (1-94) RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH 5fkh nuc 2.65 S-ADENOSYLMETHIONINE C15 H22 N6 O5 S SAM-I RIBOSWITCH BEARING THE H. MARISMORTUI KT-7 VARIANT 3BN SAM-I RIBOSWITCH: SAM BINDING DOMAIN RNA RNA, KINK TURN, RNA MOTIF, SAM-I RIBOSWITCH
Code Class Resolution Description 3nx5 nuc 2.31 13-METHYL[1,3]BENZODIOXOLO[5,6-C][1,3]DIOXOLO[4,5- I]PHENANTHRIDIN-13-IUM C20 H14 N O4 1+ THE CRYSTAL STRUCTURE OF SANGUINARINE BOUND TO DNA D(CGTACG) 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DRUG-DNA COMPLEX, DOUBLE HELIX, DNA
Code Class Resolution Description 1d97 nuc 2.17 2-DEOXY-CYTIDINE-5'-THIOPHOSPHORATE 6(C9 H14 N3 O6 P S) CHIRAL PHOSPHOROTHIOATE ANALOGUES OF B-DNA: THE CRYSTAL STRUCTURE OF RP-D(GP(S) CPGP(S)CPGP(S)C) DNA (5'-D(RP*GP*(SC)P*GP*(SC)P*GP*(SC))-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 8psh nuc NMR 2-DEOXY-CYTIDINE-5'-THIOPHOSPHORATE 2(C9 H14 N3 O6 P S) HIGH RESOLUTION NMR STRUCTURE OF THE STEREOREGULAR (ALL-RP)- PHOSPHOROTHIOATE-DNA/RNA HYBRID D (G*PS*C*PS*G*PS*T*PS*C*PS*A*PS*G*PS*G)R(CCUGACGC), MINIMIZED AVERAGE STRUCTURE RNA (5'-R(*CP*CP*UP*GP*AP*CP*GP*C)-3'), DNA (5'-D(*DGP*(SC)P*(GS)P*(PST)P*(SC)P*(AS) P*(GS)P*(GS))-3') DNA-RNA HYBRID OLIGONUCLEOTIDE, DNA-RNA HYBRID, PHOSPHOROTHIOATE, THIONUCLEOTIDE, ANTISENSE
Code Class Resolution Description 2mhz nuc NMR (S,S)-N6,N6-(2,3-DIHYDROXY-1,4-BUTADIYL)-2'- DEOXYADENOSINE-5'-MONOPHOSPHATE C14 H22 N5 O8 P STRUCTURE OF EXOCYCLIC S,S N6,N6-(2,3-DIHYDROXY-1,4-BUTADIYL DEOXYADENOSINE ADDUCT INDUCED BY 1,2,3,4-DIEPOXYBUTANE IN D 5'-D(*CP*GP*GP*AP*CP*(SDE)P*AP*GP*AP*AP*G)-3', 5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3' DNA B-FORM DNA, 11-MER, DEB INDUCED ADDUCT, DHB-DA ADDUCT, N-RAS SEQUENCE, DNA
Code Class Resolution Description 3mj3 nuc 3.10 SELENATE ION 4(O4 SE 2-) CRICKET PARALYSIS VIRUS IGR IRES DOMAIN 3 RNA BOUND TO SELEN RNA (5'-R(P*UP*AP*AP*GP*AP*AP*AP*UP*UP*UP*AP*CP*C CHAIN: C: DOMAIN 3 RNA, DOMAIN 3 OF THE CRICKET PARALYSIS VIRUS INTERGENI IRES RNA: DOMAIN 3 RNA RNA RNA PSEUDOKNOT, ANIONS, SELENATE, RNA 3mja nuc 2.80 SELENATE ION 4(O4 SE 2-) CRICKET PARALYSIS VIRUS IGR IRES DOMAIN 3 RNA BOUND TO SELEN STRUCTURE #2 RNA (5'-R(P*UP*AP*AP*GP*AP*AP*AP*UP*UP*UP*AP*CP*C CHAIN: C: DOMAIN 3 RNA, DOMAIN 3 OF THE CRICKET PARALYSIS VIRUS INTERGENI IRES RNA: DOMAIN 3 RNA RNA RNA PSUEDOKNOT, ANIONS, SELENATE, RNA
Code Class Resolution Description 5t3l nuc 1.58 SELENOUREA 2(C H4 N2 SE) B-DNA (CGCGAATTCGCG)2 SOAKED WITH SELENOUREA FOR 1 MIN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, SELENOUREA, DNA
Code Class Resolution Description 3gx2 nuc 2.90 ADENOSYL-ORNITHINE C15 H23 N7 O5 TTESAM-I RIBOSWITCH VARIANT A94GU34C BOUND TO SINEFUNGIN RNA (94-MER) RNA KINK-TURN, PSEUDOKNOT, FOUR-WAY JUNCTION, RNA
Code Class Resolution Description 3ski nuc 2.30 SUCCINIC ACID C4 H6 O4 CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE RNA (68-MER), RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skz nuc 2.60 SUCCINIC ACID C4 H6 O4 CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slm nuc 2.70 SUCCINIC ACID C4 H6 O4 CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slq nuc 2.50 SUCCINIC ACID C4 H6 O4 CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 5ihd nuc 1.57 SUCCINIC ACID C4 H6 O4 CALCIUM(II) AND COPPER(II) BOUND TO THE Z-DNA FORM OF D(CGCG COMPLEXED BY L-LACTATE AND SUCCINATE DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, COPPER(II), DNA
Code Class Resolution Description
4f8u nuc 2.00 (1S,2S,3R,4S,6R)-4,6-DIAMINO-3-{[(2S,3R)-3-AMINO-6- (AMINOMETHYL)-3,4-DIHYDRO-2H-PYRAN-2-YL]OXY}-2- HYDROXYCYCLOHEXYL 3-DEOXY-4-C-METHYL-3-(METHYLAMINO)- BETA-L-ARABINOPYRANOSIDE 2(C19 H37 N5 O7) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH SISOMICIN (C2 FORM) RNA (5'- R(P*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP*C 3'), RNA (5'- R(P*UP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*U -3') RNA/ANTIBIOTIC DECODING, RIBOSOME, RNA-ANTIBIOTIC COMPLEX
4f8v nuc 2.80 (1S,2S,3R,4S,6R)-4,6-DIAMINO-3-{[(2S,3R)-3-AMINO-6- (AMINOMETHYL)-3,4-DIHYDRO-2H-PYRAN-2-YL]OXY}-2- HYDROXYCYCLOHEXYL 3-DEOXY-4-C-METHYL-3-(METHYLAMINO)- BETA-L-ARABINOPYRANOSIDE 2(C19 H37 N5 O7) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH SISOMICIN (P21212 FORM) RNA (5'- R(P*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP*C 3') RNA/ANTIBIOTIC DECORDING, RIBOSOME, RNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description
3wru nuc 2.30 (2R,3R)-4-AMINO-N-[(1R,2S,3R,4R,5S)-5-AMINO-4-[(2,6- DIAMINO-2,3,4,6-TETRADEOXY-ALPHA-D-ERYTHRO- HEXOPYRANOSYL)OXY]-3-{[3-O-(2,6-DIAMINO-2,3,4,6- TETRADEOXY-BETA-L-THREO-HEXOPYRANOSYL)-BETA-D- RIBOFURANOSYL]OXY}-2-HYDROXYCYCLOHEXYL]-3-FLUORO-2- HYDROXYBUT 2(C27 H52 F N7 O11) CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH SYNTHETIC AMINOGLYCOSIDE WITH F-HABA GROUP RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RIBOSOMAL RNA, AMINOGLYCOSIDE, RNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 3dig nuc 2.80 L-THIALYSINE C5 H12 N2 O2 S CRYSTAL STRUCTURE OF THE THERMOTOGA MARITIMA LYSINE RIBOSWIT TO S-(2-AMINOETHYL)-L-CYSTEINE RNA (174-MER) RNA RIBOSWITCH, LYSINE, RNA
Code Class Resolution Description 5ktj nuc 2.97 SAMARIUM (III) ION 10(SM 3+) CRYSTAL STRUCTURE OF PISTOL, A CLASS OF SELF-CLEAVING RIBOZY RNA (5'-R(*UP*CP*UP*GP*CP*UP*CP*UP*CP*GP*UP*CP*CP 3'), PISTOL (50-MER) RNA RIBOZYME, SELF-CLEAVAGE, INTERNAL TRANSESTERIFICATION, RNA
Code Class Resolution Description 1k1h nuc NMR 2'-DEOXY-ADENOSINE-5'-SP-MONOMETHYLPHOSPHONATE C11 H16 N5 O5 P HETERODUPLEX OF CHIRALLY PURE METHYLPHOSPHONATE/DNA DUPLEX 5'-D(*TP*GP*TP*TP*TP*GP*GP*C)-3', 5'-D(*CP*(CMR)P*(RMP)P*(RMP)P*(SMP)P*(CMR) P*(RMP))-3' DNA METHYL PHOSPHONATE, ANTI SENSE, DNA
Code Class Resolution Description 1mlx nuc 1.25 2'-[(METHYLTHIO)ETHYLOXY]-THYMIDINE-5'-MONOPHOSPHATE 2(C13 H21 N2 O9 P S) CRYSTAL STRUCTURE ANALYSIS OF A 2'-O-[2-(METHYLTHIO)-ETHYL]- MODIFIED OLIGODEOXYNUCLEOTIDE DUPLEX 5'-D(*GP*CP*GP*TP*AP*SMTP*AP*CP*GP*C)-3' DNA DNA, DOUBLE HELIX, A-FORM, ANTISENSE MODIFICATION, NUCLEIC ACID ANALOGUE, RNA AFFINITY, NUCLEASE RESISTANCE, PROTEIN BINDING AFFINITY, HIGH RESOLUTION STRUCTURE, HYDRATION
Code Class Resolution Description 144d nuc 2.25 1-METHYL-4-[4-[4-(4-(1-METHYLQUINOLINIUM)AMINO) BENZAMIDO]ANILINO]PYRIDINIUM C29 H27 N5 O 2+ MINOR GROOVE BINDING OF SN6999 TO AN ALKYLATED DNA: MOLECULAR STRUCTURE OF D(CGC[E6G]AATTCGCG)-SN6999 COMPLEX DNA (5'-D(*CP*GP*CP*(G36) P*AP*AP*TP*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG, MODIFIED
Code Class Resolution Description 328d nuc 2.60 4-[4-[2-AMINO-4-[4,6-(N-METHYLQUINOLINIUM) AMINO]BENZAMIDO]ANILINO]-N-METHYLPYRIDINIUM MESYLATE C29 H29 N7 O 2+ STRUCTURE OF A D(CGCGAATTCGCG)2-SN7167 COMPLEX DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, COMPLEXED WITH DRUG
Code Class Resolution Description 1zph nuc 1.80 1,6-DIMETHYL-4-(4-(4-(1-METHYLPYRIDINIUM-4-YLAMINO) PHENYLCARBAMOYL)PHENYLAMINO)QUINOLINIUM C30 H47 N5 O CRYSTAL STRUCTURE ANALYSIS OF THE MINOR GROOVE BINDING QUINOLINIUM QUATERNARY SALT SN 8315 COMPLEXED WITH CGCGAATTCGCG 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA, DODECAMER, MINOR GROOVE BINDING COMPLEX
Code Class Resolution Description 1zpi nuc 1.60 8-METHOXY-1-METHYL-4-(4-(4-(1-METHYLPYRIDINIUM-4- YLAMINO)PHENYLCARBAMOYL)PHENYLAMINO)QUINOLINIUM C30 H47 N5 O2 CRYSTAL STRUCTURE ANALYSIS OF THE MINOR GROOVE BINDING QUINOLINIUM QUATERNARY SALT SN 8224 COMPLEXED WITH CGCGAATTCGCG 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA B-DNA, DODECAMER, MINOR GROOVE BINDING COMPLEX
Code Class Resolution Description 3nz7 nuc 1.10 3,6-BIS(3-(3'-(S)-FLUOROPYRROLINDINO)PROPIONAMIDO) ACRIDINE C27 H31 F2 N5 O2 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERI QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE LIG CONTAINING BIS-3-FLUOROPYRROLIDINE END SIDE CHAINS 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA QUADRUPLEX, OXTYRICHA NOVA, BSU-6039, BSU6039, ANTI-PARALLEL BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX, TELOMERE, AC FLUORINATION
Code Class Resolution Description 1duh nuc 2.70 SULFATE ION 2(O4 S 2-) CRYSTAL STRUCTURE OF THE CONSERVED DOMAIN IV OF E. COLI 4.5S RNA 4.5S RNA DOMAIN IV: DOMAIN IV RNA 4.5S RNA, DOMAIN IV, HELIX 8, SIGNAL RECOGNITION PARTICLE, SRP, FFH, SRP54, ELONGATION FACTOR G, EF-G, 23S RNA, NON- CANONICAL BASE PAIRS, MISMATCH 1q93 nuc 2.25 SULFATE ION 8(O4 S 2-) CRYSTAL STRUCTURE OF A MUTANT OF THE SARCIN/RICIN DOMAIN FROM RAT 28S RRNA SARCIN/RICIN 28S RRNA: SARCIN/RICIN DOMAIN RNA SARCIN/RICIN DOMAIN, RIBONUCLEIC ACID, RNA RECOGNITION, RIBOSOMES, ELONGATION FACTORS, MUTANT, STEM-LOOP 1q96 nuc 1.75 SULFATE ION 4(O4 S 2-) CRYSTAL STRUCTURE OF A MUTANT OF THE SARCIN/RICIN DOMAIN FROM RAT 28S RRNA SARCIN/RICIN 28S RRNA: SARCIN/RICIN DOMAIN RNA SARCIN/RICIN DOMAIN, RIBONUCLEIC ACID, RNA RECOGNITION, RIBOSOMES, ELONGATION FACTORS, MUTANT, STEM LOOP 1t0e nuc 1.70 SULFATE ION 2(O4 S 2-) CRYSTAL STRUCTURE OF 2-AMINOPURINE LABELLED BACTERIAL DECODING SITE RNA 5'- R(*CP*GP*AP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*AP*CP*CP*C)-3', 5'- R(*GP*GP*UP*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*CP*UP*CP*GP*G)- 3' RNA CRYSTAL STRUCTURE, BACTERIAL DECODING SITE RNA, 9-BETA-D- RIBOFURANOSYL-9H-PURIN-2-AMINE 1x9c nuc 2.19 SULFATE ION O4 S 2- AN ALL-RNA HAIRPIN RIBOZYME WITH MUTATION U39C 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, JUNCT LOW SALT, S-TURN, E-LOOP, CATALYTIC RNA, 2'-OME, RNA 1xp7 nuc 2.50 SULFATE ION 2(O4 S 2-) HIV-1 SUBTYPE F GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1xpe nuc 1.94 SULFATE ION 4(O4 S 2-) HIV-1 SUBTYPE B GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1xpf nuc 2.30 SULFATE ION 3(O4 S 2-) HIV-1 SUBTYPE A GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1y0q nuc 3.60 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF AN ACTIVE GROUP I RIBOZYME-PRODUCT COMPLEX 5'-R(*GP*CP*UP*U)-3': 5'-EXON, GROUP I RIBOZYME: ORF142-I2 INTRON RNA RIBOZYME, RNA-SPLICING, GUANOSINE-BINDING, RNA-FOLDING 1zft nuc 2.33 SULFATE ION O4 S 2- THE CRYSTAL STRUCTURE OF AN ALL-RNA MINIMAL HAIRPIN RIBOZYME MUTANT G8I AT THE CLEAVAGE SITE 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*CP*GP*GP*UP*GP*AP*IP*AP*AP*GP*GP*G)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3' RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, INOSI JUNCTIONLESS, LOW SALT, S-TURN, E-LOOP, RIBOSE ZIPPER, CATA RNA, 2'-OME, RNA 1zfv nuc 2.40 SULFATE ION O4 S 2- THE STRUCTURE OF AN ALL-RNA MINIMAL HAIRPIN RIBOZYME WITH MUTATION G8A AT THE CLEAVAGE SITE 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*AP*AP*AP*GP*GP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3' RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, JUNCTIONLESS, LOW SALT, S-TURN, E-LOOP, RIBOSE ZIPPER, CATALYTIC RNA 1zfx nuc 2.38 SULFATE ION O4 S 2- THE STRUCTURE OF A MINIMAL ALL-RNA HAIRPIN RIBOZYME WITH THE MUTANT G8U AT THE CLEAVAGE SITE 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*UP*AP*AP*GP*GP*G)-3', 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*G)-3', 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3' RNA HAIRPIN RIBOZYME, ALL-RNA, COBALT HEXAAMINE, MUTATION, LOW SALT, S-TURN, E-LOOP, RIBOSE ZIPPER, CATALYTIC RNA 2b8r nuc 2.60 SULFATE ION 5(O4 S 2-) STRUCTURE OF HIV-1(LAI) GENOMIC RNA DIS 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*AP*GP*CP*GP*CP*GP*CP*AP*CP*GP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, HAIRPIN 2b8s nuc 2.76 SULFATE ION 6(O4 S 2-) STRUCTURE OF HIV-1(MAL) GENOMIC RNA DIS 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA HIV-1, RNA, HAIRPIN 2bcz nuc 2.40 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF A MINIMAL, MUTANT ALL-RNA HAIRPIN RIBOZYME (U39C, G8I, 2'DEOXY A-1) 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', 5'-R(*UP*CP*CP*CP*(DA)P*GP*UP*CP*CP*AP*CP*CP*G)- 3'), 5'- R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3', 5'-R(*CP*GP*GP*UP*GP*AP*IP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, G8, INOSINE,, RNA 2bj6 nuc 2.60 SULFATE ION 5(O4 S 2-) CRYSTAL STRUCTURE OF A DECAMERIC HNA-RNA HYBRID SYNTHETIC HNA, 5'-R(*GP*GP*CP*AP*UP*UP*AP*CP*GP*GP)-3' NUCLEIC ACID (HNA/RNA) NUCLEIC ACID (HNA/RNA), DNA, RNA, HNA, HEXITOL NUCLEIC ACID, HYBRID, DUPLEX, MODIFIED NUCLEIC ACID, ANTISENSE, BACKBONE MODIFICATION 2d2k nuc 2.65 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF A MINIMAL, NATIVE (U39) ALL-RNA HAIRPIN 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*UP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, S-TURN, DUAL CONFORMATION, RNA 2d2l nuc 2.50 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF A MINIMAL, ALL-RNA HAIRPIN RIBOZYME WIT LINKER (C3) AT POSITION U39 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*G)- CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*(P1P) P*AP*UP*UP*AP*CP*CP*UP*GP*CP*C)-3', 5'-R(*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*C 3', 5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)-3' RNA RIBOZYME, PROPYL LINKER, RNA 2et5 nuc 2.20 SULFATE ION O4 S 2- COMPLEX BETWEEN RIBOSTAMYCIN AND THE 16S-RRNA A-SITE 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES 2fcy nuc 2.20 SULFATE ION O4 S 2- HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEOMYCIN HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS 2h1m nuc 2.90 SULFATE ION 3(O4 S 2-) SYNTHESIS, OXIDATION BEHAVIOR, CRYSTALLIZATION AND STRUCTURE METHYLSELENO GUANOSINE CONTAINING RNAS 5'-R(*GP*CP*AP*(XUG)P*AP*GP*UP*UP*AP*AP*AP*UP*CP* 3' RNA A-RNA STRUCTURE, MISMATCH A RNA, RIBONUCLEIC ACID, SE 2'-MET RNA 2oe5 nuc 1.51 SULFATE ION O4 S 2- 1.5 A X-RAY CRYSTAL STRUCTURE OF APRAMYCIN COMPLEX WITH RNA GGCGUCGCUAGUACCG/GGUACUAAAAGUCGCCC CONTAINING THE HUMAN RIB DECODING A SITE: RNA CONSTRUCT WITH 3'-OVERHANG RNA (5'-R(*GP*GP*CP*GP*UP*CP*GP*CP*UP*AP*GP*UP*AP 3'), RNA (5'- R(*GP*GP*UP*AP*CP*UP*AP*AP*AP*AP*GP*UP*CP*GP*CP*CP*C)-3') RNA AMINOGLYCOSIDE ANTIBIOTICS, APRAMYCIN, RIBOSOMAL DECODING SI SITE, HOMO SAPIENS, RNA DUPLEX, RNA 2oue nuc 2.05 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF A JUNCTIONLESS ALL-RNA HAIRPIN RIBOZYME ANGSTROMS RESOLUTION SUBSTRATE STRAND - MINIMAL JUNCTIONLESS HAIRPIN R CHAIN: A, LOOP B S-TURN STRAND, LOOP B RIBOZYME STRAND, LOOP A RIBOZYME STRAND RNA RNA, HAIRPIN RIBOZYME, ALL-RNA, MUTATION, LOW SALT, S-TURN, RIBOSE ZIPPER, CATALYTIC RNA 2p7d nuc 2.25 SULFATE ION O4 S 2- A MINIMAL, 'HINGED' HAIRPIN RIBOZYME CONSTRUCT SOLVED WITH MIMICS OF THE PRODUCT STRANDS AT 2.25 ANGSTROMS RESOLUTION RIBOZYME STRAND II, RIBOZYME STRAND I, 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; PRODUCT MIMIC; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 2p7e nuc 2.05 SULFATE ION O4 S 2- VANADATE AT THE ACTIVE SITE OF A SMALL RIBOZYME SUGGESTS A ROLE FOR WATER IN TRANSITION-STATE STABILIZATION 3' SUBSTRATE STRAND, OCTAMERIC FRAGMENT, RIBOZYME STRAND I, RIBOZYME STRAND II, 5' SUBSTRATE STRAND, PENTAMERIC FRAGMENT, RIBOZYME STRAND III RNA HAIRPIN RIBOZYME; VANADATE; REACTION INTERMEDIATE; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 2p7f nuc 2.35 SULFATE ION O4 S 2- THE NOVEL USE OF A 2',5'-PHOSPHODIESTER LINKAGE AS A REACTION INTERMEDIATE AT THE ACTIVE SITE OF A SMALL RIBOZYME SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP B RIBOZYME STRAND, LOOP A RIBOZYME STRAND RNA HAIRPIN RIBOZYME; 2',5' PHOSPHODIESTER; VANADATE; REACTION INTERMEDIATE; TRANSITION-STATE STABILIZATION; ACTIVE SITE WATERS; INDUCED FIT, RNA 3b58 nuc 2.65 SULFATE ION O4 S 2- MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38G MUTATION AND A 2',5'-PHOSPHODIESTER LINKAGE AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; 2', 5' PHOSPHODIESTER, RNA 3b5a nuc 2.35 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF A MINIMALLY HINGED HAIRPIN RIBOZYME INC A38G MUTATION WITH A 2'OME MODIFICATION AT THE ACTIVE SITE LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND29-MER LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2'O-METHYL, RIBOZYME, RNA 3b5s nuc 2.25 SULFATE ION O4 S 2- MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES A38DAP MUTATI O-METHYL MODIFICATION AT THE ACTIVE SITE LOOP A SUBSTRATE STRAND, 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND RNA HAIRPIN RIBOZYME; RNA; 2, 6 DIAMINOPURINE; 2'-O-METHYL, RNA 3b91 nuc 2.75 SULFATE ION O4 S 2- MINIMALLY HINGED HAIRPIN RIBOZYME INCORPORATES ADE38(2AP) AND 2',5'-PHOSPHODIESTER LINKAGE MUTATIONS AT THE ACTIVE SITE 29-MER LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME; 2'5' PHOSPHODIESTER; RNA; 2-AMINOPURINE 3bbi nuc 2.35 SULFATE ION O4 S 2- MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATING A38(2AP) 2'-O-ME MODIFICATIONS NEAR ACTIVE SITE LOOP A SUBSTRATE STRAND, LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA HAIRPIN RIBOZYME, 2-AMINOPURINE, 2'O-METHYL, PHOSPHORYL TRAN RNA, LINKER 3bbk nuc 2.75 SULFATE ION O4 S 2- MIMINALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38C AND 2'5'-PHOSPHODIESTER LINKAGE WITHIN ACTIVE SITE LOOP B S-TURN STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME, RNA, PHOSPHORYL TRANSFER, A38C, 2'5'- PHOSPHODIESTER, REVERSE LINKAGE 3bbm nuc 2.65 SULFATE ION O4 S 2- MINIMALLY JUNCTIONED HAIRPIN RIBOZYME INCORPORATES A38C AND MODIFICATION AT ACTIVE SITE LOOP A AND LOOP B RIBOZYME STRAND, LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND RNA HAIRPIN RIBOZYME, PHOSPHORYL TRANSFER, 2'O-METHYL, RNA, SMAL RIBOZYME 3cgp nuc 1.57 SULFATE ION O4 S 2- X-RAY STRUCTURE OF A PSEUDOURIDINE-CONTAINING YEAST SPLICEOSOMAL U2 SNRNA-INTRON BRANCH SITE DUPLEX BOUND TO IODIDE IONS RNA (5'-R(*GP*CP*GP*CP*GP*(PSU) P*AP*GP*UP*AP*GP*C)-3'), RNA (5'- R(*CP*GP*CP*UP*AP*CP*UP*AP*AP*CP*GP*CP*G)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING 3cgq nuc 2.55 SULFATE ION O4 S 2- X-RAY STRUCTURE OF A PSEUDOURIDINE-CONTAINING YEAST SPLICEOSOMAL U2 SNRNA-INTRON BRANCH SITE DUPLEX RNA (5'-R(*GP*CP*GP*CP*GP*(PSU) P*AP*GP*UP*AP*GP*C)-3'), RNA (5'- R(*CP*GP*CP*UP*AP*CP*UP*AP*AP*CP*GP*CP*G)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING 3cgr nuc 2.10 SULFATE ION O4 S 2- X-RAY STRUCTURE CONTAINING THE PSEUDOURIDYLATED U2 SNRNA AND INTRON BRANCH SITE CONSENSUS SEQUENCES RNA (5'- R(*CP*GP*CP*AP*CP*UP*AP*AP*CP*CP*GP*CP*G)-3'), RNA (5'-R(*GP*CP*GP*CP*GP*GP*(PSU) P*AP*GP*UP*GP*C)-3') RNA RNA DOUBLE HELIX, BRANCHPOINT SEQUENCE, BPS, U2 SNRNA, PSEUDOURIDINE, PRE-MRNA SPLICING 3cr1 nuc 2.25 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF A MINIMAL, MUTANT, ALL-RNA HAIRPIN RIBO (A38C, A-1OMA) GROWN FROM MGCL2 RNA (5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*C CHAIN: A, LOOP A AND B RIBOZYME STRAND, RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*CP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) CHAIN: C RNA RIBOZYME, A38, RNA 3czw nuc 1.40 SULFATE ION O4 S 2- X-RAY STRUCTURES OF THE (GUGGUCUGAUGAGGCC) RNA DUPLEX RNA (5'- R(*G*UP*GP*GP*UP*CP*UP*GP*AP*UP*GP*AP*GP*GP*CP*C)-3'): DUPLEX FORMED BY THE SHORTER STRANDS OF HAMMERHEAD RIBOZYME RNA RNA, DUPLEX, BASE PAIRING, G(SYN) - G(ANTI), SULPHATE ANION 3d0m nuc 2.00 SULFATE ION O4 S 2- X-RAY STRUCTURES OF THE (GUGGUCUGAUGAGGCC) RNA DUPLEX RNA (5'- R(*GP*UP*GP*GP*UP*CP*UP*GP*AP*UP*GP*AP*GP*GP*CP*C)-3'): DUPLEX FORMED BY THE SHORTER STRANDS OF HAMMERHEAD RIBOZYME RNA RNA, DUPLEX, BASE PAIRING, G(SYN) - G(ANTI), SULPHATE ANION 3gca nuc 2.75 SULFATE ION 2(O4 S 2-) THE STRUCTURAL BASIS FOR RECOGNITION OF THE PREQ0 METABOLITE BY AN UNUSUALLY SMALL RIBOSWITCH APTAMER DOMAIN PREQ1 RIBOSWITCH RNA PREQ1, PREQ0, RIBOSWITCH, RNA, RIBOSOMAL BINDING SITE, AMPTAMER, METABOLITE 3glp nuc 1.23 SULFATE ION 2(O4 S 2-) 1.23 A RESOLUTION X-RAY STRUCTURE OF (GCUGCUGC)2 5'-R(*GP*CP*UP*GP*CP*UP*GP*C)-3' RNA STRETCHED U-U WOBBLE, RNA, MYOTONIC DYSTROPHY, CUG REPEATS 3gs1 nuc 2.85 SULFATE ION O4 S 2- AN ALL-RNA HAIRPIN RIBOZYME WITH MUTATION A38N1DA RNA (5'- R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)-3'), RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3'), RNA (5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)- 3'), RNA (5'- R(P*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3') RNA RNA, RIBOZYME, HAIRPIN RIBOZYME, N1-DEAZAADENOSINE 3gs5 nuc 2.75 SULFATE ION O4 S 2- AN ALL-RNA HAIRPIN RIBOZYME A38N1DA VARIANT WITH A PRODUCT MIMIC SUBSTRATE STRAND RNA (36-MER), RNA (25-MER) RNA HAIRPIN RIBOZYME, RNA RIBOZYME, N1-DEAZAADENOSINE 3gs8 nuc 2.85 SULFATE ION O4 S 2- AN ALL-RNA HAIRPIN RIBOZYME A38N1DA38 VARIANT WITH A TRANSITION-STATE MIMIC SUBSTRATE STRAND RNA (5'- R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)-3'), RNA (5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3'), RNA (5'-R(*CP*GP*GP*UP*GP*AP*GP*AP*AP*GP*GP*G)- 3'), RNA (5'- R(P*GP*GP*CP*AP*GP*AP*GP*AP*AP*AP*CP*AP*CP*AP*CP*GP*A)-3') RNA HAIRPIN RIBOZYME, RNA RIBOZYME, N1-DEAZAADENOSINE 3i2q nuc 2.90 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH 2'OME SUBSTRA AND N1-DEAZAADENOSINE AT POSITION A9 DNA/RNA (30-MER), 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2r nuc 2.80 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE WITH N1-DEAZAADENOSINE AT POSITION A9 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2s nuc 2.75 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF THE HAIRPIN RIBOZYME WITH A 2'OME SUBST N1-DEAZAADENOSINE AT POSITION A10 5'-R(*UP*CP*CP*CP*(A2M)P*GP*UP*CP*CP*AP*CP*CP*GP* CHAIN: A, 5'-R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*C *C)-3', DNA/RNA (30-MER) RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3i2u nuc 2.80 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF THE HAIPRIN RIBOZYME WITH A 2',5'- LINKED SUBSTRATE AND N1-DEAZAADENOSINE AT POSITION A10 5'- R(*UP*CP*GP*UP*GP*GP*UP*AP*CP*AP*UP*UP*AP*CP*CP*UP*GP*CP*C) -3', DNA/RNA (30-MER), 5'-R(*UP*CP*CP*CP*AP*GP*UP*CP*CP*AP*CP*CP*GP*U)- 3' RNA HAIRPIN RIBOZYME, N1-DEAZAADENOSINE, RNA 3loa nuc 2.30 SULFATE ION 2(O4 S 2-) CRYSTAL STRUCTURE ANALYSIS OF THE RNA CONSTRUCT WITH TWO ADJ LIGAND BINDING SITES OF HELIX H44 IN 16S RIBOSOMAL RNA 5'-R(*CP*CP*GP*CP*GP*CP*CP*CP*GP*(5BU) P*CP*AP*CP*AP*CP*CP*AP*CP*CP*CP*G)-3', 5'-R(*GP*GP*GP*(5BU) P*GP*GP*UP*GP*AP*AP*GP*UP*CP*GP*UP*AP*AP*CP*GP*CP*GP*GP*C)- CHAIN: B RNA RNA, A-SITE, HYGROMYCIN B BINDING SITE, AMINOGLYCOSIDE 3mjb nuc 2.80 SULFATE ION 4(O4 S 2-) CRICKET PARALYSIS VIRUS IGR IRES DOMAIN 3 RNA BOUND TO SULFA RNA (5'-R(P*UP*AP*AP*GP*AP*AP*AP*UP*UP*UP*AP*CP*C CHAIN: B: DOMAIN 3 RNA, DOMAIN 3 OF THE CRICKET PARALYSIS VIRUS INTERGENI IRES RNA: DOMAIN 3 RNA RNA RNA PSEUDOKNOT, ANIONS, SULFATE, RNA 3nj6 nuc 0.95 SULFATE ION O4 S 2- 0.95 A RESOLUTION X-RAY STRUCTURE OF (GGCAGCAGCC)2 5'-R(*GP*GP*CP*AP*GP*CP*AP*GP*CP*C)-3' RNA CAG REPEATS, POLYQ DISEASES, RNA 3nj7 nuc 1.90 SULFATE ION 6(O4 S 2-) 1.9 A RESOLUTION X-RAY STRUCTURE OF (GGCAGCAGCC)2 5'-R(*GP*GP*CP*AP*GP*CP*AP*GP*CP*C)-3' RNA CAG REPEATS, POLY-Q DISEASES, RNA 3q50 nuc 2.75 SULFATE ION 4(O4 S 2-) STRUCTURAL ANALYSIS OF A CLASS I PREQ1 RIBOSWITCH APTAMER IN METABOLITE-BOUND STATE PREQ1 RIBOSWITCH RNA PREQ1, PREQ0, RNA, RIBOSOMAL BINDING SITE, APTAMER, METABOLI PSEUDOKNOT, H-TYPE, RIBOSWITCH 3q51 nuc 2.85 SULFATE ION O4 S 2- STRUCTURAL ANALYSIS OF A CLASS I PREQ1 RIBOSWITCH APTAMER IN METABOLITE-FREE STATE. PREQ1 RIBOSWITCH RNA PREQ1, PREQ0, RNA, RIBOSOMAL BINDING SITE, APTAMER, METABOLI PSEUDOKNOT, H-TYPE, RIBOSWITCH 3r1c nuc 2.05 SULFATE ION 7(O4 S 2-) CRYSTAL STRUCTURE OF GCGGCGGC DUPLEX RNA (5'-R(*GP*CP*GP*GP*CP*GP*GP*C)-3') RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, RNA 3r1d nuc 1.45 SULFATE ION 8(O4 S 2-) CRYSTAL STRUCTURE OF GC(8BRG)GCGGCGGC DUPLEX RNA (5'-R(*GP*CP*(GRB)P*GP*CP*GP*GP*CP*GP*GP*C)-3 CHAIN: A, B, C, D, E RNA CGG REPEATS, FRAGILE X MENTAL RETARDATION, 8-BROMOGUANOSINE, 3rg5 nuc 2.00 SULFATE ION 2(O4 S 2-) CRYSTAL STRUCTURE OF MOUSE TRNA(SEC) TRNA(SEC) RNA METAL BINDING BY RNA, RNA HYDRATION, STRUCTURAL FLEXIBILITY, TRNA FOLD, TRANSLATION, SERRS, SECS, PSTK, RNA 3ski nuc 2.30 SULFATE ION 8(O4 S 2-) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE RNA (68-MER), RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, DEOXYGUANOSINE, RNA 3skz nuc 2.60 SULFATE ION 8(O4 S 2-) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slm nuc 2.70 SULFATE ION 13(O4 S 2-) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND DEOXYGUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3slq nuc 2.50 SULFATE ION 7(O4 S 2-) CRYSTAL STRUCTURE OF THE 2'- DEOXYGUANOSINE RIBOSWITCH BOUND GUANOSINE-5'-MONOPHOSPHATE RNA (68-MER) RNA THREE-WAY JUNCTION, RIBOSWITCH, 2'-DEOXY GUANOSINE, RNA 3tzr nuc 2.21 SULFATE ION 3(O4 S 2-) STRUCTURE OF A RIBOSWITCH-LIKE RNA-LIGAND COMPLEX FROM THE H VIRUS INTERNAL RIBOSOME ENTRY SITE 5'-R(*CP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*UP*C *CP*C)-3', 5'-R(*GP*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*UP*CP*G CHAIN: B RNA INTERNAL LOOP, REGULATORY MOTIF, AMINOBENZIMIDAZOLE BINDING, 485d nuc 0.97 SULFATE ION O4 S 2- A SULFATE POCKET FORMED BY THREE GOU PAIRS IN THE STRUCTURE OF A NONAMERIC RNA RNA/DNA(5'-R(*CP*GP*UP*GP*AP*UP*CP*GP)-D(*C)-3') DNA/RNA HYBRID RNA, DNA/RNA HYBRID, SULFATE ION 4e48 nuc 2.50 SULFATE ION 5(O4 S 2-) STRUCTURE OF 20MER DOUBLE-HELICAL RNA COMPOSED OF CUG/CUG-RE 5'-R(P*GP*CP*UP*GP*CP*UP*GP*CP*UP*GP*CP*UP*GP*CP* P*GP*C)-3' RNA SIRNA, TRINUCLEOTIDE REPEAT EXPANSION, RNA 4e58 nuc 1.95 SULFATE ION 2(O4 S 2-) CRYSTAL STRUCTURE OF GCC(LCG)CCGC DUPLEX CONTAINING LNA RESI RNA DUPLEX CONTAINING CCG REPEATS RNA CCG REPEATS, 5' SLIPPERY DUPLEXES, X-LINKED MENTAL RETARDATI HUNTINGTON'S DISEASE, MYOTONIC DYSTROPHY TYPE 1, LNA GUANOS 4g6p nuc 2.64 SULFATE ION O4 S 2- MINIMAL HAIRPIN RIBOZYME IN THE PRECATALYTIC STATE WITH A38P LOOP A SUBSTRATE STRAND, LOOP B OF THE RIBOZYME STRAND, LOOP A AND LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4g6r nuc 2.83 SULFATE ION O4 S 2- MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH G8I VA LOOP B S-TURN STRAND, LOOP A SUBSTRATE STRAND, LOOP A RIBOZYME STRAND, LOOP B RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4g6s nuc 2.84 SULFATE ION O4 S 2- MINIMAL HAIRPIN RIBOZYME IN THE TRANSITION STATE WITH A38P V LOOP A SUBSTRATE STRAND, LOOP A AND LOOP B RIBOZYME STRAND, LOOP B OF THE RIBOZYME STRAND RNA RNA, STRUCTURE-ACTIVITY RELATIONSHIP, NUCLEIC ACID CONFORMAT 4mce nuc 2.21 SULFATE ION 3(O4 S 2-) CRYSTAL STRUCTURE OF THE GAS5 GRE MIMIC GAS5 GREM REV, GAS5 GREM FWD RNA RNA DOUBLE HELIX, RNA 4mcf nuc 1.90 SULFATE ION 4(O4 S 2-) CRYSTAL STRUCTURE OF THE GAS5 GRE MIMIC GAS5 GREM FWD, GAS5 GREM REV RNA RNA DOUBLE HELIX, RNA 4nlf nuc 1.00 SULFATE ION O4 S 2- 2'-TRIFLUOROMETHYLTHIO-2'-DEOXYCYTIDINE-MODIFIED SRL 23S RIBOSOMAL RNA SARCIN RICIN LOOP RNA RNA HAIRPIN, STRUCTURAL, RNA 4nxh nuc 1.16 SULFATE ION O4 S 2- 2'-TRIFLUOROMETHYLTHIOURIDINE-MODIFIED E. COLI 23S RRNA SARC LOOP 23S RIBOSOMAL RNA SARCIN RICIN LOOP RNA HAIRPIN, STRUCTURAL, RNA 4qk8 nuc 3.05 SULFATE ION O4 S 2- THERMOANAEROBACTER PSEUDETHANOLICUS C-DI-AMP RIBOSWITCH C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qka nuc 3.20 SULFATE ION O4 S 2- C-DI-AMP RIBOSWITCH FROM THERMOANAEROBACTER PSEUDETHANOLICUS HEXAMINE SOAK C-DI-AMP RIBOSWITCH RNA C-DI-AMP RIBOSWITCH, RNA 4qlm nuc 2.72 SULFATE ION 2(O4 S 2-) YDAO RIBOSWITCH BINDING TO C-DI-AMP RNA (108-MER) RNA SECOND MESSAGE MOLECULE, C-DI-AMP BINDING, RNA 4xw0 nuc 1.81 SULFATE ION 2(O4 S 2-) CRYSTAL STRUCTURE OF (GCCU(G-LNA)CCUGC)2 DUPLEX RNA (5'-R(*GP*CP*CP*UP*(LCG)P*CP*CP*UP*GP*C)-3') RNA CCUG REPEATS, RNA DUPLEX, MYOTONIC DYSTROPHY TYPE 2, TAUTOME RESIDUE, 3' OVERHANGING NUCLEOTIDES, RNA 5m0h nuc 2.65 SULFATE ION O4 S 2- CRYSTAL STRUCTURE OF THE CENTRAL FLEXIBLE REGION OF ASH1 MRN LOCALIZATION ELEMENT ASH1 E3 (42 NT-TL/TLR) RNA SHE2P, SHE3P, ASH1-MRNA, MRNA TRANSPORT, RNA 5mwi nuc 1.51 SULFATE ION 2(O4 S 2-) CRYSTAL STRUCTURE OF G(CUG)8G DUPLEX RNA G(CUG)8C DUPLEX RNA CUG REPEATS, RNA, DUPLEX 5ndh nuc 1.81 SULFATE ION 2(O4 S 2-) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P2 RNA (5'-R(*GP*(CBV) P*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*GP*C)-3') RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMER, RNA 5nef nuc 1.91 SULFATE ION O4 S 2- THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5neo nuc 1.69 SULFATE ION O4 S 2- THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA 5nep nuc 1.60 SULFATE ION 3(O4 S 2-) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH METHYLGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, METHYLGUANIDINE, RNA 5neq nuc 1.69 SULFATE ION 2(O4 S 2-) THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH AMINOGUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, AMINOGUANIDINE, RNA 5nom nuc 1.93 SULFATE ION O4 S 2- THE STRUCTURE OF THE G. VIOLACEUS GUANIDINE II RIBOSWITCH P1 WITH GUANIDINE RNA (5'- R(*GP*GP*UP*GP*GP*GP*GP*AP*CP*GP*AP*CP*CP*CP*CP*AP*(CBV)P*C CHAIN: A RNA GUANIDINE II RIBOSWITCH, STEM-LOOP, TETRA LOOP, DIMMER, RNA
Code Class Resolution Description 2gxn nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-IMIDAZOLINYL)-2-(4-METHOXYPHENYL)BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 1i2x nuc 2.40 SPERMIDINE C7 H19 N3 2.4 A STRUCTURE OF A-DUPLEX WITH BULGED ADENOSINE, SPERMIDINE FORM DNA/RNA (5'-R(*GP*CP*G)-D(P*AP*TP*AP*T)- R(P*AP*CP*GP*U)-3') DNA-RNA HYBRID 'ADENINE BULGE, A-TYPE NA, DNA/RNA HYBRID', DNA-RNA HYBRID 293d nuc 1.00 SPERMIDINE C7 H19 N3 INTERACTION BETWEEN THE LEFT-HANDED Z-DNA AND POLYAMINE-2: THE CRYSTAL STRUCTURE OF THE D(CG)3 AND SPERMIDINE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, COMPLEXED WITH SPERMIDINE 2elg nuc 1.00 SPERMIDINE C7 H19 N3 THE RARE CRYSTALLOGRAPHIC STRUCTURE OF D(CGCGCG)2: THE NATURAL SPERMIDINE MOLECULE BOUND TO THE MINOR GROOVE OF LEFT-HANDED Z-DNA D(CGCGCG)2 AT 10 DEGREE CELSIUS DNA (5'-D(*DCP*DGP*DCP*DGP*DCP*DG)-3') DNA D(CGCGCG)2, LEFT-HANDED Z-DNA, SPERMIDINE, X-RAY CRYSTALLOGRAPHY, POLYAMINE
Code Class Resolution Description 319d nuc 2.20 THERMINE C9 H24 N4 CRYSTAL STRUCTURES OF D(CCGGG(BR)5CCCGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*(CBR)P*CP*CP*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED
Code Class Resolution Description 1kgk nuc 1.00 SPERMINE (FULLY PROTONATED FORM) C10 H30 N4 4+ DIRECT OBSERVATION OF A CYTOSINE ANALOG THAT FORMS FIVE HYDROGEN BONDS TO GUANOSINE; GUANYL G-CLAMP 5'-D(*GP*(GCK)P*GP*TP*AP*TP*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, CYTOSINE ANALOGUE, DNA 1y0q nuc 3.60 SPERMINE (FULLY PROTONATED FORM) C10 H30 N4 4+ CRYSTAL STRUCTURE OF AN ACTIVE GROUP I RIBOZYME-PRODUCT COMPLEX 5'-R(*GP*CP*UP*U)-3': 5'-EXON, GROUP I RIBOZYME: ORF142-I2 INTRON RNA RIBOZYME, RNA-SPLICING, GUANOSINE-BINDING, RNA-FOLDING 4hif nuc 0.85 SPERMINE (FULLY PROTONATED FORM) C10 H30 N4 4+ ULTRAHIGH-RESOLUTION CRYSTAL STRUCTURE OF Z-DNA IN COMPLEX W IONS DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA SELF-COMPLEMENTARY DNA, DNA, Z-DNA 4hig nuc 0.75 SPERMINE (FULLY PROTONATED FORM) C10 H30 N4 4+ ULTRAHIGH-RESOLUTION CRYSTAL STRUCTURE OF Z-DNA IN COMPLEX W ION. DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA SELF-COMPLEMENTARY DNA, Z-DNA, DNA 4i9v nuc 1.02 SPERMINE (FULLY PROTONATED FORM) 2(C10 H30 N4 4+) THE ATOMIC STRUCTURE OF 5-HYDROXYMETHYL 2'-DEOXYCITIDINE BAS WITH 2'-DEOXYGUANOSINE IN DICKERSON DREW DODECAMER DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(5HC)P*GP*CP*G CHAIN: A, B DNA 5-HYDROXYMETHYL 2' DEOXYCITIDINE, 5-HYDROXYMETHYL-DC ADDUCT, DDD, DODECAMER OF B-DNA, DNA 5t83 nuc 2.71 SPERMINE (FULLY PROTONATED FORM) C10 H30 N4 4+ STRUCTURE OF A GUANIDINE-I RIBOSWITCH FROM S. ACIDOPHILUS RNA (95-MER) RNA RIBOSWITCH, GUANIDINE, S-TURN, A-MINOR, RNA
Code Class Resolution Description 100d nuc 1.90 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF THE HIGHLY DISTORTED CHIMERIC DECAMER R(C)D(CGGCGCCG)R(G)-SPERMINE COMPLEX-SPERMINE BINDING TO PHOSPHATE ONLY AND MINOR GROOVE TERTIARY BASE-PAIRING DNA/RNA (5'-R(*CP*)-D(*CP*GP*GP*CP*GP*CP*CP*GP*)- R(*G)-3') DNA-RNA HYBRID A-DNA/RNA, DOUBLE HELIX, DNA-RNA HYBRID 131d nuc 1.00 SPERMINE 2(C10 H26 N4) THE LOW-TEMPERATURE CRYSTAL STRUCTURE OF THE PURE-SPERMINE FORM OF Z-DNA REVEALS BINDING OF A SPERMINE MOLECULE IN THE MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX 198d nuc 1.97 SPERMINE C10 H26 N4 A TRIGONAL FORM OF THE IDARUBICIN-D(CGATCG) COMPLEX: CRYSTAL AND MOLECULAR STRUCTURE AT 2.0 ANGSTROMS RESOLUTION DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d10 nuc 1.50 SPERMINE C10 H26 N4 STRUCTURAL COMPARISON OF ANTICANCER DRUG-DNA COMPLEXES. ADRIAMYCIN AND DAUNOMYCIN DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d12 nuc 1.70 SPERMINE C10 H26 N4 STRUCTURAL COMPARISON OF ANTICANCER DRUG-DNA COMPLEXES. ADRIAMYCIN AND DAUNOMYCIN DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d15 nuc 1.50 SPERMINE C10 H26 N4 TERNARY INTERACTIONS OF SPERMINE WITH DNA: 4'-EPIADRIAMYCIN AND OTHER DNA: ANTHRACYCLINE COMPLEXES DNA (5'-D(*CP*GP*AP*TP*CP*G)-3') DNA RIGHT HANDED DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1d48 nuc 1.00 SPERMINE C10 H26 N4 STRUCTURE OF THE PURE-SPERMINE FORM OF Z-DNA (MAGNESIUM FREE) AT 1 ANGSTROM RESOLUTION DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX 1dcr nuc 1.60 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF DNA SHEARED TANDEM G-A BASE PAIRS 5'-D(*CP*CP*GP*AP*AP*(BRU)P*GP*AP*GP*G)-3' DNA TANDEM GA BASE PAIRS, GA MISMATCH, DEOXYRIBONUCLEIC ACID, DNA 1dns nuc 2.00 SPERMINE C10 H26 N4 BASE ONLY BINDING OF SPERMINE IN THE DEEP GROOVE OF THE A- DNA OCTAMER D(GTGTACAC) DNA (5'-D(*GP*TP*GP*TP*AP*CP*AP*C)-3') DNA A-DNA, DOUBLE HELIX 1dpl nuc 0.83 SPERMINE 2(C10 H26 N4) A-DNA DECAMER GCGTA(T23)TACGC WITH INCORPORATED 2'-METHOXY- 3'-METHYLENEPHOSPHATE-THYMIDINE 5'-D(*GP*CP*GP*TP*AP*(T23)P*AP*CP*GP*C)-3' DNA MODIFIED A-DECAMER AT 0.83 A RESOLUTION, DEOXYRIBONUCLEIC ACID, DNA 1edr nuc 1.60 SPERMINE C10 H26 N4 MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGMO6AATTCGCG) AT 1.6 ANGSTROM 5'-D(*CP*GP*CP*GP*(A47)AP*AP*TP*TP*CP*GP*CP*G)- 3' DNA B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID, MODIFIED NUCLEOTIDE, METHOXYADENOSINE, DAMAGED DNA 1ei4 nuc 1.43 SPERMINE C10 H26 N4 B-DNA DODECAMER CGCGAAT(TLC)CGCG WITH INCORPORATED [3.3.0]BICYCLO-ARABINO-THYMINE-5'-PHOSPHATE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TLC)P*(TLC) P*CP*GP*CP*G)-3') DNA MODIFIED B-DODECAMER, [3.3.0]BICYCLO-ARABINONUCLEIC ACID, DNA 1evv nuc 2.00 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1f6c nuc 2.70 SPERMINE 2(C10 H26 N4) CRYSTAL STRUCTURE OF THE B-DNA HEXAMER GGCGCC WITH SPERMINE DNA (5'-D(*GP*GP*CP*GP*CP*C)-3') DNA B-DNA, E-DNA, DOUBLE HELIX 1fq2 nuc 1.20 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE ANALYSIS OF THE POTASSIUM FORM OF B-DNA DODECAMER CGCGAATTCGCG DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA CATIONS, DICKERSON DODECAMER, DICKERSON-DREW DODECAMER, MINOR GROOVE, DNA 1fuf nuc 1.70 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF A 14BP RNA OLIGONUCLEOTIDE CONTAINING DOUBLE UU BULGES: A NOVEL INTRAMOLECULAR U*(AU) BASE TRIPLE (5'-R(*GP*GP*UP*AP*UP*UP*UP*CP*GP*GP*UP*AP*(CBR) P*C)-3') RNA BULGE, BASE TRIPLE, RNA, CRYSTAL 1i0t nuc 0.60 SPERMINE C10 H26 N4 0.6 A STRUCTURE OF Z-DNA CGCGCG 5'-D(*CP*GP*CP*GP*CP*G)-3' DNA Z-FORM DOUBLE HELIX, DNA 1i1p nuc 1.63 SPERMINE C10 H26 N4 REFINEMENT INCLUDING EXPERIMENTAL MAD PHASES ALLOWS AN EXHAU STUDY OF ORDERED SOLVENT MOLECULES FOR A PLATINATED DECANUC 5'-D(*CP*CP*TP*CP*GP*CP*TP*CP*TP*C)-3', 5'-D(*GP*AP*GP*AP*GP*CP*GP*AP*GP*G)-3' DNA ANTITUMOR DRUG, CIS-DDP, INTERSTRAND CROSS-LINK, DEOXYRIBONU ACID, SPERMINE, DNA 1i2y nuc 1.66 SPERMINE C10 H26 N4 1.66 A STRUCTURE OF A-DUPLEX WITH BULGED ADENOSINE, SPERMINE FORM DNA/RNA (5'-R(*GP*CP*G)-D(P*AP*TP*AP*T)- R(P*AP*CP*GP*U)-3') DNA-RNA HYBRID ADENINE BULGE, A-TYPE NA, DNA/RNA HYBRID, DNA-RNA HYBRID 1ick nuc 0.95 SPERMINE C10 H26 N4 LEFT-HANDED Z-DNA HEXAMER DUPLEX D(CGCGCG)2 5'-D(*CP*GP*CP*GP*CP*G)-3' DNA LEFT-HANDED Z-DNA OLIGOMER 1j8g nuc 0.61 SPERMINE C10 H26 N4 X-RAY ANALYSIS OF A RNA TETRAPLEX R(UGGGGU)4 AT ULTRA-HIGH R 5'-R(*UP*GP*GP*GP*GP*U)-3' RNA RNA TETRAPLEX, SR IONS, U TETRAD, OCTAPLEX, RNA 1m69 nuc 1.10 SPERMINE C10 H26 N4 ATOMIC RESOLUTION STRUCTURE OF 5BR-9AMINO-DACA WITH D[CGTACG 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA ATOMIC RESOLUTION, ADENINE-THYMINE DISORDER, TOPOISOMERASE I DNA 1n7a nuc 1.20 SPERMINE 2(C10 H26 N4) RIP-RADIATION-DAMAGE INDUCED PHASING RNA/DNA (5'-R(*U)-D(P*(BGM))-R(P*AP*GP*GP*U)-3') DNA, RNA DNA, RNA 1n7b nuc 1.40 SPERMINE 2(C10 H26 N4) RIP-RADIATION-DAMAGE INDUCED PHASING RNA/DNA (5'-R(*U)-D(P*(BGM))-R(P*AP*GP*GP*U)-3') DNA, RNA DNA, RNA 1ofx nuc 2.00 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF AN OKAZAKI FRAGMENT AT 2 ANGSTROMS RESOLUTION DNA (5'-D(*GP*GP*GP*TP*AP*TP*AP*CP*GP*C)-3'), DNA/RNA (5'-R(*GP*CP*GP*)- D(*TP*AP*TP*AP*CP*CP*C)-3') DNA-RNA HYBRID A-DNA/RNA, DOUBLE HELIX, DNA-RNA HYBRID 1pwf nuc 1.16 SPERMINE C10 H26 N4 ONE SUGAR PUCKER FITS ALL: PAIRING VERSATILITY DESPITE CONFORMATIONAL UNIFORMITY IN TNA 5'-D(*GP*CP*GP*TP*AP*(2MU)P*(FA2)P*CP*GP*C)-3' DNA A-DNA, HYDROGEN BONDING, NUCLEIC ACID ETIOLOGY, TETROSE, FOUR CARBON SUGAR, X-RAY CRYSTALLOGRAPHY, NUCLEIC ACID ANALOGUE 1s2r nuc 1.53 SPERMINE 2(C10 H26 N4) A HIGH RESOLUTION CRYSTAL STRUCTURE OF [D(CGCAAATTTGCG)]2 5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)-3' DNA MINOR GROOVE HYDRATION, DODECAMER, DNA 1tn1 nuc 3.00 SPERMINE C10 H26 N4 CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 SPERMINE C10 H26 N4 CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1vro nuc 1.10 SPERMINE C10 H26 N4 SELENIUM-ASSISTED NUCLEIC ACID CRYSTALLOGRAPHY: USE OF PHOSPHOROSELENOATES FOR MAD PHASING OF A DNA STRUCTURE 5'-D(*CP*(GMS)P*CP*GP*CP*G)-3' DNA LEFT-HANDED Z-DNA, PHOSPHOROSELENOATE, MULTIWAVELENGTH ANOMALOUS DISPERSION (MAD), COVALENT MODIFICATION OF OLIGONUCLEOTIDES, OLIGONUCLEOTIDE ANALOGUE, PHASING STRATEGY, SYNCHROTRON 1woe nuc 1.50 SPERMINE C10 H26 N4 X-RAY STRUCTURE OF A Z-DNA HEXAMER D(CGCGCG) Z-DNA HEXAMER DNA Z-DNA, HEAVY WATER, SPERMINE, DNA 1xpf nuc 2.30 SPERMINE C10 H26 N4 HIV-1 SUBTYPE A GENOMIC RNA DIMERIZATION INITIATION SITE 5'- R(*CP*UP*UP*GP*CP*UP*GP*AP*GP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP *CP*AP*AP*G)-3' RNA RNA, LOOP-LOOP COMPLEX, HIV-1 1y84 nuc 1.60 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (IMIDAZOLYL)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(EIT)P*AP*CP*GP*C)-3' DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER. 1y8l nuc 1.50 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (TRIFLUORO)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(TFE)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER 1yb9 nuc 1.65 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2-(N, N-DIMETHYLAMINOOXY)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(2OT)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER 1z5t nuc 1.60 SPERMINE 2(C10 H26 N4) CRYSTAL STRUCTURE OF [D(CGCGAA(Z3DU)(Z3DU)CGCG)]2, Z3DU:5- (3-AMINOPROPYL)-2'-DEOXYURIDINE, IN PRESENCE OF THALLIUM I. 5'-D(*CP*GP*CP*GP*AP*AP*(ZDU)P*(ZDU) P*CP*GP*CP*G)-3' DNA B-DNA, TL+, THALLIUM, MODIFIED DNA, CATIONS, MODIFIED THYMINE 1z7i nuc 1.28 SPERMINE C10 H26 N4 2'-ME-SE DERIVITATION OF A-DNA OCTAMER G(UMSE)GTACAC 5'-D(*GP*(UMS)P*GP*TP*AP*CP*AP*C)-3': 2'-SELENIUM A-DNA DUPLEX DNA 2'-METHYLSELENO-URIDINE, SE-DNA, SELENIUM DERIVATIZATION 206d nuc 2.50 SPERMINE 2(C10 H26 N4) BASE-PAIR OPENING AND SPERMINE BINDING-B-DNA FEATURES DISPLAYED IN THE CRYSTAL STRUCTURE OF A GAL OPERON FRAGMENT: IMPLICATIONS FOR PROTEIN-DNA RECOGNITION DNA (5'-D(*CP*CP*AP*CP*CP*G)-3'), DNA (5'-D(*CP*GP*GP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX 210d nuc 1.35 SPERMINE C10 H26 N4 CRYSTAL AND MOLECULAR STRUCTURE OF A NEW Z-DNA CRYSTAL FORM: D[CGT(2-NH2-A)CG] AND ITS PLATINATED DERIVATIVE DNA (5'-D(*CP*GP*TP*(1AP)P*CP*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 211d nuc 1.60 SPERMINE C10 H26 N4 THE CRYSTAL AND MOLECULAR STRUCTURE OF A NEW Z-DNA CRYSTAL FORM: D[CGT(2-NH2-A) CG] AND ITS PLATINATED DERIVATIVE DNA (5'-D(*CP*GP*TP*(1AP)P*CP*(PT(NH3)3)G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED 248d nuc 1.83 SPERMINE 2(C10 H26 N4) CRYSTAL STRUCTURES OF AN A-FORM DUPLEX WITH SINGLE-ADENOSINE AND A CONFORMATIONAL BASIS FOR SITE SPECIFIC RNA SELF-CLEAV DNA/RNA (5'-R(*GP*CP*GP*)-D(*AP*TP*AP*TP*AP*)-R(* 3'), ORTHORHOMBIC DNA/RNA A-DNA/RNA, DOUBLE HELIX, BULGES, DNA-RNA COMPLEX 258d nuc 1.58 SPERMINE C10 H26 N4 FACTORS AFFECTING SEQUENCE SELECTIVITY ON NOGALAMYCIN INTERCALATION: THE CRYSTAL STRUCTURE OF D(TGTACA)- NOGALAMYCIN DNA (5'-D(*TP*GP*TP*AP*CP*A)-3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 2b2b nuc 1.50 SPERMINE C10 H26 N4 STRUCTURAL DISTORTIONS IN PSORALEN CROSS-LINKED DNA 5'-D(*CP*CP*GP*CP*TP*AP*GP*CP*GP*G)-3' DNA RECOMBINATION, PSORALEN, NUCLEIC ACID STRUCTURE, DNA 2d47 nuc 2.00 SPERMINE C10 H26 N4 MOLECULAR STRUCTURE OF A COMPLETE TURN OF A-DNA DNA (5'-D(*CP*CP*CP*CP*CP*GP*CP*GP*GP*GP*GP*G)- 3') DNA A-DNA, DOUBLE HELIX 2dcg nuc 0.90 SPERMINE 2(C10 H26 N4) MOLECULAR STRUCTURE OF A LEFT-HANDED DOUBLE HELICAL DNA FRAGMENT AT ATOMIC RESOLUTION DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX 2f8w nuc 1.20 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF D(CACGTG)2 5'-D(*CP*AP*CP*GP*TP*G)-3' DNA D(CACGTG), POLYAMINE, Z-DNA, 1,3-PROPANEDIAMINE 2gun nuc 2.80 SPERMINE C10 H26 N4 RNA-BINDING AFFINITIES AND CRYSTAL STRUCTURE OF OLIGONUCLEOTIDES CONTAINING FIVE-ATOM AMIDE-BASED BACKBONE STRUCTURES 5'-D(*TP*TP*CP*(T2T)P*(CBR)P*TP*TP*C)-3', 5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*A)-3' DNA/RNA DNA:RNA HYBRID, AMIDE BEARING DNA, THYMIDINE DIMERS, INTERNUCLEOSIDIC AMIDE LINKAGE, DNA, RNA, DNA/RNA COMPLEX 2gwa nuc 1.75 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN THE DNA HOLLIDAY JUNCTION AND A BIS-ACRIDINE MOLECULE. 5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3' DNA DNA HOLLIDAY JUNCTION BIS-ACRIDINE 2o3y nuc 2.70 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF THE HOMO SAPIENS CYTOPLASMIC RIBOSOMAL DECODING SITE IN PRESENCE OF PAROMAMINE DERIVATIVE NB30 RNA (5'- R(*UP*UP*GP*CP*GP*UP*CP*GP*CP*UP*CP*CP*GP*GP*AP*AP*AP*AP*GP *UP*CP*GP*C)-3') RNA AMINOGLYCOSIDE, ANTIBIOTICS, RIBOSOME, DECODING SITE, HOMO SAPIENS, EUKARYOTE, CYTOPLASMIC, TRANSLATION INHIBITION, STOP CODON READTHROUGH, RNA 2pl8 nuc 1.65 SPERMINE C10 H26 N4 D(GTATACC) UNDER HYDROSTATIC PRESSURE OF 1.04 GPA 5'-D(*DGP*DGP*DTP*DAP*DTP*DAP*DCP*DC)-3' DNA DNA, HIGH-PRESSURE, CRYSTAL STRUCTURE 2plb nuc 1.60 SPERMINE C10 H26 N4 D(GTATACC) UNDER HYDROSTATIC PRESSURE OF 1.39 GPA 5'-D(*DGP*DGP*DTP*DAP*DTP*DAP*DCP*DC)-3' DNA DNA, HIGH-PRESSURE, CRYSTAL STRUCTURE 2rf3 nuc 1.75 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF TRICYCLO-DNA: AN UNUSUAL COMPENSATORY CHANGE OF TWO ADJACENT BACKBONE TORSION ANGLES 5'-D(CGCG(TCY)ATTCGCG)-3' DNA DNA DUPLEX, X-RAY CRYSTAL STRUCTURE, TRICYCLO-DNA, CONFORMATIONALLY CONSTRAINED DNA ANALOG 2tra nuc 3.00 SPERMINE C10 H26 N4 RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAASP T-RNA T-RNA, SINGLE STRAND, LOOPS 320d nuc 2.15 SPERMINE C10 H26 N4 CRYSTAL STRUCTURES OF D(CCGGGCCCGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*CP*GP*G)-3') DNA A-DNA, DOUBLE HELIX 321d nuc 2.15 SPERMINE 2(C10 H26 N4) CRYSTAL STRUCTURES OF D(CCGGGCCCGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*CP*GP*G)-3') DNA A-DNA, DOUBLE HELIX 323d nuc 2.15 SPERMINE C10 H26 N4 CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*(5CM)P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 324d nuc 2.15 SPERMINE 2(C10 H26 N4) CRYSTAL STRUCTURES OF D(CCGGGCCM5CGG)-ORTHOGONAL FORM DNA (5'-D(*CP*CP*GP*GP*GP*CP*CP*(5CM)P*GP*G)-3') DNA A-DNA, DOUBLE HELIX, MODIFIED 326d nuc 2.15 SPERMINE C10 H26 N4 CRYSTAL STRUCTURES OF D(CM5CGGGCCM5CGG)-ORTHOGONAL FORM DNA (5'-D(*CP*(5CM)P*GP*GP*GP*CP*CP*(5CM)P*GP*G)- 3') DNA A-DNA, DOUBLE HELIX, MODIFIED 355d nuc 1.40 SPERMINE C10 H26 N4 THE B-DNA DODECAMER AT HIGH RESOLUTION DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' CHAIN: A, B DNA B-DNA, DOUBLE HELIX, SODIUM FORM, DNA 3eui nuc 2.20 SPERMINE C10 H26 N4 A BIMOLECULAR ANTI-PARALLEL-STRANDED OXYTRICHA NOVA TELOMERIC QUADRUPLEX IN COMPLEX WITH A 3,6-DISUBSTITUTED ACRIDINE BSU-6042 IN A LARGE UNIT CELL 5'- D(*DGP*DGP*DGP*DGP*DTP*DTP*DTP*DTP*DGP*DGP*DGP*DG)-3' DNA QUADRUPLEX, OXYTRICHA NOVA, BSU-6042, BSU6042, ANTI- PARALLEL, BIMOLECULAR, MACROMOLECULE, DNA, G-QUADRUPLEX 3oz5 nuc 1.36 SPERMINE C10 H26 N4 S-METHYL CARBOCYCLIC LNA DNA (5'-D(*GP*CP*GP*TP*AP*(UMX)P*AP*CP*GP*C)-3') DNA A-FORM DNA, S-METHYL CARBOCYCLIC LNA, S-ME-C-LNA, ANTISENSE OLIGONUCLEOTIDES, S-METHYL-CARBOCYCLIC LNA, DNA 3p4j nuc 0.55 SPERMINE C10 H26 N4 ULTRA-HIGH RESOLUTION STRUCTURE OF D(CGCGCG)2 Z-DNA DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DNA 410d nuc 1.60 SPERMINE C10 H26 N4 DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O- ETHOXYMETHYLENE RIBONUCLEOSIDE DNA (5'-D(*GP*CP*GP*TP*AP*(T38)P*AP*CP*GP*C)-3') DNA DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O- ETHOXYMETHYLENE RIBONUCLEOSIDE, DNA 428d nuc 1.75 SPERMINE C10 H26 N4 STRUCTURE OF THE POTASSIUM FORM OF CGCGAATTCGCG: DNA DEFORMATION BY ELECTROSTATIC COLLAPSE AROUND SMALL CATIONS DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA DOUBLE HELIX, POTASSIUM FORM, DNA 4e8k nuc 3.03 SPERMINE C10 H26 N4 STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND A NON-HYDROLYZED OLIGONUCLEOTIDE SUBSTRATE GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*CP*G*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, RNA 4e8m nuc 3.50 SPERMINE 2(C10 H26 N4) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8n nuc 2.96 SPERMINE C10 H26 N4 STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF NH4+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8p nuc 3.28 SPERMINE C10 H26 N4 STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF RB+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYMES, SELF-SPLICING, RETROTRANSPOSITION, 4e8q nuc 2.84 SPERMINE C10 H26 N4 STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF TL+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4e8t nuc 3.34 SPERMINE 2(C10 H26 N4) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND AN OLIGONUCLEOTIDE FRAGMENT SUBSTRATE (LOW DATASET) GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*AP*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4faq nuc 3.11 SPERMINE 2(C10 H26 N4) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, CA2+ AND 5'-EXON GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4far nuc 2.86 SPERMINE 2(C10 H26 N4) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND 5'-EXON GRUUP IIC INTRON: DOMAINS 1-5, GROUP IIC INTRON: 5'-EXON RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fau nuc 2.87 SPERMINE C10 H26 N4 STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF LI+, MG2+ AND 5'-EXON GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4faw nuc 2.70 SPERMINE C10 H26 N4 STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN THE OF K+, MG2+ AND A HYDROLYZED OLIGONUCLEOTIDE FRAGMENT GROUP IIC INTRON: DOMAINS 1-5, 5'-R(*A*UP*UP*UP*AP*UP*UP*A)-3' RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4fb0 nuc 3.22 SPERMINE C10 H26 N4 STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON C377G A LIGAND-FREE STATE IN THE PRESENCE OF K+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, SELF-SPLICING, RETROTRANSPOSITION, SPLICEOSOME, RN 4hqi nuc 1.70 SPERMINE C10 H26 N4 STRUCTURE OF O6-BENZYL-2'-DEOXYGUANOSINE OPPOSITE PERIMIDINO SYNTHETIC NUCLEOSIDE IN DNA DUPLEX SHORT MODIFIED NUCLEIC ACIDS DNA B-FORM DNA, O6-BENZYL-2'-DEOXYGUANOSINE, DPER, PERIMIDINONE- NUCLEOSIDE, DICKERSON-DREW DODECAMER, DNA 4nfo nuc 1.96 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE ANALYSIS OF THE 16MER GCAGACUUAAGUCUGC GCAGACUUAAGUCUGC RNA RNA 16MER OLIGO, RNA 4p5j nuc 1.99 SPERMINE C10 H26 N4 CRYSTAL STRUCTURE OF THE TRNA-LIKE STRUCTURE FROM TURNIP YEL VIRUS (TYMV), A TRNA MIMICKING RNA TURNIP YELLOW MOSAIC VIRUS MRNA FOR THE COAT PROT CHAIN: A RNA TRNA-MIMIC VIRAL RNA PSEUDOKNOT MULTIFUNCTIONAL, RNA 4r0d nuc 3.68 SPERMINE 2(C10 H26 N4) CRYSTAL STRUCTURE OF A EUKARYOTIC GROUP II INTRON LARIAT LIGATED EXONS, GROUP IIB INTRON LARIAT RNA LARIAT, RIBOZYME, 2'-5' PHOSPHODIESTER, RNA 4r4a nuc 1.49 SPERMINE C10 H26 N4 RACEMIC CRYSTAL STRUCTURE OF A COBALT-BOUND B-DNA DUPLEX 5'-D(*CP*CP*GP*GP*TP*AP*CP*CP*GP*G)-3' DNA RACEMIC DNA, RACEMATES, DNA
Code Class Resolution Description 1njn nuc 3.70 SPARSOMYCIN C13 H19 N3 O5 S2 THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH THE ANTIBIOTIC SPARSOMYCIN 23S RIBOSOMAL RNA RIBOSOME RIBOSOMES, TRNA, PUROMYCIN, SPARSOMYCIN, PEPTIDYL- TRANSFERASE, PEPTIDE BOND FORMATION
Code Class Resolution Description 1v9g nuc 1.80 N,N'-BIS(3-AMMONIOPROPYL)BUTANE-1,4-DIAMINIUM C10 H20 N4 4+ NEUTRON CRYSTALLOGRAPHIC ANALYSIS OF THE Z-DNA HEXAMER CGCGC 5'-D(*CP*GP*CP*GP*CP*G)-3' DNA Z-DNA, HYDROGEN, HYDRATION, H/D EXCHANGE, NEUTRON, DNA
Code Class Resolution Description 2gxk nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-AMIDINO)-2-(4-METHOXYPHENYL)BENZIMIDAZOLE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 1cs7 nuc 3.20 STRONTIUM ION 4(SR 2+) SYNTHETIC DNA HAIRPIN WITH STILBENEDIETHER LINKER 5'-D(GP*(BRU)P*TP*TP*TP*GP*(S02) *CP*AP*AP*AP*AP*C)-3' DNA DNA HAIRPIN 1f1t nuc 2.80 STRONTIUM ION 8(SR 2+) CRYSTAL STRUCTURE OF THE MALACHITE GREEN APTAMER COMPLEXED WITH TETRAMETHYL-ROSAMINE MALACHITE GREEN APTAMER RNA RNA U-TURN, BASE QUADRUPLE, BASE TRIPLE, GNRA TETRALOOP, 5- BROMO-URIDINE, RNA 1j8g nuc 0.61 STRONTIUM ION 8(SR 2+) X-RAY ANALYSIS OF A RNA TETRAPLEX R(UGGGGU)4 AT ULTRA-HIGH R 5'-R(*UP*GP*GP*GP*GP*U)-3' RNA RNA TETRAPLEX, SR IONS, U TETRAD, OCTAPLEX, RNA 1m6g nuc 1.65 STRONTIUM ION 5(SR 2+) STRUCTURAL CHARACTERISATION OF THE HOLLIDAY JUNCTION TCGGTACCGA 5'-D(*TP*CP*GP*GP*TP*AP*CP*CP*GP*A)-3' DNA HOLLIDAY JUNCTION, STRONTIUM DERIVATIVE, FOUR-WAY JUNCTION, DNA 1nuv nuc 1.81 STRONTIUM ION 6(SR 2+) THE LEADZYME RIBOZYME BOUND TO MG(H2O)6(II) AND SR(II) AT 1.8 A RESOLUTION 5'-R(*GP*CP*UP*GP*GP*GP*AP*GP*UP*CP*C)-3', 5'-R(*CP*GP*GP*AP*CP*CP*GP*AP*GP*CP*CP*AP*G)-3' RNA RIBOZYME, LEADZYME, LEAD-DEPENDENT CLEAVAGE, RNA, MG(H2O) 6(II), BULGED NUCLEOTIDES, HYDRATED MAGNESIUM, SR(II), PSEUDOHELICAL PACKING, STICKY ENDS, ALTERNATE CONFORMATION, HOMOPURINE BASE PAIRS 1nvy nuc 1.50 STRONTIUM ION 5(SR 2+) STRONTIUM BOUND TO THE HOLLIDAY JUNCTION SEQUENCE D(TCGGTACCGA)4 D(TCGGTACCGA)4 DNA HOLLIDAY JUNCTION, STRONTIUM, SR2+, DNA 1wv6 nuc 2.55 STRONTIUM ION 5(SR 2+) X-RAY STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2' THYMINE IN PLACE OF T6, SR-FORM 5'-D(*GP*CP*GP*TP*AP*(2BT)P*AP*CP*GP*C)-3' DNA DNA 1ybc nuc 1.80 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (BENZYLOXY)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(BOE)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER 1yrm nuc 2.50 STRONTIUM ION 2(SR 2+) CRYSTAL STRUCTURE OF AN RNA DUPLEX CONTAINING SITE SPECIFIC SUBSTITUTIONS AT A C-A MISMATCH DNA/RNA (5'-R(*GP*CP*AP*GP*A)-D(P*(A5M))- R(P*UP*UP*AP*AP*AP*UP*CP*UP*GP*C)-3') RNA 2'-AMINE, RNA, DUPLEX, MISMATCH 1z7f nuc 2.10 STRONTIUM ION 2(SR 2+) CRYSTAL STRUCTURE OF 16 BASE PAIR RNA DUPLEX CONTAINING A C- 5'-R(*GP*CP*AP*GP*AP*CP*UP*UP*AP*AP*AP*UP*CP*UP*G CHAIN: A, B, C RNA RNA, DUPLEX, MISMATCH 2awe nuc 2.10 STRONTIUM ION SR 2+ BASE-TETRAD SWAPPING RESULTS IN DIMERIZATION OF RNA QUADRUPLEXES: IMPLICATIONS FOR FORMATION OF I-MOTIF RNA OCTAPLEX 5'-R(*UP*(BGM)P*GP*UP*GP*U)-3' RNA RNA, TETRAPLEX, OCTAPLEX 2gb9 nuc 1.70 STRONTIUM ION 2(SR 2+) D(CGTACG)2 CROSSLINKED BIS-ACRIDINE COMPLEX 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA DUPLEX CROSSLINKING 2grb nuc 1.40 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF AN RNA QUADRUPLEX CONTAINING INOSINE- TETRAD 5'-R(*(U33)P*GP*IP*GP*GP*U)-3' RNA RNA QUADRUPLEX 2pn4 nuc 2.32 STRONTIUM ION 10(SR 2+) CRYSTAL STRUCTURE OF HEPATITIS C VIRUS IRES SUBDOMAIN IIA 5'-R(*GP*CP*GP*(5BU) P*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*(5BU)P*CP*CP*GP*G)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 98-117), 5'-R(*CP*GP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*U *CP*AP*CP*GP*CP*C)-3': HCV IRES SUBDOMAIN IIA (RESIDUE 47-70) RNA HCV, IRES, SUBDOAMIN IIA, RNA, STRONTIUM, HEPATITIS 3bnq nuc 2.00 STRONTIUM ION 8(SR 2+) CRYSTAL STRUCTURE OF THE HOMO SAPIENS MITOCHONDRIAL RIBOSOMAL DECODING SITE IN THE PRESENCE OF SRCL2 (A1555G MUTANT, BR-DERIVATIVE) A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, B CHAIN, A SITE OF HUMAN MITOCHONDRIAL RIBOSOME, A CHAIN RNA RIBOSOME, DECODING SITE, RNA 3e5c nuc 2.25 STRONTIUM ION 15(SR 2+) CRYSTAL STRUCTURE OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SAM SMK BOX (SAM-III) RIBOSWITCH RNA SAM RIBOSWITCH SMK SAM-III TRANSLATION REGULATION SD, RNA 3e5e nuc 2.90 STRONTIUM ION 12(SR 2+) CRYSTAL STRUCTURES OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SAH SMK BOX (SAM-III) RIBOSWITCH FOR RNA RNA SMK SAM RIBOSWITCH SHINE-DELGARNO TRANSLATION REGULATION, RNA 3e5f nuc 2.70 STRONTIUM ION 15(SR 2+) CRYSTAL STRUCTURES OF THE SMK BOX (SAM-III) RIBOSWITCH WITH SE-SAM SMK BOX (SAM-III) RIBOSWITCH FOR RNA RNA SMK SAM RIBOSWITCH SHINE-DELGARNO TRANSLATION REGULATION, RNA 3ey3 nuc 1.25 STRONTIUM ION 7(SR 2+) A CONFORMATIONAL TRANSITION IN THE STRUCTURE OF A 2'- THIOMETHYL-MODIFIED DNA VISUALIZED AT HIGH RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*(USM)P*(USM) P*CP*GP*CP*G)-3' DNA MODIFIED DNA DUPLEX, CRYSTAL STRUCTURE, 2'-THIOMETHYL URIDINE, MODIFIED SUGAR 3goo nuc 2.50 STRONTIUM ION 3(SR 2+) STRONTIUM BOUND TO THE HOLLIDAY JUNCTION SEQUENCE D(TCGGCGCCGA)4 5'-D(*TP*CP*GP*GP*CP*GP*CP*CP*GP*A)-3' DNA HOLLIDAY JUNCTION STRUCTURE, DNA 3p4a nuc 1.20 STRONTIUM ION 9(SR 2+) 2'FLUORO MODIFIED RNA OCTAMER FA2U2 2'FLUORO MODIFIED RNA 8-MER RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, 2'-FLUORO 2'- DEOXYADENOSINE, 2'-FLUORO 2'-DEOXYURIDINE, SIRNA 3p4c nuc 1.15 STRONTIUM ION 3(SR 2+) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-R32 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA 3pbx nuc 1.88 STRONTIUM ION SR 2+ STRONTIUM BOUND TO THE SEQUENCE D(CCGGCGCCGG) DNA DNA HOLLIDAY JUNCTION (HIGHER ORDER DNA STRUCTURE), INTERMEDIATE IN HOMOLOGOUS RECOMBINATION, DNA 3sd8 nuc 1.67 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF ARA-FHNA DECAMER DNA 5'-D(*GP*CP*GP*TP*AP*(F4H)P*AP*CP*GP*C)-3' DNA A-FORM DNA, ARA-3'-FLUORO HEXITOL NUCLEIC ACID, ARA-FHNA, AN OLIGONUCLEOTIDES, DNA 3v06 nuc 1.53 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF S-6'-ME-3'-FLUORO HEXITOL NUCLEIC ACID DNA (5'-D(*GP*CP*GP*TP*AP*(F5H)P*AP*CP*GP*C)-3') DNA A-FORM DNA, 3'-FLUORO HEXITOL NUCLEIC ACID, FHNA, S-6'-ME-FH ANTISENSE OLIGONUCLEOTIDES, DNA 434d nuc 1.16 STRONTIUM ION SR 2+ 5'-R(*UP*AP*GP*CP*UP*CP*C)-3', 5'-R(*GP*GP*GP*GP*CP*UP*A)-3' RNA (5'-R(*UP*AP*GP*CP*UP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*GP*CP*UP*A)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM, DOUBLE HELIX 464d nuc 1.23 STRONTIUM ION SR 2+ DISORDER AND TWIN REFINEMENT OF RNA HEPTAMER DOUBLE HELIX RNA (5'-R(*UP*AP*GP*CP*UP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*GP*CP*(IU)P*A)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM, DOUBLE HELIX, RIBONUCLEIC ACID, DISORDERED MODEL 466d nuc 1.16 STRONTIUM ION SR 2+ DISORDER AND TWIN REFINEMENT OF RNA HEPTAMER DOUBLE HELIX RNA (5'-R(*UP*AP*GP*CP*UP*CP*C)-3'), RNA (5'-R(*GP*GP*GP*GP*CP*UP*A)-3') RNA 7 BASE-PAIR TRNA ALA ACCEPTOR STEM, DOUBLE HELIX, RIBONUCLEIC ACID, DISORDERED MODEL 4hqi nuc 1.70 STRONTIUM ION SR 2+ STRUCTURE OF O6-BENZYL-2'-DEOXYGUANOSINE OPPOSITE PERIMIDINO SYNTHETIC NUCLEOSIDE IN DNA DUPLEX SHORT MODIFIED NUCLEIC ACIDS DNA B-FORM DNA, O6-BENZYL-2'-DEOXYGUANOSINE, DPER, PERIMIDINONE- NUCLEOSIDE, DICKERSON-DREW DODECAMER, DNA 4ij0 nuc 1.54 STRONTIUM ION 3(SR 2+) STRUCTURES OF DNA DUPLEXES CONTAINING O6-CARBOXYMETHYLGUANIN LESION ASSOCIATED WITH GASTROINTESTINAL CANCER, REVEAL A ME FOR INDUCING TRANSITION MUTATION DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*CP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, MUTAGENESIS, DNA 4jab nuc 2.23 STRONTIUM ION 5(SR 2+) U/G WOBBLE BASE PAIR IN A RNA DUPLEX RNA (5'-R(*GP*UP*GP*UP*AP*UP*AP*C)-3') RNA U/G WOBBLE PAIR, RNA 4ms9 nuc 1.32 STRONTIUM ION 3(SR 2+) NATIVE RNA-10MER STRUCTURE: CCGGCGCCGG NATIVE RNA DUPLEX 10MER RNA RNA NATIVE DUPLEX 10MER, RNA 4msb nuc 1.55 STRONTIUM ION 7(SR 2+) RNA 10MER DUPLEX WITH TWO 2'-5'-LINKAGES RNA 10MER DUPLEX WITH TWO 2'-5'-LINKAGES RNA 2'-5'-LINKAGE, RNA 4msr nuc 1.20 STRONTIUM ION 5(SR 2+) RNA 10MER DUPLEX WITH SIX 2'-5'-LINKAGES RNA 10MER DUPLEX WITH SIX 2'-5'-LINKAGES RNA 2'-5'-LINKAGE, RNA 4o41 nuc 1.20 STRONTIUM ION 2(SR 2+) AMIDE LINKED RNA AMIDE LINKED RNA RNA MODIFIED RNA, RNA STRUCTURE, AMIDE RNA, AMIDE INTERNUCLEOSID LINKAGE, MODIFIED NUCLEOSIDE, RNA 4o5w nuc 1.60 STRONTIUM ION SR 2+ O6-CARBOXYMETHYLGUANINE IN DNA FORMS A SEQUENCE CONTEXT DEPE WOBBLE BASE PAIR STRUCTURE WITH THYMINE DNA (5'-D(*CP*GP*CP*(C6G)P*AP*AP*TP*TP*TP*GP*CP*G CHAIN: A, B DNA DAMAGED DNA, O6-CARBOXYMETHYLGUANINE, DNA 4rby nuc 1.19 STRONTIUM ION 2(SR 2+) FIRST X-RAY STRUCTURE OF RNA CONTAINING GUANOSINE PHOSPHOROD 5'-R(*CP*GP*CP*(2SG)P*AP*AP*UP*UP*AP*GP*CP*G)-3' RNA PHOSPHORODITHIOATE RNA, GUANOSINE PHOSPHORODITHIOATE, PHOSPHOROTHIOATE, GUANOSINE ANALOGUE, HYDROPHOBIC, BACKBONE 4rj1 nuc 0.92 STRONTIUM ION 5(SR 2+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4rkv nuc 0.88 STRONTIUM ION 6(SR 2+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4rne nuc 1.01 STRONTIUM ION 7(SR 2+) STRUCTURAL VARIATIONS AND SOLVENT STRUCTURE OF UGGGGU QUADRU STABILIZED BY SR2+ IONS RNA (5'-R(*UP*GP*GP*GP*GP*U)-3') RNA RNA QUADRUPLEXES, PARALLEL-STRANDED, RNA 4rum nuc 2.64 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF THE NICO TRANSITION-METAL RIBOSWITCH BO COBALT NICO RIBOSWITCH RNA RNA RNA HELIX, LIGAND SENSOR, COBALT AND NICKEL BINDING, RNA, RI 4tzy nuc 2.57 STRONTIUM ION 7(SR 2+) VIBRIO VULNIFICUS ADENINE RIBOSWITCH VARIANT, GROWN IN BOTH MG2+ VIBRIO VULNIFICUS ADENINE RIBOSWITCH RNA RNA, RIBOSWITCH, GENE REGULATION, ADENINE 4u3p nuc 1.87 STRONTIUM ION 2(SR 2+) OCTAMERIC RNA DUPLEX CO-CRYSTALLIZED WITH STRONTIUM(II)CHLOR RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3') RNA RNA, DUPLEX, DI- AND TRIVALENT METAL IONS 4u6l nuc 1.90 STRONTIUM ION 2(SR 2+) CRYSTAL STRUCTURE OF DNA/RNA DUPLEX OBTAINED IN THE PRESENCE [CO(NH3)6]CL3 AND SRCL2 DNA (5'-D(*(5CM)P*TP*CP*TP*TP*CP*TP*TP*(5CM))-3') CHAIN: B, RNA (5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*G)-3') DNA/RNA DNA/RNA HYBRID DUPLEX, ANTISENSE, DNA-RNA COMPLEX 4y1j nuc 2.24 STRONTIUM ION 52(SR 2+) LACTOCOCCUS LACTIS YYBP-YKOY MN RIBOSWITCH A41U BINDING SITE PRESENCE OF MN2+ YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE-BINDING, MUTANT, RNA 4y1m nuc 3.00 STRONTIUM ION 65(SR 2+) AN ESCHERICHIA COLI YYBP-YKOY MN RIBOSWITCH IN THE MN2+-FREE E. COLI YYBP-YKOY RIBOSWITCH RNA RIBOSWITCH, MANGANESE, FREE STATE, RNA 5cv2 nuc 2.69 STRONTIUM ION 3(SR 2+) STRUCTURAL IMPLICATIONS OF HOMO-PYRIMIDINE BASE PAIRS ON THE STRANDED D(GAY) MOTIF DNA (5'-D(*AP*CP*TP*CP*GP*GP*AP*CP*GP*AP*CP*GP*AP CHAIN: A, B DNA DNA HOMODUPLEX, DNA 5ew4 nuc 1.47 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF C9ORF72 ANTISENSE CCCCGG REPEAT RNA ASS WITH LOU GEHRIG'S DISEASE AND FRONTOTEMPORAL DEMENTIA, CRYS WITH SR2+ RNA (5'- R(*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP*CP*CP*CP*GP*GP*CP 3') RNA REPEAT EXPANSION DISORDER, GENETIC DISEASE, RNA 5gsk nuc 1.05 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF DUPLEX DNA3 IN COMPLEX WITH HG(II) AND DNA (5'-D(*GP*GP*TP*CP*GP*TP*CP*C)-3') DNA METALLO-BASE PAIR, T-HG(II)-T, DNA 5t83 nuc 2.71 STRONTIUM ION 9(SR 2+) STRUCTURE OF A GUANIDINE-I RIBOSWITCH FROM S. ACIDOPHILUS RNA (95-MER) RNA RIBOSWITCH, GUANIDINE, S-TURN, A-MINOR, RNA 5tdj nuc 1.50 STRONTIUM ION SR 2+ RNA DECAMER DUPLEX WITH FOUR 2'-5'-LINKAGES RNA (5'-R(*CP*CP*GP*GP*CP*GP*CP*CP*GP*G)-3') RNA 2'-5'-LINKAGE, RNA, PLANT PROTEIN 5tdk nuc 1.43 STRONTIUM ION 5(SR 2+) RNA DECAMER DUPLEX WITH EIGHT 2'-5'-LINKAGES RNA (5'-R(*CP*CP*GP*GP*CP*GP*CP*CP*GP*G)-3') RNA 2'-5'-LINKAGE, RNA, PLANT PROTEIN 5wsp nuc 1.50 STRONTIUM ION SR 2+ CRYSTAL STRUCTURE OF DNA3 DUPLEX DNA (5'-D(*GP*GP*TP*CP*GP*TP*CP*C)-3') DNA DNA DUPLEX, T:T PAIR, DNA
Code Class Resolution Description 1d0t nuc NMR ADENOSINE -5'-THIO-MONOPHOSPHATE 5(C10 H14 N5 O6 P S) SOLUTION STRUCTURE OF A PHOSPHOROTHIOATE MODIFIED RNA BINDING SITE FOR PHAGE MS2 COAT PROTEIN PHOSPHOROTHIOATE SUBSTITUTED PHAGE MS2 RNA BINDING SITE RNA RNA HAIRPIN, PHOSPHOROTHIOATE, THIOPHOSPHATE, BULGED BASE, STEM-LOOP
Code Class Resolution Description 1nta nuc 2.90 STREPTOMYCIN C21 H39 N7 O12 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RNA-APTAMER 5'-R(*CP*GP*GP*CP*AP*CP*CP*AP*CP*GP*GP*UP*CP*GP*G -3', 5'-R(*GP*GP*AP*UP*CP*GP*CP*AP*UP*UP*UP*GP*GP*AP*C *UP*GP*CP*C)-3' RNA STREPTOMYCIN RNA-APTAMER, BARIUM FORM, RNA 1ntb nuc 2.90 STREPTOMYCIN C21 H39 N7 O12 2.9 A CRYSTAL STRUCTURE OF STREPTOMYCIN RNA-APTAMER COMPLEX 5'- R(*CP*GP*GP*CP*AP*CP*CP*AP*CP*GP*GP*UP*CP*GP*GP*AP*UP*C)- 3', 5'- R(*GP*GP*AP*UP*CP*GP*CP*AP*UP*UP*UP*GP*GP*AP*CP*UP*UP*CP*UP *GP*CP*C)-3' RNA STREPTOMYCIN RNA-APTAMER, MAGNESIUM FORM
Code Class Resolution Description 3tzr nuc 2.21 (8R)-8-[(DIMETHYLAMINO)METHYL]-1-[3-(DIMETHYLAMINO) PROPYL]-1,7,8,9-TETRAHYDROCHROMENO[5,6-D]IMIDAZOL-2- AMINE C18 H29 N5 O STRUCTURE OF A RIBOSWITCH-LIKE RNA-LIGAND COMPLEX FROM THE H VIRUS INTERNAL RIBOSOME ENTRY SITE 5'-R(*CP*GP*AP*GP*GP*AP*AP*CP*UP*AP*CP*UP*GP*UP*C *CP*C)-3', 5'-R(*GP*GP*UP*CP*GP*UP*GP*CP*AP*GP*CP*CP*UP*CP*G CHAIN: B RNA INTERNAL LOOP, REGULATORY MOTIF, AMINOBENZIMIDAZOLE BINDING,
Code Class Resolution Description 455d nuc 1.43 DITHIOBIS-(PROPANE) C6 H14 S2 A6/A18 INTER-STRAND DITHIOBIS(PROPANE)-CROSSLINKED DODECAMER (CGCGAATTCGCG)2 DNA (5'-D(*CP*GP*CP*GP*AP*(SSP) AP*TP*TP*CP*GP*CP*G)-3') DNA INTER-STRAND CROSSLINKING, DODECAMER CGCGAATTCGCG/CGCGAATTCGCG, DEOXYRIBONUCLEIC ACID, DNA
Code Class Resolution Description 1nz1 nuc NMR URIDINE-5'-PHOSPHOROTHIOATE C9 H13 N2 O8 P S SOLUTION STRUCTURE OF THE S. CEREVISIAE U6 INTRAMOLECULAR STEM-LOOP CONTAINING AN SP PHOSPHOROTHIOATE AT NUCLEOTIDE U80 SP U6 INTRAMOLECULAR STEM-LOOP RNA RNA U6 RNA, STEM-LOOP, PHOSPHOROTHIOATE, SP PHOSPHOROTHIOATE, RESIDUAL DIPOLAR COUPLING, RDC 357d nuc 3.50 URIDINE-5'-PHOSPHOROTHIOATE C9 H13 N2 O8 P S 3.5 A STRUCTURE OF FRAGMENT I FROM E. COLI 5S RRNA RNA-DNA (5'-R(*UP*GP*DCP)-D(*CP(S)*)- R(*UP*GP*GP*CP*GP*GP*C)-3'), RNA (5'- R(*CP*CP*GP*AP*UP*GP*GP*UP*AP*GP*UP*GP*UP*GP*GP*GP*G*UP*C)- 3'), RNA (5'- R(*CP*CP*CP*CP*AP*UP*GP*CP*GP*AP*GP*AP*GP*UP*AP*GP*G P*GP*AP*AP*CP*UP* GP*CP*CP*AP*GP*GP*CP*AP*U)-3') RNA U-RNA, DOUBLE HELIX, KINKED, INTERNAL LOOP, OVERHANGING BASE, MODIFIED, MISMATCHED
Code Class Resolution Description 4ts0 nuc 2.80 SUCROSE 4(C12 H22 O11) CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH BARIUM IONS SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT, SPINACH RNA APTAMER, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA 4ts2 nuc 2.88 SUCROSE C12 H22 O11 CRYSTAL STRUCTURE OF THE SPINACH RNA APTAMER IN COMPLEX WITH MAGNESIUM IONS SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT, SPINACH APTAMER RNA, BIMOLECULAR CONSTRUCT RNA APTAMER, FLUORESCENCE, G-QUADRUPLEX, RNA
Code Class Resolution Description 2k7e nuc NMR 1-(BETA-D-RIBOFURANOSYL)-2-THIO-URACIL-5'-PHOSPHATE C9 H13 N2 O8 P S NMR STRUCTURE OF THE HUMAN TRNALYS3 BOUND TO THE HIV GENOME LOOP I RNA (5'-R(*GP*CP*GP*GP*UP*GP*UP*AP*AP*AP*AP*G)- 3'), RNA (5'-R(*CP*UP*(SUR)P*UP*UP*AP*AP*(PSU) P*CP*UP*GP*C)-3') RNA RNA, TRNALYS3, PSEUDOURIDINE, HIV, 2-THIOURIDINE, S2U, PSU, MODIFICATIONS 4u34 nuc 1.35 1-(BETA-D-RIBOFURANOSYL)-2-THIO-URACIL-5'-PHOSPHATE C9 H13 N2 O8 P S CRYSTAL STRUCTURES OF RNA DUPLEXES CONTAINING 2-THIO-URIDINE RNA (5'-R(*GP*GP*AP*GP*CP*UP*A)-3'), RNA (5'-R(*UP*AP*GP*CP*(SUR)P*CP*C-3') RNA RNA, 2-THIO-URIDINE 4u35 nuc 1.55 1-(BETA-D-RIBOFURANOSYL)-2-THIO-URACIL-5'-PHOSPHATE C9 H13 N2 O8 P S CRYSTAL STRUCTURES OF RNA DUPLEXES CONTAINING 2-THIO-URIDINE RNA (5'-R(*GP*GP*UP*GP*CP*UP*A)-3'), RNA (5'-R(*UP*AP*GP*CP*(SUR)P*CP*C-3') RNA RNA, 2-THIO-URIDINE
Code Class Resolution Description 4nyc nuc 3.15 THIENO[2,3-B]PYRAZIN-7-AMINE C6 H5 N3 S CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX THIENO[2,3-B]PYRAZIN-7-AMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
Code Class Resolution Description 1dpl nuc 0.83 2'-O-METHYL-3'-METHYL-3'-DEOXY-ARABINOFURANOSYL- THYMINE-5'-PHOSPHATE 2(C12 H19 N2 O8 P) A-DNA DECAMER GCGTA(T23)TACGC WITH INCORPORATED 2'-METHOXY- 3'-METHYLENEPHOSPHATE-THYMIDINE 5'-D(*GP*CP*GP*TP*AP*(T23)P*AP*CP*GP*C)-3' DNA MODIFIED A-DECAMER AT 0.83 A RESOLUTION, DEOXYRIBONUCLEIC ACID, DNA 1i0j nuc 1.06 2'-O-METHYL-3'-METHYL-3'-DEOXY-ARABINOFURANOSYL- THYMINE-5'-PHOSPHATE 2(C12 H19 N2 O8 P) 1.06 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE (T23) THYMINE IN PLACE OF T6, HIGH CS-SALT 5'-D(*GP*CP*GP*TP*AP*(T23)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA 1i0o nuc 2.00 2'-O-METHYL-3'-METHYL-3'-DEOXY-ARABINOFURANOSYL- THYMINE-5'-PHOSPHATE 2(C12 H19 N2 O8 P) 1.6 A STRUCTURE OF THE A-DECAMER GCGTATACGC WITH A SINGLE 2'-O-METHYL-3'-METHYLENEPHOSPHONATE THYMINE IN PLACE OF T6, HIGH K-SALT 5'-D(*GP*CP*GP*TP*AP*(T23)P*AP*CP*GP*C)-3' DNA A-FORM DOUBLE HELIX, MODIFIED SUGAR, DNA
Code Class Resolution Description 1k8l nuc NMR THYMIDINE-5'-DITHIOPHOSPHORATE C10 H15 N2 O6 P S2 XBY6: AN ANALOG OF CK14 CONTAINING 6 DITHIOPHOSPHATE GROUPS FIRST STRAND OF CK14 DNA DUPLEX: DITHIOATED AT T10, C11, SECOND STRAND OF CK14 DNA DUPLEX: DITHIOATED AT G17, C22, C24, G27 DNA XBY6, CK14, CK1, PHOSPHORODITHIOATE, NF-KB, DNA
Code Class Resolution Description
2gun nuc 2.80 [(2S,3S,5R)-3-[(2S)-3-({[(2R,3S,4R,5R)-3-HYDROXY-4- METHOXY-5-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL)TETRAHYDROFURAN-2-YL]METHYL}AMINO)-2-METHYL- 3-OXOPROPYL]-5-(5-METHYL-2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN-2-YL]METHYL DIH C25 H36 N5 O13 P RNA-BINDING AFFINITIES AND CRYSTAL STRUCTURE OF OLIGONUCLEOTIDES CONTAINING FIVE-ATOM AMIDE-BASED BACKBONE STRUCTURES 5'-D(*TP*TP*CP*(T2T)P*(CBR)P*TP*TP*C)-3', 5'-R(*GP*AP*AP*GP*AP*AP*GP*AP*A)-3' DNA/RNA DNA:RNA HYBRID, AMIDE BEARING DNA, THYMIDINE DIMERS, INTERNUCLEOSIDIC AMIDE LINKAGE, DNA, RNA, DNA/RNA COMPLEX
Code Class Resolution Description 1dau nuc NMR 6'-ALPHA-METHYL CARBOCYCLIC THYMIDINE 5'-MONOPHOSPHATE 4(C12 H19 N2 O7 P) ANALOG OF DICKERSON-DREW DNA DODECAMER WITH 6'-ALPHA-METHYL CARBOCYCLIC THYMIDINES, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(T32)P*(T32) P*CP*GP*CP*G)-3') DNA DNA, CARBOCYCLIC, DODECAMER, DEOXYRIBONUCLEIC ACID, NMR, MINIMIZED AVERAGE STRUCTURE 290d nuc 2.50 6'-ALPHA-METHYL CARBOCYCLIC THYMIDINE 5'-MONOPHOSPHATE 4(C12 H19 N2 O7 P) CRYSTAL STRUCTURES OF OLIGODEOXYRIBONUCLEOTIDES CONTAINING 6'-ALPHA-METHYL AND 6'-ALPHA-HYDROXY CARBOCYCLIC THYMIDINES DNA (5'-D(*CP*GP*CP*GP*AP*AP*(T32)P*(T32) P*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, CARBOCYCLUS, ANTISENSE
Code Class Resolution Description 410d nuc 1.60 2'-O-ETHOXYMETHYLENE THYMIDINE 5'-MONOPHOSPHATE 2(C13 H21 N2 O10 P) DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O- ETHOXYMETHYLENE RIBONUCLEOSIDE DNA (5'-D(*GP*CP*GP*TP*AP*(T38)P*AP*CP*GP*C)-3') DNA DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O- ETHOXYMETHYLENE RIBONUCLEOSIDE, DNA
Code Class Resolution Description 2m39 nuc NMR 2'-O-METHOXYETHYLENE THYMIDINE 5'-MONOPHOSPHATE 4(C13 H21 N2 O10 P) THE SOLUTION STRUCTURE OF 3',5'-LINKED 2'-O-(2-METHOXYETHYL) DUPLEX RNA (5'-R(*(C5L)P*(G48)P*(C5L)P*(G48)P*(A44)P*(A4 P*(T39)P*(C5L)P*(G48)P*(C5L)P*DG)-3') RNA DUPLEX, (3',5')-RNA, 2'-O-(2-METHOXYETHYL) RIBOSE, RNA 411d nuc 1.93 2'-O-METHOXYETHYLENE THYMIDINE 5'-MONOPHOSPHATE 2(C13 H21 N2 O10 P) DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O-METHOXYET RIBONUCLEOSIDE DNA (5'-D(*GP*CP*GP*TP*AP*(T39)P*AP*CP*GP*C)-3') DNA DUPLEX [5'-D(GCGTA+TACGC)]2 WITH INCORPORATED 2'-O-METHOXYET RIBONUCLEOSIDE, DNA
Code Class Resolution Description 1c2q nuc NMR THYMIDINE-3'-PHOSPHATE C10 H15 N2 O8 P SOLUTION STRUCTURE OF A DNA.RNA HYBRID CONTAINING AN ALPHAT- ANOMERIC THYMIDINE AND POLARITY REVERSALS 5'-R(GAGCACCAU)-3', 5'-D(ATGG-3'-3'-(T3P)-5'-5'-GCTC)-3' DNA-RNA HYBRID DNA/RNA HYBRID, ALPHAT-ANOMERIC THYMIDINE, 3'-3'/5'-5' PHOSPHODIESTER LINKAGES, DNA-RNA HYBRID
Code Class Resolution Description 214d nuc NMR 1-(2-O-METHYL-BETA-D-ARABINOFURANOSYL)THYMIDINE 5'- MONOPHOSPHATE C11 H17 N2 O9 P THE SOLUTION STRUCTURE OF A DNA DUPLEX CONTAINING A SINGLE 2'-O-METHYL-BETA-D-ARAT DNA (5'-D(*CP*GP*CP*AP*TP*AP*TP*AP*GP*CP*C)-3'), DNA (5'-D(*GP*GP*CP*TP*AP*(T41)P*AP*TP*GP*CP*G)- 3') DNA DNA, NMR, DOUBLE HELIX
Code Class Resolution Description 291d nuc 2.14 6'-ALPHA-HYDROXY CARBOCYCLIC THYMIDINE 5'- MONOPHOSPHATE 4(C11 H17 N2 O8 P) CRYSTAL STRUCTURES OF OLIGODEOXYRIBONUCLEOTIDES CONTAINING 6'-ALPHA-METHYL AND 6'-ALPHA-HYDROXY CARBOCYCLIC THYMIDINES DNA (5'-D(*CP*GP*CP*GP*AP*AP*(T48)P*(T48) P*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED, CARBOCYCLUS, ANTISENSE
Code Class Resolution Description 233d nuc 2.40 S4'-2'DEOXYTHYMIDINE 5'-MONOPHOSPHATE 4(C10 H15 N2 O7 P S) THE CRYSTAL STRUCTURE ANALYSIS OF D(CGCGAASSCGCG)2: A SYNTHETIC DNA DODECAMER DUPLEX CONTAINING FOUR 4'-THIO-2'- DEOXYTHYMIDINE NUCLEOTIDES DNA (5'-D(*CP*GP*CP*GP*AP*AP*)-D(*(T49)P*(T49) P*)-D(*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 2rmq nuc NMR S4'-2'DEOXYTHYMIDINE 5'-MONOPHOSPHATE 4(C10 H15 N2 O7 P S) SOLUTION STRUCTURE OF FULLY MODIFIED 4'-THIODNA WITH THE SEQUENCE OF D(CGCGAATTCGCG) DNA (5'-D(*(C4S)P*(S4G)P*(C4S)P*(S4G)P*(S4A) P*(S4A)P*(T49)P*(T49)P*(C4S)P*(S4G)P*(C4S)P*(S4G))-3') DNA 4'-THIODNA, A-FORM
Code Class Resolution Description 2nsk nuc 1.50 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-4-HYDROSELENO-5-METHYLPYRIMIDIN-2(1H)- ONE C10 H15 N2 O7 P SE DOUBLED MODIFIED SELENIUM DNA 5'-D(*GP*(UMS)P*GP*(T4S)P*AP*CP*AP*C)-3' DNA DOUBLE MODIFIED SE-DNA, MAD/SAD PHASING
Code Class Resolution Description
3t5e nuc 2.10 2,7-BIS[4-(4-METHYLPIPERAZIN-1-YL)BUTYL]-4,9-BIS{[4-(4- METHYLPIPERAZIN-1-YL)BUTYL]AMINO}BENZO[LMN][3, 8]PHENANTHROLINE-1,3,6,8(2H,7H)-TETRONE C50 H80 N12 O4 CRYSTAL STRUCTURE OF AN INTRAMOLECULAR HUMAN TELOMERIC DNA G QUADRUPLEX BOUND BY THE NAPHTHALENE DIIMIDE BMSG-SH-4 HUMAN TELOMERIC DNA SEQUENCE DNA G-QUADRUPLEX, INTRAMOLECULAR, LIGAND-COMPLEX, TELOMERIC, DNA
Code Class Resolution Description 3ijk nuc 1.30 2'-DEOXY-5-METHOXYURIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H15 N2 O9 P 5-OME MODIFIED DNA 8MER 5'-D(*GP*(UMS)P*GP*(T5O)P*AP*CP*AP*C)-3' DNA SELENIUM, DNA, 5-METHOXY-URIDINE 3ltr nuc 1.30 2'-DEOXY-5-METHOXYURIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H15 N2 O9 P 5-OME-DU CONTAINING DNA 8MER 5'-D(*GP*(UMS)P*GP*(T5O)P*AP*CP*AP*C)-3' DNA DNA, OLIGONUCLEOTIDE, 2'-SEME, 5-OME, SELENIUM, 5-METHOXY-UR
Code Class Resolution Description 3bm0 nuc 1.80 2'-DEOXY-5-(METHYLSELANYL)URIDINE 5'-PHOSPHATE C10 H15 N2 O8 P SE STRUCTURE OF DNA OCTAMER G(DUSE)G(5-SEDU)ACAC 5'-D(*GP*(2'-SE-U)P*GP*(5-SE-U)P*AP*CP*AP*C)-3' DNA SELENIUM MODIFIED DNA/RNA 3ltu nuc 1.40 2'-DEOXY-5-(METHYLSELANYL)URIDINE 5'-PHOSPHATE C10 H15 N2 O8 P SE 5-SEME-DU CONTAINING DNA 8MER 5'-D(*GP*(UMS)P*GP*(T5S)P*AP*CP*AP*C)-3' DNA DNA, OLIGONUCLEOTIDE, 5-SEME, SELENIUM, 5-METHOXY-URIDINE 4rhd nuc 1.70 2'-DEOXY-5-(METHYLSELANYL)URIDINE 5'-PHOSPHATE 8(C10 H15 N2 O8 P SE) DNA DUPLEX WITH NOVEL ZP BASE PAIR DNA 9MER NOVEL Z NUCLEOBASE, DNA 9MER NOVEL P NUCLEOBASE DNA MODIFIED NUCLEOBASE Z AND P, DNA
Code Class Resolution Description 1nr8 nuc 1.66 2-AMINOETHYLLYSINE-CARBONYLMETHYLENE-THYMINE C15 H25 N5 O5 THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX
Code Class Resolution Description 1feq nuc NMR N-[N-(9-B-D-RIBOFURANOSYLPURIN-6-YL) CARBAMOYL]THREONINE-5'-MONOPHOSPHATE C15 H21 N6 O11 P NMR SOLUTION STRUCTURE OF THE ANTICODON OF TRNA(LYS3) WITH T6A MODIFICATION AT POSITION 37 5'-R(*GP*CP*AP*GP*AP*CP*UP*UP*UP*UP*(T6A) P*AP*UP*CP*UP*GP*C)-3': ANTICODON (RESIDUES 27-43) OF TRNA(LYS3) WITH T6A MODIFICATION AT POSITION 37 RNA TRNA, ANTICODON STEM LOOP, TRNA DOMAIN, RNA HAIRPIN, T6A 1fl8 nuc NMR N-[N-(9-B-D-RIBOFURANOSYLPURIN-6-YL) CARBAMOYL]THREONINE-5'-MONOPHOSPHATE C15 H21 N6 O11 P HYPERMODIFIED NUCLEOSIDES IN THE ANTICODON OF TRNALYS STABILIZE A CANONICAL U-TURN STRUCTURE ANTICODON DOMAIN OF TRNA(LYS): 17-MER TRNA(LYS) ANTICODON DOMAIN RNA TRNA, ANTICODON, PSEUDOURIDINE, MNM5S2U, T6A 1yfg nuc 3.00 N-[N-(9-B-D-RIBOFURANOSYLPURIN-6-YL) CARBAMOYL]THREONINE-5'-MONOPHOSPHATE C15 H21 N6 O11 P YEAST INITIATOR TRNA YEAST INITIATOR TRNA T-RNA AMINO ACID TRANSPORT, TRANSFER RIBONUCLEIC ACID, T-RNA 2g1g nuc NMR N-[N-(9-B-D-RIBOFURANOSYLPURIN-6-YL) CARBAMOYL]THREONINE-5'-MONOPHOSPHATE C15 H21 N6 O11 P SOLUTION STRUCTURE OF THE ANTICODON LOOP OF S. POMBE TRNAI INCLUDING THE NATURALLY OCCURRING N6-THREONYL ADENINE 5'-R(*AP*CP*GP*GP*GP*CP*UP*CP*AP*UP*(T6A) P*AP*CP*CP*CP*GP*U)-3' RNA T-RNAI ANTICODONLOOP T6A
Code Class Resolution Description 1qkg nuc NMR (4S,5R)-3-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-5-METHYL-1,3- DIAZABICYCLO[2.2.0]HEXAN-2-ONE C10 H17 N2 O7 P DNA DECAMER DUPLEX CONTAINING T-T DEWAR PHOTOPRODUCT DNA (5'-D(*CP*GP*CP*AP*(HYD)TP*+TP*AP*CP*GP*C)- 3'), DNA (5'-D(*GP*CP*GP*TP*GP*AP*TP*GP*CP*G)-3') DNA DEOXYRIBONUCLEIC ACID, DNA PHOTOPRODUCT, DEWAR PRODUCT, (6-4) ADDUCT, MUTAGENESIS, TRANSLESION REPLICATION
Code Class Resolution Description 1dpn nuc 0.95 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 2(C10 H14 F N2 O8 P) B-DODECAMER CGCGAA(TAF)TCGCG WITH INCORPORATED 2'-DEOXY-2'- FLUORO-ARABINO-FURANOSYL THYMINE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA 0.95 A RESOLUTION STRUCTURE, DNA 1fc8 nuc NMR 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE C10 H14 F N2 O8 P NMR SOLUTION STRUCTURE OF A CHIMERIC OLIGONUCLEOTIDE HAIRPIN R(GGAC)D(TTCG)2'F-A(GTCC) 5'-R(*GP*GP*AP*CP)D(*TP*TP*CP*GP*(GFL)P*(TAF) P*(CFL)P*(CFL))-3' RNA/DNA CHIMERA 2'F-ARABINONUCLEIC ACID, RNA, DNA, HYBRID DUPLEX, HAIRPIN, RNA/DNA CHIMERA COMPLEX 2fil nuc 1.69 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 4(C10 H14 F N2 O8 P) CRYSTAL STRUCTURE ANALYSIS OF THE A-DNA DECAMER GCGT-2'OMEA- WITH INCORPORATED 2'-O-METHYLATED-ADENOSINE (2'OMEA) AND 2' FLUOROARABINO-THYMIDINE (FAT) 5'-D(*GP*CP*GP*TP*(A2M)P*(TAF)P*AP*CP*GP*C)-3' DNA 2'-FLUOROARABINO ACID, SUGAR MODIFICATIONS, A-FORM DNA, DNA 2kp4 nuc NMR 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 3(C10 H14 F N2 O8 P) STRUCTURE OF 2'F-ANA/RNA HYBRID DUPLEX DNA (5'-D(*(GFL)P*(CFL)P*(TAF)P*(A5L)P*(TAF)P*(A5 P*(TAF)P*(GFL)P*(GFL))-3'), RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3') DNA/RNA 2-DEOXY-2-FLUORO-D-ARABINOSE, FANA, NUCLEIC ACID STRUCTURE, NMR/MD/TI, HYBRID DUPLEX, DNA-RNA COMPLEX 2m84 nuc NMR 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 4(C10 H14 F N2 O8 P) STRUCTURE OF 2'F-RNA/2'F-ANA CHIMERIC DUPLEX 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA 2'F-RNA/2'F-ANA CHIMERIC DUPLEX, A-FORM, 12-MER, DICKERSON D DODECAMER, MODIFIED NUCLEOTIDES, DNA, RNA 2m8a nuc NMR 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 2(C10 H14 F N2 O8 P) 2'F-ANA/2'F-RNA ALTERNATED SEQUENCES 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA A-FORM, 12-MER, DICKERSON DREW DODECAMER, MODIFIED NUCLEOTID RNA 388d nuc 1.55 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 4(C10 H14 F N2 O8 P) CRYSTAL STRUCTURE OF B-DNA WITH INCORPORATED 2'-DEOXY-2'- FLUORO-ARABINO-FURANOSYL THYMINES: IMPLICATIONS OF CONFORMATIONAL PREORGANIZATION FOR DUPLEX STABILITY DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*(TAF) P*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 389d nuc 1.55 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 2(C10 H14 F N2 O8 P) CRYSTAL STRUCTURE OF B-DNA WITH INCORPORATED 2'-DEOXY-2'- FLUORO-ARABINO-FURANOSYL THYMINES: IMPLICATIONS OF CONFORMATIONAL PREORGANIZATION FOR DUPLEX STABILITY DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DOUBLE HELIX, MODIFIED 436d nuc 1.10 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 2(C10 H14 F N2 O8 P) THE DICKERSON-DREW B-DNA DODECAMER REVISITED-AT ATOMIC RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*TP*CP*GP*CP*G)-3' DNA B-DNA DODECAMER, HIGH RESOLUTION 460d nuc 1.20 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 2(C10 H14 F N2 O8 P) A "HYDRAT-ION SPINE" IN A B-DNA MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DODECAMER DUPLEX, TYPE 1 RB+ FORM CRYSTAL 461d nuc 1.50 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 2(C10 H14 F N2 O8 P) A "HYDRAT-ION SPINE" IN A B-DNA MINOR GROOVE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TAF) P*TP*CP*GP*CP*G)-3') DNA B-DNA, DODECAMER DUPLEX, TYPE 2 RB+ FORM CRYSTAL 478d nuc 2.20 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE 2(C10 H14 F N2 O8 P) CRYSTAL STRUCTURE OF THE B-DNA DODECAMER 5'-D(CGCGAA(TAF)TCG TAF IS 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE 5'-D(*CP*GP*CP*GP*AP*AP*(TAF)P*TP*CP*GP*CP*G)-3' DNA B-DNA DODECAMER DUPLEX, CALCIUM CRYSTAL FORM, DNA 5mjx nuc NMR 2'-DEOXY-2'-FLUORO-ARABINO-FURANOSYL THYMINE-5'- PHOSPHATE C10 H14 F N2 O8 P 2'F-ANA/DNA CHIMERIC TBA QUADRUPLEX STRUCTURE DNA (5'-D(*GP*GP*(FT)P*TP*GP*GP*TP*GP*TP*GP*GP*TP 3') DNA 2'F-ANA/DNA TBA STRUCTURE, STRUCTURE FROM MOLMOL, DNA
Code Class Resolution Description 1fj5 nuc NMR (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N- DIMETHYLETHANAMINIUM C26 H30 N O 1+ TAMOXIFEN-DNA ADDUCT DNA (5'-D(*GP*GP*TP*AP*GP*CP*GP*AP*TP*GP*G)-3'), DNA (5'-D(*CP*CP*AP*TP*CP*GP*CP*TP*AP*CP*C)-3') DNA COVALENT DNA-TAMOXIFEN COMPLEX; GROOVE BINDING; LOCALIZED HELICAL PERTURBATION; WIDENED MINOR GROOVE
Code Class Resolution Description 359d nuc 2.90 TERBIUM(III) ION 5(TB 3+) INHIBITION OF THE HAMMERHEAD RIBOZYME CLEAVAGE REACTION BY SITE-SPECIFIC BINDING OF TB(III) RNA HAMMERHEAD RIBOZYME, RNA HAMMERHEAD RIBOZYME RIBOZYME RNA HAMMERHEAD RIBOZYME, CATALYTIC RNA, LOOP 4u47 nuc 1.95 TERBIUM(III) ION 2(TB 3+) OCTAMERIC RNA DUPLEX SOAKED IN TERBIUM(III)CHLORIDE RNA (5'-R(*UP*CP*GP*UP*AP*CP*GP*A)-3') RNA RNA, DUPLEX, DI- AND TRIVALENT METAL IONS
Code Class Resolution Description 1n8c nuc NMR (9S,10R)-9-HYDROXY-7,8,9,10-TETRAHYDROBENZO[A]PYRENE C20 H16 O SOLUTION STRUCTURE OF A CIS-OPENED (10R)-N6-DEOXYADENOSINE ADDUCT OF (9S,10R)-(9,10)-EPOXY-7,8,9,10- TETRAHYDROBENZO[A]PYRENE IN A DNA DUPLEX 5'-D(*CP*GP*GP*TP*CP*AP*CP*GP*AP*GP*G)-3', 5'-D(*CP*CP*TP*CP*GP*TP*GP*AP*CP*CP*G)-3' DNA BENZO[A]PYRENE, 7,8,9,10-TETRAHYDROBENZO[A]PYRENE, DNA
Code Class Resolution Description 1djd nuc NMR 8,9,10,11-TETRAHYDRO-BENZO[A]ANTHRACENE-8,9,10-TRIOL C18 H16 O3 THE SOLUTION STRUCTURE OF A NON-BAY REGION 11R- BENZ[A]ANTHRACENE OXIDE ADDUCT AT THE N6 POSITION OF ADENINE OF AN OLIGODEOXYNUCLEOTIDE CONTAINING THE HUMAN N- RAS CODON 61 SEQUENCE DNA(5'-D(*CT*GT*GT*AT*CT*AT*AT*GT*AT*AT*G)-3'), DNA(5'-D(*CT*TT*TT*CT*TT*TT*GT*TT*CT*CT*G)-3') DNA BENZ[A]ANTHRACENE-DNA DUPLEX
Code Class Resolution Description 263d nuc 2.20 2''-(4-METHOXYPHENYL)-5-(3-AMINO-1-PYRROLIDINYL)-2,5', 2',5''-TRI-BENZIMIDAZOLE C32 H29 N8 O 1+ ISOHELICITY AND PHASING IN DRUG-DNA SEQUENCE RECOGNITION: CRYSTAL STRUCTURE OF A TRIS(BENZIMIDAZOLE)-OLIGONUCLEOTIDE COMPLEX DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 459d nuc 2.30 2''-(4-METHOXYPHENYL)-5-(3-AMINO-1-PYRROLIDINYL)-2,5', 2',5''-TRI-BENZIMIDAZOLE C32 H29 N8 O 1+ DNA MINOR-GROOVE RECOGNITION OF A TRIS-BENZIMIDAZOLE DRUG DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*AP*TP*GP*CP*G)- 3'), DNA (5'-D(*CP*GP*(CBR) P*AP*TP*AP*TP*TP*TP*GP*CP*G)-3') DNA MINOR GROOVE BINDING, B-DNA, COMPLEXED WITH TRIS- BENZIMIDAZOLE, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1tuq nuc NMR 3-(5-PHOSPHO-2-DEOXY-BETA-D-RIBOFURANOSYL)-2-OXO-1,3- DIAZA-PHENOTHIAZINE 2(C15 H16 N3 O7 P S) NMR STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CTCTCACGTGGAG WITH A TRICYCLIC CYTOSIN BASE ANALOGUE 5'-D(P*CP*TP*CP*(TC1)P*AP*CP*GP*TP*GP*GP*AP*G)- 3' DNA FLUORESCENT DNA BASE ANALOGUE, B-FORM DNA
Code Class Resolution Description 1ac3 nuc NMR 5'-METHYLTHYMIDINE C11 H16 N2 O5 SOLUTION STRUCTURE OF AN RNA-DNA HYBRID DUPLEX CONTAINING A 3'-THIOFORMACETAL LINKER AND AN RNA A-TRACT, NMR, 8 STRUCTURES DNA (5'-D(*(TCP)P*TP*GP*CP*GP*C)-3'), ANTISENSE HYBRID DUPLEX DNA/RNA HYBRID STRUCTURE, NMR, RNA, DNA, ANTISENSE OLIGONUCLEOTIDES, THIOFORMACETAL BACKBONE MODIFICATION, HYBRID DUPLEX, DNA/RNA HYBRID COMPLEX
Code Class Resolution Description 2rf3 nuc 1.75 (2R,3AS,4AR,5AR,5BS)-2-(6-AMINO-9H-PURIN-9-YL)-3A- HYDROXYHEXAHYDROCYCLOPROPA[4,5]CYCLOPENTA[1,2-B]FURAN- 5A(4H)-YL DIHYDROGEN PHOSPHATE 2(C13 H16 N5 O6 P) CRYSTAL STRUCTURE OF TRICYCLO-DNA: AN UNUSUAL COMPENSATORY CHANGE OF TWO ADJACENT BACKBONE TORSION ANGLES 5'-D(CGCG(TCY)ATTCGCG)-3' DNA DNA DUPLEX, X-RAY CRYSTAL STRUCTURE, TRICYCLO-DNA, CONFORMATIONALLY CONSTRAINED DNA ANALOG
Code Class Resolution Description 1bd1 nuc 1.60 TRIETHYLAMMONIUM ION 2(C6 H16 N 1+) CRYSTALLOGRAPHIC STUDY OF ONE TURN OF G/C-RICH B-DNA DNA (5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G)-3') DNA B-DNA, DOUBLE HELIX
Code Class Resolution Description 1p9x nuc 3.40 TELITHROMYCIN C43 H65 N5 O10 THE CRYSTAL STRUCTURE OF THE 50S LARGE RIBOSOMAL SUBUNIT FROM DEINOCOCCUS RADIODURANS COMPLEXED WITH TELITHROMYCIN KETOLIDE ANTIBIOTIC 23S RIBOSOMAL RNA RIBOSOME RIBOSOMES, TRNA, KETOLIDE, MACROLIDE, ANTIBIOTIC, EXIT- TUNNEL, BLOCKAGE
Code Class Resolution Description 1eht nuc NMR THEOPHYLLINE C7 H8 N4 O2 THEOPHYLLINE-BINDING RNA IN COMPLEX WITH THEOPHYLLINE, NMR, 10 STRUCTURES THEOPHYLLINE-BINDING RNA: BINDING FRAGMENT, RESIDUES 1 - 33 RNA RIBONUCLEIC ACID, RNA 1o15 nuc NMR THEOPHYLLINE C7 H8 N4 O2 THEOPHYLLINE-BINDING RNA IN COMPLEX WITH THEOPHYLLINE, NMR, REGULARIZED MEAN STRUCTURE, REFINEMENT WITH TORSION ANGLE AND BASE-BASE POSITIONAL DATABASE POTENTIALS AND DIPOLAR COUPLINGS THEOPHYLLINE-BINDING RNA RNA RIBONUCLEIC ACID, RNA
Code Class Resolution Description 336d nuc 1.00 N-(3-AMINO-PROPYL)-N-(5-AMINOPROPYL)-1,4-DIAMINOBUTANE 2(C10 H26 N4) INTERACTION BETWEEN LEFT-HANDED Z-DNA AND POLYAMINE-3 THE CRYSTAL STRUCTURE OF THE D(CG)3 AND THERMOSPERMINE COMPLEX DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA Z-DNA, DOUBLE HELIX
Code Class Resolution Description 1y8l nuc 1.50 2'-O-[2-(TRIFLUORO)ETHYL] THYMIDINE-5'-MONOPHOSPHATE 2(C12 H16 F3 N2 O9 P) CRYSTAL STRUCTURE OF THE A-DNA GCGTAT*CGC WITH A 2'-O-[2- (TRIFLUORO)ETHYL] THYMIDINE (T*) 5'-D(*GP*CP*GP*TP*AP*(TFE)P*AP*CP*GP*C)-3') DNA CRYSTAL STRUCTURE, A-DNA, O2'-MODIFICATION, DECAMER
Code Class Resolution Description 1n1o nuc 1.20 (L)-ALPHA-THREOFURANOSYL-THYMINE-3'-MONOPHOSPHATE 2(C9 H13 N2 O8 P) CRYSTAL STRUCTURE OF A B-FORM DNA DUPLEX CONTAINING (L)- ALPHA-THREOFURANOSYL (3'-2') NUCLEOSIDES: A FOUR-CARBON SUGAR IS EASILY ACCOMMODATED INTO THE BACKBONE OF DNA 5'-D(*CP*GP*CP*GP*AP*AP*(TFT)P*TP*CP*GP*CP*G)-3' DNA B-DNA, HYDROGEN BONDING, NUCLEIC ACID ETIOLOGY, TETROSE, FOUR-CARBON SUGAR, X-RAY CRYSTALLOGRAPHY, NUCLEIC ACID ANALOGUE
Code Class Resolution Description 3sux nuc 2.90 5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID C20 H23 N7 O7 CRYSTAL STRUCTURE OF THF RIBOSWITCH, BOUND WITH THF RIBOSWITCH RNA THREE-WAY JUNCTION, PSEUDOKNOT, GENE REGULATOR, THF, RNA
Code Class Resolution Description 4r8j nuc 1.21 THYMIDINE C10 H14 N2 O5 D(TCGGCGCCGA) WITH LAMBDA-[RU(TAP)2(DPPZ)]2+ SOAKED IN D2O DNA (5'-D(*(THM)P*CP*GP*GP*CP*GP*CP*CP*GP*A)-3') DNA DNA KINKING, INFRA-RED, RUTHENIUM, DNA 5et2 nuc 1.39 THYMIDINE C10 H14 N2 O5 LAMBDA-RU(TAP)2(DPPZ)]2+ BOUND TO D(TTGGCGCCAA) DNA (5'-D(*(THM)P*TP*GP*GP*CP*GP*CP*CP*AP*A)-3') DNA RUTHENIUM INTERCALATION DNA PHOTOACTIVE, DNA
Code Class Resolution Description
1aul nuc NMR PHOSPHONIC ACID 6-({6-[6-(6-CARBAMOYL-3,6,7,8- TETRAHYDRO-3,6-DIAZA-AS-INDACENE-2-CARBONYL)-3,6,7,8- TETRAHYDRO-3,6-DIAZA-AS-INDOCENE-2-CARBONYL]-3,6,7,8- TETRAHYDRO-3,6-DIAZA-AS-INDACENE-2-CARBONL}-AMINO)- HEXYL ESTER 5-(5-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H C50 H53 N10 O12 P SOLUTION STRUCTURE OF A HIGHLY STABLE DNA DUPLEX CONJUGATED TO A MINOR GROOVE BINDER, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*AP*GP*AP*TP*AP*AP*TP*CP*A)-3'), DNA (5'-D(P*THXP*GP*AP*TP*TP*AP*TP*CP*TP*G)-3') DNA DEOXYRIBONUCLEIC ACID, CDPI3, DNA
Code Class Resolution Description 1jgr nuc 1.20 THALLIUM (I) ION 13(TL 1+) CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAATTCGCG WITH THALLIUM IONS. 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DEOXYRIBONUCLEIC ACID, THALLIUM, DNA 1kd3 nuc 1.80 THALLIUM (I) ION 2(TL 1+) THE CRYSTAL STRUCTURE OF R(GGUCACAGCCC)2, THALLIUM FORM 5'-R(*GP*GP*UP*CP*AP*CP*AP*GP*CP*CP*C)-3' RNA RNA DUPLEX, METAL BINDING 1p20 nuc 1.34 THALLIUM (I) ION 3(TL 1+) SURPRISING ROLES OF ELECTROSTATIC INTERACTIONS IN DNA- LIGAND COMPLEXES 5'-D(*CP*GP*AP*TP*CP*G)-3' DNA ADRIAMYCIN, INTERCALATION, ELECTROSTATICS, THALLIUM, DNA 1s45 nuc 2.20 THALLIUM (I) ION 6(TL 1+) CRYSTAL STRUCTURE ANALYSIS OF THE DNA QUADRUPLEX D(TGGGGT) S1 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, THYMINE TRIADS, THALLIUM 1s47 nuc 2.50 THALLIUM (I) ION 6(TL 1+) CRYSTAL STRUCTURE ANALYSIS OF THE DNA QUADRUPLEX D(TGGGGT)S2 5'-D(*TP*GP*GP*GP*GP*T)-3' DNA QUADRUPLEX DNA, THYMINE TRIADS AND TETRADS, THALLIUM 1z5t nuc 1.60 THALLIUM (I) ION 8(TL 1+) CRYSTAL STRUCTURE OF [D(CGCGAA(Z3DU)(Z3DU)CGCG)]2, Z3DU:5- (3-AMINOPROPYL)-2'-DEOXYURIDINE, IN PRESENCE OF THALLIUM I. 5'-D(*CP*GP*CP*GP*AP*AP*(ZDU)P*(ZDU) P*CP*GP*CP*G)-3' DNA B-DNA, TL+, THALLIUM, MODIFIED DNA, CATIONS, MODIFIED THYMINE 2hbn nuc 1.55 THALLIUM (I) ION 10(TL 1+) CRYSTALLIZATION OF THE TL+-FORM OF THE OXYTRICHA NOVA G- QUADRUPLEX 5'-D(*GP*GP*GP*GP*TP*TP*TP*TP*GP*GP*GP*G)-3' DNA DEOXYRIBONUCLEIC ACID, G-QUADRUPLEX, THALLIUM, DNA 3dj2 nuc 2.50 THALLIUM (I) ION 10(TL 1+) CRYSTALLIZATION OF THE THERMOTOGA MARITIMA LYSINE RIBOSWITCH LYSINE, TL+ SOAK RNA (174-MER) RNA LYSINE, RIBOSWITCH, RNA 3ggi nuc 0.98 THALLIUM (I) ION 6(TL 1+) LOCATING MONOVALENT CATIONS IN ONE TURN OF G/C RICH B-DNA 5'-D(*CP*CP*AP*GP*GP*CP*CP*TP*GP*G) -3' DNA DNA, CATIONS, DIVALENT CATIONS, MONOVALENT CATIONS, THALLIUM ION 3oxm nuc 2.95 THALLIUM (I) ION 10(TL 1+) CRYSTAL STRUCTURE OF GLYCINE RIBOSWITCH, TL-ACETATE SOAKED DOMAIN II OF GLYCINE RIBOSWITCH, DOMAIN II OF GLYCINE RIBOSWITCH RNA GENE EXPRESSION REGULATOR, GLYCINE RIBOSWITCH, RNA 4e8q nuc 2.84 THALLIUM (I) ION 17(TL 1+) STRUCTURE OF OCEANOBACILLUS IHEYENSIS GROUP II INTRON IN A L STATE IN THE PRESENCE OF TL+ AND MG2+ GROUP IIC INTRON: DOMAINS 1-5 RNA RIBOZYME, METALLOENZYME, SELF-SPLICING, RETROTRANSPOSITION, 4en5 nuc 2.96 THALLIUM (I) ION 6(TL 1+) CRYSTAL STRUCTURE OF FLUORIDE RIBOSWITCH, TL-ACETATE SOAKED FLUORIDE RIBOSWITCH RNA PSEUDOKNOT, RNA
Code Class Resolution Description 1oci nuc NMR 2'-O,3'-C-METHYLENE-ARABINOFURANOSYL-THYMINE- 5'-MONOPHOSPHATE C11 H15 N2 O9 P [3.2.0]BCANA:DNA 5'-D(*CP*TP*GP*A TLBP*AP*TP*GP*CP)-3', 5'-D(*GP*CP*AP*TP*AP*TP*CP*AP*GP)-3' DNA DEOXYRIBONUCLEIC ACID, ARABINO NUCLEIC ACID, DNA, NMR, RNASE H
Code Class Resolution Description 1ei4 nuc 1.43 2-O,3-ETHDIYL-ARABINOFURANOSYL-THYMINE-5'- MONOPHOSPHATE 4(C12 H17 N2 O9 P) B-DNA DODECAMER CGCGAAT(TLC)CGCG WITH INCORPORATED [3.3.0]BICYCLO-ARABINO-THYMINE-5'-PHOSPHATE DNA (5'-D(*CP*GP*CP*GP*AP*AP*(TLC)P*(TLC) P*CP*GP*CP*G)-3') DNA MODIFIED B-DODECAMER, [3.3.0]BICYCLO-ARABINONUCLEIC ACID, DNA
Code Class Resolution Description 1h0q nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H15 N2 O9 P) NMR SOLUTION STRUCTURE OF A FULLY MODIFIED LOCKED NUCLEIC ACID (LNA) HYBRIDIZED TO RNA 5-R(*GP*CP*AP*UP*AP*UP*CP*AP*G)-3, 5-D(*(LKC)P*(TLN)P*(LCG)P*(LCA)P*(TLN)P*(LCA)P* (TLN)P*(LCG)P*(LCC))-3 DNA-RNA HYBRID DNA-RNA HYBRID, LNA, RNA, LOCKED NUCLEIC ACID, HYBRID, DNA/RNA HYBRID 1hhw nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE C11 H15 N2 O9 P SOLUTION STRUCTURE OF LNA1:RNA HYBRID 5- R(*GP*CP*AP*UP*AP*UP*CP*AP*G) -3, 5- D(*CP*TP*GP*AP*+TLNP*AP*TP*GP*C) -3 ANTISENSE ANTISENSE, LOCKED NUCLEIC ACID, DNA, RNA, HYBRID, RNASE H 1hhx nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 3(C11 H15 N2 O9 P) SOLUTION STRUCTURE OF LNA3:RNA HYBRID 5- D(*CP*+TP*GP*AP*+TP*AP*+TP*GP*C) -3, 5- R(*GP*CP*AP*UP*AP*UP*CP*AP*G) -3 ANTISENSE ANTISENSE, LOCKED NUCLEIC ACID, LNA, RNA, HYBRID, RNASE H 1i5w nuc 1.40 [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H15 N2 O9 P) A-DNA DECAMER GCGTA(TLN)ACGC 5'-D(*GP*CP*GP*TP*AP*(TLN)P*AP*CP*GP*C)-3' DNA A-DNA DECAMER, LOCKED RIBONUCLEOTIDE. 1s9l nuc NMR [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 8(C11 H15 N2 O9 P) NMR SOLUTION STRUCTURE OF A PARALLEL LNA QUADRUPLEX 5'-((TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN))-3' RNA LNA, QUADRUPLEX, RNA 2x2q nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H15 N2 O9 P) CRYSTAL STRUCTURE OF AN 'ALL LOCKED' LNA DUPLEX AT 1.9 ANGST RESOLUTION LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX, LOCKED NUCLEIC ACID DERIVED FROM TRNA SER ACCEPTO MICROHELIX DNA DNA, MODIFIED NUCLEIC ACID, LOCKED NUCLEIC ACID, THERMOSTABI 4l0a nuc 1.70 [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 16(C11 H15 N2 O9 P) X-RAY STRUCTURE OF AN ALL LNA QUADRUPLEX DNA/RNA (5'-R(*(TLN)P*(LCG)P*(LCG)P*(LCG)P*(TLN)) CHAIN: A, B, C, D, E, F, G, H DNA, RNA PARALLEL G-QUADRUPLEX, LOCKED NUCLEIC ACID (LNA), DNA, RNA 5dhb nuc 1.80 [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H15 N2 O9 P) COOPERATIVITY AND DOWNSTREAM BINDING IN RNA REPLICATION RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA, COOPERATIVITY, MONOMER 5hbw nuc 1.90 [(1R,3R,4R,7S)-7-HYDROXY-3-(THYMIN-1-YL)-2,5- DIOXABICYCLO[2.2.1]HEPT-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H15 N2 O9 P) RNA PRIMER-TEMPLATE COMPLEX WITH 2-METHYLIMIDAZOLE-ACTIVATED ANALOGUE RNA (5'-R(*(LCC)P*(TLN)P*(LCG)P*UP*AP*CP*A)-3') RNA RNA
Code Class Resolution Description 1hz2 nuc NMR PROPANE C3 H8 SOLUTION NMR STRUCTURE OF SELF-COMPLEMENTARY DUPLEX 5'- D(AGGCG*CCT)2 CONTAINING A TRIMETHYLENE CROSSLINK AT THE N2 POSITION OF G*. MODEL OF A MALONDIALDEHYDE CROSSLINK DNA (5'-D(*AP*GP*GP*CP*GP*CP*CP*T)-3') DNA DNA DUPLEX, INTERSTRAND CROSSLINK 1luh nuc NMR PROPANE C3 H8 SOLUTION NMR STRUCTURE OF SELF-COMPLIMENTARY DUPLEX 5'- D(TCCG*CGGA)2 CONTAINING A TRIMETHYLENE CROSSLINK AT THE N2 POSITION OF G* 5'-D(*TP*CP*CP*(TME)GP*CP*GP*GP*A)-3' DNA DNA DUPLEX, GUANINE N2-GUANINE N2 INTERSTRAND CROSSLINK 2knk nuc NMR PROPANE C3 H8 STRUCTURE OF THE TRIMETHYLENE N2-DG:N2-DG INTERSTRAND CROSS- LINK IN 5'-CPG-3' SEQUENCE CONTEXT DNA (5'-D(*AP*GP*GP*CP*GP*CP*CP*T)-3') DNA INTERSTRAND CROSS-LINK, TRIMETHYLENE, CPG SEQUENCE CONTEXT, DNA 2knl nuc NMR PROPANE C3 H8 STRUCTURE OF THE TRIMETHYLENE N2-DG:N2-DG INTERSTRAND CROSS- LINK IN THE 5'-GPC-3' SEQUENCE CONTEXT DNA (5'-D(*TP*CP*CP*GP*CP*GP*GP*A)-3') DNA INTERSTRAND CROSS-LINK, TRIMETHYLENE, GPC SEQUENCE CONTEXT, DNA
Code Class Resolution Description 1pik nuc NMR 2,6-DIDEOXY-4-THIOMETHYL-BETA-D-RIBOHEXOPYRANOSIDE C7 H14 O3 S ESPERAMICIN A1-DNA COMPLEX, NMR, 4 STRUCTURES DNA (5'-D(C*GP*GP*AP*TP*CP*CP*GP)-3') DNA DEOXYRIBONUCLEIC ACID, DRUG COMPLEX, DNA
Code Class Resolution Description 1x6w nuc NMR N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY-PHENYL)-VINYL]- BENZAMIDE 2(C21 H25 N O5) SOLUTION STRUCTURE OF THE DNA DUPLEX TGCGCA:TGCGCA CAPPED BY TRIMETHOXYSTILBENE RESIDUES 5'-D(*(TMS)P*TP*GP*CP*GP*CP*A)-3' DNA DNA, TRIMETHOXYSTILBENE, SYNTHETIC HYBRID
Code Class Resolution Description 102d nuc 2.20 1,3-BIS(AMIDINOPHENOXY)PROPANE C17 H20 N4 O2 SEQUENCE-DEPENDENT DRUG BINDING TO THE MINOR GROOVE OF DNA: THE CRYSTAL STRUCTURE OF THE DNA DODECAMER D(CGCAAATTTGCG) 2 COMPLEXED WITH PROPAMIDINE DNA (5'-D(*CP*GP*CP*AP*AP*AP*TP*TP*TP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG 1prp nuc 2.10 1,3-BIS(AMIDINOPHENOXY)PROPANE C17 H20 N4 O2 CRYSTAL STRUCTURE OF D(CGCGAATTCGCG) COMPLEXED WITH PROPAMIDINE, A SHORT-CHAIN HOMOLOGUE OF THE DRUG PENTAMIDIN DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3') DNA B-DNA, DOUBLE HELIX, COMPLEXED WITH DRUG
Code Class Resolution Description 1tob nuc NMR 3-DEOXY-3-AMINO GLUCOSE C6 H14 N O5 1+ SACCHARIDE-RNA RECOGNITION IN AN AMINOGLYCOSIDE ANTIBIOTIC- RNA APTAMER COMPLEX, NMR, 7 STRUCTURES RNA (5'-R(GGCACGAGGUUUAGCUACACUCGUGCC)-3') RNA RIBONUCLEIC ACID, RNA 2tob nuc NMR 3-DEOXY-3-AMINO GLUCOSE C6 H14 N O5 1+ SOLUTION STRUCTURE OF THE TOBRAMYCIN-RNA APTAMER COMPLEX, NMR, 13 STRUCTURES RNA (5'- R(*AP*CP*UP*UP*GP*GP*UP*UP*UP*AP*GP*GP*UP*AP*AP*UP*GP*AP*GP *U)-3') RNA AMINOGLYCOSIDE-RNA RECOGNITION, TOBRAMYCIN
Code Class Resolution Description 1tob nuc NMR 1,3-DIAMINO-5,6-DIHYDROXYCYCLOHEXANE C6 H16 N2 O2 2+ SACCHARIDE-RNA RECOGNITION IN AN AMINOGLYCOSIDE ANTIBIOTIC- RNA APTAMER COMPLEX, NMR, 7 STRUCTURES RNA (5'-R(GGCACGAGGUUUAGCUACACUCGUGCC)-3') RNA RIBONUCLEIC ACID, RNA
Code Class Resolution Description 1tob nuc NMR 2,3,6-TRIDEOXY-2,6-DIAMINO GLUCOSE C6 H16 N2 O3 2+ SACCHARIDE-RNA RECOGNITION IN AN AMINOGLYCOSIDE ANTIBIOTIC- RNA APTAMER COMPLEX, NMR, 7 STRUCTURES RNA (5'-R(GGCACGAGGUUUAGCUACACUCGUGCC)-3') RNA RIBONUCLEIC ACID, RNA 2tob nuc NMR 2,3,6-TRIDEOXY-2,6-DIAMINO GLUCOSE C6 H16 N2 O3 2+ SOLUTION STRUCTURE OF THE TOBRAMYCIN-RNA APTAMER COMPLEX, NMR, 13 STRUCTURES RNA (5'- R(*AP*CP*UP*UP*GP*GP*UP*UP*UP*AP*GP*GP*UP*AP*AP*UP*GP*AP*GP *U)-3') RNA AMINOGLYCOSIDE-RNA RECOGNITION, TOBRAMYCIN
Code Class Resolution Description 108d nuc NMR 1,1-(4,4,8,8-TETRAMETHYL-4,8-DIAZAUNDECAMETHYLENE)- BIS-4-3-METHYL-2,3-DIHYDRO-(BENZO-1,3-THIAZOLE)-2- METHYLIDENE)-QUINOLINIUM C49 H58 N6 S2 4+ THE SOLUTION STRUCTURE OF A DNA COMPLEX WITH THE FLUORESCENT BIS INTERCALATOR TOTO DETERMINED BY NMR SPECTROSCOPY DNA (5'-D(*CP*GP*CP*TP*AP*GP*CP*G)-3') DNA DNA, NMR, FLUORESCENT BIS INTERCALATOR, TOTO,BIS-THIAZOLE ORANGE
Code Class Resolution Description 1lc4 nuc 2.54 TOBRAMYCIN 2(C18 H37 N5 O9) CRYSTAL STRUCTURE OF TOBRAMYCIN BOUND TO THE EUBACTERIAL 16S SITE 5'-R(*UP*UP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*U *GP*UP*CP*GP*C)-3' RNA ANTIBIOTIC-RNA COMPLEX, ADENINE BULGES, RNA
Code Class Resolution Description 176d nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-THYMINE C11 H17 N4 O5 1+ NMR SOLUTION STRUCTURE OF A PEPTIDE NUCLEIC ACID COMPLEXED W DNA (5'-D(*GPN*APN*APN*CPN*TPN*CPN)-3'), RNA (5'-R(P*GP*AP*GP*UP*UP*C)-3') PEPTIDE NUCLEIC ACID/RNA RNA, PNA, DOUBLE HELIX, PEPTIDE NUCLEIC ACID-RNA COMPLEX 1nr8 nuc 1.66 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-THYMINE 2(C11 H17 N4 O5 1+) THE CRYSTAL STRUCTURE OF A D-LYSINE-BASED CHIRAL PNA-DNA DUP 5'-D(P*AP*GP*TP*GP*AP*TP*CP*TP*AP*C)-3', H-((GPN)*(TPN)*(APN)*(GPN)*(A66)*(T66)*(C66)*(APN *(TPN))-NH2 DNA/PEPTIDE NUCLEIC ACID CHIRAL PEPTIDE NUCLEIC ACID, DOUBLE STRANDED HELIX, P-FORM, PEPTIDE NUCLEIC ACID COMPLEX 1pdt nuc NMR 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-THYMINE 3(C11 H17 N4 O5 1+) PD235, PNA-DNA DUPLEX, NMR, 8 STRUCTURES DNA (5'-D(*GP*AP*CP*AP*TP*AP*GP*C)-3', PEPTIDE NUCLEIC ACID (COOH-P(*G*C*T*A*T*G*T*C)-NH CHAIN: B PEPTIDE NUCLEIC ACID/DNA COMPLEX (PEPTIDE NUCLEIC ACID-DNA), NUCLEIC ACID COMPLEX, DU HYBRID, PEPTIDE NUCLEIC ACID-DNA COMPLEX 5eme nuc 1.15 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-THYMINE 2(C11 H17 N4 O5 1+) COMPLEX OF RNA R(GCAGCAGC) WITH ANTISENSE PNA P(CTGCTGC) ANTISENSE PNA STRAND, RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3') RNA CAG REPEATS, RNA/PNA, PNA ANTISENSE OLIGOMER, POLY-Q DIESEAS
Code Class Resolution Description 2cky nuc 2.90 THIAMINE DIPHOSPHATE 2(C12 H19 N4 O7 P2 S) STRUCTURE OF THE ARABIDOPSIS THALIANA THIAMINE PYROPHOSPHATE RIBOSWITCH WITH ITS REGULATORY LIGAND NUCLEIC ACID NUCLEIC ACID NUCLEIC ACID 2gdi nuc 2.05 THIAMINE DIPHOSPHATE 2(C12 H19 N4 O7 P2 S 1+) CRYSTAL STRUCTURE OF THIAMINE PYROPHOSPHATE-SPECIFIC RIBOSWI COMPLEX WITH THIAMINE PYROPHOSPHATE TPP RIBOSWITCH: SENSING DOMAIN RNA RIBOSWITCH, THIAMINE PYROPHOSPHATE, RNA 2hoj nuc 2.50 THIAMINE DIPHOSPHATE C12 H19 N4 O7 P2 S 1+ CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, MANGANESE IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 2hok nuc 3.20 THIAMINE DIPHOSPHATE C12 H19 N4 O7 P2 S 1+ CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, CALCIUM IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 2hol nuc 2.90 THIAMINE DIPHOSPHATE C12 H19 N4 O7 P2 S 1+ CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE PYROPHOSPHATE, BARIUM IONS THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH 3d2g nuc 2.25 THIAMINE DIPHOSPHATE 2(C12 H19 N4 O7 P2 S 1+) STRUCTURAL BASIS OF THIAMINE PYROPHOSPHATE ANALOGUES BINDING EUKARYOTIC RIBOSWITCH TPP-SPECIFIC RIBOSWITCH RNA RNA, RIBOSWITCH, TPP, THIAMINE ANALOGUES, ANTIBIOTICS, ARABI THALIANA, EUKARYOTE
Code Class Resolution Description 2hom nuc 2.89 THIAMIN PHOSPHATE C12 H18 N4 O4 P S 1+ CRYSTAL STRUCTURE OF AN E. COLI THI-BOX RIBOSWITCH BOUND TO THIAMINE MONOPHOSPHATE THI-BOX RIBOSWITCH RNA RNA; RIBOSWITCH
Code Class Resolution Description 1c95 nuc NMR TRYPTOPHAN 2(C11 H12 N2 O2) SOLUTION STRUCTURE OF THE AMINOACYL-CAPPED OLIGODEOXYRIBONUCLEOTIDE DUPLEX TRP-D(TGCGCAC)2 5'-D((5AT)TP*GP*CP*GP*CP*AP*C)-3' DNA DOUBLE HELIX, AMINOACYL-CAPPED DNA
Code Class Resolution Description 407d nuc 2.20 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL C4 H12 N O3 1+ STRUCTURAL BASIS FOR RECOGNITION OF A-T AND T-A BASE PAIRS I MINOR GROOVE OF B-DNA DNA (5'-D(*CP*CP*AP*GP*TP*AP*CP*TP*GP*G)-3') DNA DRUGS IN THE DNA MINOR GROOVE, DNA
Code Class Resolution Description 1ac3 nuc NMR 3'-THIO-THYMIDINE-5'-PHOSPHATE C10 H15 N2 O7 P S SOLUTION STRUCTURE OF AN RNA-DNA HYBRID DUPLEX CONTAINING A 3'-THIOFORMACETAL LINKER AND AN RNA A-TRACT, NMR, 8 STRUCTURES DNA (5'-D(*(TCP)P*TP*GP*CP*GP*C)-3'), ANTISENSE HYBRID DUPLEX DNA/RNA HYBRID STRUCTURE, NMR, RNA, DNA, ANTISENSE OLIGONUCLEOTIDES, THIOFORMACETAL BACKBONE MODIFICATION, HYBRID DUPLEX, DNA/RNA HYBRID COMPLEX
Code Class Resolution Description 1ttd nuc NMR CIS-SYN CYCLOBUTANE THYMINE DIMER C20 H28 N4 O15 P2 SOLUTION-STATE STRUCTURE OF A DNA DODECAMER DUPLEX CONTAININ SYN THYMINE CYCLOBUTANE DIMER DNA (5'-D(*GP*CP*AP*CP*GP*AP*AP*(TTD)P*AP*AP*G)-3 CHAIN: A, DNA (5'-D(*CP*TP*TP*AP*AP*TP*TP*CP*GP*TP*GP*C)-3' CHAIN: B DNA DNA STRUCTURE, UV-PHOTOPRODUCTS, BII BACKBONE, DNA
Code Class Resolution Description 3fa1 nuc 1.50 2'-DEOXY-5-TELLUROXOURIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 N2 O8 P TE CRYSTAL STRUCTURE OF TELLURIUM DERIVATIZED DNA 5'-D(*DGP*(UMS)P*DGP*(TTI)P*DAP*DCP*DAP*DC)-3' DNA TELLURIUM DNA 3k18 nuc 1.50 2'-DEOXY-5-TELLUROXOURIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 N2 O8 P TE TELLURIUM MODIFIED DNA-8MER 5'-D(*GP*(UMS)P*GP*(TTI)P*AP*CP*AP*C)-3' DNA DNA TELLURIUM, DNA 3kq8 nuc 1.60 2'-DEOXY-5-TELLUROXOURIDINE 5'-(DIHYDROGEN PHOSPHATE) C9 H13 N2 O8 P TE 5-TE-URIDINE DERIVATIZED DNA-8MER 5'-D(*GP*(UMS)P*GP*(TTI)P*AP*CP*AP*C)-3' DNA TELLURIUM DNA, DNA
Code Class Resolution Description 1s37 nuc NMR N3-ETHYL-THYMIDINE-5'-MONOPHOSPHATE C12 H19 N2 O8 P ACCOMODATION OF MISPAIR-ALIGNED N3T-ETHYL-N3T DNA INTERSTRAN CROSSLINK DNA (5'-D(*CP*GP*AP*AP*AP*(TTM)P*TP*TP*TP*CP*G)-3 CHAIN: A, DNA (5'-D(*CP*GP*AP*AP*AP*TP*TP*TP*TP*CP*G)-3') DNA INTERSTRAND CROSSLINK, DNA INTERSTRAND CROSS-LINK, DNA 1xci nuc NMR N3-ETHYL-THYMIDINE-5'-MONOPHOSPHATE 2(C12 H19 N2 O8 P) MISPAIR ALIGNED N3T-BUTYL-N3T INTERSTRAND CROSSLINK 5'-D(*CP*GP*AP*AP*AP*(TTM)P*TP*TP*TP*CP*G)-3' DNA INTERSTRAND CROSS-LINK, DOUBLE HELIX, DNA
Code Class Resolution Description 1xv6 nuc NMR 5-METHYL-3'-O-METHOXYETHYL URIDINE-5'-MONOPHOSPHATE 2(C13 H21 N2 O10 P) THE SOLUTION STRUCTURE OF 2',5'-LINKED 3'-O-(2- METHOXYETHYL)-RNA HAIRPIN 5'-R(*(C2L)P*(G2L)P*(C2L)P*(G2L)P*(A2L)P*(A2L) P*(U2L)P*(U2L)P*(C2L)P*(G2L)P*(C2L)P*(G2L))-2' RNA HAIRPIN, (2',5')-RNA, 3'-O-(2-METHOXYETHYL) RIBOSE
Code Class Resolution Description 1d9h nuc 1.60 2'-O-3-AMINOPROPYL 2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C12 H20 N3 O9 P) STRUCTURAL ORIGINS OF THE EXONUCLEASE RESISTANCE OF A ZWITTERIONIC RNA DNA/RNA (5'-D(*GP*CP*GP*TP*AP)-R(*(U31)P)- D(*AP*CP*GP*C)-3') DNA, RNA EXONUCLEASE RESISTANCE, A-DNA, DNA, RNA
Code Class Resolution Description 2grb nuc 1.40 5-BROMO-2'-DEOXY URIDINE 5(C9 H11 BR N2 O5) CRYSTAL STRUCTURE OF AN RNA QUADRUPLEX CONTAINING INOSINE- TETRAD 5'-R(*(U33)P*GP*IP*GP*GP*U)-3' RNA RNA QUADRUPLEX
Code Class Resolution Description 468d nuc 1.80 2'-O-METHYOXYETHYL-URIDINE-5'-MONOPHOSPHATE 4(C12 H19 N2 O10 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 469d nuc 1.70 2'-O-METHYOXYETHYL-URIDINE-5'-MONOPHOSPHATE 4(C12 H19 N2 O10 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RNA 470d nuc 1.95 2'-O-METHYOXYETHYL-URIDINE-5'-MONOPHOSPHATE 4(C12 H19 N2 O10 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA 471d nuc 2.70 2'-O-METHYOXYETHYL-URIDINE-5'-MONOPHOSPHATE 4(C12 H19 N2 O10 P) CRYSTAL STRUCTURE AND IMPROVED ANTISENSE PROPERTIES OF 2'-O- METHOXYETHYL)-RNA RNA (5'-R(*(C43)P*(G48)P*(C43)P*(G48)P*(A44)P*(A4 P*(U36)P*(C43)P*(G48)P*(C43)P*(G48))-3') RNA 2'-O-(2-METHOXYETHYL) RIBOSE, RNA DODECAMER DUPLEX, RIBONUCL RNA
Code Class Resolution Description 5d8t nuc 1.20 1-(2,6-DIDEOXY-2-FLUORO-5-O-PHOSPHONO-ALPHA-L- TALOFURANOSYL)PYRIMIDINE-2,4(1H,3H)-DIONE 2(C10 H14 F N2 O8 P) RNA OCTAMER CONTAINING (S)-5' METHYL, 2'-F U. RNA OLIGONUCLEOTIDE CONTAINING (S)-C5'-ME-2'-FU RNA RNA, MODIFIED BASE
Code Class Resolution Description 1me0 nuc NMR URIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) CHIMERIC HAIRPIN WITH 2',5'-LINKED RNA LOOP AND DNA STEM DNA/RNA (5'-D(*GP*GP*AP*C)-R(P*(U25)P*(U25)P*(C25 D(P*GP*TP*CP*C)-3') DNA, RNA HAIRPIN, (2',5')-RNA, DNA, RNA 1me1 nuc NMR URIDINE-5'-MONOPHOSPHATE 2(C9 H13 N2 O9 P) CHIMERIC HAIRPIN WITH 2',5'-LINKED RNA LOOP AND RNA STEM 5'-R(*GP*GP*AP*CP*(U25)P*(U25)P*(C25)P*(5GP)P*GP* 3' RNA HAIRPIN, (2',5')-RNA, RNA
Code Class Resolution Description 5der nuc 1.80 1-(2,6-DIDEOXY-2-FLUORO-5-O-PHOSPHONO-BETA-D- ALLOFURANOSYL)PYRIMIDINE-2,4(1H,3H)-DIONE 4(C10 H14 F N2 O8 P) RNA OLIGONUCLEOTIDE CONTAINING (R)-C5'-ME-2'F U RNA OLIGONUCLEOTIDE CONTAINING (R)-C5'-ME-2'-FU RNA RNA, OLIGONUCLEOTIDE
Code Class Resolution Description 1fl8 nuc NMR 5-METHYLAMINOMETHYL-2-THIOURIDINE-5'-MONOPHOSPHATE C11 H18 N3 O8 P S HYPERMODIFIED NUCLEOSIDES IN THE ANTICODON OF TRNALYS STABILIZE A CANONICAL U-TURN STRUCTURE ANTICODON DOMAIN OF TRNA(LYS): 17-MER TRNA(LYS) ANTICODON DOMAIN RNA TRNA, ANTICODON, PSEUDOURIDINE, MNM5S2U, T6A
Code Class Resolution Description 1ho6 nuc NMR URACIL ARABINOSE-5'-PHOSPHATE C9 H13 N2 O9 P CHIMERIC ARABINONUCLEIC ACID (ANA) HAIRPIN WITH ANA/RNA HYBRID STEM DNA/RNA (5'-R(*GP*GP*AP*C)-D(P*TP*TP*CP*G)- (P*(GAO)P*(UAR)P*(CAR)P*(CAR)-3') DNA, RNA ARABINONUCLEIC ACID, RNA, HAIRPIN, DNA 2fih nuc 1.13 URACIL ARABINOSE-5'-PHOSPHATE 2(C9 H13 N2 O9 P) CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAA-AU- WITH INCORPORATED ARABINO-URIDINE (AU) 5'-D(*CP*GP*CP*GP*AP*AP*(UAR)P*TP*CP*GP*CP*G)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, B-FORM DNA, DNA 2fii nuc 1.24 URACIL ARABINOSE-5'-PHOSPHATE 2(C9 H13 N2 O9 P) CRYSTAL STRUCTURE ANALYSIS OF THE B-DNA DODECAMER CGCGAAT-AU WITH INCORPORATED ARABINO-URIDIN (AU) 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UAR)P*CP*GP*CP*G)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, B-FORM DNA, DNA 2fij nuc 1.19 URACIL ARABINOSE-5'-PHOSPHATE 2(C9 H13 N2 O9 P) CRYSTAL STRUCTURE ANALYSIS OF THE A-DNA DECAMER GCGT-2'OMEA- WITH INCORPORATED 2'-O-METHYLATED-ADENOSINE (2'OMEA) AND AR URIDINE (AU) 5'-D(*GP*CP*GP*TP*(A2M)P*(UAR)P*AP*CP*GP*C)-3' DNA ARABINONUCLEIC ACID, SUGAR MODIFICATIONS, A-FORM DNA, DNA 2kp3 nuc NMR URACIL ARABINOSE-5'-PHOSPHATE 3(C9 H13 N2 O9 P) STRUCTURE OF ANA-RNA HYBRID DUPLEX RNA (5'-R(*CP*CP*AP*UP*UP*AP*UP*AP*GP*C)-3'), RNA (5'-R(*(GAO)P*(CAR)P*(UAR)P*(A5O)P*(UAR)P*(A5 P*(UAR)P*(GAO)P*(GAO))-3') RNA ANA, ARABINONUCLEIC ACID, NUCLEIC ACID STRUCTURE, NMR/MD/TI, DUPLEX, RNA 2lsc nuc NMR URACIL ARABINOSE-5'-PHOSPHATE 4(C9 H13 N2 O9 P) SOLUTION STRUCTURE OF 2'F-ANA AND ANA SELF-COMPLEMENTARY DUP DNA (5'-D(*(CFL)P*(GFL)P*(CFL)P*(GFL)P*(A5O)P*(A5 P*(UAR)P*(CFL)P*(GFL)P*(CFL)P*(GFL))-3') DNA DNA, DICKERSON DREW DODECAMER
Code Class Resolution Description 1idw nuc 1.80 5-CHLORO-2'-DEOXYURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H12 CL N2 O8 P) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[CL]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UCL))-3' DNA/RNA RNA/DNA HYBRID, RHODIUM HEXAMMINE, C-U MISMATCH, G-U MISMATCH, DNA/RNA COMPLEX 4gqd nuc 1.94 5-CHLORO-2'-DEOXYURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H12 CL N2 O8 P) DNA HOLLIDAY JUNCTION STABILIZED BY CHLORINE HALOGEN BOND. DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*GP*TP*AP*(UCL)P*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND, DNA 4gsg nuc 2.00 5-CHLORO-2'-DEOXYURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H12 CL N2 O8 P) DNA HOLLIDAY JUNCTION STABILIZED BY CHLORINE HALOGEN BOND. C CONSTRUCT OF RELATED REFERENCE. DNA (5'-D(*CP*CP*GP*GP*TP*AP*(UCL)P*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND, DNA
Code Class Resolution Description 1dnf nuc 1.50 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 F N2 O8 P) EFFECTS OF 5-FLUOROURACIL/GUANINE WOBBLE BASE PAIRS IN Z- DNA. MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGFG) DNA (5'-D(*CP*GP*CP*GP*(UFP)P*G)-3') DNA Z-DNA, DOUBLE HELIX, MODIFIED, MISMATCHED 1icg nuc 1.53 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 F N2 O8 P) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[F]U IN PRESENCE OF IR(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UFP))-3' DNA/RNA RNA/DNA HYBRID, FLUORO-URACIL, C-U MISMATCH, G-U MISMATCH, RHODIUM HEXAMMINE, IRIDIUM HEXAMMINE, DNA/RNA COMPLEX 1id9 nuc 1.60 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C9 H12 F N2 O8 P) STRUCTURE OF THE HYBRID RNA/DNA R-GCUUCGGC-D[F]U IN PRESENCE OF RH(NH3)6+++ 5'-R(*GP*CP*UP*UP*CP*GP*GP*C)-D(P*(UFP))-3' DNA/RNA RNA/DNA HYBRID, FLUORO URACIL, RHODIUM(III) HEXAMMINE, C-U MISMATCH, G-U MISMATCH, DNA/RNA COMPLEX 4gsi nuc 2.38 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C9 H12 F N2 O8 P) DNA HOLLIDAY JUNCTION STABILIZED BY FLUORINE HALOGEN BOND. F CONSTRUCT OF RELATED REFERENCE. DNA (5'-D(*CP*CP*GP*GP*TP*AP*(UFP)P*CP*GP*G)-3'), DNA (5'-D(*CP*CP*GP*AP*TP*AP*CP*CP*GP*G)-3') DNA DNA HOLLIDAY JUNCTION, HALOGEN BOND, DNA
Code Class Resolution Description 1g75 nuc 1.57 2'-DEOXY-5-FORMYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 N2 O9 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG): 5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE,B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID 1g8n nuc 1.55 2'-DEOXY-5-FORMYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 N2 O9 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG):5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE,B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID 1g8u nuc 1.85 2'-DEOXY-5-FORMYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 N2 O9 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG):5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE,B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID 1g8v nuc 1.80 2'-DEOXY-5-FORMYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 N2 O9 P) MOLECULAR AND CRYSTAL STRUCTURE OF D(CGCGAATF5UCGCG):5- FORMYLURIDINE/ ADENOSINE BASE-PAIRS IN B-DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE,B-DNA, DOUBLE HELIX, DEOXYRIBONUCLEIC ACID 3ajj nuc 3.02 2'-DEOXY-5-FORMYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 N2 O9 P) CRYSTAL STRUCTURE OF D(CGCGGATF5UCGCG): 5-FORMYLURIDINE/GUAN BASE-PAIR IN B-DNA 5'-D(*CP*GP*CP*GP*GP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA MODIFIED NUCLEOTIDE, FORMYLURIDINE, DNA DAMAGE, B-DNA, DOUBL DEOXYRIBONUCLEIC ACID, DNA 3ajk nuc 1.95 2'-DEOXY-5-FORMYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 N2 O9 P) CRYSTAL STRUCTURE OF D(CGCGGATF5UCGCG): 5-FORMYLURIDINE:GUAN BASE-PAIR IN B-DNA WITH HOECHST33258 5'-D(*CP*GP*CP*GP*GP*AP*TP*(UFR)P*CP*GP*CP*G*)-3' CHAIN: A, B DNA DOUBLE HELIX, DNA 3ajl nuc 2.70 2'-DEOXY-5-FORMYLURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H13 N2 O9 P) CRYSTAL STRUCTURE OF D(CGCGGATF5UCGCG): 5-FORMYLURIDINE:GUAN BASE-PAIR IN B-DNA WITH DAPI 5'-D(*CP*GP*CP*GP*GP*AP*TP*(UFR)P*CP*GP*CP*G)-3' DNA DOUBLE HELIX, DNA
Code Class Resolution Description 2kwg nuc NMR 2'-DEOXY-2'-FLUOROURIDINE 5'-(DIHYDROGEN PHOSPHATE) 7(C9 H12 F N2 O8 P) SOLUTION STRUCTURE OF A FULLY MODIFIED 2'-F/2'-OME SIRNA CON 5'-R(P*(A2M)P*(UFT)P*(OMG)P*(AF2)P*(A2M)P*(GF2)P* P*(AF2)P*(OMU)P*(GF2)P*(OMU)P*(AF2)P*(OMU)P*(UFT)P*(OMU)P*( P*(OMC)P*(CFZ)P*(OMC)P*(UFT)P*(OMU))-3', 5'-R(*(GF2)P*(OMG)P*(GF2)P*(OMU)P*(AF2)P*(A2M)P*( P*(OMU)P*(AF2)P*(OMC)P*(AF2)P*(OMU)P*(UFT)P*(OMC)P*(UFT)P*( P*(CFZ)P*(A2M)P*(UFT)P*(OMU)P*(UFT))-3' RNA SIRNA, 2'-FLUORO, 2'-O-METHYL, RNA 2m8a nuc NMR 2'-DEOXY-2'-FLUOROURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H12 F N2 O8 P) 2'F-ANA/2'F-RNA ALTERNATED SEQUENCES 2'F-RNA/2'F-ANA CHIMERIC DUPLEX DNA, RNA A-FORM, 12-MER, DICKERSON DREW DODECAMER, MODIFIED NUCLEOTID RNA 3p4a nuc 1.20 2'-DEOXY-2'-FLUOROURIDINE 5'-(DIHYDROGEN PHOSPHATE) 12(C9 H12 F N2 O8 P) 2'FLUORO MODIFIED RNA OCTAMER FA2U2 2'FLUORO MODIFIED RNA 8-MER RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYGUANOSINE, 2'-FLUORO 2'- DEOXYADENOSINE, 2'-FLUORO 2'-DEOXYURIDINE, SIRNA 3p4b nuc 1.45 2'-DEOXY-2'-FLUOROURIDINE 5'-(DIHYDROGEN PHOSPHATE) 6(C9 H12 F N2 O8 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-P3 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA, O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA 3p4c nuc 1.15 2'-DEOXY-2'-FLUOROURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C9 H12 F N2 O8 P) ALTERNATINGLY MODIFIED 2'FLUORO RNA OCTAMER F/RA2U2-R32 5'-R(*(CFZ)P*GP*(AF2)P*AP*(UFT)P*UP*(CFZ)P*G)-3' RNA RNA, 2'-FLUORO-RNA O2'-MODIFICATION, OCTAMER, 2'-FLUORO 2'- DEOXYCYTIDINE, 2'-FLUORO 2'-DEOXYADENOSINE, 2'-FLUORO 2'- DEOXYURIDINE, SIRNA
Code Class Resolution Description 4hqh nuc 1.80 [(1R,3R,4R,5R,7S)-3-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL)-5-FLUORO-7-HYDROXY-2-OXABICYCLO[2.2.1]HEPT- 1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H14 F N2 O8 P) DECAMER FLUORO CARBOCYCLIC LNA (R-F-CLNA) CRYSTAL STRUCTURE DNA (5'-D(*GP*CP*GP*TP*AP*(ULF)P*AP*CP*GP*C)-3') DNA A-FORM DNA, CARBOCYCLIC LNA, CLNA, R-F-CLNA, DNA
Code Class Resolution Description 229d nuc NMR 2'-DEOXYURIDINE 5'-MONOPHOSPHATE 3(C9 H13 N2 O8 P) DNA ANALOG OF YEAST TRANSFER RNA PHE ANTICODON DOMAIN WITH MODIFIED BASES 5-METHYL CYTOSINE AND 1-METHYL GUANINE DNA (5'-D(*CP*CP*AP*GP*AP*CP*(UMP) P*GP*AP*AP*(MG1)P*AP*(UMP)P*(5CM)P*(UMP)P*GP*G)-3') DNA DNA, TRANSFER RNA, ANTICODON, HAIRPIN LOOP
Code Class Resolution Description 1ma8 nuc 1.30 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE 2(C10 H15 N2 O8 P SE) A-DNA DECAMER GCGTA(UMS)ACGC WITH INCORPORATED 2'- METHYLSELENO-URIDINE 5'-D(*GP*CP*GP*TP*AP*UMSP*AP*CP*GP*C)-3' DNA 2'-METHYLSELENO-URIDINE, DNA 1yls nuc 3.00 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE 6(C10 H15 N2 O8 P SE) CRYSTAL STRUCTURE OF SELENIUM-MODIFIED DIELS-ALDER RIBOZYME WITH THE PRODUCT OF THE REACTION BETWEEN N-PENTYLMALEIMIDE COVALENTLY ATTACHED 9-HYDROXYMETHYLANTHRACENE RNA DIELS-ALDER RIBOZYME, RNA DIELS-ALDER RIBOZYME RNA CARBON-CARBON BOND FORMATION, CATALYTIC MECHANISM, DIELS-ALD REACTION, RIBOZYME, RNA 1z7i nuc 1.28 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 2'-ME-SE DERIVITATION OF A-DNA OCTAMER G(UMSE)GTACAC 5'-D(*GP*(UMS)P*GP*TP*AP*CP*AP*C)-3': 2'-SELENIUM A-DNA DUPLEX DNA 2'-METHYLSELENO-URIDINE, SE-DNA, SELENIUM DERIVATIZATION 2dlj nuc 1.50 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 2'-ME-SE AND BR DERIVITATION OF A-DNA OCTAMER G(UMS)G(BRU) ACAC 5'-D(*GP*(UMS)P*GP*(BRU)P*AP*CP*AP*C)-3' DNA 2'-METHYLSELENO-URIDINE, SE-DNA, SE-BR-DNA, SELENIUM DERIVATIZATION 2gpx nuc 1.60 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 2'-ME-SE AND BR DERIVITATION OF A-DNA OCTAMER G(UMS)G(BRU) ACAC 5'-D(*GP*(UMS)P*GP*(BRU)P*AP*CP*AP*C)-3' DNA 2'-METHYLSELENO-URIDINE, SE-DNA, SE-BR-DNA, SELENIUM DERIVATIZATION 2nsk nuc 1.50 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE DOUBLED MODIFIED SELENIUM DNA 5'-D(*GP*(UMS)P*GP*(T4S)P*AP*CP*AP*C)-3' DNA DOUBLE MODIFIED SE-DNA, MAD/SAD PHASING 3bm0 nuc 1.80 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE STRUCTURE OF DNA OCTAMER G(DUSE)G(5-SEDU)ACAC 5'-D(*GP*(2'-SE-U)P*GP*(5-SE-U)P*AP*CP*AP*C)-3' DNA SELENIUM MODIFIED DNA/RNA 3c3z nuc 1.50 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE 2(C10 H15 N2 O8 P SE) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO RIBOSTAMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, ANTIBIOTIC 3c5d nuc 1.80 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE 2(C10 H15 N2 O8 P SE) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO LIVIDOMYCIN 'HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, AMINOGLYCOSIDE,LIVIDOMYCIN, EXTENDED DUPLEX 3c7r nuc 1.70 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE 2(C10 H15 N2 O8 P SE) CRYSTAL STRUCTURE OF HIV-1 SUBTYPE F DIS EXTENDED DUPLEX RNA BOUND TO NEOMYCIN HIV-1 SUBTYPE F GENOMIC RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, NEOMYCIN, EXTENDED DUPLEX 3dw6 nuc 1.00 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 U2650-SECH3 MODIFIED SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA RNA RNA, SARCIN RICIN LOOP 3dw7 nuc 1.00 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE CRYSTAL STRUCTURE OF THE SARCIN/RICIN DOMAIN FROM E. COLI 23 U2656-SECH3 MODIFIED SARCIN/RICIN DOMAIN FROM E. COLI 23 S RRNA RNA RNA, SARCIN RICIN LOOP 3fa1 nuc 1.50 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE CRYSTAL STRUCTURE OF TELLURIUM DERIVATIZED DNA 5'-D(*DGP*(UMS)P*DGP*(TTI)P*DAP*DCP*DAP*DC)-3' DNA TELLURIUM DNA 3hg8 nuc 1.38 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE CRYSTAL STRUCTURE OF 5-SME DERIVATIZED DNA 5'-D(*GP*(UMS)P*GP*(US2)P*AP*CP*AP*C)-3' DNA 5-SME DNA 3hgd nuc 1.57 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE 2(C10 H15 N2 O8 P SE) CRYSTAL STRUCTURE OF 2-SE-THYMIDINE DERIVATIZED DNA 5'-D(*GP*(UMS)P*GP*(US3)P*AP*CP*AP*C)-3' DNA 2-SE-THYMIDINE DNA, DNA 3ijk nuc 1.30 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 5-OME MODIFIED DNA 8MER 5'-D(*GP*(UMS)P*GP*(T5O)P*AP*CP*AP*C)-3' DNA SELENIUM, DNA, 5-METHOXY-URIDINE 3ijn nuc 1.80 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 5-SEME-CYTIDINE MODIFIED DNA 8MER 5'-D(*GP*(UMS)P*GP*TP*AP*(5SE)P*AP*C)-3' DNA SELENIUM, DNA, 5-SEME-CYTIDINE 3iki nuc 1.38 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 5-SME-DU CONTAINING DNA OCTAMER 5'-D(*GP*(UMS)P*GP*(US2)P*AP*CP*AP*C)-3' DNA SELENIUM, NUCLEIC ACID, 5-SME-DEOXYURIDINE, 2'-SEME-DEOXYURI 3k18 nuc 1.50 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE TELLURIUM MODIFIED DNA-8MER 5'-D(*GP*(UMS)P*GP*(TTI)P*AP*CP*AP*C)-3' DNA DNA TELLURIUM, DNA 3kq8 nuc 1.60 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 5-TE-URIDINE DERIVATIZED DNA-8MER 5'-D(*GP*(UMS)P*GP*(TTI)P*AP*CP*AP*C)-3' DNA TELLURIUM DNA, DNA 3ltr nuc 1.30 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 5-OME-DU CONTAINING DNA 8MER 5'-D(*GP*(UMS)P*GP*(T5O)P*AP*CP*AP*C)-3' DNA DNA, OLIGONUCLEOTIDE, 2'-SEME, 5-OME, SELENIUM, 5-METHOXY-UR 3ltu nuc 1.40 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE 5-SEME-DU CONTAINING DNA 8MER 5'-D(*GP*(UMS)P*GP*(T5S)P*AP*CP*AP*C)-3' DNA DNA, OLIGONUCLEOTIDE, 5-SEME, SELENIUM, 5-METHOXY-URIDINE 5ch0 nuc 1.40 2'-METHYLSELENYL-2'-DEOXYURIDINE-5'-PHOSPHATE C10 H15 N2 O8 P SE CRYSTAL STRUCTURE OF AN A-FORM DNA DUPLEX CONTAINING 5- HYDROXYLMETHYLCYTIDINE DNA (5'-R(*G)-D(P*(UMS))-R(P*G)-D(P*T)-R(P*A)-D(P R(P*AP*C)-3') DNA A-FORM DNA DUPLEX, 5HMC, DNA
Code Class Resolution Description 3oz5 nuc 1.36 [(1R,3R,4R,5S,7S)-3-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL)-7-HYDROXY-5-METHYL-2-OXABICYCLO[2.2.1]HEPT- 1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H17 N2 O8 P) S-METHYL CARBOCYCLIC LNA DNA (5'-D(*GP*CP*GP*TP*AP*(UMX)P*AP*CP*GP*C)-3') DNA A-FORM DNA, S-METHYL CARBOCYCLIC LNA, S-ME-C-LNA, ANTISENSE OLIGONUCLEOTIDES, S-METHYL-CARBOCYCLIC LNA, DNA
Code Class Resolution Description
2lvy nuc NMR 2'-O-{[(2,2-DIMETHYLPROPANOYL)OXY]METHYL}URIDINE 5'- (DIHYDROGEN PHOSPHATE) C15 H23 N2 O11 P SOLUTION STRUCTURE OF A RNA DUPLEX CONTAINING A 2'-O-PIVALOY MODIFICATION RNA (5'-R(*GP*CP*GP*UP*AP*GP*CP*GP*T)-3'), RNA (5'-R(*CP*GP*CP*(UPV)P*AP*CP*GP*CP*T)-3') RNA RNA, MODIFICATION
Code Class Resolution Description 4o41 nuc 1.20 ((2S,3S,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)- YL)-3-(2- ((((2R,5R)-5-(2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)- 3,4- DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL)AMINO)-2- OXOETHYL)-4- HYDROXYTETRAHYDROFURAN-2-YL)METHYL PHOSPHATE 4(C20 H26 N5 O14 P) AMIDE LINKED RNA AMIDE LINKED RNA RNA MODIFIED RNA, RNA STRUCTURE, AMIDE RNA, AMIDE INTERNUCLEOSID LINKAGE, MODIFIED NUCLEOSIDE, RNA
Code Class Resolution Description 3oz4 nuc 1.59 [(1R,3R,4R,5R,7S)-3-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN- 1(2H)-YL)-7-HYDROXY-5-METHYL-2-OXABICYCLO[2.2.1]HEPT- 1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H17 N2 O8 P) R-METHYL CARBOCYCLIC LNA DNA (5'-D(*GP*CP*GP*TP*AP*(URX)P*AP*CP*GP*C)-3') DNA A-FORM DNA, R-METHYL CARBOCYCLIC LNA, R-ME-C-LNA, ANTISENSE OLIGONUCLEOTIDES, DNA
Code Class Resolution Description 3hg8 nuc 1.38 2'-DEOXY-5-(METHYLSULFANYL)URIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H15 N2 O8 P S CRYSTAL STRUCTURE OF 5-SME DERIVATIZED DNA 5'-D(*GP*(UMS)P*GP*(US2)P*AP*CP*AP*C)-3' DNA 5-SME DNA 3iki nuc 1.38 2'-DEOXY-5-(METHYLSULFANYL)URIDINE 5'-(DIHYDROGEN PHOSPHATE) C10 H15 N2 O8 P S 5-SME-DU CONTAINING DNA OCTAMER 5'-D(*GP*(UMS)P*GP*(US2)P*AP*CP*AP*C)-3' DNA SELENIUM, NUCLEIC ACID, 5-SME-DEOXYURIDINE, 2'-SEME-DEOXYURI
Code Class Resolution Description 3hgd nuc 1.57 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-5-METHYL-2-SELANYLPYRIMIDIN-4(1H)-ONE 2(C10 H15 N2 O7 P SE) CRYSTAL STRUCTURE OF 2-SE-THYMIDINE DERIVATIZED DNA 5'-D(*GP*(UMS)P*GP*(US3)P*AP*CP*AP*C)-3' DNA 2-SE-THYMIDINE DNA, DNA 4f4n nuc 1.30 1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-5-METHYL-2-SELANYLPYRIMIDIN-4(1H)-ONE 2(C10 H15 N2 O7 P SE) CRYSTAL STRUCTURE OF 2-SE-THYMIDINE DERIVATIZED DNA 8MER 5'-D(*GP*TP*GP*(US3)P*AP*CP*AP*C)-3' DNA 2-SE-THYMIDINE DNA, DNA, STRUCTURAL GENOMICS
Code Class Resolution Description
3hr3 nuc 1.75 [(2R,3S,5R)-3-({[(2R,3S,5R)-5-(6-AMINO-9H-PURIN-9-YL)- 3-HYDROXYTETRAHYDROFURAN-2-YL]METHOXY}METHOXY)-5-(5- METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL) TETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN PHOSPHATE C21 H28 N7 O11 P INTERPLAY OF STRUCTURE, HYDRATION AND THERMAL STABILITY IN F MODIFIED OLIGONUCLEOTIDES: RNA MAY TOLERATE HYDROPHOBIC MOD BETTER THAN DNA 5'-D(*GP*CP*GP*(US4)P*(OMU))P*AP*CP*GP*C)-3' DNA DNA, RNA, FORMACETAL-DNA, RNA HYDRATION
Code Class Resolution Description 3hga nuc 1.30 1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL)-4- SELANYLPYRIMIDIN-2(1H)-ONE C9 H13 N2 O8 P SE CRYSTAL STRUCTURE OF 4-SE-URIDINE DERIVATIZED RNA 5'-R(*UP*(US5)P*CP*GP*CP*G)-3' RNA 4-SE-U RNA, RNA 4iqs nuc 2.60 1-(5-O-PHOSPHONO-BETA-D-RIBOFURANOSYL)-4- SELANYLPYRIMIDIN-2(1H)-ONE 6(C9 H13 N2 O8 P SE) RNA 8MER DUPLEX MODIFIED WITH 4-SE-URIDINE RNA (5'-R(*GP*UP*GP*(S5)P*AP*CP*AP*C)-3'): US5 RNA SELENIUM RNA, RNA
Code Class Resolution Description 3ey2 nuc 1.04 2'-S-METHYL-2'-THIOURIDINE 5'-(DIHYDROGEN PHOSPHATE) 2(C10 H15 N2 O8 P S) A CONFORMATIONAL TRANSITION IN THE STRUCTURE OF A 2'- THIOMETHYL-MODIFIED DNA VISUALIZED AT HIGH RESOLUTION 5'-D(*GP*CP*GP*TP*AP*(USM)P*AP*CP*GP*C)-3' DNA 2'-THIOMETHYL MODIFIED DNA, MODIFIED SUGAR, NUCLEIC ACID STRUCTURE. 3ey3 nuc 1.25 2'-S-METHYL-2'-THIOURIDINE 5'-(DIHYDROGEN PHOSPHATE) 8(C10 H15 N2 O8 P S) A CONFORMATIONAL TRANSITION IN THE STRUCTURE OF A 2'- THIOMETHYL-MODIFIED DNA VISUALIZED AT HIGH RESOLUTION 5'-D(*CP*GP*CP*GP*AP*AP*(USM)P*(USM) P*CP*GP*CP*G)-3' DNA MODIFIED DNA DUPLEX, CRYSTAL STRUCTURE, 2'-THIOMETHYL URIDINE, MODIFIED SUGAR
Code Class Resolution Description 3oz3 nuc 1.57 [(1R,3R,4R,7S)-3-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)- YL)-7-HYDROXY-5-METHYLIDENE-2-OXABICYCLO[2.2.1]HEPT-1- YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H15 N2 O8 P) VINYL CARBOCYCLIC LNA DNA (5'-D(*GP*CP*GP*TP*AP*(UVX)P*AP*CP*GP*C)-3') DNA A-FORM DNA, VINYL CARBOCYCLIC LNA, ANTISENSE OLIGONUCLEOTIDE
Code Class Resolution Description 3s7c nuc 1.10 2'-DEOXY-2'-TRIAZA-1,2-DIEN-2-IUM-1-YL-URIDINE-5'- MONOPHOSPHATE C9 H13 N5 O8 P 1+ CRYSTAL STRUCTURE OF A 2'-AZIDO-URIDINE-MODIFIED RNA ECOLI 23 S RRNA SARCIN RICIN LOOP RNA HAIRPIN RNA, RNA LABELLING, 2'-AZIDO-URIDINE, RNA
Code Class Resolution Description 1qyl nuc 1.00 VANADIUM ION V 3+ GCATGCT + VANADIUM 5'-D(*GP*CP*AP*TP*GP*CP*T)-3' DNA QUADRUPLEX DNA
Code Class Resolution Description 5bws nuc 2.60 (1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYL 2, 6-DIAMINO-2,4,6-TRIDEOXY-4-FLUORO-ALPHA-D- GALACTOPYRANOSIDE C12 H25 F N4 O5 CRYSTAL STRUCTURE OF THE BACTERIAL RIBOSOMAL DECODING SITE I WITH 4'-DEOXY-4'-FLUORO NEAMINE ANALOG (AXIAL 4'-F) RNA (5'- D(*UP*UP*GP*CP*GP*UP*CP*AP*CP*GP*CP*CP*GP*GP*CP*GP*AP*AP*GP C)-3') RNA/ANTIBIOTIC RNA, ANTIBIOTIC, RNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 4mnb nuc 1.40 9-AMINO-5-(2-AMINOPYRIMIDIN-4-YL)PYRIDO[3',2':4, 5]PYRROLO[1,2-C]PYRIMIDIN-4-OL 2(C14 H11 N7 O) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE MARINE ANTICANCER VARIOLIN B AND DNA 5'-D(*CP*GP*TP*AP*CP*G)-3' DNA DNA DUPLEX, INTERCALATION, DRUG BINDING, NUCLEUS, DNA
Code Class Resolution Description 4nyg nuc 3.05 3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY- ETHYL)-4-METHYL-THIAZOL-3-IUM C12 H17 N4 O S 1+ CRYSTAL STRUCTURE OF THE E. COLI THIM RIBOSWITCH IN COMPLEX THIAMINE THIM TPP RIBOSWITCH RNA FRAGMENT-BASED DRUG DISCOVERY, RIBOSWITCH, RNA
Code Class Resolution Description 1ag5 nuc NMR 2'-DEOXY-N7-(8,9-DIHYDRO-9-HYDROXY-10-DEHYDROXY- AFLATOXIN)GUANOSINE MONOPHOSPHATE C27 H27 N5 O14 P 1+ THE SOLUTION STRUCTURE OF AN AFLATOXIN B1 EPOXIDE ADDUCT AT THE N7 POSITION OF GUANINE OPPOSITE AN ADENINE IN THE COMPLEMENTARY STRAND OF AN OLIGODEOXYNUCLEOTIDE DUPLEX, NMR, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*GP*GP*AP*TP*CP*AP*GP*AP*TP*GP*G)-3'), DNA (5'-D(*CP*CP*AP*TP*CP*XP*AP*TP*CP*C)-3') DNA AFLATOXIN B1, N7-GUANINE ADDUCT, INTERCALATION, DNA DUPLEX, NMR, DEOXYRIBONUCLEIC ACID 1mk6 nuc NMR 2'-DEOXY-N7-(8,9-DIHYDRO-9-HYDROXY-10-DEHYDROXY- AFLATOXIN)GUANOSINE MONOPHOSPHATE C27 H27 N5 O14 P 1+ SOLUTION STRUCTURE OF THE 8,9-DIHYDRO-8-(N7-GUANYL)-9- HYDROXY-AFLATOXIN B1 ADDUCT MISPAIRED WITH DEOXYADENOSINE 5'-D(*AP*CP*AP*TP*CP*(X)P*AP*TP*CP*T)-3', 5'-D(*AP*GP*AP*TP*AP*GP*AP*TP*GP*T)-3' DNA AFLATOXIN B1- GUANINE ADDUCT OPPOSITE AN ADENINE, MIMICKING GA TRANSITION, DNA 1mkl nuc NMR 2'-DEOXY-N7-(8,9-DIHYDRO-9-HYDROXY-10-DEHYDROXY- AFLATOXIN)GUANOSINE MONOPHOSPHATE C27 H27 N5 O14 P 1+ NMR REFINED STRUCTURE OF THE 8,9-DIHYDRO-8-(N7-GUANYL)-9- HYDROXY-AFLATOXIN B1 ADDUCT IN A 5'-CPAFBG-3' SEQUENCE 5'-D(*AP*CP*AP*TP*CP*(X)P*AP*TP*CP*T)-3', 5'-D(*AP*GP*AP*TP*CP*GP*AP*TP*GP*T)-3' DNA STRUCTURE OF THE 8,9-DIHYDRO-8-(N7-GUANYL)-9-HYDROXY- AFLATOXIN B1 ADDUCT IN A 5'-CPAFBG-3' SEQUENCE CONTEXT, DNA
Code Class Resolution Description 2hou nuc NMR [(2R,3S,5S)-2,3,5-TRIHYDROXYTETRAHYDROFURAN-2- YL]METHYL DIHYDROGEN PHOSPHATE C5 H11 O8 P STRUCTURE ENSEMBLES OF DUPLEX DNA CONTAINING A 4'-OXIDIZED ABASIC SITE. 5'-D(*CP*CP*CP*GP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(X4A)P*AP*CP*CP*GP*GP*G)- 3' DNA ABASIC SITE, DNA LESION, BER, BLEOMYCIN 2hpx nuc NMR [(2R,3S,5S)-2,3,5-TRIHYDROXYTETRAHYDROFURAN-2- YL]METHYL DIHYDROGEN PHOSPHATE C5 H11 O8 P 13MER DUPLEX DNA CONTAINING A 4'-OXIDIZED ABASIC SITE, AVERAGED STRUCTURE 5'-D(*CP*CP*CP*GP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3', 5'-D(*CP*CP*AP*AP*AP*GP*(X4A)P*AP*CP*CP*GP*GP*G)- 3' DNA ABASIC SITE, DNA DAMAGE, BLEOMYCIN, NMR, MOLECULAR DYNAMICS
Code Class Resolution Description 2h9s nuc 1.75 9-(2,3-DIDEOXY-6-O-PHOSPHONO-BETA-D-ERYTHRO- HEXOPYRANOSYL)-9H-PURIN-6-AMINE 4(C11 H16 N5 O6 P) CRYSTAL STRUCTURE OF HOMO-DNA AND NATURE'S CHOICE OF PENTOSE OVER HEXOSE IN THE GENETIC SYSTEM 5'-D(*(XCT)P*(XGU)P*(XAD)P*(XAD)P*(XTH)P*(XTH) P*(XCT)P*(XGU))-3' DNA HOMO-DNA, HOMO-DNA CRYSTAL STRUCTURE, 2',3'-DI-DEOXY-BETA- D-GLUCOPYRANOSE, HEXOSE NUCLEIC ACID, GLUCOPYRANOSYL NUCLEIC ACID, DIDEOXYGLUCOPYRANOSE OCTAMER
Code Class Resolution Description 2icz nuc NMR 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-3H-IMIDAZO[4,5-G]QUINAZOLIN-8-AMINE 2(C14 H16 N5 O6 P) NMR STRUCTURES OF THE EXPANDED DNA 10BP XTGXTAXCXGCXAXGT:XACTXGCGXTAXCA 5'-D(*(XTY)P*GP*(XTY)P*AP*(XCS)P*(XGA)P*CP*(XAE) P*(XGA)P*T)-3', 5'-D(*(XAE)P*CP*TP*(XGA)P*CP*GP*(XTY)P*AP*(XCS) P*A)-3' DNA EXPANDED DNA, XDNA
Code Class Resolution Description 2h0n nuc 1.53 [(1S,4R,6R)-6-HYDROXY-4-(ADENIN-9-YL)CYCLOHEX-2-EN-1- YL]METHYL DIHYDROGEN PHOSPHATE 4(C12 H16 N5 O5 P) STRUCTURE OF THE FULLY MODIFIED LEFT-HANDED CYCLOHEXENE NUCLEIC ACID SEQUENCE GTGTACAC 5'-(*(XGL)P*(XTL)P*(XGL)P*(XTL)P*(XAL)P*(XCL) P*(XAL)P*(XCL)-PHOSPHATE)-3' DNA CYCLOHEXENE NUCLEIC ACID, DNA ANALOGUE, LEFT-HANDED, DOUBLE HELIX
Code Class Resolution Description 3gao nuc 1.90 XANTHINE C5 H4 N4 O2 CRYSTAL STRUCTURE OF THE GUANINE RIBOSWITCH BOUND TO XANTHINE. GUANINE RIBOSWITCH RNA RIBOSWITCH, GUANINE, XANTHINE, MRNA, RNA_LIGAND COMPLEX, THREE-WAY JUNCTION
Code Class Resolution Description 2p8d nuc 1.90 [(1R,4S,6S)-4-(6-AMINO-9H-PURIN-9-YL)-6- HYDROXYCYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H16 N5 O5 P) THE STRUCTURE OF THE DICKERSON SEQUENCE WITH AN INCORPORATED CENA RESIDUE 5'-D(*DCP*DGP*DCP*DGP*DAP*(XAR) P*DTP*DTP*DCP*DGP*DCP*DG)-3' DNA CENA, SUGAR MODIFICATION, DNA 3knc nuc 2.50 [(1R,4S,6S)-4-(6-AMINO-9H-PURIN-9-YL)-6- HYDROXYCYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE C12 H16 N5 O5 P CRYSTAL STRUCTURE OF THE CENA-RNA HYBRID OCTAMER CE(GCGTAGCG :R(CGCUACGC) 5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3', 5'-D(*(XGR)P*(XCR)P*(XGR)P*(XTR)P*(XAR)P*(XGR)P*( P*(XGR)P*(XGR))-3' RNA/CYCLOHEXENE-RNA HYBRID CYCLOHEXENE, SUGAR MODIFICATION, RNA, RNA-CYCLOHEXENE-RNA HY COMPLEX
Code Class Resolution Description 2h0n nuc 1.53 [(1S,4R,6R)-6-HYDROXY-4-(CYTOSIN-9-YL)CYCLOHEX-2-EN-1- YL]METHYL DIHYDROGEN PHOSPHATE 4(C11 H16 N3 O6 P) STRUCTURE OF THE FULLY MODIFIED LEFT-HANDED CYCLOHEXENE NUCLEIC ACID SEQUENCE GTGTACAC 5'-(*(XGL)P*(XTL)P*(XGL)P*(XTL)P*(XAL)P*(XCL) P*(XAL)P*(XCL)-PHOSPHATE)-3' DNA CYCLOHEXENE NUCLEIC ACID, DNA ANALOGUE, LEFT-HANDED, DOUBLE HELIX
Code Class Resolution Description 3knc nuc 2.50 [(1R,4S,6S)-4-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)-6- HYDROXYCYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C11 H16 N3 O6 P) CRYSTAL STRUCTURE OF THE CENA-RNA HYBRID OCTAMER CE(GCGTAGCG :R(CGCUACGC) 5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3', 5'-D(*(XGR)P*(XCR)P*(XGR)P*(XTR)P*(XAR)P*(XGR)P*( P*(XGR)P*(XGR))-3' RNA/CYCLOHEXENE-RNA HYBRID CYCLOHEXENE, SUGAR MODIFICATION, RNA, RNA-CYCLOHEXENE-RNA HY COMPLEX
Code Class Resolution Description 2icz nuc NMR (1R)-1-(4-AMINO-6-METHYL-2-OXO-1,2-DIHYDROQUINAZOLIN- 8-YL)-1,4-ANHYDRO-2-DEOXY-5-O-PHOSPHONO-D-ERYTHRO- PENTITOL 2(C14 H18 N3 O7 P) NMR STRUCTURES OF THE EXPANDED DNA 10BP XTGXTAXCXGCXAXGT:XACTXGCGXTAXCA 5'-D(*(XTY)P*GP*(XTY)P*AP*(XCS)P*(XGA)P*CP*(XAE) P*(XGA)P*T)-3', 5'-D(*(XAE)P*CP*TP*(XGA)P*CP*GP*(XTY)P*AP*(XCS) P*A)-3' DNA EXPANDED DNA, XDNA
Code Class Resolution Description 2h9s nuc 1.75 4-AMINO-1-(2,3-DIDEOXY-6-O-PHOSPHONO-BETA-D-ERYTHRO- HEXOPYRANOSYL)PYRIMIDIN-2(1H)-ONE 4(C10 H16 N3 O7 P) CRYSTAL STRUCTURE OF HOMO-DNA AND NATURE'S CHOICE OF PENTOSE OVER HEXOSE IN THE GENETIC SYSTEM 5'-D(*(XCT)P*(XGU)P*(XAD)P*(XAD)P*(XTH)P*(XTH) P*(XCT)P*(XGU))-3' DNA HOMO-DNA, HOMO-DNA CRYSTAL STRUCTURE, 2',3'-DI-DEOXY-BETA- D-GLUCOPYRANOSE, HEXOSE NUCLEIC ACID, GLUCOPYRANOSYL NUCLEIC ACID, DIDEOXYGLUCOPYRANOSE OCTAMER
Code Class Resolution Description 2icz nuc NMR 6-AMINO-3-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO- PENTOFURANOSYL)-3,7-DIHYDRO-8H-IMIDAZO[4,5- G]QUINAZOLIN-8-ONE 3(C14 H16 N5 O7 P) NMR STRUCTURES OF THE EXPANDED DNA 10BP XTGXTAXCXGCXAXGT:XACTXGCGXTAXCA 5'-D(*(XTY)P*GP*(XTY)P*AP*(XCS)P*(XGA)P*CP*(XAE) P*(XGA)P*T)-3', 5'-D(*(XAE)P*CP*TP*(XGA)P*CP*GP*(XTY)P*AP*(XCS) P*A)-3' DNA EXPANDED DNA, XDNA
Code Class Resolution Description 2h0n nuc 1.53 [(1S,4R,6R)-6-HYDROXY-4-(GUANIN-9-YL)CYCLOHEX-2-EN-1- YL]METHYL DIHYDROGEN PHOSPHATE 4(C12 H16 N5 O6 P) STRUCTURE OF THE FULLY MODIFIED LEFT-HANDED CYCLOHEXENE NUCLEIC ACID SEQUENCE GTGTACAC 5'-(*(XGL)P*(XTL)P*(XGL)P*(XTL)P*(XAL)P*(XCL) P*(XAL)P*(XCL)-PHOSPHATE)-3' DNA CYCLOHEXENE NUCLEIC ACID, DNA ANALOGUE, LEFT-HANDED, DOUBLE HELIX
Code Class Resolution Description 3knc nuc 2.50 [(1R,4S,6S)-4-(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9- YL)-6-HYDROXYCYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE 5(C12 H16 N5 O6 P) CRYSTAL STRUCTURE OF THE CENA-RNA HYBRID OCTAMER CE(GCGTAGCG :R(CGCUACGC) 5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3', 5'-D(*(XGR)P*(XCR)P*(XGR)P*(XTR)P*(XAR)P*(XGR)P*( P*(XGR)P*(XGR))-3' RNA/CYCLOHEXENE-RNA HYBRID CYCLOHEXENE, SUGAR MODIFICATION, RNA, RNA-CYCLOHEXENE-RNA HY COMPLEX
Code Class Resolution Description 2h9s nuc 1.75 2-AMINO-9-(2,3-DIDEOXY-6-O-PHOSPHONO-BETA-D-ERYTHRO- HEXOPYRANOSYL)-1,9-DIHYDRO-6H-PURIN-6-ONE 4(C11 H16 N5 O7 P) CRYSTAL STRUCTURE OF HOMO-DNA AND NATURE'S CHOICE OF PENTOSE OVER HEXOSE IN THE GENETIC SYSTEM 5'-D(*(XCT)P*(XGU)P*(XAD)P*(XAD)P*(XTH)P*(XTH) P*(XCT)P*(XGU))-3' DNA HOMO-DNA, HOMO-DNA CRYSTAL STRUCTURE, 2',3'-DI-DEOXY-BETA- D-GLUCOPYRANOSE, HEXOSE NUCLEIC ACID, GLUCOPYRANOSYL NUCLEIC ACID, DIDEOXYGLUCOPYRANOSE OCTAMER
Code Class Resolution Description 1pyj nuc NMR O6-[4-OXO-4-(3-PYRIDYL)BUTYL]-2'-DEOXYGUANOSINE-5'- MONOPHOSPHATE C19 H23 N6 O8 P SOLUTION STRUCTURE OF AN O6-[4-OXO-4-(3-PYRIDYL)BUTYL]GUANIN IN AN 11MER DNA DUPLEX 5'-D*GP*GP*GP*CP*CP*AP*TP*AP*TP*GP*G)-3', 5'-D(*CP*CP*AP*TP*AP*TP*GP*GP*CP*CP*C)-3' DNA DNA ADDUCT, DNA
Code Class Resolution Description 1x95 nuc NMR 1-METHYL-9-[12-(9-METHYLPHENAZIN-10-IUM-1-YL)-12-OXO-2, 11-DIAZA-5,8-DIAZONIADODEC-1-ANOYL]PHENAZIN-10-IUM C34 H38 N8 O2 4+ SOLUTION STRUCTURE OF THE DNA-HEXAMER ATGCAT COMPLEXED WITH INTERCALATING ANTICANCER DRUG XR5944 (MLN944) 5'-D(*AP*TP*GP*CP*AP*T)-3' DNA ANTICANCER DRUG, TRANSCRIPTION INHIBITION, NOVEL DNA BINDING MLN944, DNA 2mg8 nuc NMR 1-METHYL-9-[12-(9-METHYLPHENAZIN-10-IUM-1-YL)-12-OXO-2, 11-DIAZA-5,8-DIAZONIADODEC-1-ANOYL]PHENAZIN-10-IUM 2(C34 H38 N8 O2 4+) SOLUTION STRUCTURE OF TFF1 ESTROGEN RESPONSE ELEMENT COMPLEX DNA BIS-INTERCALATING ANTICANCER DRUG XR5944 (MLN944) 5'-D(*AP*GP*GP*TP*CP*AP*CP*GP*GP*TP*GP*GP*CP*CP*A CHAIN: A, 5'-D(*TP*GP*GP*CP*CP*AP*CP*CP*GP*TP*GP*AP*CP*CP*T CHAIN: B DNA BREAST CANCER DRUG, DNA BIS-INTERCALATION, ERE-TARGETING SMA MOLECULE ANTICANCER DRUG, DNA 4bzt nuc NMR 1-METHYL-9-[12-(9-METHYLPHENAZIN-10-IUM-1-YL) -12-OXO-2,11-DIAZA-5,8-DIAZONIADODEC-1-ANOYL] PHENAZIN-10-IUM C34 H38 N8 O2 4+ THE SOLUTION STRUCTURE OF THE MLN 944-D(ATGCAT)2 COMPLEX DNA DNA BIS(PHENAZINE-1-CARBOXAMIDES), DNA, INTERCALATION, DRUG DESI ANTICANCER DRUG. 4bzu nuc NMR 1-METHYL-9-[12-(9-METHYLPHENAZIN-10-IUM-1-YL) -12-OXO-2,11-DIAZA-5,8-DIAZONIADODEC-1-ANOYL] PHENAZIN-10-IUM C34 H38 N8 O2 4+ THE SOLUTION STRUCTURE OF THE MLN 944-D(TATGCATA)2 COMPLEX DNA DNA BIS(PHENAZINE-1-CARBOXAMIDES), MLN 944, DNA, INTERCALATION, DESIGN, ANTICANCER DRUG. 4bzv nuc NMR 1-METHYL-9-[12-(9-METHYLPHENAZIN-10-IUM-1-YL) -12-OXO-2,11-DIAZA-5,8-DIAZONIADODEC-1-ANOYL] PHENAZIN-10-IUM C34 H38 N8 O2 4+ THE SOLUTION STRUCTURE OF THE MLN 944-D(TACGCGTA)2 COMPLEX DNA DNA DNA, BIS(PHENAZINE-1-CARBOXAMIDES), MLN 944, INTERCALATION, DESIGN, ANTICANCER DRUG.
Code Class Resolution Description 2gy4 nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 1,4-BIS[5-(5-(2-IMIDAZOLINYL)-2 BENZIMIDAZOLYL)-2- BENZIMIDAZOLYL]BUTANE DNA 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 4f2x nuc 1.57 [(1R,4R,5S,6R)-5-FLUORO-6-HYDROXY-4-(5-METHYL-2,4- DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)CYCLOHEX-2-EN-1- YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H16 F N2 O7 P) STRUCTURE OF 3'-FLUORO CYCLOHEXENYL NUCLEIC ACID HEPTAMER 5'-D(*CP*GP*CP*AP*CP*GP*C)-3', 5'-D(*GP*CP*GP*(XTF)P*GP*CP*G)-3' DNA FLUORO CYCLOHEXENYL NUCLEIC ACID, F-CENA, MODIFIED DNA, B-FO DNA 4f2y nuc 1.59 [(1R,4R,5S,6R)-5-FLUORO-6-HYDROXY-4-(5-METHYL-2,4- DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)CYCLOHEX-2-EN-1- YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H16 F N2 O7 P) STRUCTURE OF 3'-FLUORO CYCLOHEXENYL NUCLEIC ACID DECAMER 5'-D(*GP*CP*GP*TP*AP*(XTF)P*AP*CP*GP*C)-3' DNA FLUORO CYCLOHEXENYL NUCLEIC ACID, F-CENA, MODIFIED DNA, A-FO DNA
Code Class Resolution Description 2h9s nuc 1.75 1-(2,3-DIDEOXY-6-O-PHOSPHONO-BETA-D-ERYTHRO- HEXOPYRANOSYL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE 4(C11 H17 N2 O8 P) CRYSTAL STRUCTURE OF HOMO-DNA AND NATURE'S CHOICE OF PENTOSE OVER HEXOSE IN THE GENETIC SYSTEM 5'-D(*(XCT)P*(XGU)P*(XAD)P*(XAD)P*(XTH)P*(XTH) P*(XCT)P*(XGU))-3' DNA HOMO-DNA, HOMO-DNA CRYSTAL STRUCTURE, 2',3'-DI-DEOXY-BETA- D-GLUCOPYRANOSE, HEXOSE NUCLEIC ACID, GLUCOPYRANOSYL NUCLEIC ACID, DIDEOXYGLUCOPYRANOSE OCTAMER
Code Class Resolution Description 2h0n nuc 1.53 [(1S,4R,6R)-6-HYDROXY-4-(THYMIN-9-YL)CYCLOHEX-2-EN-1- YL]METHYL DIHYDROGEN PHOSPHATE 4(C12 H17 N2 O7 P) STRUCTURE OF THE FULLY MODIFIED LEFT-HANDED CYCLOHEXENE NUCLEIC ACID SEQUENCE GTGTACAC 5'-(*(XGL)P*(XTL)P*(XGL)P*(XTL)P*(XAL)P*(XCL) P*(XAL)P*(XCL)-PHOSPHATE)-3' DNA CYCLOHEXENE NUCLEIC ACID, DNA ANALOGUE, LEFT-HANDED, DOUBLE HELIX
Code Class Resolution Description 1u01 nuc NMR [(1R,4S,6S)-6-HYDROXY-4-(5-METHYL-2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)CYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE C12 H17 N2 O7 P HIGH RESOLUTION NMR STRUCTURE OF 5-D(GCGT*GCG)-3/5- D(CGCACGC)-3 (T*REPRESENTS A CYCLOHEXENYL NUCLEOTIDE) 5'-D(*GP*CP*GP*(XTR)P*GP*CP*G)-3', 5'-D(*CP*GP*CP*AP*CP*GP*C)-3' DNA NUCLEIC ACID, RNA MIMIC, DNA 3fl6 nuc 1.17 [(1R,4S,6S)-6-HYDROXY-4-(5-METHYL-2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)CYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE 2(C12 H17 N2 O7 P) INFLUENCE OF THE INCORPORATION OF A CYCLOHEXENYL NUCLEIC ACI RESIDUE ONTO THE SEQUENCE D(GCGTGCG)/D(CGCACGC) 5'-D(*CP*GP*CP*AP*CP*GP*C)-3', 5'-D(*GP*CP*GP*(XTR)P*GP*CP*G)-3' DNA DOUBLE HELIX, CENA, SUGAR MODIFICATION, RIGHT-HANDED, DNA 3knc nuc 2.50 [(1R,4S,6S)-6-HYDROXY-4-(5-METHYL-2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)CYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE C12 H17 N2 O7 P CRYSTAL STRUCTURE OF THE CENA-RNA HYBRID OCTAMER CE(GCGTAGCG :R(CGCUACGC) 5'-R(*CP*GP*CP*UP*AP*CP*GP*C)-3', 5'-D(*(XGR)P*(XCR)P*(XGR)P*(XTR)P*(XAR)P*(XGR)P*( P*(XGR)P*(XGR))-3' RNA/CYCLOHEXENE-RNA HYBRID CYCLOHEXENE, SUGAR MODIFICATION, RNA, RNA-CYCLOHEXENE-RNA HY COMPLEX 3lln nuc 3.00 [(1R,4S,6S)-6-HYDROXY-4-(5-METHYL-2,4-DIOXO-3,4- DIHYDROPYRIMIDIN-1(2H)-YL)CYCLOHEX-2-EN-1-YL]METHYL DIHYDROGEN PHOSPHATE C12 H17 N2 O7 P COMPARISON BETWEEN THE ORTHORHOMBIC AN TETRAGONAL FORM OF TH SEQUENCE D(GCG(XT)GCG)/D(CGCACGC). DNA (5'-D(*GP*CP*GP*(XTR)P*GP*CP*G)-3'), DNA (5'-D(*CP*GP*CP*AP*CP*GP*C)-3') DNA DOUBLE HELIX, CENA, SUGAR MODIFICATION, RIGHT-HANDED, DNA
Code Class Resolution Description 2icz nuc NMR (1R)-1,4-ANHYDRO-2-DEOXY-1-(6-METHYL-2,4-DIOXO-1,2,3, 4-TETRAHYDROQUINAZOLIN-8-YL)-5-O-PHOSPHONO-D-ERYTHRO- PENTITOL 3(C14 H17 N2 O8 P) NMR STRUCTURES OF THE EXPANDED DNA 10BP XTGXTAXCXGCXAXGT:XACTXGCGXTAXCA 5'-D(*(XTY)P*GP*(XTY)P*AP*(XCS)P*(XGA)P*CP*(XAE) P*(XGA)P*T)-3', 5'-D(*(XAE)P*CP*TP*(XGA)P*CP*GP*(XTY)P*AP*(XCS) P*A)-3' DNA EXPANDED DNA, XDNA
Code Class Resolution Description 3iff nuc 1.75 2'-SE-METHYL-2'-SELENOADENOSINE 5'-(DIHYDROGEN PHOSPHATE) 2(C11 H16 N5 O6 P SE) 2'-SEME-A MODIFIED DNA DECAMER DNA (5'-D(*GP*TP*AP*CP*GP*CP*GP*TP*(XUA)P*C)-3') DNA SELENIUM, NUCLEIC ACID, ADENOSINE, DNA
Code Class Resolution Description 2h1m nuc 2.90 2'-SE-METHYL-2'-SELENOGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) 2(C11 H16 N5 O7 P SE) SYNTHESIS, OXIDATION BEHAVIOR, CRYSTALLIZATION AND STRUCTURE METHYLSELENO GUANOSINE CONTAINING RNAS 5'-R(*GP*CP*AP*(XUG)P*AP*GP*UP*UP*AP*AP*AP*UP*CP* 3' RNA A-RNA STRUCTURE, MISMATCH A RNA, RIBONUCLEIC ACID, SE 2'-MET RNA 3ifi nuc 1.20 2'-SE-METHYL-2'-SELENOGUANOSINE 5'-(DIHYDROGEN PHOSPHATE) C11 H16 N5 O7 P SE 2'-SEME-DG MODIFIED OCTAMER DNA DNA (5'-D(*GP*TP*(XUG)P*TP*AP*CP*AP*C)-3') DNA SELENIUM, NUCLEIC ACID, GUANOSINE, DNA
Code Class Resolution Description 2et8 nuc 2.50 (2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3- DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)- TETRAHYDRO-2H-PYRAN-3,4-DIOL C12 H26 N4 O6 COMPLEX BETWEEN NEAMINE AND THE 16S-RRNA A-SITE 5'- R(*CP*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP *CP*GP*C)-3' RNA RNA-AMINOGLYCOSIDE INTERACTIONS, A SITE, UOU PAIRS, AA BULGES 2f4s nuc 2.80 (2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3- DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)- TETRAHYDRO-2H-PYRAN-3,4-DIOL C12 H26 N4 O6 A-SITE RNA IN COMPLEX WITH NEAMINE 5'- R(P*GP*CP*GP*UP*CP*AP*CP*AP*CP*CP*GP*GP*UP*GP*AP*AP*GP*UP*C P*GP*C)-3' RNA A-SITE RNA, NEAMINE 2fcx nuc 2.00 (2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3- DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)- TETRAHYDRO-2H-PYRAN-3,4-DIOL 2(C12 H26 N4 O6) HIV-1 DIS KISSING-LOOP IN COMPLEX WITH NEAMINE HIV-1 DIS RNA RNA HIV-1, RNA, AMINOGLYCOSIDE, ANTIBIOTICS
Code Class Resolution Description 1ago nuc NMR 2'-DEOXY-N6-(S)STYRENE OXIDE ADENOSINE MONOPHOSPHATE C18 H22 N5 O7 P THE SOLUTION NMR STRUCTURE OF AN (S)-A-(N6-ADENYL)-STYRENE OXIDE-RAS61 OLIGODEOXYNUCLEOTIDE MODIFIED AT THE THIRD POSITION OF THE CODON 61 REGION, MINIMIZED AVERAGE STRUCTURE DNA (5'-D(*CP*TP*TP*CP*TP*TP*GP*TP*CP*CP*G)-3'), DNA (5'-D(*CP*GP*GP*AP*CP*AP*YP*GP*AP*AP*G)-3') DNA DNA DUPLEX, B-DNA, NMR, HUMAN N-RAS GENE, CODON 61 SEQUENCE, S-STYRENE OXIDE ADDUCT, N6-ADENINE ADDUCT, MAJOR GROOVE ADDUCT, DEOXYRIBONUCLEIC ACID
Code Class Resolution Description 1evv nuc 2.00 WYBUTOSINE C21 H29 N6 O12 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRANSFER RNA AT 2.0 RESOLUTION PHENYLALANINE TRANSFER RNA RNA TRANSFER RNA, PHENYLALANINE, PHE-TRNA, YEAST, AMINO-ACID TRA RNA 1fcw nuc 17.00 WYBUTOSINE 5(C21 H29 N6 O12 P) TRNA POSITIONS DURING THE ELONGATION CYCLE TRNAPHE RIBOSOME RIBOSOME, TRNA BINDING SITES, PROTEIN SYNTHESIS, ELONGATION 1i9v nuc 2.60 WYBUTOSINE C21 H29 N6 O12 P CRYSTAL STRUCTURE ANALYSIS OF A TRNA-NEOMYCIN COMPLEX PHENYLALANINE TRANSFER RNA RNA AMINO-ACID TRANSPORT, YEAST, PHE-TRNA,PHENYLALANINE, TRANSFER RNA, AMINOGLYCOSIDE, NEOMYCIN B 1ipl nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 16S RIBOSOMAL RNA, 23S RIBOSOMAL RNA, TRNAS BOUND TO A AND P SITES, 5'- R(P*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*UP*U P*UP*UP*UP*U)-3' RIBONUCLEIC ACID TRANSLOCATION, LARGE RIBOSOMAL RNA, SMALL RIBOSOMAL RNA, TRNA, MRNA 1ipv nuc model WYBUTOSINE C21 H29 N6 O12 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS TRANSFER RNA BOUND TO R SITE, 5'-R(P*UP*UP*UP*UP*UP*UP*UP*UP*U)-3' RIBONUCLEIC ACID COGNATE CODON-ANTICODON INTERACTION, MRNA, TRNA 1ipy nuc model WYBUTOSINE C21 H29 N6 O12 P RIBOSOMAL RNAS AND PROTEINS AS WELL AS FACTORS 5'-R(P*UP*UP*UP*UP*AP*UP*UP*UP*U)-3', TRANSFER RNA BOUND TO R SITE RIBONUCLEIC ACID NONCOGNATE CODON-ANTICODON INTERACTION 1k7n nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 2) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7o nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 3) P-SITE TRNA, A-SITE TRNA, MRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7p nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 4) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1k7r nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL 1) MRNA, P-SITE TRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1ks1 nuc model WYBUTOSINE C21 H29 N6 O12 P A MODEL FOR A FIVE-PRIME STACKED TRNA PHENYLALANINE TRANSFER RNA RIBONUCLEIC ACID FIVE-PRIME STACK, TRNA 1nrt nuc model WYBUTOSINE 3(C21 H29 N6 O12 P) APE-SITE TRNA, THEORETICAL MODEL TRANSFER RIBONUCLEIC ACID AMINO-ACID TRANSPORT AMINO-ACID TRANSPORT, TRNA, MODEL 1q49 nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1q5s nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxu nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1qxv nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rcz nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL A2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd0 nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL B2) A-SITE TRNA, SINGLE-STRANDED MRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd1 nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL C2) P-SITE TRNA, SINGLE-STRANDED MRNA, A-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1rd2 nuc model WYBUTOSINE 2(C21 H29 N6 O12 P) THE INTERACTION BETWEEN MRNA AND TRNA (MODEL D2) SINGLE-STRANDED MRNA, A-SITE TRNA, P-SITE TRNA RIBONUCLEIC ACID INTERACTION, MRNA, TRNA 1tn1 nuc 3.00 WYBUTOSINE C21 H29 N6 O12 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE TRNA TRNAPHE RNA TRANSLATION, RNA 1tn2 nuc 3.00 WYBUTOSINE C21 H29 N6 O12 P CRYSTALLOGRAPHIC AND BIOCHEMICAL INVESTIGATION OF THE LEAD(I CATALYZED HYDROLYSIS OF YEAST PHENYLALANINE T-RNA TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 1tra nuc 3.00 WYBUTOSINE C21 H29 N6 O12 P RESTRAINED REFINEMENT OF THE MONOCLINIC FORM OF YEAST PHENYL TRANSFER RNA. TEMPERATURE FACTORS AND DYNAMICS, COORDINATED AND BASE-PAIR PROPELLER TWIST ANGLES TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tna nuc 2.50 WYBUTOSINE C21 H29 N6 O12 P FURTHER REFINEMENT OF THE STRUCTURE OF YEAST T-RNA-PHE TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 4tra nuc 3.00 WYBUTOSINE C21 H29 N6 O12 P RESTRAINED REFINEMENT OF TWO CRYSTALLINE FORMS OF YEAST ASPA AND PHENYLALANINE TRANSFER RNA CRYSTALS TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS 6tna nuc 2.70 WYBUTOSINE C21 H29 N6 O12 P CRYSTAL STRUCTURE OF YEAST PHENYLALANINE T-RNA. I.CRYSTALLOG REFINEMENT TRNAPHE T-RNA T-RNA, SINGLE STRAND, LOOPS
Code Class Resolution Description 1ehz nuc 1.93 4-(3-[5-O-PHOSPHONORIBOFURANOSYL]-4,6-DIMETHYL-8-OXO-4, 8-DIHYDRO-3H-1,3,4,5,7A-PENTAAZA-S-INDACEN-YLAMINO- BUTYRIC ACID METHYL ESTER C21 H29 N6 O12 P THE CRYSTAL STRUCTURE OF YEAST PHENYLALANINE TRNA AT 1.93 A TRANSFER RNA (PHE) RNA TRNA, YEAST, PHENYLALANINE, RNA 2z9q nuc 11.70 4-(3-[5-O-PHOSPHONORIBOFURANOSYL]-4,6-DIMETHYL-8-OXO-4, 8-DIHYDRO-3H-1,3,4,5,7A-PENTAAZA-S-INDACEN-YLAMINO- BUTYRIC ACID METHYL ESTER C21 H29 N6 O12 P TRANSFER RNA IN THE HYBRID P/E STATE TRNA RNA DISTORTED ANTICODON-STEM-LOOP, TWISTED CCA ARM, RNA 486d nuc 7.50 4-(3-[5-O-PHOSPHONORIBOFURANOSYL]-4,6-DIMETHYL-8-OXO-4, 8-DIHYDRO-3H-1,3,4,5,7A-PENTAAZA-S-INDACEN-YLAMINO- BUTYRIC ACID METHYL ESTER C21 H29 N6 O12 P X-RAY CRYSTAL STRUCTURES OF 70S RIBOSOME FUNCTIONAL COMPLEXE E-SITE TRNA OF 70S RIBOSOME, A-SITE TRNA OF 70S RIBOSOME, P-SITE CODON OF 70S RIBOSOME, P-SITE TRNA OF 70S RIBOSOME, A-SITE CODON OF 70S RIBOSOME, 900 STEM-LOOP OF 16S RRNA IN THE 70S RIBOSOME, PENULTIMATE STEM OF 16S RRNA IN THE 70S RIBOSOME RIBOSOME FUNCTIONAL MODELS OF 70S RIBOSOME, TRNA, RIBOSOME
Code Class Resolution Description 2jja nuc 1.30 (S)-1'-(2',3'-DIHYDROXYPROPYL)-ADENINE C8 H12 N5 O5 P1 CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA 2xc6 nuc 1.83 (S)-1'-(2',3'-DIHYDROXYPROPYL)-ADENINE 2(C8 H12 N5 O5 P) CRYSTAL STRUCTURE OF THE GNA 3'-CTC(BR)UAGAG-2' GNA RNA RNA, WATSON-CRICK BASE PAIR, GLYCOL NUCLEIC ACID
Code Class Resolution Description 2wna nuc 0.97 (2S)-3-(4-AMINO-5-BROMO-2-OXOPYRIMIDIN-1(2H)- YL)-2-HYDROXYPROPYL DIHYDROGEN PHOSPHATE C7 H11 BR N3 O6 P CRYSTAL STRUCTURE OF THE GNA 3'-G(BR)CGCGC-2' GNA RNA RNA, GNA, NUCLEIC ACID, GLYCOL NUCLEIC ACID, WATSON-CRICK BASE PAIR
Code Class Resolution Description 2xc6 nuc 1.83 (S)-1'-(2',3'-DIHYDROXYPROPYL)-5-BROMO-URACIL C7 H10 BR N2 O7 P CRYSTAL STRUCTURE OF THE GNA 3'-CTC(BR)UAGAG-2' GNA RNA RNA, WATSON-CRICK BASE PAIR, GLYCOL NUCLEIC ACID
Code Class Resolution Description 2jja nuc 1.30 (S)-1'-(2',3'-DIHYDROXYPROPYL)-CYTOSINE 2(C7 H12 N3 O6 P1) CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA 2wna nuc 0.97 (S)-1'-(2',3'-DIHYDROXYPROPYL)-CYTOSINE 2(C7 H12 N3 O6 P) CRYSTAL STRUCTURE OF THE GNA 3'-G(BR)CGCGC-2' GNA RNA RNA, GNA, NUCLEIC ACID, GLYCOL NUCLEIC ACID, WATSON-CRICK BASE PAIR 2xc6 nuc 1.83 (S)-1'-(2',3'-DIHYDROXYPROPYL)-CYTOSINE 2(C7 H12 N3 O6 P) CRYSTAL STRUCTURE OF THE GNA 3'-CTC(BR)UAGAG-2' GNA RNA RNA, WATSON-CRICK BASE PAIR, GLYCOL NUCLEIC ACID
Code Class Resolution Description 1z5t nuc 1.60 5-(3-AMINOPROPYL)-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 4(C12 H20 N3 O8 P) CRYSTAL STRUCTURE OF [D(CGCGAA(Z3DU)(Z3DU)CGCG)]2, Z3DU:5- (3-AMINOPROPYL)-2'-DEOXYURIDINE, IN PRESENCE OF THALLIUM I. 5'-D(*CP*GP*CP*GP*AP*AP*(ZDU)P*(ZDU) P*CP*GP*CP*G)-3' DNA B-DNA, TL+, THALLIUM, MODIFIED DNA, CATIONS, MODIFIED THYMINE 2qef nuc 1.60 5-(3-AMINOPROPYL)-2'-DEOXYURIDINE-5'-MONOPHOSPHATE 2(C12 H20 N3 O8 P) X-RAY STRUCTURE OF 7-DEAZA-DG AND Z3DU MODIFIED DUPLEX CGCGAATXCZCG DNA (5'-D(*DCP*DGP*DCP*DGP*DAP*DAP*DTP*(ZDU) P*DCP*(7GU)P*DCP*DG)-3') DNA B-DNA, Z3DU, 7-DEAZA-DG
Code Class Resolution Description 2jja nuc 1.30 (S)-1'-(2',3'-DIHYDROXYPROPYL)-GUANINE 2(C8 H12 N5 O6 P1) CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA 2wna nuc 0.97 (S)-1'-(2',3'-DIHYDROXYPROPYL)-GUANINE 3(C8 H12 N5 O6 P) CRYSTAL STRUCTURE OF THE GNA 3'-G(BR)CGCGC-2' GNA RNA RNA, GNA, NUCLEIC ACID, GLYCOL NUCLEIC ACID, WATSON-CRICK BASE PAIR 2xc6 nuc 1.83 (S)-1'-(2',3'-DIHYDROXYPROPYL)-GUANINE 2(C8 H12 N5 O6 P) CRYSTAL STRUCTURE OF THE GNA 3'-CTC(BR)UAGAG-2' GNA RNA RNA, WATSON-CRICK BASE PAIR, GLYCOL NUCLEIC ACID
Code Class Resolution Description 2jja nuc 1.30 (S)-1'-(2',3'-DIHYDROXYPROPYL)- HYDROXYPYRIDONE 2(C9 H14 N1 O7 P1) CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA
Code Class Resolution Description 1g6d nuc 2.90 ZINC ION 3(ZN 2+) STRUCTURE OF PEPTIDYL-D(CGCAATTGCG) IN THE PRESENCE OF ZINC PEPTIDYL-D(CGCAATTGCG) DNA DNA, PEPTIDYL-DNA COMPLEX, ZN IONS 1nlc nuc 1.85 ZINC ION 6(ZN 2+) HIV-1 DIS(MAL) DUPLEX ZN-SOAKED HIV-1 DIS(MAL) GENOMIC RNA RNA HIV-1, RNA, ZINC 1p26 nuc 2.92 ZINC ION 5(ZN 2+) CRYSTAL STRUCTURE OF ZINC(II)-D(GGCGCC)2 5'-D(*GP*GP*CP*GP*CP*C)-3' DNA B-DNA, ZINC BINDING 1yxp nuc 2.40 ZINC ION 2(ZN 2+) HIV-1 DIS RNA SUBTYPE F- ZN SOAKED 5'-R(*CP*UP*(5BU) P*GP*CP*UP*GP*AP*AP*GP*UP*GP*CP*AP*CP*AP*CP*AP*GP*CP*AP*AP* G)-3' RNA HIV-1, RNA, KISSING-LOOP, METAL IONS 2loa nuc NMR ZINC ION ZN 2+ STRUCTURAL BASIS FOR BIFUNCTIONAL ZN(II) MACROCYCLIC COMPLEX RECOGNITION OF THYMINE BULGES IN DNA DNA (5'-D(*GP*CP*CP*GP*CP*AP*GP*TP*GP*C)-3') DNA THYMINE BULGE, BIFUNCTIONAL ZN(II) MACROCYCLIC COMPLEX, DNA, 2rf3 nuc 1.75 ZINC ION ZN 2+ CRYSTAL STRUCTURE OF TRICYCLO-DNA: AN UNUSUAL COMPENSATORY CHANGE OF TWO ADJACENT BACKBONE TORSION ANGLES 5'-D(CGCG(TCY)ATTCGCG)-3' DNA DNA DUPLEX, X-RAY CRYSTAL STRUCTURE, TRICYCLO-DNA, CONFORMATIONALLY CONSTRAINED DNA ANALOG 4hif nuc 0.85 ZINC ION 2(ZN 2+) ULTRAHIGH-RESOLUTION CRYSTAL STRUCTURE OF Z-DNA IN COMPLEX W IONS DNA (5'-D(*CP*GP*CP*GP*CP*G)-3') DNA SELF-COMPLEMENTARY DNA, DNA, Z-DNA 5dh8 nuc 3.30 ZINC ION 13(ZN 2+) TWO DIVALENT METAL IONS AND CONFORMATIONAL CHANGES PLAY ROLE HAMMERHEAD RIBOZYME CLEAVAGE REACTION- G12A MUTANT IN ZN2+ RNA (48-MER), 5'-R(*GP*GP*GP*CP*GP*U)-D(P*C)- R(P*UP*GP*GP*GP*CP*AP*GP*UP*AP*CP*CP*CP*A)-3' RNA RIBOZYME, HAMMERHEAD, RNA 5iye nuc 1.69 ZINC ION 2(ZN 2+) COMPARISON OF X-RAY CRYSTAL STRUCTURES OF A TETRADECAMER SEQ D(CCCGGGTACCCGGG)2 AT 1.7 RESOLUTION DNA (5'-D(*CP*CP*CP*GP*GP*GP*TP*AP*CP*CP*CP*GP*GP CHAIN: A, B DNA A-DNA DUPLEX, TETRAGONAL SPACE GROUP, ZINC INTERACTIONS, DNA 5j0e nuc 2.81 ZINC ION 9(ZN 2+) CRYSTAL STRUCTURES OF PRIBNOW BOX CONSENSUS PROMOTER SEQUENC COMPLEMENTARY SEQUENCE, PRIBNOW BOX CONSENSUS PROMOTER SEQUENCE DNA PRIBNOW BOX, CONSENSUS PROMOTER-SEQUENCE, RACEMIC DNA, DNA CRYSTALLOGRAPHY, DNA 5jvw nuc 2.00 ZINC ION 13(ZN 2+) CRYSTAL STRUCTURE OF MITHRAMYCIN ANALOGUE MTM SA-TRP IN COMP 10-MER DNA AGAGGCCTCT. DNA (5'-D(*AP*GP*AP*GP*GP*CP*CP*TP*CP*T)-3') DNA/ANTIBIOTIC ANTI-CANCER AGENT, EWING SARCOMA, TRANSCRIPTION FACTOR, MINO DNA BINDING, DNA-ANTIBIOTIC COMPLEX 5jw0 nuc 2.40 ZINC ION 6(ZN 2+) CRYSTAL STRUCTURE OF MITHRAMYCIN ANALOGUE MTM SA-PHE IN COMP 10-MER DNA AGGGTACCCT DNA (5'-D(P*AP*GP*GP*GP*TP*AP*CP*CP*CP*T)-3') DNA/ANTIBIOTIC ANTI-CANCER AGENT, DNA BINDING, NATURAL PRODUCT, TRANSCRIPTI FACTOR, EWING SARCOMA, DNA-ANTIBIOTIC COMPLEX 5jw2 nuc 3.10 ZINC ION 5(ZN 2+) CRYSTAL STRUCTURE OF MITHRAMYCIN ANALOGUE MTM SA-PHE IN COMP 10-MER DNA AGGGATCCCT DNA (5'-D(*AP*GP*GP*GP*AP*TP*CP*CP*CP*T)-3') DNA/ANTIBIOTIC ANTI-CANCER AGENT, DNA BINDING, NATURAL PRODUCT, TRANSCRIPTI FACTOR, EWING SARCOMA, DNA-ANTIBIOTIC COMPLEX
Code Class Resolution Description 2irj nuc model MODEL STRUCTURE OF DNA DODECAMER D(CGCGAATTCGCG)2 BOUND TO 5-(2-AMIDINO)-2-(4-ETHOXYPHENYL)BENZIMIDAZOLE DNA: 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)- 3' MODEL BUILT, MINOR GROOVE BINDING, DNA-DRUG, BENZIMIDAZOLE DERIVATIVE
Code Class Resolution Description 2jja nuc 1.30 (S)-1'-(2',3'-DIHYDROXYPROPYL)-THYMINE C8 H13 N2 O7 P1 CRYSTAL STRUCTURE OF GNA WITH SYNTHETIC COPPER BASE PAIR GNA RNA NUCLEIC ACID, SYNTHETIC BASE PAIR, GLYCOL NUCLEIC ACID, GNA, RNA 2xc6 nuc 1.83 (S)-1'-(2',3'-DIHYDROXYPROPYL)-THYMINE C8 H13 N2 O7 P CRYSTAL STRUCTURE OF THE GNA 3'-CTC(BR)UAGAG-2' GNA RNA RNA, WATSON-CRICK BASE PAIR, GLYCOL NUCLEIC ACID
Code Class Resolution Description 2kmj nuc NMR 5-PYRIMIDIN-2-YL-D-NORVALINE 2(C9 H13 N3 O2) HIGH RESOLUTION NMR SOLUTION STRUCTURE OF A COMPLEX OF HIV-2 TAR RNA AND A SYNTHETIC TRIPEPTIDE IN A 1:2 STOICHIOMETRY PYRIMIDINYLPEPTIDE, RNA (28-MER) RNA/PEPTIDE RNA-LIGAND COMPLEX, BINDING STOICHIOMETRY, HIV-2 TAR, RNA/PEPTIDE COMPLEX
Code Class Resolution Description 2xnw nuc 1.50 3,6-DIAMINO-1,5-DIHYDRO[1,2,4]TRIAZOLO[4,3-B] [1,2,4]TRIAZOL-4-IUM C3 H6 N7 1+ XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO A TRIAZOLO-TRIAZOLE-DIAMINE LIGAND IDENTIFIED BY VIRTUAL SCRE GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA
Code Class Resolution Description 2xo0 nuc 1.70 1,3,5-TRIAZINE-2,4-DIAMINE C3 H5 N5 XPT-PBUX C74U RIBOSWITCH FROM B. SUBTILIS BOUND TO 24-DIAMINO-1,3,5-TRIAZINE IDENTIFIED BY VIRTUAL SCREENING GUANINE RIBOSWITCH: APTAMER DOMAIN, RESIDUES 15-81 RNA RNA
 |
Beutenbergstraße 11 D-07745 Jena • Germany |
Phone: +49 3641 65-6000 Fax: +49 3641 65-6351 |
E-mail: info@leibniz-fli.de www.leibniz-fli.de |
Data Privacy Imprint |
 |